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P1
Minimising prescribing errors in the ICU
DJ Melia, S Saha
Queen’s Hospital, Romford, UK
Critical Care 2014, 18(Suppl 1):P1 (doi: 10.1186/cc13191)
Introduction We aimed to audit the prescribing practice on a busy
14-bedd general ICU, and develop standardised practices and tools
to improve safety. Prescribing errors occur as commonly as in 10% of
UK hospital admissions, costing 8.5 extra bed days per admission, and
costing the National Health Service an estimated £1 billion per annum
[1]. The majority of these mistakes are avoidable [2].
Methods We audited the daily infusion charts of all patients in
three separate spot checks, over 1 week. We assessed all aspects of
prescriptions that make them legal and valid, in accordance with
national guidance [3]. New procedures were introduced, which
included a standardised prescription sticker, with common, preprinted, infusion prescriptions on (noradrenaline, propofol, and so
forth), and education on using the new prescription stickers. A month
later the audit process was repeated.
Results We assessed 129 prescriptions in the first round, and 111 after
intervention, demonstrating a 70% improvement in safe prescribing.
Only 24% of prescriptions initially fulfilled best practice criteria,
improving to 94% afterwards. We also reduced the number of infusions
running without prescription, 7 (6%) versus 24 (19%). See Figures 1 and 2.
Conclusion Our audit supports the need for standardised prescribing
practices within critical care, especially when dealing with potentially
harmful vasoactive/sedative drugs. With a small, cost-effective
intervention (£20 for 6,200 stickers), we improved prescribing accuracy,
and thus patient safety in intensive care.

Figure 2 (abstract P1). Accuracy of prescriptions after intervention.
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Vincent et al.: Adverse events in British hospitals. BMJ 2001, 322:517-519.
Building a Safer NHS for Patients: Improving Medication Safety
[http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/
Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/
DH_4071443]
Safe Prescribing [http://www.medicalprotection.org/uk/england-factsheets/
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P2
The Limpet controlled drug cabinet alarm and camera
M Mariyaselvam, D Pearson, P Moondi, P Young
Queen Elizabeth Hospital NHS Trust, Kings Lynn, UK
Critical Care 2014, 18(Suppl 1):P2 (doi: 10.1186/cc13192)

Figure 1 (abstract P1). Accuracy of prescriptions before intervention.
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Introduction The theft and tampering of controlled drugs (CDs) remains
a prevalent patient safety issue. Sadly there are numerous reports of
critical care staff stealing CDs for personal use or financial gain and
notably there have been some cases where CDs have been substituted
for other medications in order to delay detection of the theft. This
creates both the hazard of medication errors and potentially exposes
patients to opioid intoxicated healthcare workers. As most critical care
staff have access to CDs, when drugs are found to be missing it can be
difficult to identify the perpetrators. Therefore the implementation of a
deterrent which also improves the methods of detection is warranted.
Methods The Limpet, a device which incorporates a proximity sensor
and a camera unit, was installed within the CD cupboard of the
critical care unit. Whenever the cupboard was accessed the date and
time were recorded and a photograph was taken to identify the staff
member. Mock thefts were subsequently undertaken by a designated
staff member at random times. This allowed testing of the product to
determine the number of times the ‘thief’ was correctly identified.
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Results Mock thefts were successfully accomplished on six occasions
over a 4-week period. On each occasion the Limpet photographed the
‘thief’ and recorded the date and time of access. Therefore, in the event
of a real theft it would be possible to quickly and easily indentify the
culprit.
Conclusion When CDs are missing it can be extremely stressful for
the staff involved. Those who have access to CDs may feel unfairly
scrutinised and the potential for false accusation exists. Investigating
the theft of CDs is costly and usually involves pharmacists, managers
and the police. Until the issue is resolved, potential suspects are usually
suspended from work, leading to disruptions in patient care. The utility
of the Limpet in modifying staff behaviour by reducing the number of
occasions and the duration of time that open drug cupboards are left
unattended, has previously been demonstrated [1]. By providing the
facility to determine exactly who accessed each CD cupboard at which
time, this initial study has shown the benefits of the Limpet as a tool for
detecting theft. Therefore the installation of the Limpet mitigates the
difficulties of investigating CD theft and is likely to prove an effective
deterrent.
Reference
1.

The Limpet drug cabinet alarm: technology for safer drug stewardship
[abstract and poster presentation]. Presented at International Forum on
Quality and Patient Safety; April 16-19 2013; London.

P3
Role of pharmacist in multidisciplinary pediatric intensive care
rounds: a retrospective descriptive study
S Tripathi, K Graner, K Fryer, G Arteaga
Mayo Clinic, Rochester, MN, USA
Critical Care 2014, 18(Suppl 1):P3 (doi: 10.1186/cc13193)
Introduction Multidisciplinary rounding practices in the ICU have now
become the standard of care in most institutions. Few objective data are
available, however, on the value each individual member of the team
brings to the patient care. In our institution, pediatric pharmacists have
been an integral part of the PICU rounds since 2002, although their role
has evolved over the course of years. This study was undertaken with
the primary aim of identifying the impact of pharmacist involvement in
PICU rounds, with respect to changes in therapy.
Methods Since January 2003, pharmacists have recorded their clinical
interventions and outcomes of those interventions in an institutionally
developed Pharmaceutical Care database (P-Care). An intervention is
defined as any recommendation the pharmacist makes to the patient
care team regarding a change in the patient management or medication
therapy. P-Care is designed to assist the pharmacist to optimize
medication therapy, identify medication-related problems, decrease
medication costs, improve pharmacist efficiency and document
pharmacist workload. Data concerning pharmacists’ interventions
were extracted from the P-Care database in yearly increments via a
reporting functionality that is available in the P-Care system. This study
was exempted for review by the Mayo Clinic IRB.
Results From 1 January 2003 through 31 December 2012 pharmacists
made 24,207 clinical interventions in the PICU and 19,252 of those
interventions resulted in changes in medication therapy or therapy
monitoring. Interventions that were accepted by the team involved
10,361 (53.8%) drug dosing regimen changes, 292 (1.5%) drug
interactions or incompatibility, 969 (5%) drug monitoring suggestions,
1,665 (8.7%) drug routes/methods of administration, 3,895 (20.2%) drug
selections, and 2,070 (10.8%) medication profile/order clarifications. As
the pharmacist role on the PICU multidisciplinary rounds has evolved,
the number of interventions has increased from 1,643 in 2003 to 3,799
in 2012. Of the 19,252 interventions that were implemented, 304 were
deemed to be of potentially life-threatening consequences, 10,767 had
a moderate impact, and 8,181 had minimal impact on patient outcome.
Conclusion To our knowledge this is the largest reported data on
pharmacist’s involvement in pediatric intensive care. This can serve
as background knowledge on implementing measures on novel
methodologies to integrate pharmacists in intensive care practice.
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P4
Improvement in the identification and management of inadvertent
hypothermia in the critically ill: an audit cycle
J Barnes, R Darke, A Irving, S Wright
Freeman Hospital, Newcastle upon Tyne, UK
Critical Care 2014, 18(Suppl 1):P4 (doi: 10.1186/cc13194)
Introduction The purpose of this study was to assess our practice in
identifying and managing inadvertent hypothermia and whether
this could be improved by education and introduction of a protocol.
Hypothermia is associated with multiple physiological abnormalities
including reduced myocardial contractility, peripheral vasoconstriction,
increased infection risk and impaired coagulation [1]. Inadvertent
hypothermia may therefore be an avoidable risk factor in the critically
ill. The UK National Institute of Clinical Excellence has issued guidance
for avoidance of inadvertent hypothermia (temperature <36°C)
during the perioperative period. We audited our practice against
three standards from these guidelines: all patients should have at
least 4-hourly temperature observations; no patient should become
inadvertently hypothermic; and all inadvertently hypothermic patients
should be rewarmed.
Methods Data were collected prospectively. Body temperature was
recorded routinely by nursing staff using a tympanic thermometer. We
noted any occasion where the body temperature dropped below 36°C
along with any associated interventions – such as the use of additional
bed sheets or a forced air warming device. After the first audit period
a simple education programme was delivered. We also introduced
a departmental protocol for the prevention and management of
inadvertent hypothermia. Six months later we re-audited our practice.
Results Data were collected from 130 patients (2,931 patient-hours)
in the first audit period and from 87 patients (2,070 patient-hours)
in the second audit period. In the first period 29% of patients had at
least 4-hourly temperature measurements compared with 40% in the
second period (P <0.01). The average number of overdue temperature
observations per day was 1.4 in the first period and 0.9 in the second
(P <0.01). Twenty-four per cent of patients became hypothermic in the
first period compared with 22% in the second (P = 0.07); however, the
time these patients remained hypothermic reduced from an average
of 7.9 hours to 6.1 hours (P <0.01). An intervention was made and
documented in 15% of cases in the first period and 46% in the second
(P <0.001).
Conclusion We saw some improvement following an education
programme and introduction of a clinical protocol although there
remains room for further improvement.
Reference
1.

Andrzejowski et al.: Br J Anaesth 2008, 101:627-631.

P5
Incidence of adverse events in a Brazilian coronary ICU
VF Paula1, CE Bosso1, OA Souza2, GE Valerio2, SV Ferreira2
1
Instituto do Coração de Presidente Prudente, Brazil; 2UNOESTE – Universidade
do Oeste Paulista, Presidente Prudente, Brazil
Critical Care 2014, 18(Suppl 1):P5 (doi: 10.1186/cc13195)
Introduction Security policies for the patient are an interest to any
health professional. The rates of adverse events in hospitals reach
values ranging between 3.7 and 16.6%, being the highest range (40
to 70%) considered preventable or avoidable [1]. The objective of this
study is to analyze the incidence of adverse events and their severity in
a Brazilian coronary ICU (CICU).
Methods Research conducted from database analysis regarding
hospitalizations from 1 May 2012 until 31 October 2013 in a coronary
care unit of the city of Presidente Prudente, Brazil. Statistical analysis
was performed using EPI INFO, version 3.5.2 software, which was
considered significant at P <0.05 two-tailed and CIs at 95% (CI) were
used for the odds ratios (OR) estimated in the sample. Demographics
(gender and average age) and aspects related to adverse events were
analyzed, the latter being under the impact and probability of death.

Critical Care 2014, Volume 18 Suppl 1
http://ccforum.com/supplements/18/S1

Results A total of 1,067 admissions were analyzed in the period, with
57.38% male and 42.63% female. The average age was 67.7 ± 13.2 years.
The average CICU length of stay was 3.74 ± 5.51 days. A total of 211
adverse events occurring in 140 different admissions were recorded.
The most frequent were drug administration errors (24.3%), pressure
ulcer (24.3%), phlebitis (22.1%), loss of enteric tube (13.6%) and central
venous cannulation accident (7.1%). The statistical analysis shows that
hospitalization time longer than 2 days are related to the occurrence of
the events (OR: 8.08 CI: 4.95 to 13.2) and that the presence of the first
occurrence is significant to increase the probability of death in the unit
(OR = 5.33, CI: 3.49 to 8.12). Pressure ulcer (OR = 16.73, CI: 8.04 to 34.81),
enteral tube loss (OR 3.64, CI: 1.36 to 9.75) and drug administration
errors (OR = 2.87, CI: 1.31 to 6.31) were also related to higher mortality.
Conclusion The research draws attention to a significant incidence of
adverse events and shows that their occurrence implies an increase of
death in the unit. Therefore, security measures should be employed
for the reduction, and thus enhance the quality of service provided by
health professionals to patients admitted to a coronary care unit.
Reference
1.

Foster AJ, et al.: Adverse events among medical patients after discharge
from hospital. CMAJ 2004, 170:345-349.

P6
Compliance of a ventilator-associated pneumonia care bundle in an
adult intensive care setting
G Wigmore, R Sethuraman
The Princess Alexandra Hospital NHS Trust, Harlow, UK
Critical Care 2014, 18(Suppl 1):P6 (doi: 10.1186/cc13196)
Introduction Ventilator-associated pneumonia (VAP) is the leading
cause of death amongst hospital-acquired infections and is also
linked to an increased length of stay and cost of care. The Institute for
Healthcare Improvement ventilator bundle is comprised of a series of
interventions, which, when implemented together, have been shown
to decrease the incidence of VAP. The aim of this study was to determine
the compliance of the bundle and if <95% [1] devise strategies to
improve compliance.
Methods A retrospective review of the compliance of an existing VAP
bundle was conducted for all adult patients ventilated in the ICU of
a large district general hospital in 2011. The bundle comprised four
elements: head up 30°, peptic ulcer prophylaxis, deep vein thrombosis
(DVT) prophylaxis and sedation hold. The bundle was considered
compliant if all four were performed. The findings of the audit were
presented to the department and, through subsequent discussions,
barriers to noncompliance were identified. Following a period of
education, a revised and updated bundle was implemented. A repeat
audit covering 3 months was subsequently conducted.
Results Pre-intervention, overall compliance of the bundle stood at
32% and subsequently increased to 63% post intervention (P <0.05).
Compliance at the level of individual elements varied: head up 30°,
94%; ulcer prophylaxis, 91%; DVT prophylaxis, 85%; sedation hold,
37%. Post intervention, a statistically significant increase in compliance
with regard to sedation hold was observed; 72% (P <0.05). The other
individual elements did not show a statistical change. However, the
new elements that were introduced demonstrated high levels of
compliance; cuff pressure 20 to 30 cm H2O 83% and oral hygiene with
chlorhexidine 90%.
Conclusion Post intervention, a statistically significant improvement
in overall bundle compliance was found. Thereby highlighting that
through engaging all members of the multidisciplinary team in
identifying barriers to noncompliance and delivering education,
it is possible to improve compliance. While total compliance was
suboptimal as the target was 95%, the bundle redesign has given a
tool that records compliance with greater clarity due to the presence
of clearly defined exclusion criteria. It has also been a significant step
in the right direction to improving the reliability of care delivered to
patient and reinforces the concept that quality improvement is a
continuous cycle.
Reference
1.

Marra AR, et al.: Am J Infect Control 2009, 37:619-625.
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P7
Referrals to a critical care unit: compliance with the NCEPOD
recommendations
G Wigmore1, M Campbell2, P Walker2, K Raveendran2
1
The Princess Alexandra Hospital NHS Trust, Harlow, UK; 2Barking Havering
and Redbridge University Hospital, London, UK
Critical Care 2014, 18(Suppl 1):P7 (doi: 10.1186/cc13197)
Introduction The report of the National Confidential Enquiry
into Patient Outcome and Death (NCEPOD) 2005 [1] provides
recommendations to reduce morbidity and mortality among acutely
ill patients. It highlights the importance for involvement of consultants
in the referral process, clear physiological monitoring plans for each
patient, and review by a consultant intensivist within 12 hours of
admission to critical care. The objective of the audit was to assess
compliance with these recommendations, ensuring safe management
of acutely unwell patients and appropriate utilisation of scarce critical
care resources.
Methods Prospective data on referrals to adult critical care in a 20bed unit in a teaching hospital were collected over 8 weeks. Collected
data included: source, time, seniority of doctor referring and receiving
referral, outcome of referral, involvement of team consultant prior to
referral, documented management plan and review by a critical care
consultant within 12 hours of referral.
Results Seventy-three referrals were analysed, the majority of which
were medical. One-half of referrals came out of hours; 24% of referrals
were made by a consultant; 51% were seen by a consultant prior to
referral; 73% of referrals were admitted; likelihood of admission
increased from 63% to 83% if the patient was reviewed by home
consultant prior to referral. In 56% of cases the referral was received
by a foundation doctor (all referrals were discussed with a consultant
intensivist). Among the rejected referrals (maximal ward therapy not
reached), 54% were from a trainee below registrar grade. Twenty-five
per cent of patients were not seen by a consultant intensivist within
12 hours of referral.
Conclusion Acutely unwell patients require the expertise of the most
senior clinicians regarding further management, including planning
for end-of-life care. Our audit demonstrated poor adherence to
NCEPOD [1] and Department of Health [2] recommendations. The
majority of referrals to critical care were made by nonconsultants and
for patients who had not been reviewed by a team consultant, prior to
referral. The workload in critical care demonstrated that almost onehalf of the referrals happen out of hours. These findings have resulted
in significant changes to working practice, including the presence of an
onsite consultant intensivist for a minimum of 13 hours daily.
References
1.

2.

An Acute Problem? Report of the National Confidential Enquiry into Patient
Outcome and Death. London: National Confidential Enquiry into Patient
Outcome and Death; 2005. [http://www.ncepod.org.uk/2005report/]
Guidelines on Admission to and Discharge from Intensive Care and High
Dependency Units. London: Department of Health; 1996.

P8
Organisational changes in service provision outside critical care
impact on referral patterns
A Tridente1, L Cecchini2, S Lobaz3, A Chick3, S Keep3, S Furmanova4,
D Bryden3
1
St Helens and Knowsley, Liverpool, UK; 2SMH, Manchester, UK; 3STH, Sheffield,
UK; 4UHW, Cardiff, UK
Critical Care 2014, 18(Suppl 1):P8 (doi: 10.1186/cc13198)
Introduction Demand for critical care (CC) resources is constantly
increasing in the face of limited availability. Guidance for triage
exists but may no longer reflect current practice [1,2]. We previously
identified nonmedical and medical factors (comorbidities,
physiological derangement and functional status) as predicting
likelihood of admission of referred patients to CC [3-5]. Reduction in
UK doctors’ working hours and numbers has resulted in new ways of
multidisciplinary teams working the hospital at night (H@N), which
may have an impact on CC referral. We aimed to establish any effect of
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hospital changes in service provision outside CC on the referral pattern
and admissions.
Methods Data from prospectively enrolled urgent patient referrals
were analysed comparing two periods: before (period 1: 2011/12) and
after (period 2: 2013) the introduction of H@N. We collected data on
acute physiological parameters, hospital length of stay, demographic
and functional status, dependency and comorbidities. STATA was used
for these preliminary analyses.
Results Comparing the two periods we found no significant
differences in age, gender distribution, degree of acute physiological
derangement, comorbidities, specialty of origin, time spent in hospital
prior to referral and grade of referrer. By contrast, the proportion of outof-hours referrals greatly increased (from 49.3% to 69.7%) along with
the proportion of referrals deemed inappropriate for CC (from 37.3% to
54.8%); the proportion of patients accepted increased only marginally
(from 46.7 to 50%) in the second period, compared with the first. Neither
the number of beds available within the critical care department
(P = 0.59) nor receiving the referral out of hours (P = 0.8) influenced
the likelihood of admission. The factors predicting admission to CC
(functional status, acute physiological derangement) did not differ
significantly between the two periods examined. Housebound status
was consistently found to be an independent predictor of admission
refusal (OR 0.11, 95% CI 0.05 to 0.23, P <0.001).
Conclusion Decision-making about admission to CC is based mainly on
the assessment of patients’ functional status. Organisational changes in
the provision of healthcare services outside CC, such as H@N, have had
a significant influence on CC workload and patterns of referrals.
References
1.
2.
3.

4.

5.

ACCCM Guidelines for ICU admission, discharge, and triage. Crit Care Med
1999, 27:633-638.
ATS. Fair allocation of intensive care unit resources. Am J Respir Crit Care
Med 1997, 156:1282-1301.
Tridente A, Chick A, Keep S, Furmanova S, Webber S, Bryden DC: Factors
affecting critical care admission to a UK University Hospital [Poster P508].
Presented at 32nd International Symposium on Intensive Care and Emergency
Medicine; March 19-23 2012; Brussels.
Tridente A, Chick A, Keep S, Furmanova S, Webber S, Bryden DC: Functional
status as a predictor of admission to critical care in acutely unwell patients
[Abstract 0424]. Presented at 25th Annual Congress of the European Society of
Intensive Care Medicine; October 13-17 2012; Lisbon.
Tridente A, Chick A, Keep S, Furmanova S, Webber S, Bryden DC: Non medical
factors influence likelihood of admission to critical care of acutely unwell
patients [Abstract A-570-0025-00363]. Presented at 26th Annual Congress of
the European Society of Intensive Care Medicine; October 5-7 2013; Paris.

P9
Demand versus supply in intensive care: an ever-growing problem
M Tanaka Gutiez, R Ramaiah
East Kent Hospitals University NHS Foundation Trust, Ashford, UK
Critical Care 2014, 18(Suppl 1):P9 (doi: 10.1186/cc13199)
Introduction The demand for intensive care has reached new heights,
where medical advancement and aging populations have increased
the proportion of patients with multi comorbidities. Ideally, bed
occupancy on the ICU should be around 70% whereas beyond 80% has
been associated with increased mortality. William Harvey Hospital is a
district general hospital with nine ICU beds where the ICNARC national
database suggested a consistently high occupancy. The purpose of this
study was to assess bed occupancy and its impact on service delivery.
Methods Data were collected between 2005 and 2013 to analyse trends
in ICU bed occupancy, overnight discharges, surgical cancellations, and
nonclinical transfers. Data were gathered from April 2012 to March
2013 using quality indicators (Intensive Care Society): readmissions;
premature discharges; discharges at night; cancelled planned surgery;
and nonclinical transfers. Regression analysis was conducted to assess:
correlation between mortality and effects of excess occupancy; and
causality of increasing demand for ICU beds.
Results Bed occupancy remained high between 2005 and 2013 with a
15% increase. This was associated with increased overnight discharges
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(29%), surgical cancellations (90%), and nonclinical transfers (88%).
Between 2012 and 2013, the calculated demand for beds was 174.
There were 1.8 ICU to 100 hospital beds and 4.5 ICU beds per 100,000
population, which dropped significantly when including regional
specialty services. A persistent gap between ICU bed supply and
demand was associated with increased unfavourable outcomes in all
quality indicators.
Conclusion A steady increase in occupancy over the last 8 years was
due to multiple factors, including an increase in clinical services such
as in the coronary care centre, head and neck unit, and trauma centre.
Presentation of our results to managerial level facilitated increased bed
capacity by 22%.
References
1.
2.

3.
4.

Intensive Care Society: Standards for Intensive Care Units. London: ICS; 1997.
Iapichino G, Gattinoni L, Radrizzani D, et al.: Volume of activity and
occupancy rate in intensive care units. Association with mortality. Intensive
Care Med 2004, 30:290-297.
Intensive Care Society: Standards, Safety and Quality Committee. Quality
Indicators. London: Intensive Care Society; 2010.
Department of Health: Comprehensive Critical Care. A Review of Adult Critical
Care Services. London: Department of Health; 2000.

P10
Demands on a continuing education online-study program for
physicians
J Seifried, V Titschen, J Guttmann, S Schumann
University Medical Center Freiburg, Germany
Critical Care 2014, 18(Suppl 1):P10 (doi: 10.1186/cc13200)
Introduction Physicians have an intense and irregular workday life.
Thus, they need to use their time for continuing education in the most
efficient way. This presents a major challenge to suppliers of continuing
study programs. Our online master program Physico-Technical Medicine
(PTM) addresses working physicians who want to acquire knowledge in
the fields of biomedical engineering and medical physics [1]. We attach
great importance to the special needs of our participants. Therefore,
we investigated which general conditions are most important for the
working physician regarding qualifying continuing education.
Methods The general conditions of our continuing education program
(PTM) were examined on the basis of evaluation questionnaires.
Additionally, students were asked in interviews about their demands,
and they could give anonymous feedback on feedback cards.
Results Flexibility: students appreciated flexibility regarding time and
environment of their learning activities. This flexibility enables the
students to use even small time frames or traveling times for learning.
Students can choose their preferred time and place for their learning
activities. Security in planning: students have to organize their time
frames for learning besides their daily work, their family life, and
possibly their academic career. Especially phases of attendance should
be planned and communicated as early as possible. Transparency of
structure: participants ask for transparency in terms of the expected
workload and expenditure of time to plan their studies and get
focused. Relation to previous knowledge: learning success is supported
by relating new contents to previous knowledge from the student’s
first medical degree. Mainly clinical examples illustrate abstract topics,
which also helps students to recognize the relevance of the content.
Individual support: students need contact persons in terms of learning
organization, technical support, and for questions regarding the course
material.
Conclusion We could show that an extra-occupational continuing
study program for physicians should be adjusted to their special
situation and therefore has to comply with particular requirements. As
such we could identify five main requirements which are continuously
fulfilled by the online master program PTM and regularly surveyed by
evaluations.
Reference
1.

Guttmann J, et al.: Physikalisch-Technische Medizin (PTM) – ein neuer
Master-Online Studiengang für Mediziner. GMS Z Med Ausbild 2011,
28(1):Doc01.
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P11
Do generic measures fully capture health-related quality of life in
adult, general critical care survivors?
W Lim1, N Black1, K Rowan2, N Mays1
1
London School of Hygiene & Tropical Medicine, London, UK; 2Intensive Care
National Audit & Research Centre, London, UK
Critical Care 2014, 18(Suppl 1):P11 (doi: 10.1186/cc13201)
Introduction We examined the extent to which the two generic healthrelated quality of life (HRQL) measures recommended for use in adult,
general critical care [1] – the SF-36 and EQ-5D – captured survivors’
HRQL, which is important in assessing the effectiveness of critical care.
Unlike other fields of healthcare that employ both generic and specific
HRQL measures, most recent studies in critical care have used only
generic measures, despite uncertainty as to their appropriateness.
Methods A patient-based conceptual framework for survivors’ HRQL
was built using: a systematic review of the literature; secondary analysis
of 40 in-depth interviews with adult critical care survivors; and primary
analysis of in-depth interviews with a maximum variation sample of 25
white critical care survivors in England. Two methods were then used
to assess the extent to which the SF-36 and EQ-5D captured their HRQL,
as detailed in the framework: the content of both instruments was
examined, alongside data collected from the in-depth interviews; and
the opinions that survivors expressed about how accurately the SF-36
and EQ-5D reflected their ideas on health and HRQL were analysed and
taken into account.
Results The patient-based framework was in two parts: the first
covered survivors’ personal status which consisted of their physical
status, emotional/psychological status and cognitive status; and the
second comprised nine subdomains affected by their personal status.
The latter were: activities and behaviours; physical zone of comfort
and/or activity; interactions and relationships with others; perception
of, interpretation of, and responses to life; personality; external
appearance; suitability and availability of clothes; place of residence;
and finances. The current generic measures recommended on the basis
of expert consensus for use with survivors of adult, general critical care
have substantial gaps in their coverage of this conceptual framework
for survivors’ HRQL, particularly in relation to their cognitive status and
its subsequent impact.
Conclusion The two most commonly used generic HRQL measures in
adult, general critical care have significant gaps in their coverage of
survivors’ HRQL. Any (new) critical care-specific HRQL measure should
be designed specifically to capture the impact of critical illness on
survivors’ cognitive status and its subsequent effects.
Reference
1.

Angus DC, et al.: Intensive Care Med 2003, 29:368-377.

P12
Surgical HDU admissions: utilisation, organ support and finance
G Brakmane, A Molokhia
University Hospital Lewisham, London, UK
Critical Care 2014, 18(Suppl 1):P12 (doi: 10.1186/cc13202)
Introduction The aim was to explore the HDU booking process,
organ support requirements and financial implications as the current
approach to booking surgical cases for HDU has somewhat been based
on a ‘just in case’ principle.
Methods The booking and admission details from October 2012 to
July 2013 were gathered from the HDU log-book and Ward Watcher
software. The cost of HDU beds and staff were provided by the finance
department. Data were analysed using MS Excel and SPSS software.
Results There were 105 handwritten bookings over 10 months, several
missing essential data. Only 89 admissions actually took place; 61 were
elective, 66 colorectal, six urgent, 19 scheduled and three unspecified
(Figure 1). Most patients required basic cardiovascular and respiratory
support (Figure 2). Data revealed 16 cancellations. Each booking
requires allocated nursing staff which bears a basic cost of £23/hour
(estimated annual loss >£10.000). If we add the daily cost of basic
HDU care (approximately £1,000 for single organ support), the losses
rise rapidly. We also registered 38 days in delayed discharges. This was
predominantly due to ward bed shortages. In financial terms there is at

Figure 1 (abstract P12). Admissions per speciality.

Figure 2 (abstract P12). Organ support requirements.

least £500/day difference between surgical and HDU (potential annual
loss >£22,000). In addition there were 13 patients who spent a total of
37 days on the HDU but did not require an HDU level of care.
Conclusion The currently limited resource is not being utilised
effectively with implications on both staff deployment and finances. A
more holistic approach is needed where all requests are reviewed by
a consultant anaesthetist in conjunction with preadmission data. This
could better identify patients for HDU care and potentially decrease
cancellations. We have developed an improved booking form for this
purpose.
P13
Convalescence via critical care collaboration
C Shute, A Saayman
University Hospital Wales, Cardiff, UK
Critical Care 2014, 18(Suppl 1):P13 (doi: 10.1186/cc13203)
Introduction A collaborative approach to patient management has
been shown to improve patient outcomes. In a resource-limited NHS,
critical care beds are at a premium, therefore preventing unnecessary
admissions by optimising ward-based management is essential. The
objective of this service quality improvement project was to improve
collaboration between the critical care directorate and neurosurgical
high care unit at a tertiary university teaching hospital. We proposed
that the use of a simple ward round tool on collaborative rounds would
facilitate systematic patient review, prompt early recognition of those
critically unwell and improve patient outcomes.
Methods An initial observation period of behaviours and practice on
the neurosurgical unit was conducted with qualitative and quantitative
data collection. Following analysis of these outcome measures a
simple ward round tool was constructed, with the mnemonic ‘DON’T
FORGET’, and we devised a programme for collaborative ward rounds
to take place three times per week over a 1-month period. During this
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time further data were collected to assess whether our interventions
resulted in modified behaviours and to document the number of
changes made to patient management as a consequence of the
collaborative approach to care.
Results Our results showed that improvements were made in all
assessed domains. Consultant-led ward rounds increased, attendance
by members of the multidisciplinary team (MDT) dramatically
improved and as a result MDT discussion was enhanced. In addition,
documentation of structured plans improved and review of prescription
charts significantly increased. As a consequence of collaborative
rounds, a total of 343 changes were made to patient management
under the domains of the ward round tool. This was an average of 21.4
changes per collaborative round, with most changes being made to
medication charts or decisions regarding thromboprophylaxis.
Conclusion The use of a simple ward round tool combined with a
collaborative approach to ward rounds improved MDT involvement and
discussion, promoted structured patient review and resulted in positive
changes to multiple areas of patient management. In conclusion,
structured collaborative rounds result in significant changes to patient
management that may prevent admission, or readmission, to critical
care which has the potential to reduce healthcare costs and morbidity.

P14
Can dynamic light improve melatonin production and quality of
sleep?
J Jennings1, TD Thomsen2, JW Larsen2, J Markvardt3
1
Sheffield Teaching Hospital, Sheffield, UK; 2Kolding Hospital, part of Lillebaelt
Hospital, Kolding, Denmark; 3Danish Building Research Institute/Aalborg
University, Copenhagen, Denmark
Critical Care 2014, 18(Suppl 1):P14 (doi: 10.1186/cc13204)
Introduction Hospital lighting may cause disruption in the circadian
rhythm, partly due to suppression of melatonin production. This may
create sleep difficulties and delirium for ICU patients and health issues
such as fatigue, poor sleep quality and chronic diseases for ICU staff.
Dynamic RGB coloured light which changes colour and intensity in
correlation with the time of day has been installed in a Danish ICU,
aiming to create lighting conditions being close to daylight variations
and supporting patient and staff rhythms. As the effect of dynamic
light on patients may be biased by illness, organ failure, and so forth,
the aim was to examine the influence of dynamic light on ICU nurses’
melatonin production, quality of sleep, and well-being.
Methods An intervention study examining the impact of dynamic light
regarding the impact on the circadian rhythm (measured by melatonin
profiles from saliva samples), quality of sleep (sleep efficiency, number
of awakenings and subjective assessment of sleep; measured by sleep
monitors and sleep diary), and subjective experiences of well-being,
health, and sleep quality (measured by a questionnaire survey). Results
from the intervention group were compared with a control group of
nurses from a similar ICU without dynamic light. Light conditions were
documented by measurements. Data collection was from February to
May 2013.
Results A total of 55 nurses (89%) from the intervention ICU (ICU1) and
58 nurses (88%) from the control ICU (ICU2) participated. No significant
differences were found between the two groups regarding personal
characteristics. The nurses from ICU1 described their work light as
comfortable, relaxing and natural compared with artificial, institutional
and gloomy in ICU2. Preliminary analyses did not shown any significant
differences in melatonin level. During a 10-day period, the nurses from
ICU2 assessed their actual sleep as less effective (OR 2.17; P = 0.03) and
felt less rested (OR 1.89; P = 0.006) compared with nurses from ICU1.
The nurses in ICU2 had 16% more awakenings (P = 0.05) during sleep,
but there were no significant differences in duration of awakenings or
in total sleep efficiency between the two groups.
Conclusion Most participants from the intervention ICU found the
dynamic light agreeable and assessed their sleep more positively than
participants from the control ICU. No significant differences were found
between monitored sleep efficiency and melatonin level.
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P15
Targeting blood tests in the ICU may lead to a significant cost
reduction
R Gray, F Baldwin
BSUH, Brighton, UK
Critical Care 2014, 18(Suppl 1):P15 (doi: 10.1186/cc13205)
Introduction Daily blood tests are an essential diagnostic tool and
routine practice in the management of ICU patients, but are associated
with cost and a risk of anaemia. There is no evidence for the frequency
or breadth of blood testing but there is evidence that by rationalising
blood tests, significant cost saving can be made without a negative
effect on mortality or length of ICU stay [1]. Blood tests in our ICU are
requested by nurses, this is a unique practice to the ICU compared with
other hospital departments.
Methods We had previously carried out a survey to assess blood
requesting practise in UK ICUs. This demonstrated that routine tests
were, as in our ICU, nurse led and the majority of staff underestimated
the costs of tests. Using the results of this survey and a literature review
we developed routine blood test guidelines for our general mixed 26bed ICU/HDU. Following a period of staff education, we audited our
blood requesting practice over 28 days.
Results Our blood testing did not comply with our guidelines. Over the
28-day period, €12,849.96 was spent on all blood tests. According to
our guidelines, €2,914.96 was spent on inappropriate tests (€37,998.63
per year) (Table 1). Over 40% of this cost was spent on the coagulation
screen.
Table 1 (abstract P15)
Number of
28-day cost
inappropriate requests
(€)

Test
Full blood count

4

21.82

Annual cost
(€)
284.44

Urea and electrolytes

6

29.44

383.77

Liver function tests

95

583.18

7,602.1

Coagulation screen

117

1,276.86

16,644.78

C-reactive protein

45

245.55

3,200.91

Bone profile

112

274.75

3,581.56

Magnesium

88

483.35

6,300.81

Conclusion In our ICU, unnecessary blood tests have a significant
cost burden of approximately €38,000 per year. To limit unnecessary
costs, consultants now lead requesting by completing a blood test pro
forma on the evening ICU ward round indicating which blood tests are
clinically needed the following day.
Reference
1.

Seguin P, et al.: Intensive Care Med 2002, 28:332-335.

P16
Analysis of the acoustic environment in an ICU using patient
information as a covariate
M Park1, P Vos2, A Kohlrausch1, B Vlaskamp1, AW Oldenbeuving2
1
Philips Research Laboratories, Eindhoven, the Netherlands; 2St Elisabeth
Hospital, Tilburg, the Netherlands
Critical Care 2014, 18(Suppl 1):P16 (doi: 10.1186/cc13206)
Introduction Noise levels in ICUs are often very high, potentially
affecting patient health outcome, which are also considered to be
among the risk factors contributing to ICU delirium [1]. In the current
study, multivariate linear regression models were established to relate
the acoustic data to the indicators of patient status.
Methods Acoustic measurements were taken in eight single-bed
patient rooms in a level 3 ICU, while patient information was also
collected, including APACHE IV score and mortality rate together
with other potentially relevant variables; for example, the usage of
mechanical ventilators, and so on. The hourly and daily trends of the
acoustic data were obtained, and an analysis of variance was carried
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out to investigate the effect of relevant factors (for example, the time of
day). Furthermore, multiple linear regression models were established
to relate the different types of patient-related data (as independent
variables) to each type of the acoustic data (as dependent variable),
where independent variables were selected based on an exhaustive
search method.
Results Data were collected for 3 months for 106 patients. The 24-hour
trends of acoustic parameters corresponded well to the daily routine
events in the ICU. The analyses for the first 4 days of the patients’ ICU stay
showed that the average SPL varied depending on the day (P = 0.023)
and on the time of the day (day/night) (P <0.001). The average noise
level decreased from day 1 to day 2 with a significant reduction at
night (P = 0.008), but it was found to rebound from day 2 where the
increase of the daytime noise level from day 2 to day 4 was significant
(P = 0.005). The results of the multiple linear regression showed that
various patient conditions influenced different types of noise-level
parameters. For example, the location of the patient room, the usage of
mechanical ventilators and the mortality rate were found to correlate
to the 10th-percentile SPL (L90) in the first 48 hours (adjusted R2 = 0.58;
P <0.001). Also, the room location, gender and the usage of mechanical
ventilators were found to be related to the 50th-percentile SPL (L50) in
the same period (adjusted R2 = 0.54; P <0.001).
Conclusion Noise-level parameters were found to vary depending
on the day of ICU stay, the time of day, and other indicators of the
patient’s status. For a rigorous analysis of the influence of noise on
patients’ outcome, the effects of these factors must first be controlled
or corrected.
Reference
1.

Van Rompaey et al.: Crit Care 2012, 16:R73.

P17
Results of the Telemedicine Program for implementation of the
Surviving Sepsis Campaign Protocol in a community Brazilian
hospital
C Abreu Filho1, M Steinman1, A Andrade2, F Piza1, A Caluza1, J Teixeira2,
M Bracco2, R Abaladejo1, E Silva1
1
Hospital Israelita Albert Einstein, São Paulo, Brazil; 2Hospital Municipal Dr.
Moysés Deutsch, São Paulo, Brazil
Critical Care 2014, 18(Suppl 1):P17 (doi: 10.1186/cc13207)
Introduction Sepsis has high incidence around the world, approximately
400,000 new cases occur annually in Brazil. In developing countries,
it is still an important cause of death due to poor adherence to bestpractice medicine protocols. The Brazilian mortality rate of septic shock
is around 60%. The aim of this study is to describe the initial results
for the implementation of the Brazilian initiative of a Telemedicine
(TM) Project for therapeutic support of septic patients in a community
hospital in São Paulo, Brazil.
Methods Since May 2012, a TM Program has been implemented at
two hospitals in São Paulo – Hospital Municipal Dr. Moysés Deutsch
(HMMD), a public, secondary hospital, and Hospital Israelita Albert
Einstein (HIAE), a tertiary private philanthropic entity – due to a
partnership with Brazilian Health Ministry. A TM Central Command was
located at HIAE with Endpoint 97 MXP Cisco® Solution and Medigraf
Gowireless® technology. Mobile Intern MXP ISDN/IP Cisco® and
Medigraf Gowireless® for the remote hospital (HMMD) via a dedicated
connection. At HMMD, the sepsis protocol, based on the Surviving
Sepsis Campaign, has been started for every recruited patient admitted
to the emergency department (ED) or the ICU, and assessed by the
Central Command through TM with an experienced consultant of HIAE.
We compared the results of this group of patients with the group of
patients with diagnosis of severe sepsis and septic shock, admitted to
HMMD during 2011, who were not assisted with TM resources.
Results From January to December 2011, 283 septic patients
were treated at HMMD, 161 (56.8%) patients were male, mean age
was 53.7 years and the hospital mortality was 65.3%. After the
implementation of the TM Program, 189 septic patients were admitted
to the hospital and evaluated by skilled doctors of HIAE via TM, with the
institution of the Surviving Sepsis Campaign protocol. In total, 68.9% of
the consultations originated from the ICU and 31.1% from the ED; 111
patients were male (58.4%), mean age was 54.1 years and the hospital
mortality was 32.9% (P <0.05).
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Conclusion Use of the TM Program for the implementation of
the Surviving Sepsis Campaign Protocol at a community Brazilian
hospital improved compliance with recommended care bundles and
significantly decreased the hospital mortality of septic patients.
P18
ICU nursing connectivity and the quality of care in an academic
medical center: a network analysis
DM Kelly1, DC Angus1, D Krackhardt2, JM Kahn1
1
University of Pittsburgh, PA USA; 2Carnegie Mellon University, Pittsburgh, PA,
USA
Critical Care 2014, 18(Suppl 1):P18 (doi: 10.1186/cc13208)
Introduction A collaborative nurse work environment is associated
with ICU quality, yet collaborative interaction is difficult to measure.
Network analysis may be an innovative tool to measure interactions.
We sought to determine the feasibility of network analysis to measure
ICU nurse connectivity and test whether key network measures were
associated with the ICU quality of care.
Methods We performed a network analysis in eight ICUs within an
urban academic medical center in the United States during 2011.
Using scheduling data, we defined network ties as instances when
two ICU nurses worked together in the same ICU for 4 hours or more.
We examined each ICU’s network by visualizing sociograms and by
measuring two network properties: density and clustering. Density
measures the cohesion within a network on a scale from 0 to 100, with
a higher score indicating more cohesion. Clustering assesses the local
neighborhoods on a scale from 0 to 100, with a higher score indicating
a more decentralized network. We examined variation in network
measures across ICUs and tested the correlation between network
measures and the proportion of patients receiving daily interruption
of sedation (DIS).
Results There was wide variation in the networks, with density ranging
from 79 to 96 and clustering ranging from 88 to 97. Two sample
sociograms are shown in Figure 1: ICU A had a very high density (96)
and clustering coefficient (97) suggesting a cohesive and decentralized
network, contrasting with ICU H that had the lowest density (79) and
clustering coefficient (88). Greater density and clustering was positively
associated with DIS (B = 0.02 (–0.10, 0.14); B = 0.003 (–0.07, 0.07)) but
did not achieve statistical significance in our small sample.

Figure 1 (abstract P18). Sociograms of ICU A and ICU H.

Conclusion We found substantial variation in ICU nursing networks
across eight ICUs in one academic medical center. These patterns may
have implications for evidence-based practice implementation. More
work is needed to understand the role of network analysis as a reliable
tool for improving and understanding ICU organization.
P19
Compassion fatigue and burnout among healthcare professionals
in the ICU
M Van Mol1, E Kompanje1, J Bakker1, M Nijkamp2
1
Erasmus MC, Rotterdam, the Netherlands; 2Open University, Heerlen, the
Netherlands
Critical Care 2014, 18(Suppl 1):P19 (doi: 10.1186/cc13209)
Introduction This study comprises a systematic review of studies
focusing on the prevalence of compassion fatigue (CF) and burnout
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(BO) among professionals in the ICU, to indicate the size of this
problem. Both CF and BO have an important impact on daily quality of
life of professionals and may threaten patient care. A growing body of
research suggests that BO appears to be common among ICU nurses [1]
and physicians [2] due to a highly stressful work environment. However,
BO might be overestimated and seen as a fashionable diagnosis [3]. The
overlap of BO with CF, secondary traumatic stress (STS) and vicarious
traumatisation has recently been explored [4]; CF seems to apply more
to ICU staff and might be a lead in future preventive strategies.
Methods A review of the literature between 1998 and December 2013
was conducted using eight databases, and included the keywords CF,
STS, BO, ICU, nurses and physicians. The references were screened for
relevancy at title/abstract using predefined inclusion and exclusion
criteria. Studies were limited to original and review articles in the English
language. Two independent researchers assessed the methodological
soundness of each article.
Results All references, retrieved from electronically database search (n =
1,432) and manual search (n = 3), resulted in 100 relevant publications
for full-text screening. Subsequently, articles with only an abstract
available (n = 28), a language barrier (n = 27), or prevalence not shown
in percentages (n = 23) were removed. Finally, a sample of 22 eligible
articles were appraised as methodologically sound and systematically
analysed for this review. The prevalence of BO in the ICU varied from
1.2 to 49% and differed in defining a severe BO. Two studies reported
the prevalence of CF, 7.3% and 40%, and five studies described the
prevalence of STS in a range from 21 to 44%.
Conclusion The emotional price of working at the ICU can become a
burden in personal life, but the size of the problem in ICU staff remains
unclear. Because the decreased well-being of the professionals might
negatively influence the quality of care, preventive strategies should be
developed in order to alleviate the distressed. Further exploration of CF
might provide sufficient starting points.
References
1.
2.
3.
4.

Mealer et al.: Am J Respir Crit Care Med 2007, 175:693-697.
Embriaco et al.: Am J Respir Crit Care Med 2007, 175:686-682.
Kaschka et al.: Deutsch Arztebl Int 2011, 108: 781-787.
Meadors et al.: J Pediatr Health Care 2008, 22: 24-34.
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Effect of divergences about patient’s care plan on the outcome of
critically ill patients
EL Queiroz, G Schettino
Hospital Sírio-Libanês, São Paulo, Brazil
Critical Care 2014, 18(Suppl 1):P20 (doi: 10.1186/cc13210)
Introduction There is an actual discussion about the best way to
provide medical care for critically ill patients, particularly between
the classical opened versus closed ICU models [1,2]. In Brazil, all ICUs
have to have a full-time and dedicated physician at the unit but the
primary physician also can visit his patient every day and, most of the
time, participates in the patient’s care plan. This hybrid model creates
opportunity for patient’s care plan divergences between the ICU staff
and the primary physician. The objective of this study is to evaluate
the effect of divergences about patient’s care plan on the outcome of
critically ill patients.
Methods A prospective court study was conducted (from January
to May 2013) to point out the patient’s care divergences (blood
transfusion, diuretics, antibiotics, vasopressors, mechanical ventilation,
and so forth) that happened in the first 72 hours of ICU admission in a
30-bed adult Brazilian ICU. We enrolled only patients that stayed more
than 48 hours in the ICU.
Results In a court of 357 patients at least one divergence between the
ICU medical staff and the primary(s) physician(s) were identified in 31
cases (8.6% – divergence group (DG)). The age (67.9 years), gender
(55.2% of male), SAPS3 score (45.7) and reasons for ICU admission
(emergency surgery 7.6%, nonemergency surgery 30%, clinical 62.4%)
were similar in DG and nondivergence (NDG); however, the ICU length
of stay (6.2 vs. 3.9 days, P = 0.023), use of mechanical ventilation
(48.4% vs. 27%, P = 0.012), vasopressors (77.4% vs. 46%, P = 0.001) and
blood transfusion (41.9% vs. 27.6%, P = 0.073) were higher in the DG
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compared with NDG. Discordance was associated with higher ICU and
hospital mortality (35.5 vs. 11%; OR = 4.09; P <0.001 and 45.2 vs. 20.1%;
OR = 2.77; P = 0.02 respectively).
Conclusion The occurrence of divergences, even during the first days
of ICU admission, about medical plans of care for critically ill patients is
frequent and is associated with higher ICU and hospital mortality and
more use of medical resources.
References
1.
2.

Multz AS, et al.: Am J Respir Crit Care Med 1998, 157(5 Pt 1):1468-1473.
Pronovost PJ, et al.: JAMA 2002 288:2151-2162.
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Prevalence, risk factors and consequences of intra-team conflicts in
the ICU
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Critical Care 2014, 18(Suppl 1):P21 (doi: 10.1186/cc13211)
Introduction The ICU is a stressful place with several sources of conflicts.
Among ICU workers, conflicts lead to burnout, loss of psychological
well-being, and deterioration of the work performance. Intra-team
conflicts (conflicts that occur among members of the intensive care
team) are one of the most frequent types of conflicts in the ICU. The
objectives of this study were to determine the prevalence, risk factors
and consequences associated with intra-team conflicts in the ICU.
Methods A survey was conducted in 12 Uruguayan adult ICUs in 2009.
ICUs and clinician’s characteristics were assessed for their association
with the prevalence of conflicts. All factors associated with conflicts
were introduced into a multivariable model.
Results A total of 384 questionnaires were collected, 74.5% (n = 286)
were nurses and 23.2% (n = 89) were intensivists. From the 384 forms,
45.8% perceived at least one conflict in the past year. Conflicts were
perceived more frequently by intensivists (61.8%) than nurses (40.9%)
(P = 0.001). A worse relationship with intensivists (OR 1.3; 95% CI 1.09
to 1.59; P = 0.004) is independently associated with conflicts. However,
lower grade of irritability (OR 0.8, 95% CI 0.73 to 0.97; P = 0.01) and a
higher position in the ICU (OR 0.57 95% CI 0.36 to 0.92; P = 0.02) are
factors independently associated with a lower incidence of intra-team
conflicts. Interestingly, this study confirms that workers with at least
one conflict had more frequently: libido disturbances (56% vs. 40%;
P = 0.002), eating problems (52% vs. 40%; P = 0.02), as well as the wish
to leave the ICU (53% vs. 39%; P = 0.005).
Conclusion The prevalence of conflicts is very high among ICU workers
in Uruguay. We have identified different risk factors associated with the
development of conflicts. These results confirm previous findings and
highlights that strategies to decrease intra-team conflicts in the ICU are
urgently warranted.
P22
Do we spend less on older critically ill patients? Relationship among
intensity of care, severity of illness and mortality
MD Rosa, AC Pecanha Antonio, M Mattioni, L Tagliari, F Schaich, J Maccari,
R Oliveira, C Teixeira, TF Tonietto, N Brandão da Silva
Hospital Moinhos de Vento, Porto Alegre, Brazil
Critical Care 2014, 18(Suppl 1):P22 (doi: 10.1186/cc13212)
Introduction The Therapeutic Intervention Scoring System (TISS-28)
quantifies the type and number of intensive care treatments; therefore,
it indicates the workload of ICU and may be used for calculating costs
[1]. A previous cohort study [2] demonstrated that seriously ill older
patients receive fewer invasive procedures and less resource-intensive
hospital care, showing a preferential allocation of hospital services to
younger patients regardless of severity of illness. The objective of this
study is also to compare resource utilization across different ages of
critically ill patients in an open model, mixed ICU.
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Methods During 7 years (2007 to 2013), TISS-28 was prospectively
applied to all consecutive adult critically ill patients at 24 and 72 hours
of ICU admission in a private hospital in Brazil. Demographic data,
diagnoses on admission, comorbidities, ICU length of stay and mortality
were recorded. Patients were stratified according to their ages.
Results TISS-28 scores at 24 and 72 hours of ICU admission were
analyzed for 4,128 patients. Mean patient age was 68.3 (SD ± 17.6),
46.8% were female and 37% were surgically ill. The mean APACHE II
score was 16 (SD ± 8) and 40% were submitted to mechanical ventilation
at any time of the stay. Overall mortality was 14.4%. Neither APACHE
II score adjusted for age nor TISS-28 in 24 and 72 hours of admission
differs among age groups. However, mortality was significantly higher
in patients aged 70 years or older (P <0.001).
Conclusion Mortality remained higher in older patients despite an
absence of age-related differences in resource use at ICU. Comparing
our results to a previous prospective cohort study [2], we emphasize the
lower overall mortality of our population (14.4% vs. 50%). Limitations of
our analysis include our unicenter design and lack of data for a closed
model ICU.
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New policy for ICU visits: prospective study
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Critical Care 2014, 18(Suppl 1):P23 (doi: 10.1186/cc13213)
Introduction ICU visits are generally limited to 2 hours per day
selected at any time during the 24 hours. At our institution we abide
to the international regulations which were recently modified allowing
family members and significant others to be present throughout
the day accompanying their ICU-admitted relatives, participating in
an uninterrupted timely fashion and no time limits with their daily
activities.
Methods From January 2012 through April 2012, 200 questionnaires
were filled by families of ICU-admitted patients; each questionnaire
includes 13 questions concerning their overall degree of satisfaction
at our unit and evaluating the quality. Accommodating spaces were
offered for families of ICU patients, offering them a state of freedom
within the ICU premises surrounding their beloved sick relatives;
additionally they were constantly advised by a designated secretary to
share their experience and any possible insight to improve the overall
polity of our service.
Results Two hundred patients were included in the study, the average
age of patients was 68.55 years and the average length of ICU stay was
5.2 days. Most family (85%) desired their presence accompanying their
related patients within the ICU premises when meals were served.
Those families expressed satisfaction while offering psychological
support to their beloved ill ones. Fifteen per cent of the families argued
about the permitted number of visitors (one person) per visit and
12% addressed lack of communication between the medical staff and
patient’s families.
Conclusion Compared with the limited visit status within the ICU ward
in the past, the majority of families expressed general acceptance
and satisfaction toward the newly adopted policy. Additionally and
by this new policy, patients displayed marked improvement at the
psychological level, being more cooperative and experiencing less
episodes of agitation. Even the medical team elaborated their interest
towards this policy as being a more profound and comprehensive way
of supporting the ICU patients. Further investigations are currently
being employed to strengthen the outcome of the study.
References
1.
2.

Derwick D, Kotagal M: Restricted visiting hours in ICU. J Am Med Assoc 2004,
292:736-737.
Bisaillon S, Li-james S : Family partnership in care: integrating families into
the coronary intensive care unit. Can J Cardiovasc Nurs 1997, 8:43-46.

S9

P24
Dealing with cultural diversity during the process of communication
and decision-making in the ICU: a literature review
RV Van Keer, RD Deschepper, LH Huyghens, WD Distelmans, JB Bilsen
Vrije Universiteit Brussel, Brussels, Belgium
Critical Care 2014, 18(Suppl 1):P24 (doi: 10.1186/cc13214)
Introduction Studies have shown that communication in the ICU
is related to the cultural background of all involved actors. As a
consequence, hospitals in multiethnic areas in western countries are
currently forced to rethink their models of communication as they are
increasingly transformed into spaces of cultural encounter. During this
process one needs to be aware of the cultural differences in attitudes
and experiences towards communication in critical medical situations.
However, the growing academic interest in intercultural relations
in the critical care has not yet led to the construction of cumulative
knowledge. The aim of this study is to review the experiences of the
involved actors, namely the care providers, the patients and their family
members, with cultural diversity during the process of communication
and decision-making in the ICU.
Methods A literature review was conducted. PubMed was searched.
The following combinations of Mesh terms were used: [(decisionmaking) OR (communication)] AND (intensive care) OR (intensive care
units)] AND [(cultural diversity) OR (multiculturalism) OR (migrants)
OR (culture) OR (ethnicity)]. A total of 111 studies were retrieved. We
excluded nonempirical studies, studies not written in English and
articles published before 2003. After screening the titles and abstracts
12 articles were selected. The full text of these articles was analyzed
and synthesized with a thematic-synthesis approach. During the
process we performed additional searches based on the bibliographies
of all the relevant articles.
Results Culturally specific expectations about communication and
decision-making, different views on gender roles, organization of the
care and expression and resolving emotional and social crises may
cause extra stress. The communication becomes more complex when
the language of the care providers differs from the language of the
patient and family. Intercultural communication can be improved by
specific actions such as ethnic matching, using an interpreter and the
formation of cultural-competent healthcare professionals.
Conclusion There is a lack of knowledge regarding the specific
experiences of patients, families and care providers with communication and especially decision-making in multicultural ICUs in Western
Europe.
P25
Symptoms of anxiety, depression and post-traumatic stress in pairs
of patients and their family members during and following ICU stay:
who suffers most?
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Critical Care 2014, 18(Suppl 1):P25 (doi: 10.1186/cc13215)
Introduction To compare the incidence of anxiety, depression and
post-traumatic stress symptoms in pairs of patients and respective
family members during the ICU stay and at 30 and 90 days post ICU
discharge. According to the literature, both patients and family
members suffer from psychological distress during and following an
ICU stay [1]. Although these issues have been discussed, to date few
studies have addressed the pairs at three times.
Methods A prospective study conducted in a 22-bed adult general
ICU including patients staying >48 hours. The Hospital Anxiety and
Depression Scale (HADS) was completed by pairs (patients/respective
family members). They were interviewed by telephone at 30 and
90 days after ICU discharge with the Impact of Event Scale (IES) and
the HADS. We separated them into three different groups (patients –
group A, family member of patient who survived – group B and family
member of patient who deceased – group C).
Results A total of 184 pairs were interviewed at the ICU. Mean
patient age was 59.33 ± 15.5 years. The admission SAPS III was
47.6 ± 15.7 points. Median ICU LOS was 4 days (2 to 47). Family’s age
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was 51.79 ± 13.47 and 64% were spouses. Patients had symptoms of
anxiety (26.1%), depression (12%) or both (8.7%) during the ICU stay.
Regarding family members, the incidence of anxiety, depression or
both during the ICU was 33.2%, 9.8% and 8.2% respectively. Symptoms
of PTSD within patients were found in 6.9% at 30 days and disappeared
at 90 days. Differently, these symptoms in family members were found
in 6.2% at 30 days and 9.0% at 90 days. There was a positive correlation
between HADS at ICU and IES at 30 days for family members (r = 0.527,
P <0.001). The HADS score over time between patients, family members
of patients who deceased and who survived were different (P = 0.002).
In post-hoc analysis, group A presented less symptoms than group C at
30 days (P = 0.001) and less than groups B and C at 90 days (P <0.001
for both). At 90 days, group B showed less symptoms than group C
(P = 0.039).
Conclusion Family members of ICU patients suffer more than the
patients principally when their loved one died. Patients’ symptoms
of anxiety, depression and PTSD decrease with time but in family
members these symptoms continue along the 90 days.
Reference
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Heart-focused anxiety in critically ill patients’ relatives
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University of Ioannina, Greece
Critical Care 2014, 18(Suppl 1):P26 (doi: 10.1186/cc13216)
Introduction A series of studies have shown an association between the
ICU environment and symptoms of psychological distress in critically ill
patients’ relatives [1-3]. The aim of this study was to investigate the risk
of cardiophobia and panic attack crisis on ICU patients’ family members.
Methods In the period from March 2012 to July 2013, we studied 223
family members (81 men and 142 women, mean age 41.5 ± 11.0 years)
of critically ill patients. These patients were admitted to the intensive
care department with various medical and surgical conditions (147
patients, 103 men and 44 women, mean age 58.3 ± 18.6 years). We
used a questionnaire in which were included: social–demographic
characteristics of the patients’ family environment, and the Cardiac
Anxiety Questionnaire (CAQ). The results from the CAQ [4] were
compared with those of the general population of Greece (GGP).
Results In comparison with the general Greek population, the relatives
of critically ill patients demonstrate statistically significant higher scores
(P <0.001) on the scales of fear and anxiety in regards of thoracic and
heart sensations (1.1 ± 0.9 vs. 0.9 ± 0.9 in GGP), avoidance of activities
considered to reproduce cardiac symptoms (1.3 ± 1.0 vs. 1.1 ± 0.9 in
GGP), heart-focused attention and self-monitoring of cardiac activity
(0.9 ± 0.7 vs. 0.7 ± 0.6 in GGP), and at total CAQ score (1.1 ± 0.6 vs.
0.9 ± 0.6 in GGP). Analysis of variance among family members on heartfocused attention and self-monitoring of cardiac activity showed that
hospitalization provoked heart-focused attention (that is, the main
factor of perceived panic crisis risk). In accordance with the Bonferroni
criterion, we found that patients’ siblings demonstrated statistically
significant difference compared with patients’ children (P = 0.015), with
the latter showing lower levels of heart-focused attention and selfmonitoring of cardiac activity. Further MANCOVA analysis showed a
statistically significant correlation between age and cardiophobia, and
also between education level and heart-focused anxiety (P = 0.041 and
P = 0.044 respectively).
Conclusion The hospitalization of a patient in the ICU is considered to
be a factor that is affecting the mental health of patients’ relatives. Our
results highlight a risk for psychologically induced symptoms on ICU
relatives and underline the need for a psychosocial support system for
them. The cardiophobia and self-monitoring of heart activity which
inflicts the patients’ relatives appears to be more intense in the siblings,
parents and partners of patients.
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Family satisfaction in the ICU: a 6-month experience
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1
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Critical Care 2014, 18(Suppl 1):P27 (doi: 10.1186/cc13217)
Introduction The aim of the study was to prospectively assess family
satisfaction in the intensive care setting and identify fields of possible
improvement.
Methods The study was performed over a 6-month period in a 10-bed
ICU. A properly translated and validated Family Satisfaction in the ICU
(FS-ICU 24) questionnaire was used. A total of 126 questionnaires were
handed out to family members upon patient discharge. The number of
questionnaires returned for evaluation was 120 (91.5% participation).
Five-point Likert scale responses were transformed to percentage
scores, higher values representing better satisfaction.
Results Overall satisfaction with care was reported as very good or
excellent by 81% of family members (32% and 49% respectively) both
for ICU staff concern and caring as well as symptom management.
Favorable scores were also noted in terms of decision-making, 89% of
relatives reporting very good and excellent rates as regards information
needs. On the other hand, most of the family members (73%) felt
neither included nor excluded from the decision-making process.
Moreover, a small number of them (6%) answered that they received
poor emotional support. Finally, the frequency of communication with
ICU nurses and the atmosphere in the waiting room were noted as fair
by 28% and 47% of subjects respectively.
Conclusion Most family members were highly satisfied with ICU
care their patients received. Nevertheless, our study showed that
the fields of communication with the nurses as well as the waiting
room atmosphere definitely need further improvement. Concerning
emotional support and decision-making, the study revealed that
currently used measures in our ICU still do not apply to all families and
probably require a few changes.
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Qualitative analysis of a family satisfaction in an adult ICU
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1
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Critical Care 2014, 18(Suppl 1):P28 (doi: 10.1186/cc13218)
Introduction Patient satisfaction is a key determinant of the quality
of care within the hospital environment. Critically ill patients often
lack capacity. Under such circumstances, family members are often
main decision-makers and their satisfaction about the ICU experience
resembles an important surrogate in evaluating the quality of care. We
aimed to measure family satisfaction with different aspects of medical
care.
Methods In February 2013, surveys, including 24 qualitative questions,
were sent out to relatives of 50 patients 1 month after their discharge
from ICU St George’s, UK. Responses were graded 1 to 5, with higher
values representing a greater degree of satisfaction.
Results Most respondents were satisfied with the overall performance
and the respect received (mean ± SD score 4.7 ± 0.68). Skills and
competency of doctors (4.38 ± 0.67) and nurses (4.57 ± 0.68) was
also perceived very positive. However, family satisfaction with
communication with doctors (3.52 ± 1.47) and nurses (3.71 ± 0.96),
as well as inclusion in decision-making (3.39 ± 1.24), resulted in
somewhat lower scores. In particular, ease, clarity, consistency,
honesty, and completeness of information given by doctors resulted in
inhomogeneous perceptions between relatives (Figure 1). Additionally,
the majority of responders felt only moderately satisfied with time and
support to make a decision.
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Figure 1 (abstract P28). Team performance.

Conclusion In general, relatives felt very satisfied with the ICU,
especially with the care of the patients and the professional workforce.
The complete decision-making process was rated moderately good,
which highlights some areas of improvement in involving relatives in
the care of their beloved by providing regular, clear, easy to understand
and consistent information.

P29
Outcomes of ventilated surgical and medical ICU patients: do
patients die from ARDS or with ARDS?
L Fuchs1, D Talmor2
1
Soroka University Medical Center, Beer Sheba, Israel; 2Beth Israel Deaconess
Medical Center, Boston, USA
Critical Care 2014, 18(Suppl 1):P29 (doi: 10.1186/cc13219)
Introduction Patients with acute respiratory distress syndrome (ARDS)
have a high mortality rate. Whether this excess mortality is contributed
by ARDS or is a consequence of prolonged mechanical ventilation is
unclear.
Methods A longitudinal retrospective study focusing on noncardiac
ICU patients who required mechanical ventilation. Patients were
classified as having ARDS on admission, late-onset ARDS or no ARDS.
The analysis included patients ventilated for longer than 48 hours.
Primary outcomes were mortality at 28 days, 1 year and 2 years from
ICU admission.
Results A total of 1,396 patients were enrolled between 2001 and
2008: 485 (34.7%) had ARDS on admission (early-onset ARDS), 219
(15.6%) developed ARDS during their ICU stay (late-onset ARDS) and
692 (49.5%) did not meet ARDS criteria prior to ICU discharge or death.
Twenty-eight-day mortality rates were 23.7%, 25.6% and 25.7% for
early, late and non-ARDS respectively. After adjusting for age, weight
on admission, unit of admission (MICU vs. SICU), severity of disease
score, comorbidity score, and primary diagnosis on admission, and
mortality risk at 28 days, 1 year and 2 years were not significantly
different between the three study groups. Neither severity of ARDS
or timing of ARDS (early versus late) was associated with mortality.
Sensitivity analysis, analyzing all ventilated patients, including those
who were ventilated less than 48 hours, showed the same results.
Conclusion Neither the presence of ARDS or the severity or timing
contribute independently to the short and long mortality risk after
adjustment for age, severity of disease, comorbidity score and
diagnosis on presentation in patients hospitalized in a noncardiac ICU
with acute respiratory failure.

Introduction Significant improvements in chemotherapy, haematopoietic stem cell transplantation and general intensive care mean
that more patients are now living longer and often present to the
ICU at various stages of their disease [1,2]. Encouraging patients with
haematological malignancy (HM) to express their wishes and values
on end of life (EoL) prior to ICU admission would ensure that their
autonomy is respected. The aim of our study was to determine whether
patients with HM that were admitted and died in the ICU had any form
of advance care planning (ACP) documented prior to their admission.
Methods Data were collected on all adult patients with HM that were
admitted and died in the ICU of a tertiary haematology referral centre
in London during the period of 1 year.
Results Information was collected for 34 patients and their characteristics are shown in Table 1. In 62% of the patients EoL decisions were
made, and do-not-attempt-resuscitation documentation was found
in 65% of the cases. Documentation on information exchange, and
participation in the deliberation or the decision-making process was
found in only 30% of the patients, even though more than 75% of the
haematology physicians estimated the prognosis of these patients as
moderate (17%) or poor (59%). In the vast majority of cases (31/34) the
deaths occurred after withholding or withdrawal of treatment in ICU.
Table 1 (abstract P30). Patient characteristics
Mean age

30

Median APACHE II score

26

>3 organ support

60%

Leukaemias

>50%

Conclusion Only a small number of patients with HM that die in the
ICU have documented ACP prior to admission. Since the majority of
ICU patients lack personal decision-making capacity, ACP would ensure
that care is consistent with patients’ wishes, EoL actions are congruent
with their values, the burden on family and healthcare providers is
alleviated and cost is decreased.
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Critical Care 2014, 18(Suppl 1):P31 (doi: 10.1186/cc13221)
Introduction Perceived futility of care may jeopardize patient quality
of care and increase ICU staff turnover. It is related to workload and
interdisciplinary collaboration. Our aim was to evaluate concepts
from team science, namely inclusive leadership (a style that invites
and appreciates others’ contributions) and psychological safety (a key
antecedent of speaking up and learning behavior), and to determine
their effect on perceived futility and intention to quit.
Methods A staff survey in four interdisciplinary ICUs and two
intermediate care units of two tertiary care hospitals. The questionnaire
contained validated scales to assess inclusive leadership of head nurses
and attending physicians, nurse–physician collaboration, collaborative
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decision-making, psychological safety, workload, intention to quit and
a newly developed scale for perceived futile care. English questions
were translated into German by state-of-the art forward and backward
translations. Reliability – that is, internal consistency and inter-rater
reliability of scales – was evaluated. Predictors of perceived futile care
and intention to quit were identified by multiple regressions.
Results A total of 220 nurses and 55 physicians participated. Scales
showed good reliability with all Cronbach’s alpha ≥0.8 and significant
between unit variability (all P ≤0.011). On a scale from 0 (‘never’) to 5
(‘very often’), ICU staff rated frequency of futile care as median 3.6 (IQR:
3 to 4). On a seven-point Likert scale with 7 denoting maximal values,
intention to quit was rated as 2.3 (1 to 4). Nurses gave significantly
lower ratings of job satisfaction than physicians (4 (3 to 5) vs. 5 (4 to
6), P ≤0.001), perceived futility more often than physicians (P ≤0.001),
and rated all aspects of nurse–physician collaboration worse than
physicians, including attendings’ inclusive leadership, collaboration,
decision-making and psychological safety (all P ≤0.001). Futility and
intention to quit were each predicted by high workload and low
psychological safety (all P ≤0.009). Among nurses, inclusive leadership
by the head nurse prevented intention to quit (P = 0.001) and a
composite score of good nurse–physician interactions predicted less
perception of futile care (P ≤0.001).
Conclusion The scales of the new questionnaire showed good reliability
and differentiated between nurses and physicians. Psychological safety
and inclusive leadership proved to be important concepts.

P32
ASA helps prediction of the death rate in surgical ICU patients
P Batista, R Passos, C Gomes, A Oliveira
Hospital Sao Rafael, Salvador Bahia, Brazil
Critical Care 2014, 18(Suppl 1):P32 (doi: 10.1186/cc13222)
Introduction Many scoring systems have been designed to predict
mortality in surgical patients; however, these systems require the
collection of several parameters that may not be available at ICU
admission. As a result, these classification systems are not used as a
routine part of clinical practice. The aim of this study was to evaluate
the prognostic value of ASA classification predicting ICU and hospital
mortality.
Methods We analyzed the records of 11,230 ICU admissions. ASA and
elective/nonelective nature of the admission were combined into
eight categories. We used the chi-square test and accepted the null
hypothesis if P >0.05. Areas under the ROC curve using ASA and ASA/
admission categories were constructed.
Results We included 5,998 patients admitted to the ICU immediately
after surgery. Forty-one percent were older than 65 years and 51% were
female. Length of stay previous to ICU admission was 2.5 ± 6.1 days and
duration of ICU stay was 1.9 ± 2.4 days. Elective hospital admission
occurred in 65% of the patients. Neurosurgery with 21% of the
procedures was followed by abdominal surgery (20%), and orthopedic
surgery (15%). The death rate at the hospital was 6.9% (2.8% in ASA I
patients and 31% in ASA IV/E). Higher ASA classification was significantly
associated with the death rate both in the ICU and at the hospital
(P <0.00001). The nonelective nature of the hospital admission was also
associated with higher risk of death at the ICU (P <0.0001) and in the
hospital (P <0.0001). Gender and hour of admission was not associated
with the death rate. The combination of ASA classification with the
nonelective nature of the hospital admission produced an eightcategory index significantly associated with mortality (P <0.00001).
Analyzing hospital mortality, the area under the ROC curve was 0.77
(95% CI 0.74 to 0.79) for this index and was 0.72 (95% CI 0.69 to 0.75) for
ASA. When analyzed for death at the ICU the AUROC was 0.71 (95% CI
0.69 to 0.75, P <0.0001) for ASA and 0.75 (95% CI 0.71 to 0.78, P <0.0001)
for ASA nonelective admission index.
Conclusion These results show that the ASA index can be used,
preferably in combination with other data from electronic records, to
predict mortality for surgical ICU patients.
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Introduction The aim of the ICU is to give the best life care to the
admitted patients in order to preserve and restore the patients’ quality
of life. In some critical patients, life-supporting therapies become
actions to support the end stage of their life [1]. This is the paradox
of the ICU. Patients affected by amyotrophic lateral sclerosis (ALS)
belong to this category: for these patients, all medical actions do not
improve the quality of life but just prolong it. ALS or Charcot’s disease
is the most common motor neuron disease which causes severe motor
disability and evolves in a few years to death [2]. We want to present
our experience in patients affected by ALS in the ICU.
Methods We collected data about patients affected by ALS admitted
to the ICU from 1 January 2010 to 31 October 2013. We considered
entry diagnosis, mean age, need to perform tracheostomy and/or
percutaneous endoscopic gastrostomy (PEG), and mortality in the ICU.
Results Sixty patients were admitted for neuromuscular respiratory
failure complicated by aspiration pneumonia. Mean age was 43 years.
The male to female ratio was 3:1. All patients underwent percutaneous
tracheostomy and PEG. One of them died in the ICU because of septic
shock. In every case we honestly communicated the worsening of the
disease and we perceived the awareness of it by the patients and/or
their family. In no case did patients ask us to withdraw the necessary
cures such as percutaneous tracheostomy and PEG. In no case did they
ask us to die. In Europe the ‘end of life care’ law is very dyshomogeneous
because of different cultures, traditions, religions, and beliefs. In Italy
euthanasia is not allowed by law. It is the physician often by himself
that has to make the final decision according to the patient’s mind.
Conclusion Our experience shows that patients affected by severe
motor disability are not always willing to die. It is essential that decisions
should be patient-centered and taken multidisciplinarily, based on
open and emphatic communication, involving family and caregivers.
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Death rate of patients admitted to a Brazilian ICU on weekends and
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Critical Care 2014, 18(Suppl 1):P34 (doi: 10.1186/cc13224)
Introduction Several studies conducted in a number of different
populations indicate that patients admitted to hospitals on weekends
have a higher mortality rate. Many factors have been proposed to
explain these observations and in most studies, however, this effect
disappeared after controlling for illness severity. We undertook the
present study to explore the effect that day of ICU admission may have
on death rate.
Methods We analyzed 11,230 electronic records from patients admitted
from 1 January 2006 to 30 June 2013. The ICU admission dates were
categorized as normal weekdays and as weekends and holidays. The
dependent variables were ICU mortality and hospital mortality. The chisquare test and Student t test were used as appropriate and significant
association was accepted when P <0.05. Multiple logistic regression
(backward conditional) was used accepting a variable when P <0.05
and rejecting a variable with P >0.1. SPSS version 19.0 was used.
Results Forty-nine percent of these patients were female, 53% was
admitted immediately after surgery, 56% had <2 days of previous
hospital admission, and 19.2% were admitted during weekends and
holidays. Mortality in the ICU for admissions on weekends and holidays
was 24% and was 13% for those admitted on weekdays (OR = 2.23, 95%
CI 2.02 to 2.47; P <0.0001). The hospital mortality was respectively 35%
and 20% (OR = 2.23, 95% CI 2.02 to 2.47; P <0.0001). Differences between
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patients admitted on weekends and on weekdays were found in the
group admitted after surgery (respectively 10% and 30%, P <0.0001),
originating from the emergency unit (respectively 30% and 16%;
P <0.0001), originating from step-down units (respectively 31% and
17%; P <0.0001), patients from clinical teams compared with surgical
teams (respectively 28% and 13%; P <0.0001), previous hospital length
of stay lower versus higher than 2 days (respectively 15% and 25%;
P <0.0001) and age ≥65 years (respectively 21% and 18%; P <0.0001).
The mortality ratios were significantly different between these groups.
Multiple logistic regression showed that the inclusion of other variables
reduces the odds ratio associated with admission on weekends and
holidays to 1.22 (95% CI 1.08 to 1.39, P <0.002) for ICU mortality and to
1.23 (95% CI 1.09 to 1.38, P <0.001).
Conclusion The higher death rate on weekends and holidays may be
related to case mix. The interplay of other variables possibly related
either to admission on weekends or higher death rate should be sought.
P35
How many ways are there to die? Identification of ICU death
typologies using cluster analysis
L Reineck, A Barnato, R Arnold, D Angus, J Kahn
University of Pittsburgh, PA, USA
Critical Care 2014, 18(Suppl 1):P35 (doi: 10.1186/cc13225)
Introduction Although avoidance of death is a key goal of critical care,
so too is provision of high-quality end-of-life care when life-prolonging
therapy is not desired. One often-used measure of ICU performance is
risk-adjusted mortality, yet this measure treats all deaths equally and
thus is flawed. In this work, we identify different death typologies using
cluster analysis, with the ultimate goal of more narrowly targeted ICU
quality improvement measures and efforts.
Methods We performed k-means cluster analysis in 2,047 ICU
decedents admitted to a university medical center in 2011/12.
Variables for the analysis included ICU length of stay (LOS), mechanical
ventilation, tracheostomy, gastrostomy tube insertion, dialysis, enteral
or parenteral nutrition, and cardiopulmonary resuscitation (CPR).
Results Four clusters were identified. Short ICU LOS and low lifesustaining therapy utilization but relatively frequent CPR characterized
Cluster 1. Intermediate ICU LOS and moderate life-sustaining therapy
utilization characterized Clusters 2 and 3. Prolonged ICU LOS and high
life-sustaining therapy utilization (except CPR) characterized Cluster 4.
Age and severity of illness decreased across clusters with the oldest,
sickest patients in Cluster 1 and the youngest, least sick patients in
Cluster 4. See Table 1.
Table 1 (abstract P35).

ICU LOS, mean ± SD (days)
Mechanical ventilation

Cluster 1
(n = 353)

Cluster 2
(n = 755)

Cluster 3
(n = 667)

Cluster 4
(n = 272)

0.5 ± 0.2

2.0 ± 0.8

7.2 ± 2.8

25.6 ± 15.2

282 (79.9%) 631 (83.6%) 604 (90.6%) 269 (98.9%)

Tracheostomy

3 (0.9%)

13 (1.7%)

14 (2.1%)

127 (46.7%)

CPR

20 (5.7%)

19 (2.5%)

16 (2.4%)

8 (2.9%)

Conclusion Cluster analysis can identify unique typologies of death
within ICUs. This approach may be a novel method to more specifically
target ICU efforts to reduce mortality and improve the quality of death.
P36
Independent risk factors associated with the decision to withhold
therapeutic intervention in patients admitted to the emergency
room
L Serpa-Pinto, T Cardoso
Oporto Hospital Center, Oporto, Portugal
Critical Care 2014, 18(Suppl 1):P36 (doi: 10.1186/cc13226)
Introduction The decision to withhold therapeutic intervention in a
patient is a complex decision, wrapped in profound ethical debates. The

role of the physician is to cure, treat and alleviate suffering. When the
first two goals are not possible the medical role should be dedicated to
end-of-life treatments adjusted to the patient’s benefit [1,2].
Methods A retrospective cohort study including all adult patients
with sepsis admitted to the emergency room (ER) at a tertiary care,
university hospital between 1 July 2011 and 30 June 2012.
Results During the study period 162 patients with sepsis were admitted
to the ER, of which 40 (25%) had withheld therapeutic decisions.
Comparing this group with the group without therapeutic limitations,
patients in the first group were older (81 ± 13 vs. 68 ± 14, P <0.001), with
more comorbidities (90% vs. 66%, P = 0.004) and a higher proportion
needing help in daily activities (Karnofsky performance status (KPS)
<70% = 55% vs. 8%, P <0.001). The hospital mortality in patients with
a decision to limit the therapeutic intervention was significantly higher
(83% vs. 43%, P <0.001). Variables independently associated with the
withholding therapy decision were age (adjusted OR per year = 1.078,
P <0.001), presence of comorbidities (adjusted OR = 4.632, P = 0.030),
chronic wounds (adjusted OR = 5.965, P = 0.005) and patient’s needed
of help in daily activities (KPS <70%, adjusted OR = 5.391, P = 0.012). In
the first group a lower proportion received antibiotics (70% vs. 99%,
P <0.001) and when those were considered inadequate for the agent
responsible for the sepsis episode it was less frequently changed (15%
vs. 50%, P = 0.028). However, no differences were found regarding the
elapsed time from admission to the ER until the first medical contact or
the time since the recognition of sepsis and antibiotic administration,
although the group with withholding decisions had less specimens
collected for microbiology: blood cultures (68% vs. 91%, P <0.001) or
other specimens (58% vs. 96%, P <0.001).
Conclusion In this study the decision to withhold therapy was
independently associated with increasing age, the presence of
comorbidities and loss of functional autonomy. For the same level of
intervention such as antibiotic administration, the decision to withhold
therapy did not influence the efficacy of therapeutic attitudes.
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Autopsy-detected diagnostic errors in critically ill patients with
cirrhosis
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Introduction Even with the availability of new and more effective
diagnostic procedures over the past decades, autopsy remains one of
the most reliable methods to validate clinical diagnoses. The aim of this
review was to determine whether autopsy plays a role in extending
knowledge about the cause of death in patients with cirrhosis who
died in the ICU.
Methods We conducted a retrospective review of medical records and
postmortem findings in critically ill patients with cirrhosis who were
admitted to a major university teaching medical ICU (MICU) between
August 2007 and August 2013. Agreement between diagnoses before
death and postmortem findings were compared using the Goldman
system [1]. Review was independently performed by a fellow in critical
care medicine and a board-certified attending. Autopsy diagnoses
included histologic and microbiological findings. The records were
also reviewed for demographics, APACHE II score and all performed
diagnostic procedures.
Results Of 641 patients admitted with diagnosis of cirrhosis, 86 (13%)
died in the MICU. Forty-five (52%) patients underwent an autopsy.
Forty-two autopsy reports were available for review, three histologic
and microbiological reports were missing. Major missed diagnoses
(principal underlying disease related to death and primary cause
of death itself ) were present in seven patients (17%), four in class I
(10%) and three in class II (7%) (Table 1). Minor missed diagnoses were
present in 13 patients (31%) (class III and IV). Postmortem findings were
in complete agreement (class V) with clinical cause of death in almost
one-half of the patients (n = 19, 45%).
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Table 1 (abstract P37). Major missed diagnosis
Class I (n = 11)

Class II (n = 3)

1. Metastatic linitis plastica

1. Acute pancreatitis

2. Oesophageal variceal bleeding

2. Necrotizing mucor mycosis pneumonia

3. Disseminated mucor mycosis

3. Focal aspergillosis (myocardial)
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Compared with survivors, nonsurvivors were older in age; had higher
ISS, APACHE II, BMI, lactic acid, INR and creatinine, and lower GCS, PaO2/
FiO2 and platelet count; were more likely to be mechanically ventilated
and on vasopressors; and were associated with more head injuries.
Conclusion In KSA, abdomino-pelvic traumas are serious injuries
affecting mainly young male victims; however, with a lower mortality
than predicted.

4,5,6. Invasive aspergillosis (n = 3)
7. Invasive candidiasis
8. Herpes simplex pneumonia
9. Pneumocystis pneumonia
10. Gastric rupture
11. Disseminated HCC, vs. porta thrombosis
Class I = missed major diagnosis that would have changed management and
might have resulted in cure or prolonged survival. Class II = missed major
diagnosis that would not have modified ongoing patient care.

Conclusion Despite declining rates worldwide, autopsy remains an
important tool for quality and safety assurance. In this retrospective
study, autopsy showed that knowledge of the correct premortem
diagnosis would have altered therapy in 10% of critically ill cirrhotic
patients.
Reference
1.

Goldman et al.: The value of autopsy in three medical eras. N Engl J Med
1983, 308:1000-1005.
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Profile, outcomes, and predictors of mortality of abdomino-pelvic
trauma patients in a tertiary ICU in Saudi Arabia
S Haddad, Z Youssef, S Azzam, A Aldawood, A Al-Zahrani, H Al-Zamel,
H Tamim, A Deeb, Y Arabi
King Abdulaziz Medical City, Riyadh, Saudi Arabia
Critical Care 2014, 18(Suppl 1):P38 (doi: 10.1186/cc13228)
Introduction Saudi Arabia (KSA) has the world’s highest number
of deaths from motor vehicle accidents (MVAs). Numerous trauma
victims sustain abdomino-pelvic injuries which are associated with
considerable morbidity and mortality. The purpose of this study is to
describe the profile, outcomes and predictors of mortality of patients
with abdomino-pelvic trauma admitted to the ICU in a tertiary care
trauma center in Riyadh, KSA.
Methods This is a retrospective analysis of a prospectively collected
ICU database. All consecutive patients older than 14 years with
abdomino-pelvic trauma from March 1999 to June 2013 were
included. The followings were extracted: demographics, injury severity,
mechanism and type of injury, associated injuries, use of vasopressors
and mechanical ventilation, and worse laboratory results in the first
24 hours. The primary outcome was hospital mortality. Secondary
outcomes were ICU mortality, mechanical ventilation duration, need
for tracheotomy, and ICU and hospital length of stay. We compared the
profile, outcomes, and the predictors of mortality between survivors
and nonsurvivors.
Results Of 9,974 trauma patients during the study period, 702 patients
with abdomino-pelvic trauma were admitted to the ICU. The average
age was 30.7 ± 14.4 years and the majority was male (89.5%). MVA
was the most common cause of abdomino-pelvic trauma (86%). Pelvis
(46.2%), liver (25.8%), and spleen (23.1%) were the most frequent
injuries; and chest (55.6%), head (41.9%), and lower extremities (27.5%)
were the most commonly associated injuries. Mechanical ventilation
was required in 89.6%, emergency surgery was performed in 45%
and vasopressors were used in 46.6% of patients. The most commonly
performed interventions during the ICU stay were surgery (39.5%) and
chest tube insertion (33.3%). Of the 702 patients with abdomino-pelvic
trauma, 115 (16.4%) patients did not survive. Associated head trauma
and retroperitoneal hematoma, higher level of lactic acid on admission
and ISS, and advanced age were independent risk factors for fatality.
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Radiation exposure in trauma patients is affected by age
M Wagner1, JV Vonk2, CW Wichman1, AH Hegde3, JO Oliveto3
1
Creighton University, Omaha, NE, USA; 2University of Iowa, Iowa City, IA, USA;
3
UNMC, Omaha, NE, USA
Critical Care 2014, 18(Suppl 1):P39 (doi: 10.1186/cc13229)
Introduction Trauma patients are subjected to higher radiation
exposure (RE) as a function of Injury Severity Score (ISS) [1]. Analysis of
this dataset was done to ascertain if RE varied with patient age.
Methods Data collection was as previously described [1]. RE was
measured in milliSieverts (mSv). RE as a function of the ISS and age was
explored for 7,661 trauma patients. The ISS groupings were as follows:
ISS 1 to 8, ISS 9 to 15, ISS 16 to 25, and ISS >25. Age groupings were 19
to 39, 40 to 59, 60 to 79, and >80 years.
Results The data were analyzed in a hierarchical fashion: the mean
exposure by age group was compared by one-sided, two-sample
t tests. Differences were set up to test if mean exposure decreased
with increasing age. Bonferroni adjustment was used for all multiple
comparisons to maintain the overall error rate at 0.05. Of the six
independent difference tests conducted, five were significant: 19 to 39
versus 60 to 79; 19 to 39 versus >79; 40 to 59 versus 60 to 79; 40 to 59
versus >79; and 60 to 79 versus >79 (P <0.01). Analysis was done for
ISS categories: ISS 1 to 8, ISS 9 to 15, ISS 16 to 25, and ISS >25. For ISS
1 to 8, five differences were significant: 19 to 39 versus 60 to 79; 19 to
39 versus >79; 40 to 59 versus 60 to 79; 40 to 59 versus >79; and 60 to
79 versus >79 (P <0.01). For ISS 9 to 15, all differences were significant:
19 to 39 versus 40 to 59; 19 to 39 versus 60 to 79; 19 to 39 versus >79;
40 to 59 versus 60 to 79; 40 to 59 versus >79; and 60 to 79 versus >79
(P <0.01). For ISS 16 to 25, four differences were significant: 19 to 39
versus 60 to 79; 19 to 39 versus >79; 40 to 59 versus 60 to 79; and 40
to 59 versus >79 (P <0.01). For ISS > 25, none of the differences were
significant.
Conclusion Previous studies show significant RE in trauma patients [1].
We demonstrated the significance of RE to trauma patients, that the
amount of RE has gone up chronologically over time, and that patients
with an increasing ISS have a higher RE. We sought to determine
whether age played a factor in RE. Based on our statistical analyses,
older patients receive less RE for a given ISS. Although this is a large
assessment of RE and trauma patients broken down by ISS and patient
age, data analysis by year was limited by the small number of patients
in high ISS groups at higher ages.
Reference
1.

Wagner M, et al.: 258 Increased Injury Severity Score is associated with
increased radiation exposure in trauma patients. Crit Care Med 2013,
41:A59.
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Survival rate and predictors of outcome in intubated patients with
haematological malignancies in a Greek ICU
V Tsolaki, M Karapetsa, G Ganeli, A Mpouzia, E Zakynthinos
University Hospital of Larissa, Greece
Critical Care 2014, 18(Suppl 1):P40 (doi: 10.1186/cc13230)
Introduction The admission of patients with haematological
malignancies to the ICU is associated with high mortality, especially
when mechanical ventilation is required [1,2]. The purpose of the
present study was to explore survival rates and the predictors of
survival in this group of patients.
Methods A retrospective study of intubated patients with haematological malignancies, admitted to a general ICU in central Greece, due
to any cause.
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Results During a 10-year period (2003 to 2013), 16 patients with
haematological malignancies (nine with acute myelogenous leukaemia,
four with non-Hodgkin lymphoma, one with Hodgkin lymphoma
and two with multiple myeloma, mean age 50.75 ± 16.59) (male/
female 3/13, mean APACHE II score 23.18 ± 6.67, mean SOFA score
12.50 ± 2.82, CRP 16.00 ± 10.13, WBC 2.055 ± 30.053) were admitted
to the ICU. The majority of patients were admitted due to ARDS (PO2/
FiO2 164 ± 109), one patient was admitted due to intestinal rupture
and peritonitis and the other one due to intracerebral haemorrhage.
In the majority of the patients (13/16) diagnosis of the malignancy was
made during the present admission and only three had the malignancy
for a longer period (5 months to 3 years). The mean ICU length of stay
was 10.56 ± 16.19 days. A total 68.75% (11/16) of the patients were
intubated upon admission, whereas the mean time to intubation for
the rest of the patients was 6.37 ± 4.16 hours. Neither intubation upon
admission nor time to intubation was correlated with survival. Type
of haematological malignancy, duration of immunosuppression and
preceding length of stay in the general ward did not correlate with
survival either. The survival rate was 18.7% and in linear regression
analysis, duration of treatment with NIV in the general ward, increased
SOFA score and the number of platelets (<50.000) upon admission to
the ICU were independent predictors of survival (R2 = 0.77, P = 0.017).
Conclusion The present retrospective study indicates that patients
with haematological malignancies have poor survival when they are
admitted to the ICU. Longstanding treatment with NIV before ICU
admission, high SOFA scores and low platelet levels upon admission
negatively affect survival.
References
1.
2.

Cherif H, et al.: Support Care Cancer 2007, 15:1393-1398.
Comet AD, et al.: Eur J Haematol 2005, 74:511-516.

P41
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malignancies admitted to critical care
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Critical Care 2014, 18(Suppl 1):P41 (doi: 10.1186/cc13231)
Introduction Critical care (CC) admission has traditionally been
viewed as likely to result in a poor outcome for immune-compromised
haemato-oncological (HO) patients [1,2]. Recent studies have
challenged such views [3,4]. We recently reported results from a cohort
of HO patients admitted to CC, showing the pAO2/FiO2 (P/F) ratio to be
the only independent predictor of mortality [5]. We report analyses of a
larger cohort of HO patients admitted to CC.
Methods We assessed outcome for HO patients at CC (primary
outcome) and hospital discharge, and at 6-month and 1-year followup. Single variable logistic regression analyses, adjusted by age,
gender and haematological diagnosis, and multivariate analyses were
performed to identify independent predictors of outcome using STATA.
Results A total of 225 HO patients were admitted to CC. Median age
was 59 (interquartile range (IQR) 46 to 66) years. The most common
haematological diagnoses on admission were acute myeloid
leukaemia in 57 (25.3%) cases, non-Hodgkin lymphoma in 54 (24%)
cases and multiple myeloma in 42 (18.7%) patients. Median APACHE II
score was 21 (IQR 17 to 26). A total of 164 patients (72.9%) had at least
one organ supported. Unit and hospital mortality rates were 34.7% (78
patients) and 49.3% (111 patients), respectively. At 6-month and 1-year
follow-up, mortality increased to 63.1% (142 patients) and 70.5% (153
patients), respectively. The APACHE II score (OR = 0.93, 95% CI = 0.89 to
0.97, P <0.001), number of organs supported (OR = 0.34, 95% CI = 0.23
to 0.48, P <0.001), P/F ratio (OR = 1.06, 95% CI = 1.03 to 1.09, P <0.001),
inotropic requirement (OR = 0.27, 95% CI = 0.15 to 0.49, P <0.001), and
IMV status (OR = 0.06, 95% CI = 0.03 to 0.14, P <0.001) influenced unit
survival at single variable analyses. At multivariate analysis, the P/F ratio
(OR = 1.05, 95% CI = 1.02 to 1.09, P = 0.002) and IMV status (OR = 0.12,
95% CI = 0.04 to 0.35, P <0.001) independently predicted outcome.
Conclusion Organ failures and need for organ support correlated with
outcome. P/F ratio and need for IMV were independent predictors of
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mortality, in agreement with previously published data [6]. The CC
mortality rate was 34.7%; at 1 year, mortality had risen to 70.5%.
Acknowledgement AT and KB are joint first authors.
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Introduction There are no well-validated risk scores for patients
with oncological and hematological malignancies presenting to the
emergency department (ED). Previous research found the prognostic
blood biomarker pro-adrenomedullin (proADM) to be associated with
infection-related complications and mortality and thus may be helpful
in managing febrile patients with malignancies. Yet the prognostic
value of proADM in general oncological patients presenting to the
ED remains unclear. Herein, the objective of this study is to evaluate
the prognostic potential of proADM and clinical parameters in a
consecutive cohort of patients with oncological and hematological
malignancies with regard to ICU admission and 30-day mortality.
Methods We enrolled all consecutive patients with oncological and
hematological malignancies seeking ED care at a tertiary care hospital
from February 2013 to October 2013. We prospectively collected
various clinical features, and measured blood parameters including
proADM upon admission. To assess outcomes, data from electronic
medical records – that is, ICU admission, length of stay (LOS), and postacute care location – were used and we contacted all patients 30 days
after hospital admission. Logistic regression models with area under
the receiver operating curve (AUC) were used to assess association of
baseline parameters and outcomes.
Results We included a total of 469 patients with oncological and
hematological malignancies, of whom 8.9% (n = 42) were admitted
to the ICU and 18.7% (n = 88) did not survive until the 30-day followup. There was a strong association of initial proADM levels and 30-day
mortality risk (odds ratio (OR) per 10-fold increase 9.9, 95% CI 4.3, 22.9)
with an AUC of 0.67 (95% CI 0.60, 0.74). This association remained
significant after multivariate adjustment for initial vital signs (blood
pressure, pulse, temperature) and comorbidities (chronic heart failure,
chronic obstructive pulmonary disease, diabetes, coronary heart
disease) with an adjusted OR of 9.0 (95% CI 3.1, 26.4). There was also
a significant association of proADM and LOS (adjusted regression
coefficient per 10-fold increase: 6.6, 95% CI 2.0, 11.2).
Conclusion This study including consecutive patients with oncological
and hematological malignancies found a moderate association of
proADM with 30-day mortality and LOS. proADM in combination with
clinical parameters may help to improve site-of-care decisions for these
patients in the future.
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Calculated radiation exposure for trauma patients is lower when
using the New Injury Severity Score versus the Injury Severity Score
to calculate injury severity
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Critical Care 2014, 18(Suppl 1):P43 (doi: 10.1186/cc13233)
Introduction We studied radiation exposure (RE) in trauma patients [1].
To adjust for injury severity the New Injury Severity Score (NISS) or the
Injury Severity Score (ISS) can be used to group patients. We sought to
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determine whether there is a difference in the calculated RE per group
when the patients are grouped using either the NISS or ISS.
Methods Data collection was as previously described [1]. RE was
measured in milliSieverts (mSv). Group analysis was done for both ISS
and NISS using the following severity score ranges (SSR) 1 to 8, 9 to 15,
16 to 25, and >25.
Results The analysis conducted in previous research [1] was repeated
for the data recategorized by NISS. The conclusions were identical;
increased NISS is associated with increased radiation exposure. A
total of 465 patients fell into different SSR when classified by NISS. The
distribution of exposure for each SSR, NISS versus ISS, was compared
using Wilcoxon’s test. For the range 1 to 8, there was no detectable
difference. There was a significant shift in the distribution of exposures
for the remaining three ranges (P <0.02). The exposure shift was
downward for NISS compared with ISS.
Conclusion In this analysis, with the exception of patients in groups
1 to 8 there was a significant decrease in RE in the NISS groups when
compared with the compared ISS group. Further analysis is needed to
determine the cause for this change and whether this difference will be
clinically significant.
Reference
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Introduction A prospective multicentre observational study was
carried out to assess the extent to which critical care teams manage
patients in hospital who are cared for outside the critical care unit.
The Health Service Executive (HSE) in Ireland is in the process of
implementing a national Early Warning Score (EWS) and, at an EWS of 7
or above, a referral to critical care is recommended. This study recorded
the EWS of patients referred to the critical care team and describes the
subsequent interventions made by the critical care team and patient
outcomes.
Methods Six critical care departments in university-affiliated hospitals
across Ireland collected data on all referrals to the critical care team over
a 6-week period. Data were anonymised, coded and analysed centrally.
Results A cumulative total of 399 calls were made to the critical care
teams in the six hospitals. The most common reason for referral was to
request a critical care review of a patient (n = 319, 79.9%). Other reasons
for referral included cardiac arrest, request to transfer patients from
other hospitals and requests for vascular access. The average duration
spent by the critical care team reviewing patients on the wards was
57 minutes. This increased up to 67 minutes for cardiac arrest calls. Of
the 319 critical care reviews, 160 (50.2%) patients were subsequently
admitted to critical care. A total 118 of this 160 had EWS of 7 or above,
while 42 scored less than 7 but were still deemed to require admission
to critical care.
Conclusion Regardless of the EWS, critical care teams are heavily
involved in the management of patients outside critical care units. Fifty
per cent of patients reviewed by the critical care team subsequently
required admission to a critical care unit. The trigger threshold (7 and
above) for referral to a critical care team currently recommended by
the EWS escalation protocol is more likely to predict need for critical
care admission. However, one in four patients referred below the
threshold also required admission to a critical care environment. This
study questions the safety of introducing such a protocol into acute
hospitals. Will noncritical care staff be forced to wait until patients
deteriorate further and reach the trigger threshold for referral or will
the role of the critical care team expand further to look after all patients
with abnormal EWS in hospital?
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Introduction We aimed to assess actions taken in response to variations
in the National Early Warning (NEW) score and to identify factors
associated with a poor response. The NEW score is a physiological score,
which prescribes an appropriate response for the deteriorating patient
in need of urgent medical care. This allows enhanced observation and
clinical review of patients, identifying patients at risk of acute mortality.
Methods We performed a prospective observational study of adult
patients admitted to an acute medical ward in a London district general
hospital over a 2-week period. Patient characteristics, NEW score, time
of day, day of week and clinical response data were collected for the
first 24 hours of admission. Patients with less than a 12-hour hospital
stay were excluded. The primary outcome measure was the quality of
clinical response. Data were analysed with univariate and multivariate
logistic regression.
Results During the study period 200 patients were included with a
median age of 70 (20 to 102) years. NEW scores were evenly distributed
between day and night (52% vs. 48%) with a greater proportion on
weekdays compared with weekend days (82% vs. 18%). The majority
of patients scored <5 (93% vs. 7%). Forty-seven (27%) patients
received an inadequate clinical response. Univariate analysis showed
no association with time of day (night 34% vs. day 38%, OR 0.83
(0.47 to 1.49), P = 0.556). However, day of the week (weekend 56%
vs. weekday 32%, OR 2.8 (1.30 to 5.84), P = 0.01) and increasing score
(NEWS ≥5 100% vs. NEWS <5 31%, OR 65 (3.8 to 1100), P < 0.0001)
were significantly associated with an inadequate response. Day of the
week was independently associated with an inadequate response after
adjusting for confounders (OR 3.08 (1.27 to 7.46), P = 0.013).
Conclusion Clinical response to NEW score triggers is significantly
worse at weekends, highlighting an important patient safety concern.
Reference
1.

Royal College of Physicians: National Early Warning Score (NEWS):
Standardising the Assessment of Acute Illness Severity in the NHS. Report of a
Working Party. London: RCP; 2012.

P46
Impact of obesity on outcomes in patients with sepsis
PP Dobesh, TR McGuire, DG Klepser, AL Himmelberg, DA Roberts,
KM Olsen
University of Nebraska Medical Center College of Pharmacy, Omaha, NE, USA
Critical Care 2014, 18(Suppl 1):P46 (doi: 10.1186/cc13236)
Introduction The purpose of this study was to evaluate the impact of
obesity on outcomes in patients with severe sepsis. Since obesity is
considered an inflammatory disease and is associated with elevations
in several inflammatory mediators important in the outcome of sepsis,
the relationship between obesity and outcome in septic patients was
studied.
Methods This retrospective cohort study included all patients over the
age of 40 with a confirmed diagnosis of severe sepsis and an ICU stay
at our academic medical center from 1 January 2005 to 31 March 2011.
Obesity was defined as a body mass index of 30 or greater. Data on
other patient demographics and APACHE II score at the time of sepsis
were collected from patient charts. Outcomes measured included inhospital mortality, development of acute respiratory distress syndrome
(ARDS), days on mechanical ventilation, hospital cost, and length of
stay.
Results We identified 824 patients who met the inclusion criteria for
this study. Of these patients, 257 (31.2%) were classified as obese.
The mean APACHE II score was similar between obese and nonobese
patients (23.3 vs. 22.4; P = 0.068). Obese patients had a similar rate
of in-hospital mortality (31.9% vs. 33.7%; P = 0.810) compared with
nonobese patients, but a significantly higher rate of development of
ARDS (49.4% vs. 34.4%; P <0.001). Obese patients also had significantly

Critical Care 2014, Volume 18 Suppl 1
http://ccforum.com/supplements/18/S1

more days on mechanical ventilation (6.2 days vs. 5.0 days; P = 0.005).
There was no relationship between mortality in obese patients on
mechanical ventilation (34.4% vs. 39.5%; P = 0.26) or ARDS (33.9% vs.
42.6%; P = 0.13) compared with nonobese patients. Hospital costs and
length of stay did not differ between the groups.
Conclusion Obesity significantly increased the incidence of ARDS and
days on mechanical ventilation in patients with sepsis. Previous work
has reported that obesity is associated with elevations in inflammatory
cytokines and adipokines, particularly IL-6, which is a known risk factor
for ARDS. The higher rate of ARDS in obese patients with sepsis identifies
a high-risk group where new therapies may be most beneficial and
where new methods of preventing ARDS can be targeted.
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Obesity is not associated with poor outcomes in older patients with
sepsis
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Introduction Studies suggest that obesity may influence mortality
in patients who develop sepsis. However, the mechanisms linked to
improved outcomes are unclear. Our aim was to assess the impact of
obesity on mortality at 30 and 180 days and cytokine expression.
Methods We used a platform of a negative randomized control trial in
subjects (n = 51) with a diagnosis of severe sepsis with ≥1 organ failure.
The cohort of severe septic subjects was stratified by obesity status
based on the body mass index (BMI >30). Primary outcomes: 30-day
and 180-day mortality; secondary outcome: difference in median (IQR)
of five inflammatory cytokines including tumor necrosis factor alpha
(TNFα), TNFα-receptor 2, interleukin (IL)-6, IL-1-receptor-antagonist (IL1ra) and IL-10. The measurement of median baseline cytokine levels
was done in serum by Luminex technology. Statistical significance was
defined as P <0.05.
Results Fifty-one subjects with severe sepsis were included in the
study; 37% of the patients were obese (BMI >30). Paradoxically, obese
severe septic patients had lower 30-day mortality (n = 1 (5%) vs. n =
9 (28%), P = 0.069) and 180-day mortality (n = 1 (5%) vs. n = 13 (41%),
P = 0.008), when compared with nonobese. The expression of TNFα,
TNFα-receptor 2, IL-6, IL-1ra and IL-10 was not statistically significant
different among obese versus nonobese severe septic patients.
Conclusion Obesity is associated with lower mortality rates at 30
and 180 days in patients diagnosed with severe sepsis. This survival
benefit was not associated with lower cytokine production among
obese patients. Further studies are needed to assess the mechanisms
associated with the survival benefit related to obesity in patients with
severe sepsis.
P48
Long-term outcome in COPD patients with pneumonic and
nonpneumonic exacerbation: a 6-year prospective follow-up study
EG Grolimund, AK Kutz, MA Alan, BM Mueller, PS Schuetz
Kantonsspital Aarau, Switzerland
Critical Care 2014, 18(Suppl 1):P48 (doi: 10.1186/cc13238)
Introduction Predicting long-term outcome in patients surviving a
pneumonic or nonpneumonic COPD exacerbation remains challenging.
This study investigates the association of clinical parameters and the
prognostic blood marker pro-adrenomedullin (proADM) measured
upon hospital discharge with 6-year mortality in well-defined cohort
of COPD patients.
Methods We prospectively followed consecutive COPD patients from a
previous Swiss multicenter trial (2006 to 2008) [1] over a 6-year followup and investigated all-cause mortality following hospital discharge.
Patients and/or treating general practitioners were contacted by
telephone interview to assess the vital status of patients. We used
Cox regression models and the area under the receiver operating
characteristics curve (AUC) to investigate associations of baseline
predictors and mortality.
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Results Overall mortality in the 469 included COPD patients was 55%
(95% CI 0.5 to 0.6) with a 14% (95% CI 0.1 to 0.2) mortality incidence
rate per year. Patients with pneumonic COPD exacerbation had a
more pronounced inflammatory response compared with patients
with nonpneumonic exacerbation with regard to levels of initial
C-reactive protein levels (median 158 mg/dl vs. 39 mg/dl, P <0.0001),
procalctionin (median 0.4 μg/l vs. 0.1 μg/l, P <0.0001) and proADM
(median 1.3 nmol/l vs. 0.9 nmol/l, P <0.0001), but long-term survival
was similar (HR 1.0, 95% CI 0.8 to 1.2). In univariate regression models,
proADM was significantly associated with mortality after 1, 3 and
6 years (HR 16.1 (95% CI 6.9 to 37.7), 10.5 (95% CI 5.7 to 19.6) and 10.4
(95% CI 6.2 to 17.7), respectively). There was no effect modification
by type of exacerbation. A model including clinical parameters (age,
coronary heart disease, heart failure, diabetes mellitus, chronic renal
failure, neoplastic disease, pneumonia, smokers) and proADM showed
good discrimination of long-term survivors from nonsurvivors with
AUC of 0.74 (95% CI 0.6 to 0.7).
Conclusion Clinical parameters and discharge levels of proADM allow
accurate long-term prognostication in COPD patients independent
of initial type of exacerbation. The focus on the best use of long-term
prognostic information to improve patient care and clinical outcomes
seems promising/rational.
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Introduction Based on expert opinion and case note review, the
UK National Confidential Enquiry into Peri-operative Outcome has
recommended provision of perioperative level 2 and 3 care to support
major surgery in older people, and particularly those with comorbidity
[1]. We wished to identify whether we could predict if the need was
uniform and whether any factors could predict the degree of organ
supports needed.
Methods A retrospective note review of all patients admitted to
a level 2 critical care unit in the 12-month period from 1 January
2012 to 31 December 2012 undergoing revision hip surgery either
as a two-stage or single-stage process. Surgery was undertaken at a
national referral unit and chosen to represent an appropriate group of
older, comorbid patients. Predefined preoperative and perioperative
data were collected from chart review, along with postoperative
physiological data whilst the patient was in critical care. This included
frailty, comorbidities, operative blood loss, anaesthetic technique and
level and duration or organ supports including the need for additional
medical review whilst on the unit. Frailty was assessed preoperatively

Figure 1 (abstract P49). Proportion of patients requiring additional
medical review on critical care by degree of frailty.
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using the Rockwood assessment tool by trained staff [2]. Data were
analysed using Microsoft Excel for Mac 2011 and Stata/IC 11.2 for Mac.
Results A total of 182 patients with a mean age of 69.8 years (range 29
to 92) were identified. Frail patients were significantly more likely to need
additional medical input in the postoperative period whilst on critical
care (Figure 1, P = 0.002) but this was not significantly linked to need for
vasopressors, evidence of sepsis or choice of anaesthetic technique.
Conclusion In complex revision orthopaedic surgery, the need
for postoperative level 2/3 support cannot be predicted from any
preoperative or intraoperative factors but patient frailty does indicate
the need for medical input in the postoperative period.
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Frailty measures in the critically ill: are we approaching a critical
age? A systematic review
R Pugh1, DL John1, C Thorpe2, C Subbe2
1
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Critical Care 2014, 18(Suppl 1):P50 (doi: 10.1186/cc13240)
Introduction As the general population ages, the proportion of critically
ill patients in whom frailty may adversely affect outcome is likely to
rise. The aim of this systematic review was to evaluate performance of
frailty measures in predicting ICU, hospital and long-term outcomes
following intensive care admission.
Methods We performed a literature search for original studies
in: EMBASE, MEDLINE, Web of Knowledge, Cochrane database of
systematic reviews, and Database of Abstracts of Reviews of Effects,
using the terms ‘frailty’, ‘frail elderly’, ‘critical care’, ‘critically ill’, ‘critical
illness’ and ‘intensive care’. Our study inclusion criteria were that the
study: included patients cared for in intensive care, captured data
relating to premorbid frailty, and reported ICU, hospital and/or longterm outcome data.
Results Initial searches identified 606 reports, of which, following
review of abstracts and removal of duplicates, 66 full-text papers were
evaluated. Of these, 11 met inclusion criteria. A further 19 papers that
met inclusion criteria were identified from relevant review articles
and reference lists. There was huge variation in populations studied,
methodology, frailty measures utilised and reported outcome
measures. Of the 30 included studies, 11 studies evaluated patients
undergoing major (including cardiothoracic) surgery, two studies
specifically assessed patients with pneumonia, one study investigated
patients in a burns ICU and one study restricted its investigation to
former nursing home residents. The most commonly used measures
of frailty were: measures of Activities of Daily Living (n = 9), which
predicted need for long-term institutional care, 30-day, 90-day,
6-month and 12-month mortality; Clinical Frailty Score [1] (n = 5), which
predicted ICU mortality, hospital mortality, 12-month mortality, quality
of life and functional dependence; and Knaus score [2] (n = 4), which
predicted ICU mortality, hospital and 12-month mortality.
Conclusion Measures of frailty appear to predict mortality and
functional dependence following critical admission across a wide
range of clinical conditions. However, comparative data regarding the
relative accuracy and reliability of frailty measures in the intensive care
population are currently deficient.
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Prediction of 1-year mortality of patients treated for more than
72 hours in an ICU
S Steenbergen, S Rijkenberg, H Endeman
Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands
Critical Care 2014, 18(Suppl 1):P51 (doi: 10.1186/cc13241)
Introduction ICU or hospital mortality rates have been reported as the
endpoint of ICU therapy for many years. The aim of this study was to
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determine the 1-year mortality after discharge from the ICU in patients
who were treated in the ICU for more than 72 hours and to identify
predictors for 1-year mortality.
Methods This study was conducted in a 20-bed mixed ICU of a teaching
hospital. The study sample was extracted from a dataset of all ICU
patients treated for more than 72 hours between 1 January 2007 and 1
October 2012. Demographic characteristics and clinical characteristics
at admission and during the ICU stay were collected. Characteristics of
patients alive 1 year after ICU discharge were compared with patients
who died within the first year after ICU discharge. Descriptive statistics
were calculated. Multivariate analysis of 1-year mortality was performed
using a logistic regression model with backward elimination. Survival
was analysed by the Kaplan–Meier method using the time interval from
day of ICU discharge until death.
Results During the study period, 740 patients were treated for more
than 72 hours in the ICU. The ICU mortality was 106/740 (14%). The
data of 617 ICU survivors were further analysed (17 patients were
lost to follow up). One-year mortality was 175/617 (28%), of which
85/175 (49%) patients died during hospital stay after ICU discharge.
Independent predicting factors of 1-year mortality were: age at ICU
admission (OR: 1.03; 95% CI: 1.01 to 1.05), APACHE IV predicted mortality
score (OR: 1.02; 95% CI: 1.02 to 1.03), number of comorbidities (one or
two co morbidities OR: 2.14; 95% CI: 1.42 to 3.23) (>3 comorbidities OR:
2.56; 95% CI: 1.16 to 5.62), readmission after ICU discharge within the
same period of hospital stay (OR: 1.98; 95% CI: 1.13 to 3.46) and the
diagnosis at admission (cardiovascular OR: 4.31; 95% CI: 1.73 to 10.76)
(sepsis OR: 2.67; 95% CI: 1.50 to 4.77).
Conclusion Of patients being treated for more than 72 hours in
the ICU, 28% died within 1 year after ICU discharge. One-half of
them within the hospital stay after ICU discharge. High age at ICU
admission, high APACHE IV predicted mortality score, high number
of comorbidities, readmission and an admission diagnosis within the
categories ‘cardiovascular’ and ‘sepsis’ are associated with an increased
1-year mortality after ICU discharge in this population. The burden of
patients dying after ICU discharge underlines the necessity for clear ICU
discharge criteria and post-ICU care.
P52
Long-term physical functioning and health-related outcomes in
survivors of intensive care
K Solverson, C Doig
University of Calgary, Canada
Critical Care 2014, 18(Suppl 1):P52 (doi: 10.1186/cc13242)
Introduction The long-term impact of critical illness on survivors’
physical and mental health remains unknown. Our aim was to create a
follow-up clinic for survivors of critical illness in order to quantitatively
examine muscle weakness, physical functioning and mental health and
relate these findings to health-related quality of life (HRQL) and ICU risk
factors.
Methods Study patients were selected from a 24-bed multidisciplinary
ICU. Fifty-six patients who were ≥18 years old, stayed longer than 4 days
in the ICU and did not have an acute brain injury were followed-up at 2
and 4 months post hospital discharge. Peripheral muscle strength (grip,
triceps, biceps, hamstrings, quadriceps and dorsiflexors) and physical
functioning were objectively assessed using hand-held dynamometry
and the six-minute walk test (6MWT); both were compared with age/
sex normative data. HRQL and mental health were assessed using the
Short Form-36 (SF-36), EuroQol-5D (EQ-5D) and Hospital Anxiety and
Depression Scale.
Results The median age of patients was 60 years, 68% were admitted
for respiratory illnesses, they were severely ill (median APACHE II, 19)
and had long ICU lengths of stay (median, 11 days). Muscle strength
was significantly reduced when compared with normative data in all
muscle groups at the 2-month and 4-month visits (2-month average
indexed overall strength, 72%, P <0.05). The median distance walked
during the 6MWT was 382 m at 2 months (median percent predicted,
72%) and it did not significantly change at the 4-month visit. Reduced
peripheral muscle strength was significantly correlated with lower
distance walked during the 6MWT. Reported HRQL by the SF-36 was
below national averages at both 2-month and 4-month visits (2-month
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physical composite score (PCS) 36.2, mental composite score 48.1; 50 =
national average). Reduced muscle strength was associated with low
scores on the SF-36 physical function and general health domains.
Performance on the 6MWT correlated with the SF-36 including the
PCS (P = 0.001). Screening positive for anxiety was associated with
both poor 6MWT performance and reporting dysfunction on the EQ5D domains. ICU/hospital length of stay, number of days ventilated,
severity of illness and organ dysfunction were not found to be
predictive of muscle strength or physical functioning.
Conclusion Our study gives qualitative evidence that survivors of
critical illness have reduced muscle strength, physical functioning and
HRQL after hospital discharge. Also, we have shown muscle weakness is
predictive of overall physical functioning, which in turn impacted HRQL
and mental health. No ICU risk factors were identified that predicted
deficits in muscle strength or physical functioning.
P53
Patients with prolonged stay on ICUs and the risk of mortality
within 1-year of cardiac surgery
A Grayson, N Coulson, N Scawn
The Liverpool Heart and Chest Hospital, Liverpool, UK
Critical Care 2014, 18(Suppl 1):P53 (doi: 10.1186/cc13243)
Introduction The aim of this study was to determine an appropriate
risk model to identify patients at high risk of prolonged ICU stay and to
aid patient consent prior to cardiac surgery.
Methods Data were prospectively collected on 5,440 consecutive
cardiac surgery cases between April 2009 and March 2012. The primary
outcome measure was the combined outcome of prolonged ICU stay
(length of stay greater than 20 days) and/or in-hospital mortality.
Logistic regression was performed to assess the predictability of
logistic EuroSCORE against the primary outcome. Low-risk, mediumrisk and high-risk groups were identified and subsequent risk of 1-year
mortality assessed. Survival status was determined at 1 year.
Results A total of 192 (3.5%) patients had a prolonged ICU stay and
187 (3.4%) in-hospital deaths occurred, resulting in a combined
primary outcome of 349 (6.4%). At 1 year, 371 (6.8%) deaths occurred.
The risk of death in-hospital and at 1 year was significantly higher in
patients with prolonged ICU stay (in-hospital mortality, 15.6% vs.
3.0%; P <0.001/1 year, 27.6% vs. 6.1%; P <0.001). The mean logistic
EuroSCORE for all patients was 10.9. Patients with prolonged ICU stay

Figure 1 (abstract P53). Risk of long stay versus 1-year mortality.
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had a significantly higher logistic EuroSCORE (20.3 vs. 10.6; P <0.001).
The logistic EuroSCORE was a reasonable predictor of prolonged ICU/
in-hospital mortality (OR 1.04, 95% CI 1.04 to 1.05, P <0.001) with a
receiver operating characteristic (ROC) curve of 0.72. The relationship
between a patient’s logistic EuroSCORE and predicted risk of prolonged
ICU is shown in the figure; including low-risk, medium-risk and high
risk groups. Around 50% of the entire cohort of patients had a logistic
EuroSCORE of 10 or less and an associated risk of prolonged ICU stay of
5% or less. See Figure 1.
Conclusion Using an existing risk prediction model, a patient’s risk of
prolonged ICU stay can be calculated using contemporaneous data.
This information could be relevant for aiding in providing informed
consent for cardiac surgery patients.
P54
Six-month outcomes in lung cancer patients surviving ICU
admission: results from a multinational multicenter study
M Soares1, JF Timsit2, G Burghi3, C Irrazabal4, N Pattison5, E Tobar6,
BF Almeida7, UV Silva8, LC Azevedo9, JI Salluh1, E Azoulay10
1
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Brompton NHS Foundation Trust, London, UK; 6Hospital Clinico Universidad
de Chile, Santiago, Chile; 7Hospital A.C. Camargo, São Paulo, Brazil; 8Fundação
Pio XII – Hospital do Câncer de Barretos, Barretos, Brazil; 9Hospital Sírio
Libanês, São Paulo, Brazil; 10Hôpital Saint Louis, Paris, France
Critical Care 2014, 18(Suppl 1):P54 (doi: 10.1186/cc13244)
Introduction Information about lung cancer patients surviving critical
illnesses is very scarce. Our aim was to evaluate the outcomes and
continuing of anticancer treatments in lung cancer patients surviving
ICU admission.
Methods Secondary analysis of a prospective multicenter study
including patients admitted for >24 hours to 22 ICUs in six countries
from Europe and South America during 2011. Readmissions and
patients in cancer remission >5 years were excluded. Logistic regression
was used to identify predictors for hospital mortality.
Results A total of 449 patients (small-cell (SCLC) = 55; non-SCLC =
394)) were admitted to ICUs, and out of them 275 (SCLC = 29; NSCLC =
246) were discharged alive from the hospital. Among them, 200
(73%) patients were alive and 72 (26%) had died at 6 months; three
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(1%) patients were lost to follow-up. Mortality rates were far lower
in the patient subset with nonrecurrent/progressive cancer and a
good performance status (PS), even those with sepsis, multiple organ
dysfunctions, and need for ventilatory support. Cancer recurrence
or progression occurred in 53 (26%) hospital survivors. Anticancer
treatments were recommended for 108 (39%) hospital survivors and
administered to 102. Treatments used were variable combinations of
surgical resection (7%), radiation therapy (34%), and chemotherapy
(80%). The initial treatment plan required reduction or modification in
35 (34%) patients. Post-hospital mortality was nonsignificantly lower in
the patients given the initial treatment plan than in the other patients
(17% vs. 32%, P = 0.065). Poor PS was the only factor associated with a
lower probability of receiving the initial treatment plan (OR = 0.20; 95%
CI, 0.05 to 0.87; P = 0.032). At 6 months, 71% patients were at home,
15% were hospitalized, and 7% were in hospice care; the location
was unknown for 6% patients. PS at 6 months was 3 to 4 in 19 (9.5%)
survivors.
Conclusion Post-hospital mortality in critically ill lung cancer patients
is relatively high and many patients require anticancer treatments after
discharge. PS before ICU admission is a major determinant of both
mortality and ability to receive optimal anticancer treatment in these
patients.
P55
Survival and quality of life in patients acquiring acute kidney injury
in the first 24 hours of ICU admission
I Soliman, L Peelen, D De Lange, D Van Dijk
University Medical Center, Utrecht, the Netherlands
Critical Care 2014, 18(Suppl 1):P55 (doi: 10.1186/cc13245)
Introduction Survival and quality of life (QoL) in ICU patients with
acute kidney injury (AKI) have been repeatedly reported as poor [1-3].
It is unknown whether early AKI, occurring during the first 24 hours of
ICU treatment, is also a strong predictor of poor long-term outcome.
Our aim was to describe the long-term outcomes of this specific group
of ICU patients.
Methods All patients admitted to our mixed ICU from July 2009 to May
2012 with early AKI were included. All survivors received the EuroQoL
EQ-6D-3L questionnaire. Early AKI was defined as creatinine >1.5 mg/
dl and urine output <150 ml/8 hours. Poor ICU outcome was defined as
either death or EuroQoL index <0.4 at 1-year follow-up.

Figure 1 (abstract P55). Survival.
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Results Out of 5,934 admissions, 269 patients were identified with early
AKI. After ICU discharge a large and significant difference in survival
between included patients and the Dutch population, matched for age
and gender, was seen (P <0.001). The median QoL index in surviving
patients was 0.65 (interquartile range (IQR) 0.45 to 1.00), versus 0.86
(IQR 0.84 to 0.89) in the Dutch population (P <0.001). Low QoL was
found in 11/59 (18.6%) survivors. In total, poor ICU outcome was seen
in 171/269 (63.6%) patients. See Figure 1.
Conclusion Patients developing AKI in the first 24 hours of ICU stay are
prone to poor outcome. Future research into prognostic factors for ICU
patients should include early AKI in their models.
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P56
Increasing age of patients admitted to intensive care, and
association between increased age and greater risk of post-ICU
death
B Creagh-Brown, S Green
Royal Surrey County Hospital, Guildford, UK
Critical Care 2014, 18(Suppl 1):P56 (doi: 10.1186/cc13246)
Introduction The population of the UK is ageing, with the fastest
increase in those ≥85 years. Increased age has been repeatedly
associated with adverse outcome and it is uncertain to what extent
this relates to the changes of ageing in themselves, or due to other
considerations. Age is a key variable in the majority of scoring systems
that relate patient characteristics to adverse outcome. We aimed
to assess change in age distribution of patients admitted to our ICU
over 20 years and examine the relationship between age of patient,
mortality and length of stay (LOS).
Methods Data were extracted from electronic records (WardWatcher)
and analysed using SPSS 20, GraphPad Prism 5.0 and Excel 2007.
Results ICU patients have become older by 4.4 months/year. By 2013
the median age was 66 and 15% of all patients are now ≥80 years –
a 36% increase since 1993. Compared with the reference group (61
to 70 years), those in the older deciles have increased risk of ICU and
hospital mortality (P <0.01). Fifteen per cent of all those 81 to 90 years
old and 20% of those >91 years old who do not die on the ICU go on
to die on the ward. It is unknown what proportion of these post-ICU
deaths was unexpected. Older patients had prolonged hospital LOS
(P <0.01) but not ICU LOS. See Figures 1 and 2.
Conclusion There are increasing numbers of older patients on ICUs in
the UK. In analyses uncorrected for severity of illness or comorbidities,
older patients are more likely to die on the ICU, and on the ward after
ICU. They also spend longer in hospital prior to discharge.

Figure 1 (abstract P56). Proportion of patients admitted to ICU aged
>80 years, over time.
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Conclusion The data on resource utilisation for this group of patients
may inform planning of critical care support for military operations
overseas.
P58
Very old patients with cancer admitted to the ICU: outcome and
predictive factors of mortality
L Hajjar1, M Franca1, J Almeida1, J Fukushima1, F Bergamin1, C Zambolim1,
P Camargo1, C Park1, E Osawa1, M Sundin2, R Nakamura1, F Galas1
1
Instituto do Cancer do Estado de São Paulo, Brazil; 2Heart Institute, São Paulo,
Brazil
Critical Care 2014, 18(Suppl 1):P58 (doi: 10.1186/cc13248)

Figure 2 (abstract P56). Post-ICU in-hospital mortality, by age.
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Outcomes of military patients treated at the UK Royal Centre for
Defence Medicine 2007 to 2013
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1
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Critical Care 2014, 18(Suppl 1):P57 (doi: 10.1186/cc13247)
Introduction UK military personnel injured overseas are repatriated
to the Royal Centre for Defence Medicine (RCDM) based at the Queen
Elizabeth Hospital Birmingham (QEHB) in Birmingham UK. We report
the demographics and outcomes of military patients treated on the
ICU at RCDM using data from the Intensive Care National Audit and
Research Centre over a 6.5-year period.
Methods Data on 570 admissions of 527 patients to the ICU at RCDM/
QEHB were analysed by ICNARC using standard methodology.
Results Some physiology and CCMDS data were missing for 175
patients. Age, sex and mortality are described in Table 1. A total of
90.9% of patients had traumatic injuries, 2.1% received CPR prior to
ICU admission, 1.5% prehospital. A total of 20.6% had head, neck or
spinal trauma. A total of 85.7% were transferred directly to the ICU from
a military hospital overseas, others coming to the ICU following surgery
at RCDM. Of the 382 patients with APACHE II score data the mean score
was 11.0 (SD 4.9), probably reflecting stabilisation in military hospitals
overseas or during aeromedical critical care transfer. The mean number
of ICU days was Level 3: 7.6 (SD 11.6); Level 2: 2.0 (SD 2.8). A total of
70.4% of patients required advanced respiratory support for a mean
of 7.5 days, and 33% required advanced cardiovascular support for a
mean of 3.7 days.
Table 1 (abstract P57). Case mix, demographics and outcome
n

570

Male (%)

97.9

Age

25.7

Trauma (%)

90.9

Died (%)

6.8

LOS

8.8

MV (%)

70.4

CRRT (%)

10.9

Neuro (%)

24.8

CV (%)

33.2

Introduction The rate of very old patients (≥80 years old) admitted to
intensive care has increased in the last years. Older age is associated
with a higher prevalence of chronic diseases, including cancer [1]. The
aim of the present study was to describe characteristics, outcomes and
predictive factors of mortality in very old patients admitted to the ICU.
Methods We performed a retrospective analysis of all cancer patients
who were 80 years or older admitted to the ICU between January 2009
and December 2012 in a tertiary reference cancer center. Data were
collected from medical records.
Results A total of 597 patients with cancer were included in the analysis.
Hospital mortality was 28.5%. These patients were more likely to have a
solid tumor, a localized disease and underwent surgery, chemotherapy
or radiotherapy recently. Variables associated with hospital mortality
in these patients were: lung cancer, metastatic cancer and at ICU
admission vasopressor requirements, acute respiratory failure, low
hemoglobin levels, elevated creatinine levels, elevated bilirubin
levels, acidosis and hyperlactatemia. By the multivariate analysis, the
following factors were independent factors associated with hospital
mortality: lung cancer (odds ratio (OR) = 6.3, 95% CI = 2.6 to 15.0,
P <0.001), lactate levels on ICU admission (OR = 1.03, 95% CI = 1.02 to
1.04), P <0.001), bilirubin levels on ICU admission (OR = 1.16, 95% CI =
1.04 to 1.30, P = 0.007) and creatinine levels on ICU admission (OR =
1.58, 95% CI = 1.35 to 1.85, P <0.001).
Conclusion Very old patients with cancer present acceptable rates
of survival after ICU admission. Similarly to younger patients, organ
function evaluation in the first hours of ICU can predict outcomes in
this specific population.
Reference
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A retrospective review of mortality and complications following
oesophagectomy in a large UK teaching hospital
N Pawley, CM Ball, K Wickenden, B Riley, M Clapham, B Eltayeb, A Glossop,
A Raithatha
Sheffield Teaching Hospital, Sheffield, UK
Critical Care 2014, 18(Suppl 1):P59 (doi: 10.1186/cc13249)
Introduction Just over 1,200 curative oesophagectomies are carried out
in the UK annually. Although in-hospital mortality rates have fallen (12
to 13% in 1998 to 2.5% 2013), complication rates remain high [1] with
anastomotic failure and respiratory failure common postoperatively
[2]. The aim of this retrospective review was to examine the outcomes
in patients who underwent oesophagectomies in our unit between
January 2010 and October 2012.
Methods We examined demographic data, survival (30 day and
1 year) and length of ICU and hospital stay. Case notes were reviewed
to identify postoperative complications including anastomotic
breakdown, reintubation and respiratory failure. Data were analysed
to examine the relationship between the use of postoperative noninvasive ventilation and intraoperative fluid volume and the incidence
of postoperative complications.
Results Seventy-two patients were identified as having undergone an
oesophagectomy between January 2010 and October 2012. Median
age was 65 and 82% were male. One patient died within 30 days (1.39%)
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and nine patients had died by 1 year (12.5%). The median length of
ICU and hospital stay was 4 days and 14 days respectively. Six patients
had an anastomotic leak (of which two were chyle leaks). Use of noninvasive ventilation (in 23.1% of patients) was not associated with an
anastomotic leak (chi-square P = 0.53), nor was the amount of fluid
given intraoperatively (Mann–Whitney U P = 0.410). Six patients had to
be reintubated and this was associated with a significantly increased
length of both ICU and hospital stay (Mann–Whitney U P = 0.01 and 0.03
respectively). Lower P/F ratios were also associated with a significant
increase in length of both ICU and hospital stay (P = 0.007 and 0.043).
Conclusion The overall mortality and morbidity rate was comparable
with that seen nationally. Our data suggest that the use of non-invasive
ventilation was not associated with anastomotic breakdown. A lower
P/F ratio in the postoperative period was associated with prolonged
ICU and hospital stay.
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Critical Care 2014, 18(Suppl 1):P60 (doi: 10.1186/cc13250)
Introduction The first description of SAPS II dates back to 1993 [1], but
little is known about the scoring accuracy in daily practice and factors
possibly affecting it. The purpose of this study was to evaluate accuracy
of SAPS II scoring by means of a nationwide survey.
Methods Twenty clinical scenarios, covering a broad range of illness
severity, were randomly assigned to a convenience sample of clinicians
or nurses of Swiss adult ICUs. They were asked to assign a SAPS II score
(including details for each item of the score) for one scenario. Results
were compared with a reference, as defined by five experienced
researchers using a Delphi method, and cross-matched with data
related to training and quality control for scoring, information on daily
practice of scoring, and structural and organizational properties of
each participating ICU.
Results Sixty-three (81%) of 78 adult ICUs participated in this survey. A
perfect match with each single reference item was found in 27 (7.8%)
of 345 scorings. The participants’ mean SAPS II scoring was 42.6 ± 23.4,
with a bias of +5.7 (95% CI 2.0 to 9.5) as compared with the reference
score. There was no evidence of variation of the bias according to
case severity, number of beds in the unit, number of residents during
workshifts, linguistic area, profession (physician vs. nurse), experience,
initial SAPS II training, and presence of a quality control system. The
items with highest scoring accuracy were bilirubin, temperature and
chronic disease (93%, 93% and 91% respectively), whereas the lowest
agreement was found for urinary output and for the Glasgow Coma
Scale (63% and 64%).
Conclusion This nationwide survey suggests a wide variability of SAPS
II scoring results. On average, SAPS II was overestimated by more than
10%, irrespective of the profession or experience of the scorer or the
structural characteristics of the ICUs. At least one person per unit
involved in the scoring should be trained by the national society and
should be responsible for the scoring quality.
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Abandoning the National Early Warning Score in our district general
hospital
B Mylrea Lowndes, M Mercer, H Robinson
Torbay Hospital, Torquay, UK
Critical Care 2014, 18(Suppl 1):P61 (doi: 10.1186/cc13251)
Introduction Early Warning Scores (EWS) are used in UK hospitals to
identify patients who are acutely unwell or needing urgent review. The
National EWS (NEWS) [1] was implemented in our institution and led
to a noticeable increase in the numbers of patients being triggered
for escalation of medical care, although clinically this was thought
unwarranted. This led to a potentially dangerous lack of faith in the
NEWS by clinical staff. We assessed whether it was safe to move to
VitalPAC™ EWS (ViEWS), a commercially available electronic EWS [2].
Methods All patients scored as ‘high risk’ by NEWS (with a score of 6
or more) in a snapshot audit of patients in our 500-bed acute district
general hospital were identified and reviewed clinically. All of these
patients were then recategorised using ViEWS. The clinical safety of this
recategorisation was then assessed.
Results Forty-six patients were identified in our hospital at the time of
the snapshot as being high risk according to NEWS. After recategorising
this cohort of patients using ViEWS, 36 were classified as high risk (in
this instance meaning a score of 5 or more). Subjectively the authors
did not have any clinical concerns created by moving 10 patients out of
the high-risk classification.
Conclusion ViEWS is more specific without being less sensitive. We
have replaced NEWS with ViEWS and feel that this is clinically safe.
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Introduction There is an unknown role for macrocirculation and
microcirculation endpoint resuscitation, which are combined as the
component of a prediction model for early mortality of patients with
severe sepsis and septic shock [1,2]. The aim of this study is to develop
a prediction model for early mortality (first 120 hours after onset [3]) of
patients with severe sepsis and septic shock based on macrocirculation
and microcirculation endpoint resuscitation.
Methods A retrospective cohort study was conducted in adult patients
with severe sepsis and septic shock hospitalized in the ICU, Cipto
Mangunkusumo Hospital, Indonesia. Patients’ outcome and time to
outcome were observed during the first 120 hours after severe sepsis
and/or septic shock onset. Independent predictors for early mortality
were identified by Cox’s proportional hazard regression analysis and
each was quantified to develop an early mortality prediction model. The
calibration and discrimination abilities of the model were determined.
Results Subjects consisted of 268 patients. Early mortality developed
in 70 patients. Two independent predictors for early mortality were:
lactate clearance <10% (adjusted hazard ratio (HR) 11.81 (95% CI 6.50
to 21.46)) and number of organ dysfunctions (two organs, adjusted HR
1.47 (95% CI 0.58 to 3.72); >2 organs, adjusted HR 3.79 (95% CI 1.65
to 8.69)). A scoring system as the predictive model was performed by
assigning 1 point for two organ dysfunctions, 6.5 points for >2 organ
dysfunctions, and 12 points for lactate clearance <10%. This scoring
system was stratified into two levels: low-risk (score <12, probability
for early mortality 7.8%) and high-risk (score ≥12, probability for
early mortality 72.3%) groups. The Hosmer–Lemeshow test revealed
good precision (P = 0.745) and the area under the receiver operating
characteristic curve showed very good discrimination ability (0.91 (95%
CI 0.87 to 0.97)).
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Conclusion A prediction model for early mortality of patients with
severe sepsis and septic shock can be developed based on two
parameters, lactate clearance and number of organ dysfunctions. A
model has been developed to predict and classify mortality risk.
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Introduction The Golden hour (GH) complies the concept that
definitive trauma care must be initiated within 60 minutes in order to
improve outcome, but evidence is conflicting [1,2]. A variety of injury
and health loss scores are used in post-impact care for assessing the
injury severity, probability of survival and long-term loss of health [3].
The aim of this study is to establish a relationship between the concept
of GH and disability or health-related quality of life (HRQoL) in trauma
patients and to compare injury scores and health loss scores in this
population.
Methods We analyzed patients from a trauma registry of a 700-bed
university hospital between January 2003 and December 2007 who
were alive 6 months after injury. A follow-up interview with the EQ-5D
questionnaire was conducted. Data included patient demographics,
type of injury, ISS, RTS and TRISS scores, ICU and hospital length of stay
(LOS), mortality and EQ-5D domains.
Results There were 78% (n = 589) males and the average age was
44 ± 20 years. Most trauma cases originated from metropolitan areas
and 91% (n = 688) of patients were managed within the GH. There was
an association of mortality with older age and penetrating trauma.
Mortality was higher for those with shorter length of stay. Those
treated within the GH were less likely to die. In the HRQoL analysis, over
one-half of the patients had moderate to severe problems in the Usual
Activities domain. The median EQ-5D Index was 0.66 (0.47 to 0.98).
There was no association of GH with HRQoL domains 6 months after
discharge from the ICU. For the TRISS there was a lower probability of
survival for the patients with severe problems in the physical health
domains. The same results were obtained for association with age and
LOS.
Conclusion The GH may be important as a survival outcome but not
as a HRQoL outcome. Patients with severe problems in EQ-5D physical
health domains showed lower probability of survival, were older and
had a longer ICU LOS.
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Introduction Blunt chest wall trauma accounts for over 15% of
all trauma admissions to emergency departments worldwide [1].
Reported mortality rates vary between 4 and 60% [2]. Management
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of this patient group is challenging as a result of the delayed onset
of complications. The aim of this study was to develop and validate
a prognostic model that can be used to assist in the management of
blunt chest wall trauma.
Methods There were two distinct phases to the overall study; the
development and the validation phases. In the first study phase, the
prognostic model was developed through the retrospective analysis
of all blunt chest wall trauma patients (n = 274) presenting to the
emergency department of a regional trauma centre in Wales (2009
to 2011). Multivariable logistic regression was used to develop the
model and identify the significant predictors for the development of
complications. The model’s accuracy and predictive capabilities were
assessed. In the second study phase, external validation of the model
was completed in a multicentre prospective study (n = 237) in 2012.
The model’s accuracy and predictive capabilities were re-assessed for
the validation sample. A risk score was developed for use in the clinical
setting.
Results Significant predictors of the development of complications
were age, number of rib fractures, chronic lung disease, use of preinjury anticoagulants and oxygen saturation levels. The final model
demonstrated an excellent c-index of 0.97.
Conclusion In our two-phase study, we have developed and validated
a prognostic model that can be used to assist in the management
of blunt chest wall trauma patients. The final risk score provides the
clinician with the probability of the development of complications for
each individual patient.
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Introduction Crush syndrome is often encountered in natural
disasters. It is a critical condition leading to multiple organ failure.
However, the mechanisms by which the local traumatic injuries
affect distant organs remain unknown. We paid attention to bone
marrow-derived mononuclear cells (BMMNCs) as therapeutic strategy
against crush injury. Transplantation of BMMNCs can elicit protection
and regeneration against damaged organs through their paracrine
properties and its clinical application has been realized to treat ischemia
reperfusion-related various diseases. We have previously reported that
multiple organ damage based on systemic inflammatory response is
induced in crush injury and the pathogenesis is largely dependent
on massive ischemia–reperfusion. We investigated whether BMMNCs
could suppress systemic inflammation and improve mortality in a rat
model of crush injury.
Methods To develop crush syndrome, both hind limbs of rats were
compressed for 6 hours under weights (3.0 kg each). Rats in the treated
group were intravenously administrated BMMNCs (1×107 cells in 1 ml
phosphate-buffered saline (PBS)) immediately after weight removal
(BMMNC group) and PBS alone was administered in the control
group (CR group). The sham group underwent the same procedure
without compression of hind limbs (SH group). The rats were observed
over 7 days after the injury to evaluate survival. To estimate antiinflammatory effects of BMMNCs, sera were collected 3 hours, 6 hours
and 24 hours after the injury. The levels of interleukin 6 (IL-6) and tumor
necrosis factor alpha (TNFα) were measured by ELISA and statistically
analyzed.
Results The survival rate at day 7 in the BMMNC group was 80.0%,
and that in the CR group was 47.6%, revealing that the 7-day survival
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was significantly improved by the BMMNC injection (P <0.05). Crush
injury-induced upregulation of serum IL-6 was significantly reduced by
the BMMNC treatment at all time points (P <0.05). The level of TNFα
decreased significantly in the BMMNC group compared with that in
the CR group 24 hours after the compression release (P <0.05). These
findings suggest that transplantation of BMMNCs has an ability to
evade the devastating condition following crush injury by suppressing
systemic inflammation.
Conclusion The administration of BMMNCs reduced production of
inflammatory cytokines and improved survival rate in a rat model
of crush injury. Cell therapy using BMMNCs might become a novel
therapy against crush injury.
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Introduction In this study we determine the impact of a dedicated
trauma desk on the identification of patients suffering from major
trauma and on time to allocate critical care resources. Trauma is
increasingly recognised as a serious global health problem and is
the leading cause of death in those under the age of 45, accounting
for 1,300 deaths in Scotland each year [1]. In addition, trauma
causes considerable short-term and long-term morbidity and has
personal, social and financial impact on the population [2]. Evidence
and expert opinion strongly support the presence of appropriately
trained, clinically active, personnel integrated and fundamental to the
command and control structure in order to optimise the right resource
being dispatched to the right patient at the right time.
Methods From October 2012 to April 2013 a trauma desk, staffed by
experienced paramedics, was created in ambulance control with access
to all emergency calls across Scotland. The operational hours of the desk
were 08:00 to 18:00, 7 days a week. A customised database provided
a data entry portal. Retrospective data were collated for comparison.
Primary outcome measures were the number of emergency calls
identified as potential major trauma and the time to allocation of
critical care resources. Secondary outcome measures were the effects
on stand-down rates of prehospital critical care teams.
Results There were 190 activations of critical care teams during the study
period compared with 73 from the historical data from the same time
frame in the previous year, representing a 160% increase in activations.
The mean time from emergency call to allocation of critical care resource
was 6 minutes compared with 19 minutes from historical data. The
stand-down rate for prehospital critical care resource from emergency
calls identified by trauma desk clinicians was 31.5% compared with 56%
for those by nontrauma desk clinicians or dispatchers.
Conclusion A clinician focusing on major trauma in the ambulance
control room improves activation times of prehospital critical care
teams. The number of patients receiving life-saving and limb-saving
interventions has substantially increased. The stand-down rate of
teams following activation by the trauma desk is considerably reduced.
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Introduction Some patients presenting to the emergency department
(ED) currently face inacceptable delays in initial treatment due to
suboptimal initial triage. Triage scores, such as the Manchester Triage
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System (MTS), have not been well validated in unselected medical
patients. Herein, we performed a prospective cohort study to assess
the prognostic potential of the MTS and the prognostic biomarker proadrenomedullin (ProADM) to identify patients at high initial treatment
priority, patients with admission to the ICU, and patients who die
within a 30-day follow-up.
Methods This is a prospective, observational cohort study including all
consecutive medical patients seeking ED care between June 2013 and
October 2013, except nonadult and nonmedical patients. We collected
detailed clinical information including the initial MTS and measured
ProADM levels on admission in all patients. Initial treatment priority
was adjudicated by two independent, blinded physicians based on
all available results at the time of ED discharge to the medical ward.
To assess outcomes, data from electronic medical records were used
and all patients were contacted by telephone 30 days after hospital
admission. The prognostic performance of MTS and ProADM was
assessed in multivariate regression models with area under the receiver
operating curve (AUC) as an overall measure of discrimination.
Results We included a total of 1,452 patients (58% males, mean age
66.6 years). A total of 20.1% (n = 292) were classified as high treatment
priority, 5.4% (n = 79) were admitted to the ICU and 4.4% (n = 64) died
within 30 days. The initial MTS showed a good prognostic accuracy to
predict treatment priority (AUC 0.75) and ICU admission (AUC 0.76),
but not for mortality prediction (AUC 0.58). Initial ProADM levels
were independent predictors for all three outcomes and significantly
improved the MTS score to AUCs of 0.78 for treatment priority, 0.80 for
ICU admission and 0.84 for mortality.
Conclusion Within this large cohort of consecutive unselected
medical patients seeking ED care, the MTS instrument in combination
with a prognostic biomarker (ProADM) allowed accurate initial
risk assessment in regard to treatment priority, ICU admission and
mortality. A combined score has the potential to significantly improve
initial risk assessment in patients, which may translate into faster and
more targeted care and better clinical patient outcomes.
P68
Introduction of the Kaifu telemedicine system for emergency medicine
to ambulance services with improvement of the survival rates
F Obata1, R Tabata2, K Mori1, T Kageji3, K Tani2, H Bando1
1
Tokushima Prefectural Kaifu Hospital, Tokushima, Japan; 2Institute of Health
Biosciences, University of Tokushima Graduate School, Tokushima, Japan;
3
Tokushima University Hospital, Tokushima, Japan
Critical Care 2014, 18(Suppl 1):P68 (doi: 10.1186/cc13258)
Introduction Our hospital has introduced the telemedicine system for
emergency medicine (k-support) using a smart device to rectify health
disparity and reduce the burden to general physicians since February
2013. We have expanded to the ambulance services’ k-support toward
further survival rate improvement.
Methods The registration device, patient information and image
information such as magnetic resonance imaging and computed
tomography taken in the hospital were transferred in real time to
k-support using the smart device. Since September 2013, we newly
developed k-support to the Kainan Fire Department Mugi branch
office, Kainan Fire Department Hiwasa branch office, Kaifu Fire-fighting
Union Kainan fire department, and Muroto Fire-Fighting Headquarters
Touyou branch office, and reviewed our experience of this approach
in the use of k-support during the first 3 months of the introduction.
Results k-support was used for 62 patients, and 13 (21.0%) of them
were categorized as neurosurgical diseases. The detail of neurosurgical
diseases consisted of six patients (46.1%) with head injury, followed
by five patients (38.5%) with cerebral infarction, one patient (7.7%)
with cerebral hemorrhage and one patient (7.7%) with miscellaneous
diseases. We shared the information by ambulance services to tweet the
patient information or transmit vital signs and electrocardiograms. We
experienced a case that was diagnosed with cardiogenic embolism and
tried the ‘drip and ship’ method of rt-PA. The outcomes were as follows:
hospitalization, 28 (45.2%); discharge, 18 (29.0%); and transfer, 16 (25.8%).
Conclusion Introduction of k-support is the first trial in Japan. For
emergency diseases such as ischemic heart diseases and stroke, we
could perform responses earlier than ever by providing this system.
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Introduction Japanese emergency medical technicians are not allowed
to perform some advanced medical practices such as a tracheal
intubation, establishment of an intravenous line, administration of a
drug to a patient who retains their own circulation. So medical staff
have to be dispatched to the accident scene to give a patient such
medical practices. In Japan, we have developed and dispersed the
educational course of the Disaster Medical Assistance Team since 2005.
But the role of medical teams at the scene is not widely known among
rescue workers. It is also distant for medical staff to coordinate rescue
teams, because most of them do not work with rescue workers in their
daily work. We have felt a need for practical training to achieve the
coordination of rescue and medical teams.
Methods We held a disaster-relief training workshop from 2010 to
2013. Prior to starting the drill, we gave two lectures about the role of a
medical team in a rescue site and the basic knowledge of rescue skills.
The drill was organized for 1 to 1.5 hours. The scenario was secret for
participants. Before and after the workshop, we had a questionnaire
survey for attitude changes about a collaborative work between a
rescue team and a medical team.
Results A total of 160 people participated in the workshop (63 rescue
workers, 27 ambulance workers, 33 paramedics, 37 medical staff ). At
first, rescue workers tended to downplay the importance about the
division of roles or the establishment of command and control system
between rescue teams and medical teams, but their attitude changed
after the drill (P <0.05). They also understood the need to know about
basic trauma survey skills and some medical terms.
Conclusion To achieve mutual understanding, it is important to have
drills in which both rescue teams and medical teams participate.
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Introduction At the hospital we are faced with situations of violence,
whether verbal or physical, especially in the emergency department
(ED) [1]. The objective of this study is to evaluate the phenomenon
of violence at hospitals in Lebanon, especially in the ED, and to
recommend techniques to prevent it.
Methods A questionnaire consisting of 18 questions was sent to the
caregivers in the ED of three randomly selected hospitals in Beirut,
Lebanon in 2012. A total of 111 people (nurses, aides, doctors, interns,
residents, social workers and security guards) responded to the survey
questionnaire.
Results The majority of the surveyed people are young women (62%)
aged between 20 and 40 years (78%) with a nursing degree (74%) and
professional experience <5 years (48%). In total, 59% of respondents
have experienced violence in the ED during the night (58%) from
the patients (31%) or their companions (68%). The caregivers most
affected by the violence are nurses (54%) and employees of reception
(46%). Violence can be verbal (threats 47%, insults 36%, criticism
18%) or physical (hitting 43%, slapping 40%, stabbing 17%). The
dissatisfaction of the patient in his care (42%) and his anxiety (33%) are
the most important factors in the generation of violence that may have
repercussions on the care workers and their psychological status.
Conclusion Violence in the ED may be due to the heavy workload of
the caregivers causing a delay in care. Secondly, patients in the ED may
feel insufficiently informed and heard by the nursing staff. The priority
given to emergencies depending on the severity and not the order
of arrival can be misunderstood [2]. Therefore, we recommend the
following actions: encourage caregivers to improve their knowledge
and training on the management of patients in emergency situations;
train emergency caregivers to mediation, nonviolent communication
and managing stressful situations; and increase the number of nurses
and security guards in the ED and motivate them to ensure a better
quality of care and minimize the delay in their care.
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Introduction Recently, the dispatch system with a medical doctor in
pre-hospital care has made rapid progress in Japan. We usually use
an ambulance helicopter or an ambulance car/rapid response car for
dispatch. In this report, we analyzed the cases in which the medical
doctors were dispatched using both means at the same time.
Methods We analyzed 29 cases with simultaneous dispatch with the
medical doctors using ambulance helicopter and car during October
2012 to September 2013.
Results The average distance of dispatch was 25.6 km. The correspondence to the plural patients was three trauma cases. In nine cases,
the ambulance car was first selected for the dispatch vehicle and
the ambulance helicopter was added. In three cases, both devices
were canceled on the dispatch way to the scene. In seven cases, the
ambulance car was canceled. In 10 cases, the patients were transferred
by the ambulance helicopter.
Conclusion In the selection of the dispatch means, the time to contact
with the patient is the most important factor. However, the decision of
the suitable means is occasionally quite difficult at the moment of first
information. The ambulance helicopter and car were complementary
to each other in the dispatch mean of the medical doctors.

Introduction Intentional self-poisoning is one of the most common
presentations to acute medical units across the UK [1]. To our
knowledge no studies have been published on incidence of admissions
to critical care in England after overdose. Our aim was to investigate
the epidemiology, clinical features and outcomes of patients admitted
to critical care after intentional self-poisoning to establish patterns in
our community.
Methods We performed a retrospective data collection using our
critical care database ‘Metavision’ to select all patients admitted with a
diagnosis of ‘overdose’. Records were scrutinised to collect information
on patient demographics, clinical features and medical management.
Results Thirty-eight patients (male:female ratio 1:1.53) were admitted
to critical care over a 1-year period (September 2011 to 2012). This
represented 2.45% of the total admissions to critical care during the
same period. The sample had a significantly younger median age
(45 years) than the standard patient population in critical care (68 years)
during the same period (P <0.0001). Despite the young age and paucity
of comorbidities, there was no difference in length of stay between
overdose patients (2.0 days) and all other patients on critical care
(1.58 days, P = 0.3). The median number of agents ingested was three
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(1 to 7) with 84.2% ingesting ≥2 agents. Hypnotics and antidepressants
made up 45% of the agents ingested. A total 92.1% of the sample
was admitted out-of-hours or at weekends. Fifty per cent had a past
history of overdose, 25% had a history of alcohol misuse. A total of 79%
of patients were referred to critical care due to a low conscious level
but only 50% required IPPV and 20% received vasopressors/inotropes.
The mortality rate was 2.6%, with one further death 6 months after
discharge due to alcoholic liver disease. Estimated financial cost was
£80,555 or £2,119 per patient (57 level 3 bed-days, 35 level 2 bed-days).
Conclusion Intentional self-poisoning mortality rates are low in spite
of the number of patients admitted. Despite the young age of patients
and lack of comorbidities, their length of stay is similar to the average
length of stay for all patients admitted to the unit, representing a
significant financial cost. Self-poisoning requiring critical care support
is more common out-of-hours when less senior expertise is available.
Education of junior doctors into management of overdose is therefore
vital to ensure the early identification and appropriate treatment of
these patients.
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Introduction A number of studies have demonstrated the significant
and increasing morbidity and mortality associated with alcohol-related
disease in the UK, and the corresponding impact this has on critical care
services [1]. This study was designed to similarly evaluate the current
burden of alcohol-related disease on admission rates to a regional ICU,
but also to calculate the financial costs of such admissions.
Methods Data-entry fields derived from recommendations in a public
heath publication [2] were introduced to the local electronic records
system to enable prospective data collection for all admissions that
were either wholly or partially attributable to alcohol consumption.
Using locally defined values for the cost per day of an admission to
the ICU, depending on the maximum level of organ support required
during the admission, it was possible to calculate the total expense
incurred by the unit for each alcohol-related admission.
Results In 1 year from December 2012 to November 2013 inclusive,
the ICU recorded 84 alcohol-related admissions, accounting for
approximately 9% of annual unplanned admissions. With an average
length of stay (5.8 days) similar to that of all other unplanned
admissions, this totalled 534 ICU bed-days. A total of 86% of patients
with alcohol-related conditions were male with an average age of
46.4 years (range 15 to 83 years), and the majority (42%) presented with
chronic conditions partially attributable to alcohol consumption. The
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number of admissions per month varied from zero in May to a peak
of 14 in November, with the majority (40%) of admissions occurring
over the autumn months (Figure 1). Eighty-nine per cent of patients
with alcohol-related conditions required support for at least two organ
failures, which subsequently equated to an overall cost to the unit of
£725,308 and 12% of an approximate £6 million annual budget.
Conclusion The results of this study support the hypothesis that
alcohol-related disease contributes considerably to admissions to
this ICU. Furthermore, they have shown that the financial impact was
proportionally greater than the percentage number of admissions
attributable to alcohol consumption, reflecting the high frequency of
multiorgan failure in this patient cohort.
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Introduction The objective was to analyze the clinical features of
multiple organ dysfunction syndrome (MODS) induced by severe heat
stroke, and to investigate the pathogenesis, diagnosis and prevention
strategies in patients with MODS caused by severe heat stroke.
Methods We retrospectively studied nine cases of MODS caused by
severe heat stroke, and systemically reviewed the relevant literature.
Results (1) Nine patients with MODS caused by severe heat stroke were
all exposed in hot and humid environments. All nine patients are severe
heat stroke, including seven cases of classic heat stroke (77.8%) and two
cases of exertional heat stroke (22.2%). (2) Among nine cases of MODS
caused by severe heat stroke, eight patients met the diagnostic criteria
for SIRS. In addition, there was a significant increase in blood PMN
proportion and serum CRP of all nine patients. Of note, there was also a
marked increase in serum IL-6 (average (36 ± 19) pg/ml; reference range
(0 to 5.9 pg/ml)); and TNFα level (average (21 ± 10) pg/ml; reference
range (0 to 8.1 pg/ml)), while IL-8 was normal (average (22 ± 25) pg/
ml; reference range (0 to 62 pg/ml)). (3) There were 34 organ damages
involved in all nine patients with MODS induced by severe heat stroke.
The kidney, circulatory and liver accounted for 58.8% of all these
organ dysfunctions. The incidence of severe heatstroke-induced organ
dysfunction in turn was the kidney, circulation, liver, blood coagulation,
metabolism, brain, lungs, and gastrointestinal tract. (4) During
hospitalization, the common complication was pulmonary infection in
patients with MODS caused by heat stroke. (5) After early intensive care
of organ supportive treatment, there was a quick improvement and
recovery in most cases in several days. Seven patients survived, and the
average length of stay in hospital was 9.5 days.
Conclusion Severe heat stroke results in significant abnormal changes
in inflammatory markers in patients with MODS induced by heat stroke.
The types of organ dysfunction in heat stroke-induced MODS are
usually distinct from those of infection and trauma. After active cooling
and intensive organ function supportive treatment, most patients
recovered in a relatively short period.
Acknowledgements Supported by the Research Projects CPSFG
2013M542578, JSPSFG 1301005A, SYS201251 and 2013NJZS50.
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Figure 1 (abstract P73).

Introduction The systemic effect of inflammatory mediators released
after severe burn is a severe cardiovascular dysfunction called burn
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shock. Patients need vasopressor infusion to maintain adequate
delivery of oxygen but it could have deleterious effects on skin perfusion
and worsen the burn depth. This shock could result from the interplay
of the initial hypovolemia and the release of multiple inflammatory
mediators [1]. It has been shown that a low-dose of hydrocortisone
could reduce the shock duration but the mechanisms involved remain
unclear. We investigated the systemic genomic response after severe
burn injuries and determine whether patterns of gene expression
could be associated with a low dose of glucocorticoids.
Methods Thirty burn patients with over 30% of total body surface
area were enrolled into a randomized double-blind clinical study.
Fifteen patients were treated with a low dose of hydrocortisone and
15 patients were treated with placebo. Whole blood samples were
collected after shock onset (S1) before any treatment, 1 day after
treatment beginning (S2), and 120 hours and 168 hours after the burn
injury (S3/S4). Blood samples of 13 healthy volunteers were collected.
Pangenomic expression was evaluated with Affymetrix HG-U133plus
2.0 microarrays. Moderated t tests and F test were used to compare
burn patients with controls and gene expression profiles between the
two groups (B–H correction, P <0.05).
Results Severe burn injury induced the deregulation of a considerable
number of genes (n >2,200 at S1) in comparison with controls with
an increased number of deregulated genes over time. Within burn
patients, more than 300 genes were deregulated by hydrocortisone
over time. The treatment had a rapid effect on gene expression, 339
and 627 genes were differentially expressed at S2 and S3 respectively.
However, the number of these genes decreased drastically at S4 (only
24 genes significant). The genes identified at S2 were mostly related to
the decrease of growth, development and quantity of leukocytes but
these biological processes were not found significant at S3, indicating
that the action of glucocorticoid in the response to burn injury is short
lived and time dependent.
Conclusion This study is an informative overview of the genomic
responses after burn injuries. More importantly, it is the first study
providing information about mechanisms involved in glucocorticoid’s
reduced shock duration after burn.
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Critical Care 2014, 18(Suppl 1):P76 (doi: 10.1186/cc13266)
Introduction The Managed Clinical Network for Care of Burns in
Scotland (COBIS) was launched in April 2007. Primary aims included
establishing and maintaining a registry of complex burn injury in
Scotland and setting mechanisms to regularly audit outcome of burn
treatment against nationally agreed standards of care. On behalf of
COBIS, we present 3-year incidence and mortality data of Scottish
patients admitted with a complex burn injury in this abstract.
Methods From January 2010 onwards, data were prospectively
collected for all patients in Scotland with complex burn injury admitted
to Scottish burns units. Data collection was initially on a paper pro
forma, but subsequently evolved into a web-based audit data capture
system to securely link hospital sites involved in the delivery of care of
complex burns. Data collected included extent and mechanism of burn,
presence of airway burn or smoke inhalational injury, comorbidities,
complications, length of stay, interventions and mortality. Quality,
completeness and consistency of data collection are audited with
feedback to the individual units.
Results In a population of approximately 5.3 million, the annual
incidence of complex burn injury is 499 to 537 (9 to 10 per 100,000).
The incidence of a major burn is 5% of burn admissions. The hospital
mortality from a burn is 1 to 2.2%. See Table 1.
Conclusion From these data, Scotland now has comprehensive national
figures for complex burn injury. This allows for benchmarking against
other international indices, few of which provide comprehensive
data. COBIS data can now also be correlated with other mortality data
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Table 1 (abstract P76). Numbers of complex burns in Scotland 2010 to 2012
2010

2011

2012

Adult

304

392

399

Paediatric

195

185

138

Adult >15%

27

28

26

Paediatric >15%

0

2

4

Mortality

5

7

13

sources. As data quality improves, detailed analysis of mortality data
will allow COBIS to identify contributing issues affecting burns patients.
Some issues identified already are that patients with burns often die
soon after their discharge from hospital of other related and unrelated
causes. Subsequent analysis of this will allow COBIS to identify and
address issues that may be contributing to these statistics.
P77
Low socioeconomic status, ethnicity and geographical location
confers high risk of significant accidental burns injuries in London
JS Heng, O Clancy, I Jones, J Atkins, J Leon-Villapalos, A Williams, M Hayes,
M Vizcaychipi
Chelsea & Westminster Hospital, London, UK
Critical Care 2014, 18(Suppl 1):P77 (doi: 10.1186/cc13267)
Introduction The majority of burns injuries are considered accidental,
although previous studies have identified demographic factors
associated with higher risk of burns such as socioeconomic deprivation
[1] and being from ethnic minority groups [2]. This study aims to
identify population subgroups in London at high risk of burns injuries
requiring admission to a burns centre through geographic mapping
and socioeconomic statistics.
Methods Records of all paediatric and adult inpatients admitted to the
burns centre at Chelsea and Westminster Hospital were retrospectively
reviewed for age, ethnic group and deprivation score of residence,
as measured by the English Index of Multiple Deprivation 2010.
Corresponding population data for London were obtained.
Results In total, 2,195 patients from London were admitted between
January 2009 and August 2013, with 1,963 (89.4%) classified as having
accidental injuries. A total 1,725 (87.8%) of accidental burn injuries
occurred in the patients’ own homes. Patients from ethnic minorities
have the highest rate of burn injury at 7.1 per 100,000 population per
annum (P <0.0001). Patients below the median for socioeconomic
deprivation in London are more likely to suffer burn injuries (P <0.0001).
Patients from the most deprived quartile are more likely to suffer burns
injuries of >10% TBSA (P = 0.04), and have a trend towards higher rates
of ICU admission (P = 0.144). Domestic accidental burns were mapped
to their respective administrative wards, and the rate of burns per
100,000 was calculated and divided into quintiles. The areas with the
top quintile of burn injury rate, of up to 18.8 per 100,000 population per
year, were almost four times the national average.
Conclusion Ethnicity, socioeconomic deprivation and geographical
location appear to be risk factors for burn injuries. Identifying such
groups may allow the development of targeted preventative strategies.
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Effectiveness of noncontrast abdominal multidetector CT for
evaluating the patient with renal insufficiency in the emergency
department
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Critical Care 2014, 18(Suppl 1):P78 (doi: 10.1186/cc13268)
Introduction Contrast-enhanced abdominal multidetector CT (MDCT)
is an important and accurate diagnostic approach for acute abdominal
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symptoms or searching for an infection focus such as sepsis. But
contrast dye can cause renal damage especially in critically ill patients.
Noncontrast CT can be alternative options but few studies have
shown the effectiveness of noncontrast MDCT. We want to evaluate
the effectiveness of noncontrast abdominal MDCT in the emergency
department.
Methods This is a retrospective chart review study conducted in a
single tertiary academic hospital from January 2011 to April 2012.
Patients were enrolled if they visited the emergency department with
acute abdominal symptoms or infection signs, had elevated serum
creatinine level, and received noncontrast 16-channel MDCT.
Results During study period, 78 patients with renal insufficiency
received noncontrast abdominal CT. Causes of CT were infection
focus (48, 61.5%), abdominal pain (21, 26.9%), GI bleeding (4, 5.2%),
abnormal labs (3, 3.9%), ureter stone (1, 1.3%) and abdominal
distension evaluation (1, 1.3%). Any abnormal CT findings were
detected in 61 (78.2%) patients. For 42 (53.8%) patients, noncontrast
CT findings showed diagnostic abnormal findings. For excluding
abdominal pathology, 35 (44.9%) were helpful. In one (1.6%) case with
hematochezia, noncontrast CT showed no benefit for patient diagnosis.
Additional contrast-enhanced CTs were performed in 32 (41%) and
additional findings were found in five cases (6.4%). There were 40
patients with severe sepsis or septic shock. Abnormal CT findings were
found in 30 (75%) cases. Additional contrast enhanced CT was done for
13 (32.5%) patients but no additional information was detected.
Conclusion Performing noncontrast abdominal MDCT to the patient
with renal insufficiency for evaluating acute abdominal symptoms,
severe sepsis or septic shock in the emergency department was
feasible and effective.

P79
Antipyretics in the emergency department – intravenous
paracetamol versus intramuscular diclofenac: a comparative study
N Purayil, N Vamanjore, F Paramba, O Mohammad, P Chandra
Hamad Medical Corporation, Doha, Qatar
Critical Care 2014, 18(Suppl 1):P79 (doi: 10.1186/cc13269)
Introduction Fever is a common problem in adults visiting the
emergency department (ED) [1]. Although it is important to treat the
cause of fever, symptomatic management of fever is also necessary.
Multiple studies are available on the efficacy of various antipyretics in
children, but very little has been done in adults [1,2]. Hence we aimed
to compare the antipyretic efficacy of intravenous (i.v.) paracetamol
and intramuscular (i.m.) diclofenac in adult patients presenting with
fever to the ED.
Methods In this parallel-group, open-label trial, participants aged 14
to 75 years who had a temperature more than 38.5°C were enrolled
and treated in the ED, Alkhor, Hamad Medical Corporation, during the
period June 2008 to December 2011. Patients were randomly assigned
to receive either 1,000 mg i.v. paracetamol or 75 mg i.m. diclofenac. The
primary outcome was degree of reduction in mean oral temperature
at 90 minutes and the secondary outcomes were degree of reduction
at 30, 60 and 120 minutes. The efficacy of drugs was assessed by a
superiority comparison. Analysis was done using intention-to-treat
(ITT) principles.
Results In total, 139 patients received i.v. paracetamol and 150 received
i.m. diclofenac. The mean age was 35.5 ± 14.24 and 36.4 ± 14.98 years
in the i.m. diclofenac and i.v. paracetamol groups respectively. The
majority of the patients were males in both groups. After 90 minutes
both groups showed a significant reduction in mean temperature, i.m.
diclofenac showing a greater reduction (–1.44 ± 0.43(95% CI –1.4, –2.5))
than i.v. paracetamol (–1.35 ± 0.46 (95% CI –1.3, –3.1) P <0.0001). After
120 minutes, a significant difference was observed in the mean change
from the baseline temperature between the groups, –1.81 ± 0.46 (95% CI
–1.7, –2.9) in i.m. diclofenac versus –1.63 ± 0.55 (95% CI –1.5, –4.1) in the
i.v. paracetamol group (P <0.0001). Significant changes in temperature
were observed in favor of i.m. diclofenac over i.v. paracetamol at each
time point from 60 minutes through 120 minutes inclusive.
Conclusion Both i.m. diclofenac and i.v. paracetamol showed significant
antipyretic activity, with diclofenac having a greater effect. In view of
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ease of administration, i.m. diclofenac can be used as a first-choice
antipyretic in febrile adults in the ED.
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Introduction A pragmatic survey of shock management in Thai
physicians is unavailable. The objective of this study is to identify shock
management patterns for severe sepsis and septic shock in Thailand.
Methods Two thousand questionnaires were sent to physicians
involved in caring for shock patients across Thailand. The frequency
scale was defined as five levels by patient proportion estimation at
routine practice.
Results Between April and August 2013, a total of 533 questionnaires
(26.7%) were returned. For severe sepsis and septic shock management,
a total of 406 physicians (76.2%) reported their routine usage of
quantitative resuscitation protocols. Urine output, mean arterial
pressure and central venous pressure are more frequently used than
central venous oxygen saturation and lactate as the resuscitation
endpoint. Nearly 80% of these had an ‘often and always’ resuscitation
goal within 6 hours. Most physicians (65.3%) never used procalcitonin.
The antimicrobial empirical treatments were started within 1 hour for
87.7% and these were continued less than 5 days in 67.3% before deescalation. Crystalloid was the common initial fluid therapy in 98.9%.
The most common used vasopressor was norepinephrine (69.6%).
The median of cortisol threshold level for steroid replacement therapy
was 15 (interquartile range, 5 to 19) mg/dl. Almost all of the physicians
used hydrocortisone (96.4%). The median daily dose of hydrocortisone
was 300 mg (interquartile range, 200 to 300). Nearly 50% divided the
dose every 8 hours and 31.8% infused continuously. The duration for
tapering was varied (33.6% in 2 to 3 days). Central venous pressure
(CVP) and fluid challenge test were more frequently used for preload
evaluation than new fluid responsiveness methods. Less than 15% still
used a pulmonary artery catheter in their routine practice.
Conclusion Most physicians manage shock with protocols.
Hemodynamic endpoints are preferred to tissue perfusion targets. Early
antimicrobial therapy and de-escalation are routine practices without
use of infective biomarkers. Crystalloid is preferred rather than colloid
at initial resuscitation. CVP and fluid challenge are still more popular
than new fluid responsiveness methods on preload assessment.
Hydrocortisone is the most common steroid prescription in septic
shock but the threshold of initiation, frequency and discontinuation
are varied.
P81
Laboratory early warning score versus clinical early warning score
as a predictor of imminent cardiac arrest
M Keil, S Hutchinson, T Leary
Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich, UK
Critical Care 2014, 18(Suppl 1):P81 (doi: 10.1186/cc13271)
Introduction NCEPOD reported in 2012 that 75% of patients had
warning signs for cardiac arrest present prior to their arrest [1]. NICE
recommends a vital sign-based early warning score (EWS) to identify
patients at risk of deterioration or death [2]. In our trust, audit has
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shown that only 20 to 35% of patients trigger the clinical EWS prior to
cardiac arrest. Jarvis and colleagues proposed that an EWS based on
common laboratory findings can predict patient mortality [3]. The aim
of this study, as part of a wider review of cardiac arrests in our hospital,
was to determine whether the laboratory early warning score (LEWS)
might be of use identifying patients at risk of cardiac arrest in our trust.
Methods Retrospective data collected identified cardiac arrest calls that
lead to CPR or defibrillation over 6 months. The LEWS was calculated
according to the formula devised by Jarvis and colleagues [3]. LEWS ≥4
for males and ≥5 for females was taken as being a ‘trigger’ as suggested
by Jarvis and colleagues [3].
Results Eighty-nine cardiac arrest calls lead to CPR and/or defibrillation
in this time period. Of these, 65 patients had had blood tests within the
last 24 hours. Median LEWS was 6 for females and 7 for males (range 1
to 12). Most patients (77%) had a LEWS trigger (≥4 for females and ≥5
for males).
Conclusion The collected data suggest that more patients at risk
of cardiac arrest in our hospital might be identified using a LEWS
rather than a clinical EWS. It is evident that for a clinical EWS regular
observations need to be taken and are subject to user error. Clinical EWS
could also not be sensitive enough or there is a failure to implement it
successfully. LEWS can be generated automatically when bloods are
taken. The downside is that it relies on bloods being done. It is beyond
the scope of this study to examine the sensitivity/specificity of LEWS
or suggest that LEWS should replace EWS. We suggest that LEWS may
compliment EWS by identifying a different group of patients. The
ongoing data collection aims to correlate the clinical EWS for each
patient directly with their LEWS to confirm the initial findings.
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Introduction The Rapid Response Team (RRT) represents an important
advance in the management of deteriorating ward patients and
is recommended as a patient safety measure. Most studies on RRT
evaluate the effects of its implementation on rate reduction of
cardiopulmonary arrest outside the ICU and hospital mortality, with
limited information on the criteria for RRT calls and predictive factors
associated with hospital mortality [1,2]. Therefore, our objective was
to determine what factors are associated with hospital mortality for
patients seen by the RRT at the Hospital Israelita Albert Einstein (HIAE).
Methods A total of 1,051 patients assessed by RRT between January
and December 2012 at the HIAE, a general hospital with 650 beds, were
included in this study. Multivariate analysis was used to evaluate what
variables were associated with hospital mortality. Early RRT call was
defined as RRT activation <48 hours from hospital admission and late
RRT call if it happened >48 hours from hospital admission.
Results The mean age was 64 ± 19.8 years and 48% (n = 513) were male.
There were 513 (48.9%) early calls and 537 (51.1%) late calls. The main
reasons for RRT activation were respiratory failure in 18.2% (n = 191)
and severe sepsis/septic shock in 13.1% (n = 138). The distribution of
RRT activation was uniform over the 24-hour period, with 50.5% (n =
531) of calls during the day (7:00 a.m. through 7:00 p.m.) and 49.5%
(n = 520) overnight (7:00 p.m. through 7:00 a.m.). A total of 460 patients
(43.7%) were admitted to the ICU. The multivariate analysis showed the
following variables as significantly associated with hospital mortality:
age (OR 1.03; 95% CI 1.01 to 1.04), late (>48 hours) RRT call (OR 2.73;
95% CI 1.79 to 4.71), acute change in oximetry saturation to <90% (OR
1.94; 95% CI 1.28 to 2.95) and acute change in respiratory rate to <8 or
>28 breaths/minute (OR 1.79 95% CI 1.09 to 2.94).
Conclusion In this study, hospital mortality predictive factors for
patients seen by the RRT were: age, acute respiratory failure and late
RRT call.
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Introduction To improve early detection and the mortality rate of inhospital cardiac arrest, the Emergency Response Team (ERT) system
was planned and implemented since June 2009 to detect pre-arrest
conditions and for any concerns. The ERT consisted of on-duty
physicians and nurses from emergency department. ERT calling criteria
[1,2] consisted of acute change of HR <40 or >130 beats per minute,
systolic blood pressure <90 mmHg, respiratory rate <8 or >28 breaths
per minute, O2 saturation <90%, acute change in conscious state, acute
chest pain or worried about the patients. From the data on ERT system
implementation in our hospital in the early phase (during June 2009 to
2011), there was no statistical significance in difference in in-hospital
cardiac arrest incidence and overall hospital mortality rate. Since the
introduction of the ERT service in our hospital, we have conducted a
continuous educational campaign to improve awareness in an attempt
to increase use of the service.
Methods To investigate the outcome of the ERT system in in-hospital
cardiac arrest and the overall hospital mortality rate, we conducted
a prospective, controlled before and after examination of the longterm effect of an ERT system on the incidence of cardiac arrest. We
performed chi-square analysis to find statistical significance.
Results Of a total 623 ERT cases from June 2009 until December
2012, there were 72 calls in 2009, 196 calls in 2010, 139 calls in 2011
and 245 calls in 2012.The number of ERT calls per 1,000 admissions in
year 2009 to 2010 was 7.69, 5.61 in 2011 and 9.38 in 2013. The number
of Code Blue calls per 1,000 admissions decreased significantly from
2.28 to 0.99 per 1,000 admissions (P <0.001). The incidence of cardiac
arrest decreased progressively from 1.19 to 0.34 per 1,000 admissions
and was significant in difference in year 2012 (P <0.001). The overall
hospital mortality rate decreased by 8% from 15.43 to 14.43 per 1,000
admissions (P = 0.095).
Conclusion ERT system implementation was associated with
progressive reduction in cardiac arrests over the 3-year period,
especially statistically significant in difference in the fourth year
after implementation. We also found an inverse association between
number of ERT use and the risk of occurrence of cardiac arrests, but we
found no difference in overall hospital mortality rate.
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Epidemiology of unplanned intensive care admissions through inhospital referrals at a tertiary referral centre university hospital
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Critical Care 2014, 18(Suppl 1):P84 (doi: 10.1186/cc13274)
Introduction The provision of intensive care has lagged behind
demand [1]. Intensive care services in the UK have significant resource
restriction. Although rationing of beds has been a priority, equally
important is to establish patient safety and also identify strategies
to prevent admissions [2], which echoes the importance of early
recognition of deteriorating patients and prompt intervention. This
study evaluates the epidemiology of unplanned admissions to the ICU
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in order to identify the associative trends that led to the admission and
hence to mitigate the processes of interventional strategies.
Methods A prospective observational evaluation of ICU unplanned
admission through in-hospital ward referral over a 3-month duration.
Anonymised data collection included baseline demographics, timing
and grade of referral, Modified Early Warning Score (MEWS) at time
of referral, clinical reason for referral, senior review prior to referral,
MEWS trend 24 hours prior to referral, if appropriate basic intervention
commenced, time delay between referral and assessment by the ICU
team, organ failure score, length of stay (LOS) and survival status.
Results So far 22 patients have been enrolled, of which 60% of the
unplanned admissions were ‘out of hours’, 60% of admissions were
from medical wards and 33% from surgical wards. Pneumonia was the
main reason for referral and admissions were due to respiratory failure
requiring advanced ventilator care. Twenty per cent of the patients
did not have senior medical review for at least 4 hours prior to the ICU
referral. Basic interventions such as antibiotics and intravenous fluids
were not started in a few patients (13%) prior to admission. The mean
ICU review time from referral was 70 minutes and the mean MEWS at
the time of referral was 8.
Conclusion The study is due to be completed by mid-January 2014.
With the limitation of incompleteness, the findings so far have
alluded that there is a necessitation for change and education for
early identification and intervention in deteriorating patients. The
completed study with outcomes (that is, survival rates and ICU LOS) will
help us identify whether delay or deficiency in the early management
had a causal relationship.
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Introduction In 1995, Smith and colleagues first proposed the use
of low-dose CT KUB for the diagnosis of ureteric colic [1]. Since then,
popularity of this imaging modality has increased due to a number
of reasons: a sensitivity of 94 to 97%, a specificity of 96 to 99%, lack
of intravenous contrast injection and speed of examination. The UK
College of Emergency Medicine considers CT KUB as best practice
for radiological investigation of renal colic. A review of the literature
suggests that the true positive rate (number of patients diagnosed
with an obstructing or symptom causing calculus) should be between
47.5 and 67% and alternative diagnoses should be confirmed in
approximately 10% of patients imaged [2].
Methods All patients over the age of 18 years who had a CT KUB
requested from the emergency department of the Homerton University
Hospital, London over a period of 3 months, between May 2012 and
July 2012, were identified. Individual case notes were examined and
data were collected on an Excel spreadsheet. Data were analysed and
results were divided into positive for renal colic (true positive), positive
for other pathology (other significant diagnoses) and negative results.
Results A similar previous audit carried out in 2009 at the same hospital
demonstrated a true positive rate of 48.5%. The 2012 audit examined
the outcome of 124 consecutive scans and a true positive rate of 29%
(P = 0.0006) was identified. Alternative diagnoses were 10% in 2009
compared with 17% in 2012 (P = 0.02).
Conclusion The true positive rate of CT KUB for renal colic has decreased
significantly. We are getting more negative scan results and more scans
diagnosing other significant pathology. The authors believe clinicians’
thresholds for imaging may have decreased due to the apparent lowdose radiation of CT KUBs. Furthermore, there is a perceived ease of
access to CT KUB imaging and hence this modality appears to be being
used to identify other significant pathology.
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Bled dry? An audit of blood sampling practices on an adult
intensive therapy unit
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Critical Care 2014, 18(Suppl 1):P86 (doi: 10.1186/cc13276)
Introduction The aim of this audit was to evaluate whether guidelines
produced in a local intensive therapy unit (ITU) with regard to blood
sampling practices were being adhered to. The volume of blood taken
and cost was also evaluated.
Methods A retrospective audit investigating the number of routine
blood tests ordered on an ITU in January 2013 was performed. There
were no exclusion criteria. Computer-based data collection systems
were used to gather data with regard to patient details and when blood
tests were processed. The collection bottles used were examined to see
how much blood was needed to fill them. Thirty nurses were asked how
much ‘dead space’ blood they discarded, and an average was recorded.
The cost of the blood tests was also calculated. Following a period of
education regarding the contents of the guidelines, this was re-audited
in July 2013 retrospectively.
Results The initial audit examined 901 patient-days. Urea and
electrolytes (U&Es) and full blood counts (FBC) were requested in line
with the guidelines. Liver function tests (LFTs), bone profile, magnesium
and a clotting screen were ordered approximately four times more
than advocated. It was shown that many bone profiles and magnesium
tests were probably inappropriate requests. Moreover, twice as much
blood was taken from patients compared with that recommended by
guidelines (almost 16 litres in total in January). The cost of the routine
blood tests in January was €11,019. If guidelines had been followed,
the estimated yearly saving would be €65,588. During the repeat audit,
731 patient-days were examined. The amount of times a U&E or FBC
were requested was largely unchanged, but the amount of times a LFT,
bone profile, magnesium and clotting screen were ordered reduced
by approximately 50%. Almost one-third more blood was taken from
patients when compared with the suggested volume in the guidelines.
The cost of the blood tests done in July was €5,423. Despite an
improvement in the frequency of blood testing, an estimated €21,907
per year could still be saved.
Conclusion The results underline that the unit’s guidelines were not
being followed. The re-audit does show an improvement in adherence.
Patients are being exposed to unnecessary blood tests, which not
only is implicated in iatrogenic anaemia, but also places a significant
financial burden on the department. Continued staff education and
encouragement are required in order to aid the transition from current
to recommended practice.
P87
Decreasing central-line blood draws by consolidation of
phlebotomy timing: results of a quality improvement project
G Arteaga, S Tripathi, Y Ouellette, M Nemergut, G Rohlik, K Fryer, C Huskins
Mayo Clinic, Rochester, MN, USA
Critical Care 2014, 18(Suppl 1):P87 (doi: 10.1186/cc13277)
Introduction The direct central line entry rate is believed to be a major
contributor to the risk of central line infections. At Mayo Clinic there was
historically no schedule for obtaining blood for analysis in the pediatric
ICU. A policy was implemented in May 2013 to restrict blood draws to
three times daily for nonemergent blood draws only. We subsequently
conducted this study to determine whether implementation of this
policy was associated with a reduction of blood draws as well as
central-line unique entries.
Methods Data from the laboratory as well as database for Central Line
Unique Entry were analyzed at baseline and after implementation of
the policy change for identification of any decrease in line entry/blood
draw rate. As per Mayo Clinic policy, IRB approval was not required for
a QI project.
Results In the pre-implementation phase there were a total of 4,602
blood draws in 5,227 total patient-days, (0.88 blood draws/patientdays). After consolidation, there were 1,095 blood draws in 1,491
patient-days (0.73 blood draws/patient-day; 17% reduction). Of these
line entries, 24.7% were arterial line entry, 50.5% central line entry and
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12.5% were by peripheral venipuncture. After policy implementation,
these numbers were 10.9%, 49.7%, and 23.8%, respectively. The
average central line unique entry after blood draw consolidation
decreased from 10 to 6 line entries/central line-day. Consolidation of
blood draws was associated with a cost saving of $7,200/year.
Conclusion Consolidating time frames for blood draws in the PICU was
associated with decreased central line entries, decreased utilization of
vascular access teams, and decreased phlebotomy cost. We hypothesize
that this policy will be associated with a decreased incidence of CLABSI
when more patients are included for analysis.
P88
Introducing an arterial non-injectable connector into clinical
practice
D Laba, M Mariyaselvam, R Heij, P Young
The Queen Elizabeth Hospital, Kings Lynn, UK
Critical Care 2014, 18(Suppl 1):P88 (doi: 10.1186/cc13278)
Introduction The standard arterial system for blood withdrawal
provides no impediment to intra-arterial injection [1] and bacterial
contamination. We assessed the probability of inadvertent intra-arterial
injection, transmission of bacterial contamination and surveyed the
nursing staff following introduction of a non-injectable connector
(NIC).
Methods The simulation study data were descriptive. Fifteen junior
doctors managed a case of bradycardia. A simulated patient had a
peripheral intravenous cannula, central venous catheter and brachial
arterial cannula. Atropine was available on request. A laboratory
controlled trial compared a transmission of bacteria through standard
arterial ports against the NIC when attached to an arterial sampling
hub. The colonization rates were compared using a two-tailed Fisher’s
exact test. A closed-circuit arterial sampling system was designed. A
contaminated syringe tip was inserted into the conventional arterial
hub or the NIC to take an arterial sample. Transducer flush fluid flowing
to the patient bloodstream was cultured. In a survey the nursing staff
were asked questions regarding the NIC system, including its manual
handling, sampling of the blood and its durability.
Results In the simulation study 10/15 clinicians (67%) injected atropine
directly into arterial cannula via a three-way tap. Five of 15 doctors
(34%) injected safely. In the laboratory study, swabbing of the arterial
hubs showed bacterial contamination of all of the samples in the
standard group (20/20) and no contamination in the NIC group (0/20),
P <0.0001. Eighty-five per cent (17/20) of samples in the standard
arterial group showed onward transmission of pathogens to the
patient circulation, and none of the patient samples taken from the NIC
group were contaminated (0/20), P <0.0001. In the survey, 80% of the
nurses found manual handling of a new device equally simple and 20%
even simpler. Sampling of the blood was equally challenging for 87%
participants. Ninety-four per cent found similar durability of the new
device and better protection against accidental intra-arterial injection.
Sixty-six per cent of the nursing staff would replace the standard
system with a NIC.
Conclusion Most of the doctors would inject the drug intra-arterially.
Currently, no other device is available to eliminate accidental intraarterial injection or bacterial transmission. The nursing staff found the
management of the NIC equally challenging.
Reference
1.

Sen S, et al.: Complications after unintentional intraarterial injection of
drugs: risks, outcomes, and management strategies. Mayo Clin Proc 2005,
80:783-795.

P89
Novel hemostatic technique using a silicone gel dressing for
tangential excision in burn surgery
A Osuka, Y Kuroki, H Kojima, M Sekido, S Okuma, S Onishi, M Ueyama
Social Insurance Chukyo Hospital, Nagoya, Japan
Critical Care 2014, 18(Suppl 1):P89 (doi: 10.1186/cc13279)
Introduction The purpose of this study is to demonstrate the efficacy
of our novel hemostatic technique for burn surgery. Significant
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bleeding remains a challenge in tangential excision of the burn wound.
Although various techniques to reduce intraoperative blood loss have
been described, there is an absence of uniformity and consistency in
their application. In the literature, the blood loss in burn surgery is
estimated to be at least 123 ± 106 ml per percentage body surface
area excised [1]. Recently we developed a novel hemostatic technique
using a silicone gel dressing (SI-AID®; ALCARE Co., Ltd, Tokyo, Japan)
to stop intraoperative bleeding. Briefly, soon after tangential excision
with the Humby knife, the wounds were sprayed with thrombin and
with 1:100,000 adrenalin solution and wrapped tightly with SI-AID®
for a full 10 minutes. Burn wounds on limbs were tangentially excised
under tourniquet control and wrapped with SI-AID® before deflation of
the tourniquet. After deflation of the tourniquets, we waited for a full
10 minutes. When the SI-AID® was removed, any major bleeders were
cauterized, and the grafts were applied after rinsing the wounds with
warm saline.
Methods This is a prospective observational study. From 1 January to
31 October 2013 we collected preoperative and 24-hour postoperative
hemoglobin levels from the patients who underwent tangential
excision for burn injury, and calculated blood loss in the perioperative
period. The data for amounts of blood transfusion, excised area, and
harvest area were also collected.
Results Nine patients, 13 operations were included. The mean excised
area was 8.3 ± 4.6% body surface area. Estimated blood loss was
35.3 ± 38.3 ml per percentage body surface area excised. Intraoperative
transfusion requirements were 86.2 ± 134.5 ml per case. The mean skin
graft take rate was 4.5 ± 2.2%.
Conclusion The application of our new technique during burn excision
and grafting resulted in a remarkable reduction in blood loss and
transfusion requirements.
Reference
1.

Cartotto R, et al.: Minimizing blood loss in burn surgery. J Trauma 2000,
49:1034-1039.

P90
Should we avoid invasive treatment in cancer patients with
pericardial tamponade?
F Galas, J Fukushima, E Osawa, C Park, J Almeida, D Nagaoka, L Hajjar
Instituto do Cancer do Estado de São Paulo, Brazil
Critical Care 2014, 18(Suppl 1):P90 (doi: 10.1186/cc13280)
Introduction Patients with cancer now live longer due to advances
in oncologic treatment. ICU admission is progressively more frequent
in this population due to complications of both disease and therapy.
Pericardial effusion leading to tamponade and hemodynamic
compromise is a common finding in the advanced stages of disease
and results in death if not treated on an urgent basis. However, we
do not know midterm outcomes of these patients after pericardial
drainage. The aim of this study was to evaluate prospectively cancer
patients with pericardial tamponade regarding mortality in 6 months.
Methods We evaluated consecutively 105 patients with cardiac
tamponade consecutively admitted to the ICU of the Cancer
Institute, a reference cancer hospital, during a 3-year period. Baseline
characteristics and clinical data were collected prospectively. Patients
were followed during a 6-month period.
Results Fifty-three patients (50%) were female. Most patients had
a previous diagnosis of lung neoplasia (46%), followed by breast
neoplasia (15%) and hematological neoplasia (15%). The mean
Karnofsky performance status of patients was 70. All these patients
underwent surgical drainage in a mean time of 1.5 hours since ICU
admission until surgery. Length of ICU stay was 8 days (2 to 15) and of
hospital stay was 16 days (8 to 31). ICU mortality was 75.2%, hospital
mortality was 83% and at 3 months 92% of patients were dead.
Conclusion Cardiac tamponade is a serious complication in cancer
patients. Despite adequate treatment, high rates of mortality are
observed. Prospective studies are needed to better define whether in
these patients end-of-life discussion should be implemented early in
the diagnosis, avoiding futility.
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P91
Goal-directed hemostatic therapy using rotational
thromboelastometry in patients requiring emergent cardiovascular
surgery
D Sartorius, JL Waeber, G Pavlovic, M Aldenkortt, MJ Licker
Hôpital Cantonal Universitaire de Genève, Geneva, Switzerland
Critical Care 2014, 18(Suppl 1):P91 (doi: 10.1186/cc13281)
Introduction Massive bleeding remains a leading cause of potentially
preventable death after cardiovascular surgery [1]. Conventional
coagulation tests (CCT) fail to characterize the multiple hemostatic
abnormalities observed in surgical patients and are further limited by
their slow results and poor correlation with transfusion requirements.
We assessed the clinical impact of goal-directed coagulation management based on rotational thromboelastometry (ROTEM) in patients
undergoing an emergent cardiovascular surgical procedure.
Methods Over a 2-year period, data from 71 patients were collected
prospectively and blood samples were obtained for coagulation
testing. Administration of packed red blood cells (PRBC) and
hemostatic products was guided by an algorithm using ROTEMderived information and hemoglobin level. Based on the amount of
PRBC transfused, two groups were considered: high bleeders (≥5 PRBC;
HB) and low bleeders (<5 PRBC; LB). Data were analyzed using the chisquare test, unpaired t test and ANOVA as appropriate.
Results Preoperatively, the HB group (n = 31) was characterized by
lower blood fibrinogen and decreased clot amplitude at ROTEM
compared with the LB group (n = 40). Intraoperatively, larger amounts
of fibrinogen, fresh frozen plasma and platelets were deemed
necessary to normalize the coagulation parameters in the HB group.
Postoperatively, the incidence of major thromboembolic and ischemic
events did not differ between the two groups (<10%) and the observed
in-hospital mortality was significantly less than expected by the
POSSUM score (22% vs. 35% in HB group and 5% vs. 13% in LB group).
Conclusion ROTEM-derived information is helpful to detect early
coagulation abnormalities and to monitor the response to hemostatic
therapy. Early goal-directed management of coagulopathy may
contribute to improve outcome after cardiovascular surgery.
Reference
1.

Ranucci M, et al.: The deadly triad of cardiac surgery. Ann Thorac Surg 2013,
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P92
Thromboelastometric examination on the ICU before elective
procedures
P Lukas
University Hospital Motol, Prague, Czech Republic
Critical Care 2014, 18(Suppl 1):P92 (doi: 10.1186/cc13282)
Introduction In critically ill patients a number of elective procedures
with a potential risk of bleeding are performed. In this population,
coagulation disorder is frequently observed according to the commonly
used laboratory parameters of APTT (activated partial thromboplastin
time), INR (international normalized ratio) or platelet count.
Thromboelastometric examination (ROTEM) evaluates coagulation
of whole blood and thus allows the testing of all components of
secondary hemostasis.
Methods Identification of patients with pathological values of INR,
APTT and platelet count before the planned intervention. Through a
questionnaire we found a potential correction of coagulopathy carried
out by the physician. Performed ROTEM methodology: ExTEM (external
pathway thromboelastometry). Inclusion criteria: normal curves and
values, CT (clotting time), MCF (maximum clot firmness). In those
patients with normal values according to ExTEM examination, no blood
products were administered.
Results During March 2013 to November 2013, 40 patients were
identified as relevant, 26 men of average age 53 years and 14 women
of average age 59 years. Central venous cannulation, 12 cases; surgical
revision, nine cases; thoracic drainage, six cases; percutaneous
endoscopic gastrostomy, five cases; nephrostomy, two cases; epidural
catheter, two cases; tracheostomy, two cases; permanent pacemaker,
one case; and bronchoscopy, one case. INR normal values were 0.8 to
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1.2. The average measured value of INR in men was 1.50, and in women
was 1.35. APTT normal values were 0.8 to 1.2. The average measured
value of APTT in men was 1.09, and in women was 1.14. Platelet count
was 150×109/l to 300×109/l level of platelets; in men was 252.57,
in women was 226.78. ExTEM CT normal values at 41 to 74 seconds:
measured value of CT in men was 62.58 and in women was 62.07.
MCF normal values were 50 to 72 mm; the measured value of MCF in
men was 69.88, and in women was 73.28. Considered administration
of blood derivatives: fresh frozen plasma, 123 transfusion units
(TU); platelets, 4 TU. In the examined cases no blood products
were administered to avoid the risk of bleeding before the elective
procedure. No periprocedural bleeding was observed.
Conclusion Examination EXTEM in these patients proved to be
effective and efficient in predicting bleeding complications in relation
with interventions routinely performed on the ICU. Also, these specific
cases proved not indicated and thus ineffective administration of
blood products.
P93
ROTEM: Multiplate monitoring in the ICU and outcome scores
U Schött, A Larsson
Lund University, Lund, Sweden
Critical Care 2014, 18(Suppl 1):P93 (doi: 10.1186/cc13283)
Introduction Hemostatic disorders are common in intensive care
patients and can be used as prognostic markers. The aim of this
prospective clinical study was to study platelet function in intensive care
patients using point-of-care viscoelastic and platelet aggregometry
instruments and platelet count (PLC). Our hypothesis was that
measurement of platelet function would give more information about
disseminated intravascular coagulation (DIC), morbidity and mortality
than PLC alone.
Methods Patients admitted to the ICU were monitored with ROTEM
viscoelasticity and a new Multiplate platelet aggregometer; routine
coagulation analyses; International Society of Thrombosis and
Haemostasis and Japanese Association for Acute Medicine DIC
calculated scores; Sequential Organ Failure Assessment scores,
Simplified Acute Physiology Score III – Expected Mortality Rate; and
real in-hospital mortality. Nonparametric tests were chosen for all
statistical evaluation. P <0.05 was considered significant.
Results A total of 128 patients with different diagnoses were studied,
with 330 sampling events. Multiplate analyses correlated significantly
with PLC and ROTEM. However, there were more test results below
normal limits for Multiplate analyses than for ROTEM in patients with
thrombocytopenia. Multiplate, ROTEM and PLC results were low in
patients with high SOFA scores and in patients with overt DIC scores.
These test results at admission to the ICU did not differ between
survivors and nonsurvivors, and did not correlate with the length of
stay in the ICU. Only EMR differed between survivors and nonsurvivors
and correlated with ICU length of stay.
Conclusion In this study, Multiplate and ROTEM did not provide any
more information than PLC about DIC, morbidity and mortality.
Multiplate showed lower platelet function in more patients with
low platelets than ROTEM. In patients without thrombocytopenia,
all patients had normal ROTEM results, but 36% of Multiplate
measurements were low. This higher sensitivity of the Multiplate to
measure lowered platelet function needs to be linked to real bleeding
in larger patient series to define its clinical significance.
P94
Retrospective observational study of interventional radiology and
critical care coagulopathy
SP Hibbs, S McKechnie, M Little, M Desborough
John Radcliffe Hospital, Oxford, UK
Critical Care 2014, 18(Suppl 1):P94 (doi: 10.1186/cc13284)
Introduction Estimation of bleeding risk in critical care patients
undergoing interventional radiological procedures is often made on
the basis of coagulation tests. If these tests are abnormal, fresh frozen
plasma (FFP) is often given to reduce the risk of bleeding, despite
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a poor evidence base for this practice [1]. There is a relatively better
evidence base for prophylactic platelet transfusion [2] but clinical
practice is inconsistent. Through a retrospective study we aimed to
establish the thresholds triggering use of FFP and platelet transfusion
prior to percutaneous drain insertion in critical care patients.
Methods We identified 68 consecutive chest, abdominal or pelvic drain
insertions in 54 critical care patients between 1 January 2008 and 11
October 2012 at the John Radcliffe Hospital, Oxford. The prothrombin
time (PT), activated partial thromboplastin time (APTT) and platelet
counts prior to each procedure were recorded to demonstrate triggers
used for FFP and platelet transfusion. In patients who underwent
transfusion, the next PT, APTT and platelet count post transfusion were
recorded.
Results Patients who received FFP had a mean PT of 18.5 seconds
while those who did not receive FFP had a mean PT of 16.7 seconds
(unpaired t test, P = 0.275). In the nine patients given FFP, the pretransfusion mean PT was 18.5 seconds whereas the post-transfusion
mean PT was 17.1 seconds (paired t test, P = 0.235). The pre-transfusion
mean APTT was 41.6 seconds compared with a post-transfusion mean
APTT of 38.1 seconds (paired t test, P = 0.127). No patient had platelet
levels below the recommended transfusion threshold [2], but one
patient nevertheless received a double-dose platelet transfusion. One
patient had a recorded immediate bleeding complication. Their PT was
15.6 seconds and APTT was 40.9 seconds and they did not receive FFP.
One patient had an anaphylactic reaction whilst receiving FFP.
Conclusion This study demonstrates inconsistent use of FFP, with no
significant difference in PT between patients who were transfused
and those that were not. The lack of effect of FFP transfusion on PT
and APTT creates additional confusion for its prophylactic usage.
There is a need for further clarification around coagulopathy and
interventional radiology in the critical care setting. The low absolute
incidence of bleeding complications and risk of complications from
transfusion lends further support to the view that FFP should be used
therapeutically rather than as prophylactic ‘cover’ [1].
References
1.
2.
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P95
Monitoring of treatment with low molecular weight heparins using
viscoelastic devices
U Schött1, A Larsson1, O Thomas1, N Tynngård2
1
Lund University, Lund, Sweden; 2Linköping University, Linköping, Sweden
Critical Care 2014, 18(Suppl 1):P95 (doi: 10.1186/cc13285)
Introduction Few studies have investigated the use of viscoelastic
devices for monitoring of treatment with LMWHs and to our knowledge
there are no studies comparing different LMWHs or different
visocoelastic methods.

Methods Enoxaparin (Klexane) and tinzaparin (Innohep) were added
to 2 ml citrated blood from 10 intensive care patients to obtain plasma
concentrations of 0, 0.5, 1.0 and 1.5 IU/ml enoxaparin and tinzaparin,
respectively. The study was approved by the local ethics committee
and with written consent (relatives). Clot formation and clot retraction
was studied using ROTEM and ReoRox.
Results ROTEM analysis showed prolonged clot formation (CT) with
increasing concentrations of enoxaparin and tinzaparin (more so).
ReoRox analysis showed that the initiation of clot formation (COT1)
increased with increasing doses of enoxaparin and tinzaparin (more so),
as did the progression of clot formation (COT2 – COT1), thus resulting in
a prolongation until complete clot formation (COT2). See Table 1.
Conclusion Clot initiation was prolonged with both drugs and detected
by both ROTEM and ReoRox. Clot formation was more decreased with
tinzaparin than enozaparin and only detected by ReoRox.

P96
Heparin stability in parenteral nutrition bags prepared in a neonatal
ICU
A Foinard1, M Perez1, B Décaudin2, C Barthélémy1, A Tournoys3, L Storme4,
P Odou2
1
Faculté de Pharmacie, Lille, France; 2Institut de Pharmacie, CHRU, Lille, France;
3
Fédération de Biologie Pathologie du CHRU, Lille, France; 4Hôpital Jeanne de
Flandre, CHRU, Lille, France
Critical Care 2014, 18(Suppl 1):P96 (doi: 10.1186/cc13286)
Introduction Heparin is commonly given in our neonatal ICU (NICU)
by continuous intravenous infusion. Heparin is diluted in parenteral
nutrition bags and administered over a period of 24 hours with in-line
filtration. However, there are no data on heparin stability in parenteral
nutrition bags, especially on its compatibility with 50% dextrose mainly
present in bags. The aim of our in vitro study was to determine heparin
stability in parenteral nutrition bags prepared in a NICU after 24-hour
infusion and to assess its interaction or not with 50% dextrose.
Methods We prepared both types of bag: parenteral nutrition bags
whose composition was defined in the unit, including sodium heparin
(77 UI/ml); and bags containing only sodium heparin diluted in 50%
dextrose (193 UI/ml). These bags (n = 6 per type) were infused over a
period of 24 hours with and without in-line filtration. Heparin activity
was measured using a chromogenic anti-Xa method in bags just being
prepared (references for other measures) and after 24-hour infusion
and in effluents at the end of infusion line after 24 hours.
Results Our results show values of heparin activity measured in bags
and effluents with and without in-line filtration after 24-hour infusion
for both types of bag assessed (Tables 1 and 2). Results are expressed as
median values (minimum to maximum) in percent.

Table 1 (abstract P95). ROTEM and FOR variables for enoxaparin and tinzaparin
Enoxaparin

Tinzaparin

0 IU/ml

0.5 IU/ml

1.0 IU/ml

1.5 IU/ml

0.5 IU/ml

1.0 IU/ml

1.5 IU/ml

CT (seconds)

175 ± 38

191 ± 89*

214 ± 109

249 ± 94*

223 ± 53*

289 ± 84*

326 ± 125*

CFT (seconds)

77 ± 23

87 ± 21

85 ± 16

83 ± 22

74 ± 27

84 ± 45

80 ± 21

Angle (°)

75 ± 4

74 ± 4

75 ± 3

74 ± 4

75 ± 5

73 ± 5

73 ± 4

MCF (mm)

62 ± 5

61 ± 7

63 ± 5

63 ± 6

ROTEM

MCL (%)

8±4

6 ± 3+

30 ± 5

35 ± 7*

68 ± 7*

64 ± 8

65 ± 6*

5±4

2 ± 5*

5 ± 4*

6±4

2 ± 4*

39 ± 8*

38 ± 11*

36 ± 4*

45 ± 9*

48 ± 15*

ReoRox
COT1 (seconds)
COT2 (seconds)

65 ± 11

76 ± 13*

82 ± 14*

85 ± 20*

74 ± 5*

91 ± 16*

108 ± 29*

COT2 – COT1 (seconds)

34 ± 10

41 ± 8*

43 ± 9*

46 ± 10*

37 ± 4

46 ± 11*

51 ± 15*

Data presented as median (SD). *P <0.05 compared with 0 IU/ml LMWH.
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Table 1 (abstract P96). Results of heparin activity in parenteral nutrition
bags
Bags at T0

Bags at T0 +
24 hours

Effluent at T0 +
24 hours

With filtration

100
(84.09 to 109.09)

95.45
(79.55 to 102.27)

97.73
(75.00 to 104.55)

Without filtration

100
(90.48 to 114.29)

97.62
(83.33 to 107.14)

97.62
(83.33 to 114.29)

Table 2 (abstract P96). Results of heparin activity in bags with sodium
heparin in 50% dextrose
Bags at T0

Bags at T0 +
24 hours

Effluent at T0 +
24 hours

With filtration

100
(77.45 to 108.82)

95.10
(90.20 to 109.80)

98.04
(95.10 to 100.98)

Without filtration

100
(85.44 to 107.77)

92.23
(88.35 to 100.00)

94.17
(86.41 to 108.74)

Conclusion We conclude that there is no loss of heparin activity
when drug is infused over 24 hours for both types of bag prepared,
with and without in-line filtration, showing heparin activity remains
stable during this period and there is no interaction of drug with other
nutrient components of bags, especially 50% dextrose.

P97
Bivalirudin or heparin: which anticoagulation strategy for critically
ill cardiac surgery patients?
F Pappalardo1, B Arnaez1, M Celinska-Spodar1, M Pieri1, F Isella1, S Silvetti1,
A Montisci1, O Saleh1, A Koster2
1
San Raffaele Scientific Institute, Milan, Italy; 2Heart and Diabetes Centre,
North Rhine-Westphalia Ruhr-University Bochum, Bad Oeyenhausen,
Germany
Critical Care 2014, 18(Suppl 1):P97 (doi: 10.1186/cc13287)
Introduction Anticoagulation with unfractionated heparin in cardiac
surgery patients has several limitations, and above all the risk of
heparin-induced thrombocytopenia. Bivalirudin is a direct thrombin
inhibitor, use of which in cardiac surgery patients has expanded in
recent years. The aim of the study was to analyze two strategies for
introducing bivalirudin in this setting (as secondary drug switching
from heparin or as primary anticoagulant) and to evaluate clinical
outcomes.
Methods Data from 100 propensity matched patients who received
heparin (Group H, n = 50) or bivalirudin (Group B, n = 50), from January
2009 to January 2012, in a cardiac surgery ICU of a university hospital
were analyzed. Bivalirudin was administered as either first-line or
second-line drug after heparin discontinuation if heparin-induced
thrombocytopenia was presumed.
Results Bivalirudin treatment was associated with a reduction of major
bleeding (P = 0.05) compared with the control group. Interestingly, in
an intention-to-treat analysis, patients receiving primary bivalirudin
showed a significant reduction in minor bleeding (P = 0.04), and
mortality (P = 0.01) compared with the secondary bivalirudin group,
and similarly if compared with UFH and secondary bivalirudin patients
(P = 0.01 and P = 0.05 respectively). Predictors of hospital mortality at
multivariate analysis included urgent admission (OR = 2.7; 95% CI, 1.03
to 7.2; P = 0.04), septic shock (OR = 8.0; 95% CI, 2.26 to 28.7; P <0.005) and
primary therapy with UFH (OR = 19.2; 95% CI, 2.2 to 163.9; P = 0.007).
Conclusion Novel anticoagulant strategies might play a crucial role
in critically ill cardiac surgery patients. In a propensity-matched
population, our study showed that primary bivalirudin anticoagulation
may reduce bleeding complications and mortality. Further studies are
therefore warranted.

P98
Reversal of edoxaban-induced anticoagulation by the four-factor
prothrombin complex concentrate Beriplex® in a rabbit model
E Herzog1, F Kaspereit1, W Krege1, B Doerr1, J Mueller-Cohrs1, I Pragst1,
Y Morishima2, G Dickneite1
1
CSL Behring GmbH, Marburg, Germany; 2Daiichi Sankyo Co., Ltd, Tokyo,
Japan
Critical Care 2014, 18(Suppl 1):P98 (doi: 10.1186/cc13288)
Introduction The oral direct and selective factor Xa inhibitor edoxaban
(Daiichi Sankyo) is currently available in Japan for the prophylaxis
of venous thromboembolism (VTE) in patients undergoing major
orthopedic surgery and is undergoing investigation in phase III trials
for the prevention of stroke in patients with atrial fibrillation and the
treatment and secondary prevention of VTE. The primary complication
of any available anticoagulant therapy is the risk of bleeding. Rapid
reversal of anticoagulation may be necessary in patients requiring
emergency treatment due to uncontrolled bleeding. Prothrombin
complex concentrates (PCC) are frequently used to reverse the effect of
vitamin K antagonists such as warfarin and have also been suggested
to be potentially effective in reversing the effects of the new oral
anticoagulants. The present study was therefore designed to determine
whether the four-factor PCC Beriplex® can effectively reverse bleeding
and normalize coagulation following edoxaban administration in a
rabbit kidney injury model.
Methods Rabbits were treated with a high intravenous bolus dose of
edoxaban (1,200 μg/kg) followed by the administration of Beriplex® (25
to 75 IU/kg). Bleeding was assessed based on the time to hemostasis
and the total blood loss after induction of a standardized kidney injury.
In parallel, the following biomarkers of hemostasis were determined:
factor Xa inhibition, prothrombin time (PT), activated partial thromboplastin time (aPTT), whole blood clotting time (WBCT), and thrombin
generation (TGA).
Results The results confirmed increased and prolonged bleeding
of edoxaban-treated animals following standardized kidney injury
compared with vehicle administration. Parallel monitoring of
biomarkers of hemostasis showed a prolongation of PT, aPTT, WBCT,
and changes in thrombin generation parameters. Subsequent
administration of Beriplex® resulted in a dose-dependent reversal
of edoxaban-induced bleeding as indicated by reduced time to
hemostasis and total blood loss. Both parameters achieved statistical
significance compared with placebo at the Beriplex® dose of 50 IU/kg
under fully blinded study conditions. The biomarkers correlating best
with Beriplex®-mediated edoxaban anticoagulation reversal included
PT, WBCT and endogenous thrombin potential.
Conclusion In summary, Beriplex® treatment effectively reversed
edoxaban-induced anticoagulation in an animal model of acute
bleeding at clinically relevant dose levels.

P99
Use of a specific antidote to dabigatran (idarucizumab)
reduces blood loss and mortality in dabigatran-induced and
trauma-induced bleeding in pigs
M Honickel1, O Grottke1, J Van Ryn2, H Ten Cate3, R Rossaint1, H Spronk3
1
RWTH Aachen, Germany; 2Boehringer Ingelheim, Biberach, Germany;
3
Maastricht University, Maastricht, the Netherlands
Critical Care 2014, 18(Suppl 1):P99 (doi: 10.1186/cc13289)
Introduction The reversal of the anticoagulant effects of the new
oral anticoagulants in severely bleeding patients requires new
therapeutic strategies. This study investigated the effectiveness of a
specific antidote for idarucizumab to reverse bleeding in a dabigatran
anticoagulated pig trauma model.
Methods After ethical approval, male pigs (n = 30) were given
dabigatran etexilate for 3 days (30 mg/kg bid p.o.), and the sham group
(n = 6) received placebo. To achieve supra-therapeutic anticoagulation,
dabigatran was infused prior to injury on day 4 in anesthetized pigs, and
the sham group received placebo. A standardized blunt liver injury was
inflicted and blood loss (BL) was recorded 10 minutes post trauma. The
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dabigatran-treated animals were randomized (n = 6/group) to a single
injection of idarucizumab at 30, 60 or 120 mg/kg i.v. or vehicle (control
animals). Blood loss and hemodynamic variables were monitored over
4 hours or until time of death. Data were analyzed by ANOVA (± SD) and
by the log-rank test.
Results Dabigatran levels were 1,147 ± 370 ng/ml with no differences
between groups prior to injury. BL in sham animals was 409 ± 53 ml
10 minutes after injury and 700 ± 107 ml after 4 hours (survival rate
100%). Anticoagulation with dabigatran (control animals) resulted in
significantly higher BL 10 minutes after injury (801 ± 66 ml, P <0.05).
Mortality in these animals was 100%, with a mean survival time
of 121 minutes (range: 90 to 153 minutes; P <0.05 vs. sham and
idarucizumab-treated animals). Total BL in dabigatran-treated animals
was 2,977 ± 316 ml. In contrast, treatment with idarucizumab was
associated with a dose-dependent reduction in BL. The lowest dose of
30 mg/kg resulted in 17% mortality (1/6 animals) and BL was reduced
by 50% (1,586 ± 619 ml). BL was further reduced in animals receiving
60 (1,077 ± 103 ml) or 120 mg/kg idarucizumab (1,137 ± 121 ml; both
100% survival). Hemodynamic parameters and markers of shock were
similar to pre-trauma levels in latter groups receiving idarucizumab.
Conclusion This study demonstrates for the first time that
anticoagulation with dabigatran can be reversed effectively and
safely by idarucizumab. Even under supra-therapeutic dabigatran
concentrations, the antidote decreased blood loss and mortality in this
lethal pig animal model. Thus, data from clinical studies are warranted
to confirm the findings of this study.
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Plasma-free hemoglobin and microvascular response to fresh or old
blood transfusion in septic patients
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P Pelaia1, C Ince2
1
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Critical Care 2014, 18(Suppl 1):P101 (doi: 10.1186/cc13291)
Introduction Free hemoglobin (fHb) can scavenge nitric oxide and
induce vasoconstriction [1]. The fHb content may be higher in older
blood bags. We studied whether old red blood cell (RBC) transfusion
increases plasma fHb in septic patients and if this affects the
microvascular response.
Methods Twenty septic patients randomly received either fresh
(<10 days storage) or old (>15 days) RBC transfusion. Plasma fHb
was measured before and 1 hour after transfusion; the sublingual
microcirculation was assessed with sidestream dark-field imaging.
The perfused boundary region (PBR) was measured as an index of
glycocalyx damage [2]. The thenar Tissue Hb index (THI) was measured
(near-infrared spectroscopy).
Results fHb increased in the old RBC group (Figure 1). THI increased
in both groups, while SDF parameters were unaltered. Negative
correlations were found between ΔfHb and changes in total vessel
density (r = –0.57, P <0.01; Figure 2) and THI (r = –0.71, P <0.001). These
relations were lacking in patients with PBR <2.68 μm.

P100
Primary bivalirudin anticoagulation for patients with an
implantable ventricular assist device
M Pieri, B Arnaez, AL Di Prima, M Celinska-Spodar, S Ajello, O Saleh, F Isella,
A Montisci, F Pappalardo
San Raffaele Scientific Institute, Milan, Italy
Critical Care 2014, 18(Suppl 1):P100 (doi: 10.1186/cc13290)
Introduction Bivalirudin is a direct thrombin inhibitor that is
increasingly used in patients undergoing mechanical circulatory
support as it presents many advantages compared with heparin. The
aim of this study was to describe our experience with bivalirudin as
primary anticoagulant in patients undergoing ventricular assist device
(VAD) implantation.
Methods An observational study on the 12 consecutive patients
undergoing VAD implantation from October 2011 at out institution.
Five patients were implanted the Heart Mate II LVAD (Thoratec Corp.,
Pleasanton, CA, USA), six patients the Heartware HVAD (HeartWare
Inc., Miramar, FL, USA), and one patient a Cardiowest Total Artificial
Heart (Syncardia Systems Inc., Tucson, AZ, USA). Patients received a
continuous infusion of bivalirudin, with a starting dose of 0.025 μg/
kg/hour. The target activated partial thromboplastin time (aPTT) was
between 45 and 60 seconds.
Results Patients never received heparin during hospitalization
nor had a prior diagnosis of HIT. Preoperative platelets count
was 134,000 ± 64,000 platelets/mm3. The bivalirudin dose was
0.040 ± 0.026 mg/kg/hour, and the duration of therapy was 5
(5 to 12) days. The lowest platelet count during treatment was
73,000 ± 23,000 platelets/mm3. No thromboembolic complications
occurred. Two episodes of minor bleeding from chest tubes which
subsided after reduction or temporary suspension of bivalirudin
infusion were observed. Six patients required blood red cell
transfusions, and one patient had one fresh frozen plasma transfusion.
No platelet transfusions were performed during treatment. The ICU
stay was 8 (7 to 17) days, and the hospital stay 25 (21 to 33) days.
Conclusion Bivalirudin is a valuable option for anticoagulation in
patients with VAD, and can be easily monitored with aPTT. The use of
a bivalirudin-based anticoagulation strategy in the early postoperative
period may overcome many limitations of heparin, and above all the
risk of HIT which is higher in patients undergoing cardiac surgery.
Bivalirudin should no longer be regarded as a second-line therapy for
anticoagulation in patients with VAD.

Figure 1 (abstract P101). Changes in fHb.

Figure 2 (abstract P101). Relation between changes in fHb and TVD.
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Conclusion Old RBC transfusion increased plasma fHb in septic
patients. Increasing plasma fHb levels after transfusion were associated
with decreased microvascular density and lower increase in tissue
Hb content. This relation might be blunted when the glycocalyx is
preserved.
References
1.
2.

Donadee C, et al.: Circulation 2011, 124:465-476.
Donati A, et al.: Microvasc Res 2013, 90:86-89.

P102
Fatty acid composition of blood plasma in multiple organ
dysfunction syndrome
AN Osipenko1, AV Marochkov2
1
A. Kuleshov Mogilev State University, Mogilev, Belarus; 2Mogilev Regional
Hospital, Mogilev, Belarus
Critical Care 2014, 18(Suppl 1):P102 (doi: 10.1186/cc13292)
Introduction The aim of study was to assess the fatty acid (FA)
composition of blood plasma in multiple organ dysfunction syndrome
(MODS).
Methods The objects of the study were 18 people with multiple organ
failure (35.6 ± 8.7 years) of various etiologies. The blood of 16 healthy
volunteers aged 37.7 ± 3.2 years served as control. There were also
analyzed blood plasma and fragments of artery luminal part from patients
who died from different causes. Analysis of FA was conducted using
capillary gas–liquid chromatography. Quantitative evaluation of individual
FA content was made as a mass percentage of their total. Statistical analysis
was performed using the Mann–Whitney U test (P <0.05).
Results Normalized contents of oleic and palmitoleic monounsaturated
FA increase in patients with MODS, while the levels of stearic saturated
FA and polyunsaturated FA decrease, as compared with the control.
Considering these results, we conclude that blood plasma FA
composition in MODS biased towards composition of FA characteristic
of adipose and muscle tissue triglycerides, which quantitatively
predominant monounsaturated FA, and stearic and polyunsaturated
FA have a significantly lower level [1,2]. Thus, the composition of the
FA in MODS reflects the degree of lipolysis activation in fat depots. As
a result of these processes there should occur an imbalance in vascular
endothelial cells between monounsaturated and polyunsaturated FA
and, as a consequence, changes in metabolism of eicosanoids and
other lipid vasoactive mediators should develop. One should note that
in plasma of people who died in a hospital environment due to various
reasons, similar changes in FA blood composition are observed. The
degree of change of FA composition in postmortem blood samples
presumably primarily depends on severity and duration of a previous
critical and serious condition. Postmortem changes presumably exert
some influence on blood plasma FA composition. Moreover, the
composition of FA in blood plasma in the case of MODS is similar to
that of FA in the luminal part of the artery wall. This suggests a decrease
in the influence of intertissue differences in lipid composition on
metabolic processes.
Conclusion Given that the monounsaturated FAs in the case of MODS
enter the bloodstream primarily from adipose and muscle tissues,
one can assume that their blood plasma level reflects the degree of
hypermetabolism processes in the organism.
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between older and nonolder patients with severe sepsis
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Introduction The present study investigated the relationship between
age [1] and biomarkers of coagulation and fibrinolysis [2] and their
impact on outcome in severe sepsis patients.
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Methods A prospective observational study of adult patients with
severe sepsis was conducted in a single academic hospital. Plasma was
analyzed for coagulation and fibrinolysis markers on days 1, 2, and 3.
Patients were stratified according to the age 67 years, which was the
point of the Youden index (maximum sensitivity + specificity – 1) in a
receiver operation characteristics plot for a logistic regression model of
in-hospital mortality.
Results For the in-hospital survival rate, that of older sepsis patients
was significantly lower than younger patients, 9/15 (60.0%) versus
27/28 (96.4%), P <0.05. Older patients had markedly higher total
plasmin activator inhibitor-1 (TPAI-1) on day 1, thrombin–antithrombin
complex (TAT) on days 2 and 3, and fibrin monomer complex on day 2,
and markedly lower plasminogen (PMG) on day 3 and alpha-plasmin
inhibitor (αPI) on days 2 and 3 compared with younger patients (all
P <0.05). Age was an independent predictor of high TAT on days 2 and
3, high fibrin monomer complex on day 2, low PMG on day 3, and low
αPI on days 2 and 3 after adjusting for some cofactors and covariables.
TPAI-1 on day 2, TAT on day 2, and PMG on day 3 were risk factors of inhospital mortality in older sepsis patients (Table 1).
Table 1 (abstract P103). Univariate analysis of logistic regression for
in-hospital mortality
HR

95% CI

P

PAI-1 day 2

1.02

1.0 to 1.06

<0.01

TAT day 2

1.49

1.02 to 19

<0.05

PMG day 3

0.64

0.1 to 0.95

<0.01

SOFA day 1

1.2

0.9 to 1.69

0.21

IL-6 day 1

0.99

0.9 to 1.00

0.21

Conclusion In severe sepsis, older patients displayed a biomarker
profile suggestive of enhanced response of coagulation and fibrinolysis
system compared with younger patients. Change of some markers
depended on age and may contribute to the poor outcome in older
patients.
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Introduction Antifibrinolytic drugs recently have been associated
with adverse outcomes in patients undergoing cardiac surgery. We
reviewed our experience with prophylatic ε-aminocaproic acid in
patients undergoing cardiac surgery at InCor – Heart Institute.
Methods We retrieved data on 2,852 consecutive patients undergoing
cardiac surgery at revascularization at Duke between 1 January
2004 and 31 December 2008. We compared patients receiving or
not prophylatic ε-aminocaproic acid in coronary artery bypass graft
surgery, or valve procedures or combined ones. We evaluated baseline
characteristics, intraoperative data and severe clinical endpoints
during 30 days.
Results A total of 2,852 patients were included in the analysis and 1,389
(48.7%) received prophylactic ε-aminocaproic acid. The others did not
receive any antifibrinolytic. In the risk-adjusted model, survival was
similar among patients treated with aminocaproic acid or not treated
(1.9 vs. 1.6%, P = 0.48). Bleeding in 24 hours was reduced in the treated
group as compared with the nontreated (391 vs. 472 ml, P = 0.012).
There were no differences regarding acute renal failure, stroke and
infection in 30 days.
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Conclusion In cardiac surgery, prophylactic use of aminocaproic acid
reduces bleeding and does not result in higher incidence of acute
complications.
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Introduction Atypical haemolytic uraemic syndrome (aHUS) is
a rare, life-threatening disease in which patients experience uncontrolled complement activation leading to systemic thrombotic
microangiopathy (TMA). We report on the effect of eculizumab (Ecu), a
terminal complement inhibitor approved for the treatment of aHUS, in
the largest prospective clinical trial in aHUS.
Methods Adult aHUS patients (≥18 years) with platelets <150×109/l and
LDH ≥1.5 ULN were recruited into a 26-week single-arm, phase 2 study
evaluating Ecu treatment. Patients with STEC-HUS (Shiga toxin and E.
coli) and severe ADAMTS13 deficiency (activity <5%) were excluded.
Identification of complement mutation was not required for enrolment.
The primary endpoint was complete TMA response (platelet and LDH
normalisation (>150×109/l and <ULN, respectively) and <25% increase
in serum creatinine from baseline (BL)). Other efficacy evaluations
measured platelet counts and eGFR improvement (by MDRD).
Results Forty-one patients were enrolled (mean (SD) age 40.3 (15.3)
years; 28 (68%) females), 30 (73%) of whom with first presentation of
aHUS (median 2 weeks before Ecu). BL mean (SD) platelets and eGFR
were 119 (66.1) ×109/l and 17.3 (12.1) ml/minute/1.73 m2, respectively.
Thirty-eight (93%) patients received Ecu for 26 weeks. Table 1 shows
improvements in outcomes. Dialysis was discontinued in 20 (83%)
among the 24 patients requiring dialysis at inclusion. Ecu was generally
well tolerated, with no deaths or unexpected safety concerns.
Meningococcal infections occurred in two patients, one of whom
continued treatment.
Table 1 (abstract P105). Outcomes at 26 weeks in adult aHUS patients
receiving Ecu
Complete TMA response, n (%) patients

30 (73); 95% CI 57 to 86

Platelet count normalisation, n (%) patients

40 (98); 95% CI 87 to 100

Mean (SD) platelet count increase from baseline, ×109/l

135 (114); P <0.0001
2

Mean (SD) eGFR increase from baseline ml/minute/1.73 m 29.3 (23.6); P <0.0001

Conclusion Results from this large prospective clinical trial in adult
patients with aHUS confirm prior trials with Ecu to inhibit complementmediated TMA, improve renal and haematological outcomes and show
the benefit of early diagnosis and treatment. There were no unexpected
safety concerns. The trial is ongoing.
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Variation in red blood cell transfusion thresholds in critically ill
patients
K Wilton, R Fowler, T Walsh, J Lacroix, J Callum
Sunnybrook Hospital, Toronto, Canada
Critical Care 2014, 18(Suppl 1):P106 (doi: 10.1186/cc13296)
Introduction Restrictive transfusion practice in recent randomized
trials and systematic reviews continues to have favorable outcomes [1].
Despite this, substantial variability in transfusion practice persists [2].
It is important to identify contemporary variability, and which patient,
provider, and institutional factors drive this variability. Therefore, we
performed a retrospective analysis hypothesizing that red blood cell

(RBC) transfusion practice remains variable and is influenced by patient
characteristics and institutional transfusion culture.
Methods We performed a multicenter retrospective analysis within the
ongoing prospective randomized, Age of Blood Evaluation (ABLE) trial.
The patient population included patients admitted to the ICU with an
anticipated length of invasive or non-invasive mechanical ventilation
>48 hours and who required a first RBC transfusion during the first
7 days of ICU admission. As of March 2013, completed and verified data
from 45 sites in Canada, France, and the UK were included. Sites with at
least 12 patients were included in site analysis. The primary outcome is
the association of enrolling centers on the median hemoglobin prior
to transfusion.
Results As of March 2013, there were 1,288 patients randomized
in the ABLE study. The median patient age was 63 years (IQR 50 to
74). The majority of patients were emergent admissions (97%) with
nonoperative diagnoses (85%), including respiratory illness (27%) and
sepsis (18%). Bleeding was infrequent (0.4%). At least one comorbidity
was common (43%), frequently significant cardiac disease (14%) and
diabetes (12%). There is significant variability in the median pretransfusion hemoglobin across different sites (P <0.05). The median
pre-transfusion hemoglobin by site was 75 g/l (IQR 71 to 77). Six of
24 sites had a significantly higher, and four had a significantly lower,
median transfusion threshold compared with the median. Significant
variability in the median pre-transfusion hemoglobin remained in
multivariate analysis, after adjustment for age and type of ICU.
Conclusion There was a 16 g/l difference in median hemoglobin
between the lowest and highest site and wide inter-site variation.
These differences may be due to transfusion education, monitoring
and blood-bank enforcement practices. Site, not country, remains a
significant predictor of transfusion. Future directions in transfusion
best practices should focus on local transfusion culture. Significant and
nonevidence-based variability persists in transfusion thresholds for
critically ill patients.
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Introduction Owing to their high risk in cardiac surgery, it is essential
to define which transfusion strategy results in a lower rate of cardiovascular complications in older patients [1]. The aim of this study was
to compare clinical outcomes after the implementation of either a
restrictive or a liberal transfusion strategy in patients aged 60 years and
above.
Methods This study was a substudy of the Transfusion Requirements
After Cardiac Surgery study. In this subgroup analysis we included all
patients aged 60 years and above randomized to a restrictive or a liberal
strategy of RBC transfusion. A composite endpoint for cardiovascular
complications was used and defined as a combination of 30-day allcause mortality and severe cardiovascular morbidity.
Results The primary composite endpoint – all-cause 30-day mortality,
cardiogenic shock, or myocardial infarction – occurred in 9.6% of
patients in the liberal strategy group and in 18.4% in the restrictive
strategy group (P = 0.041). The incidence of cardiogenic shock was
5.2% in the liberal group and 12.8% in the restrictive group (P = 0.031)
and of myocardial infarction was 2.2% in the liberal group and 5.6%
in the restrictive group (P = 0.203). There was no significant difference
between transfusion strategies in 30-day mortality rates (4.4% vs. 8%,
respectively; P = 0.23).
Conclusion In this prospective, randomized clinical trial, older patients
submitted to a restrictive strategy of RBC transfusion had a rate of
cardiovascular complications in 30 days after cardiac surgery twice
as high than a liberal strategy. In this group of patients, probably
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untreated anemia would be more harmful than in a younger or
healthier population undergoing cardiac surgery.
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Introduction Anemia and its association with mortality among
emergency department (ED) patients with suspected infection has to
our knowledge never been investigated. We hypothesize that anemia
as well as high hematocrit increases the risk of in-hospital death among
these patients.
Methods A prospective observational study of adult ED patients with
suspected infection presenting to an urban, academic medical center
ED at Beth Israel Deaconess Medical Center, Boston, MA, USA. Inclusion
criterion was clinically suspected infection at ED presentation. Patients
were enrolled over a 1-year period. Laboratory and clinical data were
collected at enrollment. Primary outcome was in-hospital mortality.
Logistic regression was performed determining the independent
mortality odds adjusting for confounders.
Results A total of 4,952 patients were enrolled with an in-hospital
mortality rate of 4% and a mean age of 58 ± 21 years. In total, 4,683
(95%) patients had their hematocrit measured: 3,857 (82%) patients
had a normal hematocrit (30 to 44%), 413 (8.8%) patients had 25 to
29% hematocrit, and 66 (1.4%) patients ≤24% hematocrit. A total of 248
(5.3%) had a high hematocrit (≥45%). After adjusting for age, present
or prior cancer, diabetes I and II, end-stage renal disease, AIDS and liver
disease, anemia remained an independent predictor of in-hospital
mortality with odds ratios of respectively 1.7 and 2.5 with worsening
anemia as well as high hematocrit, with odds ratio 2.3 (Table 1). The
AUC for the model was 0.78.
Table 1 (abstract P108). Effect of severity of anemia or high hematocrit on
in-hospital mortality
Hematocrit

Mortality OR

P value

≥45%

2.3(1.3 to 4.1)

0.007

30 to 44%, ref.

1.0

25 to 29%

1.7(1.1 to 2.6)

0.019

< 20%

2.5(1.1 to 5.8)

0.032

Conclusion Anemia and elevated hematocrit seem to be associated
with in-hospital mortality among patients with suspected infection.
Treatment of high or low hematocrit as a part of the ED resuscitation
could be a subject for further investigation.
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New simplified criteria for predicting massive transfusion in trauma
T Yumoto, A Iida, E Knaup, N Nosaka, S Morisada, T Hirayama, N Shiba,
K Tsukahara, H Nosaka, Y Kinami, M Terado, H Yamanouchi, K Sato,
T Ugawa, S Ichiba, Y Ujike
Okayama University Hospital, Okayama, Japan
Critical Care 2014, 18(Suppl 1):P109 (doi: 10.1186/cc13299)
Introduction Several predicting models have been described to
identify the necessity for massive transfusion (MT) for trauma patients
[1]. The purpose of this study is to validate the simplified scoring
systems reported previously and establish new criteria at emergency
and in the ICU in Japan.

Methods We retrospectively analyzed trauma patients transported
to our center for the recent 2 years. Patients transferred from other
hospitals with minor injuries or confirmed cardiac arrest at the scene
were excluded.
Results A total of 297 trauma patients were included in this study.
Thirty-one (10.4%) patients required MT. Sensitivity and specificity
for the Assessment of Blood Consumption (ABC) score were 48% and
99%, respectively. Because blunt injuries account for most trauma
patients in Japan, we established new simple criteria using significant
factors that were derived from the examination on arrival. If trauma
patients met any of the following conditions – that is, shock index (SI)
>1, base excess (BE) <–3 mmol/l, and positive focused assessment of
sonography for trauma (FAST) – sensitivity and specificity was 97% and
80%, respectively. The area under the receiver operating characteristic
curve of ABC and the new criteria was 0.889 (95% CI, 0.815 to 0.963) and
0.927 (95% CI, 0.881 to 0.974), respectively.
Conclusion We suggest new criteria for early predicting MT in trauma
using SI, BE, and FAST. This method may be valid especially in such
areas because blunt injuries are the major cause of trauma in Japan.
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Introduction A massive transfusion protocol (MTP) aims to provide
standardized and early delivery of blood products and prohemostatic
agents by keeping pre-thawed fresh frozen plasma (FFP) available.
Implementation of MTP is assumed to result in transfusion with higher
ratios of FFPs and platelets to red blood cells (RBCs). Pre-thawing may
also result in waste of FFPs. These MTP benefits or disadvantages have
not yet been demonstrated. The aim of this study was to evaluate
efficacy of a MTP 1 year after implementation in our level I trauma
center in an academic hospital.
Methods A retrospective analysis of an electronic blood bank
transfusion database comparing massive transfusion before (January to
December 2011) and after (January to December 2012) implementation
of MTP. Activation of MTP consists of delivery of packages of 6 units of
RBC, 6 units of pre-thawed FFP and 2 units of platelets collected from
five donors. Massive bleeding was defined as transfusion ≥10 units of
RBCs. Statistics by t test and Mann–Whitney U test.
Results In 2012, a total of 101 MTP activations was registered. Accurate
prediction of massively bleeding patients (n = 30) was 29.7% of MTP
activations. Of all massively bleeding patients in 2012, MTP was
not activated in 55.2%. In patients for whom MTP was activated, the
RBC:FFP ratio was 1:0.9. In patients for whom MTP was activated and
who were massively bleeding, the RBC:FFP ratio was 1:0.9, which was
significantly higher compared with 1:0.6 in massive bleeders in 2011
(n = 70) (P = 0.001). The median of blood products administered was
12.5 (6 to 21) in massive bleeding after MTP implementation, compared
with 8 (3 to 13) in 2011 (P <0.001). In patients for whom MTP was
activated, 9.7% of thawed FFPs were not transfused and wasted. When
massive transfusion was accurately predicted, the waste of FFPs was
4.8% versus a waste of 16.2% in the group of unjustified MTP activation.
Conclusion Implementation of MTP is associated with an increase of
blood products transfused and a significant shift of RBC:FFP ratio to 1:1.
However, MTP is also associated with a 9.7% waste of FFP. Improving
prediction for massive bleeding patients may result in a decrease of
wasted, costly blood products.
P111
Blood product transfusions in septic patients are associated with
mortality, ARDS, and more days on mechanical ventilation
PP Dobesh, DG Klepser, TR McGuire, DA Roberts, AL Himmelberg, KM Olsen
University of Nebraska Medical Center College of Pharmacy, Omaha, NE, USA
Critical Care 2014, 18(Suppl 1):P111 (doi: 10.1186/cc13301)
Introduction The objective of this study was to determine whether
septic patients requiring blood product transfusions have worse
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outcomes compared with those who do not require transfusions. It
is not uncommon for patients with sepsis to require blood product
transfusions. The need for transfusions may be indicative of inflammatory
consumption of blood cells, active blood loss, or impaired hematopoiesis.
Regardless of the etiology, need for transfusion may be an indicator of a
more severely ill patient and a valuable prognostic factor.
Methods This retrospective cohort study included all patients over
the age of 40 years with a confirmed diagnosis of sepsis and an ICU
stay at our academic medical center from 1 January 2005 to 31 March
2011. Use of blood product transfusion, patient demographics, and
APACHE II score at the time of sepsis were collected from patient charts.
Outcomes of interest were in-hospital mortality, development of acute
respiratory distress syndrome (ARDS), days on mechanical ventilation,
hospital cost, and length of stay.
Results We identified 824 patients who met the inclusion criteria
for this study. Of those patients, 543 (66%) received at least 1 unit
of blood products during hospitalization. Patients receiving blood
products had significantly higher in-hospital mortality (36.1% vs.
26.9%; P = 0.003) and a higher rate of development of ARDS (45.3%
vs. 27.1%; P <0.001) compared with patients not receiving blood
products. Patients receiving packed red blood cells (PRBCs) (60%) did
not demonstrate a significant increase in mortality (35.1% vs. 28.8%;
P = 0.058), while patients receiving platelets (20%) did have higher
mortality (45.1% vs. 29.5%; P <0.001). Transfusions of PRBCs or platelets
were both associated with a higher development of ARDS (P <0.001
for both). There was a significant increase in days on mechanical
ventilation (7.0 days vs. 2.3 days; P <0.001), hospital cost ($88,331 vs.
$35,047; P <0.001), and length of stay (17.3 days vs. 9.7 days; P <0.001)
for patients receiving blood products, regardless of the type. These
differences were seen despite the mean APACHE II score being similar
(22.8 vs. 22.5; P = 0.645).
Conclusion Patients with sepsis receiving blood products, particularly
platelets, were significantly more likely to develop ARDS, had more
days on mechanical ventilation, and had higher mortality. The lack of
an increase in mortality associated with PRBC transfusion may be due
to the benefit in oxygen delivery or sample size.
P112
Transfusion requirements in septic shock patients: a randomized
controlled trial
F Bergamin1, J Almeida1, C Park1, E Osawa1, J Silva1, F Galas1, D Nagaoka1,
J Fukushima1, S Vieira1, L Candido1, CO Oshiro1, JL Vincent2, L Hajjar1
1
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Critical Care 2014, 18(Suppl 1):P112 (doi: 10.1186/cc13302)
Introduction Perioperative red blood cell transfusion is commonly
used to address anemia, an independent risk factor for morbidity
and mortality in critically ill patients [1]; however, evidence regarding
optimal blood transfusion practice in septic shock is lacking. The aim of
this study was to define which is the best transfusion strategy in septic
shock patients regarding 28-day mortality and clinical outcomes:
restrictive or liberal.
Methods The Transfusion Requirements After Cardiac Surgery (TRACS)
study is a prospective, randomized, controlled clinical noninferiority
trial conducted between February 2009 and February 2010 in an
ICU at a university hospital cardiac surgery referral center in Brazil.
Consecutive adult patients (n = 502) who underwent cardiac surgery
with cardiopulmonary bypass were eligible; analysis was by intention
to treat.
This is a randomized controlled parallel-group trial, which included
300 patients admitted to a cancer ICU with diagnosis of septic
shock. Patients were randomly assigned to a liberal strategy of blood
transfusion (to maintain hemoglobin >9 g/dl) or to a restrictive
strategy (hemoglobin >7 g/dl). Mortality in 28 days was the main
outcome. Secondary outcomes were clinical complications days free of
organ dysfunction, ICU and hospital length of stay, adverse effects of
transfusion and 60-day mortality.
Results A total of 136 patients were included in the first part of the
trial. Mean age was 62 ± 14 years, SAPS 3 at admission was 65 ± 15 and
all patients had the diagnosis of solid neoplasm. Sixty-three patients
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(46.3%) were included in the liberal strategy and 73 patients (53.7%)
in the restrictive strategy. Occurrence of 28-day mortality was similar
between groups (54% in liberal group vs. 56.2% in restrictive group;
P = 0.395).
Conclusion Among cancer patients with septic shock, the use of a
restrictive perioperative transfusion strategy compared with a more
liberal strategy resulted in similar rates of 28-day-mortality.
Reference
1.

Hajjar LA, Vincent JL, Galas FR, Nakamura RE, Silva CM, Santos MH, et al.: JAMA
2010, 304:1559-1567.

P113
Inflammatory properties of microparticles in stored red blood cell
transfusion products
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Introduction Blood transfusion is associated with increased morbidity
and mortality in the critically ill [1]. Adverse effects of transfusion may
be mediated by changes in the blood product that accumulate with
storage time [2]. The mechanisms, however, are largely unknown.
Erythrocyte-derived microparticles (MPs) have been found in
transfusion bags [3,4] and their concentration increases with storage
duration [5]. We hypothesize that accumulation of MPs during storage
induces a proinflammatory state in the recipient.
Methods Microparticles were isolated by high-speed centrifugation
from red blood cell transfusion bags stored for 41 or 42 days. Whole
blood from healthy volunteers was incubated for 24 hours with
supernatant from the bags either containing MPs or depleted from
MPs. Controls were incubated with medium or LPS (10 ng/ml). TNFα, IL10 and IL-6 were measured in supernatant by ELISA. Data are expressed
as median and range.
Results MP-depleted supernatant induced a modest increase in
median levels of TNFα (9.2 (2.3 to 22.2) pg/ml) and IL-6 (2,140.7 (1,507 to
2,199) pg/ml) compared with the negative controls (2.3 (2.3 to 2.3) pg/
ml and 94.4 (64.7 to 124.1) pg/ml, respectively), while IL-10 levels were
not affected. Addition of MP-containing supernatant resulted in highly
increased levels of TNFα (699 (687 to 742) pg/ml), IL-6 (37,443 (26,493 to
40,967) pg/ml) and IL-10 (1,201 (1,178 to 1,533) pg/ml) compared with
negative controls. This MP-induced increase in cytokine production
was comparable with the increase observed after the addition of LPS.
Conclusion Erythrocyte-derived MPs from aged red blood cell
transfusion bags induce a strong inflammatory response in vitro, which
is largely negated when MPs are removed. Whether MPs mediate
adverse effects of blood transfusion in the critically ill remains to be
determined.
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Influenza A (H1N1): the first hit for transfusion-related acute lung
injury?
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Critical Care 2014, 18(Suppl 1):P114 (doi: 10.1186/cc13304)
Introduction Transfusion-related acute lung injury (TRALI) is the
leading cause of transfusion-related fatalities [1]. A two-hit hypothesis
has been proposed for TRALI. The first hit is underlying patient factors,
resulting in adherence of primed neutrophils to the pulmonary
endothelium, such as severe pneumonia due to influenza A H1N1.
The second hit is caused by mediators in the blood transfusion that
activate the endothelial cells and pulmonary neutrophils, resulting
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in capillary leakage and subsequent pulmonary edema [2]. TRALI is a
clinical diagnosis with the following criteria: acute onset within 6 hours
of blood transfusion, PaO2/FIO2 ratio <300 mmHg, or worsening of the
P:F ratio, bilateral infiltrative changes on chest radiograph, no sign of
hydrostatic pulmonary edema (pulmonary arterial occlusion pressure
≤18 mmHg or central venous pressure ≤15 mmHg) and no other risk
factor for acute lung injury [2].
Methods We describe a fatal TRALI in a patient with influenza A (H1N1),
suggesting a relationship between a first-hit lung injury followed by
the second lung impairment after blood transfusions.
Results We report a 57-year-old female, without a previous medical
record. She had an acute onset of fever, cough, muscle pain and
progressive dyspnea leading to acute respiratory distress syndrome.
The test for influenza A H1N1 was positive. She was recovering, but on
day 12 of admission, after 1 hour of platelet transfusion, she started
with intensive tachycardia, dyspnea and hypoxemia. Her mechanical
ventilation parameters increased dramatically. She was in plan for
extubation with FiO2 of 30% and positive end-expiratory pressure of
8, which became 100% and 14 respectively. The P:F ratio dropped to
62. Her leukocytes were 10.6×109/l a few hours earlier and went down
to 1.5×109/l after the onset. Previous lactate was normal, but jumped
to 42 mg/dl. She was free of vasopressors and after the offending
transfusion went through refractory shock and died approximately
24 hours after the blood transfusion.
Conclusion For our knowledge this is the first case reported of TRALI in
an influenza A (H1N1) patient. Although blood transfusion can be life
saving, it also can be a life-threatening intervention. Prevention is still
the best hit.
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Prothrombin complex concentrate restores haemostasis in a
dabigatran anticoagulated polytrauma pig model
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Introduction Prothrombin complex concentrate (PCC) has been
suggested as a measure to terminate trauma and dabigatran-induced
bleeding. Owing to the conflicting data concerning such therapy, we
investigated the impact of a four-factor PCC to terminate massive
bleeding following the infliction of multiple trauma in dabigatran
anticoagulated pigs.
Methods After ethical approval, 24 male pigs were administered
dabigatran etexilate (30 mg/kg bid p.o.) for 3 days. On day 4, dabigatran
in anaesthetised animals was infused prior to injury to achieve supratherapeutic levels. Twelve minutes after infliction of bilateral femur
fractures and standardised blunt liver injury, animals randomly received
PCC (25, 50 or 100 IU/kg; n = 6) or placebo (n = 6). Time-adjusted blood
loss as primary endpoint (observation period 300 minutes) and a
panel of coagulation variables were continually measured. Data were
analysed by two-way ANOVA. Data are mean ± SEM.
Results Concentrations of dabigatran prior to infliction of trauma
was comparable between groups (590 ± 40 ng/ml). Anticoagulation
with dabigatran and trauma caused severe coagulopathy as shown
by prolonged TEM variables (CT, CFT), PT and aPTT. Following PCC
application these effects were partially reversed. Due to ongoing blood
loss both PT and TEM variables prolonged over time in PCC 25 IU/kg
substituted animals. Accordingly, no-PCC (38.5 ± 4.7 ml/minute) and
PCC 25 IU/kg (22.6 ± 5.5 ml/minute) animals showed highest blood loss
(P <0.05 vs. PCC 50 IU/kg and PCC 100 IU/kg) with a mean survival time
of 106 minutes (no-PCC animals) and 204 minutes for PCC 25 IU/kg
animals, respectively. All animals of the PCC 50 IU/kg and PCC 100 IU/kg
group survived. Blood loss in both groups was comparable (PCC 50 IU/
kg: 5.9 ± 0.2 ml/minute; PCC 100 IU/kg 6.0 ± 0.3 ml/minute).
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Conclusion The use of high doses of PCC reversed the anticoagulant
effects of dabigatran, which was associated with a significant reduction
of blood loss. However, the results of this study show that sufficient
concentrations of PCC are necessary to overcome thrombin inhibition.
P116
Effect of a fixed dose of fresh frozen plasma on systemic inflammation
and endothelial damage in nonbleeding critically ill patients
M Straat, M Muller, J Meijers, M Schultz, N Juffermans
Academic Medical Center, Amsterdam, the Netherlands
Critical Care 2014, 18(Suppl 1):P116 (doi: 10.1186/cc13306)
Introduction Fresh frozen plasma (FFP) is associated with onset of
acute lung injury [1], the mechanism of which is largely unknown.
On the other hand, FFP may be beneficial, as a higher ratio of FFP to
red blood cells decreases mortality in bleeding trauma patients [2]
and is associated with an endothelial stabilizing effect in vitro [3]. We
investigated the effect of transfusion with FFP on host response and
markers of endothelial damage in nonbleeding critically ill patients.
Methods This was a substudy of a multicenter trial in which nonbleeding
critically ill patients with an increased International Normalized Ratio
(1.5 to 3.0) were randomized to omitting or administering a prophylactic
transfusion of FFP (12 ml/kg) prior to an invasive procedure. In 38
patients randomized to receive FFP transfusion, we measured levels
of factor VIII, von Willebrand factor, and markers of proinflammatory
response before and after transfusion. Data are presented as medians.
Results FFP transfusion resulted in a significant decrease of TNFα (from
12.3 to 3.1 pg/ml, P = 0.01), von Willebrand factor (from 475 to 424%,
P <0.01) and factor VIII (from 246 to 244%, P <0.01). FFP did not alter
levels of IL-1β, IL1-RA, IL-8, IL-10, MCP1, MIP1A or sCD40L. Patients had
some degree of lung injury at baseline as reflected by a lung injury
score of 2 (0.8 to 2.5), which did not change following transfusion. None
of the patients developed TRALI.
Conclusion FFP transfusion is not associated with a proinflammatory
response in the critically ill. Rather, FFP seemed to have an endothelial
stabilizing effect.
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Application of damage control resuscitation strategies to patients
with severe traumatic hemorrhage: review of plasma to packed red
blood cell ratios at a single institution
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Introduction When treating trauma patients with severe hemorrhage,
massive blood transfusions are often needed. Damage control
resuscitation strategies can be used for such patients, but an adequate
fresh frozen plasma:packed red blood cell (FFP:PRBC) administration
ratio must be established.
Methods We retrospectively reviewed the medical records of 100
trauma patients treated with massive transfusions from March 2010
to October 2012. We divided the patients into two groups according
to the FFP:PRBC ratio: a high-ratio group (≥0.5) and a low-ratio group
(<0.5). The patient demographics, fluid and transfusion quantities,
laboratory values, complications, and outcomes of both groups were
analyzed and compared.
Results There were 68 patients in the high-ratio group and 32 in the
low-ratio group. There were statistically significant differences between
groups in the quantities of FFP, FFP:PRBC, platelets, and crystalloids
administered, as well as the initial diastolic blood pressure. When
comparing the incidence of complications, bloodstream infections
were noted only in the high-ratio group, and the difference was
statistically significant (P = 0.028). Kaplan–Meier plots revealed that the
24-hour survival rate was significantly higher in the high-ratio group
(71.9% vs. 97.1%, P <0.001). The 30-day survival rate was also higher
in the high-ratio group (56.2% vs. 67.6%), but the difference was not
statistically significant (P = 0.117).
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Conclusion For treating patients with severe hemorrhagic trauma,
raising the FFP:PRBC ratio to 0.5 or higher may increase the chances
of survival (especially the 24-hour survival rate). Efforts to minimize
bloodstream infections during the resuscitation process must be
increased.
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concentrates and a specific antidote (idarucizumab) are effective to
reverse the anticoagulant effects of dabigatran
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Introduction Strategies to reverse the anticoagulant effects of the new
oral anticoagulants in severely bleeding patients remain challenging
and conflicting results have been presented regarding the efficacy
of PCCs to alter dabigatran-induced coagulopathy. Thus, this study
assessed the ability of PCC, activated PCC (aPCC), recombinant FVII
(rFVIIa) and idarucizumab to reverse the anticoagulant effects of
dabigatran in a porcine model of trauma.
Methods Studies were performed in five pigs. Dabigatran etexilate (DE) was
given orally for 3 days (30 mg/kg bid) and on the 4th day dabigatran was
infused 90 minutes (30 minutes: 0.77 mg/kg/hour; 60 minutes 0.52 mg/kg/
minute) prior to blunt liver injury. Blood samples were taken before and
after dabigatran infusion and 60 minutes post injury. Two doses of PCC (30,
60 IU/kg), aPCC (30, 60 IU/kg), rVIIa (90, 180 μg/kg) and idarucizumab (30,
60 mg/kg) were added to blood samples ex vivo. Coagulation was assessed
by thromboelastometry, PT and diluted TT. One-way analysis of variance
with the Dunnett post-hoc test for multiple comparisons was used for
statistical analysis. Data are presented as mean ± SD.
Results Oral DE prolonged clot formation (CFT: 159 ± 39 seconds) and
PT (27 ± 9 seconds). Following the 90-minute infusion of dabigatran,
the mean plasma levels of dabigatran increased to 1,423 ± 432 ng/
ml. This supra-therapeutic level was associated with a further
prolongation of PT, aPTT, and the EXTEM variables CT and CFT. These
changes in coagulation parameters were compounded by blood loss
following trauma (total blood loss at 60 minutes: 1,978 ± 265 ml). Sixty
minutes after trauma, four out of five animals had no measurable clot
formation (EXTEM CFT ≥4,000 seconds) and clot strength (EXTEM
MCF) had reduced to 11 ± 7 mm. Both PCCs and aDabi-Fab, but not
rFVIIa, reversed the effects of dabigatran on thromboelastometry
parameters (clotting time and clot formation time) and PT at all time
points. In contrast, aPTT was only normalised by idarucizumab. Plasma
concentrations of dabigatran remained elevated after PCC therapy, but
were not measureable after idarucizumab.
Conclusion Both PCC and aPCC are effective in reducing coagulopathy
in a porcine trauma model with dabigatran anticoagulation. The ex
vivo addition of idarucizumab fully corrected all coagulation measures
and significantly decreased plasma concentrations of dabigatran. No
significant effects on haemostasis were observed after the application
of rFVIIa.
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for hemorrhagic shock by low-dose inhaled nitrite or carbon
monoxide
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Introduction Fluid resuscitation of hemorrhagic shock is frequently
associated with reperfusion injury and secondary organ damage.
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Studies suggest that low doses of both nitrite and carbon monoxide
may protect tissues and organs from this reperfusion injury by limiting
mitochondrial free radical production. We explored the effects of very
small doses of nitrite and carbon monoxide on tissue injury in a porcine
model of hemorrhagic shock.
Methods Fluid resuscitation of hemorrhagic shock is frequently
associated with reperfusion injury and secondary organ damage.
Studies suggest that low doses of both nitrite and carbon monoxide
may protect tissues and organs from this reperfusion injury by limiting
mitochondrial free radical production. We explored the effects of very
small doses of nitrite and carbon monoxide on tissue injury in a porcine
model of hemorrhagic shock.
Results Although no increase in blood nitrite concentrations was
observed after inhalation, nitrite was associated with significant
decreases in blood, muscle, and peritoneal fluid lactate concentrations
(P <0.05), whereas both nitrite and carbon monoxide were associated
with significant decreases in glycerol in peritoneal fluid (P <0.05).
Following resuscitation, the muscle mitochondrial respiratory control
ratio was preserved in the nitrite and carbon monoxide groups and
reduced in the control group. Adjuvant drugs had no effects on any
gross hemodynamic parameters.
Conclusion We conclude that at low doses, nebulized sodium nitrite
and inhaled carbon monoxide are associated with tissue protection
during resuscitation from severe hemorrhagic shock.
Acknowledgement This work was supported in part by DoD grant
W81XWH-11-2-0049, NHLBI HL07820, and 2013121 from The SouthEastern Norwegian Health Authorities.
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Introduction Currently, most non-invasive blood pressure (NIBP)
monitoring is based on the oscillometric method and determines
the blood pressure during cuff deflation [1]. On the other hand, a
measurement during cuff inflation may be advantageous, as cuff
inflation requires lower cuff pressure and shorter duration than
deflation. In surgical patients during anesthesia, the inflationary NIBP
has reasonable accuracy compared with conventional deflationary NIBP
[2]. Few studies have reported NIBP monitoring using the inflationary
NIBP in ER patients with various unstable conditions. A purpose of this
study is to verify the usefulness of the inflationary NIBP monitoring in
the emergency department.
Methods A total of 2,981 NIBP data were collected from 174 patients
(age; 56.5 ± 22.2 (7 to 92) years) who have been accommodated in the
resuscitation area of the ER at Keio University Hospital, using alternately
two algorithms with a standard monitor (BSM-6000; Nihon Kohden
Inc., Tokyo, Japan). One algorithm consists of continuous inflationary
and deflationary measurement in a single cycle (dual algorithm, 1,502
data) performed in order to verify a success rate and a precision of data.
The deflationary algorithm (1,479 data) consists of only conventional
deflationary measurement performed in order to verify the duration of
the measurement cycle.
Results The success rate of the inflationary NIBP (completed only by
inflationary method) was 69.0%. The bias and precision of systolic
pressure and diastolic pressure (difference of systolic and diastolic
pressure between inflationary and deflationary NIBP) were –0.6 ± 8.8
and 3.5 ± 7.5 mmHg, respectively (Figure 1). Inflationary NIBP could
also determine NIBP more quickly compared with deflationary NIBP
(16.8 vs. 29.1 seconds, median) (Figure 2).
Conclusion These data suggest that inflationary NIBP has reasonable
accuracy and sufficient rapidity compared with deflationary NIBP in
emergency room patients.
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Figure 1 (abstract P120). Precision of measurements between inflationary and deflationary NIBP.

calibration of the CNAP™ device and the corresponding IAP values
resulted in a mean difference (± standard deviation) of –0.8 mmHg
(±8 mmHg), –5 mmHg (±14 mmHg), and +10 mmHg (±9 mmHg),
respectively. (3) CAC of the CNAP™ finger AP values to IAP values
instead of calibration to oscillometric upper-arm AP measurements
resulted in a mean difference (± standard deviation) of +4 mmHg
(±8 mmHg), +5.5 mmHg (±14 mmHg), and +3 mmHg (±7 mmHg),
respectively. The accuracy of CAC-CNAP™-derived systolic and diastolic
AP compared with the CNAP™-derived AP calibrated to oscillometric
AP was significantly higher (P = 0.004 and P <0.001, respectively).
Conclusion When using the CNAP™ system, calibration to oscillometric
upper-arm AP values integrated into the CNAP™ system is a relevant
source of difference between CNAP™-derived continuous non-invasive
AP measurements and invasively assessed AP values.
Figure 2 (abstract P120). Frequency histogram of measurement time.
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and precision of continuous non-invasive arterial pressure
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Introduction The CNAP™ system (CNSystems Medizintechnik AG,
Graz, Austria) provides continuous non-invasive arterial pressure (AP)
measurements based on the volume clamp method using a finger
cuff. Finger AP values are calibrated to oscillometric upper-arm AP
measurements. In the present study we investigated the influence
of the calibration approach based on oscillometric upper-arm cuff
measurements on the accuracy and precision of the CNAP™ device in
comparison with invasively obtained AP measurements.
Methods The datasets of simultaneously recorded invasive (via arterial
catheter) and non-invasive (using the CNAP™ system) AP measurements
in 43 patients treated in the medical ICU of a university hospital were
analyzed in this study. The following comparative analyses between
the two AP measurement techniques were performed: (1) comparison
of CNAP™-derived AP values with invasive AP (IAP) measurements;
(2) comparison of the CNAP™ oscillometric AP values used for the
calibration of finger AP with IAP measurements; and (3) computeraided calibration (CAC) of the CNAP™ finger AP values to IAP values
instead of calibration to oscillometric upper-arm AP measurements
with IAP measurements.
Results (1) The comparison of CNAP™-derived AP values with IAP
measurements revealed a mean difference (± standard deviation) for
mean AP, systolic AP, and diastolic AP of +0.6 mmHg (±10 mmHg),
+11 mmHg (±17 mmHg), and –6 mmHg (±9 mmHg), respectively.
(2) The comparison between the oscillometric AP values used for
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Arterial pulse waveform as an n-soliton evolution of the left
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Introduction The time profile of the arterial pulse is known to have
features such as the dicrotic notch and subsidiary peaks. Such features
may provide useful information about the vascular system and are
traditionally explained in terms of aortic valve closure or multiple
reflections from impedance mismatches within the arterial system.
However, experimental evidence of such reflections has been elusive.
It has been proposed that arterial dynamics may obey a nonlinear
equation [1]. This model predicts the existence of multipeaked solitons
which can travel long distances without dissipation. We demonstrate
that within the soliton model it is not necessary to model valve closure
or wave reflection: single or multiple notches arise de novo even from
featureless theoretical LV pressure pulse profiles. We show that a
number of clinically relevant features of the invasive blood pressure
are reproduced by the soliton model and examine the role of LV pulse
energy on pulse wave shape and progression.
Methods A model for the arterial pressure is given by solutions to a
KdV equation with constants depending on the properties of the
artery [1]. This can be solved with the initial condition of a parabolic left
ventricular pressure pulse.
Results The evolution of the arterial pulse along the arterial tree is
shown in Figure 1. We also predict arterial pulses for increasing left
ventricular ejection energies.
Conclusion Our simple model explains many features of the arterial
pulse observed in clinical practice such as the development of the
dicrotic notch, the change in shape along the arterial tree and the
steepening and acceleration with hypertension. Some phenomena
that have traditionally been attributed to arterial wave reflections or
resonance of the invasive arterial pressure measurement can instead
be explained by intrinsic properties of the arterial pulse.
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Figure 1 (abstract P122).
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Tackling the burden of postsurgical complications in the USA:
would perioperative goal-directed therapy help?
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Introduction Pay-for-performance programs and economic constraints
call for solutions improving the quality of healthcare without increasing
costs. Many studies have shown decreased morbidity in major surgery
when perioperative goal-directed therapy (PGDT) is used. We assessed
the clinical and economic burden of postsurgical complications in
the University HealthSystem Consortium (UHC) in order to predict
potential savings with PGDT.
Methods Data from adults who had 10 major surgical procedures
in 2011 were screened in the UHC database. Thirteen postsurgical
complications were tabulated. In-hospital mortality, hospital length
of stay and costs from patients with and without complications were
compared. The risk ratios reported by the most recent meta-analysis
were used to estimate the potential reduction in postsurgical morbidity
with PGDT. Potential cost savings were calculated from the actual and
anticipated morbidity rates.
Results A total of 75,140 patients met the search criteria. In total,
8,421 patients developed one or more postsurgical complications
(morbidity rate 11.2%). In-hospital mortality was 12.42% and 1.39%
(P <0.001), mean hospital length of stay was 20.48 ± 20.09 days and
8.05 ± 7.11 days (P <0.001), and mean direct cost was $47,284 ± 49,170
and $17,408 ± 15,612 (P <0.001) in patients with and without
complications, respectively. With PGDT, morbidity rate was projected
to decrease to 6.5 to 9.0%, yielding gross costs savings of $50 million
to 151 million for the study population or $670 to $1,406 per patient.
Conclusion Postsurgical complications have a dramatic impact on
mortality, hospital length of stay and costs. Potential cost savings
resulting from PGDT are substantial. PGDT may be recommended to
improve quality of care and decrease costs.
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Radiological control of central venous catheter (CVC) versus
electrocardiogram-guided control inserted CVC: confirm with
transesophageal echocardiography
F Righetti, G Castellano
St Boniface Hospital Verona, Italy
Critical Care 2014, 18(Suppl 1):P124 (doi: 10.1186/cc13314)
Introduction The placement of a central venous catheter (CVC) is now
common practice. Control of the seat of the tip occurs through the
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antero-posterior radiograph of the chest (RX). New techniques have
been developed to control the seat of the CVC, to avoid complications
during the procedure and the RX control post insertion. The aim of this
study is to demonstrate the ECG’s P-wave amplitude (PWA) increases
as we approach the atrio-caval junction (ACJ) by recording the intracavity and show that this method is more sensitive and specific
compared with RX control. To confirm this, we use the direct view of
the tip by transesophageal echocardiography (TEE), a method which
has the most recognized high sensitivity and specificity [1].
Methods In 55 adult patients, hospitalized in the ICU, a CVC was placed.
We excluded patients with cardiac arrhythmias or pacemaker wearers.
All CVCs were placed with an ultrasound-guided puncture technique
of the internal jugular vein (IJV) or subclavian vein (SV). The CVC was
introduced by the Seldinger technique. Introducing the CVC along the
Seldinger guide links to the same terminal on the cable connection
as the intra-cavity derivation ECG (set CVC Certofix B; Braun), in turn
connected to the adapter for ECG (Certodyn Universaladapter B; Braun).
Then the detection mode of the adapter is converted by the ECG trace
outside (through surface electrodes) to the ECG mode intra-cavity
and an increase of PWA confirmed the CVC in the vicinity of the ACJ.
Through the TEE with esophageal average scan at 120° we measured
the distance between the tip and the ACJ. The results were expressed
as mean with standard deviation.
Results Forty-five CVCs were placed in the IJV while 10 were in the SV.
No complications or arrhythmias were detected during the procedure.
All CVCs produced an increase in PWA. Where the PWA increased by
25% compared with normal, the TEE scanning tip was 2.5 ± 1.3 cm
from the ACJ. Where the PWA increased by 33%, the TEE scanning tip
was 1.9 ± 1.1 cm from the ACJ. Where the PWA increased by 50%, the
TEE scanning tip was 1.3 ± 0.6 cm from the ACJ. The RX reports have
described briefly the presence of the catheter in the superior vena cava
without making explicit the exact position relative to the ACJ.
Conclusion We have shown the increase in PWA by detecting that the
endo-cavity, as we proceed with the insertion of the CVC, corresponds
to higher proximity to the ACJ. These results canceled the need for RX
control in the future.
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P125
Impact of the neutral position and rotation of the head in
ultrasound-guided internal jugular vein catheterization on duration
of procedure and complications
M Kurt, A Ozgultekin, G Turan, F Ormancı, S Batan, O Ekinci
Haydarpasa Numune Teaching and Research Hospital, Istanbul, Turkey
Critical Care 2014, 18(Suppl 1):P125 (doi: 10.1186/cc13315)
Introduction In internal jugular vein (IJV) catheterization, neck
rotation may enhance the visibility of anatomical landmarks; however,
it may increase the risk of carotid artery (CA) puncture by replacing
the position of the IJV in relation to the CA. In our study, during USguided IJV catheterizations, we investigated the effects of changing the
position of the IJV by the CA depending on the neutral position and
45° rotation of the head on duration of procedure and complications.
Methods After obtaining hospital ethics committee approval, 100
intensive care patients aged >18 years were included in the study.
Patients were randomly selected and catheterization was performed in
a neutral position of the head (n = 50) and by turning the head 45° to
the opposite side (n = 50). The US-guided catheterization procedure
was performed in accordance with general principles. Once the needle
entered the IJV and blood was aspirated, the US probe was released
from the hand, and the catheter was placed and fixed according to the
Seldinger technique. The data of the intervention side for each process,
the count number of successful catheter insertion, whether there is
arterial access or not and the duration of procedure (from skin contact
of the needle to catheter insertion) were recorded.
Results The localization of the IJV in relation to the CA is 66%
anterolateral, 4% anterior and 30% lateral in a neutral position, and
62% anterolateral, 28% anterior, 10% lateral position in 45° rotation.
So while there is no change in a significant proportion of patients in
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the localization of the IJV in relation to the CA, the anterior placement
rate increasing the risk of CA puncture was significantly higher in a
position of rotation compared with the neutral position (P = 0.001).
No significant difference was found between procedure durations.
Complications were recorded when observed.
Conclusion In our study, it has been shown that anterior placement
of the IJV in the neutral position is less but this has no advantage in
avoiding arterial puncture. The smaller area of procedure in a neutral
position can cause difficulties in practice. However, the processing
times between each head position were not different. Nevertheless,
further studies evaluating whether there are comparable complication
rates and the same duration of procedure in emergency and trauma
patients in whom head rotation cannot be possible are needed.
P126
Anthropometric formulas versus intracavitary ECG for optimal tip
position of central venous catheters
MS Vallecoccia, M Biancone, F Cavallaro, D Settanni, C Marano,
MG Annetta, M Pittiruti, M Antonelli
Catholic University, Rome, Italy
Critical Care 2014, 18(Suppl 1):P126 (doi: 10.1186/cc13316)
Introduction Peres [1] and more recently Lum [2] developed some
anthropometric formulas to correlate patient’s height (H) and ideal
length of central venous catheter (CVC) in order to identify optimal
tip position. The aim of this study is to compare the reliability of the
anthropometric formulas with the method based on intracavitary ECG.
Methods We enrolled patients admitted to our ICU candidate to
elective CVC insertion, who had a detectable P wave on surface ECG.
Intracavitary ECG was used to identify the optimum tip location since
a maximal P wave indicates the cavo-atrial junction [3]. Post-insertion
chest X-ray (CXR) was performed in all patients to verify the tip position.
Assuming that the cavo-atrial junction is about 3 cm from the carina [4],
the tip position was considered correct between 1 and 5 cm from the
carina (between the lower 1/3 of the superior vena cava and the upper
1/3 of the right atrium). For each patient we retrospectively evaluated
whether the catheter length calculated with Lum’s and Peres’ formulas
on an estimated height would have been acceptable.
Results Sixty-five CVCs were placed: 51 in the right internal jugular vein
(IJV), 14 in the left IJV. The mean catheter length by intracavitary ECG
was significantly deeper than predicted by Lum’s formulas (18.2 ± 1.9
vs. 16.7 ± 1.7 cm, P <0.001) and not different from Peres’ formulas
(18.2 ± 1.9 vs. 18.2 ± 1.7 cm, P = 0.8).
At post-procedural CXR, 88% of the tips were in the target zone. In
three cases (5%) the catheter went in the wrong direction but was
immediately corrected during the procedure since the intracavitary P
wave did not change its amplitude. Compared with the intracavitary
ECG, the incidence of malposition would have been significantly higher
with Lum’s formulas (48% vs. 12%, P <0.001) and Peres’ formulas (51%
vs. 12%, P <0.001).
Conclusion The intracavitary ECG was associated with a lower incidence
of tip malposition than Peres’ and Lum’s formulas. It is also the only
technique allowing one to immediately correct a primary malposition
during catheter insertion.
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P127
Residents learning ultrasound-guided catheterization are not
sufficiently skilled to use landmarks
J Maizel, L Guyomarc’h, P Henon, S Samy Modeliar, B De Cagny,
G Choukroun, M Slama
CHU Amiens, France
Critical Care 2014, 18(Suppl 1):P127 (doi: 10.1186/cc13317)
Introduction An ultrasound-guided (UG) technique is the recommended procedure for central venous catheterization (CVC). But ultrasound
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may not be available in emergency situations, and therefore guidelines
also propose that physicians remained skilled in landmark (LM)
placement. We conducted this prospective observational study to
determine the learning curve of the LM technique in residents only
learning the UG technique.
Methods During the first 3 months of their rotation in our ICU, residents
inexperienced in CVC used only the real-time UG technique. During the
following 3 months, residents were allowed to place CVC by means of
the LM technique when authorized by the attending physician.
Results A total of 172 procedures (84 UG and 88 LM) were performed
by the inexperienced residents during the study. The success rate
was lower (72% vs. 84%; P = 0.05) and the complication rate was
higher (22% vs. 10%; P = 0.04) for LM compared with UG procedures.
Comparison between the five last UG procedures and the first five LM
procedures performed demonstrated that the transition between the
two techniques was associated with a marked decrease of the success
rate (65% vs. 93%; P = 0.01) and an increase of the complication rate
(33% vs. 8%; P = 0.01). After 10 LM procedures, residents achieved a
success rate and a complication rate of 81% and 6%, respectively.
Conclusion Residents who only learn the UG technique will not be
immediately able to perform the LM technique, but require specific
training based on at least 10 LM procedures. Whether the LM technique
should still be taught when an ultrasound device is not available must
therefore be addressed.

P128
Development of a standardized method of peripherally inserted
central catheter (PICC-line) bedside installation
J Hobeika, K Serri, M Albert
Hôpital Sacré-Coeur de Montréal, Montreal, Canada
Critical Care 2014, 18(Suppl 1):P128 (doi: 10.1186/cc13318)
Introduction Bedside insertion of peripherally inserted central
catheters (PICCs) results in tip malposition in up to 48% [1], with
catheters frequently terminating in the internal jugular vein (IJV) or
in peripheral veins [2]. In an attempt to reduce tip malposition, we
developed a standardized approach to PICC installation. This study
aims to validate that method.
Methods From a 34-bed adult ICU, we retrospectively reviewed PICC
insertions over a 6-month period before the intervention program
(control group). We designed a prospective interventional pilot study
on 40 consecutive patients (intervention group). Patients in the
intervention group were positioned in a standardized fashion and the
PICC length was measured from easily identified anatomic landmarks.
During PICC insertion, the patient’s head was either rotated ipsilaterally
to the site of PICC insertion or the ipsilateral IJV was manually
compressed, depending on the patient’s capacity to collaborate. Once
the PICC was inserted, an ultrasound survey was conducted to identify
the catheter in the subclavian vein (SC) and ensure its absence in the
ipsilateral IJV. The primary endpoint was defined as PICC tip position,
obtained from the post-procedural chest X-ray. A catheter was
considered to be in an optimal position if the tip resided in the distal
third of the superior vena cava (SVC), adequate if it resided between
the subclavian vein (SC) and the distal third of the SVC, and aberrant if
in any other location.
Results In the retrospective control arm, 105 PICCs were reviewed for
tip position. Optimal, adequate, and aberrant positions were found in
22 (21%), 49 (47%), and 34 (32%) respectively, in comparison with 17
(43%), 15 (38%), and eight (20%) in the intervention group (P <0.05
between both groups). In the control arm, 11 (10%) PICCs terminated
outside the central venous system, whereas none failed to achieve
central venous access in the intervention arm.
Conclusion Using the standardized method described above, PICC
tip positioning can be greatly improved. In our results, 100% of
catheters placed using the standardized method allowed for central
venous access. This pilot study paves the way for a larger, multicentric
evaluation of the bedside installation method of PICC.
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Is chest X-ray necessary after central venous catheter insertion?
MS Vallecoccia, F Cavallaro, M Biancone, D Settanni, C Marano,
MG Annetta, M Pittiruti, M Antonelli
Catholic University, Rome, Italy
Critical Care 2014, 18(Suppl 1):P129 (doi: 10.1186/cc13319)
Introduction According to the European Society of Parenteral and
Enteral Nutrition guidelines [1], post-insertion chest X-ray (CXR) is
not necessary if the location of the tip has been verified during the
procedure and if pleura-pulmonary damage has been ruled out by
other methods. The aim of this study is to assess feasibility and safety
of an echo-ECG-guided method of central venous catheter (CVC)
insertion and to evaluate whether post-insertion CXR can be avoided.
Methods We enrolled only patients admitted to our ICU and candidate
to elective CVC insertion, who had a detectable P wave on surface ECG.
Our insertion protocol included: preliminary ultrasound (US) scan of
central veins and pleural space; US-guided puncture and US control
of the correct direction of the guidewire; intracavitary ECG method for
tip location (cavo-atrial junction (CAJ) = maximal P wave); and US scan
of pleural space to rule out pneumothorax (PNX). Post-insertion CXR
was performed in all patients to rule out PNX and verify tip location
close to the CAJ (CAJ = 3 cm below the carina [2]). Tip location between
1 and 5 cm below the carina – in the lower 1/3 of the superior vena
cava (SVC) or in the higher 1/3 of the right atrium (RA) – was considered
acceptable [1].
Results Eighty CVCs were placed in 78 patients, either by residents in
training or by attending doctors. The vein was selected by US scan: right
internal jugular (IJ) 64%, left IJ 17%, right axillary 11%, left axillary 4%,
right innominate 4%. One pre-existing PNX was identified by US before
the procedure. Accidental arterial puncture occurred in three cases
(two by residents). In five cases, the wrong direction of the wire was
detected by US and corrected during the procedure. The mean number
of attempts was 1.65 (1.35 for attending vs. 1.95 for residents, P <0.02)
and mean insertion time was 10.4 minutes (8.72 for attending vs. 12.11
for residents, P <0.005). Pleural US scan ruled out puncture-related PNX
in all patients. At post-procedural CXR: no PNX was detected, 90% of
tips were in the target zone, 5% were in the middle 1/3 of SVC and 5%
were in the middle 1/3 of RA (all CVC with tips out of the target zone
were inserted by residents).
Conclusion Our insertion protocol was safe and effective, with minor
differences between experienced versus nonexperienced operators.
Our data suggest that immediate CXR is not necessary soon after CVC
insertion, since PNX can be ruled out by US and since the intracavitary
ECG method allows tip location in the SVC and RA in all cases.
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Diagnostic value of chest ultrasound after cardiac surgery: a
comparison with chest X-ray and auscultation
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F Corradi3, T Gherli1
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Critical Care 2014, 18(Suppl 1):P130 (doi: 10.1186/cc13320)
Introduction Chest auscultation and chest X-ray are commonly used
to detect postoperative abnormalities and complications in patients
admitted to intensive care after cardiac surgery [1,2]. The aim of the
study was to evaluate whether chest ultrasound represents an effective
alternative to bedside chest X-ray to identify early postoperative
abnormalities.
Methods A total of 151 consecutive patients (103 male and 47 female)
were studied by chest auscultation, ultrasound and X-ray upon
admission to intensive care after cardiac surgery. Six pathologic entities
were explored by each method: postero-lateral pleural effusion and/
or alveolar consolidation (PLAPS), alveolar-interstitial syndrome (AIS),
alveolar consolidation (AC), pneumothorax (PTX), pleural effusion (PE),
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and pericardial effusion with or without cardiac tamponade. Positions
of the endotracheal tube and central venous catheter were also
checked.
Results Ninety-four of the 151 patients included (62%) showed
abnormalities on chest X-ray (AC 9%, AIS 25%, PLAPS 42%, PE 3.3%, PTX
2%). Compared with chest X-ray, chest ultrasound had a sensitivity of
86% and a specificity of 99% for AC, a sensitivity of 95% and a specificity
of 100% for AIS, a sensitivity of 97% and a specificity of 98% for PLAPS,
a sensitivity of 99% and a specificity of 100% for PE, and a sensitivity
and specificity of 100% for PTX. Furthermore, chest ultrasound
detected all pericardial effusions while neither chest X-ray nor chest
auscultation were able to identify them. Chest ultrasound identified all
cases of endotracheal tube (two patients) and central venous catheter
(two patients). There was a highly significant correlation between
abnormalities detected by chest ultrasound and X-ray (k = 0.90), but a
poor correlation between chest auscultation and X-ray abnormalities
(k = 0.15).
Conclusion Chest auscultation may help identify endotracheal
misplacement and tension pneumothorax but it may miss most of major
abnormalities. Chest ultrasound represents a valid alternative to chest
X-ray to detect all postoperative abnormalities and misplacements.
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Ultrasound measurement of carotid flow time changes with volume
status
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1
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Critical Care 2014, 18(Suppl 1):P131 (doi: 10.1186/cc13321)
Introduction Assessment of volume status and responsiveness guides
resuscitation strategy. Non-invasive techniques are desirable. Changes
in carotid flow time have been proposed as a marker of volume status,
but few data support their use. We sought to determine whether carotid
flow time decreased in the volume-depleted state of acute blood loss,
and whether volume-depleted individuals would demonstrate an
increase in carotid flow time after a passive leg raise (PLR) maneuver.
Methods Volunteers aged 18 to 55 presenting to the hospital’s blood
donor center for whole blood donation were eligible to participate.
Individuals with a history of aortic or carotid artery disease, atrial
fibrillation, or a contraindication to blood donation were excluded.
Prior to blood donation, an investigator performed an ultrasound of the
right common carotid artery with a high-frequency linear transducer,
obtaining a Doppler tracing of carotid artery flow. Measurements of
peak velocity, systole time, and carotid flow time were obtained. A
PLR was performed for 30 seconds, followed by repeat measurements
of carotid velocity and flow time. Whole blood was then collected
according to the blood donor center’s protocol. Immediately after
blood donation, repeat measurements of carotid flow and velocity
were obtained in the supine position and after a PLR. Carotid flow times
corrected for heart rate (FTc) were analyzed with Student’s t test. The
institutional review board approved the study.
Results Eighty donors were screened for participation by two
investigators; 68 consented and completed donation (60.3% female,
mean age 31). Donors had mean blood loss of 450 ml. The mean FTc
supine after blood donation was 296 ms; this was significantly different
from the FTc prior to donation (supine = 320 ms, PLR = 323 ms;
P <0.0001). The mean FTc following blood donation and PLR was
321 ms, significantly different from the supine position after donation
(P <0.0001), but not pre-donation measurements.
Conclusion Ultrasound measurement of carotid flow time was
significantly decreased in the setting of acute blood loss. An autobolus by PLR after blood loss restored FTc to pre-donation levels.
Further investigation of FTc as a non-invasive predictor of volume
responsiveness is warranted.
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Real-time ultrasound-guided subclavian vein cannulation in cardiac
surgery: comparison between short-axis and long-axis techniques
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Critical Care 2014, 18(Suppl 1):P132 (doi: 10.1186/cc13322)
Introduction Central venous catheters play an important role in patient
care; however, their use is associated with various complications and
more frequently through the subclavian vein (SCV) route. A previous
study showed that ultrasound-guided cannulation of the SCV in critical
care patients is superior to the landmark method and should be the
method of choice in these patients [1]. The aim of this study was to
compare short-axis and long-axis approaches for ultrasound-guided
subclavian vein cannulation with respect to indicators of success.
Methods Eighty-three patients undergoing cardiac surgery and
requiring central venous cannulation were randomized to receive longaxis or short-axis ultrasound-guided cannulation of the subclavian
vein by a skilled anesthesiologist. First-pass success, unsuccessful
placement, number of attempts, number of needle passes, skin and
vessel puncture, time to successful catheterization and complications
were considered as outcomes.
Results The subclavian vein was successfully cannulated by ultrasoundguided techniques in all patients. Central venous cannulation failed
in two and 10 cases respectively with short-axis and long-axis view
and the other view was used successfully. The first-pass success rate
was significantly higher in the short-axis group (73%) compared with
the long-axis group (40%) (P = 0.005). The procedure time, number
of attempts, needle redirection, and skin and vessel punctures were
significantly lower in the short-axis than long-axis group (P <0.05). The
overall number of complications did not differ significantly between
groups even if artery puncture and hematoma occurred more frequently
in the long-axis group. Moreover, the need to change the ultrasoundguided insertion technique was more frequent in the long-axis group.
Conclusion Ultrasound-guided subclavian vein cannulation by an
experienced operator has a higher first-pass success rate and lower
access time using the short-axis than long-axis approach.
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Figure 1 (abstract P133). ΔSV-TTE after PLR≥13.6% may predict fluid
responsiveness with sensitivity of 83.33%, specificity of 70% and AUC of
0.78 (95% CI: 0.54 to 1.00). Initial PPV ≥11% predicted fluid responsiveness
with sensitivity of 83.33%, lower specificity of 60% and AUC of 0.64 (95%
CI: 0.35 to 0.93).
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Transthoracic echocardiography used in conjunction with passive
leg raising for assessment of fluid responsiveness in severe sepsis or
septic shock patients
K Jaikriengkrai, K Chittawatanarat, A Limsukon
Chiang Mai University, Chiang Mai, Thailand
Critical Care 2014, 18(Suppl 1):P133 (doi: 10.1186/cc13323)
Introduction During passive leg raising (PLR), we need a real-time
device to demonstrate the hemodynamic change [1-3]. This study
investigates the ability of transthoracic echocardiography (TTE) to
predict fluid responsiveness (FR) in terms of detecting change of
stroke volume (ΔSV) after PLR compared with the transpulmonary
thermodilution technique (TPTD) ΔSV after volume expansion (VE).
Methods A prospective study was carried out in a medical ICU. Eligible
patients were age ≥18 years without necessarily full adaptation to the
ventilator with hemodynamic instability who were considered for VE.
SV assessment using the subaortic velocity–time measurement was
obtained by TTE simultaneously with other hemodynamic parameters
derived from TPTD at baseline, within 2 minutes of PLR and following
VE (250 ml fluid in 10 minutes). A fluid responder was defined by ΔSV
≥15% after VE by TPTD.
Results Preliminary reports on 16 patients with satisfactory cardiac
windows were analyzed. ΔSV-TTE after PLR ≥13.6% predicts FR with
sensitivity of 83.33%, specificity of 70% and AUC of 0.78 (95% CI: 0.54
to 1.00). Initial PPV ≥11% predicted FR with sensitivity of 83.33% with

Figure 2 (abstract P133). Bland–Altman plot, comparing two methods,
showing 95% limits of agreement from –8.96 to +8.83%ΔSV and the mean
difference (bias) of measurement is –0.07%ΔSV. Dashed lines, upper and
lower limits of agreement (95% CI for repeated measurements).

lower specificity of 60% and AUC of 0.64 (95% CI: 0.35 to 0.93) (Figure 1).
The Bland–Altman plot showed 95% limits of agreement from –8.96 to
+8.83% and mean difference (bias) of –0.07% (Figure 2).
Conclusion We may use %ΔSV measured by TTE after PLR to predict
FR, which is noninvasive and less time-consuming than other invasive
techniques.
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Transoesophageal echocardiography and extracorporeal membrane
oxygenation: fancy for enthusiasts or indispensable tool?
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Introduction Echocardiography is commonly used during both venoarterial (V-A) and venovenous extracorporeal membrane oxygenation
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(ECMO). In many circumstances, transoesophageal echocardiography
(TOE) is the preferred monitoring tool. It can aid in cannula positioning,
especially during double-lumen cannula placement for V-V ECMO,
weaning of V-A ECMO and diagnose causes of high-access pressures
and circuit flow problems. We use TOE as our preferred monitoring
equipment before, during and after establishing ECMO. We sought
to investigate how often information gained from TOE imaging had a
major impact on management decisions.
Methods A single-centre observational study at a tertiary referral
institution. All patients supported with V-A or V-V ECMO during an
18-month period were included. Routine procedures such as wire
position checks during cannulation or information gained to assist
weaning from V-A support were not included.
Results Twenty patients were supported with either V-A (all peripheral)
or V-V ECMO during the observation period. In 12 patients (60%) TOE
was instrumental in diagnosing potentially fatal complications or
altered clinical management. In three patients on V-A support, afterload
reduction and modulation of inotropic support was necessary due to
extensive spontaneous echo contrast formation in the left ventricle
and stagnant pulmonary blood flow; two out of these three patients,
immediately after establishing support, required intra-aortic balloon
counterpulsation to reverse clot formation around the aortic valve
and root. Further diagnosis were Avalon cannula misplacement in the
blind end of a piggyback cava following liver transplant, collapsing
right atrial free wall with ‘sucking down’ into the access cannula (n = 3),
pericardial clot formation and tamponade (n = 1), persistent left
superior vena cava making planned cannula placement into the right
atrium impossible or potentially fatal, diagnosis of patent foraminae
ovale providing left atrial decompression and appropriate drainage
cannula positioning during liver transplantation on ECMO.
Conclusion In our practice, TOE is an indispensable tool for safe ECMO
practice, both during V-A and V-V support.
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Accuracy of synthesized right-sided/posterior chest lead
electrocardiograms
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Critical Care 2014, 18(Suppl 1):P135 (doi: 10.1186/cc13325)
Introduction Right-sided precordial leads (V3R to V5R) and posterior
chest leads (V7 to V9) provide important information for the right
ventricle and posterior wall. These additional lead electrocardiograms
(ECGs) improve diagnostic value in acute coronary syndrome patients
[1]. However, these additional electrocardiograms are not routinely
recorded due to the time-consuming procedure involved. Recently
these synthesized six additional lead ECGs using the standard 12-lead
ECG system (Nihonkoden Co. Ltd) have been developed [2,3]. But the
accuracy is not clear. The purpose of the present study was to evaluate
the accuracy of synthesized ECGs at the ST part.

Figure 1 (abstract P135). Correlation between actual and synthesized
ECG at V7.
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Methods Standard 12-lead and actual V3R to V5R, V7 to V9 lead ECGs
at Tokyo Medical University Hospital were successfully recorded and
compared with synthesized ECGs at the J point, M point that was
defined for the point after 1/16 RR interval and T wave amplitude. ECGs
of the complete right branch block, complete left branch block and
pacing rhythm were excluded.
Results A total of 1,216 ECGs were correctly recorded. The differences
of actual and synthesized at the J point, M point and T wave amplitude
were very small. Means of the difference ± 2SD were V3R/V4R/V5R/V7/
V8/V9: J point, 17 ± 1/14 ± 1/13 ± 1/12 ± 1/15 ± 1/18 ± 1 μV; M point,
15 ± 1/13 ± 1/12 ± 1/12 ± 1/12 ± 1/13 ± 1 μV; and T wave amplitude,
20 ± 3/32 ± 2/16 ± 2/37 ± 2/39 ± 2/43 ± 3 μV. There were positive
correlations between all actual and synthesized ECGs of J point, M
point and T wave amplitude (Figure 1).
Conclusion The ST part of synthesized V3R to V5R and V7 to V9 lead
ECGs appears to be highly reliable. Synthesized additional lead ECGs
might be useful to diagnose ischemic heart disease.
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Aortic stiffness in patients with early sepsis
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Introduction Acute and chronic systemic inflammatory conditions
are associated with aortic stiffening. Carotid–femoral pulse wave
velocity (PWV), a marker of aortic stiffness, increases in patients with
inflammatory diseases and independently correlates to levels of
C-reactive protein (CRP). The effects of massive inflammatory response
in early sepsis on mechanical properties of the aorta have not been
investigated. The objective of the current study was to prospectively
assess aortic stiffness in patients with early severe sepsis and septic
shock and relate it to inflammatory and haemodynamic variables and
outcome.
Methods We recruited patients meeting criteria for severe sepsis and
septic shock within 24 hours of admission to ICU. After haemodynamic
stabilisation, PWV was recorded at inclusion and after 48 hours using
dual-channel plethysmography. Severity of illness was assessed with
APACHE II and serial SOFA scores, haemodynamic and inflammatory
parameters (CRP, procalcitonin and fibrinogen) recorded. A 28-day
follow-up was performed to distinguish between survivors and
nonsurvivors.
Results Twenty consecutive general ICU patients (six with severe sepsis
and 14 with septic shock) were enrolled in the study; median age
59 years (IQR 56.5 to 72), APACHE II score 17 (13 to 20.5), SOFA score 5
(IQR 4 to 9). At 28 days, six patients had died. Median initial PWV was
10.4 (IQR 6.9 to 12.1) m/second in patients with severe sepsis, and 6.8
(IQR 5.3 to 7.5) m/second in patients with septic shock (P = 0.13). After
48 hours, PWV in the severe sepsis and septic shock groups had become
similar, 9.3 (IQR 7.3 to 11.1) m/second and 9.2 (IQR 7.8 to 13) m/second
respectively (P = 0.96). PWV had significantly increased in survivors (7.8
to 12.3 m/second) (P = 0.04) versus nonsurvivors (6 to 7.8 m/second)
(P = 0.69). Higher PWV correlated with increasing systolic pressure and
lower CRP levels (r = 0.73, P = 0.01).
Conclusion In early sepsis, aortic stiffness is decreased in patients
with greater disease severity, and in survivors increases to median
levels within 48 hours. The main factors associated with lower pulse
wave velocity are lower systolic pressure and higher CRP levels. The
association of high serum CRP levels with low aortic stiffness in patients
with sepsis does not match data described in the literature [1].
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Introduction Approximately 15 million people worldwide suffer from
congestive heart failure (CHF). The most severe symptom of CHF is
pulmonary congestion – an acute increase in extravascular lung fluid
due to acute decompensation of heart failure. To date, no direct,
reliable, simple and non-invasive method is available for assessment
of thoracic fluids. Continuous dependable monitoring of pulmonary
edema for hospital patients can improve management and reduce
duration of hospitalization. KYMA’s solution is based on a matchboxsized monitoring device, which monitors thoracic fluid content and
trends. The μCor monitor transmits and receives electromagnetic
signals that are propagated through tissue layers. Conduction is
highly related to the amount of accumulated fluids in tissues. This trial
investigated the correlation between KYMA’s lung water index (LWI)
and directly assessed extravascular lung water (EVLW) in the scenario
of acute pulmonary edema induced in seven sheep.
Methods Acute pulmonary edema was induced by intravenous infusion
of noradrenaline and dextrane, with stepwise increased dosage. KYMA
measurements of LWI were compared with PiCCO extravascular lung
volume as the reference gold standard. The experiment continued until
maximum increase of EVLW and complete heart failure were reached.
Results All seven sheep developed pulmonary edema, which was
validated by increased LVEDP and EVLW. A linear correlation was found
between invasive measurements of EVLW (PiCCO) and non-invasive
KLWI.
Conclusion KYMA’s fluid index demonstrated excellent correlation with
invasive lung water measurement (R2 = 0.96; P <0.0001) and was able
to detect dynamic accumulation of EVLW in a range of 40 to 50 cm3
increments (Figure 1). Since the change in fluid content between a
normal and congested lung ranges between 250 and 500 cm3, the
demonstrated sensitivity as reflected in this study, supports its use for
high-resolution and accurate thoracic fluid monitoring.

Figure 1 (abstract P137). Pooled correlation between EVLW and KYMA
LWI.
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Introduction The aim of this work is to verify that low incidence of
hemodynamic interventions in hemodynamically monitored patients
in our postoperative ICU is not caused by insufficient attention being
paid to the drop of noncalibrated cardiac index (nCI). In the last
2 years there was a need for hemodynamic intervention in 92% of
patients with perioperative cardiac output monitoring, while only
31% of these patients needed at least one hemodynamic intervention
postoperatively in the ICU.
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Methods High-risk patients planned to undergo elective major
abdominal surgery were routinely monitored with LiDCOrapid; the
monitoring continues overnight after surgery. The target nCI for the
postoperative monitoring, as well as hemodynamic interventions in
case of its drop, were prescribed by the anesthetist in the protocol upon
handover of the patient to the postoperative ICU. The hemodynamic
protocol in the ICU was then nurse driven with compulsory recording
of patient’s hemodynamic data into the patient’s documentation every
2 hours and at the time of each intervention. Data from the memory of
the LiDCOrapid monitor were analyzed using LiDCOview software and
compared with patients’ documentation.
Results A total 649 hours of hemodynamic record were analyzed in
40 patients chosen at random from 121 patients monitored in the last
2 years. We found 22 drops in nCI that were noticed by the nursing staff
and led to volume challenge in accordance with the protocol. One-half
of these interventions was carried out outside the 2-hour interval of
protocol-required monitoring and documentation entry. We identified
nine drops in nCI that were not reacted to. None of them happened
within the first 4 hours postoperatively and all of them were outside
the 2-hour interval of protocol-required monitoring. In five of these
episodes the pulse pressure also dropped, suggesting impairment of
the reading of the waveform from the arterial line.
Conclusion The need for hemodynamic intervention in postoperative
care was quite rare in our patients. The drop in nCI was noticed in most
of the cases and the patient was treated according to the protocol.
However, isolated episodes of nCI drop were missed during the night
after the operation. The results were pointed out to the nursing staff
and a comparative survey will be conducted. As with any monitoring
modality, (non)adherence to the protocol may become the limiting
issue to the benefit for the patient.
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Pulse wave transit time technique for perioperative non-invasive
hemodynamic monitoring
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Introduction The aim of this work is to evaluate perioperative
hemodynamic monitoring for major abdominal surgery using the
estimated continuous cardiac output (esCCO) technique available with
the NIHON KOHDEN Vismo monitor as compared with the LiDCOrapid
hemodynamic monitoring system.
Methods The esCCO technique is a novel noncalibrated non-invasive
method of cardiac output monitoring. It is based on the estimation
of pulse pressure from the speed of pulse wave propagation, which
is measured as a time delay between the ECG R-wave and the
corresponding peripheral pulse wave detected by pulse oximetry – the
delay being called the pulse wave transit time (PWTT) [1]. LiDCOrapid
estimates noncalibrated cardiac output (nCO) by pulse wave contour
analysis from an arterial line and is a well-established monitoring
modality in our department. The patients planned for elective major
abdominal surgery with ASA score of III and expected operation
duration over 90 minutes are routinely monitored by LiDCOrapid with
a perioperative hemodynamic optimalization protocol. In accordance
with the protocol, an arterial line was inserted and LiDCOrapid
monitoring was started before the induction of anesthesia. At the same
time, non-invasive esCCO monitoring was started.
Results Ten patients were monitored with a total of 141 esCCO–nCO
measurement pairs. The correlation coefficient between esCCO and
nCO was 0.65 and in the Bland–Altman difference analysis bias was
+1.2 l/minute and 95% limits of agreement were ± 2.6 l/minute. The
change of cardiac output between two consecutive measurements
detected by LiDCOrapid was detected by esCCO in 80% of cases.
Conclusion Hemodynamic monitoring with esCCO yields cardiac
output values different from those measured by LiDCOrapid. The
reliability of PWTT is questionable when systemic vascular resistance
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changes (as with any other noncalibrated cardiac output monitor), but
it can still trace the trends of CO changes. Due to its non-invasiveness,
esCCO might be the monitoring of choice for high-risk patients
undergoing low-risk surgery.
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Introduction The Mostcare monitor is a non-invasive cardiac output
monitor. It has been well validated in cardiac surgical patients but there
is limited evidence on its use in patients with severe sepsis and septic
shock [1].
Methods The first 22 consecutive patients with severe sepsis and
septic shock in whom the floatation of a pulmonary artery catheter
was deemed necessary to guide clinical management were included.
Cardiac output measurements were simultaneously calculated and
recorded from a thermodilution pulmonary artery catheter and from
the Mostcare monitor respectively. The two methods of measuring
cardiac output were compared by Bland–Altman statistics and linear
regression analysis. A percentage error less than 30% was defined as
acceptable for this study.
Results Bland–Altman analysis for cardiac output showed a bias of
0.31 l/minute, precision (=SD) of 1.97 l/minute and a percentage error
of 62.54%. Linear regression produced a correlation coefficient r2 for
cardiac output of 0.403. See Figure 1.
Conclusion Compared with thermodilution cardiac output, cardiac
output studies obtained from the Mostcare monitor have an
unacceptably high error rate. The Mostcare monitor is not a reliable
monitoring device to measure cardiac output in patients with severe
sepsis and septic shock on an ICU.
Reference
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Figure 1 (abstract P140). Cardiac output Bland–Altman analysis.
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Introduction The aim of this animal study was to determine the
feasibility and accuracy of a new non-invasive system for determination
of cardiac output (CO) compared with a known device (PiCCO; Pulsion
Medical). In ICUs and ORs, hemodynamic management using goaldirected therapy has been shown to improve patient outcomes
[1,2]. The invasiveness of current technology may prevent clinicians
from obtaining hemodynamic information. We developed a noninvasive system for detection of hemodynamic variables utilizing a
photo-acoustic sensor (PA-S) and indicator dilution. The PA-S utilizes
a combination of a miniature ultrasound sensor, a laser diode and an
optical detector to accomplish the measurement.
Methods Five pigs weighing 25 to 29 kg were used in the study
approved by the local animal use and care committee. The animals
were anesthetized, medically paralyzed, intubated and mechanically
ventilated. Central venous and arterial catheters were placed for
injection of the indicator and connection to the PiCCO system. The
PA-S was placed in contact with the skin over the saphenous artery
on the animal and adjusted to receive the maximum acoustic signal.
The adjustment included the depth of ultrasonic penetration and the
exact location on top of the blood vessel. Each indicator dilution was
accomplished using three central venous injections of 15 ml normal
saline at room temperature. Variation in CO was accomplished by
removing up to 50% of the blood volume after splenectomy. The PA-S
results were obtained using the empirical regression method. The
resulting cardiac output readings from the PA-S were compared with
the PiCCO readings.
Results The correlation between the PA-S and the PiCCO system was
(R2 = 0.746) over a range of CO from 1 to 6 l/minute. The Bland–Altman
analysis demonstrated a bias of –0.05 l/minute and precision of 0.50 l/
minute.
Conclusion This animal study demonstrated the feasibility of the new
PA-S for determination of indicator dilution CO in a limited range. The
system showed good correlation with the PiCCO system even in the
case of vasoconstriction as a result of blood loss. Since the PA-S utilizes
transpulmonary indicator dilution, other variables such as intrathoracic
blood volume, global end-diastolic volume and extravascular lung
water can be calculated. Additionally, continuous CO can be obtained
from the optical sensor signal utilizing arterial waveform analysis.
References
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Introduction The aim was to evaluate the performance of arterial
pressure-based cardiac output (APCO) [1] and pulse wave transit timebased cardiac output (esCCO) [2] monitors in Thai patients undergoing
coronary artery bypass graft surgery (CABG) with cardiopulmonary
bypass.
Methods We studied 50 Thai surgical patients undergoing CABG with
cardiopulmonary bypass and requiring pulmonary artery catheter
and radial artery catheter placement as a standard of clinical care. All
patients were measured for APCO using the Vigileo/FloTrac and for
esCCO using the esCCO monitoring system. The data were compared
with thermodilution cardiac output (TDCO) monitoring as a reference
method, simultaneously at pre-induction, post-induction, and every
30 minutes thereafter until the completion of the surgery. The bias and
precision were assessed using Bland–Altman analysis.
Results In total, 310 pairs of simultaneous measurements of APCO
versus TDCO and 303 pairs of esCCO versus TDCO were obtained from
50 patients. Both APCO (R = 0.53, P <0.0001) and esCCO values (R = 0.56,
P <0.0001) were correlated with TDCO values. Either of the changes in
APCO (R = 0.63, P <0.0001) or any changes in esCCO (R = 0.60, P <0.0001)
were correlated with changes in TDCO. For APCO relative to TDCO, the
bias, precision, and the limits of agreement were 0.70, 1.63, and –2.5
to 3.9 l/minute, while those of esCCO were 1.20, 1.59, and –1.9 to 4.3 l/
minute, respectively. Comparisons of the bias of APCO and esCCO
revealed a level of significance of P <0.001.
Conclusion Despite the overestimation of cardiac output measurements, APCO and esCCO calibrated with patient information has
shown an acceptable trend as compared with TDCO in Thai patients
undergoing CABG with cardiopulmonary bypass. Compared with
esCCO, APCO demonstrated no significant differences of precision;
however, a lower mean bias was exhibited.
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Introduction Transpulmonary thermodilution is useful in the critical
care. Following PiCCO, VolumeView is now available. Although previous
studies concluded that significant correlation was found between
VolumeView and PiCCO [1,2], all experiments and data analysis were
done by Edwards Lifescience. The aim of the present study was to
compare the new VolumeView with PiCCO to clarify their compatibility
and to give a neutral answer.
Methods Six pigs (about 10 kg) were used and we made sepsis models
by LPS administration. All pigs were instrumented with a right (PulsioCath) and a left (VolumeView) thermomistor-tipped femoral arterial
catheter. The central venous catheter was inserted through the right
jugular vein. CO, GEDV and EVLW were measured by the two systems.
Results We performed measurements at 57 points. There was a good
correlation between the two devices regarding CO and GEDV, but
VolumeView showed higher GEDV than PiCCO. Regarding EVLW, there
was no significant correlation between two systems. VolumeView
showed significantly higher EVLW than PiCCO (Figure 1 and Table 1).
Table 1 (abstract P143). Explanation of abbreviations
CO

GEDV

EVLW

PiCCO

PCO

PGEDV

PEVLW

VolumeView

ECO

EGEDV

EEVLW

Figure 1 (abstract P143). CO, GEDV, EVLW correlation and Bland–Altman analysis.
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Conclusion Our data analysis showed that PiCCO and VolumeView were
not the same. Neither the normal values of two devices nor the rates of
change were same. Careful attention should be paid to interpret the
data obtained from two systems.
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Introduction Goal-directed therapy used in the perioperative period
of patients undergoing cardiac surgery shortens the length of ICU
stay [1]. We aimed to compare the postoperative results of the liberal
and restrictive fluid strategy used in patients undergoing pulmonary
resection surgery (PRC).
Methods We have been using the restrictive fluid strategy since March
2013 in our institute. Patients who were on the liberal fluid regime were
analyzed retrospectively. From March 2013 until today, patients who
were on restrictive fluid strategy were analyzed prospectively. A total
of 125 patients were included in the study. Age, duration of anesthesia,
type of fluids given intraoperatively, fluid index (ml/kg/hour), fluid
intake/output balance, creatinine and lactate levels were compared
with pulmonary and renal morbidity, and length of stay in ICU, using
multivariate analysis.
Results A significant correlation (P <0.05) was established between
the amount of crystalloid given intraoperatively, fluid index and fluid
balance with pulmonary morbidity (n = 52). The fluid index and inotropes
usage were correlated with the postoperative creatinine levels (P <0.05).
There was no correlation between perioperative lactate levels with fluid
balance and fluid index. Intraoperative blood loss, the amount of given
crystalloid, colloid, blood and FFP, fluid balance, duration of anesthesia
and postoperative blood transfusion were found to be related (P <0.05)
with the length of ICU stay. Four percent of the patients required renal
replacement therapy and the overall mortality was 0.8%.
Conclusion To reduce the morbidity of patients undergoing major
surgery, the protocols of using the restrictive fluid strategy in the
perioperative period and simultaneous protection of end organs,
especially the kidneys, is currently the subject of this discussion. We
observed that the restrictive fluid strategy did not lead to global organ
hypoperfusion, which was monitored by lactate. Even though there was
a negative correlation between the fluid index with creatinine levels and
renal failure, the need for renal replacement therapy was observed only
in one case. As a conclusion, the postoperative pulmonary morbidity and
length of ICU stay can be reduced in patients who undergo PRC by using
the restrictive fluid strategy (4.2 ± 0.3 ml/kg/hour), without causing any
vital organ dysfunction.
Reference
1.

Goepfert MS, et al.: Anesthesiology 2013, 119:824-836.

P145
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creatinine in patients admitted to critical care after elective major
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Introduction The rationale for perioperative fluid therapy has been
to preserve organ perfusion. However, conservative postoperative
fluid balance (FB) is now encouraged to avoid the effects of iatrogenic
fluid overload. In addition, fluid expansion has been described as a
confounder of acute kidney injury (AKI) diagnosis by dilution serum
creatinine (SCr).

Figure 1 (abstract P145). Serum creatinine changes after major surgery.

Methods We conducted a prospective audit of FB and renal function
in patients undergoing major elective surgery admitted to critical care
over a 28-day period. Fluid overload was defined as: (positive FB) /
(weight × 0.6) × 100%.
Results Thirty-two patients (56% female, median age 64) were studied
over a median of 3 critical care days (range 1 to 7). Total FB was +3.9 l
at discharge; however, 75% of this occurred intraoperatively so that
positive FB in critical care was only +390 ml/day. Patients had median
9% fluid overload at discharge. Two patients had transient AKI stage
1. Overall SCr decreased significantly from preoperatively to discharge
(P = 0.003), median 73 to 55 μmol/l, with decreases occurring both
postoperatively and during critical care stay (Figure 1).
Conclusion We achieved near-neutral fluid balances after admission,
but did not resolve intraoperative fluid accumulation. SCr fell
significantly, even after there was no further net fluid accumulation.
This suggests a decrease in creatinine generation after major surgery,
rather than fluid expansion, may largely account for sCr decreases in
these patients.
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Very limited usefulness of pulse pressure variation as a predictor of
volume responsiveness in critically ill septic patients
GG Gavriilidis, IK Kostakou, VT Tsagari, AK Kyriakoudi, NK Koulouris,
AK Koutsoukou
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Critical Care 2014, 18(Suppl 1):P146 (doi: 10.1186/cc13336)
Introduction The aims of the study are to assess the usefulness of pulse
pressure variation (PPV) as a predictive marker of fluid responsiveness
and to estimate the value of central venous–arterial difference of
carbon dioxide (PCO2cv-a) to predict the outcome of critically ill
septic patients. The question of whether a septic patient needs fluids
or not is crucial. Although PPV is a very reliable predictor of volume
responsiveness, there are many limitations for its application. Cardiac
arrhythmia, spontaneous breathing and low tidal volume ventilation
prevent the extended use of this index.
Methods This is a post-hoc analysis of data from a prospective
observational study [1], which included a population of patients with
severe sepsis or septic shock as the main reason for ICU admittance.
After an echo for the assessment of the cardiac systolic performance,
we measured PPV, central venous oxygen saturation, blood gases from
arterial and central venous lines, central venous pressure, systolic,
diastolic, mean and pulse pressures, before and after volume challenge.
We calculated changes in pulse pressure before and after volume
challenge, and an increase of 9% was used as criterion to define volume
responsiveness [2].
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Results Among 72 patients (71% men, APACHE II score 23.2) included
in this study, 41 (57%) were responders. Due to spontaneous breathing
and cardiac arrhythmia we were able to calculate PPV only in 18
patients (25%). Moreover, only eight (11%) calculations of PPV proved
useful because of the application of low tidal ventilation (4 to 6 ml/kg
ideal body weight) in the remaining 10 patients. We did not find any
value of the PCO2cv-a to predict the outcome of the patients (mortality
26.3%), since the difference between survivors and nonsurvivors was
not statistically significant (7.7 vs. 7.9, P >0.05).
Conclusion The usefulness of PPV, the marker with the best
performance in the prediction of volume responsiveness, due to its
limitations, is very limited.
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Introduction The renal resistive index (RI) determined by Doppler
ultrasonography allows a semiquantitative evaluation of kidney
vasculature at the bedside. Interpretation of the RI in clinical practice
is difficult due to interaction with cardiac output, heart rate (HR) and
blood pressure [1,2]. The impact of global hemodynamics on the RI
remains to be evaluated. This study aims to investigate the relationship
between the RI and changes in central hemodynamic during a central
hypovolemia model in healthy volunteers (HV).
Methods Eleven healthy volunteers (27 ± 8 years; eight male)
participated in this study. Two different models were performed: the
first model was performed by applying the head-up tilt (HUT) test.
The complete maneuver was done by a 10-minute step that consisted
of tilting the table from a supine position (Sup) to an angle of 70°
(HUT) and back to supine (Sup’). The second model was performed by
applying three consecutive valsalva maneuvers. Global hemodynamics
included stroke volume (SV), HR, and mean arterial pressure, which
were continuously measured non-invasively with a Finometer. At least
three RI readings were obtained and averaged from the right and left
kidneys in all HV.
Results All HV had a significant decrease of SV from 83 ± 17 ml to
63 ± 14 ml and an increase in HR from 67 ± 10 bpm to 88 ± 13 bpm
during the HUT. Figure 1 shows the temporal changes of mean RI in
both kidneys. A significant decrease in the RI in both kidneys was seen
during HUT. After the move back to supine, RI returned to baseline
values, with a significant variation of RI in the early measurements on
the right kidney compared with late measurements on the left kidney
(0.67 ± 0.05 vs. 0.61 ± 0.05, P <0.05). Valsalva maneuvers significantly

Figure 1 (abstract P147). Doppler-based renal resistive index in both
kidneys during HUT.
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increased the RI in the right and left kidneys, from 0.6 ± 0.04 and
0.6 ± 0.05 to 0.7 ± 0.1 and 0.68 ± 0.15 (P <0.05), respectively.
Conclusion These preliminary results showed that Doppler renal RI was
affected equally in both kidneys during HUT, suggesting an effect of
hemodynamic alterations during our model of central hypovolemia.
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Introduction Tissue hypoxia occurs frequently during surgery and may
contribute to postoperative organ dysfunction [1]. We hypothesised
that intraoperative optimisation of tissue oxygenation reduces
postoperative complications and evaluated the feasibility of the
optimisation protocol used.
Methods We randomised 50 high-risk patients who underwent
major abdominal surgery. Tissue oxygenation was monitored at the
thenar eminence using near-infrared spectroscopy. All patients were
treated according to a standard care algorithm. In addition, patients
in the intervention group received dobutamine if necessary to keep
tissue oxygenation ≥80%. Data were recorded continuously and
complications were recorded during the hospital stay with a maximum
of 28 days.
Results The number of complications tended to be lower in the
intervention group (11 vs. 20). Eleven patients in the intervention
group had no complication, versus seven in the control group. There
was no significant difference between groups in length of stay in
ICU or in hospital. Administration resulted in a 5% increase of tissue
oxygenation. The cardiac index increased 0.3 (0.0 to 0.6) l/minute/m2
(Figure 1). The overall protocol adherence was 94%.
Conclusion Intraoperative optimisation of tissue oxygenation will
potentially result in better outcome after high-risk abdominal surgery.
The protocol used may be considered feasible for clinical practice.
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Figure 1 (abstract P148). Evolution of individual patient values (thin
lines) and the average values (thick lines) of the tissue oxygenation
(StO2) and the relative change of cardiac index (CI), delta CI. All graphs
are synchronised at the moment of the first dobutamine administration
(time = 0; arrow). Values are shown from 10 minutes before dobutamine
administration until 45 minutes after.
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Introduction Passive leg raising (PLR) has been suggested as a simple
diagnostic tool to guide fluid administration in critically ill patients [1].
Although the basic principles of PLR have been well studied, little is
known about the impact of the introduction of this technique in daily
clinical practice. The aim of the study was to describe the changes in
fluid balance of ICU patients before and after the introduction of PLR,
and to determine the compliance of medical personnel with a PLRdriven protocol of fluid administration.
Methods In this single-centre prospective study, mixed ICU patients
equipped with a PiCCO system received fluid therapy on the basis of PLR
test results in the first 48 hours of treatment, after careful introduction of
a new PLR-driven protocol. Exclusion criteria were increased abdominal
pressure, fracture of leg or pelvis, deep vein thrombosis, head trauma
and pregnancy. The control group existed of patients admitted to the
ICU 1 year prior to the introduction of the protocol.
Results We included 21 patients in each group. There was no significant
differences in the fluid balance between the control and study group
after 24 hours (5.0 ± 2.9 l vs. 3.6 ± 2.7 l, P = 0.11) and 48 hours (5.7 ± 3.5 l
vs. 4.8 ± 3.7 l, P = 0.39). However, compliance with the protocol was
poor (56%). After 2/11 positive tests, fluid was not administered; and
after 21/39 tests, fluid was administered despite a negative test result
(Figure 1).
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Methods In a period of 1 year, 42 adult patients were admitted to
the ICU in septic shock. All patients were treated according to the
guidelines of the Surviving Sepsis Campaign International Guidelines
for Management of Severe Sepsis and Septic Shock 2012 [2]. All patients
were mechanically ventilated and subjected to transesophageal
echocardiography in bicavale projection, calculating the DIIVC through
the M-mode by measuring the change in diameter with the acts of
positive pressure ventilation and using the formula: (100 × (maximum
diameter – minimum diameter)) / minimum diameter. A value >18% was
considered a predictor of an increase in CI >15%. The CI was measured
continuously through use of the pressure recording analytical method
on a Mostcare Vytech monitor. All patients were subjected to a bolus of
500 ml crystalloid through a central venous catheter only after reaching
central venous pressure (CVP) ≥10 mmHg during treatment. The results
were expressed as the mean with standard deviation and percentage.
Results Sixteen patients (38%) had a change in DIIVC <18%, on average
11 ± 5%, and when subjected to fluid challenge did not have an increase
in CI >15%, average 8 ± 3%, not proving to be a fluid responder. Twentysix patients (62%) had a change in DIIVC >18%, on average 45 ± 22%,
and when subjected to fluid challenge had an increase of the CI >15%,
on average 31 ± 8%, proving to be a fluid responder.
Conclusion We have shown that the DIIVC can predict the response
of patients to fluid challenge regardless of the values of CVP and then
distinguish fluid responders from nonresponder patients. This can help
us in the choice of treatment for patients in septic shock.
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Figure 1 (abstract P149). SVI, stroke volume index; –, negative PLR;
+, positive PLR; fluid 250 cm3 RL solution.

Conclusion The implementation of a PLR-driven protocol of fluid
administration did not change mean fluid balances after the first
48 hours. Noncompliance with the protocol was an important
confounder.
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Introduction The correct assessment of volume status and prediction
of response to filling fluid challenge is of crucial importance in the
patient with septic shock. A patient is a fluid responder if there is an
increase in cardiac index (CI) >15% in response to the fluid challenge.
Identifying which patient will be a fluid responder is crucial. The aim of
this prospective study is to evaluate which patient is a fluid responder in
septic shock using dynamics echocardiography with the distensibility
index of the inferior vena cava (DIIVC), which has been shown to be
predictive of an increase in CI [1].

Introduction Dynamic arterial elastance (Eadyn), defined as the pulse
pressure variation (PPV) to stroke volume variation (SVV) ratio, has
been suggested as a predictor of the arterial pressure response to
fluid administration. Rather than a steady-state assessment, Eadyn
depicts the actual slope of the pressure–volume relationship providing
a dynamic evaluation of the arterial load. So the higher the Eadyn
value, the more likely arterial blood pressure is to improve after fluid
challenge (FC). The aim of this study was to assess the effectiveness of
Eadyn, measured non-invasively in preload-dependent, spontaneously
breathing patients.
Methods Patients admitted postoperatively and monitored with the
Nexfin monitor were enrolled in the study. Patients were included
if they were spontaneously breathing and had an increase in cardiac
output ≥10% after a FC. They were classified according to the increase
in mean arterial pressure (MAP) after FC into MAP-responders (MAP
increase ≥10%) and MAP-nonresponders (MAP increase <10%). Eadyn
was calculated from the PPV and SVV values obtained from the monitor.
Results A total of 34 FCs from 26 patients were studied. Seventeen
FCs (50%) induced a positive MAP response. Preinfusion Eadyn was
significantly higher in MAP-responders (1.39 ± 0.41 vs. 0.85 ± 0.23;
P = 0.0001) (Figure 1). Preinfusion Eadyn predicted a positive MAP
response to FC with an area under the ROC curve of 0.92 ± 0.04 of SE
(95% CI: 0.78 to 0.99; P <0.0001). A preinfusion Eadyn value ≥1.06 (grey
zone: 0.9 to 1.15) discriminated MAP-responders with a sensitivity and
specificity of 88.2% (95% CI: 64 to 99%).
Conclusion Non-invasive dynamic arterial elastance, defined as the
PPV to SVV ratio, predicted the arterial pressure increase to fluid
administration in spontaneously, preload-dependent patients.
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Figure 1 (abstract P151). Distribution of individual arterial load parameters at preinfusion time.
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Introduction Recent studies showed that the plethysmographic
variability index (PVI), a dynamic index resulting from cardiopulmonary
interactions, could predict fluid responsiveness (FR) in mechanically
ventilated patients during general anesthesia and in the ICU [1,2]. In
this study, we aimed to compare, in patients after cardiac surgery, the
clinical utility of the PVI versus traditional statics and dynamics indices
to predict FR.
Methods We prospectively enrolled 52 consecutive adult patients
in sinus rhythm and mechanically ventilated (tidal volume of 8
(7.5 to 8.5) ml/kg ideal body weight) admitted to the ICU of CHU de
Charleroi (Belgium) after scheduled cardiac surgery. Before and after
fluid challenge (FC), we measured: heart rate (HR), BP, PVI (Masimo
Corporation, Irvine, CA, USA) and PPV. PAOP and cardiac index (CI)
were estimated by Swan–Ganz catheter (Edwards Lifesciences LLC,
Irvine, CA, USA). Patients with an increase in CI of at least 15% after
FC and subsequently were considered responders (R). Continuous
variables were analyzed with Mann–Whitney U tests. Categoric
variables were analyzed with the Fisher’s exact test. Correlations were
assessed by Spearman’s correlation. The discriminatory ability of each
haemodynamic parameter to determine FR was assessed by area
under the receiver operating characteristic curve (AUC), between R and
nonresponders (NR). P <0.05 was considered statistically significant.
Results Twenty-five (48%) patients were classified as R. Before FC, R and
NR patients were comparable except for HR (91 (83 to 108) for R vs.
80 beats/minute (72 to 89) for NR; P = 0.009), PVI (18 (12 to 26) for R
vs. 12% (9 to 15) for NR; P = 0.003), PAOP (8 (6 to 9) for R vs. 11 mmHg
(8 to 12) for NR; P = 0.001), and PPV (13 (8 to 19) for R vs. 10% (4 to
13) for NR; P = 0.086). PVI and delta PP before FC were correlated (r =
0.53, P <0.0001). AUC showed a better prediction of FR for PVI (AUC =
0.74, P <0.001) than for PPV (AUC = 0.64, P = 0.05). Nevertheless, the
sensitivity (Se) and specificity (Sp) of both indices were low: for a PPV
over 13%, Se = 48% (0.301 to 0.665),and Sp = 82% (0.627 to 0.921); for a
PVI over 12%, Se = 68% (0.482 to 0.828) and Sp = 69% (0.498 to 0.835).
As for PAOP, increasing values are associated with NR (AUC = 0.22,
P <0.0001).
Conclusion The PVI appears to be useful to predict FR in mechanically
ventilated patients after cardiac surgery. However, Se and Sp remain low
in the type of patients with relative euvolemia and cardiac dysfunction.
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Introduction According to Guyton and colleagues [1], expansion of
blood volume can increase cardiac output (CO) in so far as the change
in volume affects the mean systemic filling pressure (Pmsf ). However,
rapid stress relaxation occurs after acute intravascular volume
expansion so that the effect of volume on Pmsf and CO may disappear
after a few minutes. The objective of the present study is to describe the
extent of the haemodynamic changes generated by a fluid challenge
during 10 minutes on critically ill patients.
Methods Patients admitted to the ICU were monitored with a calibrated
LiDCOplus (LiDCO, UK) and Navigator (Applied Physiology, Australia) to
estimate Pmsf analogue (Pmsa). Then 250 ml Hartmann’s solution or
Volplex was infused over 5 minutes. Data were recorded automatically
from baseline to 10 minutes after the end of fluid infusion. The time to
maximum response and percentage change between baseline and last
value of different haemodynamic parameters are also reported.
Results Sixty fluid challenges were studied in 34 patients, with a mean
duration of 5.3 minutes (± 2.5). In 22 events (37%), CO increased more
than 10% (responders). The change between baseline and last value
was greater in nonresponders for heart efficiency (Eh) (–9.2% ± 9.7 vs.
–3.1% ± 13.9, P = 0.05) but not in other haemodynamic variables. Time
to maximal response on CO was 2 minutes after the end of the infusion
(Figure 1).
Conclusion Stress relaxation damps down the effect of a fluid challenge
after 10 minutes except in terms of heart efficiency. The effect of a fluid
challenge should be assessed up to 2 minutes after the end of fluid
infusion. Failure to do so may mislead clinicians about the patient’s
fluid responsiveness.

Figure 1 (abstract P153). Change of CO during and after a fluid
challenge. BL, baseline; end, end of fluid infusion.
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Introduction The latest sepsis guideline has emphasized early
resuscitative fluid management [1]. Early goal-directed therapy (EGDT)
has been shown to improve 28-day mortality in recent studies [2,3]. This
strategy was based on improving tissue perfusion and oxygenation in
spite of other supportive and therapeutic measures. Technically and
historically, central venous pressure (CVP) measurement is one of
the most dependent methods to estimate fluid responsiveness and
intravascular volume status on resuscitation. The Surviving Sepsis
Campaign (SSC) guidelines recommended goal levels of CVP 8 to
12 mmHg in order to obtain appropriate tissue perfusion [1]. In this
study, we objected to re-evaluate effectiveness of a fluid resuscitation
strategy in sepsis, comparing the effect of patients’ daily fluid balances
(DFB) and CVP on patients’ survival.
Methods Patient records (APACHE II, length of stay (LOS), CVP, DFB,
vasopressor and ventilator needs) were retrospectively collaborated,
and a randomly-assigned 100 (63 men and 37 women, age
64.2 ± 15.5 years) were statistically analyzed for survival function.
Results The mean APACHE II score was 23.6 ± 7.7, LOS was
9.7 ± 10.0 days, intubated period was 6.4 ± 8.6 days, vasopressor period
was 4.7 ± 5.5 days, CVP was 10.5 ± 5.5 mmHg, DFB was 1,147.9 ± 1,157.6
ml, and 42 survived. Kaplan–Meier survival and COX regression analysis
showed that CVP levels of 6 to 9 mmHg and DFB +800 to +900 ml,
but not above, significantly predicted survival, and also shorter LOS,
intubated days and lower vasopressor needs with earlier discharge
possibility. On the other hand, over-increased DFB and CVP levels
strictly correlated with longer LOS and higher mortality rates, and the
first 24-hour mean fluid balance alone was surprisingly not predictive.
Conclusion Fluid resuscitation therapy is a double-edge-sword. (1)
Despite lower volumes, higher volumes also increase mortality. (2)
Overall, DFB seemed more important than the first 24-hour DFB.
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Figure 1 (abstract P155). Relative change of P-fibrinogen compared with
preoperative values.

may lead to undercorrection of fibrinogen in critical bleeding situations.
The aggravated response on the FibTEM-MCF may better reflect HES
effects on clot structure.
P156
BXL 628 ameliorates toxicity of lactated Ringer in HK-2 human renal
proximal tubule cells in a hypovolemia mimicking model
YT Huang, CC Cheng, TC Lin, PC Lai
Buddhist Tzu Chi General Hospital, Hualien, Taiwan
Critical Care 2014, 18(Suppl 1):P156 (doi: 10.1186/cc13346)
Introduction Lactated Ringer (L/R) for resuscitation of hemorrhagic
shock is suggested by the ATLS program. However, prior studies
showed that resuscitation with L/R was associated with more kidney
damage in rats with severe hemorrhagic shock. The direct effects of L/R
on human renal tubule cells have not been reported.
Methods Human proximal renal tubular cell line HK-2 was used. Viability
was examined by MTT assay. An additional equal volume of phosphatebuffered saline (PBS) served as control. Addition of 200 nM dipyridyl
and 1 mM H2O2 served as conditions of hypoxia and oxidative stress,
respectively. Patterns of cell death were observed by flow cytometry.
Results To imitate early resuscitation in hypovolemic shock, medium
was replaced with 40% v/v of L/R with dipyridyl plus H2O2 for 4 hours,
followed by replacing with complete medium for 44 hours. In such
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Introduction Previous in vitro studies have shown that photometric
assays may overestimate fibrinogen levels after hemodilution with HES.
The in vivo effect of HES on fibrinogen assays was therefore studied.
Methods Forty patients with intracranial tumor gave their consent
to participate in this ethical approved study. Plasma fibrinogen
levels were analyzed with ELISA, two photometric assays (Dade and
Multifibren) and one mechanical (Hook). In addition, ROTEM FibTEMMCF was analyzed.
Results Twenty-five of the 40 patients received 1 l HES. Mean reduction
of hematocrit was 17%. ELISA was lower than Hook and Multifibren.
The FibTEM relative decrease of 43% differed significantly from the
other assays. See Figure 1.
Conclusion After in vivo hemodilution with HES, some assays
overestimated fibrinogen levels. An overestimation of around 0.3 g/l

Figure 1 (abstract P156). Cell death of HK-2 cells after lactated Ringer
administration in a hypovolemia mimic model.
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sodium, chloride, lactate or creatinine levels were not significantly
different between the two groups.
Conclusion The administration of hypotonic fluids in the first 72 hours
of liver transplantation may be a risk factor for prolonged ICU
admission. This effect appears independent of serum electrolyte levels
or renal dysfunction.
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Figure 2 (abstract P156). Elocalcitol (BXL 628) ameliorates toxicity of
lactated Ringer in HK-2 human renal tubule cells.

conditions, L/R augmented cytotoxicity, and more annexin V (+) cells
were observed. Co-treatment or post-treatment with BXL 628, a novel
VDR agonist, reversed L/R-induced cytotoxicity. See Figures 1 and 2.
Conclusion BXL 628 rescued L/R-induced apoptosis in human renal
proximal tubule cells in a hypovolemia mimicking model.
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Introduction Morbidity after liver transplantation has been linked
with preoperative MELD scores and transfusion volumes [1]. We
hypothesized that in the immediate post-transplant period there may
be modifiable risk factors associated with prolonged ICU stays.
Methods In a retrospective, case–control study, we reviewed all liver
transplant adult recipients over a 33-month period, January 2010
to September 2013. Recipients were divided into two groups based
on a priori determined cutoff value of 8 days after transplantation.
Significant associations for prolonged ICU admission were identified
using chi-square analysis for categorical and ANOVA for continuous
variables. P <0.05 was considered significant. SPSS version 22.0 was
used for all analyses.
Results Total numbers of transplants performed were 162. Mean pretransplant MELD score was 19.5 ± 7.7; viral hepatitis was the most
common indication for transplant, 44 (27%). Living-related donor
transplants were carried out in 87 (54%) cases. Median ICU length of
stay was 4 ± 11.9 days and ICU mortality was 15 (9%). Acute kidney
injury developed in 30 (19%) with 5% needing renal replacement
therapy. Early complications developed in 33%. Prolonged ICU stay
was related to: a higher pre-transplant INR (P = 0.000), larger volumes of
RBC (2,064 ± 1,701 vs. 1,176 ± 1,454 ml, P = 0.000), platelets (453 ± 271
vs. 365 ± 276 ml, P = 0.046) and cryoprecipitate transfusions (47 ± 98
vs. 23 ± 85 ml, P = 0.037) received in the OR and mean volumes of
hypotonic crystalloids administered in the first 24 hours (P = 0.002),
48 hours (P = 0.010) and 72 hours (P = 0.007) of ICU admission. Serum

Introduction Vasopressin is frequently used to maintain blood pressure
in refractory septic shock [1]. This study is looking into the hypothesis
that vasopressin compared with norepinephrine would decrease the
severity of septic status, evolution to multiple organ dysfunction,
length of hospitalization, and mortality among patients with septic
shock.
Methods In this randomized, double-blind study, we assigned patients
who still needed vasopressor to restore tissue perfusion after fluid
resuscitation to receive norepinephrine (0.05 to 2.0 μg/kg/minute) or
vasopressin (0.01 to 0.03 U/minute) with low doses of norepinephrine.
Both groups had the vasoactive drug infusions titrated and tapered
to maintain a target mean blood pressure. The analysis included the
total time of use and dosage of vasopressors every 6 hours, the move
to single organ dysfunction and multiple organ failure, length of ICU
stay and hospitalization, and mortality 7, 14 and 28 days after the start
of infusions.
Results A total of 407 patients underwent randomization but 387
patients were included in this study (191 patients received vasopressin,
and 196 received norepinephrine only). The total time for vasopressors
was 37 hours and 68 hours in the vasopressin and norepinephrine
groups with P = 0.02. Single organ dysfunction and multiple organ
dysfunction using vasopressin and norepinephrine were respectively:
37.7% vs. 49.2%, P = 0.02; and 17.8% vs. 26%; P = 0.05. Length of stay
in the ICU was 14 and 17 days (P = 0.29) and the time of hospitalization
was 23 and 28 days (P = 0.11) respectively. There was a significant
difference between the vasopressin and norepinephrine groups in the
mortality rate at 14 and 28 days (29.3% vs. 36.7%, P = 0.05; 34% and
42.3%, P = 0.03), but there were no significant differences in the overall
rates for 7-day mortality (21.2% vs. 23.9%, respectively; P = 1.1).
Conclusion Early application of vasopressin reduced the time of
vasopressor use, progression to multiple organ dysfunction, length
of stay in the ICU, and mortality rates at 14 and 28 days as compared
with norepinephrine only. This observed difference can be attributed
to early restoration of tissue perfusion in the control group making the
state of septic shock shorter and reducing the potential for multiple
organ dysfunction, which directly influenced patient survival.
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Introduction Terlipressin is a vasopressin (V1 receptor) agonist that
causes splanchnic constriction and is used in the management
of variceal bleeding. This case report demonstrates the profound
hyponatraemia, sufficient to cause a fall in conscious level, developing
following terlipressin administration for variceal gastrointestinal
bleeding.
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Methods A 28-year-old man was admitted to the ICU following
intubation and sedation for seizures due to acute alcohol withdrawal.
A CT scan of the brain was normal. In the ICU the patient became
haemodynamically unstable and fresh blood was aspirated from the
nasogastric tube. Gastroscopy showed bleeding oesphageal varicies
and hypertensive portal gastropathy. The patient was treated with
variceal banding, tazobactam/pipacillin (4.5 g three times daily) and
terlipressin (2 g four times daily) as per protocol for variceal bleeding.
He was successfully extubated 48 hours later.
Results On admission the patient’s serum sodium was 139 mmol/l. The
patient received terlipressin for 4 days in the following regimen: 2 g
four times daily for 48 hours, then 1 mg four times daily for 24 hours
and then 0.5 mg four times daily for a further 24 hours before stopping.
On the last day of his terlipressin therapy, the patient’s GCS dropped
from 15 to 11. Serum sodium had fallen acutely to 116 mmol/l. The
last two doses of terlipressin were cancelled and no other treatment
for hyponatraemia was administered. His serum sodium and GCS
returned to normal limits within 13 hours of terlipressin cessation with
no neurological consequences.
Conclusion There are few case reports of terlipressin-induced
hyponatraemia [1]. Hyponatraemia is considered a rare side effect
brought about by the partial agonist effect of terlipressin on renal
vasopressin V2 receptors. Sola and colleagues monitored serum sodium
concentrations in patients with acute variceal bleeding. They found that
rapid reduction in serum sodium was common (up to 36%) and one
patient developed osmotic demyelination syndrome. Hyponatraemia
resolved on cessation of terlipressin [2]. Close monitoring of serum
sodium levels is essential in patients on terlipressin therapy so rapid
drops in sodium can be identified and managed to stop associated
neurological complications.
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Introduction Patients with distributive shock who require high-dose
vasopressors have a high mortality. Vasopressors belong to two classes:
catecholamines and vasopressin analogs. Each class has limitations.
Patients receiving catecholamines often develop tachyphylaxis and
metabolic complications (for example, lactic acidosis). Vasopressin
analogs can cause mesenteric or myocardial ischemia and oliguria.
Angiotensin II (ATII) is an endogenous peptide that increases blood
pressure and aldosterone production. Preclinical data suggest a role
for ATII in the treatment of sepsis-associated acute kidney injury.
ATII may prove useful in patients who remain hypotensive despite
catecholamine and vasopressin therapy. This is the first randomized
clinical trial to date which seeks to evaluate ATII for use in distributive
shock.
Methods Twenty patients with distributive shock and a cardiovascular
Sequential Organ Failure Assessment score ≥4 were randomized
to either ATII infusion (n = 10) or placebo (n = 10) plus standard of
care. ATII was started at a dose of 20 ng/kg/minute, and titrated per
a protocolized schedule for a goal of maintaining a mean arterial
pressure (MAP) of 65 mmHg. The infusion (either ATII or placebo) was
continued for 6 hours and then titrated off. The primary endpoint was
the effect of ATII on the standing dose of norepinephrine required to
maintain a MAP of 65 mmHg. Secondary endpoints included the effect
of ATII on urine output, serum lactate and creatinine clearance, as well
as 30-day mortality.
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Results The mean age was 62.9 ± 15.8 years. Of the patients, 75%
were male, 45% were Caucasian and 40% were African American.
The 30-day mortality for the two groups were similar for the ATII
cohort and the placebo cohort (50% vs. 60%, P = 1.00). ATII resulted
in marked reduction in norepinephrine dosing in all patients. The
mean norepinephrine dose for the placebo cohort was 20.1 ± 16.8 μg/
minute vs. 7.3 ± 11.9 μg/minute for the ATII cohort (P = 0.022). The most
common adverse event was hypertension, which occurred in 20% of
patients receiving ATII.
Conclusion ATII is an effective vasopressor agent in patients with
distributive shock requiring multiple vasopressors. The initial dose
range of ATII that appears to be appropriate for patients with
distributive shock is 2 to 10 ng/kg/minute. Further studies to assess the
use of ATII in patients with distributive shock are warranted.
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Introduction Patients with septic shock die mainly due to refractory
shock. Vasopressin is commonly used as an adjunct to catecholamines
to support blood pressure in refractory septic shock, but its effect on
mortality is unknown. We hypothesized that vasopressin as compared
with norepinephrine would decrease mortality among cancer patients
with septic shock.
Methods In this, randomized, double-blind trial, we assigned patients
who had cancer and septic shock and needed a vasopressor to receive
norepinephrine or vasopressin in addition to open-label vasopressors.
All vasopressor infusions were titrated and tapered according to
protocols to maintain a target blood pressure. The primary endpoint
was the mortality rate 28 days after the start of infusions.
Results A total of 107 patients underwent randomization in this first
part of trial, and were infused with the study drug (53 patients received
vasopressin, and 54 norepinephrine), and were included in the analysis.
There was no significant difference between the vasopressin and
norepinephrine groups in the 28-day mortality rate (67.9 and 58.5%,
respectively; P = 0.31). There were no significant differences in the
overall rates of serious adverse events (5.3% and 5.5%, respectively;
P = 1.00).
Conclusion Vasopressin did not reduce mortality rates as compared
with norepinephrine among patients with cancer and septic shock who
were treated with catecholamine vasopressors.
Acknowledgement Clinical Trials number: NCT 01718613.
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Introduction Clinical study suggests that beta-blockers, by decreasing
the heart rate (HR) together with an increase in stroke volume (SV), do
not negatively affect cardiac output (CO), allowing an economization
of cardiac work and oxygen consumption in patients with septic shock
[1]. Whether this hemodynamic profile leads to an amelioration of
myocardial performance is still unclear. The objective of the present
study was therefore to elucidate whether a reduction in HR with esmolol
is associated with an improvement of cardiac efficiency in patients
with septic shock who remained tachycardic after hemodynamic
optimization.
Methods After 24 to 36 hours of initial hemodynamic stabilization, 24
septic shock patients with HR >95 bpm and requiring norepinephrine
(NE) to maintain mean arterial pressure (MAP) between 65 and 75 mmHg
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despite adequate volume resuscitation received a continuous esmolol
infusion to maintain the HR between 94 and 80 bpm. NE was titrated
to achieve a MAP between 65 and 75 mmHg. To investigate myocardial
performance, we simultaneously assessed LV ejection fraction (LVEF),
tricuspidal annular plane solid excursion (TAPSE) by echocardiography,
the dP/dt MAX and the cardiac cycle efficiency (CCE) both estimated
from the arterial pressure waveform. Data were obtained at baseline
and after achieving the predefined HR threshold (T1).
Results For a MAP between 65 and 75 mmHg, esmolol administration
significantly decreased HR (115 ± 10 to 91 ± 7 bpm), NE (0.7 ± 0.4 to
0.5 ± 0.3 μg/kg/minute), and dP/dt MAX (1.1 ± 0.3 to 0.8 ± 0.3 ms/
mmHg). Conversely, TAPSE (15 ± 3 to 20 ± 3 mm), CCE (–0.2 ± 0.4 to
–0.03 ± 0.4 units) and SV (37 ± 8 to 42 ± 10 ml) significantly increased
at the end of the study period (all P <0.05). CO (4.1 ± 0.8 to 3.9 ± 0.8 l/
minute) and LVEF (46 ± 10 to 48 ± 10%) did not change.
Conclusion In patients with established septic shock who remained
tachycardic after hemodynamic optimization, titration of esmolol to
reduce the HR to a predefined threshold economized cardiac function,
resulting in a maintained CO with a lower HR and a higher stroke
volume. Such a hemodynamic profile was characterized by an improved
cardiac efficiency, as indicated by the decrease in dP/dt MAX associated
with an increase in CCE. Finally, echocardiographic data suggest that
reducing HR with esmolol positively affects right ventricular function.
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A new automatic urinometer shows lower bias, no loss of precision
due to temporal deviation and higher user evaluation when
compared with a manual standard urinometer in an ICU setting
A Eklund, J Van der Linden
Karolinska University Hospital, Stockholm, Sweden
Critical Care 2014, 18(Suppl 1):P163 (doi: 10.1186/cc13353)
Introduction In the intensive care setting, most physiologic
parameters are monitored automatically. However, urine output (UO)
is still monitored hourly by manually handled urinometers. This study
evaluated an automatic urinometer (AU) and compared it with a
manual urinometer (MU).
Methods This was a prospective study in the ICU of a cardio-thoracic
surgical clinic. In postoperative patients (n = 36) with indwelling
urinary catheters and an expected stay of 24 hours or more, hourly
UO samples were measured with an AU (n = 220, Sippi®; Observe
Medical, Gothenburg, Sweden) or a MU (n = 188, UnoMeter™ 500;
Unomedical a/s, Birkeroed, Denmark), and thereafter validated
by cylinder measurements. Malposition of instrument at reading
excluded measurement. Data were analyzed with the Bland–Altman
method. The performance of the MU was used as minimum criteria of
acceptance when the AU was evaluated. The loss of precision with the
MU due to temporal deviation from fixed hourly measurements was
recorded (n = 108). A questionnaire, filled out by the ward staff (n = 28),
evaluated the ease of use of the AU compared with the MU.
Results Analysis according to Bland–Altman showed a smaller mean
bias for the AU, +1.9 ml, compared with the MU, +5.3 ml (P <0.001).
There was no statistical difference in measurement precision between
the two urinometers, defined by their limits of agreement (±15.2 ml
vs. ±16.6 ml, P = 0.11). The mean temporal variation with the MU was
±7.4 minutes (±12.4%), limits of agreement ±23.9 minutes (±39.8%),
compared with no temporal variation with the AU (P <0.001). A total
86% of the ward staff considered the AU superior to the MU (P <0.001).
Conclusion The AU had a significantly lower bias than the MU and the
loss of precision of hourly UO due to temporal deviations using the MU
was avoided with the AU. The AU was also evaluated higher by the ward
staff, reflecting perception of higher reliability, easier use, less contact
with urine bags and less time usage for measurements. The features of
the AU may also indicate a favorable clinical impact in the normal ward,
when staffing does not allow hourly measurements with a MU.
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Haemodynamic effects of phenylephrine commenced prior to
induction of anaesthesia in older patients undergoing high-risk
vascular surgery
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Critical Care 2014, 18(Suppl 1):P164 (doi: 10.1186/cc13354)
Introduction Fall in mean arterial blood pressure (MAP) during
anaesthetic induction is common and may result in profound hypotension. Using the LiDCORapid (LiDCO Ltd, UK), we previously
demonstrated that the fall in MAP is usually driven by a reduction in
stroke volume (SV) that was presumed due to venodilation. Lowdose phenylephrine (PE), a venoconstrictor, commenced immediately
prior to induction ameliorated these effects to a significant degree
[1]. However, it is important that the pre-induction administration
of PE should not cause any marked changes in MAP and CO. We
retrospectively studied a group of 40 high-risk patients about to
undergo major peripheral vascular surgery where PE was commenced
immediately pre-induction. The haemodynamic effects of this dose of
PE on MAP, SV and CO were analysed.
Methods A radial artery line was inserted prior to induction of
anaesthesia, and baseline MAP, CO and SV were obtained using the
LiDCORapid. The PE infusion was commenced at a rate of 1 to 2 mg/
hour. Remifentanil was then administered using a target-controlled
infusion pump until a 2 ng/ml predicted effect site concentration (Ceff )
was reached. Propofol was then administered to induce anaesthesia.
Haemodynamic changes from the pre-PE baseline to commencement
of propofol were recorded at 5-second intervals. The changes in MAP,
SV and CO were assessed as the percent change in values obtained
immediately prior to PE and followed for at least 5 minutes until
commencement of propofol.
Results Patient demographics, mean (range): age 71 (46 to 89) years,
31 male, weight 80 (55 to 115) kg, ASA 3 (2 to 4). The changes in MAP
and CO were not clinically or statistically significant. MAP increased by
an average of only 2%, range –25 to +12; CO by 0%, range –23 to +16
(P = 0.35 and P = 0.36 respectively).
Conclusion In a previous study [1], PE administered prospectively prior
to induction markedly reduced the haemodynamic changes following
induction of anaesthesia in high-risk patients using remifentanil and
propofol. This effect was achieved without significant changes in MAP
and CO in the 5-minute to 10-minute period between commencement
of PE and induction of anaesthesia.
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Introduction Acetaminophen (APAP) is commonly administered in the
surgical ICU (SICU) for its analgesic and antipyretic effects. Case reports
have described the potential for APAP to cause allergic reactions with
and without hypotension. Furthermore, there have been case reports
of APAP causing isolated hypotension in the absence of other allergic
responses [1]. This has been well described following intravenous
administration [2]. However, other routes of administration causing
hypotension and associated diagnoses remain to be elucidated.
The present case series describes 11 patients with APAP-induced
hypotension in the SICU at a Level I trauma center.
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Methods Patients admitted to the SICU over a 7-month time frame who
were reported by the nursing staff to have experienced hypotension
following the oral or rectal administration of APAP were included. Their
electronic medical records were retrospectively reviewed to describe
the change in systolic blood pressure (SBP) and mean arterial pressure
(MAP) within the first hour following all administrations of APAP.
Additional data collected consisted of patient age, sex, admission
diagnoses and formulation/route of APAP administration.
Results Of the 11 patients included, six had spontaneous intracranial
hemorrhage (ICH), four had traumatic ICH and one was free of
neurologic injury. Following administration of 393 doses of APAP, the
average change in MAP for all patients was –7.52 mmHg and SBP was
–12.04 mmHg. When evaluated on an individual basis, patients with
ICH had an average change in MAP of –10.64 (–5.2 to –19.08) and SBP
of –17.81 (–7.54 to –35.75). The patient without neurologic injury had
an average change in MAP and SBP of –3.01 and –2.42. The average
change in MAP and SBP following administration of oral APAP solution
(n = 357) was –7.84 and –12.39 while the change following rectal
administration (n = 3) was –4.22 and –8 and tablet administration
(n = 33) was –4.4 and –8.61.
Conclusion It appears from this small case series that patients with ICH
may experience more isolated hypotension following administration
of APAP when compared with others. These changes seemed to be
greater than previously reported for intravenous administration. It may
also be possible that APAP solution exudes hypotensive effects more
commonly when compared with tablet or rectal formulations.
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Introduction Profound myocardial depression can occur after cardiac
surgery. Use of ventricular assist support through venoarterial
extracorporeal membrane oxygenation (ECMO) has been positively
reported. This study will focus on the outcomes of patients who, upon
suffering hemodynamic failure after cardiac surgery, were supported
by the use of ECMO during their stay in the surgical ICU of Incor FMUSP.
Methods This was a retrospective, single-center and observational
study. The records of 48 patients who underwent cardiac surgery
and, subsequently, needed percutaneous or surgical implantation of
ventricular assist devices were evaluated. The evaluation considered
the following criteria: basal characteristics, indications for ventricular
assistance, duration, length of ICU and hospital stay, and hospital
mortality, through data collection forms.
Results Of the 48 patients included on the study, 26 (54%) were
males, and 31 (64%) were younger than 18 years old. These patients
developed cardiogenic shock during 72 hours after cardiac surgery. In
all cases, ECMO was inserted after cardiac surgery. Of all patients, 32
(66%) were central ECMO, inserted in the operative room, and 16 were
percutaneous, inserted in the ICU. The median duration of ventricular
assistance was 6 days (IQR 0 to 41), the length of ICU stay was 16 days
(IQR 1 to 111), and hospital stay was 29 days (IQR 1 to 198). Twenty
patients survived (41%) and were discharged from our hospital.
Conclusion The use of mechanical circulatory assists devices is an
efficient tool to manage seriously ill patients after cardiac surgery. This
tool should be considered early in the diagnosis of cardiogenic shock
after cardiac surgery.
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Potential use of veno-arterial extracorporeal membrane
oxygenation for cardiogenic shock refractory to mechanical assist
devices: baseline physiology and mortality data
C Vimalanathan, N Barrett, N Ioannou, C Langrish, C Meadows, G Salt,
G Glover
Guy’s & St Thomas’ NHS Trust, London, UK
Critical Care 2014, 18(Suppl 1):P167 (doi: 10.1186/cc13357)
Introduction Mortality from cardiogenic shock remains high [1] and,
despite a physiological rationale, intra-aortic balloon counterpulsation
(IABP) has recently been shown to be ineffective in reducing mortality
[2,3]. Veno-arterial extracorporeal membrane oxygenation (V-A ECMO)
may offer a survival advantage over IABP. The objective of this study
was to describe the characteristics and outcomes of patients supported
with IABP or Impella and to identify the characteristics of patients who
die, despite mechanical assistance, for whom a proposed V-A ECMO
programme may be beneficial.
Methods A retrospective cohort study in a 30-bed, medical–surgical
ICU. All adult patients supported with IABP or Impella over 2 years
to March 2013 were identified and data were extracted by case-note
review. Subgroup analysis was carried out for patients aged ≤65 and
for those who fulfilled the modified Melbourne criteria for V-A ECMO
[4]. Data collected included demographic data, physiology and organ
support at baseline and at 6, 12, and 24 hours, ICU and hospital
outcomes and cause of death. Comparisons between survivors and
nonsurvivors were made with t test/chi-squared tests as appropriate.
Results A total of 129 patients were identified: 78% were male, mean
age was 70 years (SD ±11.8), mean APACHE II score was 20 (±5) and ICU
mortality was 44%. Comparing survivors with nonsurvivors the only
statistically significant difference was metabolic acidosis (–6.8 ± 5.3 vs.
–10.9 ± 7.0 mEq/l; P <0.05). Heart rate, mean arterial pressure, lactate,
central venous oxygen saturation, cardiac index, arterial blood pH and
mechanical ventilation failed to show a significant difference. Eleven of
these patients would have fulfilled the proposed criteria for V-A ECMO,
with an ICU mortality of 36%.
Conclusion Only metabolic acidosis was associated with mortality in
patients supported with mechanical assist devices. Our data do not
allow discrimination of survivors from nonsurvivors. Patients who
fulfilled the proposed criteria for V-A ECMO showed a similar mortality
to a recent series treated with V-A ECMO [4]. The proposed criteria do
not identify a cohort, in this population, that would expect a mortality
benefit from V-A ECMO.
References
1.
2.
3.
4.

Jeger RV, et al.: Ann Intern Med 2008, 149:618-626.
Thiele H, et al.: N Engl J Med 2012, 367:1287-1296.
Werdan K, et al.: Eur Heart J 2013. [Epub ahead of print]
Aubron C, et al.: Crit Care 2013, 17:R73.

P168
Normobaric oxygen paradox and the microcirculation in the
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Introduction The normobaric oxygen paradox (NOP) is a recent
concept that postulates the use of intermittent hyperoxia to stimulate
erythropoietin (EPO) production [1]. Hyperoxia increases oxygen free
radicals and may lead to endothelial damage and vasoconstriction [2].
We evaluated the microvascular response to transient hyperoxia and its
effects on EPO production.
Methods Six patients with hemodynamic stability and mechanically
ventilated with FiO2 <50% were included in this prospective
observational study. Patients underwent a 2-hour period of hyperoxia
(FiO2 100%). The sublingual microcirculation (sidestream dark-field
imaging (SDF)) was evaluated at baseline (t0), 2 hours after hyperoxia
(t1), and 2 hours after return to basal FiO2 (t2). SDF monitoring was
continuously performed also during the variation of FiO2 for 2 minutes.
EPO levels were assayed at baseline and for 2 days.
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(odds ratio, 4.95; 95% CI, 1.19 to 7.24; P <0.001), hemoperitoneum/
pneumoperitoneum/intraperitoneal fluid collection (odds ratio, 3.61;
95% CI, 1.29 to 10.12; P = 0.014), obesity (odds ratio, 3.41; 95% CI 1.97
to 5.90; P <0.001), fluid received >2.3 l (odds ratio, 2.68; 95% CI, 1.48 to
4.84; P = 0.001), abbreviated SOFA score >4 points (odds ratio, 2.49; 95%
CI, 1.49 to 4.15; P <0.001) and lactate >1.4 mmol/l (odds ratio, 2.28; 95%
CI, 1.33 to 3.91; P <0.001) were identified as independent predictors of
IAH upon admission to ICU. The presence of three or more of these risk
factors at admission predicted the onset of IAH with sensitivity of 75%
and a specificity of 76%, and the onset of grade II, III and IV IAH with a
sensitivity of 91% and a specificity of 62%.
Conclusion IAH is a common clinical entity in the intensive care setting.
Predictive criteria, based on data readily available upon a patient’s
admission to ICU, were developed and effectively predicted the risk of
developing IAH.

Figure 1 (abstract P168). TVD and NOP.

Results An early vasoconstriction and a trend towards total vessel
density (TVD) reduction were observed at t1 (Figure 1). The TVD tended
to increase without returning to baseline levels at t2. EPO increased
in four patients out of 6 (P = NS). A negative correlation was found
between the change in TVD after hyperoxia (t1 – t0) and the change in
EPO (r = –0.88, P = 0.03).
Conclusion Hyperoxia leads to vasoconstriction that seems to be
reversible at hyperoxia cessation. Further data are needed to verify
the efficacy of the NOP in stimulating erythropoiesis in the critically
ill. There might be a relation between hyperoxia-induced reduction in
vessel density and the EPO increase.
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Predictive criteria for the development of intra-abdominal
hypertension and abdominal compartment syndrome
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Introduction This study aims to develop predictive criteria to identify
which patients are at risk of developing intra-abdominal hypertension
(IAH) and abdominal compartment syndrome (ACS) upon admission to
the ICU.
Methods This is a prospective, observational study of 403 consecutively
admitted ICU patients in a 3-month period, requiring the insertion of an
indwelling urinary catheter. Intra-abdominal pressure was measured at
least twice daily in all patients.
Results Thirty-nine and 2% of patients developed IAH and ACS as per
consensus definitions. Upon ICU admission, patients that would go on
to develop IAH had a significantly higher APACHE III score (62 (44 to
81) vs. 50 (37 to 68); P <0.001), abbreviated SOFA score (6 (4 to 8) vs. 4
(2 to 6); P <0.001), CVP (17 (13 to 20) vs. 15 (12 to 17) mmHg; P <0.001),
lactate (2.2 (1.4 to 3.8) vs. 1.5 (1.1 to 2.4) mmol/l; P <0.001), INR (1.3 (1.1
to 1.5) vs. 1.2 (1.1 to 1.3); P <0.001), bilirubin (11 (7 to 19) vs. 10 (6 to 15)
μmol/l; P = 0.027), creatinine (108 (76.8 to 175) vs. 84.0 (66.0 to 118)
μmol/l; P <0.001), 24-hour fluid balance (2.47 (0.95 to 4.05) vs. 1.23 (0.29
to 2.27) l; P <0.001), vasopressor requirement (60 vs. 39%; P <0.001),
mechanical ventilation requirement (71 vs. 58%; P = 0.011), PEEP (8.00
(5.00 to 10.00) vs. 5.50 (5.00 to 8.00) cmH2O; P <0.001), and peak airway
pressure (24 (21 to 30) vs. 22 (19 to 24) cmH2O; P <0.001). These patients
also had a significantly lower abdominal perfusion pressure (61 (55 to
71) vs. 69 (60 to 77) mmHg; P <0.001), pH (7.29 (7.22 to 7.35) vs. 7.33
(7.28 to 7.37); P <0.001) and PaO2:FiO2 ratio (182 (100 to 263) vs. (264
(168 to 371); P <0.001) upon ICU admission. Abdominal distension
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Introduction It is unknown whether lactate monitoring aimed to
decrease levels during the first hours in patients undergoing cardiac
surgery improves outcome. The aim of this study was to evaluate the
effect of lactate monitoring and resuscitation directed at decreasing
lactate levels in patients admitted to the ICU in the first 8 hours with
lactate level ≥3.0 mEq/l.
Methods Patients were randomly allocated to two groups. In the lactate
group, treatment was guided by lactate levels with the objective to
decrease lactate by 20% or more per 2 hours for the initial 8 hours of
ICU stay. In the control group, the treatment team had no knowledge
of lactate levels (except for the admission value) during this period.
The primary outcome measure was the incidence of complications in
28 days.
Results The lactate group received more fluids and dobutamine.
However, there were no significant differences in lactate levels between
the groups. The rate of complications was similar between groups (11%
vs. 7%, P = 0.087). Length of ICU stay was higher in the lactate group
(3.5 vs. 2.4 days, P = 0.047) when compared with the control group.
Conclusion In patients with hyperlactatemia on ICU admission,
lactate-guided therapy did not reduce complications and was related
to a longer ICU length of stay. This study suggests that goal-directed
therapy aiming to decrease initial lactate levels does not result in
clinical benefit.
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Lactate as a predictor of deterioration in emergency department
patients with and without infection
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Critical Care 2014, 18(Suppl 1):P171 (doi: 10.1186/cc13361)
Introduction The use of serum lactate level to risk-stratify emergency
department (ED) patients with sepsis is widely used. Studies in
nonsepsis populations also suggest its utility in predicting adverse
outcomes. Whether lactate prognosticates equally across disease
states is not clearly defined. This study compares the ability of
lactate to identify patients at risk for deterioration (intubation, acute
renal dysfunction, vasopressor use, or death) and mortality during
hospitalization in infected and non-infected populations.
Methods A prospective, observational cohort study of ED adult patients
presenting from 11 November 2012 to 1 February 2013 who had lactate
measured and abnormal vital signs (hearth rate ≥130, respiratory rate
≥24, shock index ≥1, systolic blood pressure <90 mmHg). Patients with
isolated atrial tachycardia, seizure, intoxication, or psychiatric agitation
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were excluded. Patients were stratified into three groups by lactate
<2.5 (low), 2.5 to 4 (intermediate), and >4 mmol/l (high). Chi-square test
for trend was used to compare outcome rates between lactate levels
for each diagnostic category.
Results Of 1,152 patients identified, 366 were excluded and 298 did
not have lactate measurements, leaving 488 for the analysis: 289 sepsis
patients and 202 nonsepsis patients. Of these, 168 (34.4%) met the
deterioration outcome, and there were 61 (12.5%) deaths. For infected
patients, 46/342 (13.5%; 95% CI 10.2 to 17.5) low, 34/100 (34.0%; 95% CI
25.4 to 43.7) intermediate, and 20/46 (43.5%; 95% CI 30.2 to 57.8) high
lactate patients suffered deterioration (P <0.01). Likewise, 6/342 (1.6%;
95% CI 0.7 to 3.9) low, 19/100 (19.0%; 95% CI 12.4 to 27.9) intermediate,
and 11/46 (23.9%; 95% CI 13.8 to 38.0) high lactate patients died during
hospitalization (P <0.01). For non-infected patients, 42/342 (12.3%; 95%
CI 9.2 to 16.2) low, 13/100 (15.1%; 95% CI 7.6 to 21.1) intermediate,
and 13/46 (28.2%; 95% CI 17.2 to 42.7) high lactate patients suffered
deterioration (P = 0.01). In the regression models, lactate was strongly
associated with deterioration for both infected (odds ratio (OR) =
1.94; 95% CI 1.4 to 2.3) and non-infected (OR = 1.48; 95% CI 1.14 to
1.91) groups. In regression models for mortality, lactate had better
discrimination ability in infected (OR = 1.8; 95% CI 1.4 to 2.3) patients
than in the non-infected (OR = 1.11; 95% CI 0.85 to 1.47) patients.
Conclusion Lactate levels can be used to identify patients who are at
increased risk of deterioration regardless of infection status. Lactate
identifies high-risk patients for mortality in infected patients more
strongly than in non-infected patients.
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Adipose tissue lactate clearance but not blood lactate clearance is
associated with clinical outcome in severe sepsis or septic shock
during the post-resuscitation period
M Theodorakopoulou, S Orfanos, N Nikitas, D Vasilliadi, S Apolonatou,
A Diamantakis, G Karkouli, C Diakaki, A Armaganidis, I Dimopoulou
University Hospital of Athens Greece ‘ATTIKON’, Attiki, Greece
Critical Care 2014, 18(Suppl 1):P172 (doi: 10.1186/cc13362)
Introduction Blood lactate clearance, a surrogate of tissue hypoxia,
is associated with increased mortality in septic patients. However, no
study has directly measured lactate clearance at the tissue level in
the post-resuscitation period of sepsis. This study aimed to examine
the relative kinetics of blood and tissue lactate clearances and to
investigate whether these are associated with outcome in ICU patients
having severe sepsis or septic shock during the post-resuscitation
phase.
Methods A microdialysis catheter was inserted in the subcutaneous
adipose tissue of the upper thigh and interstitial fluid samples were
collected. Serial measurements of blood and interstitial fluid lactate
levels were performed over a 48-hour period. Lactate clearance was
calculated according to the formula: (lactate (initial) – lactate (delayed) /

Figure 1 (abstract P173). Scatterplot of (a) MAP and SL and (b) PT and SL.

S61

lactate (initial)) × 100%. Lactate (initial) is blood or tissue lactate within
the first 24 hours after ICU admission (H0). Lactate (delayed) is blood or
tissue lactate at H4, H8, H12, H16, H20, H24 and H48 (H = hours).
Results A total of 112 patients having septic shock (n = 79) or severe
sepsis (n = 33) were examined. Tissue lactate clearance was higher
compared with blood lactate clearance at H0 to H8 (P = 0.02), H0 to
H12 (P = 008), H0 to H16 (P = 0.01), H0 to H20 (P = 0.01), and H0 to H24
(P = 0.02). Tissue lactate clearance was higher in survivors compared
with nonsurvivors at H0 to H12, H0 to H20 and H0 to H24 (P = 0.02,
for all). Multivariate analysis showed that ARACHE II along with
tissue clearances at H0 to H12, H0 to H20 and H0 to H24 <30% were
independent outcome predictors. Blood lactate clearance was not
related to survival.
Conclusion In critically ill septic patients, after the initial resuscitation
phase, adipose tissue clears lactate earlier than blood. High tissue
lactate clearance, but not blood lactate clearance, is associated with a
favorable clinical outcome.
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Introduction The aim of this study was to determine the correlation
between levels of serum lactate (SL) and conventional hemodynamic
parameters (HPs) (mean arterial pressure (MAP), heart rate (HR), central
venous pressure (CVP), urinary output (UP)) in patients with severe
sepsis. In a subgroup, advanced HPs (central venous saturation (SvO2),
peripheral temperature (PT), cardiac index (CI), global end-diastolic
volume index (GEDI) and extravascular lung water (ELWI)) were
compared with levels of SL.
Methods An observational prospective, single-center, pilot study
was performed in intensive care (IC) of a medium-sized teaching
hospital. Adult patients with severe sepsis were included and received
standard goal-directed therapy (Surviving Sepsis Guidelines). Every
patient received an arterial line and a central venous line in the upper
diaphragm position. A subgroup received pulse contour cardiac
output (PiCCO)-guided resuscitation and PT measurements. Pearson
correlation coefficients (PCCs) were calculated between HPs and SL,
which were measured every 4 hours for the first 48 hours after inclusion.
P <0.05 was considered statistically significant.
Results Twenty-five patients (12 men) were included. Mean age was
68 years (30 to 93), mean APACHE II score 31 (20 to 42). The most
frequent reasons for IC admission were abdominal sepsis (n = 11) and
pneumosepsis (n = 7). Mean HPs (with SD and range) were respectively:
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MAP 73 mmHg (13, 37 to 120), HR 101 beats/minute (22, 51 to 172), CVP
12 mmHg (5, 1 to 29), UP 55 ml/hour (62, 0 to 500), SL 3.2 mmol/l (3, 1
to 18.6), CI 4.1 ml/kg/minute (1.1, 1.6 to 6.7), GEDI 871 ml/m2 (210, 500
to 1,691), ELWI 11 ml/kg (5, 4 to 23), PT 32.1 C (2.8, 26.4 to 38), and SvO2
75% (8, 39 to 93). Relevant and significant (P <0.005) PCCs between HPs
and SL were respectively: MAP –0.417, HR 0.195, UP –0.237, SvO2 –0.204
and PT –0.569. Figure 1 shows the relation between two HPs with the
highest correlation with SL.
Conclusion The conventional HPs MAP, HR, UP and SvO2 are significantly
correlated to levels of SL, but clinical value might be limited due to the
relatively low correlation coefficients. In a small subgroup, PT is better
correlated to the level of SL.
P174
Delayed assessment of serum lactate in sepsis is associated with an
increased mortality rate
R Arnold1, Z Zhang1, S Patel2, S Smola1, J Isserman1, E Jackson1
1
Christiana Care Health System, Newark, DE, USA; 2Cooper University Hospital,
Camden, NJ, USA
Critical Care 2014, 18(Suppl 1):P174 (doi: 10.1186/cc13364)
Introduction Lactate assessment early in the resuscitation of sepsis has
been recommended as a diagnostic biomarker. An abnormal lactate,
independent of blood pressure, is an indication for aggressive fluid
resuscitation and its normalization is a recommended endpoint of
resuscitation. The objective of this study was to evaluate the effect of
the timing of lactate assessment on patient outcomes in sepsis.
Methods Data were compiled using the Clinical Vigilance for Sepsis
electronic health record (EHR) screening tool, which identified
consecutive patients from two hospital systems over 12 months at a
300-bed community hospital and over 24 months from a 500-bed
academic tertiary care center. CV Sepsis alert screens the EHR to identify
the presence of infection based on a multifactor alert system including
labs, vital signs, and treatment team documentation. A physician order
for intravenous antibiotics was used as a surrogate for suspected
infection. The database identified 37,160 consecutive patients treated
for infection from a total of 216,550. Patients with a measured lactate
were divided relative to its measurement within 3 hours (eLac) or
greater than 3 hours (dLac) of sepsis identification as recommended by
the Surviving Sepsis Campaign. The CV Sepsis alert was the reference
standard for time zero. Patients were compared in each group for the
occurrence of the primary outcome of in-hospital mortality.
Results A total 5,072 of 37,160 consecutive patients (13%) had
a measured lactate. Sepsis patients experienced an overall 3%
(1,186/37,160) mortality rate. In total, 4,153 (82%) patients had
measured lactate within 3 hours, and 919 (18%) were delayed, with a
decreased morality rate (eLac 6.8 vs. dLac 24.7, P <0.0001). There was no
difference in average lactate levels between the groups (eLac: 2.1 ± 2.6,
dLac: 2.3 ± 3.0, P = NS). A larger ratio of delayed-lactate patients had a
lactate ≥4 mmol/l (dLac 12.6% vs. eLac 8.7%).
Conclusion The delay in lactate assessment relative to clinical evidence
of infection was associated with an increased mortality rate. The average
lactate level in each group did not account for this effect. The timing of
the assessment, not the lactate level, was prognostic of outcome. The
mortality benefit associated with lactate assessment within the 3-hour
guideline suggests that an increased clinical awareness may lead
to early initiation of time-sensitive interventions known to improve
outcomes.
P175
Lactate clearance as a predictor of mortality in colonic perforation
R Egashira, T Kobayashi
Osaki Citizen Hospital, Miyagi, Japan
Critical Care 2014, 18(Suppl 1):P175 (doi: 10.1186/cc13365)
Introduction The objective of this study was to determine whether
lactate clearance (LC) is a significant indicator of mortality in patients
with colorectal perforation. LC has been associated with mortality in
heterogeneous critically ill patients, but its role as a predictor of mortality
in homogeneous patients with colorectal perforation is unclear.
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Methods We retrospectively analyzed the clinical data of patients who
underwent emergency surgery for colorectal perforation and were
admitted to the ICU of our hospital from January 2003 to August 2013.
Patients with traumatic, iatrogenic, and appendicitis perforations were
excluded. The primary endpoint was survival to hospital discharge.
The modified Sequential Organ Failure Assessment (mSOFA) score,
a customized SOFA score excluding the central nervous system
component [1], was used for prognostic scoring. The mSOFA score and
several clinical factors were analyzed by univariate analysis as possible
predictors of survival. We collected lactate levels and base excess (BE)
measured during surgery and at 6, 12, and 24 hours after the first
measurement and calculated the respective LC values. The associations
of initial blood lactate level, LC, and BE with mortality were assessed by
receiver operating characteristics (ROC) curve and logistic regression
analyses.
Results Of the 61 patients identified, five were excluded as their ICU
stay was <24 hours. The overall mortality in the remaining 56 patients
(mean age of 76.7 ± 10.4 (SD) years) was 21.4%. In univariate analysis,
mSOFA and several other variables correlated significantly (P <0.05)
with mortality. The area under the ROC curve for LC at 6, 12, and
24 hours was 0.601, 0.719, and 0.731, respectively. LC at 24 hours was
the most accurate, and its optimum cutoff value was 37.5%. LC, lactate
level, and BE at 24 hours, as well as the significant factors in univariate
analysis, were entered into a stepwise logistic regression model, which
revealed 24-hour LC ≤37.5% (odds ratio (OR), 23.0) and mSOFA score
(OR, 2.1) as independent predictive values of mortality.
Conclusion In patients with colorectal perforation, 24-hour LC is more
accurate than LC measured at earlier time points. Patients with 24hour LC ≤37.5% and a high mSOFA score have a high risk of in-hospital
mortality.
Reference
1.

Nates JL, et al.: Automating and simplifying the SOFA score in critically ill
patients with cancer. Health Informatics J 2010, 16:35-47.

P176
Lactate quartile concentration and prognosis in severe sepsis and
septic shock
M De La Torre-Prados1, A Garcia-de la Torre2, C Trujillano-Fernández1,
J Perez-Vacas1, A Puerto-Morlan1, E Camara-Sola1, A Garcia-Alcantara1,
A Garcia-Alcantara1
1
Hospital Virgen de la Victoria, Málaga, Spain; 2Puerto Real University
Hospital, Cadiz, Spain
Critical Care 2014, 18(Suppl 1):P176 (doi: 10.1186/cc13366)
Introduction The Surviving Sepsis Campaign (SSC) indicates that
a lactate (LT) concentration greater than 4 mmol/l indicates early
resuscitation bundles. However, several recent studies have suggested
that LT values lower than 4 mmol/l may be a prognostic marker of
adverse outcome. The aim of this study was to identify clinical and
analytical prognostic parameters in severe sepsis (SS) or septic shock
(ShS) according to quartiles of blood LT concentration.
Methods A cohort study was designed in a polyvalent ICU. We studied
demographic, clinical and analytical parameters in 148 critically ill
adults, within 24 hours from SS or ShS onset according to SSC criteria.
We tested for differences in baseline characteristics by lactate interval
using a Kruskal–Wallis test for continuous data or a chi-square test for
categorical data and reported the median and interquartile ranges;
SPSS version 15.0 (SPSS Inc., Chicago, IL, USA).
Results We analyzed 148 consecutive episodes of SS (16%) or ShS
(84%). The median age was 64 (interquartile range, 48.7 to 71) years;
male: 60%. The main sources of infection were respiratory tract 38%
and intra-abdomen 45%; 70.7% had medical pathology. Mortality at
28 days was 22.7%. Quartiles of blood LT concentration were quartile
1 (Q1): 1.87 mmol/l or less, quartile 2 (Q2): 1.88 to 2.69 mmol/l, quartile
3 (Q3): 2.7 to 4.06 mmol/l, and quartile 4 (Q4): 4.07 mmol/l or greater
(Table 1). The median LT concentrations of each quartile were 1.43
(Q1), 2.2 (Q2), 3.34 (Q3), and 5.1 (Q4) mmol/l (P <0.001). The differences
between these quartiles were that the patients in Q1 had significantly
lower APACHE II scores (P = 0.04), SOFA score (P = 0.024), number of
organ failures (NOF) (P <0.001) and ICU mortality (P = 0.028), compared
with patients in Q2, Q3 and Q4. Patients in Q1 had significantly higher
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Table 1 (abstract P176). Baseline characteristics in SS and ShS patients by quartiles of blood LT
Lactate <1.87 (n = 33)

Lactate 1.88 to 2.69 (n = 41)

Lactate 2.7 to 4.06 (n = 34)

Lactate>4.07 (n = 37)

Age (years)

57 (45 to 71)

APACHE II

25 (18.5 to 30)

SOFA
NOF

P

64 (51.5 to 74.5)

65 (48 to 69)

60 (48.5 to 71)

NS

25 (19.5 to 27)

25 (21.5 to 29.5)

27 (22 to 33)

0.04

9 (7 to 10.5)

9 (7 to 11)

9 (8 to 11)

11(8 to 13)

0.024

3 (3 to 4)

3 (3 to 4)

4 (3 to 5)

5 (3.5 to 5)

<0.001

LT (mmol/l)

1.43 (1.16 to 1.56)

2.2 (1.99 to 2.47)

3.34 (3 to 3.72)

5.1 (4.4 to 7.34)

<0.001

Procalcitonin (ng/ml)

2.81 (0.76 to 20.7)

11.5 (2.88 to 37.15)

13.47 (1.91 to 42.1)

21.6 (5.2 to 5.8)

0.05

Cholesterol (mg/dl)

127 (97.5 to 165)

130 (95.5 to 152.5)

100 (72 to 128)

91 (79 to 116.7)

0.06

28-day mortality (%)

10.8

21.2

24.4

35.1

0.029

ShS (%)

83.8

85.4

81.1

87.9

NS

value

cholesterol (P = 0.06) and lower procalcitonin (P = 0.05) at enrolment. At
the extremes, patients in Q1 had decreased 28-day mortality (P = 0.023)
and, patients in Q4 had increased 28-day mortality, compared with
the other quartiles of patients (P = 0.009). Interestingly, patients in
Q2 had significant increased mortality compared with patients in Q1
(P = 0.043), whereas the patients in Q2 had no significant difference in
28-day mortality compared with patients in Q3.
Conclusion Adverse outcomes and several potential risk factors,
including organ failure, are significantly associated with higher
quartiles of LT concentrations. It may be useful to revise the cutoff value
of lactate according to the SSC (4 mmol/l).

P177
Correlation between arterial lactate and venous lactate in patients
with sepsis and septic shock
P Theerawit, C Na Petvicharn
Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
Critical Care 2014, 18(Suppl 1):P177 (doi: 10.1186/cc13367)
Introduction Measurement of arterial lactate (A-LACT) levels has
been used to monitor poor tissue perfusion, predicting mortality and
guiding resuscitation. Peripheral venous lactate (V-LACT) has been
regarded as an unreliable test, but a less invasive approach. We aimed
to determine correlation between A-LACT and V-LACT and agreement
of both in order to determine the usefulness of V-LACT as a biomarker
for assessment in sepsis.
Methods We conduct a prospective, cross-sectional study during June
to December 2011 at a university hospital. Septic patients in the ICU
were enrolled in this research. Sepsis was defined according to the
Surviving Sepsis Campaign: International Guidelines for Management
of Severe Sepsis and Septic Shock: 2008. The exclusion criteria were:
contraindication for arterial puncture; and denying inform consent. The
venous lactate would be sampled at the same point in time as arterial
lactate measurement. The correlation and agreement between arterial
and venous lactate was the primary outcome.
Results A total of 73 pair-samples in 45 intensive care patients
were collected. Mean age was 68.33 ± 14.5 years. Fifty percent of all
patients received the vasopressors to stabilize hemodynamics. The
mean serum creatinine level was 2.78 mg/dl and the mean anion
gap was 13.55 mmol/l. The mean arterial lactate (A-LACT) level was
3.73 ± 4.0 mmol/l, and the mean venous lactate (V-LACT) level was
4.6 ± 4.2 mmol/l. The A-LACT and V-LACT were strongly correlated as
shown in Figure 1 (r = 0.927, P <0.0001, r2 = 0.859). The mean difference
between V-LACT and A-LACT was 0.889 mmol/l. The 95% limits of
the V-A difference in the individual patients were between –2.3 and
4.1 mmol/l. However, the agreement looks very good at lactate levels
not higher than 4 mmol/l (Figure 2). The regression equation was:
A-LACT = (0.877 × V-LACT) – 0.320.

Figure 1 (abstract P177).

Figure 2 (abstract P177).

Conclusion The arterial lactate and venous lactate levels were strongly
correlated in the condition of sepsis or septic shock. Consequently,
V-LACT may be used in substitution for A-LACT particularly in lactate
levels not higher than 4 mmol/l. However, trending should be generally
applied instead of the absolute value.
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Comparison of the effects of histidine–triptophan–ketoglutarate
solution and crystalloid cardioplegia on myocardial protection
during pediatric cardiac surgery
S Kuslu, P Zeyneloglu, A Pirat, A Camkiran, M Ozkan, G Arslan
Baskent University Faculty of Medicine, Ankara, Turkey
Critical Care 2014, 18(Suppl 1):P178 (doi: 10.1186/cc13368)
Introduction The major components of myocardial protection during
cardiac surgery are the combination of cardioplegia solutions with
hypothermia. The primary endpoint of this study is to compare the
effects of histidine–triptophan–ketoglutarate (HTK) solution and
crystalloid cardioplegia on release of cardiac troponin-I (cTn-I) and
creatine kinase-myocardial band (CK-MB), which are perioperative
determinants of myocardial protection; the secondary endpoint is to
evaluate the intraoperative and postoperative hemodynamic variables
and clinical outcome parameters.
Methods A total of 66 children aged 1 month to 6 years undergoing
elective congenital heart surgery were randomly allocated to HTK
solution (Group H, n = 32) or crystalloid cardioplegia (Group C, n = 34)
after aortic cross-clamping. Blood samples for cTn-I and CK-MB levels
were measured before the surgical incision, at the end of surgery and
at 4, 16, 24 and 48 hours postoperatively.
Results Demographic features were similar in both groups. Duration
of surgery, aortic clamp and cardiopulmonary bypass times, amounts
of intraoperative fluids used and urine outputs were similar between
the groups. The groups were not significantly different in terms
of cTn-I and CK-MB levels at the intraoperative and postoperative
period (P >0.05 for all). The dose of positive inotropic drug at the
end of surgery was significantly high in Group H (P = 0.01). The
requirements for defibrillation were similar in both groups. There were
no significant differences between the groups regarding postoperative
hemodynamic parameters, positive inotropic requirements, amounts
of fluids and blood given and pacemaker requirements (P >0.05 for all).
Duration of mechanical ventilation, lengths of ICU and hospital stay
were similar in both groups.
Conclusion The present study demonstrated that there is no
superiority of HTK solution and crystalloid cardioplegia to each other
for myocardial protection during pediatric cardiac surgery.
P179
Hyperdynamic ejection fraction in the critically ill patient
JR Paonessa1, TP Brennan2, LA Celi1
1
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA,
USA; 2Massachusetts Institute of Technology, Cambridge, MA, USA
Critical Care 2014, 18(Suppl 1):P179 (doi: 10.1186/cc13369)
Introduction The hyperdynamic left ventricular ejection fraction
(HDLVEF) in the ICU is a common finding thought to be associated with
critical illness and possibly sepsis. The exact etiology of hyperdynamic
ejection fraction has yet to be determined, and the prognosis of these
patients has not been well defined.
Methods The cohort consisted of 2,632 adults admitted to the ICU with
echocardiogram reports using the MIMIC-II database, and was divided
into those with HDLVEF and those with normal left ventricular ejection
fraction (NLVEF). Those with impaired ejection fraction were excluded
from the analysis. Baseline comparisons were performed using chisquared tests for equal proportion with results reported as numbers,
percentages, and 95% CIs. Continuous variables were compared
using t tests and reported as means with 95% CIs, while non-normally
distributed data were compared using Wilcoxon rank-sum tests and
reported as medians.
Results Patients with HDLVEF had increased mortality in hospital,
at 28 days and at 1 year when compared with patients with NLVEF.
HDLVEF patients more frequently required renal replacement therapy
(RRT), vasopressors and mechanical ventilation. Of the 2,632 patients,
1,220 were septic. There was an increased proportion of HDLVEF in the
septic compared with the nonseptic groups (11.2% vs. 8.6%, P = 0.026).
Interestingly, other statistically significant associated comorbidities
were cancer, CHF, arrhythmias, and hypertension, which were more
commonly seen in the HDLVEF group. See Table 1.
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Table 1 (abstract P179)
Normal
Hyperdynamic
(n = 2,373, 90%) (n = 259, 10%)
Male

P value

1,159 (49)

98 (38)

<0.001

MICU

1,234 (52)

138 (53)

0.695

CCU

364 (15)

28 (11)

0.052

SICU

572 (24)

69 (27)

0.367

CSRU

188 (8)

23 (9)

0.590

Service type

Primary outcome
Twenty-eight-day mortality

458 (19)

79 (31)

<0.001

One-year mortality

892 (38)

129 (50)

<0.001

ICU mortality

296 (12)

60 (23)

<0.001

Hospital mortality

433 (18)

80 (31)

<0.001

363 (15)

55 (21)

0.013

Treatment
RRT
Vasopressor

1,063 (45)

139 (54)

0.006

Ventilated

1,453 (61)

186 (72)

<0.001

Conclusion Patients with hyperdynamic LVEF in the ICU clearly
have increased mortality. Hyperdynamic LVEF may be a result of
increased catecholamines during cytokine storm. It is unclear whether
hyperdynamic LVEF itself worsens outcomes. Further investigation is
needed.
P180
Impact of nitric oxide on pulmonary regurgitation and cardiac
function in the acute stage after right ventricular outflow surgery
Y Ko, K Morita, R Nagahori, T Abe, K Hashimoto
Jikei University School of Medicine, Tokyo, Japan
Critical Care 2014, 18(Suppl 1):P180 (doi: 10.1186/cc13370)
Introduction Pulmonary regurgitation (PR) that develops after
right ventricular (RV) outflow reconstruction including the Rastelli
and Norwood procedure may often result in serious cardiac events
early after surgery. We hypothesized that PR may be associated with
pulmonary vascular resistance (PVR) and RV contraction. Accordingly,
we assessed the impact of PVR on PR and RV function using a swine
model.
Methods Eight pigs (14 ± 2 kg) underwent total resection of the
pulmonary valve cusps under cardiopulmonary bypass (PR group).
This was compared with a control group (n = 6) that underwent only
bypass. In both groups, the pulmonary regurgitant fraction (PRF) and
cardiac output were measured by a pulsed Doppler flow meter, and
the percent segmental shortening of RV (%RVSS) and RV end-diastolic
dimension (RVDd) were measured by sonomicrometry. We also
performed dobutamine stress evaluation as well as changing the PVR
by carbon dioxide (PaCO2) and inhaled nitric oxide (NO).
Results All bypass time was 18 ± 3 minutes. In the PR group, the PRF was
40 ± 4% and the RVDd was 53 ± 9 mm* (vs. control 34 ± 6 mm). *P <0.05.
A significant reduction in the %RVSS (18 ± 1%* vs. control 22 ± 1%) and
the cardiac output (2.1 ± 0.2 l/minute* vs. control 2.5 ± 0.3 l/minute)
were observed. The PRFs were 60 ± 5% (PaCO2 >80 mmHg), 37 ± 2%
(PaCO2 <20 mmHg), 24 ± 2% (NO 20 ppm; PaCO2 40 mmHg), and were
positively correlated with the PVR (Figure 1A). During the dobutamine
stress, the %RVSS was increased (baseline 18 ± 1%, 5γ 21 ± 2%, 10γ
26 ± 3%), and was negatively correlated with the PRFs (Figure 1B).
Conclusion These results indicated that massive PR resulted in marked
deterioration of RV performance; however, low PVR and high RV
contractility may contribute to reduce the severity of PR and improve
cardiac function. Nitric oxide may be a useful treatment modality the
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of inotropes and intravascular volume might have contributed to the
decrease in cardiogenic oscillation.
Conclusion In pediatric patients after cardiac surgery, cardiogenic
oscillation was initially large but was decreasing at the extubation.
References
1.
2.

Figure 1 (abstract P180).

same as catecholamine during the acute stage after RV outflow surgery
with PR.
P181
Cardiogenic oscillation in pediatric patients after cardiac surgery
H Imanaka, N Okuda, T Itagaki, M Onodera, M Nishimura
Tokushima University Hospital, Tokushima, Japan
Critical Care 2014, 18(Suppl 1):P181 (doi: 10.1186/cc13371)
Introduction Cardiogenic oscillation is the fluctuation in flow tracing
in mechanically ventilated patients. Large cardiogenic oscillation
may cause autotriggering in adult patients after cardiac surgery [1]
and inaccurate volume monitoring [2]. However, it is unknown how
cardiogenic oscillation is problematic in pediatric patients. Therefore,
we prospectively surveyed cardiogenic oscillation in pediatric patients
after cardiac surgery.
Methods We enrolled 17 pediatric patients who underwent cardiac
surgery using cardiopulmonary bypass. They were mechanically
ventilated with pressure-controlled ventilation. We measured the
amplitude in cardiogenic oscillation and compared them between their
admission to the ICU and before extubation. We performed statistical
analysis with the t test and considered P <0.05 significant.
Results Cardiogenic oscillation was 2.1 ± 0.6 l/minute just after the
surgery (Figure 1). Autotriggering occurred in seven of 17 patients
when triggering sensitivity was set at 1 l/minute. Before the extubation,
cardiogenic oscillation significantly decreased to 1.4 ± 0.4 l/minute
when autotriggering disappeared. Intensive care including adjustment

Crit Care Med 2000, 28:402.
Crit Care Med 2004, 32:1546.

P182
Intraoperative dexamethasone on left atrial function and
postoperative atrial fibrillation in cardiac surgical patients
K Jacob, S Dieleman, H Nathoe, D Van Osch, E De Waal, M Cramer, J Kluin,
D Van Dijk
Utrecht University Medical Center, Utrecht, the Netherlands
Critical Care 2014, 18(Suppl 1):P182 (doi: 10.1186/cc13372)
Introduction Postoperative new-onset atrial fibrillation (PNAF) is very
common after cardiac surgery. The inflammatory response due to
surgery and cardiopulmonary bypass (CPB) may contribute to PNAF by
inducing atrial dysfunction [1]. Corticosteroids reduce the inflammatory
response and may thus reduce atrial dysfunction and PNAF [2]. The aim
of this study was to determine whether dexamethasone protects from
left atrial dysfunction and PNAF in cardiac surgical patients.
Methods Patients undergoing cardiac surgery were randomized to a
single dose of dexamethasone (1 mg/kg) or placebo after inducing
anesthesia. Transesophageal echocardiography was performed in
patients after CPB. The primary outcome was left atrial total ejection
fraction (LA-TEF) after sternal closure; secondary outcomes included
left atrial diameter and PNAF, detected by Holter monitoring.
Results Sixty-two patients were included. Baseline characteristics were
well balanced. Postoperative LA-TEF was 36.4% in the dexamethasone
group and 40.2% in the placebo group (P = 0.15) (Figure 1). Secondary
echocardiographic outcomes were also insignificant (Table 1). The
incidence of PNAF was 30% in the dexamethasone group and 39% in
the placebo group (P = 0.47).
Table 1 (abstract P182). Secondary postoperative echocardiographic
parameters in both groups
Dexamethasone

Placebo

P value

LA-TEF

Parameter

36.4

40.2

0.15

LA diameter

4.6

4.3

0.19

LA area

16.0

16.4

0.81

Conclusion Intraoperative high-dose dexamethasone did not have any
protective effect on postoperative LA-TEF or dimension and did not
reduce the risk of PNAF in cardiac surgical patients.

Figure 1 (abstract P181). Cardiogenic oscillation.

Figure 1 (abstract P182). Primary outcome preoperatively and
postoperatively in dexamethasone and placebo groups.
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P183
White blood cell count and new-onset atrial fibrillation after cardiac
surgery
S Dieleman, K Jacob, H Nathoe, M Ten Berg, D Van Osch, J Frencken,
D Van Dijk
Utrecht University Medical Center, Utrecht, the Netherlands
Critical Care 2014, 18(Suppl 1):P183 (doi: 10.1186/cc13373)
Introduction Postoperative new-onset atrial fibrillation (PNAF) is the
most common complication after cardiac surgery. Inflammation as
an underlying mechanism has been studied by various inflammatory
markers, and white blood cell count (WBC) is the only present consequent
inflammatory marker predicting PNAF [1]. This study aimed to determine
the association between perioperative WBC and PNAF.
Methods Patients >18 years undergoing elective cardiac surgery with
a sinus rhythm preoperatively were recruited from the Dexamethasone
for Cardiac Surgery-PNAF trial for this post-hoc cohort study. The
WBC was prospectively measured preoperatively and once during
each of the first four postoperative days. Development of PNAF was
evaluated with continuous 12-lead ECG monitoring the first 5 days
postoperatively.
Results A total of 657 patients were included in this trial, 277 developed
PNAF. The WBC was significantly higher in the PNAF group on day 2
and day 4 (Figure 1). However, multivariate analysis showed that
preoperative and postoperative WBC, days 1 to 3, were not associated
with PNAF (Table 1). Older age (OR: 1.05; CI: 1.03 to 1.07; P <0.001),
CABG plus valve surgery (OR: 2.95; CI: 1.78 to 4.88), single valve surgery
(OR: 3.09; CI: 2.03 to 4.69; P <0.001) and other surgery (OR: 2.21; CI: 1.23
to 3.97; P <0.001) were correlated with the occurrence of PNAF.
Table 1 (abstract P183). Multiple regression analysis of association between
high WBC and developing PNAF
Time point

OR

95% CI

Baseline

1.04

0.96 to 1.13

Day 1

1.03

0.98 to 1.08

Day 2

1.03

0.99 to 1.08

Day 3

1.03

0.96 to 1.11

Day 4

1.09

1.01 to 1.16

Conclusion Preoperative and postoperative WBC were not associated
with development of PNAF.
Reference
1.
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Figure 1 (abstract P183). WBC at baseline (t = 0) and in the four
postoperative days (t = 1 to 4), PNAF versus no PNAF.

P184
Anti-adrenergic effects of ranolazine in isolated rat aorta
P Marchio, MD Mauricio, FB El Amrani, S Guerra, D Aguirre-Rueda,
SL Vallés, JM Vila, M Aldasoro
University of Valencia, Spain
Critical Care 2014, 18(Suppl 1):P184 (doi: 10.1186/cc13374)
Introduction Ranolazine, a piperazine derivative, is used as an antianginal drug to treat patients with chronic angina in clinical practice [1]
and may improve coronary blood flow by reducing compression effects
of ischemic contracture, and by improving endothelial function [2,3].
In the present study we investigate the vascular effects of ranolazine
on the endothelium, adrenergic system and Ca2+ in isolated rat aorta.
Methods Rat aortic segments (3 mm long) with and without
endothelium were mounted for isometric tension recording in organ
baths containing Krebs–Henseleit solution. Electrical field stimulation
(2, 4 and 8 Hz, 20 V, 0.25 ms duration for 30 seconds) was provided
by a Grass S88 stimulator via two platinum electrodes positioned on
each side and parallel to the axis of the aortic segment. Concentration–
response curves of ranolazine (10–7 to 10–4 M) were obtained in a
cumulative manner using endothelin-1, noradrenaline, thromboxane
A2 and KCl as constrictor agents.
Results The contractile responses to electrical field stimulation were
abolished by tetrodotoxin, guanethidine and prazosin, indicating
that the contractile effect is due to the action of noradrenaline on
alpha adrenoreceptors. Ranolazine diminished (P <0.05) neurogenic
adrenergic contractions induced by electrical field stimulation in
aortic rings with and without endothelium. Ranolazine produced
concentration-dependent relaxation in rings precontracted with
noradrenaline (Emax 86 ± 6%, n = 10; P <0.05) but not in rings
precontracted with endothelin-1, thromboxane A2 and KCl. Neither
L-NAME (10–4 M), an inhibitor of nitric oxide synthase, nor indomethacin
(10–5 M), an inhibitor of cyclooxygenase, modified the relaxation
induced by ranolazine. The calcium antagonist nifedipine (10–6 M)
reduced the relaxation induced by ranolazine.
Conclusion These results indicate that ranolazine diminished the
contractile response induced by adrenergic stimulation, suggesting an
effect as an adrenergic blocker. The relaxant effects of ranolazine on
rat aortic vessels is not dependent on the endothelium-derived factors
(nitric oxide or dilator prostanoids) but involves an interference with
the entry of calcium through dihydropyridine calcium channels.
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Delays in extubation following elective adult cardiac surgery
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Introduction Early extubation post coronary artery bypass grafting
does not increase perioperative morbidity and reduces the length
of stay (LOS) in the ICU and in hospital [1]. Use of low-dose opioidbased general anaesthesia and time-directed protocols for fasttrack interventions does not increase mortality or postoperative
complications in low–moderate-risk patients and has been found to
have a reduced time to extubation and shortened ICU stay [2]. Our mean
time to extubation is 6 hours, although patients are assessed to be safe
to be weaned from mechanical ventilation at 2 hours following arrival
in the ICU. This study aims to identify factors that delay extubation in
patients undergoing routine cardiac surgery at our institution.
Methods A prospective analysis was performed on all patients post
adult cardiac surgery from 14 May 2013 to 10 July 2013. Emergency
surgical patients and those with intraoperative complications were
excluded.
Results A two-sample t test was used to analyse the data. Patient
demographics are presented in Table 1. There were significant delays in
time of extubation in those who received morphine prior to extubation
compared with those that did not (P = 0.0184) (Table 2). There were no
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Table 1 (abstract P185). Patient demographics
Age (years)
EUROSCORE (%)

66 (10.1)
2.90 (1.84)

Table 2 (abstract P185). Morphine versus no morphine
Morphine
Patient number
Time to extubation (hours)
LOS ICU (hours)
LOS hospital (days)

No morphine

51

20

7:48 (4:42)

4:48 (2:19)

51:21 (55:16)

40:06 (28:47)

9.83 (5.01)

10.8 (13.5)

significant differences in LOS in ICU or hospital. Factors such as age,
EUROSCORE and type of operation did not have an influence on time
to extubation.
Conclusion Administering morphine prior to extubation causes
significant delays in weaning from mechanical ventilation. We plan
to introduce intraoperative and postoperative protocols to facilitate
rapid weaning from mechanical ventilation for elective cardiac surgical
patients.
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Effects of perfusion pressure on the splanchnic circulation after
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Introduction No randomized trial has assessed the effects of different
mean arterial pressure (MAP) targets in postcardiac surgery intensive
care. We investigated the short-term effects of MAP of 65 or 85 mmHg
on splanchnic oxygen flux, metabolic function, mucosal perfusion and
cytokine regulation.
Methods A single-center, randomized controlled, double cross-over
trial was performed. Patients were randomized to: HLH (high–low–
high) where MAP targets were 85–65–85 mmHg in sequence, with each
lasting 2 hours, or LHL (low–high–low) where MAP targets were 65–
85–65 mmHg. Blood pressure was adjusted with noradrenalin infusion.
Results Six + six patients were included in the study. MAP targets were
achieved in all patients at all time points (64 ± 3, 84 ± 4; 65 ± 5 mmHg
in the LHL group and 84 ± 3; 66 ± 2; 85 ± 5 mmHg in the HLH group at
the first, second and third time points), with corresponding changes
in filling pressures. Cardiac output did not change over time. Hepatic
venous saturation was 41 ± 15; 58 ± 24; 56 ± 21% in the LHL group and
50 ± 19; 43 ± 20; 41 ± 18% in the HLH group at the first, second and
third time points, with a significant time group interaction (P <0.05). No
changes were observed in global or trans-splanchnic lactate levels and
cytokine levels or in gastric tonometry CO2.
Conclusion Increasing MAP with norepinephrine has some effects
splanchnic oxygenation, but has no impact on metabolic or
biochemical function and key cytokine removal or release. MAP targets
of 60 to 65 mmHg or 80 to 85 mmHg appear physiologically equivalent
for the splanchnic circulation.
P187
Isoflurane attenuates left ventricular akinesia and preserves cardiac
output in the Tako-tsubo rat model
J Oras1, B Redfors2, Y Shao2, H Seeman-Lodding1, SE Ricksten1, E Omerovic2
1
Institute of Clinical Sciences, Gothenburg, Sweden; 2The Wallenberg
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Introduction Tako-tsubo cardiomyopathy (TCM) is an acute cardiac
syndrome with regional hypokinesia in the left ventricle (LV), often

affecting the apex causing apical ballooning. TCM is frequent in
patients with adrenergic overstimulation and is probably common in
ICU patients [1]. In a TCM rat model we evaluated whether different
anesthetic agents could attenuate LV akinesia in TCM.
Methods Isoprenaline was intraperitoneal (i.p.) injected, which
induces LV akinesia and apical ballooning within 90 minutes [2]. We
performed the study in two different settings. In the first setting,
spontaneously breathing rats (n = 12 in each group) were sedated with
either pentobarbital, ketamine, isoflurane or no anesthetic before i.p.
isoprenaline. One additional group received the K-ATP blocker glyburide
before sedation with isoflurane. In the second setting, rats were
anaesthetized with ketamine + midazolam, mechanically ventilated
and the carotid artery was cannulated. Before i.p. isoprenaline, animals
were randomized to either no isoflurane (0 MAC), isoflurane 0.5 MAC
or isoflurane 1.0 MAC (n = 12 in each group). Arterial blood gas was
obtained before isoprenaline and 60 minutes after isoprenaline. The
heart rate (HR), systolic blood pressure (SBP) and body temperature
(BT) were recorded continuously. After 90 minutes, echocardiography
was performed. Extent of akinesia was expressed as the percentage of
total LV endocardial length. End-diastolic and end-systolic LV volumes
were measured, and stroke volume (SV) and cardiac output (CO) were
calculated.
Results In spontaneously breathing rats, the degree of akinesia was
significantly lower with pentobarbital and isoflurane (± glyburide) but
not with ketamine compared with controls. The degree of akinesia was
lowest with isoflurane. In ventilated rats, the degree of apical akinesia
(%) was significantly lower at 0.5 MAC (8.7 ± 7.3) and 1 MAC (5.7 ± 7.4)
versus 0 MAC (17.7 ± 8.0). This was accompanied by a higher CO and
SV. HR was lower at 1 MAC (6%) and SBP was lower at 0.5 MAC (106 ± 7)
and 1 MAC (98 ± 7) versus 0 MAC (126 ± 8). BT and pH was lower in
both isoflurane groups. In a multivariate model, isoflurane was the
only variable that was independently associated with the degree of LV
akinesia.
Conclusion Isoflurane prevents experimental TCM and preserves LV
function, an effect not mediated via opening of K-ATP channels. The
effect cannot be explained entirely by attenuation of myocardial
stress. Isoflurane sedation in the ICU might be an interesting approach
for patients suffering from hyperadrenergic conditions at risk of
developing TCM.
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Preoperative therapy with angiotensin-converting enzyme
inhibitors in cardiac surgery patients: is there any impact on
postoperative renal function?
F Ampatzidou, M Sileli, K Diplaris, C Koutsogiannidis, T Karaiskos,
G Drossos
General Hospital ‘G. Papanikolaou’, Thessaloniki, Greece
Critical Care 2014, 18(Suppl 1):P188 (doi: 10.1186/cc13378)
Introduction Preoperative therapy with angiotensin-converting
enzyme inhibitors (ACEI) is common in patients undergoing cardiac
surgery. The aim of this study was to evaluate the still-debated impact
of preoperative use of ACEI on postoperative renal function in cardiac
surgery patients [1,2].
Methods A total of 624 consecutive patients, who underwent cardiac
surgery from July 2012 to October 2013, were evaluated. Data were
prospectively collected in our clinic’s electronic database and were
retrospectively analyzed as to preoperative ACEI therapy. The chisquare test was used for correlations. Endpoints of the study were
the development of postoperative acute kidney injury (AKI) and the
difference between hospital admission and discharge glomerular
filtration rate (GFR). The AKI definition was based on modified RIFLE
classification. GFR values were estimated by the MDRD formula.
Results A total of 354 patients (56.7%) were treated with ACEI
preoperatively. Overall, 95 patients (15.3%) developed postoperative
AKI. Preoperative use of ACEI was not associated with the development
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Table 1 (abstract P188). AKI and GFR difference
ACEI users (n = 354)

ACEI nonusers (n = 270)

54 (15.3%)

41 (15.2%)

0.981

+1.43

+2.3

0.511

AKI
GFR difference (mean)

P value

of postoperative AKI (P = 0.981). Mean GFR values on admission day
were 65.23 ± 16.89 for ACEI users, and 65.06 ± 19.62 for the rest of the
cohort. Mean GFR values on discharge day were 66.77 ± 21.25 and
67.35 ± 25.64 respectively. The difference in GFR at the time of hospital
admission and on discharge day had no statistical difference, P = 0.511
(Table 1). Overall, 25 patients (4%) needed dialysis.
Conclusion The impact of preoperative ACEI treatment on
postoperative renal function after cardiac surgery is still debated.
We found no association, neither protective nor harmful, between
preoperative ACEI therapy and renal function impairment.
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Introduction Cardiovascular disease is the leading cause of death
worldwide and the outlook for 2020 data is even more alarming [1,2].
In this context, the coronary ICUs (CICUs) have become increasingly
numerous. However, data concerning this are still very limited in the
literature. This study aims to characterize the profile of CICU admissions
in Brazil and the main clinical variables associated with increased
mortality.
Methods To conduct the study we analyzed the database of a CICU
of a medium-sized hospital in the city of Presidente Prudente, Brazil.
Admissions that occurred during the period 1 September 2010 to 31
August 2013 were analyzed. The information was collected from the
EPIMED MONITOR system and statistically analyzed using EPI INFO,
version 3.5.2 software. P <0.05 two-tailed was considered significant,
and confidence intervals at 95% (95% CI) were used for the logistic
regression multivariate estimated in the sample.
Results A total of 2,098 admissions were recorded, of which 42.1% were
female and 57.9% male. The average age was 66.99 ± 13.30 years. The
prognosis for SAPS 3 admission score averaged 40.8 ± 15.48 points and
the mean unit length of stay was 3.5 ± 5.01 days. The main admission
diagnoses were unstable angina (13.06%), non-ST-segment elevation
myocardial infarction (8.29%), ST-segment elevation myocardial
infarction (8.10%) and supraventricular cardiac tachyarrhythmia
(6.91%). We observed a higher risk of death among patients who had,
at admission, congestive heart failure NYHA 2, 3 or 4 (odds ratio (OR) =
2.81, 95% CI: 2.07 to 3.83, P = 0.001), chronic renal failure (OR = 2.48,
95% CI: 1.68 to 3.67, P = 0.001), peripheral artery disease (OR = 1.93,
95% CI: 1.04 to 3.58, P = 0.033), severe chronic obstructive pulmonary
disease (OR = 3.17, 95% CI: 1.82 to 5.51, P = 0.002), and infection at
admission (OR = 7.88, 95% CI: 5.27 to 11.78, P = 0.001).
Conclusion The results reported may direct healthcare professionals to
profile the patient hospitalized in a CICU, paying attention to the most
disturbing and lethal comorbidities present on admission.
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Hospital visit pattern and its effect on reperfusion time and clinical
outcomes in ST-segment elevation acute myocardial infarction
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Introduction The reperfusion time is critical in ST-segment elevation
myocardial infarction (STEMI), and it makes a difference to clinical
outcomes. This study was designed to investigate the hospital visit
pattern and its effect on reperfusion time and clinical outcomes of
STEMI patients.
Methods A total of 199 STEMI patients were registered in this study
from three university hospitals in Kyungsang-do area, Korea, and were
divided into two groups; group 1 (n = 69) who directly visited the
hospitals capable of percutaneous coronary intervention (PCI), and
group 2 (n = 130) who first visited local hospitals and then transferred
to PCI-capable hospitals. We analyzed the estimated distance and time
to the hospitals using a driving navigation system, elapsed time from
chest pain to primary PCI hospitals, chest pain to reperfusion time, and
in-hospital outcomes.
Results There was no difference in first medical contact time between
groups 1 and 2. But the time from chest pain to PCI hospital was shorter
in group 1 (206.2 ± 268.5 vs. 370.3 ± 415.2 minutes, P = 0.001). Sixty
patients in group 1 and 108 patients in group 2 underwent reperfusion
therapy (P = 0.473). The chest pain to reperfusion time was shorter in
group 1 (294.6 ± 255 vs. 397.2 ± 341.9 minutes, P = 0.045). The difference
in estimated time by navigator and actual hospital visit time was also
shorter in group 1 (194.2 ± 269.9 vs. 321.6 ± 411.0 minutes, P = 0.009).
In-hospital mortality was higher in group 2 (0 vs. 4.6%, P = 0.094).
Conclusion A primary visit to a local hospital was associated with
longer reperfusion time and was associated with higher mortality.
Therefore, the reperfusion time could be reduced by patient education
and management of the community healthcare system.
P191
Tissue-aggressive inflammatory response defines the tissue
aggressiveness of the post-infarction milieu
E Grins, L Algotsson, H Engblom, M Carlsson, H Arheden, S Jovinge
Scania University Hospital, Lund University, Lund, Sweden
Critical Care 2014, 18(Suppl 1):P191 (doi: 10.1186/cc13381)
Introduction A potential measure of post-ischemic milieu in
myocardium subject to acute ischemic injury is to assess the socalled myocardial salvage index (SI) by relating the final infarct size
to the initial myocardium at risk (MaR). Cardiac magnetic resonance
(CMR) has previously been shown to enable determination of both
infarct size using late gadolinium enhancement and MaR using T2weighted imaging. This technique could thus potentially be used to
identify inflammatory responses that could be targeted to accomplish
cardioprotection. The aim of this study was to relate SI, as determined
by CMR, to the inflammatory response in patients with acute myocardial
infarction.
Methods Fifteen patients with first-time ST-elevation myocardial
infarction were included in the study. All patients underwent primary
PCI due to an acute occlusion in one branch of the left coronary artery.
Final infarct size and MaR was determined by CMR performed 1 week
after the acute event. The ischemic time was defined as the time from
pain onset to opening of the occluded vessel. Blood samples were
taken for assessment of inflammatory response. Inflammatory cells
were analyzed by flow cytometry in a BD FACS Aria. Parameters were
gated against control antibody and fluorescence minus one strategy.
Cytokine patterns were analyzed by BioRad BioPlex multiplex protein
analysis technology.
Results The SI did not correlate with MaR (P = 0.2720, R2 = 0.09191).
The population was divided into the lowest half of the SI (representing
the most hostile milieu; SI: 23 to 57%) and the upper half of the SI
(representing the friendliest post-infarction milieu; SI: 71 to 95%). The
patients’ profile of adaptive inflammatory response was characterized
by flow cytometry. The two groups did not differ with regard to their
T-regulatory response (CD25+FoxP3+, P = 0.7203) or NK-cell (CD3–CD56+,
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P = 0.5742) response. However, the proportion of TH1 (CD4+ IFNγ+)
cells was higher in the group with the lowest SI (57.47 ± 4.805 vs.
38.10 ± 6.514, P = 0.0349).
Conclusion This is the first study that identifies inflammatory cell
patterns which influence the hostility of the infarction milieu in
vivo. The study indicates that SI can be used as an evaluator of postischemic milieu and that TH1 response is associated with unfavorable
post-infarction injury and could therefore be a possible target for
future studies to limit infarction size. The current study is, by its size
and observational character, important; an argument for rather than a
substitute for future interventional studies in this area.
P192
Impact of positive end-expiratory pressure application on
ventriculo-arterial coupling in decompensated left ventricles after
cardiac surgery: a non-invasive echocardiographic study
P Bertini, V Simone, R Baldassarri, L Doroni, F Guarracino
University Hospital, Pisa, Italy
Critical Care 2014, 18(Suppl 1):P192 (doi: 10.1186/cc13382)
Introduction The management of ICU patients following heart
surgery can be hustling when coping with severe left ventricular
(LV) dysfunction. Single beat (Sb) measurements of ventriculoarterial coupling (VAc) can be used by the intensivist when dealing
with altered hemodynamic states [1]. LV elastance (Ees) and arterial
elastance (Ea) can be measured by trasthoracic echocardiography
(TTE) in a Sb fashion [2], so allowing quick assessment of VAc. PEEP
application is common practice in the ICU but can have hemodynamic
consequences and lead to instability. Speckle tracking analysis by TTE
has been recently reported to help titrating PEEP in critically ill patients
[3]. However, this can be demanding and require specific ultrasound
tools. In this study we aimed to assess whether standard TTE can be
useful in evaluating the effect of respiratory treatment with PEEP on
cardiovascular efficiency by measuring VAc after coronary artery
bypass surgery (CABG).
Methods TTE was performed before anesthesia induction and upon
ICU arrival in 15 patients with preoperative diagnosis of LV dysfunction
defined as an EF <35%. In-ICU measurements of Ees, Ea and VAc were
taken at different steps of PEEP application lasting 3 minutes as follows:
0 cmH2O PEEP (ZEEP), 5 cmH2O PEEP, 10 cmH2O PEEP and 15 cmH2O
PEEP. TTE and hemodynamic parameters were recorded and analyzed.
Results All patients were uncoupled preoperatively (VAc >1.31, average
VAc (AVAc) = 1.56) before anesthesia induction and showed worsened
uncoupling postoperatively at ZEEP. PEEP application altered VAc by
modifying both Ees and Ea at all steps and all patients showed further
uncoupling at any level of PEEP application (AVAc at ZEEP = 1.97, at
5 cmH2O PEEP = 1.61, at 10 cmH2O PEEP = 1.87, at 15 cmH2O PEEP =
2.23) A PEEP of 5 cmH2O provided the more favorable VAc.
Conclusion Sb evaluation of Ea/Ees shows that following CABG the
patients with depressed LV remain uncoupled, and that in such patients
the application of PEEP leads to further decoupling. In this preliminary
experience, 5 cmH2O PEEP seems to be the most appropriate in
preventing further worsening of the VAc. A large RCT is needed to draw
conclusions on the PEEP effect on VAc following CABG in a depressed
heart.
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predictive of mortality. The recently introduced high-sensitivity cardiac
troponin T (HS cTnT) assay has resulted in an increased detection of
elevated cTnT in ICU patients [1]. The aim of this study was to determine
the prevalence of elevated cTnT using the HS assay and its relationship
with mortality.
Methods A retrospective observational study was performed on all
ICU admissions over a 12-month period. Data were obtained from the
clinical information system (ICIP; Philips) and the ICU audit databases
(AcuBase). Data collected included patient demographics, peak cTnT
value, APACHE II score, requirement for organ support and mortality.
The primary outcome measure was hospital mortality. Data were
analysed using SPSS v.17.0. cTnT levels were divided into categories
for analysis: normal (<14 ng/l) and elevated. The elevated category was
further subdivided into quartiles. Univariate analysis was performed
between potential risk factors and mortality followed by multivariate
regression analysis to ascertain independent predictors of mortality.
Results There were 417 admissions to the ICU during the study period,
89 of whom were excluded because of an absent cTnT value, leaving 328
patients included in the analysis. cTnT was elevated in 85% of patients.
ICU mortality was 19% and hospital mortality was 28%. Hospital
mortality (%) per cTnT category was: <14 ng/l = 2%; 14 to 38 ng/l =
19%; 39 to 90 ng/l = 26%; 91 to 252 ng/l = 39%; >252 ng/l = 43%. On
univariate analysis, cTnT levels, age, ventilation and APACHE II score
were significantly associated with mortality. cTnT levels were significant
in multivariate regression independent of age and ventilation but did
not reach significance (P = 0.06) in a multivariate analysis that included
the APACHE II score.
Conclusion In 85% of general ICU patients, troponin measured by
HS cTnT assay was elevated. cTnT levels were significantly associated
with mortality and are predictive of mortality independent of age and
mechanical ventilation, but not independently of APACHE II score. There
was a high correlation between troponin levels and APACHE II scores.
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Introduction In the view of robust consequences following
cardiac surgery, acute kidney injury (AKI) remains a major concern.
Rhabdomyolysis (RML) following cardiac surgery and its relation to
AKI need to be investigated. We aim to study the prevalence of RML
development following cardiac surgery and the perioperative risk
factors that may expedite the occurrence of RML.
Methods All patients undergoing cardiac surgeries in our hospital
were enrolled in the study during the period of 1 year in a prospective
descriptive study measuring the occurrence of RML and its association
with AKI, where all patients in the study underwent serial assessment
of serum creatinine kinase (CK) and serum myoglobin. Serial renal
function, prior statin treatment, cardiac injury, lengths of ventilation,
and lengths of stay in the ICU and hospital were monitored.
Results We recruited 202 patients in our study, 185 males and 17 females
with mean age 52 ± 12.4 years. According to the existence of RML (CK
2,500 U/ml or more) [1], patients were divided into group 1 where
RML was identified in 17 patients (8.4%), which was associated with
AKI in seven patients (41%), and group 2 without RML (185 patients),
where AKI occurred in 34 patients (18.4%) (P = 0.025). We observed a
significantly longer duration of ventilation and lengths of stay in the
ICU and in hospital in the RML group (P <0.01 for all observations).
Conclusion Early increase in the serum CK and myoglobin in
postoperative high-risk cardiac surgeries may predict the concomitance
of early AKI, where proper intervention may prevent the sequelae of
logistic organ dysfunction.
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Open cavity abdominal surgery in octogenarians and
nonagenarians admitted to a university teaching hospital ICU:
a retrospective review
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Introduction This review was undertaken to establish the ICU and
hospital mortality rates in patients aged 80 and over admitted to
our ICU following abdominal cavity surgery. Intensive care mortality
increases progressively with age [1] and as the population changes
we are likely to see increasing numbers of patients over the age of 80
admitted to critical care units.
Methods We searched the ICNARC database from 2006 to 2013 for
patients aged 80 years or over, admitted from theatre or after surgery.
Data were referenced against the electronic theatre management
system, and patients not undergoing abdominal cavity surgery
were excluded. The data were analysed using an Excel spreadsheet
(Microsoft) and Medcalc software.
Results Eighty-five patients were included, with ages ranging from 80
to 99 years. Fifty-one (60%) patients were male and 79 (93%) patients
were categorized as having an emergency operation. ICU mortality was
34/85 (40%) and hospital mortality was 48/85 (56%). Variables assessed
for association with hospital mortality can be seen in Table 1. Only
invasive ventilation and time (days) from hospital admission to ICU
admission were significant predictors of hospital mortality.
Table 1 (abstract P195). Survivors versus nonsurvivors
Survivors

Nonsurvivors

P value

Age

83

83

0.82

Time

1, 1 to 8

4.5, 1 to 8

0.004

17, 14 to 20

17, 14 to 21

0.96

M57, F43

M63, F37

0.65

Ventilation (n, %)

31, 83

48, 100

0.005

RRT (n, %)

6, 16

11, 23

0.58

APACHE II
Sex (%)

Data presented as median, IQR or n, %.

Conclusion ICU and hospital mortality rates were high at 40% and 56%
respectively. Increasing age did not correlate with mortality. However,
invasive ventilation and time between hospital and ICU admission
were associated with a higher mortality. This may be due to a delay in
diagnosis or surgical intervention. We suggest that one considers early
intervention in patients aged over 80. A functional outcome measure at
discharge may be a more clinically relevant endpoint.
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Introduction The aim of this study was to clarify the risk factors for
acute renal impairment (ARI) in patients with severe acute pancreatitis
(SAP).
Methods We conducted a retrospective observational case–control
study. The data of all patients admitted to the ICU at a university
hospital with the diagnosis of SAP from January 2008 to December
2012 were abstracted from the hospital database. ARI was defined
according to RIFLE criteria. Patients with any signs of renal impairment
(serum creatinine value ≥1.5-fold from the estimated baseline) on
admission or history of kidney disease were excluded. A control group

was composed of randomly selected patients with SAP who did not
develop ARI.
Results Of 145 patients, 24 patients who developed ARI at any time
during hospitalization (ARI group) were contrasted with 24 patients
without ARI (control group). The patients were older in the ARI group:
age 57 ± 13 versus 49 ± 16, P = 0.046. Although none of the patients
in the ARI group had creatinine values ≥1.5-fold from the estimated
baseline, the creatinine values on admission were higher in this group:
100 ± 38 versus 68 ± 16, P = 0.001. The severity of pancreatitis was
similar. On admission, the APACHE II and SOFA scores were higher in the
ARI group (12.7 ± 3.7 vs. 8.6 ± 3.4, P = 0.001 and 5.6 ± 3.4 vs. 2.8 ± 1.9,
P = 0.002, respectively). The patients in the ARI group had higher intraabdominal pressure and SOFA respiratory score on admission and after
72 hours (P <0.01). Although on admission the cardiovascular SOFA
score was similar in both groups, it increased significantly after 72 hours
in the ARI group from 1.1 ± 1.7 to 2.1 ± 1.8, P = 0.012 and became higher
compared with the control group: 2.1 ± 1.8 versus 0.6 ± 1.2, P = 0.001.
Lactate was higher in the ARI group on admission and after 72 hours
(P <0.05). The percentage of patients requiring vasopressors over
72 hours was greater in the ARI group: 66.7% versus 29.2%, P = 0.01.
Positive fluid balance after 72 hours in ICU was higher in the ARI group:
8,594 ± 7,044 ml versus 4,192 ± 4,467 ml, P = 0.004; however, the
infused volume of crystalloids did not differ between groups. Central
venous pressure was higher on admission (P = 0.036) and after 72 hours
(P = 0.001) in the ARI group. Multivariable logistic regression analysis
revealed that development of ARI was independently associated with
cardiovascular SOFA score after 72 hours: odds ratio = 1.475, 95% CI
1.049 to 2.073, P = 0.025.
Conclusion The development of ARI in SAP was associated with
hemodynamic instability, whereas excessive volume expansion does
not prevent ARI.

P197
Severe acute pancreatitis in ICU: a 5-year audit
R Durrani, O Murphy, A Kibeida, G Fitzpatrick
Tallaght Hospital & Trinity College Dublin, Ireland
Critical Care 2014, 18(Suppl 1):P197 (doi: 10.1186/cc13387)
Introduction Severe acute pancreatitis (SAP) is associated with
significant mortality and morbidity. The objective of this study is to
examine the profile, outcome and resource utilization for patients with
SAP admitted to the ICU in a university teaching hospital over a 5-year
period.
Methods A retrospective observational study was carried out of all
patients admitted to the ICU from 1 January 2008 to 31 December
2012 with SAP. Data were collected from the ICU database (AcuBase),
the medical records and the ICU clinical information system. Data
collected included patient demographics, etiology of SAP, data for
APACHE II, Imrie, Ranson and Acute Kidney Injury Network (AKIN)
scores, and requirement for organ support. Outcomes recorded were
length of stay, ICU mortality and hospital mortality. Cost of ICU care was
calculated based on previously reported methodology.
Results Thirty-eight eligible patients were identified. Mean age was
51.4 years (range 24 to 86), 68% were male. The commonest etiologies
were alcohol (53%) and gallstone pancreatitis (24%). The mean APACHE
II score was 18.5 (IQR 14 to 23). Twenty-eight patients (74%) required
mechanical ventilation, three of whom required high-frequency
oscillation (all three survived). Twenty-two patients (58%) had evidence
of an acute kidney injury on admission (AKIN criteria). Eighteen (47%)
required renal replacement therapy and 60% required inotropes.
The ICU mortality and the hospital mortality were 26%. There was
no significant difference in age, APACHE II, Imrie, or Ranson scores
between survivors and nonsurvivors. The median length of stay in the
ICU was 11 days (IQR 5.25 to 28.5) and the median hospital stay was
45.4 days (IQR 22.25 to 104.5). Nine patients (24%) required multiple
ICU admissions and the mortality was significantly higher in this group
(P <0.05, chi-square test). In total, 834 ICU bed-days were taken up by
38 patients. Based on a median cost for an ICU bed-day of €2,205 [1],
the total cost of ICU care for these patients is estimated at €1,838,970 or
almost €50,000 per patient.
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Conclusion A hospital mortality rate of 26% is similar to that reported
recently from a specialist unit in the UK [2] but less than the 42%
reported in the UK in 2007 [1], suggesting some improvement in recent
years. SAP is associated with prolonged ICU and hospital stay and
significant resource utilization.
References
1.
2.

Harrison et al.: Crit Care 2007, 11(Suppl 1):S1.
Pavlidis et al.: Crit Care Res Pract 2013, 2013:897107.

P198
Bacterial infection in severe acute pancreatitis patients admitted to
the ICU
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Critical Care 2014, 18(Suppl 1):P198 (doi: 10.1186/cc13388)
Introduction Controversy surrounds the empirical use of antibiotics in
severe acute pancreatitis (SAP). There are concerns that the widespread
use of antibiotic therapy in the absence of documented infection may
lead to selection of drug-resistant organisms [1]. The aim of this study
was to review the profile of pancreatic fluid isolates in patients with
SAP admitted to the ICU.
Methods Data were reviewed for 38 patients admitted to the ICU over
a 5-year period. We evaluated organisms cultured from pancreatic
specimens, as well as the prevalence of drug-resistant organisms in this
group of patients.
Results Aspirate of pancreatic material for culture was obtained in
55% of patients (n = 21). The mean time to acquisition of samples for
culture from admission to ICU was 15.5 days. Fluid was sterile in 67%
(n = 14) of initial samples. Gram-positive organisms were cultured from
43% (n = 9) of samples, Gram-negative organisms from 5% (n = 1) and
yeasts from 5% (n = 1). Antibiotic therapy was administered in 95% of
patients prior to samples being obtained for culture. On review of all
samples received from patients (including nonpancreatic specimens),
vancomycin-resistant enterococci (VRE) were isolated in 13 patients.
Linezolid-resistant enterococci (LRE) were isolated in six patients,
five of whom had VRE isolated prior to the culture of LRE. Extendedspectrum beta-lactamase organisms were isolated in two patients,
and carbapenem nonsusceptible Gram-negative organisms in three
patients. The mean APACHE II score was 18.5 and overall hospital
mortality was 26%.
Conclusion In the majority of patients, initial aspirates of pancreatic
material were sterile. This may be a result of prior antibiotic usage.
Where organisms were cultured from initial aspirates, Gram-positive
organisms predominated, possibly as a result of prior anti-Gramnegative antibiotic use. Therefore, in patients with ongoing sepsis who
are receiving broad-spectrum antibiotic therapy, consideration needs
to be given to the empiric treatment of Gram-positive infection, and
in particular drug-resistant organisms such as VRE. Local epidemiology
should be taken into account. Rationale use of antibiotics, in
accordance with best-practice guidelines, may limit development of
drug resistance; however, other risk factors for resistance may exist in
this group and this would need to be further evaluated.
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Determining late predictors of outcome for acetaminopheninduced acute liver failure using classification and regression tree
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Introduction Liver transplantation (LT) in acetaminophen-induced
acute liver failure (APAP-ALF) patients often presents significant
challenges. The King’s College Criteria (KCC) have been validated on
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admission but not in later phases of illness. The aim was to improve
determinations of prognosis on and after admission in APAPALF patients using the classification and regression tree (CART)
methodology to construct optimal binary splits on independent
variables to predict outcome.
Methods CART models were applied to US ALFSG registry data for
prediction of 21-day spontaneous survival on admission and late stage
(days 3 to 7). Analyses were carried out using R software (package rpart)
for all (n = 803) APAP-ALF patients enrolled between January 1998 and
September 2013 with complete outcome data. Training data were used
to build CART trees and test data were used to evaluate prediction
accuracy (AC), sensitivity (Sn) and specificity (Sp).
Results Of the 803 APAP-ALF patients, the median age was 37 (29 to
47) years and 76% were female. A total of 238 (30%) patients were listed
for and 87 (11%) received LT. A total of 531 (66%) patients recovered
without LT at 21 days. Using standard logistic regression methods for
all patients with complete data (n = 679), KCC (INR, creatinine, coma
grade 3/4, pH) yielded an AC of 69% (Sn 90%, Sp 27%) at admission.
For late-stage data (n = 341), KCC provided similar AC (70%) and Sn
(97%), but suffered poor Sp (15%). CART analysis using the KCC
variables on admission offered predictive AC (66%) and Sn (65%), with
increased Sp (67%). Using day 3 to 7 data, the KCC-CART model had
increased AC (82%) and Sn (86%), with improved Sp (46%) compared
with logistic KCC. New CART models were developed with 18 variables
based on previous literature. A new CART model on admission (MELD,
lactate and MV: test AC 72%, Sn 71%, Sp 77%) performed better than
KCC-CART. For days 3 to 7, a CART model (MELD, lactate, coma grade)
offered superior prediction (test AC 86%, Sn 91%, Sp 46%) compared
with days 3 to 7 KCC-CART.
Conclusion CART analysis increased predictive performance compared
with traditional KCC. KCC-CART trees have higher Sp and similar
predictive AC compared with traditional KCC, with newer CART trees
providing marginal improvement over KCC-CART models.
Acknowledgment Supported in part by a U-01 58369-014 from NIDDK
to the US Acute Liver Failure Study Group.
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Introduction Cerebral edema is a severe and life-threatening
complication in acute liver failure (ALF). Concerns exist that therapeutic
hypothermia (TH) may increase the risk of infection, worsen
coagulopathy and inhibit hepatic regeneration. We therefore reviewed
the experience in use of TH in participating US Acute Liver Failure Study
Group (ALFSG) centers. The aims were to determine utilization of TH
in ALF patients at high risk for cerebral edema (grade III or IV hepatic
encephalopathy (HE)) and to determine its effect on survival and
complication rates.
Methods A retrospective cohort study of all ALF patients enrolled in
the US ALFSG registry between January 1998 and September 2013 with
grade III or IV HE. TH using an external cooling device was used in 97
(8%) patients while in 1,135 (92%) patients it was not (controls).
Results TH ALF patients were younger (36 vs. 40, P = 0.03) and had
acetaminophen etiology (63 vs. 47%, P = 0.04). Admission MELD (32
vs. 34) and lactate (5.4 vs. 5.0 mmol/l, P >0.2 for all) were similar. More
TH ALF patients received renal replacement therapy (63 vs. 40%),
vasopressors (61 vs. 43%) and ICP monitoring (40 vs. 22%, P <0.0002 for
all). Overall (38% vs. 40%, P = 0.7) and 21-day transplant survival (45 vs.
49%, P = 0.5) were similar. There were no differences in bleeding (12%
vs. 12%) or bloodstream infections (17 vs. 18%, P >0.7 for both). More
TH ALF patients had arrhythmias (38 vs. 27%, P = 0.03). There were no
differences in listing (43 vs. 40%, P = 0.5) or receipt of transplant (18
vs. 25%, P = 0.1). After controlling for MELD, requirement for organ
support on multivariable analysis, hypothermia was not independently
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associated with 21-day spontaneous survival (P = 0.93) while MELD
(P <0.0001) and vasopressors (P <0.02) were.
Conclusion TH was not associated with increased bleeding/infection
rates nor differences in survival in ALF patients with high-grade HE. ICP
monitoring was not universally used in TH ALF patients (~40%). There is
a need for a prospective trial to clarify the use of TH in patients with ALF.
Acknowledgement Supported in part by a U-01 58369-014 from
NIDDK to the US ALFSG.
P201
Postoperative resource utilization and survival among liver
transplant recipients with Model for End-stage Liver Disease score
≥40: a retrospective cohort study
F Sousa Cardoso, C Karvellas, N Kneteman, G Meeberg, P Fidalgo,
S Bagshaw
University of Alberta, Edmonton, Canada
Critical Care 2014, 18(Suppl 1):P201 (doi: 10.1186/cc13391)
Introduction Cirrhotic patients with Model for End-stage Liver Disease
(MELD) score ≥40 have high risk of death without liver transplant
(LT) [1]. This study aimed to evaluate these patients’ outcomes after
transplant.
Methods The retrospective cohort included 519 adult cirrhotic patients
who underwent LT at one Canadian center between 2002 and 2012.
Primary exposure was severity of end-stage liver disease measured by
MELD score at transplant (≥40 vs. <40) [2]. The primary outcome was
duration of first ICU stay after LT [3]. Secondary outcomes were duration
of first hospital stay after LT, rate of ICU readmission, re-transplant rate,
and survival rates.
Results On the day of LT, 5% (28/519) of patients had a MELD score ≥40.
These patients had longer first ICU stay after LT (14 vs. 2 days; P <0.001).
MELD score ≥40 at transplant was independently associated with first
ICU stay after transplant ≥10 days (OR, 3.21). These patients had longer
first hospital stay after LT (45 vs. 18 days; P <0.001); however, there was
no significant difference in the rate of ICU readmission (18% vs. 22%;
P = 0.58) or re-transplant rate (4% vs. 4%; P = 1.00). Cumulative survival
at 1 month, 3 months, 1 year, 3 years, and 5 years was 98%, 96%,
90%, 79%, and 72%, respectively. There was no significant difference
in cumulative survival stratified by MELD score ≥40 versus <40 at
transplant (P = 0.59).
Conclusion Cirrhotic patients with MELD score ≥40 at transplant utilize
greater postoperative health resources; however, they derive similar
long-term survival benefit with LT.
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E Mouloudi, C Dimitriadis, G Imbrios, N Gritsi-Gerogianni
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Critical Care 2014, 18(Suppl 1):P202 (doi: 10.1186/cc13392)
Introduction Patients with liver transplantation suffer a major
risk of infections immediately after the surgery due to heavy
immunosuppression, severe stress and underlying pathology. The aim
of this study is to find their causes and consequences in our ICU.
Methods We studied 72 cirrhotic patients who were transplanted
in our hospital during the years 2011 and 2012. The cases that
developed intrahospital infection, its source and microbiology, the
surgical complications, the function of the transplant, the duration of
mechanical ventilation and their outcome were fully examined.
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Results Twenty patients (27.1%) developed 33 episodes of infection.
Among them 35% suffered from liver dysfunction, 40% took large
doses of immunosuppression and 50% were re-operated. Five out
of them showed signs of infection promptly after transplantation.
Medium duration of mechanical ventilation was 16.5 ± 12.75 days (vs.
3.24 ± 5.5 of those without an infection) and medium length of stay was
22.14 ± 18.35 days (vs. 6.79 ± 8.86). The medium APACHE II score was
17.8 ± 5.5 (vs. 16.4 ± 4.37, P = 0.256) and medium SOFA was 11.32 ± 2.62
(vs. 9.9 ± 2.62, P = 0.054). The majority of patients was transfused with
many blood units, FFP and cryoprecipitates and was hemodynamically
unstable (56.3%). MELD score and MELD-Na were higher (22.57 and
27.5 relatively vs. 19.02 and 22.5). Eight cases had VAP from Gramnegative bacteria, 15 had bacteraemia (mainly Gram-negative, but
also fungaemia), 10 had intraabdominal infection (most of them
with two or three re-operations) and urine infection. The majority of
pathogens were multidrug resistant. Regarding Klebsiella pneumoniae
Carbapenemase, 60% was sensitive to colimycine, 20% to tobramycin,
70% to gentamycin and 40% to tygecycline. In four cases the donors
had an infection that was transmitted to the recipient as much as 75%.
Fourteen patients died (10 in ICU and four in the transplantation clinic)
soon after with multiorgan failure.
Conclusion Patients after liver transplantation with organ dysfunction
and multiple transfusions, due to surgical complications, have a major
risk of developing an infection inside the ICU that affects their survival.
P203
Extracorporeal membrane oxygenation before and after adult liver
transplantation: worth the effort?
G Auzinger, C Willars, R Loveridge, A Vercueil, T Best, J Wendon
King’s College Hospital London, UK
Critical Care 2014, 18(Suppl 1):P203 (doi: 10.1186/cc13393)
Introduction Extracorporeal membrane oxygenation (ECMO) is
increasingly used for the treatment of refractory but potentially
reversible respiratory and/or cardiac failure. Data on perioperative
support with veno-arterial (V-A) and veno-venous (V-V) ECMO for adult
liver transplant recipients are scarce [1,2]. We report our experience of
ECMO support in patients with acute liver failure (ALF) as a bridge to
transplant and postoperative ECMO use following complications after
surgery.
Methods A retrospective study in a specialist tertiary referral ICU.
Patients supported with V-V or V-A ECMO before, during, or after
orthotopic liver transplant (OLT) were identified.
Results In total, four patients were supported during a 12-month
period. Two patients required V-V and two patients V-A support. Two
patients with ALF were bridged to OLT, one patient V-V ECMO for
refractory respiratory failure and the other patient required emergency
V-A support for treatment of intraoperative arrest. Both patients
were successfully transplanted but died subsequently on ECMO:
disseminated aspergillosis and haemophagocytic syndrome, and
anoxic brain injury respectively. Two patients received postoperative
ECMO support. The first was treated with V-V ECMO for refractory
persistent hypoxaemia following OLT for hepato-pulmonary syndrome,
the second received emergency V-A support (eCPR) following cardiac
tamponade and arrest on postoperative day 2. Both patients made a
full recovery.
Conclusion Emergency ECMO support before and after liver transplant
is feasible. Despite the poor outcome in patients with ALF, we consider
ECMO a valuable option to bridge selected patients to transplant.
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Is cirrhotic cardiomyopathy a risk factor for post-reperfusion
syndrome during liver transplantation?
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Introduction A period of hemodynamic instability following
revascularization of the liver graft during liver transplantation is
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frequently observed and is termed post-reperfusion syndrome. Recent
studies showed the existence of a specific heart disease associated
with cirrhosis termed cirrhotic cardiomyopathy (CCM). The aim of this
study was to investigate whether the CCM has an influence on the
development or the severity of post-reperfusion syndrome.
Methods Fifty-two consecutive liver transplant patients were included
in a retrospective observational study. The variables recorded were:
age, etiology of the liver disease, MELD and MELD Na scores, the
associated pathologies, the length of the QT interval, and plasma
levels of brain natriuretic peptide (BNP). The patients with known renal
or heart disease and the recipients of organs from extended criteria
donors were excluded from the study. The QT interval was corrected
for the heart rate using Bazett’s formula (QTc). Statistical analysis was
performed using SPSS Statistics v.19.1.
Results In our study the criteria used to define post-reperfusion
syndrome relied on the hemodynamic changes that occurred at
reperfusion. Preoperative echocardiography showed normal systolic
and diastolic function at rest in all of the patients. For the identification
of patients at risk for CCM we used two of the supportive criteria from
the recent definition of CCM: prolonged QTc interval and increased
BNP levels. The study group included 28 men (53.8%) and 24 women.
Mean (± SD) age was 50.5 (± 11.4). Mean MELD and MELD Na scores
were respectively 15.51 (± 5.43) and 18.9(± 6.22). The value of BNP
correlated well with the length of the QTc interval (P = 0.005), and
with MELD and MELD Na scores (P = 0.025 and P = 0.001). In our study,
post-reperfusion syndrome occurred in 63.4% of the patients. We
could not find a correlation between post-reperfusion syndrome and
the BNP levels (P = 0.85) or the prolonged QTc interval (P = 0.38). The
post-reperfusion syndrome did not correlate with the severity of the
liver disease as assessed by MELD and MELD Na scores. The severity of
post-reperfusion syndrome did not correlate with QTc prolongation or
BNP levels.
Conclusion Reperfusion is a critical time during liver transplantation.
The clinical predictors of post-reperfusion syndrome are still under
debate [1]. Our study showed that the post-reperfusion syndrome is
not correlated with the severity of the liver disease or with the presence
of risk factors indicating CCM.
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Perioperative management of patients undergoing combined
heart–liver transplantation
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Introduction Combined heart–liver transplantation (CHLT) is an
uncommonly performed procedure for patients with coexisting cardiac
and liver disease [1]. The purpose of this study was to examine and
describe the perioperative management of patients undergoing CHLT.
Methods A retrospective review was performed of patients undergoing
CHLT at our institution from 1999 to 2013.
Results Twenty-seven CHLTs were performed, with 4/27 including
simultaneous kidney transplantation. Familial amyloidosis was
the indication for 21 CHLTs (78%), and 12 of these explanted livers
were used for domino transplantations. Nineteen patients (70%)
were receiving inotropic infusions at the time of organ availability.
The median preoperative MELD score was 12, and elevations in
preoperative international normalized ratio were due to warfarin in all
but one patient. Liver transplantation immediately preceded cardiac
transplantation in 2/27 cases to reduce high-titer donor-specific
antibodies. Venovenous bypass was utilized in 14 operations (52%)
performed with the caval interposition liver transplantation approach,
cardiopulmonary bypass during liver transplantation in two cases (7%),
and no bypass in 11 operations (41%) performed with a caval sparing
(piggyback) surgical technique. Postoperatively, the median duration
of mechanical ventilation, ICU stay, and hospital stay until discharge
were 1 day, 5.5 days, and 15 days, respectively. Transfusions in the
first 48 hours following CHLT were not substantial in the majority of
patients. One patient died within 30 days of CHLT.
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Conclusion CHLT is a life-saving operation that is performed with
relatively low mortality and can be successfully performed in select
patients with congenital heart disease. Patients undergoing CHLT at our
institution had relatively preserved hepatic function but limited cardiac
function often requiring inotropic support. Cardiac transplantation
typically precedes liver transplantation during CHLT given the
decreased ischemic tolerance of the cardiac graft [2]. However, liver
transplantation prior to cardiac transplantation may serve to mitigate
high-titer donor-specific antibodies. Various aforementioned operative
approaches may be successfully utilized for the liver transplantation
portion of these procedures. We attribute the favorable outcomes and
perioperative courses to the multidisciplinary approach to care that
CHLT patients receive at our institution.
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Impaired balance between coagulation and fibrinolysis plays a
prominent role in patients with sepsis
Y Umemura1, K Yamakawa2, T Kiguchi1, H Ogura2, T Shimazu2, S Fujimi1
1
Osaka General Medical Center, Osaka, Japan; 2 Osaka University Graduate
School of Medicine, Osaka, Japan
Critical Care 2014, 18(Suppl 1):P206 (doi: 10.1186/cc13396)
Introduction The balance between coagulation and fibrinolysis was a
prominent factor in the pathophysiology of sepsis, but this mechanism
has been poorly understood. We aimed to determine whether
collapsing this balance during the first day of sepsis correlates with
progression of organ dysfunction and subsequent death.
Methods This study included all patients with sepsis admitted to
a tertiary referral hospital in Japan. Global coagulation tests and
hemostatic molecular markers such as fibrin/fibrinogen degradation
products (FDP), D-dimer, thrombin–antithrombin complex (TAT) and
plasmin-alpha 2 plasmin inhibitor complex (PIC) were measured within
12 hours after admission, and then SOFA and APACHE II scores and
in-hospital mortality were evaluated. Patients were divided into three
groups based on the levels of TAT/PIC and FDP/D-dimer and differences
of clinical outcome between groups were assessed by chi-square
analysis and ANOVA.
Results We enrolled 101 patients; 87 patients survived, and 14 died.
Mortality was significantly higher in the high TAT/PIC group (0%,
19% and 24% for low, middle and high TAT/PIC groups, respectively;
P = 0.011). In addition, SOFA and APACHE II scores were significantly
higher in the low FDP/D-dimer group (APACHE II = 22.3, 18.9 and 15.3;
P <0.01, SOFA = 8.6, 6.5 and 5.1; P <0.01, for low, middle and high FDP/
D-dimer groups, respectively). See Figure 1.
Conclusion We demonstrated that the balance between coagulation
and fibrinolysis, assessed with FDP/D-dimer and TAT/PIC ratios, was
correlated with disease severity and clinical outcomes in sepsis,
suggesting that impaired balance of the hemostatic system might play
a pivotal role in progression of sepsis pathophysiology.

Figure 1 (abstract P206). Comparison of the characteristics between the
three groups.
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Clinical usefulness of measurement of plasma soluble fibrin levels in
critically ill patients
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Introduction The soluble fibrin monomer fibrinogen complex (SF)
is a complex coupling fibrin monomer and fibrinogen molecules. As
the level of SF reflects the thrombin generation activity in plasma, we
may estimate the early-activated state of blood coagulation by the
measurement of SF. The aim of this study is to evaluate the clinical
usefulness of SF for the hypercoagulated state.
Methods We measured the plasma level of SF in 63 patients within
48 hours after admission and on the 1st, 3rd, 5th and 7th days after
admission. Underlying disease mainly includes sepsis, shock, and so
on. According to the disseminated intravascular coagulation diagnostic
criteria established by the Japanese Association of Acute Medicine, we
defined the DIC group as JAAM-DIC score more than 3 within 48 hours
after admission, the Subclinical DIC group as score more than 3 within
7 days beyond 48 hours after admission, and the No DIC group as score
less than 4 during the entire study period. The SF value of each group
was compared with the Mann–Whitney U test.
Results The SF values in the DIC and the Subclinical DIC groups were
significantly higher than in the No DIC group. We created the receiver
operating characteristic curve of SF value for DIC onset (JAAM-DIC score
≥4) and the SF value of 35 μg/ml was set as the cutoff SF value. The high

Figure 1 (abstract P207). SF values of the DIC, Subclinical DIC and No
DIC groups.
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SF group (SF ≥35 μg/ml) had significantly higher JAAM-DIC score, SOFA
score and APACHE II score than the low SF group (SF <35 μg/ml). Mainly
in the high SF group except DIC patients on admission, we found that
SF increased before the JAAM-DIC score changed. See Figures 1 and 2.
Conclusion We think measurement of the plasma SF level may be
clinically useful in evaluating the severity of critically ill patients such
as those with sepsis.
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Value of microbial metabolites in blood serum as criteria for
bacterial load in the pathogenesis of hemodynamic disorders in
critically ill patients
Y Sarshor, N Beloborodova, V Moroz, A Osipov, A Bedova, E Chernevskaya,
M Getsina
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Critical Care 2014, 18(Suppl 1):P208 (doi: 10.1186/cc13398)
Introduction Hemodynamic disorders in critically ill patients are often
connected with bacterial load. Bacterial load is usually associated with
bacteremia, LPS, high level of IL-6, PCT and also with aromatic microbial
metabolites [1-3], and so forth. In our opinion, microbial metabolites can
participate in hemodynamic disorders in critically ill patients, particularly
due to their influence on NO production [4] and intestinal permeability.
Methods In a prospective study we observed critically ill patients on
the day of admission to a polyvalent ICU, severe cardiac pathology
was excluded. The level of phenylpropionic, phenyllactic, p-OHphenyllactic, p-OH-phenylacetic acids and total phenylcarboxylic acids
(PhCAs) were measured in blood serum using gas chromatography
(GC-FID). The level of PCT and NT-proBNP were measured using Elecsys
2010. Comparison between patients with hypotension (on vasopressor
support) (group A) and without (group B) was performed.
Results We studied 50 ICU patients with different diseases: pneumonia
(n = 15), severe kidney failure (n = 13), abdominal surgical pathology
(n = 10), alcoholic cirrhosis (n = 5), soft-tissue infection (n = 7). In
group A (24/50) the median of PhCAs was 17.8 (IR 11.4 to 30.0) μmol/l,
and in group B (26/50) it was 7.2 (IR 3.7 to 13.2) μmol/l, P = 0.003 (t test).
In group A, all patients (with or without documented infections) had
symptoms of infection manifestation [5], 20/24 (83.3%) of them died.
In group B, the symptoms of infection manifestation were revealed
in 12/26 (46%) cases, and the mortality was significantly lower, 3/26
(11.5%) (P <0.05). General mortality was 23/50 (46%). The profile of
PhCAs differed in groups A versus B.
Conclusion The total level of PhCAs in critically ill patients with
hypotension was considerably higher than in hemodynamically stable
patients. The participation of microbial factor in pathogenesis of
hemodynamic disorders in the presence of systemic inflammation may
be validated with the load of microbial metabolites (PhCAs).
Acknowledgement This work was supported by the Russian
Foundation for Basic Research (project number 13-04-01758/13).
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P209
Fibrinogen at admission is an independent predictor of mortality in
severe sepsis and septic shock
M Azfar, M Khan, M Khurshid
King Saud University, Riyadh, Saudi Arabia
Critical Care 2014, 18(Suppl 1):P209 (doi: 10.1186/cc13399)

Figure 2 (abstract P207). ROC curve of the SF value for DIC.

Introduction Coagulation abnormalities are common in severe sepsis
or septic shock [1].
Methods A prospective observational cohort study of 100 patients
above 18 years of age diagnosed with severe sepsis or septic shock
on admission. The first blood sample collected on admission was
analyzed. Data were collected through a predesigned pro forma. Those
with previous history of any coagulation disorders were excluded.
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Results Univariate analysis showed significant correlation of APACHE
II, platelet, PT, aPTT, fibrinogen and D-dimer with mortality in patients
with severe sepsis or septic shock. Multivariate analysis showed APACHE
II >20 (P = 0.001), fibrinogen <2 (P = 0.019) and D-dimer >1(P = 0.06) are
independent predictors of mortality in severe sepsis or septic shock.
See Table 1.

in-hospital mortality. The AUCs were calculated as 0.768 ± 0.073 for the
mean PDMP/PLT ratio (P = 0.00) and 0.811 ± 0.048 for the APACHE II
score (P = 0.00).
Conclusion The PDMP/PLT ratio is a good predictor of in-hospital
mortality in critically ill patients, especially in patients with DIC.
Reference
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Table 1 (abstract P209).
Variable

Died
(n = 65)

Survived
(n = 35)

ARR

95% CI
of ARR

Platelet <150

33 (50.8)

10 (28.6)

1.37

0.03, 1.84

0.03

PT >16

41 (63.1)

14 (40)

1.40

1.02, 1.91

0.027

P value

aPTT >40

41 (63.1)

14 (40)

1.40

1.02, 1.91

0.027

Fibrinogen <2

40 (61.5)

15 (42.9)

1.31

0.96, 1.70

0.07

D-dimer >1

64 (98.5)

31 (88.6)

3.37

0.48, 19.5

0.03

APACHE II >20

53 (81.5)

18 (51.4)

1.80

1.15, 2.84

0.002

Age >65

27 (41.5)

8 (22.9)

1.60

1.04, 2.46

0.02

Conclusion The fibrinogen level at admission is an independent
predictor of mortality in patients with sepsis or septic shock. It also
confirms correlation of other coagulation abnormalities with the
outcome.
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P210
Plasma platelet-derived microparticles to platelet count ratio as a
marker of mortality in critically ill patients
M Ohuchi, K Hashimoto, A Ushiba, T Kishimoto, T Yamane, T Hamamoto,
T Tabata, Y Tsujita, M Matsushiga, K Takahashi, K Matsumura, K Fujino,
Y Eguchi
Shiga University of Medical Science, Otsu-shi, Japan
Critical Care 2014, 18(Suppl 1):P210 (doi: 10.1186/cc13400)
Introduction While the crosstalk between coagulopathy and
inflammation plays a key role in the development of multiple organ
dysfunction in critically ill patients, the mechanisms governing this
crosstalk have yet to be established. Microparticles (MPs) are submicron
vesicles shed from a variety of cells that are considered to have
proinflammatory and prothrombotic properties. Although plateletderived MPs (PDMPs) are the main form of MPs, the role of PDMPs in
critically ill patients remains unclear [1]. The aims of this study were
to investigate serum PDMP levels in critically ill patients and to assess
their prognostic value.
Methods This study comprised 119 critically ill patients who were
admitted to the ICU. PDMPs were measured by ELISA three times a
week, and 372 samples were obtained. We calculated both the mean
PDMP value and the mean PDMP/platelet (PDMP/PLT) ratio (converted
to plasma PDMP levels per 104 platelets) during the course of the ICU
stay. Baseline patient data, including APACHE II score, SOFA score,
Japanese Association for Acute Medicine DIC score, International
Society for Thrombosis and Haemostasis overt DIC score, blood
coagulation parameters, C-reactive protein and lactate, were collected
at the time of admission to the ICU. The primary outcome was inhospital mortality. Potential predictors were analyzed for possible
association with outcomes.
Results The mean PDMP/PLT ratio was significantly different when
comparing hospital survivors (n = 98; median, 1.95) and nonsurvivors
(n = 21; median 8.40; P = 0.00). The mean PDMP/PLT ratio was
significantly higher in patients with (median, 4.28) than in those
without DIC (median, 1.57; P = 0.00). In DIC patients, the mean PDMP/
PLT ratio was significantly higher in nonsurvivors (median, 9.39) than
in survivors (median, 3.65; P = 0.02). Multivariate logistic regression
analysis revealed that both the mean PDMP/PLT ratio (P = 0.04)
and APACHE II score (P = 0.00) were independently associated with

P211
Receptor for advanced glycation end products axis in critically ill
patients
C Ingels, I Derese, PJ Wouters, G Van den Berghe, I Vanhorebeek
KU Leuven, Belgium
Critical Care 2014, 18(Suppl 1):P211 (doi: 10.1186/cc13401)
Introduction Systemic inflammation caused by infection or trauma
often leads to adverse outcome in critically ill patients. Binding of ligands
to the receptor for advanced glycation end products (RAGE) activates
several pathways, including the nuclear factor-kappa B pathway, which
generates inflammatory cytokines, proteases and oxidative stress. RAGE
activation has been suggested to link amplification and perpetuation
of inflammation to subsequent organ damage and adverse outcome
in sepsis, acute lung injury and myocardial dysfunction [1]. The soluble
receptor, sRAGE, is thought to act as a decoy, thus protecting against
further RAGE activation. High mobility group box 1 (HMGB1) is a nuclear
protein that is released during cellular stress and damage. S100A12 is
a neutrophil-derived protein that acts as a proinflammatory danger
signal. Both are ligands for RAGE. We hypothesized that excessive RAGE
activation is linked to adverse outcome in critically ill patients and
that a different pattern of RAGE activation and inflammation may be
present in patients according to underlying pathology.
Methods We measured sRAGE, HMGB1 and S100A12 serum levels
upon admission, day 7 and the last day in the ICU in 405 critically ill
surgical patients who needed intensive care for at least 7 days and
in 69 matched healthy controls. We assessed the relation of these
levels with clinical complications and outcome, in comparison with
C-reactive protein (CRP) as a routinely measured clinical parameter of
inflammation.
Results Upon ICU admission, levels of sRAGE, HMGB1, S100A12 and
CRP were higher as compared with healthy levels. HMGB1, S100A12
and CRP remained elevated throughout the ICU stay but sRAGE
decreased to levels lower than in healthy volunteers by day 7. sRAGE
and CRP showed distinct time profiles during the ICU stay in patients
undergoing cardiac versus other surgery and in patients with versus
without sepsis upon admission. Elevated sRAGE upon admission,
unlike CRP, was associated with need for renal replacement therapy,
liver dysfunction, circulatory failure and mortality. Except for mortality,
these associations remained in multivariate logistic regression analysis
correcting for baseline risk factors.
Conclusion Critical illness alters several components of the RAGE axis.
Elevated sRAGE levels upon admission to the ICU were associated with
adverse outcome, independent of baseline pathology.
Reference
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P212
Usefulness of the endotoxin activity assay as a biomarker to assess
severity in ICU patients
M Noguchi, T Ikeda, K Ikeda, S Suda, A Kodaira, T Ueno, A Ohmi
Tokyo Medical University, Tokyo, Japan
Critical Care 2014, 18(Suppl 1):P212 (doi: 10.1186/cc13402)
Introduction Endotoxin is a component of the membrane of Gramnegative bacteria and plays a key role in the pathogenesis of sepsis
[1]. Measurement of endotoxin levels in patient blood is important
for the early diagnosis of and appropriate determination of the
treatment strategy for sepsis. The aim of this study was to investigate
the prevalence of endotoxemia in Japanese critically ill patients using
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the endotoxin activity assay (EAA), a newly developed rapid assay of
endotoxin. Blood endotoxin levels (EA levels) of 314 patients admitted
to our university hospital ICU were measured within 24 hours from
admission, and their correlation with disease severity and outcome
was examined.
Methods The study is a single-center retrospective analysis of critically
ill patients admitted to our university hospital ICU from November
2006 to March 2012. All patients whose EA and procalcitonin levels
were measured and severity criteria of disease recorded were enrolled.
A total of 314 patients were analyzed.
Results The mean ± SD of all ICU-admitted patients (n = 314) was
0.39 ± 0.25, and that of healthy volunteers (n = 61) was 0.10 ± 0.09. The
mean APACHE II score at admission increased in parallel with increased
EA levels. The mean (± SD) APACHE II score in the very low group of
patients (EA <0.2) was 17.3 ± 8.9, while that in the low group (0.2 ≤EA
<0.4) was 20.6 ± 9.2; it was 22.6 ± 8.1 in the intermediate group (0.4
≤EA <0.6) and 25.3 ± 8.5 in the high group (0.6 ≤EA). The difference
between the groups was statistically significant. The difference
between the groups was statistically significant. The percentages of
patients diagnosed with severe sepsis or septic shock were 19.3%,
34.5%, 50.0% and 81.3% in the very low, low, intermediate and high
groups, respectively.
Conclusion Our patients’ EA levels were significantly correlated with
disease severity criteria and 28-day mortality of the patients. When
the EA level and procalcitonin level were used concomitantly, disease
severity could be assessed more precisely than when either marker was
used alone. These results suggest that the EA level is a useful marker
for disease severity assessment and outcome prediction in critically ill
patients.
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Usefulness of presepsin and procalcitonin levels in the diagnosis of
sepsis in patients with acute kidney injury
Y Nakamura, H Ishikura, R Ichiki, K Hoshino, M Mizunuma, J Tanaka,
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Fukuoka University, Fukuoka, Japan
Critical Care 2014, 18(Suppl 1):P213 (doi: 10.1186/cc13403)
Introduction The presepsin (PSEP) and procalcitonin (PCT) levels
are useful biomarkers for differentiating between sepsis and noninfectious systemic inflammatory response syndrome (SIRS). The PSEP
and PCT levels have been reported to be abnormally high in patients
with chronic renal failure. However, there have been no significant
investigations regarding the relationships between these biomarkers
and the presence of acute kidney injury (AKI) in the diagnosis of sepsis.
The purpose of this study was to clarify the diagnostic accuracy of PSEP
and PCT levels in patients with AKI.
Methods This study was conducted as a single-center retrospective
study. Blood samples were collected from patients immediately after
admission to the Department of Emergency and Critical Care Medicine,
Fukuoka University Hospital between June 2010 and August 2013.
We enrolled 629 patients in whom both the PSEP and PCT levels were
measured on admission. We classified the patients into two groups
according to the RIFLE criteria (Risk, Injury, Failure, Loss of kidney
function and End-stage kidney disease: Loss and ESKD): the AKI group
and the non-AKI group. The patients in the AKI group were further
classified into the sepsis group and the nonsepsis group according
to each stage of AKI. We subsequently investigated the diagnostic
accuracy of the PSEP and PCT levels for detecting sepsis in these groups.
Results We evaluated 254 patients with AKI and 375 patients without
AKI. The AKI group included 103 patients who met the Risk criteria,
65 who met the Injury criteria, 66 who met the Failure criteria and 18
who met the Loss and ESKD criteria. The mean PSEP and PCT levels
were significantly higher in the sepsis group than in the nonsepsis
group among the non-AKI patients and those meeting the Risk, Injury
and Failure criteria (P <0.01). The diagnostic accuracy of the PSEP and
PCT levels for detecting sepsis was determined according to a ROC
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analysis; the area under the curve (AUC) for the PSEP and PCT levels
was 0.883 and 0.870, respectively, in the non-AKI group. In addition,
the AUC values for the PSEP and PCT levels in the Risk, Injury and
Failure groups were 0.843 and 0.843, 0.818 and 0.922 and 0.669 and
0.804, respectively. In the Failure group, the AUC for the PSEP and
PCT levels was 0.828 and 0.852, respectively, after dividing the PSEP
and PCT levels by the creatinine (Cr) level. The optimal cutoff values
for the PSEP and PCT levels for diagnosing sepsis were 409 pg/ml/Cr
(sensitivity: 66.0%, specificity: 91.7%) and 1.5 ng/ml/Cr (sensitivity:
63.6%, specificity: 95.8%), respectively.
Conclusion The diagnostic accuracy of PSEP and PCT levels for
detecting sepsis decreased in the Failure group; however, the value of
these parameters for diagnosing sepsis in patients meeting the Failure
criteria increased after dividing them by the Cr level.
P214
Differentiating sepsis from non-infective systemic inflammatory
response syndrome: comparison between C-reactive protein and
leptin
N Farag1, K Taema2, E Abdel-Latif2, G Hamed2
1
Alsahel Teaching Hospital, Cairo, Egypt; 2Cairo University, Cairo, Egypt
Critical Care 2014, 18(Suppl 1):P214 (doi: 10.1186/cc13404)
Introduction Differentiation of sepsis from non-infectious SIRS is
important in improving sepsis outcome. We intended in this study
to evaluate the role of serum leptin and to compare it with CRP in
differentiating sepsis from non-infectious SIRS.
Methods We included 30 patients with SIRS. According to the presence
or absence of infection, our patients were classified into the SIRS group
and the sepsis group. Leptin and CRP were evaluated in all patients on
admission, day 2 and day 4.
Results Our patients had mean age of 52.3 ± 18.6 years, 10 males
(33.3%). There were no significant differences regarding baseline
demographic and clinical data apart from blood pressures, which were
lower in sepsis group. Serum leptin on day 2 only was higher in the
sepsis group (44.2 ± 17.7 μg/l vs. 31.1 ± 2.1 μg/l, P = 0.008) with no
difference on days 0 and 4 of admission. We detected a serum leptin
level of 38.05 μg/l on day 2 to be 93% sensitive and 100% specific to
diagnose sepsis. The three serum CRP levels were higher in the sepsis
group compared with the SIRS group (61.2 ± 9 mg/l vs. 48.9 ± 7.1 mg/l,
P <0.001 on day 0, 71.5 ± 9.6 mg/l and 196.8 ± 39.8 mg/l in the sepsis
group vs. 56.9 ± 8 mg/l and 73.7 ± 32.5 mg/l in the SIRS group for days 2
and 4 respectively, P <0.001 for both). We found a CRP of 67.5 mg/l on
day 2 having 87% sensitivity and 93% specificity for the diagnosis of
sepsis.
Conclusion We concluded that although serum leptin may not be
beneficial in early differentiation between sepsis and non-infectious
SIRS on admission, it may be highly specific on the second day.
P215
Use of procalcitonin and white blood cells as combined predictors
of infection in cardiac surgery patients
E Gomez1, M Heredia1, P Jorge1, M Lorenzo2, J Gomez-Herreras1,
E Tamayo1, S Gutierrez1, E Alvarez1
1
Hospital Clínico Universitario de Valladolid, Spain; 2Hospital Río Hortega,
Valladolid, Spain
Critical Care 2014, 18(Suppl 1):P215 (doi: 10.1186/cc13405)
Introduction The aim of this study is to identify a marker able to
predict sepsis in cardiac surgery patients and to differentiate SIRS from
infectious and non-infectious origin. The occurrence of sepsis after
cardiac surgery increases the mortality risk. Sepsis may be mistaken
for the cardiac surgery-associated systemic inflammatory response
syndrome (SIRS) [1].
Methods A prospective, observational study was carried out to
compare procalcitonin (PCT), C-reactive protein (CRP) and white
blood cells (WBCs) during the first 10 postoperative days after cardiac
surgery with cardiopulmonary bypass (CPB) between 122 patients with
infection (Infection group) and 301 without (Control group) to identify
predictors of infection.
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Results The WBC and PCT median values were significantly (P <0.05)
higher in infected than control patients, during 10 postoperative days
and on the third and fourth postoperative day, respectively, both
variables showing a peak at 3 days in infected patients. The number
of times that the WBC count surpassed its second postoperative
median value (13,000 cells/mm3) during the first 3 postoperative
days plus the number of times that PCT surpassed its own (1.7 ng/
ml) was a parameter (ranging from 1 to 6) with three categories (R1=
surpassed zero to one time; R2 = two to three times; R3 = four to six
times) significantly associated with risk of infection, which increased
with increasing number of times (R2: OR = 2.48 (1.32 to 4.65) and R3:
OR = 7.06 (3.17 to 15.71)).
Conclusion Daily assessment of WBC and PCT during the first 3
postoperative days may be of value to diagnose and predict infection
in cardiac surgery patients.
Reference
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Single pro-adrenomedullin determination in septic shock and
28-day mortality
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C Trujillano-Fernandez2, A Puerto-Morlan2, E Camara Sola2,
A Garcia-Alcantara2
1
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Critical Care 2014, 18(Suppl 1):P216 (doi: 10.1186/cc13406)
Introduction The early phase of septic shock is dominated by severe
alterations of the cardiovascular system. The prognostic value of proadrenomedullin (pADM), a vasoactive pro-hormone, measured within
24 hours from septic shock onset was assessed.
Methods A prospective, observational study in 100 patients >18 years with
septic shock in a polyvalent ICU of a university hospital. Demographic,
clinical parameters and pADM, C-reactive protein (CRP) and procalcitonin
(PCT) were studied during the first 24 hours after admission in 2011.
Descriptive and comparative statistical analysis was performed using the
statistical software packages StatSoft STATISTICA 7.1 and MedCalc 9.2.1.0.
Results We analyzed 100 consecutive episodes of septic shock in the
ICU. The median age of the study sample was 64 years, interquartile
range 16.8 years, 59% were men; the main sources of infection were
respiratory tract (48%) and intra-abdominal (24%). The 28-day mortality
was 36%. The profile of dead patients showed significantly higher
clinical severity scores, APACHE II (27 vs. 25; P <0.001) and SOFA (12 vs.
10; P <0.001). The area under the curve was 0.72 for pADM, significantly
higher than those for CRP (0.62) and PCT (0.65), but similar to those
for APACHE II score (0.69) and SOFA score (0.78). Kaplan–Meier survival
analysis was significant (P = 0.0012) for patients with pADM <1.2 nmol/l.
Cox regression analysis also showed statistical significance (P = 0.0004)
and a likelihood ratio =1.26 per each 1 nmol/l increase in pADM.
Conclusion Pro-adrenomedullin is an important prognostic biomarker
of survival when measured on admission of septic shock patients to
the ICU.
P217
Surfactant protein A: a candidate predictive biomarker of mortality
in acute respiratory distress syndrome in sepsis
V Moroz, A Kuzovlev, A Goloubev
V.A. Negovsky Scientific Research Insitute of General Reanimatology, RAMS,
Moscow, Russia
Critical Care 2014, 18(Suppl 1):P217 (doi: 10.1186/cc13407)
Introduction Prediction of mortality in septic acute respiratory distress
syndrome (ARDS) is a problem of great significance. The aim of this
study was to investigate the role of surfactant protein A (SPA) as a
candidate predictive biomarker of mortality in ARDS.
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Methods The observational study in ICU ventilated septic patients
with peritonitis (65%), pancreonecrosis (20%) and mediastinitis (15%)
was performed in 2010 and 2013. ARDS was diagnosed and staged
according to the V.A. Negovsky Research Institute criteria [1,2] and the
Berlin definition. Plasma SPA was measured on ARDS diagnosis (day
0) and days 3 and 5 by the immunoenzyme essay (BioVendor, USA).
Patients were treated according to the international guidelines. Data
were statistically analyzed by STATISTICA 7.0, ANOVA method, and
presented as median and 25th to 75th percentiles, ng/ml; P <0.05 was
considered statistically significant. Areas under the receiver operating
curves were calculated.
Results Eighty-five patients (out of 300 screened) were enrolled in
the study according to the inclusion/exclusion criteria. Patients were
assigned into groups: ARDS (n = 50, 48 ± 5.7 years old, M/F 35/15,
mortality 26%) and noARDS (n = 35, 46 ± 8.7 years old, M/F 30/5,
mortality 23%). Groups were comparable in APACHE II scores. In the
ARDS group SPA was higher at all points than in the noARDS group
(day 0: 32.6, 25 to 75 IQR 18.2 to 60.7 vs. 23.4, 25 to 75 IQR 17.8 to 28.6;
day 3: 31.5, 25 to 75 IQR 20.9 to 31.5 vs. 24.6, 25 to 75 IQR 19.7 to 24.6;
day 5: 32.5, 25 to 75 IQR 17.3 to 66.4 vs. 22.5, 25 to 75 IQR 13.4 to 29.5,
P <0.05). The plasma SPA was significantly lower in surviving versus
dead patients with ARDS (day 0: 20.9, 25 to 75 IQR 13.0 to 35.7 vs. 45.7,
25 to 75 IQR 23.5 to 67.9; day 3: 25.5, 25 to 75 IQR 11.8 to 35.5 vs. 45.0, 25
to 75 IQR 29.6 to 68.4; day 5: 24.5, 25 to 75 IQR 11.4 to 33.6 vs. 49.6, 25 to
75 IQR 31.3 to 79.0, P <0.05). Plasma SPA on day 0 had a good capacity
for prediction of mortality in ARDS patients: SPA on day 0 ≥38.8 ng/ml
yielded a sensitivity of 65% and specificity of 80% (AUC 0.74; 95% CI
0.577 to 0.866; P = 0.0026).
Conclusion Plasma SPA level ≥38.8 ng/ml on the day of ARDS diagnosis
is a sensitive and specific candidate biomarker of mortality prediction
in ARDS septic patients.
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Club Cell protein: a candidate diagnostic biomarker of Pseudomonas
aeruginosa nosocomial pneumonia
V Moroz1, A Kuzovlev1, S Polovnikov2
1
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Moscow, Russia; 2N.N. Burdenko Main Military Hospital, Moscow, Russia
Critical Care 2014, 18(Suppl 1):P218 (doi: 10.1186/cc13408)
Introduction Early etiological diagnosis of nosocomial pneumonia (NP)
determines prompt targeted treatment. The aim of this study was to
investigate the role of Club Cell protein (CCP) as a candidate diagnostic
biomarker of Pseudomonas aeruginosa (PA) NP.
Methods The observational study in ICU ventilated septic patients with
peritonitis (65%), pancreonecrosis (20%) and mediastinitis (15%) was
performed in 2010 and 2013. Diagnosis of NP was made according
to the standard clinical criteria. Associations of multiresistant Gramnegative bacteria were detected in sputum of all patients. PA was
detected in 75% of patients. Plasma CCP was measured on the day of
NP diagnosis (day 0) and days 3, 5 and 7 by the immunoenzyme essay
(BioVendor, USA). Data were statistically analyzed by STATISTICA 7.0,
ANOVA method, and presented as Me and 25 to 75 percentiles, ng/ml;
P <0.05 was considered significant. Areas under the receiver operating
curves (ROC) were calculated.
Results Ninety patients (out of 350 screened) were enrolled in the study
according to the inclusion/exclusion criteria. Patients were assigned to
groups: NP (n = 50, 45 ± 4.3 years old, M/F 36/14) and noNP (n = 40,
48 ± 7.2 years old, M/F 30/10). Groups were comparable in APACHE
II and CPIS scores. In patients with PA NP (n = 30), plasma CCP was
significantly lower at all points than in the patients with no PA detected
(n = 20; Figure 1). Plasma CCP on day 0 had a good capacity for the
diagnosis of PA NP: CCP on day 0 ≤17.5 ng/ml yielded a sensitivity
of 86.5% and specificity of 66.7% (AUC 0.74; 95% CI 0.630 to 0.829;
P = 0.0001; Figure 2).
Conclusion Plasma CCP level ≤17.5 ng/ml is a sensitive and specific
candidate diagnostic biomarker of PA NP.
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practice, but a definitive diagnostic tool for an early detection of
systemic inflammation remains to be identified. The neurotransmitter
acetylcholine (Ach) has been shown to play an important role in the
inflammatory response. Serum cholinesterase (butyrylcholinesterase
(BChE)) is synthesized in the liver and acts as the major Ach hydrolyzing
enzyme in plasma. Hence, BChE activity has been widely used as a
biomarker for liver function. However, the role of this enzyme in the
inflammatory pathomechanism has not yet been fully understood.
Here, we describe a strong correlation between the BChE activity and
the systemic inflammatory response.
Methods In this study we measured BChE activity in healthy subjects
and in critically ill patients, clinically diagnosed with systemic
inflammation or sepsis. Furthermore, we measured the levels of routine
inflammation biomarkers and liver function parameters in blood of
critically ill patients. Data were statistically analyzed using unpaired
Student t test, Pearson correlation or ANOVA followed by Dunnett’s
post hoc analysis. P <0.05 was considered statistically significant.
Results We found that the activity of BChE in patients with systemic
inflammation was dramatically reduced in comparison with
healthy subjects and negatively correlated with the serum levels of
conventional inflammatory biomarkers. BChE synthesis depends on
hepatic function. Surprisingly, the observed reduction in the BChE
activity during systemic inflammation does not correlate with liver
failure.
Conclusion Our results suggest that BchE activity might play an
important role in the diagnosis of systemic inflammation independent
of overall hepatic function.

Figure 1 (abstract P218). Club Cell protein concentration in patients
with Pseudomonas aeruginosa NP.

P220
Lymphopenia as a predictor of bacteremia in the emergency
department
R Lowsby1, C Gomes1, I Jarman2, P Nee1
1
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2
Liverpool John Moores University, Liverpool, UK
Critical Care 2014, 18(Suppl 1):P220 (doi: 10.1186/cc13410)
Introduction Bloodstream infection (BSI) is associated with a reduction
in circulating lymphocytes. Lymphopenia has been proposed as an
early marker of BSI in pyrexial adults in the emergency department
(ED) setting [1]. The aim of this study was to compare lymphocyte

Figure 2 (abstract P218). ROC curve for Club Cell protein (day 0) for the
diagnosis of Pseudomonas aeruginosa NP.

P219
Plasma cholinesterase activity as diagnostic marker for systemic
inflammation
AR Zivkovic, K Schmidt, T Brenner, S Hofer
Universitätsklinikum Heidelberg, Germany
Critical Care 2014, 18(Suppl 1):P219 (doi: 10.1186/cc13409)
Introduction Systemic inflammation is a generalized response to
internal or external inflammatory stimuli often resulting in multiple
organ failure. Therefore, early diagnosis of systemic inflammation
would be of great therapeutic and prognostic importance. Various
inflammation biomarkers have been used in clinical and experimental

Figure 1 (abstract P220). ROC curve comparing blood test parameters in
predicting bacteremia.
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count with conventional markers in patients presenting to the ED of a
UK hospital with suspected sepsis.
Methods A retrospective review was undertaken of adult patients
presenting to the ED (annual census 90,000) with pyrexial illness over a
12-month period, 2011 to 2012. Data included white cell count (WCC),
neutrophil count (NC), lymphocyte count (LC) and C-reactive protein
(CRP). The results were compared. Sensitivity and specificity were
calculated for each parameter and receiver operating characteristic
(ROC) curves were constructed.
Results A total of 2,515 patient records were screened. Patients on
chemotherapy were excluded, as were those under 18 years old. In
total, 1,954 patients (53% female, median age 66 years) were included
in the analysis. Blood cultures were positive in 13.7% of cases. There
were significant differences between all variables measured, with the
exception of WCC, between bacteremic and nonbacteremic patients. The
area under the curve of 70.8 was best for lymphocyte count (Figure 1).
Conclusion In adult patients presenting to the ED with pyrexial illness,
lymphopenia predicts bacteremia better than the usual markers of
infection.
Reference
1.

deJager et al.: Crit Care 2010, 14:R192.

P221
Pre-analytic factors and initial biomarker levels in communityacquired pneumonia patients
A Kutz, E Grolimund, B Mueller, P Schuetz
Kantonsspital Aarau, Switzerland
Critical Care 2014, 18(Suppl 1):P221 (doi: 10.1186/cc13411)
Introduction Blood biomarkers are increasingly used to diagnose,
guide therapy in, and risk-stratify community-acquired pneumonia
(CAP) patients in emergency departments (EDs). How pre-analytic
factors affect these markers’ initial levels in this population is unknown.
Methods In this secondary analysis of consecutive ED patients
with CAP from a large multicentre antibiotic stewardship trial [1],
we used adjusted multivariate regression models to determine the
magnitude and statistical significance of differences in mean baseline
concentrations of five biomarkers (procalcitonin (PCT), C-reactive
protein (CRP), white blood cell count, proadrenomedullin (ProADM),
copeptin) associated with six pre-analytic factors (antibiotic or
corticosteroid pretreatment, age, gender, chronic renal failure or liver
insufficiency).
Results Of 925 CAP patients (median age 73 years, 58.8% male), 25.5%
had antibiotic pretreatment, 2.4%, corticosteroid pretreatment, 22.3%
chronic renal failure, and 2.4% chronic liver insufficiency. Differences
associated with pre-analytic factors averaged 6.1 ± 4.6%; the three
largest statistically significant changes (95% CI) were: PCT, +14.2%
(+2.1 to +26.4%, P = 0.02) in patients with liver insufficiency; ProADM,
+13.2% (+10.2 to +16.1%, P <0.01) in patients with age above median;
and CRP, –12.8% (–25.4 to –0.2%, P = 0.05) with steroid pretreatment.
Conclusion The influence of pre-analytic factors on the examined
biomarkers is marginal and not clinically relevant. Our observations
reinforce the concept of using biomarkers in algorithms with widelyseparated cutoff values and overruling criteria considering the entire
clinical picture, without adjustment for pre-analytic factors.
Reference
1.

Schuetz et al.: JAMA 2009, 302:1059-1066.

P222
Use of procalcitonin for identification of postoperative
complications after coronary artery bypass surgery with
cardiopulmonary bypass
A Baysal1, M Doğukan2, H Toman3
1
Kartal Kosuyolu High Speciality Research and Training Hospital, Istanbul,
Turkey; 2Adıyaman University Training and Research Hospital, Adıyaman,
Turkey; 3Çanakkale 18 Mart Research Hospital, Çanakkale, Turkey
Critical Care 2014, 18(Suppl 1):P222 (doi: 10.1186/cc13412)
Introduction The values of C-reactive protein (CRP) and procalcitonin
(PCT) were investigated to determine their effects on postoperative
complications in patients with or without systemic inflammatory
response syndrome (SIRS).
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Methods In 183 patients, in a prospective observational study, serum
CRP and PCT values were collected every day starting on postoperative
day 1 through day 5. The definition of SIRS includes two or more of the
following: temperature >38 or <36°C; heart rate >90 beats/minute;
respiratory rate >20/minute; arterial carbon dioxide pressure <32 mmHg;
white blood cell count >12,000/mm3 and <4.00/mm3. The ability of PCT to
predict sepsis and other postoperative complications were determined
by performing receiver operative characteristic curve analysis.
Results All patients were divided post hoc into patients with SIRS
(Group 1, n = 83) and patients without SIRS (Group 2, n = 100). A PCT
threshold value of 2.79 ng/ml on postoperative day 1 was able to
discriminate postoperative complications in patients with or without
SIRS with a sensitivity of 82.5% and a specificity of 70% (area under
curve: 0.76, P <0.01).
Conclusion (1) Serum PCT values increased significantly after
cardiopulmonary bypass in the SIRS group in comparison with patients
without SIRS on postoperative day 1 and remain elevated until
postoperative day 5. (2) Serum CRP values also follow a similar pattern,
but a CRP threshold value was not obtained to differentiate between
postoperative complications in patients with or without SIRS. A PCT
threshold value of 2.79 ng/ml on postoperative day 1 is a valuable
marker to discriminate between patients with or without SIRS.
P223
Altered T-cell repertoire diversity in septic shock patients
N Takeyama1, A Tomino2, M Hashiba2, A Hirakawa2, T Hattori2, H Miyabe2
1
Fujita Health University, Aichi, Japan; 2Fuita Health University, Aichi, Japan
Critical Care 2014, 18(Suppl 1):P223 (doi: 10.1186/cc13413)
Introduction The occurrence of sepsis-induced immune suppression is
associated with multiple organ dysfunctions, although the exact role of
T-cell malfunction is obscure. We investigated the impact of sepsis on the
adaptive immune system and to monitor T-cell receptor (TCR) diversity.
Methods TCR diversity was analyzed in peripheral blood mononuclear
cells (PBMCs) isolated from septic shock patients at three time points
(days 1, 3 and 7 after diagnosis of septic shock). TCR diversity was
measured in genomic DNA isolated from PBMCs using the Human
Immun TraCkeRb test (ImmunID Technologies, Grenoble, France)
[1]. Multi-N-plex PCR was performed using a primer specific to a V
gene family and several primers specific to J segments. The signal is
measured as a function of the fluorescence intensity of the reference
marker. Rearrangement validation and map generation were detected
and analyzed using the Constel’ID software (ImmunID Technologies).
HLA-DR expression on CD14 cells was measured by flow cytometry.
Results TCR diversity was markedly decreased in septic patients at
day 1 compared with healthy volunteers. A recovery of TCR diversity
was observed at days 3 and 7 except for dead patients. HLA-DR
expression was significantly decreased in septic patients at day 1. The
total lymphocyte count reduced in septic patients at day 1, but the
lymphocyte count recovered at days 3 and 7 except for dead patients.
Conclusion We observed a lower TCR diversity and lymphopenia in
the early stages of septic shock. A quick recovery of TCR diversity and
lymphocyte count was observed in live patients. On the other hand,
dead patients stayed on the lower level over the course of the study.
These results suggest that altered TCR diversity and lymphopenia
might participate in increased mortality and susceptibility to secondary
nosocomial infections.
Reference
1.

Venet F, Filipe-Santos O, et al.: Decreased T-cell repertoire diversity in sepsis:
a preliminary study. Crit Care Med 2013; 41:111-119.
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Association between DNA haplogroups and severe sepsis in
patients who underwent major surgery
E Gomez1, M Heredia1, S Resino2, M Jimenez-Sousa2, J Gomez-Herreras1,
E Tamayo1, P Jorge1, M Lorenzo3, P Ruiz1
1
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Critical Care 2014, 18(Suppl 1):P224 (doi: 10.1186/cc13414)
Introduction The aim of this study was to analyze whether
mitochondrial DNA haplogroups are associated with severe sepsis and
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mortality after major surgery in European populations. Mitochondrial
DNA (mtDNA) variants may play an important role for predicting
clinical outcome in sepsis [1].
Methods We carried out a case–control study on 240 septic patients
(severe sepsis or septic shock; Case group) and 267 patients with
systemic inflammatory response syndrome (SIRS; Control group).
Furthermore, a longitudinal substudy for analyzing survival was
performed in septic patients. mtDNA genotyping was performed by
Sequenom’s MassARRAY platform.
Results Regarding cardiac surgery, patients with clusters JT and
haplogroup J had higher likelihoods of sepsis than patients with
clusters HV (OR = 2.76 (95% CI = 1.27; 6.02); P = 0.010) and haplogroup H
(OR = 3.68 (95% CI = 1.17; 11.54); P = 0.026), respectively. No significant
association was found for abdominal surgery. When analyzing
survival, 45.4% patients died with a survival median of 39 (95% CI =
31.4; 46.62) days. When the clusters were analyzed for all patients,
41% (55/134) of patients within cluster HV died versus 71.4% (10/14)
patients within cluster IWX (P = 0.018). The adjusted Cox regression
showed that patients within cluster IWX had a higher risk of dying
than patients within cluster HV (hazard ratio (HR) = 2.24 (95% CI =
1.10; 4.56); P = 0.027). No significant association between haplogroups
and mortality was found when patients were stratified by the type of
surgery.
Conclusion European mitochondrial haplogroups are associated with
sepsis development in patients who underwent major cardiac surgery,
but not in patients who underwent major abdominal surgery. Besides,
mtDNA haplogroups also influence mortality. Haplogroups HV and H
were related to low risk of sepsis and death, while JT and J were related
to high risk of sepsis, and IWX was associated with death.
Reference
1.

Yang Y, Shou Z, Zhang P, He Q, Xiao H, Xu Y, Li C, Chen J: Mitochondrial DNA
haplogroup R predicts survival advantage in severe sepsis in the Han
population. Genet Med 2008, 10:187-192.
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T-cell receptor activation-associated cytokine release is impaired in
septic patients with faecal peritonitis
DG Gore1, L Preciado-Llanes2, GH Mills1, AW Heath2, RC Read3
1
Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK;
2
The University of Sheffield, UK; 3University of Southampton, UK
Critical Care 2014, 18(Suppl 1):P225 (doi: 10.1186/cc13415)
Introduction Sepsis is associated with immune hyporesponsiveness
but the immunological processes behind this are ill defined.
Methods This study quantified differences in plasma concentrations
of cytokines between septic patients with faecal peritonitis, age
and gender-matched surgical patients (without sepsis) and age and
gender-matched healthy participants. In addition, cytokine levels
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were measured in supernatant from peripheral blood mononuclear
cells stimulated with anti-CD3 and anti-CD3+anti-CD28, incubated
for 4 days. Cytokine concentrations of IL-1β, IL-5, IL-6, IL-8, IL-10, IL-13,
IL-17A, IFNγ and TNFα were determined by multiplex cytometric bead
array.
Results Plasma levels of IFNγ and IL-13 were lower in septic patients
compared with healthy participants. In contrast, plasma levels of IL-6
(see Figure 1) and IL-8 were increased in septic patients compared
with both surgical patients and healthy participants. Plasma levels
of IL-10 were significantly higher only in comparison with surgical
patients. Following incubation with anti-CD3 and anti-CD3+anti-CD28,
concentrations of IL-1β, IL-5, IL-6 (see Figure 1), IL-13, IL-17A, IFNγ
and TNFα were markedly decreased in samples from septic patients.
In addition, stimulation with anti-CD3+anti-CD28 resulted in lower
production of IL-10 in septic patients. Lower concentrations of IL-8
were detected in septic patient samples stimulated with only anti-CD3.
We found cytokine levels of IL-12p70 remained unaffected across all
groups and stimuli.
Conclusion We demonstrated a proinflammatory cytokine profile
in blood from septic patients, preceding a pan downregulation of
all assessed cytokines following in vitro T-cell stimulation. To our
knowledge, this study is the first to perform an immune functional
assay across these three groups.
P226
Activated protein C consumption and coagulation parameters in
severe sepsis and septic shock
M De La Torre-Prados1, A Garcia-de la Torre2, C Trujillano-Fernandez1,
J Perez-Vacas1, A Puerto-Morlan1, E Camara-Sola1
1
Hospital Virgen de la Victoria, Málaga, Spain; 2University Hospital Puerto
Real, Cadiz, Spain
Critical Care 2014, 18(Suppl 1):P226 (doi: 10.1186/cc13416)
Introduction Activated protein C (APC) deficiency is prevalent in severe
sepsis and septic shock patients. The aim of the study was to relate
the anticoagulation activity evaluated by APC with other coagulation
parameters adjusted to 28-day mortality.
Methods A cohort study of 150 critically ill adults. Age, sex, sources
of infection and coagulation markers within 24 hours from severe
sepsis or septic shock onset, defined according to Surviving Sepsis
Campaign (SSC) criteria, were studied. We analyzed APC activity using
a hemostasis laboratory analyzer (BCS® XP; Siemens). A descriptive and
comparative statistical analysis was performed using SPSS version 15.0
(SPSS Inc., Chicago, IL, USA).
Results We analyzed 150 consecutive episodes of severe sepsis (16%)
or septic shock (84%) admitted to the UCI. The median age of the study
sample was 64 (interquartile range (IQR): 22.3 years; male: 60%). The
main sources of infection were: respiratory tract 38%, intra-abdomen

Figure 1 (abstract P225). Concentration of IL-6 in plasma on day 0 (a) and supernatant on day 4 (b).
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Figure 1 (abstract P226). Relationship between activated protein C and antithrombin III and INR.

45%, and 70.7% had medical pathology. The 28-day mortality was
22.7%. Nonsurvivors had a significantly higher consumption of APC
than survivors, 56% (IQR: 38.5) versus 68.6 (IQR: 41.4); P = 0.023. The
profile of lower levels of APC was a surgery patient with septic shock,
neurological focus or catheter-related infection and Gram-negative
pathogens from blood cultures. Spearman’s showed relationship with
antithrombin III, r = 0.674 (P <0.001) and International Normalized Ratio
(INR), r = –0.611 (P >0.001). See Figure 1.
Conclusion Low levels of PC are associated with poor outcome and
severity in severe sepsis, and it is well correlated with antithrombin III
and INR.

P227
Flow-cytometric analysis in traumatic brain injury to evaluate
immunosuppression
S Di Valvasone, L Perretta, M Bonizzoli, F Liotta, F Annunziato, F Socci,
P Ruggiano, A Peris
Careggi Hospital, Firenze, Italy
Critical Care 2014, 18(Suppl 1):P227 (doi: 10.1186/cc13417)
Introduction Flow-cytometric analysis is still restricted to cancer and
immunocompromised patients. There are no clinical studies that
evaluate the immunological changes in traumatic brain injury (TBI)
patients. The objective of this study is to determine whether patients
with severe TBI (GCS <9) manifest early (<48 hours after injury) signs
of immunosuppression and whether this condition increases the
incidence of infection during the ICU stay.
Table 1 (abstract P227). Collected data
Age (years), mean ± SD
Sex (M/F)

55.43 ± 23.12
44/10

Body mass index, mean ± SD

25.51 ± 2.69

ISS, mean ± SD

29.04 ± 26.57

RTS, mean ± SD

5.76 ± 1.53

TRISS, mean ± SD

68.73 ± 28.77

Admission SAPS II, mean ± SD

44.96 ± 14.87

Admission GCS, mean ± SD

7.63 ± 3.88

Flow-cytometric analysis day (days), mean ± SD

1.69 ± 3.34

Discharge GCS, mean ± SD

10.48 ± 3.19

ICU LOS, mean ± SD

10.67 ± 8.08

Table 2 (abstract P227). Flow-cytometric data
Normal value
9

WBC (×10 /l)
Total lymphocytes (×106/l)
CD3+ lymphocytes (×106/l)

10.67 ± 4.82

4 to 10

1,123.15 ± 547.02

1,200 to 3,000

67.11 ± 11.86

1,100 to 1,700

493.07 ± 313.92

600 to 1,400

CD3 CD8 lymphocytes (×10 /l)

250.65 ± 171.94

300 to 900

CD4+DR+ lymphocytes (×106/l)

23.19 ± 15.09

CD8+DR+ lymphocytes (×106/l)

16.26 ± 20.83

CD3+CD4+ lymphocytes (×106/l)
+

+

6

Methods We retrospectively analyzed data from 54 patients, including
10 patients with isolated brain injury and 44 patients with brain and
extracranial injuries. The flow-cytometric analysis was performed
within 48 hours of trauma. Collected data are shown in Table 1.
Results Preliminary analysis is limited to descriptive statistics that show
an immediate immunosuppression condition after TBI, as established
by reduction of CD4+ T lymphocytes and CD8+ T lymphocytes.
Significant data are collected in Table 2.
Conclusion In severe TBI patients, an immunosuppression state is early
developed. It is relevant to establish whether this condition could
affect the course and prognosis of ICU patients.
P228
Polymorphonuclear cell surface expression patterns differ in
inflammatory and infectious stages in polytraumatized and septic
shock patients
M Weiss, Z Gueldue, M Georgieff, F Gebhard, M Huber-Lang, M Schneider
University Hospital Medical School, Ulm, Germany
Critical Care 2014, 18(Suppl 1):P228 (doi: 10.1186/cc13418)
Introduction Each cell of the immune system shows a characteristic
expression of cell surface molecules depending on the grade of
activation or suppression. We examined the cell surface profile on
polymorphonuclear cells (PMN) of polytraumatized patients and
compared them with those of healthy controls and furthermore with
patients with severe sepsis or septic shock. Moreover, we wanted to
find out in the polytraumatized patients whether there are associations
of PMN surface marker patterns with severity of injury, of disease and
of organ dysfunctions.
Methods In a prospective observational study, cell surface expression
of CD16, CD88, CD64, CD66b, CD11b, CD95, CD33, CD39, IL-17RA, TLR2, TLR-4 and HLA-DR on PMN was determined using flow cytometry.
Thirteen healthy volunteers, eight patients with severe sepsis and
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septic shock, and longitudinally, on admission (0 hours), and 4, 12,
24, 48, 120 and 240 hours thereafter, eight polytraumatized patients
were monitored. ISS, SAPS3 and SOFA score reflect severity of injury, of
disease and of organ dysfunctions.
Results In polytraumatized patients (24 hours measurement), but also
in septic patients, CD88+ expression and CD33+/CD66b– expression were
significantly lower and CD33–/CD66b+ higher than in healthy controls.
Especially, the lowest values of CD88+ occurred in patients with
polytrauma developing septic complications.
Furthermore, the polytraumatized patients revealed higher levels of
CD66b, CD11b and CD16, whereas CD16+ was lower. Considering the
post-traumatic course, polytraumatized patients with better prognostic
evaluation in SOFA and SAPS3 initially expressed higher levels of TLR-2.
Polytrauma patients could be divided into two subgroups, one with and
the other without septic complications. The septic subgroup presented
predominantly higher values in SOFA, SAPS3 and ISS scoring.
Conclusion Cell surface molecules on PMN of polytraumatized patients
differ from those of healthy volunteers. Besides, distinct expression
patterns resemble those of patients with sepsis. Patents with higher ISS
values go along with higher scores in SOFA and SAPS3, and are at risk
to develop septic complications.
P229
Lymphocyte surface expression patterns differ in inflammatory and
infectious stages in polytraumatized and septic shock patients
M Weiss, L Brach, M Georgieff, F Gebhard, M Huber-Lang, M Schneider
University Hospital Medical School, Ulm, Germany
Critical Care 2014, 18(Suppl 1):P229 (doi: 10.1186/cc13419)
Introduction Lymphocytes show different cell surface molecules
depending on the degree of their activation or suppression. We used
this surface expression to look at inflammatory or infectious states in
patients with polytrauma and patients with sepsis. The present study was
performed to clarify: what is the expression profile of lymphocyte surface
markers in polytraumatized patients over time; and are there differences
in the expression patterns of polytraumatized patients compared with
healthy controls and with patients with severe sepsis and septic shock?
Methods In a prospective observational study in a surgical ICU,
surface expression of CD3, CD4, CD8, IL7R, CD4/25, CD8/25, CD2/86,
CD28, CD3/56, CD2, CD39, CD244, CD11b, and CD56 on lymphocytes
was measured by flow cytometry. We collected data from six healthy
controls, from eight patients with severe sepsis or septic shock, and,
longitudinally from eight polytraumatized patients on admission
(0 hours), and at 4, 12, 24, 48, 120, and 240 hours. ISS, SAPS 3 and SOFA
score reflect severity of injury, of disease and of organ dysfunctions of
the polytraumatized patients.
Results In septic and polytraumatized patients, the expression
of CD3, CD28 and CD2 was significantly lower than in controls.
In polytraumatized patients, surface expression of CD244, CD39
and CD8/25 was significantly higher than in controls. Within the
polytraumatized patients, we found two different subgroups, group
A with septic progression and Group B without septic progression of
disease. Especially, the septic polytraumatized patients revealed very
low levels of CD3, CD2 and CD28. Moreover, their levels of CD39 and
CD8/25 were less increased and their ISS higher than those of the
nonseptic subgroup.
Conclusion Surface expression molecules of polytraumatized patients
differ from those of the healthy controls and within the group. The
more heavily injured polytraumatized patients are more likely to
develop severe sepsis and septic shock with surface expression profiles
on lymphocytes comparable with those of septic patients.
P230
Cl:Na ratio on ICU admission as a prognostic indicator of mortality
in sepsis patients
HK Atalan1, B Gucyetmez2, N Cakar3
1
Atasehir Memorial Hospital, Istanbul, Turkey; 2International Hospital,
Istanbul, Turkey; 3Istanbul Medical Faculty, Istanbul, Turkey
Critical Care 2014, 18(Suppl 1):P230 (doi: 10.1186/cc13420)
Introduction The aim of the study is to investigate the relationship
between Cl:Na ratio disturbances and mortality in sepsis patients.

Figure 1 (abstract P230). In the multivariate model, effect of Cl:Na ratio
group was adjusted for pH, lactate, anion gap and base excess.

Stewart’s strong ion theory can be used in the interpretations of acid–
base abnormalities [1]. The Cl:Na ratio is a simple alternative test that
obviates the need to solve the complex strong ion gap (SIG) equations
[2].
Methods A total of 434 sepsis and severe sepsis patients hospitalized
in the ICU of two centers between 2006 and 2012 were included in
the study. Three groups were formed as patients having low (<0.75),
normal (>0.75 to <0.80) and high (>0.80) Cl:Na ratio within the first
24 hours in the ICU. Patients’ age, gender, APACHE II score, SOFA score,
pH, PaCO2, HCO3, base excess, Na, K, Cl, Ca, lactate, strong ion difference,
anion gap, length of ICU stay and mortality were recorded. Logistic
regression analysis was used to calculate odd ratios and 95% CIs for the
association of Cl:Na with mortality. In the fully adjusted model, pH, BE,
AG, lactate and Cl:Na ratio were entered into the model. P <0.05 was
considered statistically significant.
Results The distribution of the patients was as follows: low Cl:Na (75,
17%), normal Cl:Na (243, 56%), high Cl:Na (116, 27%). Univariate analysis
revealed that in low and high Cl:Na ratio patients, mortality was higher
by 1.56-fold (0.87 to 2.81) and 2.22-fold (1.36 to 3.61) (P = 0.135 and
P <0.01). In multivariate analysis, increased mortality by 1.95-fold (0.92
to 4.12) and 2.02-fold (1.01 to 4.03) was found in low and high Cl:Na
ratios (P = 0.081 and P = 0.046) (Figure 1).
Conclusion Stewart’s strong ion theory provides assessment for the
etiology of acid–base disturbances. This evaluation can be performed
easier and faster with the Cl:Na ratio. This study demonstrates that the
disturbed Cl:Na ratio is associated with increased mortality in sepsis
and severe sepsis patient groups.
References
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Dysfunction of peroxisomes as one of the possible causes of
multiple organ dysfunction syndrome development
AN Osipenko1, AV Marochkov2
1
A. Kuleshov Mogilev State University, Mogilev, Belarus; 2Mogilev Regional
Hospital, Mogilev, Belarus
Critical Care 2014, 18(Suppl 1):P231 (doi: 10.1186/cc13421)
Introduction This study demonstrates that low level of plasmalogens
(Pls) is an important marker of peroxisomal dysfunction. The primaryOH group in glycerol Pls was not substituted by the acyl group (fatty
acid) as in diacylphospholipids but by the aldehydogenic alkenyl group
(fatty aldehyde) found in the form of vinyl ether [1]. It is known that
there is disruption of several organ systems in diseases connected with
peroxisomal dysfunction, as in the case of multiple organ failure.
Methods The objects of study were 18 people with multiple organ
failure (35.6 ± 8.7 years) of various etiologies. The blood of 16 healthy
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volunteers aged 37.7 ± 3.2 years served as control. The preanalytical
phase was to prepare a solution of ethyl esters of fatty acids (FAc) and
diethylacetals of fatty aldehydes (FAl) of blood plasma samples by
acidic ethanolysis. Analysis of FAl and FAc in plasma was carried out
using capillary gas–liquid chromatography. Quantitative evaluation of
the analytes was performed as a mass percentage of the FA and FAl
amount. Statistical analysis was performed using the Mann–Whitney
U test (P <0.05).
Results In contradistinction to triglycerides, diacylphospholipids and
Pls participate in exchange of polyunsaturated fatty acids (PUFA) with
a large number of double bonds, such as primarily arachidonic and
docosahexaenoic PUFA, acting as an intermediate station, through
which these fatty acids are transported to cell membranes [1]. Thus, the
ratio of level of FAl to the level of aforementioned blood plasma PUFA
may reflect a change in the share of Pls relative to diacylphospholipids.
According to our data, at MODS the ratio of fatty aldehydes to amount
of arachidonic and docosahexaenoic PUFA is 0.16, while in the control
group the figure is 0.27 (P <0.001). Thus, we can conclude that the level
of Pls towards diacylphospholipid plasma levels of the experimental
group decreased by approximately 40%. Currently, there is evidence
that there is a reduction of cholesterol levels in blood plasma of patients
with the diseases associated with peroxisome biogenesis disorders
[2]. In our study, patients had low levels of plasma total cholesterol
(124.6 ± 28.7 mg/dl), which may also indicate peroxisome dysfunction
in MODS patients.
Conclusion On the basis of determined deficiency of analyzed
compound levels, we concluded the possibility of peroxysomal
dysfunction in MODS.
References
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Methods Whole blood was taken from healthy volunteers and was
placed in tubes containing EDTA and immediately transferred to the
laboratory. Heparinized blood samples were diluted 1:10 in RPMI 1640
culture medium (100 μl whole blood added in 900 μl RPMI 1640).
Samples were preincubated with 0‚ 5‚ 12.5‚ 25‚ 50‚ 100 and 200 mM
alcohol (EtOH) for 10 minutes at room temperature. After incubation,
500 pg LPS was added to each sample for 4 hours at 37°C. At the
end of the process, samples were centrifuged (1,800 rpm, 5 minutes,
r.t.). Culture supernatants were collected and stored at –70°C until
measurements. TNFα and TNFR levels were determined in culture
supernatant using the ELISA method [2].
Results We studied 24 healthy males volunteers aged 36.5 ± 1.4
(X ± SEM). TNFα was not detected in samples treated without alcohol
in the absence of LPS stimulation (control) or in the presence of alcohol
alone (data not shown). TNFα production was significantly decreased
at a dose of 25 mM alcohol after LPS stimulation (P <0.0001) compared
with LPS-challenged samples (Figure 1A). Alcohol had no effect on
TNFR I production when incubated with or without LPS (data not
shown). Alcohol at lower doses (<50 mM) seemed to decrease TNFR II
levels, but an increase in TNFR II levels was observed at higher doses
(>50 mM) of alcohol, which was statistically significant at doses of 100
and 200 mM alcohol after LPS stimulation ex vivo (P <0.001) (Figure 1B).
Conclusion Our observations indicate a suppression of proinflammatory response, but also a differential effect of alcohol on TNFR II
production of whole blood in the presence of LPS challenge depending
on the degree of alcohol intoxication.
References
1.
2.

Cook RT‚ et al.: Alcohol Clin Exp Res 1998, 22:1927.
Myrianthefs P, et al.: Cytokine 2003, 24:286-292.

Braverman N, Moser A: Bioch Biophys Acta 2012, 1822:1442-1452.
Kovacs W, et al.: J Mol Cell Biol 2004, 24:1-13.

P232
Differential effect of alcohol on TNFα receptor II production in the
presence of LPS challenge ex vivo
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Critical Care 2014, 18(Suppl 1):P232 (doi: 10.1186/cc13422)
Introduction Acute alcohol exposure suppresses proinflammatory
response, which may be related to increased susceptibility to
infections [1].The purpose of the study was to investigate the effect
of acute exposure to alcohol on TNFα production capacity and TNFα
receptors (TNFRs) in an ex vivo model of whole-blood stimulation with
lipopolysaccharide (LPS).

Figure 1 (abstract P232).

P233
Neutrophil phenotype model for extracorporeal treatment of sepsis
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Critical Care 2014, 18(Suppl 1):P233 (doi: 10.1186/cc13423)
Introduction Neutrophils play a central role in eliminating bacterial
pathogens, but may also contribute to end-organ damage.
Interleukin-8 (IL-8), a key modulator of neutrophil function, signals
through neutrophil specific surface receptors CXCR-1 and CXCR-2.
Expression of these surface receptors can be altered by perfusion
through an extracorporeal device. Extracorporeal methods of immune
modulation have shown promise for treatment of sepsis; however,
achieving an appropriate response is a major challenge [1]. In this study
a mechanistic mathematical model was used to evaluate and deploy an
extracorporeal sepsis treatment that modulates CXCR-1/2 levels.
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Methods A simplified mechanistic mathematical model of IL-8mediated activation of CXCR-1/2 receptors was developed.
Receptor-level dynamics and systemic parameters are coupled with
multiple neutrophil phenotypes to generate dynamic populations
of activated neutrophils that reduce pathogen load, and/or primed
neutrophils that cause adverse tissue damage when misdirected. The
mathematical model was calibrated using experimental data from
baboons administered a 2-hour infusion of E. coli and followed for a
maximum of 28 days. An extracorporeal intervention was implemented
by introducing a trapped receptor state that limits IL-8 signaling
through CXCR-1/2. Time of onset, duration, and capture efficacy of
the extracorporeal device were explored to provide probabilistic
predictions of the impact on mortality.
Results Of 16 baboons, 11 (69%) died, six (38%) within 1 day of
bacterial infusion. The model was well calibrated to the data from
survivors and nonsurvivors. Sensitivity analysis identified six model
parameters, out of 21, as key determinants of mortality. Predictions
indicate best effect with introduction of the proposed extracorporeal
intervention within 1 hour of infection for a 72-hour duration, results
in the survivor population increasing from 31% to 61%. The treatment
can result in harm if initiated <10 hours from infection and continued
<24 hours. A delay of 10 hours increases survival by 7% on average.
Treatment efficacy quickly diminishes if not introduced within 15 hours
of infection.
Conclusion These findings support the continued development of
an extracorporeal treatment that modulates CXCR-1/2 levels. Further
development of the mathematical model will help guide device
development and determine which patient populations should be
targeted by treatment.
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Prolactin, cortisol and heat shock proteins in early sepsis:
preliminary data
K Vardas1, K Apostolou1, K Psarra2, E Botoula2, S Tsagarakis2, E Magira1,
C Routsi1, E Briassouli1, D Goukos1, S Nanas1, G Briassoulis3
1
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Critical Care 2014, 18(Suppl 1):P234 (doi: 10.1186/cc13424)
Introduction Besides cortisol, prolactin might also be important in
maintaining normal immune response in stress states. Its role in the
hypothalamus–pituitary–adrenal axis hormonal and immune stress
response in sepsis has hardly been investigated in a critically ill setting.
The aims of the study were to evaluate the early (first 48 hours) ACTH,
cortisol and prolactin plasma levels in ICU patients with severe sepsis/
septic shock (SS) or systemic inflammatory response syndrome (SIRS)
compared with healthy control subjects (C) and to correlate their
expression with heat shock proteins (HSPs), interleukins (ILs) and
outcome.
Methods Thirty consecutively admitted patients with SS, 22 with SIRS,
and 15 C were enrolled in the study. Patients’ demographics, laboratory
examinations, and APACHE II, SOFA and SAPS III scores were recorded
on ICU admission. Blood sampling was performed between 9:00 and
10:00 a.m. Prolactin and cortisol were measured using the ADVIA
centaur system, ACTH using the Immulite 2000. Intracellular monocyte
HSP (iHSP) was determined after staining with surface antigens CD33–
PE/Cy5 and CD45 PE/Cy7 followed by either HSP72-FITC or HSP90a-PE
intracellular staining (four-color flow cytometry). Mean fluorescence
intensity values for each HSP were noted and analyzed. ELISA was used
to determine extracellular (e) HSP, IL-6 and IL-10 levels.
Results Prolactin (P <0.034), cortisol (P <0.0001), and ACTH (P <0.02)
levels differed among groups. Prolactin, cortisol, IL-6, and eHSP90 were
higher in SS (P <0.03) and SIRS (P <0.04) compared with C. Cortisol
and eHSP90 were higher in SS compared with SIRS (P <0.005; P <0.03);
iHSP72 and iHSP90 were higher in SIRS compared with SS (P <0.05;
P <0.05) or C (iHSP72, P <0.02). Cortisol related with eHSP90 (r = 0.45,
P <0.02), lactate (r = 0.33, P <0.02) and HCO3 (r = –0.45), and prolactin
with SAPS III (r = 0.34, P <0.02), but not with mortality or LOS.
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Conclusion Prolactin seems to be a stress hormone, probably related to
the severity of illness, increased along with IL-6 and eHSP90 levels in SS.
Also in these patients, cortisol correlates to lactate and eHSP90, but in
contrast to SIRS the iHSP72 and iHSP90 immune response is depressed.
Acknowledgements This research has been co-financed by the
European Union (European Social Fund) and Greek national funds
through the Operational Program ‘Education and Lifelong Learning’
of the National Strategic Reference Framework Research Funding
Program: THALES.
P235
AMP-protein kinase may protect against sepsis-induced acute
kidney injury through modulation of immune response and
endothelial activation
H Gomez, D Escobar, A Botero, BS Zuckerbraun
University of Pittsburgh, PA, USA
Critical Care 2014, 18(Suppl 1):P235 (doi: 10.1186/cc13425)
Introduction Organ injury is a hallmark of sepsis, in particular acute
kidney injury (AKI). Yet the mechanisms involved in sepsis-induced
AKI are not well understood. Energy prioritization is an important
cell defense mechanism, and thus we hypothesized that exogenous
activation of AMP-protein kinase (AMPK), a master regulator of cellular
energy metabolism, protects against sepsis-induced AKI.
Methods Sixty C57BL/6 male mice, 6 to 8 weeks of age, weighing 20 to
25 g were divided into six groups: 1, cecal ligation and puncture (CLP);
2, CLP+AICAR (AI, AMPK activator, 100 mg/kg 24 hours before CLP); 3,
CLP+compound C (AMPK inhibitor, 30 mg/kg; CoC); 4, sham; 5, sham+AI;
6, sham+CoC. Blood/tissue samples were collected 8 hours after CLP.
Renal function (creatinine (Cr, mg/dl), BUN (mg/dl) and cystatin C (CysC,
ng/ml)), cytokine expression (ELISA), endothelial activation (ICAM1 expression), neutrophil adhesion (PMN, fluorescence, anti-CD11b
mAb-tagged PMNs) and vascular leak (Evan’s blue) were assessed.
The effect of AI given 4 hours (n = 12) before and 2 hours after (n = 11)
CLP was also evaluated. The experiment was reproduced in vitro using
cell culture (renal epithelial, endothelial cells and macrophages), with
similar groups: 1, control; 2, control+AI (1 mM/1 hour pre LPS); 3, LPS
(100 ng/ml for 4 hours); 4, LPS+AI; 5, control+CoC (10 μM/1 hour
pre LPS); 6, LPS+CoC. Cytokines were measured with ELISA. Data are
presented as mean ± SD and as LPS/CLP and LPS/CLP+AI.
Results AI prevented Cr, BUN and CysC from increasing after CLP
(0.43 ± 0.18, 0.2 ± 0.02, P = 0.0003; 62.2 ± 10.8, 43.7 ± 17.7, P = 0.01;
103.9 ± 54.8, 49.3 ± 30.8, P = 0.01, respectively). AICAR decreased
cytokine release after CLP (IL-6: 1,818 ± 344 vs. 1,374 ± 268, P = 0.04; IL10: 7,592 ± 5,038 vs. 2,245 ± 2,668, P = 0.05; TNFα: 213 ± 172 vs. 39 ± 16,
P = 0.03) and LPS in macrophage culture (IL-6: 241.7 ± 1.5 vs. 7.2 ± 1.5,
P = 0.055; TNF: 1,882 ± 583 vs. 82 ± 28, P = 0.04). However, AI lost its
protective signal when administered 4 hours pre or 2 hours after CLP
(Cr CLP vs. CLP+AI: 0.2 vs. 0.2, P = 0.1 and 0.45 ± 0.3 vs. 0.56 ± 0.3, P = 0.5,
respectively). AI also decreased ICAM-1 expression in vivo and in vitro,
vascular leak (0.09 ± 0.01 vs. 0.06 ± 0.008, P = 0.003) and PMN adhesion
(1,055 ± 179 vs. 751 ± 242, P = 0.04).
Conclusion AMPK activation by AICAR prevented sepsis-induced AKI.
AICAR decreased cytokine release, endothelial activation and vascular
leak, suggesting that organ protection may be mediated by modulation
of the inflammatory response and protection of the microvasculature.
However, AICAR’s protective effect may be conditional to timing of
administration.
P236
Study of the ex vivo immune response of polytrauma older patients
in the ICU on admission: preliminary results
L Filippou, K Venetsanou, G Voulalas, D Markopoulou, D Chroni,
C Maltezos, I Alamanos
KAT Hospital Athens, Kifisia, Athens, Greece
Critical Care 2014, 18(Suppl 1):P236 (doi: 10.1186/cc13426)
Introduction Immunological status is differentiated with age,
influencing treatment and outcome [1]. The aim is to determine the
immune response of severely traumatized older patients compared
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Figure 1 (abstract P236). Serum proinflammatory cytokines in older
patients.

Figure 1 (abstract P237). Cytokine stimulations after sterile injury.

Figure 2 (abstract P236). Ex vivo proinflammatory cytokine release after
whole-blood LPS stimulation in older patients.

with a group with arterial disease, expressed by proinflammatory
cytokine release after ex vivo whole-blood LPS stimulation [2].
Methods The study comprised 16 polytrauma patients admitted to
the ICU, aged 78 ± 8 (Group I) and 16 with arterial disease, aged 74 ± 5
(Group II). Ten milliliters of peripheral blood were collected from each
patient, divided into two tubes with/without anticoagulant. Diluted
1:10 whole-blood samples were stimulated with 500 pg/ml LPS, at
37°C, for 4 hours. Serum and cell culture supernatants (CCSP) were
removed and stored at –70°C. TNFα and IL-6 were measured in serum
and CCSP by ELISA.
Results Serum proinflammatory cytokines were significantly elevated
after severe trauma against control group (TNFα, P <0.001 and IL-6,
P <0.001). Ex vivo cytokine release showed the opposite direction.
There was a significantly lower TNFα and IL-6 release for Group I (TNFα,
P <0.05 and IL-6, P <0.01) compared with Group II. TNFα ex vivo release
from the samples of Group II was >300 pg/ml. See Figures 1 and 2.
Conclusion Older patients showed adequate immunological
response, considering the limit of 300 pg/ml. The incidence of severe
trauma was involved in the downregulation of immune activity and
should be considered. Group I patients do not have the opportunity
to precondition their immune status. Group II patients can better
compensate operative therapies.
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Multiple trauma is linked with reversal of immunoparalysis and
provides survival benefit from Pseudomonas aeruginosa
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Introduction Patients with multiple injuries are prone to hospitalacquired infections. We hypothesized that exposure to multiple injuries
may modulate the innate immune response and the subsequent
outcome of infections.

Methods Ninety-seven C56Bl6 male mice were subject to multitrauma
after crush of the femur and chemical pneumothorax by turpentine.
Mice surviving 72 hours after the injuries were challenged
intravenously with one 7log10 log-phase inoculum of P. aeruginosa and
survival was recorded. In separate experiments, mice were sacrificed
post injury; splenocytes were isolated and stimulated with 10 ng/
ml LPS and cytokines were measured in supernatants by an enzyme
immunoassay. Quantitative cultures of the right lung, kidney and liver
were performed. The same procedures were done for sham-operated
mice and for mice subject only to femur crush and to pneumothorax.
Results Initial experiments with 21 mice showed that the overall
death rate for this model of multitrauma was 66.7% with most deaths
occurring in the first 48 hours. In the second set of experiments,
12 mice remaining alive 72 hours post injury were challenged with
P. aeruginosa; mortality was 37.5% compared with 75% of 12 noninjured and infected mice (log-rank: 5.77, P = 0.016). Respective mean
production of TNFα from splenocytes isolated at sacrifice 24 hours and
96 hours post sham injury was 651 and 523 pg/ml (P = NS); post femur
crush 217 and 916 pg/ml (P = 0.010); post pneumothorax 286 and
1,056 pg/ml (P = 0.018); and post both femur crush and pneumothorax
207 and 1,011 pg/ml (P = 0.019). Respective mean production of IFNγ
from splenocytes isolated at sacrifice 24 hours and 96 hours post
sham injury was 324 and 230 pg/ml (P = NS); post femur crush 278
and 840 pg/ml (P = 0.021); post pneumothorax 377 and 2,356 pg/ml
(P = 0.025); and post both femur crush and pneumothorax 252 and
908 pg/ml (P = 0.019). Mean production of TNFα from splenocytes of
injured mice sacrificed 24 hours after bacterial challenge was 1,184 pg/
ml compared with 484 pg/ml non-injured and infected mice (P = 0.024).
Similar differences were not found for IFNγ or for quantitative tissue
cultures. See Figure 1.
Conclusion Mice survivors from multiple trauma become resistant
to subsequent infection. This is probably linked with the induction of
tolerance of the innate immunity to substances released after sterile
tissue injury.
P238
Does clopidogrel change morbidity and mortality in ICU sepsis
patients?
DG Klepser, PP Dobesh, TR McGuire, DA Roberts, AL Himmelberg,
KM Olsen
University of Nebraska Medical Center College of Pharmacy, Omaha, NE, USA
Critical Care 2014, 18(Suppl 1):P238 (doi: 10.1186/cc13428)
Introduction The purpose of this study was to evaluate whether
patients with sepsis exposed to clopidogrel have lower mortality and
fewer days on mechanical ventilation compared with patients not
exposed to clopidogrel. A recent post-hoc analysis of the PLATO trial
suggests that the antiplatelet agent ticagrelor provided a significant
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reduction in sepsis-related mortality and pulmonary adverse events
compared with clopidogrel. It is unknown whether clopidogrel
also provides benefit in patients with sepsis compared with no
therapy. Knowing this information may help focus future research on
determining the mechanism of ticagrelor’s benefit.
Methods This retrospective cohort study included all patients over
the age of 40 with a confirmed diagnosis of severe sepsis and an ICU
stay at our academic medical center from 1 January 2005 to 31 March
2011. Clopidogrel use, patient demographics, and APACHE II score at
the time of sepsis were collected from patient charts. Clinical outcomes
included in hospital mortality, development of acute respiratory
distress syndrome (ARDS), days on mechanical ventilation, in-hospital
cardiac events, hospital cost, and length of stay.
Results We identified 824 patients who met the inclusion criteria for this
study. Of these patients, 76 (9.2%) had been exposed to clopidogrel.
The mean APACHE II score was similar for patients receiving clopidogrel
and those who did not (23.4 vs. 22.6; P = 0.426). Patients exposed to
clopidogrel had a similar rate of in-hospital mortality (26.3% vs. 33.2%;
P = 0.223) and ARDS (43.4% vs. 38.6%; P = 0.415). While mortality was
also similar between the groups for patients with a low APACHE II
score (<25), mortality was lower in clopidogrel-exposed patients with
an APACHE II score ≥25 (27.3% vs. 45.6%; P = 0.045). Patients exposed
to clopidogrel did not have a higher use of blood products (65.8%
vs. 65.9%; P = 0.983). Patients exposed to clopidogrel did not have
significantly more days on mechanical ventilation, or ventilation-free
days. Cardiac events during the hospital stay were not lower in patients
on clopidogrel (4.0 vs. 2.4; P = 0.432). Hospital costs and length of stay
did not differ between the groups.
Conclusion While clopidogrel may not increase the risk of bleeding in
these patients, these data suggest that clopidogrel does not reduce
adverse outcomes in patients with sepsis. A potential benefit in patients
with APACHE II scores ≥25 may need further study. Future research into
the mechanism of ticagrelor’s benefit reported in the PLATO trial may
be directed at the non-P2Y12 receptor mechanism.
P239
Continuous administration of corticosteroids in septic shock can
reduce risk of hypernatremia
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I Grintescu1, D Mirea3
1
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Institute of Endocrinology, Bucharest, Romania; 3Elias University Emergency
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Critical Care 2014, 18(Suppl 1):P239 (doi: 10.1186/cc13429)
Introduction Although the administration of hydrocortisone in septic
shock generates adverse effects, the risk of corticosteroid-induced
hypernatremia may be reduced by continuous administration of the
drug [1,2].
Methods A total of 171 patients with septic shock were randomized
into three study groups: group A (n = 58), 200 mg/day hydrocortisone
hemisuccinate in four doses; group B (n = 59), same dose of
hydrocortisone hemisuccinate in continuous administration; group C
(n = 54), no hydrocortisone hemisuccinate. Mean serum sodium values,
the number of hypernatremia episodes and variations in serum sodium
(Na var) were investigated for 7 days. The local ethics committee
approved the study.
Results There were no differences between the three groups at
the beginning of the study regarding demographic data and the
clinical characteristics. Mean values of natremia were normal in
group C (140.35 ± 7.390 mEq/l to 144.79 ± 8.338 mEq/l) during
the study period. High mean values appeared on day 4 in group A
(147.21 ± 8.470 mEq/l to 149.37 ± 8.973 mEq/l on day 7) and on day 5
in group B (146.36 ± 8.272 mEq/l to 147.70 ± 8.865 mEq/l). Na var was
8.59 ± 5.960 mEq/l (–8 and 21 mEq/l) in group A, 6.63 ± 7.609 mEq/l (–17
and 23 mEq/l) in group B and 4.54 ± 7.455 mEq/l (–12 and 22 mEq/l)
in group C. This variation is statistically significant when groups A and
B are compared with group C (P = 0.012) and when only group A is
compared with group C (P = 0.0019). The risk of hypernatremia after
hydrocortisone hemisuccinate was almost three times higher than
that of patients who did not receive this drug (RR 2.82, 1.35 <OR <5.90,

S86

P = 0.0041) and slightly higher when HHS was delivered as a bolus (RR
3.08, 1.32 <OR <7.25, P = 0.0071).
Conclusion Continuous administration of hydrocortisone hemisuccinate in septic shock is associated with a lower risk of hypernatremia
than bolus administration.
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Introduction The aim of this study was to determine the correlation
between regional tissue oxygenation (SrO2) measured by near-infrared
spectroscopy (NIRS), central venous oxygen saturation (SvO2) and
levels of serum lactate (SL) in patients with severe sepsis.
Methods An observational pilot study was performed in an ICU of a
medium-sized teaching hospital. Adult patients admitted with severe
sepsis were included and three NIRS electrodes were attached: on the
left side of the forehead (LF), the right side of the forehead (RF) and
the right forearm (RA). SL and SvO2 measured in a jugular or subclavian
central venous line sample were determined every 4 hours. Descriptive
statistics were calculated. Pearson correlation coefficients (PCC) were
calculated between SrO2, SvO2 and SL. Normal values for SrO2 were
defined as the median ± 1 interquartile range in patients with SL
<1.7 mmol/l. Differences between groups were calculated by Pearson
chi-square tests. P <0.05 was considered statistically significant.
Results Twenty-five patients (12 men) were included. Mean age was
68 years, mean APACHE score 31. The most frequent reasons for ICU
admission were abdominal sepsis (n = 11) and pneumosepsis (n = 7).
Statistically significant correlations were found between SvO2 and SrO2:
PCC SrO2 LF, 0.46; PCC SrO2 RF, 0.50; PCC SrO2 RA, 0.21. Low, although
statistically significant, correlations were found between SrO2 and
SL: PCC SrO2 LF, –0.16; PCC SrO2 RF, –0.15; and PCC SrO2 RA, –0.20.
Calculated normal values for SrO2 LF were 60 to 80%, for SrO2 RF were
60 to 76% and for SrO2 RA were 64 to 84%. An out-of-range SrO2 had
a high positive predictive value (PPV) for an increased SL. The PPV for
out-of-range SrO2 LF was 85% versus 58% for normal SrO2 LF (OR 4.27;
95% CI 2.09 to 8.72), the PPV for out-of-range SrO2 RF was 77% versus
60% for normal SrO2 RF (OR 2.32; 95% CI 1.25 to 4.31) and the PPV for
out-of-range SrO2 RA 75% versus 60% for normal SrO2 RA (OR 1.94; 95%
CI 0.95 to 4.00).
Conclusion This pilot study shows a statistically significant correlation
between SvO2 and SrO2 in patients with severe sepsis. An out-of-range
SrO2 LF or RF had a high predictive value for increased serum lactate.
We therefore conclude that NIRS could have a role in goal-directed
therapy of patients with severe sepsis.
P241
Delayed admission to the ICU is associated with increased
in-hospital mortality in patients with community-acquired severe
sepsis or shock
A Schnegelsberg, J Mackenhauer, M Pedersen, H Nibro, H Kirkegaard
Aarhus University Hospital, Aarhus C, Denmark
Critical Care 2014, 18(Suppl 1):P241 (doi: 10.1186/cc13431)
Introduction The aim of this study is to determine whether ward
transfers causing delayed ICU admission are associated with increased
in-hospital mortality in patients with community-acquired severe
sepsis or shock. Community-acquired infections are among the leading
causes of ICU admission [1]. The 30-day mortality for adult emergency
department (ED) patients with a delay in ICU admission of up to
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24 hours has been found to be significantly higher compared with
patients admitted directly to the ICU from the ED [2].
Methods A retrospective cohort study of patients admitted with
community-acquired sepsis to a 12-bed, tertiary ICU at a universityaffiliated teaching hospital, November 2008 to October 2010. Patients
were divided into two groups based on their ICU admission pattern:
direct transfer from the ED (direct group); and one or more ward
transfers between the ED and ICU within 48 hours (delayed group). Our
primary outcome measure was mortality.
Results We identified 277 patients admitted to the ICU within 48 hours
from arrival in the ED. Of these, 186 were admitted directly from the
ED, and 91 patients had more than one ward transfer between the
ED and the ICU. In-hospital mortality in the delayed group was 32%
compared with 21% in the direct group (P = 0.0477). Patients with
delayed admission had significantly lower APACHE II scores: 21 (16; 26)
and 24 (18.75; 31) respectively (P = 0.0016). The in-hospital LOS was
similar in the two groups. For patients in the delayed group, we found a
trend toward increased 30-day mortality (P = 0.0723), 90-day mortality
(P = 0.0838) and higher Charlson Comorbidity Index (P = 0.0609).
Conclusion We found that patients admitted with communityacquired severe sepsis or shock are more likely to die in-hospital if they
experience redundant ward transfers within 48 hours of admission.
However, the delayed group was significantly lower risk stratified in the
ICU based on their APACHE II score. Identification of severe sepsis and
risk assessment in the ED is crucial for patient outcome.
References

pyelonephritis or intraabdominal infection were blindly assigned to
placebo or clarithromycin for four consecutive days as adjunctive
treatment to standard of care. Clarithromycin was administered at a
dose of 1 g once daily in 1 hour of continuous infusion. Organ failures
before allocation to blind treatment were defined according to the
Surviving Sepsis Campaign 2003 definitions. Cox regression analysis
was done to verify the effect of clarithromycin as a moderator. Hazard
ratios (HRs) and 95% confidence intervals (CIs) were calculated.
Results Forty-nine patients of the placebo arm and 55 patients of the
clarithromycin arm had acute lung injury (ALI); mortality was 51.0%
and 30.9% respectively (P = 0.046). Forty-seven patients of the placebo
arm and 54 patients of the clarithromycin arm had acute coagulopathy;
mortality was 44.7% and 44.4% respectively (P = 1.000). Twenty
patients of the placebo arm and 19 patients of the clarithromycin arm
had metabolic acidosis; mortality was 55.0% and 52.6% respectively
(P = 1.000). Twenty-nine patients of the placebo arm and 39 patients
of the clarithromycin arm had acute oliguria; mortality was 55.2%
and 48.7% respectively (P = 0.631). ALI (HR = 2.42; 95% CI = 1.45 to
4.03, P = 0.001), acute coagulopathy (HR = 2.65; CI = 1.69 to 4.16) and
cardiovascular failure (HR = 3.36, CI = 2.09 to 5.39) were independently
associated with unfavorable outcome. Adding treatment with
clarithromycin in the equation reduced the risk for death by ALI by
1.86-fold (HR = 0.54; CI = 0.29 to 0.99, P = 0.049).
Conclusion Clarithromycin is a major moderator of the physical course
of Gram-negative sepsis complicated with ALI.
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Introduction A recent randomized trial of our group showed that
blind treatment with clarithromycin decreased mortality from septic
shock and multiple organ dysfunction, shortened time until resolution
of infection in patients with severe sepsis/shock and decreased
hospitalization costs [1]. The efficacy of clarithromycin in relation with
the type of failing organs is analyzed.
Methods Six hundred patients with systemic inflammatory response
syndrome due to primary Gram-negative bacteremia or acute

Giamarellos-Bourboulis EJ, et al.: J Antimicrob Chemother 2013. [Epub ahead of
print]
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Introduction Recombinant human soluble thrombomodulin (rhTM)
demonstrated promising evidence suggestive of efficacy in a phase
IIb, randomized, controlled trial [1] and is currently under evaluation
in a phase III trial. However, the benefit profiles of rhTM have not been
elucidated. The purpose of this study was to explore whether patients
with a high disease severity (according to Acute Physiology and
Chronic Health Evaluation (APACHE) II and Sequential Organ Failure
Assessment (SOFA) scores) might have a treatment benefit from rhTM
administration.

Figure 1 (abstract P243). Estimated survival curves for each of three disease severities.
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Methods This was a post-hoc, subgroup analysis of a multicenter
retrospective cohort study [2] conducted in three tertiary referral
hospitals in Japan. All patients with sepsis-induced DIC who required
ventilator management were included. We stratified all patients with
different disease severity, as defined by APACHE II and SOFA scores
to three strata. Intervention effects estimated as hazard ratios were
analyzed by Cox regression analysis adjusted for propensity model to
detect subgroup heterogeneity of the effects of rhTM on in-hospital
mortality.
Results Eligible were 162 patients with sepsis-induced DIC; 68 patients
received rhTM and 94 did not. After adjusting for imbalances, rhTM
administration was significantly associated with reduced mortality only
in patents in the stratum II group (APACHE II, 22 to 27) (adjusted hazard
ratio, 0.20; 95% confidence interval, 0.05 to 0.74; P = 0.016), while not
significant in stratum I and stratum III (Figure 1). A similar tendency was
observed in analysis for SOFA score (stratum I (SOFA, –10), P = 0.368;
stratum II (SOFA, 11 to 12), P = 0.012; stratum III (SOFA, 13–), P = 0.673).
Conclusion A survival benefit with rhTM treatment was observed
in sepsis-induced DIC and a high risk of death according to baseline
APACHE II and SOFA scores.
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Comprehensive assessment of the true sepsis burden using
electronic health record screening augmented by natural language
processing
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Critical Care 2014, 18(Suppl 1):P244 (doi: 10.1186/cc13434)
Introduction Interventional trials for sepsis have not shown an
improvement in patient outcomes, often due to the lack of a diagnostic
gold standard resulting in large heterogeneity of the patients enrolled.
Electronic health record (EHR) screening tools have been applied to
the sepsis population but limited to vital sign and laboratory data to
identify target patients. Our objective was to describe an investigational
database created through the application of a new EHR screening tool
that applies natural language processing (NLP) analysis to clinical
documentation to augment the identification of infection.
Methods We acquired data from the Clinical Vigilance for Sepsis
EHR screen on consecutive patients from two hospital systems over
12 months at a 300-bed community hospital and 24 months from a 500bed academic tertiary care center. A physician order for intravenous
antibiotics was used as a surrogate for suspected infection, removing
patients receiving a single dose of antibiotics without subsequent
administration. Each patient’s in-hospital course was tracked from
arrival to final disposition, identifying vital signs, laboratory values,
radiological results, and interventions as they occurred. Patients
were followed for the primary outcome of mortality, with secondary
outcomes of transfer to the ICU, vasopressor initiation and mechanical
ventilation.
Results The EHR screen identified 216,550 patients over a total of
36 months from the two hospitals. A total of 37,160 (17%) patients
were treated with i.v. antibiotics. Sepsis patients experienced a 3%
(1,186/37,160) mortality rate relative to 0.5% (448/216,550) in patients
without infection at any time. Sepsis at any time represented 73%
(1,186/1,634) of all in-hospital deaths. ICU transfer occurred in 18%
(6,865/37,160) of patients, with septic shock (vasopressor requirement)
occurring in 10% (3,837), and 13% (5,072) requiring mechanical
ventilation.
Conclusion Application of this novel EHR screening tool to identify
sepsis patients utilizes NLP applied to clinical documentation, providing
greater clinical context than laboratory and vital sign screening alone.
This database represents the entire sepsis acuity spectrum, allowing
for a more granular description of the infectious process as well as
subgroups with adequate sample size. The dataset collected as a
patient-centered time series will enable future studies to focus on the
trajectory of clinical deterioration and shock before its occurrence.
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Outcomes of neutropenic patients with severe sepsis on a specialist
cancer ICU
S Jhanji, S Hallam, T Wigmore
Royal Marsden NHS Trust, London, UK
Critical Care 2014, 18(Suppl 1):P245 (doi: 10.1186/cc13435)
Introduction The hospital survival rate for patients with septic shock
remains at approximately 50% [1]. Critically ill cancer patients have
often been considered poor candidates for ICU management due to
the perception of poor outcomes for this group, in particular in the
presence of neutropenia. There is a paucity of data supporting this. The
objective of this study was to describe clinical outcomes for a group of
septic neutropenic patients admitted to a cancer ICU.
Methods All neutropenic patients (neutrophils <1,000/mm3) admitted
to the ICU at the Royal Marsden hospital (London, UK) between October
2010 and December 2012 with a diagnosis of severe sepsis/septic
shock were included retrospectively. Data were collated from patients’
electronic records after approval by the hospital audit committee. Data
are presented as the absolute value (%) or median (IQR). Fisher’s exact
test or the Mann–Whitney U test was used as appropriate.
Results Sixty-four neutropenic patients were admitted to the ICU
during this period. Forty-seven (73%) patients survived to ICU discharge
and 34 (53%) patients to hospital discharge. Twenty-two (34%) patients
were alive at 6 months and 18 (28%) patients were alive at 12 months.
Seventy-seven percent of patients had microbiologically documented
infections. There was no significant difference between ICU survivors
and nonsurvivors in duration of neutropenia, the presence of, or
removal of, indwelling catheters, or the source of sepsis. Mechanical
ventilation and need for vasopressors were associated with worse
outcomes. Patient characteristics are presented in Tables 1 and 2.
Table 1 (abstract P245). Patient characteristics
ICU survivors
n
Age (years)
BM transplant

ICU nonsurvivors

47 (73%)

17 (27%)

53 (38 to 65)

49 (33 to 62)

24 (51%)

7 (41%)

Table 2 (abstract P245). Characteristics on admission to the ICU
ICU survivors

ICU nonsurvivors

Neutrophil count

0.5 (0.3)

0.2 (0.3)*

Days of neutropenia

3 (0 to 8)

6 (0 to 19)

*P <0.05.

Conclusion In a group of oncology patients admitted to the ICU with
neutropenia and severe sepsis/septic shock, we found an in-hospital
mortality of less than 50%. This is similar to the general population.
Reference
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Vitamin D and ICU outcome in septic patients: a difficult
connection?
FI Socci, A Cecchi, S Di Valvasone, M Ciapetti, L Perretta, ML Migliaccio,
G Zagli, S Batacchi, G Cianchi, M Bonizzoli, A Terreni, A Peris
AOU Careggi, Florence, Italy
Critical Care 2014, 18(Suppl 1):P246 (doi: 10.1186/cc13436)
Introduction Vitamin D, a secosteroid hormone, has roles in the
optimal functioning of many organ systems and illnesses [1]. Recent
reports show that most patients admitted to the ICU are vitamin D
insufficient [2].
Methods In a 10-bed general ICU at the emergency department of a
tertiary teaching hospital in Florence (Italy), 71 medical patients with
severe sepsis or septic shock (51% men, 40% women) admitted to the
ICU between January 2013 and September 2013 were studied. Vitamin
D levels were measured by radioimmunoassay at admission, as well
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topic. Published data, summarized by this meta-analysis of randomized
trials, show that statin therapy has no detrimental effect on survival in
the overall population of adult septic patients.

Table 1 (abstract P246).
Length Length
of stay of stay in Vitamin
ICU
hospital
D
(days)
(days) (ng/ml)

Age

SAPS

BMI

Mean

62.59

52.48

10.14

24.90

11.35

26.38

Median

67.00

54.00

6.00

20.00

9.60

24.83

Mode

77.00

40.00

3.00

8.00

4.00

24.69

Standard deviation

17.85

18.35

10.17

20.70

7.16

8.33

as demographic data (Table 1) and the Simplified Acute Physiology
Score II (SAPS II). Exclusion criteria were: age <18 years, malnutrition
state (body mass index (BMI) <18 kg/m2), pregnancy. Statistical analysis
was carried out by linear regression and t test with SPSS 13. This study
was approved by the Internal Review Board. Informed consent was
obtained.
Results Most patients showed vitamin D levels below 20 ng/ml, and
we have not demonstrated a statistical significance correlation in
the univariate regression between vitamin D level and both SAPS
(P = 0.300) or length of stay in hospital (P = 0.154). Also our data do not
demonstrate a statistical significance difference at t test between the
value of vitamin D in the dead group and the alive group.
Conclusion Several groups have reported an inverse association
between vitamin D levels in critically ill patients, severity of disease,
outcome length of ICU stay and mortality [3,4]. In our experience we
have not found an evident correlation between low vitamin levels and
ICU outcomes. However, considering the prevalence of low vitamin D
levels among the medical patients admitted to the ICU, further studies
should be performed.
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A meta-analysis of randomized controlled trials on the use of statins
in septic patients
G Landoni, L Nobile, D Febres, E Frati, N Villari, AL Di Prima, R Dossi, L Pasin
Vita-Salute San Raffaele University, Milan, Italy
Critical Care 2014, 18(Suppl 1):P247 (doi: 10.1186/cc13437)
Introduction Beneficial effects of 3-hydroxy-3-methylglutaryl
coenzyme A (HMG-CoA) reductase inhibitors (statins) on vascular
diseases have been demonstrated in several clinical trials. Recently
discovered anti-inflammatory effects of statins seem to have an
important role in counteracting the harmful effects of sepsis on the
coagulation system. Many epidemiologic studies evidence that statin
treatment may be associated with a better prognosis in severe bacterial
infections, and a recent randomized trial found a reduced mortality
in the statin group. We decided to perform a meta-analysis of all
randomized controlled trials ever performed on statin therapy in septic
patients to evaluate their effect on survival.
Methods Four trained investigators searched and assessed pertinent
studies in BioMed Central, PubMed, Embase and the Cochrane Central
Register (divergences resolved by consensus). Inclusion criteria
were: random allocation to treatment; comparison of statins versus
any comparator in septic patients. Exclusion criteria were: duplicate
publications; nonadult studies; no data on main outcomes.
Results Data from 650 patients in five randomized controlled studies
were analyzed. Overall analysis showed no difference in mortality
between patients receiving statins (44/322 (14%)) versus control
(50/328 (15%)), RR = 0.90 (95% CI 0.65 to 1.26), P = 0.6.
Conclusion Scientific evidence for the role of statins in septic patients
is still limited and larger randomized trials should be performed on this
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Efficacy of early administration of thrombomodulin alfa in patients
with sepsis-induced disseminated intravascular coagulation:
subanalysis from post-marketing surveillance data
Y Eguchi1, S Gando2, H Ishikura3, D Saitoh4, J Mimuro5, H Takahashi6,
I Kitajima7, H Tsuji8, T Matsushita9, Y Sakata5
1
Shiga University of Medical Science, Shiga, Japan; 2Hokkaido University
Graduate School of Medicine, Hokkaido, Japan; 3Fukuoka University, Fukuoka,
Japan; 4National Defense Medical College, Saitama, Japan; 5Jichi Medical
University, School of Medicine, Tochigi, Japan; 6Niigata Prefectural Kamo
Hospital, Niigata, Japan; 7Graduate School of Medical and Pharmaceutical
Science, University of Toyama, Japan; 8Kyoto Prefectural University of
Medicine, Kyoto, Japan; 9Nagoya University Hospital, Nagoya, Japan
Critical Care 2014, 18(Suppl 1):P248 (doi: 10.1186/cc13438)
Introduction We hypothesize that the early administration of thrombomodulin alfa (TM-alfa) (Recomodulin® injection; Asahi Kasei Pharma
Corporation, Tokyo, Japan) could improve mortality in patients with
sepsis-induced disseminated intravascular coagulation (DIC). TM-alfa
has been approved for use as a curative medicine for DIC in Japan from
2008 that was examined in a multicenter, randomized, clinical trial [1].
Methods DIC was diagnosed based on the Japanese Association
for Acute Medicine (JAAM) criteria. From May 2008 to April 2010, a
total of 1,787 patients with sepsis-induced DIC from post-marketing
surveillance data [2] were analyzed. The survival rates on day 28 after
the last TM-alfa administration were evaluated.
Results The 28-day survival rate was 64.5%. Use of other anticoagulants
before and after TM-alfa administration did not affect the survival rate
(present vs. absent: 63.8% vs. 65.2% (P = 0.782) and 62.5% vs. 65.3%
(P = 0.606) respectively). The survival rate decreased significantly
in proportion to the duration of DIC before TM-alfa administration
(P <0.001). More precisely, the 28-day survival rate was 66.4% when TMalfa was injected on the same day that DIC was diagnosed, whereas it
was 48.5% and 31.1% when TM-alfa was started 4 days later and 7 days
or more after DIC was diagnosed, respectively. These differences were
significant (P = 0.033 and P <0.001, respectively).
Conclusion The early administration of TM-alfa may be effective for
patients with sepsis-induced DIC diagnosed based on the JAAM criteria.
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Dynamic myocardial depression in septic cardiomyopathy
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Introduction Depression of left ventricular contractility appears in
many diseases resulting from various etiology factors. One of the most
interesting features of septic cardiomyopathy is the significant dynamic
myocardial depression that is commonly observed. In this context, the
objective of the present work is to characterize clinically, by laboratory,
by echocardiography, and by invasive measures the patients with
septic cardiomyopathy.
Methods A single-center database investigates all patients who were
admitted and treated for severe sepsis or septic shock in the ICU over
a period of 2 years (November 2011 to October 2013), and who were
discharged with a diagnosis of septic cardiomyopathy or new left
ventricular dysfunction. The clinical, laboratory, echocardiography, and
invasive measures, and clinical outcome were recorded.
Results From the 105 patients that were investigated, 15 patients were
found with septic cardiomyopathy. Septic cardiomyopathy is more
prevalent among men (60%). Patients with septic cardiomyopathy
have an increased prevalence of immune compromised disease (46%),
and hypertension (40%). There was a need for mechanical respiratory
support for 86% of patients. The improvement in cardiac function

Critical Care 2014, Volume 18 Suppl 1
http://ccforum.com/supplements/18/S1

occurred at an average of 6.9 days. E. coli is the commonest bacterial
pathogen (33%). Laboratory findings show elevated liver enzyme and
kidney function impairment in all patients. Thirty-three percent of
patients were treated with N-acetyl cysteine, and 46% were treated
with renal replacement therapy. High CRP was observed in all patients.
Paroxysmal atrial fibrillation was diagnosed in 46%. Invasive measures
in 50% of the patients have demonstrated high cardiac index (CI) and
low systemic vascular resistant index (SVRI) on their admission, and 93%
demonstrate low CI and high SVRI a few hours later. Hospitalization stay
was between 3 and 42 days with an average of 14.6 days.
Conclusion Septic cardiomyopathy is more common among immune
compromised patients. It is characterized by dynamic changes in the
cardiac function based on echocardiography and invasive measures. A
persistent hyperkinetic state was associated with high mortality rate. In
addition to echocardiography follow-up, invasive monitoring even in
their admission is of great importance for more effective and adequate
treatment.
P250
Significant change in the practice of chest radiography in Dutch ICUs
M Tolsma1, TA Rijpstra2, MJ Schultz3, NJ Van der Meer2
1
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Critical Care 2014, 18(Suppl 1):P250 (doi: 10.1186/cc13440)
Introduction We performed a survey under Dutch intensivists on
the current practice of chest radiography in their departments. Chest
radiographs (CXRs) are obtained frequently in ICU patients, despite the
diagnostic and therapeutic efficacy of routine CXRs being known to be
low. The discussion regarding specific indications for CXRs in critically ill
patients and the safety of abandoning routine CXRs is still continuing [1].
Methods A web-based questionnaire was sent to the medical director
of all adult ICUs in the Netherlands. This survey contained questions
regarding ICU characteristics, ICU patients, daily CXR strategies,
indications for routine CXRs and the practice of radiologic evaluation.
Results Of the 83 ICUs that were contacted, 69 (83%) responded to the
survey. Only 7% of ICUs still perform daily routine CXRs for all patients
while 65% of ICUs say never to perform CXRs on a routine basis. A daily
meeting with a radiologist is established in the majority of ICUs and is
judged to be important or even essential. The therapeutic efficacy of
routine CXRs was assumed by intensivists to be lower than 10% or to
be between 10 and 20%. The efficacy of on-demand CXRs was assumed
to be between 10 and 60%. There is consensus between intensivists
to perform a routine CXR after endotrachial intubation, chest tube
placement or central venous catheterization.
Conclusion The strategy of daily routine CXRs for critically ill patients
has developed from a common practice (63%) in 2006 [2] to a rare
practice (7%) nowadays. Intensivists still assume the value of routine
CXRs to be higher than the efficacy that is reported in the literature.
This might be due to the clinical value of negative findings, which has
not been studied before.
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increases their efficacy and safely reduces costs
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Introduction We investigated the efficacy and safety of chest
radiographs (CXRs) performed on specified indications only, directly
after cardiac surgery. CXRs in the ICU are frequently obtained routinely
for postoperative cardiosurgical patients, despite the fact that the
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diagnostic and therapeutic efficacy of these CXRs is now known to be
low [1]. Routine CXRs may only be beneficial for certain indications
and the discussion regarding these indications and the safety of
abandoning routine CXRs is still continuing [2].
Methods We prospectively included all patients who underwent
major cardiac surgery in the year 2012. A direct postoperative CXR was
performed only for certain specified indications. An on-demand CXR
could be obtained during the postoperative period according to other
specified indications. For all patients who did not have a CXR taken
before the morning of the first postoperative day, a control CXR was
then performed. All CXR findings were noted and classified, including
whether or not they led to an intervention. Diagnostic and therapeutic
efficacy values were calculated.
Results A total of 1,351 patients were included who mainly underwent
coronary artery bypass grafting, valve surgery or a combination of
both. Eighteen percent of patients underwent a minimally invasive
cardiac surgery. The diagnostic efficacy for major abnormalities was
clearly higher for the postoperative and on-demand CXRs, performed
on indication, when compared with the next-morning routine CXR
(6.7% and 6.9% vs. 2.9%) (P = 0.002). The therapeutic efficacy was also
clearly higher for the postoperative and on-demand CXRs (2.9% and
4.1%), while the need for intervention after the morning control CXR
was now reduced to be minimal (0.6%) (P = 0.002).
Conclusion Stating clear indications for CXRs following cardiac surgery
increases the efficacy of these CXRs and safely reduces the total number
of CXRs significantly.
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Introduction The aim of the study was to investigate early graft
function in terms of biological and radiological variables in a case series
of lung transplant (Ltx).
Methods We performed a prospective analysis of patients that
underwent Ltx at Fondazione IRCCS Cà Granda Policlinico of Milan
from 1 December 2012 to 10 December 2013. Donors’ lung parameters
were recorded. Recipients’ clinical data were collected daily and lung
computed tomography (CT) at end expiration was performed within
7 days after Ltx. On the same day, bronchoalveolar lavage was collected
[1]. Quantitative CT analysis was run on separate lungs for each patient.
Results Out of 25 LTx, 12 paired data for donors and recipients were
analyzed. Lung donors’ PaO2/FiO2 was 392 ± 118, Oto score was 5 ± 3,
and ICU length of stay was 2 ± 1 days. Recipients’ age was 56 ± 11 years,
and body mass index was 24 ± 4 kg/m2. Four patients received double
Ltx, and the warm ischemia time was 85 ± 16 and 94 ± 14 respectively
for right lung and left lung. When the CT scan was performed (on
Table 1 (abstract P252). Quantitative CT scan analysis on transplanted lungs
Lung CT
Volume (ml)

Mean ± SD (n = 16)
1,639 ± 437

Weight (g)

761 ± 175

Hyper inflated (%)

0.0 ± 0.0

Normal (%)

38.9 ± 17.1

Poorly (%)

29.4 ± 8.4

Not inflated (%)

31.7 ± 14.9
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day 4 ± 1), four patients were mechanically ventilated, PaO2/FiO2 was
270 ± 93 and PaCO2 was 44.6 ± 10.0 mmHg. Primary graft dysfunction
grade 2 or 3 at 72 hours post Ltx was diagnosed in six patients. All
patients were discharged from ICU. Table 1 presents quantitative
analysis of transplanted lungs. The alveolar protein concentration and
not aerated tissue weight are significantly related (R2 =0.69; P = 0.001).
Conclusion Alveolar protein concentration is related to morphological
features of lungs early after Ltx.
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Can laboratory blood tests be used to risk stratify patients admitted
with pneumonia?
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Introduction Our objective was to determine whether an Early
Warning Score (EWS) based on laboratory tests could risk stratify
patients admitted to the Norfolk & Norwich University Hospitals
NHS Foundation Trust with pneumonia. Physiological EWS systems
producing an escalated response to an increasing score are used
effectively within the Trust, yet mortality is high in patients admitted
with a diagnosis of pneumonia. The CURB-65 score may not be an
effective risk stratification tool for predicting mortality in the older
patient nor to guide intensive care admission [1]. Jarvis and colleagues
developed an EWS based on laboratory blood tests and used it in
conjunction with physiological EWS to effectively risk stratify all
medical patients [2].
Methods Of 2,158 patients admitted with pneumonia during
12 months from August 2012, data were collected for 1,598 who had
received the required blood tests. Data included dates of admission,
discharge and death if appropriate, gender, haemoglobin (g/dl), white
cell count (109/l), sodium (mmol/l), potassium (mmol/l), urea (mmol/l),
creatinine (mmol/l) and albumin (g/l) on admission. A composite EWS
was calculated and measured against outcome.
Results Of 1,598 patients, 538 died during this admission. It is uncertain
whether death was due to pneumonia as only admission diagnosis is
recorded but overall mortality was 35%. Analysis of data showed a
strongly positive relationship between increasing EWS and increased
risk of mortality with a correlation coefficient of 0.97.
Conclusion Observational results suggest an EWS based on laboratory
tests can be used to risk stratify patients with pneumonia and could
be used to treat those with higher scores more aggressively earlier in
their illness. Further analysis is required to determine whether age is
a contributing factor and how this may modify the EWS. We need to
determine whether laboratory-based EWS risk stratification can be
used in isolation, or whether it contributes sufficiently to an existing
physiological EWS that a combined system would improve outcome
in our patients.
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Lung function in the immediate postoperative period after videoassisted thoracoscopic and thoracotomy pulmonary resection
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Introduction Previous studies reported that video-assisted thoracoscopic surgery (VATS) is more beneficial for pulmonary lobectomy
concerning the late postoperative period than open thoracotomy [1,2].
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However, the early postoperative period when the rate of complications
is highest has been scarcely examined. Our study aimed to compare
the residual pulmonary function of pulmonary lobectomy patients
after VATS and the standard thoracotomy approach in the immediate
postoperative period.
Methods This prospective study included 14 VATS and 13 thoracotomy
lobectomy (THOR) patients (age 58.8 ± 10.9 vs. 59 ± 8.9 years, P = 0.96;
preoperative FVC 3.4 ± 1 vs. 3.4 ± 0.95 l, P = 0.98 and preoperative
FEV1 2.7 ± 0.96 vs. 2.7 ± 0.6 l, P = 0.9, respectively). All patients
received standard surgical and postoperative care with standardized
pain management including i.v. diclofenac combined with epidural
administration of bupivacaine and fentanyl. Spirometry was performed
with a bedside MIR Spirolab II spirometer (Rome, Italy) preoperatively
and 4, 8, 24, 48 and 72 hours after the surgery. FVC, FEV1, PaO2, PaCO2,
complication rate, and length of ICU and hospital stay were recorded.
Postoperatively measured FVC and FEV1 values were divided by
preoperatively predicted values and multiplied by 100 to give the
normalized FVC (nFVC) and FEV1 (nFEV1) [3].
Results The nFVC and nFEV1 values were significantly higher in the
VATS group in the fourth and eighth postoperative hours compared
with the THOR group (84.3 ± 14.4 vs. 64.3 ± 23.4, P = 0.013 and 84 ± 18.8
vs. 64 ± 22, P = 0.017, respectively). There was no statistically significant
difference between the groups in the 24th, 48th and 72nd hours,
although VATS patients showed higher values at each time points. The
length of ICU stay was similarly 1 day, but the length of hospital stay
was significantly longer in the THOR group (5 (3 to 6) vs. 7 (3 to 42) days
(median and range) (P = 0.011)).
Conclusion Preoperative lung function prediction severely overestimates the real lung capacity of lobectomy patients in the immediate
postoperative period. VATS lobectomy seems more beneficial from the
point of early postoperative lung function. VATS lobectomy should be
considered in patients with poor preoperative spirometry results to
ensure better postoperative outcome.
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Lung ultrasound reaeration score: a useful tool to predict
non-invasive ventilation effectiveness
L Nobile, P Beccaria, M Zambon, L Cabrini, G Landoni, A Zangrillo
Ospedale San Raffaele, Milan, Italy
Critical Care 2014, 18(Suppl 1):P255 (doi: 10.1186/cc13445)
Introduction The aim of our study is to evaluate the lung ultrasound
(LUS) reaeration score (ReS) as a predictive tool for non-invasive
ventilation (NIV) efficacy in general wards for acute respiratory failure
(ARF) treatment. Even if ICUs are considered the safest place to perform
NIV, a shortage of intensive beds has lead to NIV application outside
the ICU. With appropriate patient selection, treatment-timing choice,
adequate monitoring and staff training, NIV application in general
wards can allow one to safely treat patients at an early stage with better
cost-effectiveness [1]. Few data assessing the right tool to evaluate NIV
treatment efficacy are available.
Methods We present preliminary data of a prospective observational
ongoing study. Sixteen patients undergoing NIV treatment outside the
ICU for ARF of any origin were evaluated with LUS at three times: before
NIV application (T0), and at 5 minutes (T5) and 60 minutes (T60) of NIV
treatment. US scan was performed in six regions for each emithorax.
LUS patterns were defined as: consolidation (C); multiple coalescent
B-lines (B+); multiple irregularly spaced B-lines (B) and normal aeration
(A). A LUS-ReS [2] was calculated detecting changes in the US pattern
when comparing T0 to T5 and T0 to T60 assessments. Outcome was
defined as NIV failure in the case of tracheal intubation or death within
1 week from ARF outset, otherwise NIV success.
Results NIV treatment failed in five patients. Eleven patients have been
successfully treated with NIV. Mean LUS-ReS (SD) at T0 to T5 was 0
(± 3.1) in group 0 and 2.5 (± 2.5) in group 1 (P = 0.15). Mean LUS-ReS
(SD) at T0 to T60 was –1.2 (± 3.9) in group 0 and 4.2 (± 3.4) in group
1 (P = 0.03). ROC curves were obtained for the two LUS-ReS at T0 to
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Figure 1 (abstract P255).

T5 (AUC 0.72) and T0 to T60 (AUC 0.83) (Figure 1). A LUS-ReS cutoff
value of 0 can predict NIV effectiveness, with a sensibility of 91% and a
specificity of 80%.
Conclusion If confirmed, our preliminary results suggest that LUS-ReS
could be a useful tool in predicting NIV effectiveness for ARF treatment.
Caution has to be applied when interpreting our results considered the
small amount of patients enrolled.
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P256
Ultrasound in the diagnosis of pneumothorax: a survey of current
practice
T Berlet, T Fehr, T Merz
Inselspital/University Hospital Bern, Switzerland
Critical Care 2014, 18(Suppl 1):P256 (doi: 10.1186/cc13446)
Introduction The purpose of this study was to survey current practice
for the use of lung ultrasound (LUS) in the diagnosis of pneumothorax.

Figure 1 (abstract P256). Accuracy of LUS in pneumothorax.
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Methods Physician sonographers accredited by the German Medical
Ultrasound Society (DEGUM) for ultrasonography in surgery,
anaesthesia or medicine were invited to participate in an online survey.
Frequency of exposure to patients with suspected pneumothorax,
frequency of LUS use, assessment of diagnostic accuracy of LUS for
ruling-out or ruling-in pneumothorax and preferences regarding
technical aspects were enquired about.
Results Eighty-nine physicians responded. Average exposure to
pneumothorax cases was 1/week. Fifty-five per cent of respondents
used LUS ‘always’ or ‘frequently’. Thirty-four per cent of physicians rated
LUS as ‘always accurate’, and a further 54% as ‘accurate in a majority
of cases’ in ruling out pneumothorax. Twenty-one per cent rated
LUS as ‘always accurate’ and 69% as ‘accurate in a majority of cases’
in ruling in pneumothorax. Physicians reporting frequent exposure
to pneumothorax patients used LUS in a higher proportion of cases
(‘high caseload sonographers’) and were more confident to rule
out pneumothorax (Figure 1). In total, 16 different combinations of
transducers, probe orientations and scanning modes were reported.
Linear transducers, sagittal probe-orientation, and B-mode and
M-mode scanning were most often selected (38%).
Conclusion Physicians’ use of LUS in the diagnosis of pneumothorax
was modest. Assessment of diagnostic accuracy gave markedly lower
scores than reported in clinical trials [1]. Correlation between frequency
of exposure, likelihood of LUS usage and confidence in diagnostic
accuracy warrants further research into the nature of the learning
curve. Considerable variations regarding technical aspects of LUS
reflect the ambiguity of current recommendations [2]. More research
is required to establish the most efficient way of performing LUS for
suspected pneumothorax and efforts need to be made to promote its
use in these scenarios.
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Computed tomographic assessment of airflow obstruction in smoke
inhalation injury
H Yamamura, T Yamamoto, S Kaga, K Kaneda, Y Mizobata
Osaka City University, Osaka, Japan
Critical Care 2014, 18(Suppl 1):P257 (doi: 10.1186/cc13447)
Introduction Smoke inhalation injury (SII) is progress to pulmonary
edema, pneumonia, and acute respiratory distress syndrome. SII may
cause bronchial mucosal edema; we hypothesized that narrowing
of luminal air bronchus due to bronchial wall edema correlated with
respiratory deterioration of SII patients.
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Methods We prospectively studied 42 patients with a diagnosis of
SII, according to visualized bronchoscopic findings at admission,
and 15 control subjects. The thoracic high-resolution computed
tomography (HRCT) scan was obtained within a few hours of admission
to our hospital. Airway wall dimensions were calculated using a
validated method. The images were viewed on a workstation using a
magnification of ×5, and measurements of overall (D) and internal (L)
diameter of the bronchi were made using electronic calipers, with wall
thickness (T) being derived from these measurements (T = (D – L) / 2).
Luminal area (Ai, mm2) and total airway wall area (Ao) were calculated
from L and D, respectively, using the formula: A = r2. We used both
the ratio of airway wall thickness to total diameter (T/D ratio) and the
percentage luminal area (LA% = (Ai / Ao + Ai) × 100).
Results The mean age of the patients was 59 years, 32 of the patients
were men. The mean (SD) diameter of the bronchi in SII patients
measured was 3.9 (1.5) mm (range 0.9 to 9.0 mm). There were
statistically significant positive associations between wall thickening
(expressed as T/D ratio) and luminal narrow (expressed as LA%) and
the developed pneumonia (T/D ratio: R2 = 0.56, P <0.01 and LA%: R2 =
0.19, P = 0.005) and mechanical ventilation days (T/D ratio: R2 = 0.37,
P <0.0001 and LA%: R2 = 0.32, P <0.001, respectively). No statistically
significant associations were identified between T/D ratio or LA% and
initial P/F ratio, infusion volume initial 24 hours, ICU stay days, and
outcome. The mean T/D ratio and LA% were 0.25 (0.04) and 25.9% (7.6)
for patients with SII and 0.35 (0.04) and 44.7% (5.6) for controls.
Conclusion We have shown with the use of HRCT scanning on admission
that patients with SII have airway wall thickening compared with
normal controls. Furthermore, airflow obstruction due to bronchial wall
edema related with developed pneumonia and mechanical ventilation
days in SII patients.

P258
Semi-upright position improves ventilation and oxygenation in
mechanically ventilated intensive care patients
F Van Beers, P Vos
St Elisabeth Hospital, Tilburg, the Netherlands
Critical Care 2014, 18(Suppl 1):P258 (doi: 10.1186/cc13448)
Introduction A semi-upright position (45° position) in ventilated
patients is recommended to prevent ventilator-associated pneumonia
(VAP) and is one of the first steps in progressive early mobility. We
studied ventilated intensive care patients in a semi-upright position
compared with a supine position to explore whether there was an
improvement of oxygenation and ventilation.
Methods We retrospectively studied 60 patients in a mixed medical,
surgical, neurological ICU during 2003 and 2007 [1-3]. In this study the
effects of 45° position on the peripheral oxygen saturation (SpO2) and
the end-tidal carbon dioxide (ETCO2) were measured. Body position was
changed with a Total Care® bed (Hill-Rom) after results for the supine
position (10°) were obtained. Half an hour after the body position was
changed, measurements were taken, which included SpO2 and ETCO2.
The results of body position change in the individual patients were
analysed with paired-samples t test. A significance level <0.05 was
considered significant.
Results Mean SpO2 supine was 96.55% ± SD 2.404 versus mean
SpO2 semi-upright 97.4% ± SD 2.423, and mean ET-CO2 supine was
4.62% ± SD 1.988 versus mean ET-CO2 semi-upright 4.31% ± SD 1.060.
The SpO2 (P <0.0001) and the ETCO2 (P <0.0001) improved significantly
for the 45° position compared with <10° position.
Conclusion We demonstrated a significant increase in oxygen
saturation and a significant decrease in end-tidal CO2 when the head
of the bed was elevated during mechanical ventilation. We believe
positional therapy in intensive care patients is very important. The
semi-upright position is an easy, effective and safe treatment in ICU
patients. This position is effective in the bundle prevention of VAP,
is the first step in progressive early mobility and is also effective in
oxygenation and ventilation in mechanically ventilated patients. This
clinical benefit of head-of-bed elevation >30° must lead to a standard
of care in mechanically ventilated patients. Since 2009 the semi-upright
position is a standard of care in our hospital.
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Effects of sitting on the respiratory pattern, mechanics and work of
breathing in mechanically ventilated patients
F Ruiz-Ferron1, J Serrano-Simon2
1
Complejo Hospitalario de Jaen, Spain; 2Hospital Reina Sofia, Cordoba, Spain
Critical Care 2014, 18(Suppl 1):P259 (doi: 10.1186/cc13449)
Introduction The effect of sitting in an armchair on mechanically
ventilated patients has not been studied enough. We study a group
of patients ready for weaning for the respiratory pattern, mechanics
and work of breathing during reclining in bed and after sitting in an
armchair.
Methods Thirteen patients who needed mechanical ventilation after
18 days (1 to 60) were studied during volume assist-control mechanical
ventilation and spontaneous breathing (O2T, CPAP or PSV) in both
positions. Airways, esophageal pressures and flow were registered for
posterior analysis. Passive respiratory mechanics were measured by
multiple linear regression methods, respiratory drive in esophageal
pressure (P01) and respiratory effort using the pressure time product
(PTP).
Results On controlled mechanical ventilation the respiratory system
and chest wall elastance were significantly higher in sitting compared
with reclining positions (Ers 39 ± 24 vs. 33 ± 25 cmH2O/l and 10 ± 3
vs. 7 ± 3 cmH2O/l), respiratory resistances were similar (15 ± 3 vs.
14 ± 5 cmH2O/l/second) in both positions. Breathing pattern did not
change significantly: tidal volume (0.406 ± 0.108 vs. 0.394 ± 0.118 l),
inspiratory flow (0.74 ± 0.27 vs. 0.69 ± 0.23 l/second), inspiratory
(0.97 ± 0.23 vs. 0.97 ± 0.28 seconds) and expiratory (1.43 ± 0.55 vs.
1.39 ± 0.44 seconds) times and respiratory frequency (27 ± 7 vs.
26 ± 7 bpm). Respiratory drive and effort tend to be higher in the sitting
position, but not significantly. P01: 3.7 ± 1.9 versus 3.0 ± 1.4 cmH2O,
Δpes: 19 ± 10 versus 15 ± 8 cmH2O, PTPmin: 373 ± 192 versus
284 ± 162 cmH2O/second*minute.
Conclusion A sitting position for mechanically ventilated patients
increased the rigidity of chest wall and the respiratory system. The
effects of this mobilization must be evaluated because some patients
show higher respiratory drive and effort in this position.
P260
The win ratio method: a novel hierarchical endpoint for pneumonia
trials in patients on mechanical ventilation
A Montgomery1, T Abuan1, M Kollef2
1
Cardeas Pharma, Seattle, WA, USA; 2Washington University, St Louis, MO, USA
Critical Care 2014, 18(Suppl 1):P260 (doi: 10.1186/cc13450)
Introduction Development of novel antibiotics for VAP is hampered
by the need for large phase 3 trials with mortality endpoints. With allcause mortality rates decreasing, the large sample size for these trials,
in particular for non-inferiority trials, has become a barrier to rapid drug
development. Recently, a hierarchical approach to defining a composite
endpoint for CV trials (win ratio method) has been described [1].
Methods We have adapted this approach in an ongoing superiority
trial (Clinicaltrials.gov NCT01969799) comparing adjuvant use of a
combination of fosfomycin and amikacin aerosol delivered by the PARI
eFlow® Inline nebulizer in patients with Gram-negative pneumonia
who are on mechanical ventilation. Both groups are receiving standardof-care i.v. antibiotics. Patients from the active and placebo groups are
matched in pairs based on presence of MDR Gram-negative bacteria,
and disease severity by APACHE II score. Each pair has a winner and a
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loser, or is a draw. The pair is first compared on mortality; if no difference,
then ventilator-free days (VFD) are compared. If the outcomes are the
same for both endpoints, a draw results. Active versus placebo groups
will then be compared using the win ratio, defined as the number of
pairs in which the active group was the winner divided by the number
of pairs that did not result in a draw. We examined sample size and
power characteristics of the win ratio endpoint using trial simulations.
Results Assuming a 15% 28-day mortality rate in the active arm and
20% in the control arm, to have 80% power with a two-tailed 0.05-level
test for mortality would require 906 subjects per arm. Under the same
assumptions with a difference in mean VFDs of 3 favoring the active
arm (with common SD of 6), 130 subjects per arm provides 80% power.
In approximately 32% of simulations, the win ratio result for each
pair was determined by mortality. These simulation results assumed
results within pairs were uncorrelated. If a positive correlation for each
endpoint within pairs is assumed, power for the win ratio endpoint
increases.
Conclusion The win ratio method is both clinically meaningful and
straightforward to explain. This method could provide a new approach
to powering both superiority and non-inferiority trials of novel
antibiotics. In particular, this method allows for well-powered phase 2
trials, and potentially decreases the required size of phase 3 trials.
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Failure to obtain admission sputum culture is associated with
higher mortality and fewer ventilator-free days for intubated
pneumonia patients: a quality improvement project
Y Mahal, K Smith, R Riker
Maine Medical Center, Portland, ME, USA
Critical Care 2014, 18(Suppl 1):P261 (doi: 10.1186/cc13451)
Introduction The primary objective was to assess the impact of failure
to obtain sputum culture (SC) among patients requiring intubation for
pneumonia. For patients admitted to an ICU with severe pneumonia,
guidelines recommend obtaining a lower respiratory tract sample
for culture. Our experience suggested this is rarely ordered from the
emergency department (ED).
Methods We retrospectively reviewed charts of all patients admitted
through the ED with a diagnosis of pneumonia requiring intubation
in the first 24 hours between January 2011 and November 2012.
Patients were classified as SC collected or not collected. We recorded
demographic data, SC results, antibiotic choice and de-escalation,
ventilator-free days (up to day 14), and mortality in ICU and hospital.
Inferential statistics were performed using SPSS version 20.0, with
P <0.05 considered significant.
Results Of 50 patients we reviewed, 43 (86%) were intubated in the ED,
45 had SC ordered (only eight (18%) by ED physicians), and 37 (74%)
had SC collected. There was no difference in age, gender or severity
of illness as measured by APACHE score between the two groups. ICU
mortality was lower in the SC collected group (24% vs. 69%, P = 0.007),
as was hospital mortality (30% vs. 77%, P = 0.007) and antibiotics
were de-escalated more often (89% vs. 8%, P <0.001). Patient with SC
collected showed a trend toward significantly more ventilator-free days
(6.5 vs. 0, P = 0.053).
Conclusion Sputum cultures were rarely ordered by ED physicians, and
when not obtained in intubated patients with pneumonia, ICU and
hospital mortality was higher, there was less antibiotic de-escalation,
and a trend toward fewer ventilator-free days. Efforts to improve
collection of sputum cultures in these patients are warranted.
P263
Nonventilatory factors affecting noninvasive mechanical ventilation
success in hypercapnic critical care patients
S Demir, Y Aldağ, M Aydogdu, G Gürsel
Gazi University Medical Faculty, Ankara, Turkey
Critical Care 2014, 18(Suppl 1):P263 (doi: 10.1186/cc13453)
Introduction The aim was to determine the nonventilatory factors
that affect the noninvasive mechanical ventilation (NIMV) success in
patients with hypercapnic respiratory failure.
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Methods A total of 41 patients were included in this prospective cohort
study, who were followed for at least 96 hours in the ICU between
January 2010 and November 2012 with the diagnosis of hypercapnic
respiratory failure. Patients with ≥10 mmHg decrease in PaCO2 in the
first 72 hours were accepted as successful (Group 1) and those without
this decrease were accepted as unsuccessful (Group 2). Among the
patients with similar NIMV application characteristics, the effect of age,
APACHE II score, infection, bronchospasm (daily respiratory function
tests were performed with portable spirometry), heart failure, thyroid
dysfunction and physiologic dead space ventilation (VD/VT) on success
were evaluated. In statistical analysis, t test, Mann–Whitney U test and
regression analysis were used.
Results Among the 41 patients, 28 (68%) were classified as Group 1
and 13 (32%) as Group 2. No differences were identified among the
ventilatory parameters of the two groups (P >0.05). Patients in Group 1
were younger, had higher admission PaCO2 levels, higher free T3 levels
and ejection fraction in echocardiography (P <0.05). VD/VT values of
Group 1 measured at admission and on the second and third days
of NIMV were lower than Group 2 (P <0.05). Similarly, they had lower
FEV1 percent predicted values in the stable period and on the first and
second days of NIMV (P <0.05). FEV1/FVC was lower in Group 1 when
measured in the stable period and on the third and fourth days of NIMV.
In Group 2, CRP values measured during the first day (P = 0.014) and
third day (P = 0.031) of NIMV were identified as higher. In multivariate
regression analysis, admission PaCO2 (OR: 1.59, 95% CI: 1.1 to 2.3, P =
0.014), free T3 (OR: 12, 95% CI: 1.51 to 101, P = 0.019), and VD/VT (OR:
1.23, 95% CI: 1.01 to 1.52, P = 0.048) were identified as independent risk
factors affecting NIMV success.
Conclusion The results of this study revealed that among the NIMV
nonresponsive hypercapnic patients, nonventilatory factors such as
thyroid dysfunction and increased dead space ventilation should be
considered.
P264
Physiologic comparison between NAVA, PAV+ and PSV in critically
ill patients
E Akoumianaki, G Prinianakis, E Kondili, D Georgopoulos
University Hospital of Heraklion, Greece
Critical Care 2014, 18(Suppl 1):P264 (doi: 10.1186/cc13454)
Introduction The aim of the present study was to compare, in a group
of difficult to wean critically ill patients, the short-term effects of PSV,
PAV+ and NAVA on breathing pattern, patient effort and patient–
ventilator interaction.
Methods Seventeen patients were studied during NAVA, PAV+ and PSV
with and without artificial increase in ventilator demands (challenge)
using either dead space (DS, n = 10) or chest elastic load (CL, n = 7)
application. Airway and transdiaphragmatic (Pdi) pressures, electrical
activity of the diaphragm (EAdi), volume and flow were measured
breath by breath, while inspiratory integral of Pdi (PTPPdi) and EAdi
(EAdi) were calculated.
Results At resting conditions all modes provided equal support as
indicated by a similar PTPPdi per breath, per minute and per liter of
ventilation. Apart from triggering delay, which with and without the
challenge was significantly higher with PAV+ than that with NAVA
and PSV, patient–ventilatory synchrony did not differ among modes.
Independent of challenging conditions, inspiratory effort to trigger the
ventilator was significantly higher with PAV+ than with NAVA and PSV.
Compared with PSV, PAV+ and NAVA favored a more variable breathing
pattern as indicated by the significantly higher coefficient of variation
of tidal volume (VT). CL increased PTPPdi significantly less with PAV+
than with PSV and NAVA, while the increase of PTPPdi after DS did
not differ among modes. The relationship between VT and PTPPdi
was weaker with NAVA (median (IQR) r2 = 25.6% (2.7 to 58.1%)) than
with PAV+ (55.6% (34.4 to 61.6%)) and PSV (53.9% (23.2 to 77.4%)) on
account of a poor EAdi–PTPPdi relationship (r2 = 16.2% (1.4 to 30.9%))
during NAVA.
Conclusion Compared with PSV proportional modes favored breathing
variability, while in the face of changing respiratory system mechanics
PAV+ might be superior. However, significant drawbacks of both NAVA
and PAV+ limit the effectiveness of these modes to proportionally assist
the inspiratory effort.
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Does average volume-assured pressure support make any
difference compared with BIPAP?
G Canpolat, A Ozgultekin, G Turan, A Iskender, E Adıyeke, O Ekinci
Haydarpasa Numune Teaching and Research Hospital, Istanbul, Turkey
Critical Care 2014, 18(Suppl 1):P265 (doi: 10.1186/cc13455)
Introduction Average volume-assured pressure support (AVAPS) has
been developed to ensure a more fixed tidal volume along with the
convenience and advantages of pressure support ventilation. In this
study we compared the AVAPS with the BIPAP.
Methods Approval was obtained from the hospital’s ethics committee
for the study. Thirty-three patients over 18 years of age with acute
respiratory failure as a result of either internal or surgical reasons
were included in the study. This study was conducted with the Philips
V 60 ventilator, which includes both BIPAP and AVAPS mode. The
implementation protocol for non-invasive ventilation (NIV) included,
firstly, a 2-hour BIPAP application (Period Bi) and then, without interruption, a 2-hour AVAPS application (Period AV). After measuring the
basal blood gas analysis, patients were informed of how NIV would be
practiced and what function it would have. In BIPAP mode, the ventilator
parameters were adjusted as follows; EPAP: 5 to 7 cmH2O, IPAP: 15 to
20 cmH2O. Patient comfort was analyzed with a scale ranging from 0
to 2 (0: compatible, 1: medium-compatible, 2: noncompatible). During
BIPAP ventilation, levels of arterial blood gases (pH, pO2, pCO2 and
SPO2), comfort scale and hemodynamic data were recorded at the 30th
minute, first hour and second hour. After the patient was monitored
for 2 hours in BIPAP mode, the mode was changed to the AVAPS by
setting the required rates without removing the mask. EPAP settings
were adjusted as follows for AVAPS: 5 to 7 cmH2O, Pmin to max: 10 to 25
cmH2O, tidal volume: 6 to 8 ml/kg. As in the BIPAP mode, we analyzed
and recorded the rates of arterial blood gases, comfort scale and
hemodynamic parameters at the 30th minute, first hour and second
hour. In case of agitation that prevents NIV, patients were sedated by
dexmedetomidine.
Results When we analyzed patients according to their body mass
indexes (BMI), pH and pCO2 values of the patients with BMI ≤30
showed a greater improvement at all three measurements in the
AVAPS compared with BIPAP (P <0.001). When patient compliance was
examined, the number of patients regarded as comfortable in the BIPAP
period was 20 (66.7%), but this figure was 25 (83.3%) for the AVAPS.
Conclusion Patient comfort was higher and need for sedation was
lower in AVAPS. According to the results obtained from this study, the
AVAPS had positive effects on pH, gas variation and patient comfort;
therefore, it can be confidently used in clinical practice.
P266
Oxygenation index outperforms the P/F ratio for mortality
prediction
K Davies1, C Bourdeaux1, T Peiris2, T Gould1
1
Bristol Royal Infirmary, Bristol, UK; 2University of Southampton, UK
Critical Care 2014, 18(Suppl 1):P266 (doi: 10.1186/cc13456)
Introduction The P/F ratio is widely used clinically and as part of
research to categorise severity of respiratory failure [1]. However, no
account is made of an important determinant of oxygenation; mean
airway pressure (MAP). The oxygenation index (OI) incorporates the
MAP and has been suggested as a more accurate means of determining
severity of respiratory failure [2]. In addition, the optimal time for
this assessment is unclear. We sought to answer these questions by
analysing a large database of patient and ventilator data.
Methods The ICU of the Bristol Royal Infirmary has used an electronic
clinical information system (CIS) since 2008, with every hour of care
available for analysis as a result. Ventilated patients were identified,
the P/F ratio and OI were calculated and the worst values for these
determined for four time periods (first 12, 24, 36 and 48 hours of
ventilation). Logistic regression analysis was used to create models to
predict unit and hospital mortality.
Results Data for over 150,000 hours of care in 4,886 patients was
available for analysis. Excluding nonventilated patients and those
transferred ventilated from another ICU, 2,156 patients provided data.
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In comparison with survivors, nonsurvivors were older, with higher OI
and 24-hour SOFA scores and lower P/F ratios. The optimal time for
calculation of both OI and P/F ratio for mortality prediction is the first
12 hours of ventilation. The models using worst OI are better predictors
of ICU and hospital mortality than those using worst P/F ratio (area
under receiver operating curve 0.840 vs. 0.822).
Conclusion Our analysis suggests that the OI is a more sensitive
descriptor of the severity of respiratory failure than the P/F ratio and
that this calculation should be performed using data from the first 12
hours of ventilation.
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Determining the mechanical ventilation mode and pressure
support combination that is best compatible with the rapid shallow
breathing index calculated in spontaneous ventilation
S Demirtas Yilmaz, G Gürsel, M Aydogdu
Gazi University Medical Faculty, Ankara, Turkey
Critical Care 2014, 18(Suppl 1):P267 (doi: 10.1186/cc13457)
Introduction Weaning from the mechanical ventilation (MV) composes
about 40 to 50% of the total length of MV. Besides, there is no single
reliable parameter indicating that patient will tolerate extubation safely.
The rapid shallow breathing index (RSBI) is relatively the best predictive
parameter for the initial assessment of readiness for discontinuation
of MV support. But evaluation of the RSBI is valuable during T-tube
ventilation; and in clinical practice it is not always possible to perform
this assessment. In this study, we aimed to determine the best MV
mode and pressure combinations that can predict successful RSBI
closest to values calculated in spontaneous ventilation and estimate
the patients’ readiness for weaning.
Methods In this prospective cohort study, 25 mechanically ventilated
patients were included. After 24 hours of MV, if the patients can
successfully pass the daily screening test a spontaneous breathing trial
(SBT) was initiated. RSBI and other weaning parameters were calculated in
different combinations (PS:5 PEEP:5, PS:0 PEEP:5, PS:5 PEEP:0, PS:0 PEEP:0)
before T-tube trial in all patients. Measurements in the spontaneous
ventilation was performed with the COSMOPLUS Novometrix device that
has both capnography and respiratory monitorisation function; other
measurements were performed with ventilators.
Results The mean age of the study group was 73 ± 10 years; 11
of them were female and mean APACHE II score was 19 ± 6. RSBI
did not differ significantly between spontaneous mode and other
combinations, but the best correlation with spontaneous mode was
found with PS:5 PEEP:0 (P = 0.0001, r = 0.719), and the worst with PS:0
PEEP:5 combination. RSBI calculated in each combination showed no
predictive value for weaning success. Respiration rate (f) was higher in
the SBT failure group than the SBT success group. When measured at
PS:0 PEEP:5 and PS:5 PEEP:0 combinations, the threshold value of f was
found to be 27/minute (P = 0.03).
Conclusion Although there was a correlation between RSBI measured
in the T-tube and RSBI measured in different mode and pressure
combinations, especially with the combination of PS:5 PEEP:0, a threshold
value for RSBI cannot be detected during MV to predict SBT success.
P268
New setting of neurally adjusted ventilatory assist during mask
noninvasive ventilation
F Longhini1, C Pan2, G Cammarota1, R Vaschetto1, J Xie2, L Liu2, Y Yian2,
F Della Corte1, P Navalesi1, H Qiu2
1
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Nanjing, China
Critical Care 2014, 18(Suppl 1):P268 (doi: 10.1186/cc13458)
Introduction Noninvasive ventilation through a mask is commonly
applied in pressure support ventilation (nPSV). Recent studies
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showed that noninvasive neurally adjusted ventilatory assist (nNAVA)
improves patient–ventilator interaction and synchrony. More recently
we described a new setting for nNAVA (nNAVA15) able to reduce the
peak of electrical activity of the diaphragm (EAdipeak) and dyspnea
(assessed by a visual analogue scale, VASd), compared with both nPSV
and nNAVA, in patients undergoing NIV through a helmet, by improving
the rate pressurization. We therefore designed a physiological study to
evaluate and compare the effects of nNAVA15 with nPSV and nNAVA
on VASd, EAdipeak, pressurization rate and arterial blood gases (ABGs).
Methods Fourteen patients undergoing noninvasive ventilation
because of acute respiratory failure underwent three randomized
30-minute trials: nPSV (inspiratory support above positive endexpiratory pressure (PEEP) ≥8 cmH2O, fastest rate of pressurization);
nNAVA (NAVA level to achieve a comparable EAdipeak as during nPSV);
nNAVA15 (NAVA level at 15 cmH2O/μV and the maximum inspiratory
airway pressure (Paw) set at the value corresponding to PEEP +
inspiratory support during nPSV). Oxygen inspiratory fraction and PEEP
remained unmodified throughout the study period. The last minute of
each trial was analyzed. Paw-time products of the initial 200 ms from
the onset of ventilator pressurization (PTP200), of the initial 300 and
500 ms from the onset of the EAdi swing indexed to the ideal PTP
(PTP300i and PTP500i, respectively), and of the triggering area (PTPt)
were computed. ABGs and VASd were assessed at the end of each trial.
Results nNAVA15 reduced VASd (3.0 (2.0; 3.0)), compared with both
nPSV (5.0 (4.0; 5.2)) and nNAVA (4.0 (3.0; 5.0)) (P <0.001), without
affecting ABGs and EAdipeak. nNAVA15 improved PTP300i and
PTP500i (42% (32.5; 46.5) and 63% (54; 68)%, respectively) compared
with nPSV (25 (4; 33)% and 44 (23; 52)%, P <0.001) and nNAVA (25
(20; 34)% and 46 (33; 57)%, P <0.001). PTP200 was lower in nNAVA
(62 (46; 82) cmH2O*second) with respect to both nPSV (87 (77; 112)
cmH2O*second) and nNAVA15 (85 (70; 127) cmH2O*second) (P = 0.001).
PTPt was significantly improved by both nNAVA (–00.9 (–3.2; –0.2)
cmH2O*second) and nNAVA15 (–0.6 (–2.3; –0.2) cmH2O*second) as
opposed to nPSV (–9.4 (–12.3; –5.9) cmH2O*second, P <0.001).
Conclusion Compared with nPSV and nNAVA, nNAVA15 through a mask
reduces VASd, assuring an optimal pressurization rate and triggering
performance, without affecting the breathing pattern, neural drive and
ABGs.
P269
A new setting to improve noninvasive neurally adjusted ventilatory
assist by helmet
F Longhini, G Cammarota, C Olivieri, R Perucca, R Vaschetto, D Colombo,
A Messina, F Della Corte, P Navalesi
Università del Piemonte Orientale, Novara, Italy
Critical Care 2014, 18(Suppl 1):P269 (doi: 10.1186/cc13459)
Introduction Noninvasive neurally adjusted ventilatory assist by helmet
(hNAVA) was shown to improve, compared with pressure support
ventilation by helmet (hPSV), patient–ventilator interaction and
synchrony in patients with acute respiratory failure without affecting
peak electrical activity of the diaphragm (EAdipeak) [1]. Recently, a
new helmet is available, which improves pressurization during hPSV.
We propose a new setting of hNAVA (hNAVA15) to achieve further
improvement. We compare hPSV, hNAVA and hNAVA15, all delivered
using the new helmet, with respect to patient’s dyspnea, assessed by
a visual analogue scale (VASd), arterial blood gases (ABGs), EAdipeak,
rate of ventilator pressurization and triggering performance.
Methods Fifteen patients underwent three randomized 30-minute
trials: hPSV, set with an inspiratory support above positive endexpiratory pressure (PEEP) ≥10 cmH2O and the fastest rate of
pressurization; hNAVA, setting the NAVA level to achieve the same
EAdipeak as during hPSV; hNAVA15 setting the NAVA level at 15 cmH2O/
μV and the maximum inspiratory airway pressure (Paw) at the value
corresponding to PEEP + inspiratory support during nPSV. Oxygen
inspiratory fraction and PEEP remained unmodified throughout the
study period. Paw-time products of the initial 200 ms from the onset of
ventilator pressurization (PTP200), of the initial 500 ms from the onset
of the EAdi swing indexed to the ideal PTPaw (PTP500i), and of the
triggering area (PTPt) were computed. ABGs and VASd were assessed
at the end of each trial.
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Results hNAVA15 reduced the EAdipeak (10.2 (7.1; 16.2) μV) with
respect to both hPSV (16.9 (12.7; 19.8) μV, P <0.001) and hNAVA (15.3
(10.7; 18.8) μV, P <0.001), while decreasing VASd (3.0 (3.0; 4.0) in hPSV,
3.0 (2.0; 4.0) in hNAVA and 1.0 (1.0; 2.0) in hNAVA15; P <0.01). PTP200
and PTP500i were improved by hNAVA15 (36 (28; 57) cmH2O*second
and 40 (30; 47)%, respectively) compared with hPSV (31 (24; 45)
cmH2O*second and 17 (9; 26)%, respectively) and hNAVA (23 (16; 30)
cmH2O*second and 23 (17; 37)%, respectively) (P <0.01). PTPt was lower
in hNAVA15 (2.9 (1.6; 4.4) cmH2O*second, P <0.01) compared with both
hPSV and hNAVA, and lower in hNAVA (6.0 (2.7; 11.6) cmH2O*second),
compared with hPSV (18.5 (11.2; 22.5) cmH2O*second, P <0.01). ABGs
were no different between trials.
Conclusion In comparison with hPSV and hNAVA, hNAVA15
significantly reduced EAdipeak and VASd, improving the pressurization
and triggering performance, without affecting ABGs.
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Critical Care 2014, 18(Suppl 1):P270 (doi: 10.1186/cc13460)
Introduction Neurally adjusted ventilatory assist (NAVA) has so far
been used in minimally sedated intensive care patients. NAVA has not
been applied in patients in the operation room. The effect of different
sedatives/anesthetics on the electrical activity of the diaphragm (Edi)
has not so far been studied. The aim of our study was to compare the
effect of sevoflurane and propofol on the Edi signal and breathing
pattern during sedation and anesthesia and also in combination with
remifentanil.
Methods A randomized cross-over study comparing sevoflurane and
propofol sedation and anesthesia in 10 juvenile pigs. Remifentanil
0.1 μg/kg/minute was added after a period of anesthetic agent
administration. The animals were ventilated with NAVA with fixed level
throughout the study. Respiratory variables were measured for the last
5 minutes of each 15-minute exposure.
Results The Edi signal and spontaneous breathing were preserved
with both anesthetics. The breathing variability, expressed as the
coefficient of variation (SD/mean) of the tidal volume (CVvt), was high
with both drugs. CVvt was greater during with propofol than with
sevoflurane (CVvt 32 vs. 18% during sedation and CVvt 23 vs. 14%
during anesthesia). The frequency of sighs was higher with propofol
both during sedation (29 vs. 12 sighs/hour) and anesthesia (21 vs. 1
sighs/hour) than with sevoflurane.
Conclusion NAVA can be applied during propofol and sevoflurane
anesthesia in pigs, with well-preserved Edi and spontaneous breathing.
The natural variability is maintained with NAVA even during anesthesia.
In contrast to sevoflurane, propofol sedation and anesthesia is
associated with a high frequency of sighs and post-sigh apneas,
probably due to a centrally induced mechanism. Our data warrant
studies of NAVA in humans undergoing anesthesia and surgery when
neuromuscular blockade is not required.
P271
Intensive alveolar recruitment after cardiac surgery: a randomized
controlled clinical trial
A Leme1, L Hajjar1, M Amato1, J Fukushima1, C Hashizume1, E Nozawa1,
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1
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Critical Care 2014, 18(Suppl 1):P271 (doi: 10.1186/cc13461)
Introduction Protective mechanical ventilation has been associated
with lower incidence of pulmonary and extrapulmonary complications
in major surgery. The aim of the present study is evaluate whether
adding an intensive alveolar recruitment protocol improves clinical
outcomes and reduces healthcare utilization in patients undergoing
cardiac surgery.
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Methods In this single-center, parallel-group trial, we randomly
assigned adult patients presenting signals of deficient gas exchange
(PaO2/FIO2 <250 at a PEEP of 5 cmH2O) in the immediate postoperative
period to either intensive alveolar recruitment or a standard protocol,
both using low-tidal volume ventilation (6 ml/kg/ibw). Our hypothesis
was that an aggressive alveolar recruitment protocol will be translated
to better lung compliance, better gas exchange, fewer pulmonary
complications and reduced length of hospital stay when compared
with the control group.
Results A total of 320 patients were enrolled in the study, 163 patients
in the standard protocol group and 157 in the intensive alveolar
recruitment group. Patients of the interventional group presented a
higher incidence of pneumonia than patients for the control group
(5 (3.3%) vs. 19 (22%), P = 0.004). The length of the hospital stay was
shorter among patients receiving intensive alveolar recruitment than
among those receiving standard care (10.9 (9.9 to 11.9) vs. 12.4 days
(11.3 to 13.6); P = 0.045). There was no difference between groups
according to extrapulmonary complications and mortality.
Conclusion In this trial, an intensive alveolar recruitment protocol
associated with a protective mechanical ventilation strategy reduced
pulmonary complication and length of hospital stay in patients
undergoing cardiac surgery (NCT01502332).
Reference
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Introduction We used transthoracic endoscopy [1] to continuously
record images of subpleural alveoli during recruitment manoeuvres
and different steady plateau pressures between the manoeuvres.
Methods We investigated two groups of 13 rats each. Animals were
ventilated with ZEEP or PEEP of 5 mbar, FiO2 of 1.0 and tidal volume
of 10 ml/kg. A double low-flow manoeuvre was designed, consisting
of two consecutive low-flow manoeuvres with a peak pressure of
30 mbar, interrupted by a 5-second plateau phase at different pressures
(2, 4, 8 and 12 mbar). Alveolar size at the peak pressures and during the
plateau levels was analyzed from the recorded videos frame by frame.
Therefore the alveolar outline of 10 alveoli was marked manually and
the outlined area was calculated [2]. Compliance of tidal breaths before
and after the manoeuvres was calculated using two-point compliance.
Results In both groups, analysis of the alveolar area revealed that
alveolar size at the second peak of the manoeuvre did not differ
significantly compared with the first peak (100.97% in ZEEP group,
102.37% in the PEEP group). During the plateau phases there was
a slight increase in alveolar size at higher plateau pressures (slope
of linear regression at plateau 4 mbar: 0.1 %/500 ms for ZEEP group,
0.18%/500 ms for PEEP group; at plateau 8 mbar: 0.42%/500 ms for
ZEEP group, 0.565%/500 ms for PEEP group). After the manoeuvres,
compliance increased to 137.73% in the ZEEP group and 119.91% in
the PEEP group.
Conclusion In the healthy lung, once recruited, alveoli stay stable in
size over wide pressure ranges. Further recruitment manoeuvres do
not lead to further increase of alveolar size, but increase of compliance.
During plateau phases, alveolar size increases dependent on pressure.
This leads to the assumption that recruitment is not only pressure
dependent but also time dependent.
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Introduction Lung-protective mechanical ventilation requires positive
end-expiratory pressure (PEEP) and tidal volume (VT) to be chosen with
regard to the individual state of the lung. The shape of the intratidal
compliance–volume profiles might reflect the state of the lung
(atelectatic, open, overdistended) and could therefore be classified
into shape categories that translate into PEEP suggestions [1]. Intratidal
resistance–volume profiles might reflect intratidal opening and
collapse of the lung [2]. Using respiratory data from an animal study we
suggest a classification into resistance shape categories based on the
slope of the R(V) profiles.
Methods Fifteen pigs with lavage-induced lung damage were
ventilated at two PEEP levels (0 and 12 mbar) and three tidal volumes
(8, 12 and 16 ml/kg bodyweight). Compliance (C(V)) and resistance
(R(V)) profiles for each individual animal and ventilation setting were
calculated from respiratory data using the gliding-SLICE method [3].
C(V) profiles were associated with one of the six suggested shape
categories. The dependency of the mean R(V) slope of all animals on the
ventilation setting was used as a basis for classification into resistance
shape categories. Resistance shape categories were compared with
compliance shape categories for each individual animal to test whether
similar PEEP suggestions result from both methods.
Results Small PEEP and VT were typically associated with increasing
C(V), and decreasing C(V) corresponds to large PEEP and VT. A
classification of each C(V) profile into one of six compliance shape
categories was possible. The shapes of the R(V) profiles of individual
animals were remarkably similar. The R(V) slope was typically largest for
a PEEP and VT setting at which derecruitment was likely and smallest
where overdistension was likely. Based on this a classification scheme
was defined: 10 <slope <21 mbar s/L2 (category 1, ‘increase PEEP’),
slope ≥21 mbar s/L2 (category 2, ‘keep PEEP’) and slope ≤10 mbar s/L2
(category 3, ‘decrease PEEP’). Comparison of resistance and compliance
shape categories for single animals shows a good correlation.
Conclusion Resistance shape categories might provide additional
guidance for PEEP setting. Combining compliance and resistance
shape categories could improve lung-protective ventilation.
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Introduction A protective ventilatory strategy should prevent VILI,
but in patients with larger nonaerated areas hyperinflation may occur
during tidal ventilation even during a protective ventilatory strategy
[1]. The gliding sign is used as a marker of pneumothorax and, in a
study [2], to quantify preoperatively the degree of pleural adhesion
in thoracic surgery patients. In our study we measured the variations
of gliding (G) and static compliance (Cstat) according to incremental/
decremental variations of PEEP in patients with hypoxic respiratory
failure.
Methods Ten patients with hypoxic respiratory failure (P/F <300) were
ventilated in VCV (Vt of 7 ml/kg, FiO2 100%, RR 10/minute); keeping
Vt constant, PEEP was gradually increased from ZEEP to 22 cmH2O,
unless there was occurrence of hypotension or SpO2 <90% or Pplat
>45 cmH2O or G no more visible, and then similarly reduced from
22 cmH2O to ZEEP. The gliding was assessed at six points of intercostal
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Table 1 (abstract P275). P. aeruginosa log mean, wet to dry ratio, and PaO2/
FiO2 at 5 hours
P. aeruginosa (cfu/g)

W/D

PaO2/FiO2 at 5 hours (mmHg)

Prot-V

3.5 ± 0.7

1.7 ± 0.2

434 ± 62

Control

4.2 ± 0.7

2.7 ± 1.3

343 ± 61

Data presented as mean ± SD.

Reference
1.

Figure 1 (abstract P274). PCC between mean G (cm) and mean Cstat at
different PEEP, in axis Pplat.

spaces bilaterally and the movement of a hyperechoic point of pleura
or a b-line was observed during tidal ventilation. For each step,
the excursion of G during the inspiratory phase was measured and
compared with the Cstat values. Statistical analysis was performed with
the Pearson correlation coefficient (PCC).
Results All patients completed the study without adverse events. In all
patients we observed a reduction of G and Cstat at the increase of PEEP
and specularly an increase of G and Cstat during the reduction of PEEP
(Figure 1). In five patients at the lower levels of PEEP (from 0 to 10) an
increase of Cstat and G was observed. For all patients the PCC of Cstat
and G and was >0.5 (P <0.03), ranging from 0.537 (P = 0.017) to 0.964
(P <0.0001).
Conclusion The variations of G at different levels of PEEP are consensual
with those of Cstat. The study of G during tidal ventilation could help to
identify hyperinflation in nondependent lung regions and to optimize
lung-protective ventilatory strategies.
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Introduction Bacterial pneumonia is a common indication for
mechanical ventilation in the ICU. Ventilation with high positive endexpiratory pressure (PEEP) and low tidal volume (VT) is recommended
in patients with adult respiratory distress syndrome. This improves
clinical outcome compared with ventilation with low PEEP and
medium-high VT [1]. However, the effect of VT and PEEP on bacterial
growth in lung tissue is not known. This study contrasted the effect of
a protective ventilator protocol with a standard medium-high VT and
lower PEEP protocol on lung bacterial growth, lung edema formation
and lung injury. It was performed in a porcine model of intensive care
with the frequently found pathogen Pseudomonas aeruginosa.
Methods Sixteen pigs were anesthetized and randomized to
mechanical ventilation with two different ventilator settings for 6 hours;
Prot-V (PEEP 10 cmH2O, VT 6 ml/kg, n = 8) and Control (PEEP 5 cmH2O,
VT 10 ml/kg, n = 8). At 0 hours, 1×1011 colony-forming units (cfu) of P.
aeruginosa were instilled intratracheally. At the end of the experiment,
six postmortem lung biopsies from predefined declivial locations were
taken from each animal for cultures and weight measurements.
Results P. aeruginosa growth in lung tissue and wet to dry ratio were
lower in the Prot-V group than in the Control group (P <0.05 and
P <0.05). PaO2/FiO2 was higher in the Prot-V group than in the Control
group (P <0.05) (Table 1).
Conclusion Protective ventilation with low VT and higher PEEP reduces
P. aeruginosa growth in lung tissue, lung edema formation and lung
injury in contrast with medium-high VT and lower PEEP ventilation in
this porcine pneumonia model.
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Introduction The purpose was to compare effects of PEEP on computed
tomography (CT) and estimated ventilation/perfusion (V/Q) mismatch.
Previously, an oxygenation-based method was shown more related to
the CT-measured effect of PEEP than lung mechanics [1], indicating
lung aeration is better quantified using V/Q mismatch. Pulmonary
shunt and low and high V/Q mismatch can be estimated from varying
FIO2 and measuring ventilation and blood gas contents [2].
Methods Preliminary results in six ARDS patients. CT scans were
taken in static conditions at PEEP 5, 45 and 15 to 20 cmH2O. V/Q was
estimated at 5 and 15 to 20 cmH2O as: shunt, low V/Q as alveolar to lung
capillary PO2 difference (ΔAcPO2), high V/Q as alveolar to lung capillary
PCO2 difference (ΔAcPCO2) [2]. Nonaeration, poor aeration, and normal
aeration plus hyperinflation were calculated from Hounsfield units.
Aeration and V/Q were compared (Pearson, ρ).
Results PEEP improved V/Q in four patients, shunt reducing 7 to 42% with
no/small increase in ΔAcPCO2. Two deteriorated, with large ΔAcPCO2 or
shunt increase. No systematic changes in ΔAcPO2 were seen. Figure 1
shows response to PEEP in two patients. Changes in nonaerated regions
and shunt were correlated (ρ = 0.94, P = 0.002). No correlations were
found between poorly aerated regions and ΔAcPO2 (ρ = –0.09, P = 0.84)
or hyperinflated regions and ΔAcPCO2 (ρ = 0.07, P = 0.88).
Conclusion In these preliminary cases, changes in shunt and nonaerated
tissue correlated well. However, results indicate poor agreement
between changes in low and high V/Q and lung morphology.
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Introduction In data collected during the Third International Study on
Mechanical Ventilation, we compared data from the Netherlands with
a global cohort. We hypothesized that tidal volumes (Vt) were smaller
and applied positive end-expiratory pressure (PEEP) was higher in the
Netherlands, compared with the global cohort. We also compared use
of non-invasive ventilation (NIV) and outcomes in both cohorts.
Methods A post-hoc analysis of a prospective observational study of
patients receiving invasive mechanical ventilation was conducted in
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Figure 1 (abstract P276). Gas exchange and CT for patient improving (A) or worsening (B) with PEEP change.

494 ICUs around the world [1]. The Dutch cohort covered 196 patients
and the global cohort 7,952.
Results Vt was 7.6 ml/kg predicted bodyweight in the Dutch cohort
versus 8.0 ml/kg and the median applied PEEP was 8 cmH2O versus
5.8 cmH2O (both P <0.01). In the subgroup of patients with ARDS, Vt
ml/kg was 7.6 and applied PEEP 8.8 cmH2O in the Netherlands versus
8.6 ml/kg (P = 0.41) and 8.3 cmH2O worldwide. In the Netherlands
7.1% of admitted patients received NIV as first mode of mechanical
ventilation versus 15% in the global cohort. In both cohorts 18% of
patients were hypercapnic at ICU admission. Fewer patients in the
Dutch cohort showed an ICU-acquired pneumonia (4.1 vs. 9.4%, P =
0.007) and sepsis (5.1 vs. 9.0%, P = 0.042), but more patients evolved
delirium (16 vs. 5%, P <0.01).
Conclusion According to our hypothesis, Vt was smaller and applied
PEEP was higher in the Dutch cohort. Patients in both cohorts received
larger Vt than recommended in prevention of ARDS [2]. Hypercapnia is
a main criterion for the use of NIV [3], which suggests that NIV could be
used more often in the Netherlands. The lower incidence of delirium
worldwide could be caused by differences in sedation or may be due to
the used methods of screening.
References
1.
2.
3.

Esteban et al.: Am J Respir Crit Care Med 2013, 188:220-230.
The Acute Respiratory Distress Syndrome Network: N Engl J Med 2000,
342:1301-1308.
Brochard: Eur Respir J 2003, 22:31s-37s.

P278
Graphical user interface for visualization of a decision support
system for PEEP titration
S Lozano-Zahonero, S Buehler, S Schumann, J Guttmann
University Medical Center Freiburg, Germany
Critical Care 2014, 18(Suppl 1):P278 (doi: 10.1186/cc13468)
Introduction The analysis of dynamic volume-dependent compliance
provides the rationale basis for PEEP titration during mechanical
ventilation. Due to its volume dependence, the compliance of the
respiratory system is nonlinear within each single breath (intratidal),
which is reflected in the compliance–volume curve (CV curve). The
shape of the CV curve is determined by the PEEP level. The mechanical
stress for the mechanically ventilated lung is expected to be minimal
when the lung is ventilated within the volume range of maximal

compliance. We present a new graphical user interface (GUI) that
supports the clinician to titrate the PEEP level by means of a shape
category analysis of the CV curve.
Methods A decision support system in the form of a computer-based
GUI was developed and tested using respiratory data obtained from
patients of the University Medical Center Freiburg. The new clinicianoriented approach provides a breath-by-breath visualization of the
patient’s individual intratidal CV curve. The dynamic compliance was
analyzed using the gliding-SLICE method [1]. The resulting intratidal
CV curve was classified into one of six shape categories according to
the definition from Mols and colleagues [2]. The actual shape category
of the CV curve indicates whether PEEP setting should be changed or
whether the volume range of maximal compliance is reached.
Results The GUI provided a breath-by-breath visualization of the
intratidal CV curve and the intuitive individual compliance shape
category. Based on the compliance shape category, different guidelines
of PEEP titration were applied with the objective of ventilating the
patient mechanically within the range of maximal compliance.
Conclusion The newly developed GUI allows a breath-by-breath
visualization of the intratidal CV curve with high reliability. Automated
classification of the intratidal CV curve into compliance shape
categories provides the rationale basis for patient-individual PEEP
titration.
References
1.
2.

Schumann S, et al.: Physiol Meas 2009, 30:1341-1356.
Mols G, et al.: Intensive Care Med 1999, 25:1084-1091.

P279
Time-dependent apoptosis induction after spontaneous-breathing
or ventilation-analogue experimental mechanostimulation of
monolayer lung cell cultures
S Meyer, S Schumann, J Guttmann, K Gamerdinger
University Medical Center Freiburg, Germany
Critical Care 2014, 18(Suppl 1):P279 (doi: 10.1186/cc13469)
Introduction The cyclic strain of lung tissue during mechanical
ventilation compared with spontaneous breathing is associated
with a largely increased mechanical load due to larger pressure
amplitudes and higher acceleration forces. This additional load may
change tissue mechanics and may lead to tissue damage. Although
experimental mechanostimulation in vitro is a widely used method
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to analyse mechanical load on cells or tissue, in vitro experiments
with ventilation-analogue stimulation are missing. In this work we
compare for the first time the changes of monolayer lung cells after
ventilation-analogue stimulation with spontaneous-breathing
analogue mechanostimulation. The aim of the study was to show timedependent differences in the induction of apoptosis due to mechanical
overload, by fluorescence microscopic observations.
Methods Alveolar epithelial cells (A549) were grown on RGD-coated,
highly flexible polydimethyl siloxane membranes. After becoming
approximately 100% confluent, cells were stained with Hoechst
33342/TMRE/caspase-3 and caspase-7/PI and continuously observed
by fluorescence microscopy. The cells were stimulated either with
ventilation-analogue or spontaneous-breathing analogue profile [1].
For both settings the frequency was 0.25 Hz, the surface increase 20%
and the cell monolayers were stimulated over a time period of 2 hours
in the bioreactor [2].
Results The analysis of fluorescence microscopic images showed
the first evidence of apoptosis induction after 40 minutes of
ventilation-analogue stimulation. In contrast, apoptosis induction
after spontaneous-breathing analogue stimulation occurred after 90
minutes.
Conclusion The observation of cells during stimulation with continuous
fluorescence microscopic imaging allowed us to analyse the timedependent induction of apoptosis under the aspects of different
stimuli. We could prove our hypothesis that ventilation-analogue
stimulation was worse for the cellular viability then spontaneousbreathing analogue stimulation. In future, the direct optical tracking of
cell damage should allow one to analyse other stimulation profiles as
well, and thereby to improve the stimulation profiles and ultimately the
ventilation profile as well.
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Introduction Cyclic recruitment and derecruitment (R/D) of lung
parenchyma during mechanical ventilation are responsible for
atelectrauma. Theoretically, cyclic R/D can lead to varying degrees
of pulmonary shunt fraction throughout the respiratory cycle.
Measurements of dynamic pulmonary shunt fraction could help
in assessing the degree of cylic R/D. However, common methods
of measuring pulmonary shunt do not allow for dynamic serial
measurements during one respiratory cycle. In this study, we measured
serial dynamic pulmonary shunt fractions during one breathing cycle
and investigated the effect of positive end-expiratory pressure (PEEP)
on cyclic R/D in artificially ventilated pigs before and after saline
washout induced acute lung injury.
Methods Pigs (n = 10) were anesthetized and ventilated at a tidal
volume of 8 ml/kg and two levels of PEEP (0 and 15 cmH2O – conditions:
PEEP0; PEEP15). Hemodynamic, respiratory and multiple inert gas
analysis by micropore membrane inlet mass spectrometery (MMIMSMIGET; Oscillogy, USA) measurements were taken at PEEP0 and PEEP15
before and after saline washout. Retention of SF6, measured five times
during one breathing cycle, was taken as a reflection of shunt fraction.
MIGET sample acquisition was synchronized by electrical impedance
tomography.
Results We observed dynamic changes in pulmonary shunt fraction,
expressed as changes in SF6 retention, within all breathing cycles
recorded, before and after induction of ALI. In healthy lungs at PEEP0
there was a decrease in SF retention at the end of inspiration and a
return to baseline levels during expiration. In contrast, SF6 retention
increased at PEEP0 in ALI during inspiration and decreased during
expiration. In healthy pigs ventilated with PEEP15 there was an increase
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in SF6 retention at the end of inspiration and a return to baseline during
expiration similar to the changes observed in pigs with ALI at PEEP0. In
ALI at PEEP15, shunt decreased throughout inspiration and returned to
baseline levels during expiration.
Conclusion Serial dynamic pulmonary shunt measurements during
mechanical ventilation showed distinct variations over the respiratory
cycle in both healthy and injured lungs. Increasing PEEP from 0 to
15 cmH2O altered the patterns of dynamic pulmonary shunt before
and after ALI. Thus, serial assessment of dynamic pulmonary shunt
fraction by SF6 retention with MMIMS-MIGET could prove useful for
optimization of mechanical ventilation in healthy and injured lungs.
P281
Effect of positive end-expiratory pressure on right ventricle
function assessed by speckle tracking echocardiography
SR Orde, A Behfar, PG Stalboerger, JK Oh, GC Kane
Mayo Clinic, Rochester, MN, USA
Critical Care 2014, 18(Suppl 1):P281 (doi: 10.1186/cc13471)
Introduction We sought to determine in a swine model whether a
novel echocardiography method, speckle tracking echocardiography
(STE), could determine deterioration in right ventricle (RV) function
induced by escalating levels of positive end-expiratory pressure (PEEP),
and to compare STE with RV fractional area change (FAC). Acute cor
pulmonale and hypotension can be induced by high levels of PEEP
used in the management of acute respiratory distress syndrome [1].
Quantifying RV function by echocardiography can be challenging due
to its shape and position. STE is a relatively new, feasible, sensitive,
angle-independent method for describing cardiac deformation (strain)
[2] and is particularly useful in analyzing RV function (RV free wall strain,
RVfwS), as has been shown in pulmonary hypertension cohorts [3].
Methods Ten pigs, 40 to 90 kg, anaesthetized, fully mechanically
ventilated at 6 to 8 mg/kg were subject to stepwise escalating levels of
PEEP at 2-minute intervals (0, 5, 10, 15, 20, 25 and 30 cmH2O). RV images
were obtained using intracardiac echocardiography (for optimal framerate and endocardial definition) and were analyzed offline for FAC and
RVfwS (using Velocity Vector Imaging; Siemens).
Results Escalating levels of PEEP were strongly associated with
significant reductions in mean blood pressure (R2 = 0.8, P <0.0001), FAC
(R2 = 0.8, P <0.0001) and RVfwS (R2 = 0.9, P <0.001). Paired t tests indicated
significant reductions in RVfwS with each step increase in PEEP. FAC
only showed significant deterioration at 15 cmH2O PEEP. Significant
hypotension (a decrease of more than 20 mmHg) occurred after
10 cmH2O PEEP. RVfwS decreased by a larger extent and earlier than
FAC and mean blood pressure with increasing levels of PEEP.
Conclusion RVfwS measured by STE is a sensitive method for
determining RV dysfunction induced by PEEP. RVfwS displays a stronger
association, greater deterioration and earlier reduction than FAC and
mean blood pressure with escalating levels of PEEP. This potentially has
interesting implications for the role of STE in managing PEEP levels in
critically ill patients with acute lung injury.
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Introduction Airway pressure release ventilation (APRV) is a pressurelimited, time-cycled mode of mechanical ventilation. It increases the
cardiac index, resulting in improved organ perfusion, which is crucial
in cardiogenic shock patients preventing organ failure secondary to
inadequate perfusion [1]. The purpose of this study was to evaluate
the effectiveness of APRV in restoring hemodynamic stability and
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improving oxygenation in ventilated patients with cardiogenic shock
and severe progressive hypoxemia.
Methods All cardiac and cardiac surgical patients with cardiogenic
shock and ALI/ARDS admitted to our ICU were enrolled between
January 2012 and September 2013. Data were collected on admission
while the patients were on the conventional mode of ventilation and
after 48 hours from switching to APRV. All enrolled patients were
hemodynamically monitored with a pulmonary artery catheter and
frequent echocardiography assessment. A retrospective analysis of
these data was performed.
Results Completed datasets were obtained from 29 patients. The
cardiac index was increased by 30% (P <0.013), serum lactate decreased
by 37% (P <0.001), central venous saturation increased by 42%
(P <0.001) and peak airway pressure decreased 19% (P <0.001), with
50% increase of mean airway pressure, hypoxemia improved within
the first few hours of alveolar recruitment with PaO2/FIO2 increased by
23% (P <0.018), and there was less use of vasopressors, sedation and
neuromuscular blockage over the course of APRV application.
Conclusion In our patient series, APRV significantly improved
oxygenation and allowed for spontaneous breathing and a reduction
in peak airway pressures. Furthermore, this strategy improved
hemodynamics and facilitated weaning from MV. Therefore, our data
suggest that this ventilation modality has favorable results and appears
to be an effective alternative for lung recruitment in patients with
cardiogenic shock and acute lung injury during their course of stay in
cardiac ICU [2].
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Introduction We developed an experimental model of VILI, ventilating
piglets at a strain (TV/FRC) >2.5. It is possible that lung inhomogeneities
act as stress raisers within the lung parenchyma, locally multiplying
pressures. In a healthy lung the pleural surface, vessels and bronchi are
detected as natural lung inhomogeneities. We studied the development
of VILI with CT scan to determine where the first lung lesion developed.
Methods Piglets were sedated, orotracheally intubated and
instrumented with arterial and central venous catheter and urinary
catheter. The whole study was performed in the animal CT scan facility,
which was equipped as an ICU, and CT scan was performed every
3 hours or if respiratory parameters (plateau/peak pressure) changed.
We defined as new lesion lung regions the appearance of poorly
inflated/not inflated lung regions not present in the previous CT scan
image. We select the first CT scan in which a relevant number of new
lesions appeared (>15) and manually delineated the lesions; the lesions
were classified as close/not close to the pleural surface.
Results Six piglets were studied (22 ± 8 kg) that were ventilated with
a TV of 750 ± 71 ml (41 ± 1 ml/kg) up to development of VILI, defined
radiologically as infiltrates present in all pulmonary fields at CT scan
plus development of lung edema. In the first CT scan where lesions
appeared, a median of 28 lesions (IQ range 22 to 30) were present. Of
these lesions, 18 (17 to 22) (72%) were located near the pleura and nine
(6 to 11) (28%) near vessels/bronchi. See Figure 1.
Conclusion In an experimental model of VILI the first lung lesions
appear below the pleural surface. Mutiple nonmutually exclusive
possible explanations are possible: the pleural surface acts as a stress
raiser; the mechanical friction of the lung with the ribs at very high tidal
volume leads to parenchimal injury; and the lung skeleton is a fan-like
structure starting from the hilum and going to the pleural surface,
leading to increased stress/strain of the subpleural regions.
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Figure 1 (abstract P283).
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Introduction During mechanical ventilation some of the energy
delivered to the respiratory system (RS) is dissipated within it, while
some is recovered during expiration. The amount of unrecovered
energy represents mechanical work done on the RS by the ventilator
and may be related to the development of ventilatory-induced lung
injury (VILI). The unrecovered energy is measured as the hysteresis area
of the pressure–volume (PV) curve in static and dynamic conditions.
We explored how and where the energy is dissipated inside the RS.
Methods In five piglets (weight 21 ± 2 kg) under general anesthesia,
we recorded PV curves to quantify dynamic dissipated energy (DE)
at increasing tidal volume (TV) (150, 300, 450, 600, 750, 900) and at
increasing respiratory rate (RR) (3, 6, 9, 12, 15). We then recorded PV
curves for the same TV inflated with a super-syringe (100 ml), to quantify
static DE. We also quantified airway DE connecting the postmortem
isolated tracheobronchial tree to the ventilator and recording PV
curves at the respiratory setting previously described.

Figure 1 (abstract P284). Relationship between flow (l/minute) and
(dynamic–static) dissipated energy (J).
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Results Static DE(J) had a nonlinear relationship with the TV (ml/kg)
applied: static DE = 0.0031*TV1.5198, R2 = 0.96. Subtracting from the
PV curve hysteresis area of a single breath (dynamic DE) the airway
DE, the resulting curve overlapped static DE at every RR considered,
suggesting that the amount of energy spent on the RS is equal to the
static DE. Static DE can be estimated knowing flow (l/minute) and
dynamic DE(J) since:
(dynamic–static)DE = 0.0014*[flow]2 – 0.0173*flow + 0.1387, R2 = 0.90
(Figure 1).
Conclusion According to our data, the amount of energy that may be
related to the development of VILI is static DE; it is a nonlinear function
of TV and can be estimated knowing flow and dynamic DE.

poorly aerated areas (area score 1 to 2) versus reduction of qCT poorly
aerated volume (R2 = 0.74). Change at LUS of at least three areas to
well aerated (LUS recruiters, n = 4) corresponded to a qCT increase in
well-aerated lung volume of 788 ± 262 g versus 431 ± 35 g in the LUS
nonrecruiter group (n = 3) (P <0.05).
Conclusion These preliminary data suggest that LUS could be an
accurate tool to assess lung aeration and recruitment at the bedside,
avoiding the risks and workload related to the use of CT scan.
Reference
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Introduction CT-scan quantitative analysis (qCT) represents the gold
standard to assess lung aeration and recruitment in ARDS patients.
Lung ultrasound (LUS) has been proposed as a bedside nonirradiating
alternative to assess lung recruitability, identifying patients who may
benefit from higher PEEP levels. We compared the two methods in the
assessment of PEEP-induced lung aeration changes.
Methods LUS and whole-lung CT scan were performed on ARDS
sedated, paralyzed, mechanically ventilated patients at PEEP 5 and
15 cmH2O. LUS was performed considering six areas for each lung,
with a comprehensive scan of the intercostal spaces in each area. We
assigned to each area a score of aeration [1]: 0 (normal lung), 1 (≥3
noncoalescent B-lines), 2 (≥3 coalescent B-lines), 3 (consolidation). A
cumulative LUS score (LUSS, ranging from 0 to 36 for the two lungs)
was obtained as sum of all areas’ individual scores, each area’s score
being the average of all pertaining LUS findings. LUS recruiters upon
PEEP increase from 5 to 15 cmH2O were defined by the switch of at least
three areas to well aerated (area score 0). LUS-based assessment of lung
aeration and lung recruitability was compared with qCT findings.
Results We enrolled seven patients (six males, age 54.1 ± 22.2 years,
BMI 24.2 ± 4.9 kg/m2, PaO2/FiO2 186 ± 78, tidal volume 445 ± 140 ml, RR
14.5 ± 3.4 breaths/minute, PEEP 12.5 ± 3.3 cmH2O). In the 14 conditions
evaluated, median LUSS was 19 (IQR 14 to 23); LUSS ≤19 (n = 8)
corresponded to 34 ± 13% of nonaerated tissue at qCT; LUSS >20 (n =
6) to 48 ± 18% (P <0.05). A good linear correlation was found between
reduction at LUS of consolidated areas (area score 3) versus reduction
of qCT nonaerated volume (R2 = 0.66), and between reduction at LUS of
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Introduction Growing evidence suggests that, as long as the total lung
capacity is not overcome, dynamic (that is, tidal volume, VT) is more
injurious than static (that is, positive end-expiratory pressure, PEEP)
lung deformation [1]. Because the lung behaves like a viscoelastic
body [2], hysteresis may play a role in the development of ventilatorinduced lung injury. The aim of the study was to investigate the effects
of increasing VT or PEEP on lung hysteresis.
Methods In eight healthy piglets we measured total hysteresis and
the peak inspiratory pressure (Ppeak) while randomly increasing VT
(with no PEEP) or PEEP (with fixed VT). P1 was extrapolated from the
drop in airway pressure during an end-inspiratory pause [3]. Hysteresis
attributable to lung parenchyma was computed as: total hysteresis –
((Ppeak – P1) × VT).
Results The main findings are shown in Figure 1. P values refer to oneway repeated-measures analysis of variance.
Conclusion Lung hysteresis increases with VT, but not with PEEP.
Further studies are needed to prospectively evaluate the role of lung
hysteresis in the pathogenesis of ventilator-induced lung injury.
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Figure 1 (abstract P286). Lung hysteresis as a function of VT (A) and PEEP (B). *P <0.05 versus VT 250 ml or PEEP 0 cmH2O (Holm–Sidak method).
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Introduction Mechanical ventilation (MV) aims to enhance blood
oxygenation and to remove carbon dioxide. However, excessive
hyperinflation by MV may cause lung injury.
Methods Eighteen cats (4 ± 1 kg) were anesthetized with propofol
(loading dose of 6 mg/kg and constant rate infusion of 0.5 mg/kg/
minute) and neuromuscular blockade was achieved with rocuronium
at 1 mg/kg/minute. Their lungs were initially mechanically ventilated
in FiO2 of 40%, with peak inspiratory pressure (Ppeak) of 5 cmH2O for
20 minutes, and then the Ppeak was increased by 5 cmH2O increments
until 15 cmH2O every 5 minutes. Following that, Ppeak was decreased
by 2 cmH2O every 5 minutes until reaching Ppeak of 5 cmH2O. The
ventilator maintained the respiratory rate and inspiratory time at
15 breaths/minute and 1 second, respectively. Between the Ppeak
increments, we applied a 4-second pause for a 5-mm computed
tomography (CT) scan of the thorax area. The radiographic attenuation
(in Hounsfield units, HU) was classified as over-insufflation (1,000 to
900 HU), normal insufflation (900 to 500 HU) and atelectasic (500 to
100 HU). We split the lungs into three proportional gravitational zones
(I, II and III) from apex to base.
Results The three zones presented increased over-insufflated areas and
decreased areas with normal insufflation with increasing Ppeak from
5 to 15 cmH2O. At 5 cmH2O, the areas of over-insufflation and normal
insufflation in zones I, II and III were 13% and 36%; 4% and 22%; and
0.7% and 15%, respectively. At 15 cmH2O, the areas of over-insufflation
and normal insufflation in zones I, II and III were 74% and 55%; 81% and
57%; and 82% and 71%, respectively.
Conclusion The higher proportion of overly distended pulmonary
areas in high Ppeak may increase the risk of lung injury. The lowest
Ppeak (5 cmH2O) showed less potential to lung injury as it has higher
areas of normal insufflation and less areas of over-insufflation in all
gravitational zones.
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Effect of inhaled nitric oxide on apoptosis of lymphocytes in
newborns in a critical state
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Critical Care 2014, 18(Suppl 1):P288 (doi: 10.1186/cc13478)
Introduction Activation of lymphocyte apoptosis while reducing the
endogenous nitric oxide is a predictor of adverse outcome in newborns
on mechanical ventilation [1]. With the aim to improve the results
of treatment we studied the effect of inhalable nitric oxide on the
immune system in newborns with respiratory diseases on mechanical
ventilation [2].
Methods With the permission of the ethics committee in a controlled,
randomized, blind clinical trial we included 27 newborns with respiratory
diseases on mechanical ventilation. Randomization was performed by
the method of envelopes. Group I (n = 17), patients receiving inhalation
of nitric oxide at a concentration of 10 ppm for 24 hours controlling the
level of methemoglobin (Pulmonox mini; Messer II NO Therapeutics,
Austria). Group II (n = 10) did not receive inhaled NO. At admission
and at 3 to 5 days we studied subpopulations of lymphocytes by
one-parameter immunophenotyping using reagents (Immunotech
Beckman Coulter, USA): fitz-labeled CD3, CD4, CD8, CD14, CD19, CD34,
CD56, CD69, CD71, CD95 monoclonal antibody, the relative content of
lymphocytes in early and late apoptosis using Annexin V+-labeled FITK
and propidium iodide (PL+), labeled with PE (Saltag, USA), with results
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on the Beckman Coulter Epics XL cytometer (USA). The statistical power
of the study was 80% (α ≤0.05).
Results In Group I relative to group II at 3 to 5 days we registered an
increase in mature monocytes (CD14) – 23.1 ± 0.8% (P <0.05); reduction
in the relative content of CD69 – 3.8 ± 0.21%, lymphocyte of apoptosis:
(Annexin V–FITC+PI–) – 7.12 ± 0.46% and (Annexin V–FITC+PI+) –
0.79 ± 0.07% (P <0.001). The duration of mechanical ventilation was
4.1 ± 1.4 days (P <0.05). All patients survived. None of the patients
showed clinical or laboratory evidence of adverse effects of inhaled
nitric oxide. In Group II seven newborns died, and the duration of
mechanical ventilation in survivors was 18 ± 3.4 days.
Conclusion Inhalable of nitric oxide activates monocyte–macrophage
immunity, stabilizes the apoptosis of T-lymphocytes, and reduces
mortality and duration of mechanical ventilation in newborns with
respiratory diseases on mechanical ventilation.
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Introduction Sepsis-induced diaphragm dysfunction (SIDD) has
been widely described in the literature as a condition affecting the
diaphragm muscle characterized by contractility loss of function and
associated with a high mortality, assessed at around 54% [1]. Previous
studies have investigated the pathogenesis of ventilator-induced
diaphragmatic dysfunction (VIDD), its lipid metabolic alterations [2]
and microcirculatory function processes. This study was designed
to investigate on diaphragm muscle the effects of LPS-induced
endotoxemia in rabbits undergoing two different modes of mechanical
ventilation.
Methods A prospective randomized animal study in 25 invasively
monitored and mechanically ventilated New Zealand White rabbits.
The rabbits were randomized to control (n = 5), controlled mechanical
ventilation (CMV) (n = 5), pressure support ventilation (PSV) (n = 5),
or CMV or PSV with LPS-induced endotoxemia (CMV-LPS and PSVLPS respectively) (n = 5 for each). The endotoxemia was induced
by LPS injection in the CMV-LPS and PSV-LPS groups. Rabbits were
anesthetized and ventilated for 24 hours, except for the control
(30 minutes). A catheter able to detect the electrical activity of the
diaphragm was placed to evaluate the diaphragm contractility at
baseline and after 6, 12 and 24 hours. After 24 hours, we evaluated:
the diaphragm microcirculation assessed by a sidestream dark-field
videomicroscopy; the mitochondria membrane potential; the lipid
accumulation; and the diaphragm muscular fiber structure.
Results In endotoxemic animals, after 24 hours, the diaphragm
contractility and fiber structure, the microcirculation, mitochondrial
membrane potential and lipid accumulation were severely
compromised, but not in the CMV and PSV groups. Moreover, a slight
but significant increase of lipid accumulation was observed in the CMV
and PSV groups in comparison with control (P <0.05).
Conclusion In endotoxemic rabbits, the impaired microcirculation
resulted in an increased lipid accumulation and in a disturbance of the
mitochondria membrane potential and contractility of the diaphragm.
No microvascular alterations have been observed in ventilated
non-endotoxemic animals. Moreover, the diaphragm contractility
dysfunction was more pronounced in endotoxemic animals.
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Introduction Limited evidence exists as to the value of high-frequency
oscillatory ventilation (HFOV) for patients with H1N1 [1,2]. We describe
a subgroup of patients, from a single UK centre, who received HFOV
and had H1N1-positive virology.
Methods Local permissions for research were obtained. Patients with
confirmed H1N1 who underwent HFOV between 2008 and 2012 were
included. Data collected retrospectively included demographics,
diagnosis, illness severity and outcome measures.
Results We identified 10 patients (Table 1) who received both HFOV
and had confirmed H1N1. Two patients were transferred to a tertiary
centre to receive ECMO and both critical care and 6-month mortality
were 40%.
Table 1 (abstract P290). Patient characteristics
Male (%)

60

Age (years)

39.4 ± 9.75

Mean APACHE II

19.5 ± 4.88

Pre-HFOV neuromuscular blockade infusion (%)
Pre-HFOV vasoactive drug infusion (%)
Mean pre-HFOV V T exp (ml/kg)
Median P/F ratio (mmHg)
Pre HFOV
0 hours
4 hours

40
50
8.54 ± 2.68
67.5
94.35
110.4

Conclusion This study adds to the literature on the use of HFOV in H1N1
patients. We managed to replicate some of the existing evidence in
respect to the population age [1,2] and the incidence of mortality. Whilst
P/F ratios improved on initiation of HFOV, these patients subsequently
had long critical care and hospital stays. There is uncertainty regarding
the use of HFOV in ARDS, but it may be a valuable treatment for H1N1
patients. The ventilation strategies employed and the subsequent
consequences for H1N1 patients require further evaluation.
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Introduction The aim was to study EIT as a monitoring tool for tidal
ventilation (TV) redistribution following switching patients from
volume-controlled ventilation (VCV) to airway pressure release
ventilation (APRV) in patients with severe ARDS.
Methods Six patients with severe ARDS having Pplat ≥30 cm were
included in the study. Patients ventilated with the ARDSnet strategy
were subjected to EIT analysis. Regional TV distribution was monitored
by an EIT system (PulmoVista 500®; Dräger Medical GmbH, Lübeck,
Germany), dividing the lung field into four same-size regions of interest
(ROIs): ventral right (ROI 1) and left (ROI 2) and dorsal right (ROI 3) and
left (ROI 4). In step 1, patients ventilated with VCV as per the ARDSnet
protocol were subjected to EIT analysis. In step 2, patients were
switched to APRV. Ventilation parameters, arterial blood gas analysis

Figure 1 (abstract P291). EIT comparison of VCV and APRV.

and percentage of tidal ventilation distribution in the four ROIs were
recorded at steps 1 and 2. Analyses were performed by paired t test.
Results Patients on VCV had P/F ratio of 79.5 ± 12.5 with PEEP of
14.16 ± 1.32 There was a significant improvement in P/F ratios
on switching to APRV (126.16 ± 23.69, P = 0.002) at 30 minutes of
ventilation on APRV. There was a trend to decrease in FiO2 (0.82 ± 0.15
vs. 0.68 ± 0.10, P = 0.068) and PCO2 (52.5 ± 6.15 vs. 45.00 ± 8.67, P =
0.071) and increase in PaO2 (65.83 ± 14.53 vs. 84.83 ± 12.22, P = 0.056)
at step 2. The proportional distribution of ventilation in the dorsal ROI 3
and ROI 4 also improved on switching to APRV. TV in ROI 3 during VCV,
12.76 ± 6.76%, improved to 24.58 ± 6.61% (P = 0.067). Similarly TV in
ROI 4 during VCV, 24.58 ± 6.61%, improved to 26.6 ± 6.09% (P = 0.068).
Due to small sample size, improvement in TV in dorsal ROIs was not
statistically significant. Upper panel of Figure 1 shows end-inspiratory
and end-expiratory images of EIT on VCV with poor TV in dorsal ROI 3
and ROI 4. Lower panel of figure shows two EIT images at Phigh = 30 cm
showing improved TV in dorsal ROIs.
Conclusion EIT may help to identify patients with severe ARDS on VCV
with a potential of increasing recruitment by tidal redistribution of
ventilation with APRV.
P292
Lung-protective ventilation suppresses plasma levels of cell-free
DNA in porcine experimental postoperative sepsis
A Nyberg1, J Sperber1, M Lipcsey2, J Jylhävä3, M Hurme3, M Castegren1
1
Centre for Clinical Research Sörmland, Uppsala University, Eskilstuna, Sweden;
2
Uppsala University, Uppsala, Sweden; 3University of Tampere, Finland
Critical Care 2014, 18(Suppl 1):P292 (doi: 10.1186/cc13482)
Introduction Mechanical ventilation affects systemic inflammation
where protective ventilation attenuates the response [1]. Plasma
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levels of cell-free DNA (cfDNA) increase and have prognostic value in
sepsis [2]. In the present study, the effect of tidal volume and PEEP on
arterial and transorgan levels of cfDNA was investigated in a porcine
postoperative sepsis model.
Methods Two groups of anaesthetised pigs were ventilated with
either protective ventilation (VT 6 ml/kg, PEEP 10 cmH2O; n = 20) or
controls (VT 10 ml/kg, PEEP 5 cmH2O; n = 10) for 7 hours. An artery, the
hepatic vein, the portal vein and the jugular bulb were catheterized.
Continuous endotoxin infusion at 0.25 μg/kg/hour for 5 hours was
started after 2 hours of laparotomy that simulated a surgical procedure.
Results The group receiving protective ventilation showed lower levels
of cfDNA in arterial blood compared with controls (P = 0.02). Transhepatic levels of cfDNA were higher compared with trans-splanchnic
levels during the experiment (P = 0.02), but this effect was attenuated
in the group receiving protective ventilation. No difference between
the groups was detected in blood samples from the jugular bulb.
Conclusion In experimental postoperative sepsis, protective ventilation
suppresses arterial levels of cfDNA. The liver seems to be a significant
contributor to systemic cfDNA levels, an effect that is suppressed
during protective ventilation.
References
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Comparison of HFOV and conventional ventilation in H1N1
influenza ARDS
S Jog, S Sable, D Patel, N Kapadnis, P Rajhans, P Akole, B Pawar, B Bhurke,
M Kothari, S Gururaj
Deenanath Mangeshkar Hospital and Research Center, Pune, India
Critical Care 2014, 18(Suppl 1):P293 (doi: 10.1186/cc13483)
Introduction HFOV is a promising rescue therapy for refractory hypoxia
in severe ARDS.
Methods This is a retrospective comparative study. We retrieved data
for all patients with H1N1 influenza-related severe ARDS treated in the
ICU during October 2009 to April 2013. Our ICU had only one HFOV
machine during the pandemic. Patients were divided into two groups:
HFOV group (received HFOV at first eligibility) and conventional lung
protective ventilation (CLPV) group (did not receive HFOV at first
eligibility due to nonavailability of HFOV). Eligibility criteria for rescue
therapy by HFOV were: P/F ratio ≤100; PEEP needed above 12 cm; Pplat
≥30 cm on CLPV. There was no selection or omission bias for HFOV
application and HFOV was applied to the first eligible patient. Patient
demographic data, laboratory parameters, hemodynamic variables,
and oxygenation and ventilator settings were recorded while on CLPV
at first HFOV eligibility in all patients.
Results The total of 43 patients who met the rescue therapy criteria
were further grouped into the HFOV group (24 patients) and the
CLPV group (19 patients) depending upon modality of ventilation
received after satisfying first-time HFOV eligibility criteria. Both groups
were comparable for differences with Fisher’s t test for qualitative
variables and ANOVA for quantitative variables (Table 1), except for
higher mortality in the CLPV group (16/19 (84.4%) vs. 12/12 (50%), P =
0.026). On logistic regression analysis to find independent variables
differentiating the two groups, mortality was higher in the CLPV group
Table 1 (abstract P293).
Variable

CLPV (n = 19)

HFOV (n = 24)

P value

Age

41.15

32.83

0.07

SOFA

4.95

4.62

0.41

Pplat

29.57

30.46

0.26

O.I.

38.88

35.70

0.54

P/F

70.63

76.79

0.50

PCO2

59.89

59.92

0.99

Death

16

12

0.02

(P = 0.02, odds ratio (CI) 71.60 (1.85 to 2,766.59)) compared with the
HFOV group.
Conclusion HFOV when applied as rescue therapy for refractory
hypoxia due to severe ARDS caused by H1N1 influenza pneumonia is
associated with better outcome compared with CLPV.
P294
Opening pressures and intratidal opening and closing in ARDS lung
I Algieri1, D Chiumello2, M Cressoni1, A Colombo1, G Babini1, S Luoni1,
M Brioni1, F Crimella1, C Chiurazzi1, B Comini2, M Monti2
1
Università degli Studi di Milano, Milan, Italy; 2Fondazione IRCCS Cà Granda –
Ospedale Maggiore Policlinico, Milan, Italy
Critical Care 2014, 18(Suppl 1):P294 (doi: 10.1186/cc13484)
Introduction Intratidal opening/closing is believed to be one of the
main triggers of ventilator-induced lung injury; the application of
higher PEEP united with the limitation of plateau pressure at 30 cmH2O
may limit this phenomenon. We aim to evaluate the intratidal opening/
closing at different PEEP levels and the amount of lung parenchyma
that regains inflation going from 30 (pressure limit of tidal ventilation)
to 45 cmH2O.
Methods Patients with ARDS underwent whole-lung low-dose (60 mAs,
120 kV) computed tomography at PEEP 5 cmH2O end expiration and
end inspiration, PEEP 15 cmH2O end expiration and end inspiration,
and airway pressure 30 and 45 cmH2O end inspiration. Quantitative
analysis of CT data was performed and recruitability was defined as the
fraction of lung parenchyma that regains inflation going from 5 cmH2O
end expiration to 45 cmH2O end inspiration. Patients were classified as
high recruiters (HR) and low recruiters (LR) according to the median
lung recruitability (14% of lung parenchyma).
Results Eighteen patients (male 12, age 56.0 ± 18.6 years, BMI
25.6 ± 5.2 kg/m2, PaO2/FiO2 166 ± 70, tidal volume 496 ± 84 ml, RR
19 ± 7.4 breaths/minute, PEEP 11.4 ± 3.7 cmH2O) were enrolled. The
fraction of lung parenchyma that could be recruited at plateau pressure
above 30 cmH2O was highly variable with a median of 5% (IQ range 1
to 17%) corresponding to a median 16% (IQ range 10 to 47%) of total
lung recruitability. Indeed we observed a statistically relevant difference
in lung recruitment between airway pressures of 30 and 45 cmH2O (P =
0.016). With PEEP 5 cmH2O, median opening/closing was 129 g (IQ range
124 to 145 g) in the HR group and 50 g (IQ range 24 to 76 g) in LR (P =
0.006), corresponding to 8% of lung parenchyma (IQ range 6 to 8%) in HR
and 4% (2 to 7%) in LR (P = 0.053). Increasing the PEEP level to 15 cmH2O,
median opening/closing was 67 g (IQ range 24 to 95 g) in the HR group
and 45 g (0 to 80 g) in the LR group (P = 0.512), corresponding to 3% (1
to 5%) in HR and 3% (0 to 5%) in LR (P = 0.93). We observed a statistical
difference between recruitments with PEEP 5 and PEEP 15 in the HR
group (P = 0.013) but not in the LR group (P = 0.781).
Conclusion A highly variable and significant fraction of lung
parenchyma is always closed with tidal ventilation at 30 cmH2O plateau
pressure, regardless of the PEEP level applied; this implies that sigh
or periodic recruitment maneuvers may lead to opening and closing.
Intratidal opening/closing was reduced but not abolished in all patients
while ventilating at higher PEEP level (15 cmH2O).
P295
Compliance with protective lung ventilation in an Irish teaching
hospital
S Chong, E Moloney, M Donnelly, G Fitzpatrick
Tallaght Hospital, Dublin, Ireland
Critical Care 2014, 18(Suppl 1):P295 (doi: 10.1186/cc13485)
Introduction The importance of protective lung ventilation in reducing
mortality in adult respiratory distress syndrome (ARDS) patients is well
described [1]. However, suboptimal compliance with the recommended
tidal volumes has been reported [2]. Therefore, we wished to assess our
compliance in adhering to protective lung ventilation in patients with,
or at risk of developing, ARDS.
Methods A retrospective review was done on all mechanically
ventilated patients in the ICU of Tallaght Hospital over a 6-month
period (February to July 2013). Hourly tidal volumes were recorded
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automatically in electronic charts. Compliance was assessed by
calculating the total time patients with, or at risk of developing, ARDS
were ventilated with tidal volumes <6 ml/kg, 6 to 8 ml/kg, and >8 ml/
kg during the first 72 hours on mechanical ventilation. ARDS is defined
as per the Berlin criteria [3]. Exclusion criteria were patients who did
not receive invasive ventilation or who were ventilated for less than
72 hours. We also assessed whether patients’ height was documented.
Results A total of 72 patients were ventilated for >72 hours. Of these
patients (44 males, 28 females, mean age 65.5 years), ARDS criteria
were met in 17 patients and 22 patients were determined to be at risk
of developing ARDS. For patients with ARDS, the ventilated time with
tidal volumes <6 ml/kg, 6 to 8 ml/kg, and >8 ml/kg was 25.3%, 31.7%
and 43% respectively. For patients at risk of developing ARDS, the
ventilated time with tidal volumes <6 ml/kg, 6 to 8 ml/kg, and >8 ml/
kg was 15.7%, 29.3%, 55%, respectively (Table 1). A total of 16 patients
(nine who had ARDS) had no documentation of their height.
Table 1 (abstract P295).
Tidal volume

With ARDS (%)

At risk of ARDS (%)

<6 ml/kg

25.3

15.7

6 to 8 ml/kg

31.7

29.3

43

55

>8 ml/kg

Conclusion Compliance with protective lung ventilation in our ICU is
suboptimal. This may be due to the lack of education and guidelines
in the unit regarding protective lung ventilation. Moreover, accurate
recording of patient height and determination of predicted body
weight should be documented to facilitate accurate tidal volume
calculation and protective lung ventilation.
References
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Mechanisms underlying the lung-protective effects of FLowcontrolled EXpiration
S Schumann, U Goebel, J Haberstroh, J Guttmann
University Medical Center Freiburg, Germany
Critical Care 2014, 18(Suppl 1):P296 (doi: 10.1186/cc13486)
Introduction During mechanical ventilation the expiration occurs
passively and is determined by the recoil forces of the respiratory
system. In an experimental study in pigs we could find that linearization
of the expiratory flow via FLow-controlled EXpiration (FLEX) [1] is lung
protective [2]. Utilizing electrical impedance tomography (EIT) we
aimed at investigating the mechanisms underlying the lung-protective
effects of FLEX.
Methods All experiments were approved by the local animal welfare
committee. Twelve pigs with oleic acid-induced lung injury were
ventilated in the volume-controlled mode (VCV). In six animals,
expiratory flow was linearized via FLEX. PEEP was set to achieve similar
mean airway pressure in the control group (n = 6) and in the FLEX group
(n = 6). Using EIT, the local distribution of ventilation was measured and
alveolar derecruitment during the no-flow phase in late expiration was
quantified.
Results During ventilation with FLEX the no-flow phase in late
expiration was reduced by 50% compared with passive expiration.
Derecruitment during the no-flow phase was clearly reduced by FLEX
compared with VCV. Furthermore, intratidal ventilation was more
homogeneously distributed during ventilation with FLEX compared
with conventional passive expiration.
Conclusion In comparison with conventional VCV with passive
expiration, the no-flow phase in late expiration is reduced and so is the
time the lung persists on the lowest pressure level (PEEP) during the
breath. The reduced low-pressure time is associated with reduced endtidal derecruitment. In a lung mechanically stabilized and recruited
by sustained airway pressure throughout the expiration phase, the

distribution of ventilation is more homogeneous. These mechanisms
of alveolar recruitment maintenance can explain the lung-protective
effects of FLEX.
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Value of peak flow rates measured during a spontaneous breathing
trial to predict success of weaning from mechanical ventilation
K Gundogan, S Baldane, R Coskun, I Bahar, G Altunyurt, H Mumcuoglu,
M Guven, M Sungur
Erciyes University, Kayseri, Turkey
Critical Care 2014, 18(Suppl 1):P297 (doi: 10.1186/cc13487)
Introduction Numerous parameters have been suggested for the
prediction of weaning from mechanical ventilation; however, these
parameters have limited success in the prediction of weaning outcome.
The aim of this study is to assess the success of minute peak flow rates
(spontaneous peak inspiratory flow rate (SPIF) and spontaneous peak
expiratory flow rate (SPEF)) measured during a spontaneous breathing
trial (SBT) in the prediction of weaning outcome.
Methods Patients managed and receiving mechanical ventilation
support for at least 24 hours in the medical and surgical ICUs of Erciyes
University between March 2011 and May 2012 were included in the
present study. Over 30 minutes, SPIF and SPEF values were measured
during a SBT in patients spontaneously breathing by T tube. Patients
who tolerated 30 minutes of SBT were extubated. Patients who did
not need reintubation for 48 hours after extubation were considered
successful weaning, while those needing reintubation were considered
weaning failure.
Results The study was completed with 36 patients overall, being 11
patients in failure and 25 patients in the success group. In both groups,
areas under the curve (AUCs) were calculated for each minute via ROC
analysis using minute SPIF and SPEF values measured during SBT. The
maximum AUC was calculated at minute 23 for SPIF (0.564; 95% CI:
0.363 to 0.764) and at minute 9 for SPEF (0.542; 95% CI: 0.316 to 0.376).
Cutoff values were determined for the minutes in which maximum AUC
values for SPIF and SPEF were detected; and sensitivity and specificity
values were calculated. When the cutoff value for SPIF was accepted as
>26.7 l/minute at minute 23, sensitivity and specificity was calculated
as 72.0% and 28.0%, respectively. When the cutoff value for SPEF was
accepted as >24.7 l/minute at minute 9, sensitivity and specificity were
calculated as 63.6% and 48.8%, respectively.
Conclusion We think that minute SPIF measurement which has
better sensitivity and minute SPEF measurement which has better
specificity compared with available traditional predictors [1] may be
used as a potential bedside weaning predictor when evaluated in
comprehensive studies.
Reference
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Boles JM, et al.: Weaning from mechanical ventilation. Eur Respir J 2007,
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Lung ultrasound findings predict weaning failure from mechanical
ventilation
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C Teixeira1, M Knorst2
1
Hospital Moinhos de Vento, Porto Alegre, Brazil; 2UFRGS, Porto Alegre, Brazil
Critical Care 2014, 18(Suppl 1):P298 (doi: 10.1186/cc13488)
Introduction Lung ultrasound is increasingly becoming a diagnostic
tool in the critical care setting. The B-line is an artifact that correlates
with interstitial edema. Decreases in intrathoracic pressure during
a spontaneous breathing trial (SBT) will augment venous return and
impede left ventricular ejection, increasing intrathoracic blood volume.
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Therefore, the presence of cardiovascular dysfunction can contribute to
weaning failure (WF). A randomized trial concluded that bedside lung
ultrasound could predict post-extubation distress through changes
in aeration during a T-tube test; however, it could not screen patients
before submission to a SBT [1]. We aim to assess the reliability of lung
ultrasound as a predictor of weaning outcomes.
Methods We conducted a prospective, multicenter, observational study
in two adult medical–surgical ICUs. Lung ultrasound was performed
immediately before SBT. Three or more B-lines in a single view were
called a B-pattern. B-predominance was defined as a B-pattern on at
least one of the four anterior chest wall zones. All enrolled patients met
eligibility criteria for ventilation liberation. Patients with tracheostomy
were excluded.
Results During 2 years, 250 SBTs were analyzed. WF, defined as an
inability to tolerate a T-tube trial during 30 to 120 minutes, occurred
in 51 (20.4%). There was a higher prevalence of chronic obstructive
pulmonary disease in the WF group as well as higher duration of
mechanical ventilation. WF patients were also younger. Patients
succeed at SBT and were extubated at first time in 75.9% of cases. We
observed a significant association between B-predominance prior to
submission to SBT and WF (OR = 1.99 (1.04 to 3.84)). For diagnosing WF,
B-predominance showed 69% sensitivity, 48% specificity, 25% positive
predictive value, and 86% negative predictive value.
Conclusion The finding of B-predominance at bedside lung ultrasound
performed before SBT predicts WF, although it shows low accuracy.
Reference
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pulmonary disease patients
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Critical Care 2014, 18(Suppl 1):P299 (doi: 10.1186/cc13489)
Introduction Fluid balance (FB) has been associated with weaning and
extubation failure, particularly of cardiac origin. Also, the increased
right ventricular afterload, a feature common in chronic obstructive
pulmonary disease (COPD) patients especially during a weaning test,
may hinder diastolic filling of the left ventricle through a biventricular
interdependence mechanism. We aimed to investigate the relationship
of the FB in the 48 hours prior to a spontaneous breathing trial (SBT)
and weaning outcomes in a subgroup of COPD patients admitted to a
medical–surgical ICU.
Methods We conducted a 2-year prospective, multicenter, observational study in two adult medical–surgical ICUs. All enrolled
patients met eligibility criteria for ventilation liberation. Patients with
tracheostomy were excluded. We collected demographic, physiologic,
48-hour FB (measured inputs minus outputs) and lung ultrasound
findings immediately before a SBT in 29 COPD patients. Our main
outcome of interest was weaning failure (WF), defined as the inability
to tolerate a T-tube trial during 30 to 120 minutes, in which case
patients were not extubated.
Results Weaning success (WS) (n = 19) and WF (n = 10) patients were
similar in relation to age, sex, APACHE II score, reason for mechanical
ventilation (MV) and comorbidities. Mean duration of MV was 11 days.
FB in the 48 hours prior to the SBT did not differ between the WS
and WF groups (1,091.11 ± 2,195.89 ml and 2,398.80 ± 1,533.15 ml,
respectively). Nevertheless, comparing individuals with 48-hour
FB above and under the cutoff value of 0 ml according to weaning
outcomes resulted in significant association between positive FB and
WF in COPD patients (odds ratio = 1.77 (1.24 to 2.53)). That cutoff point
was obtained on the ROC curve. See Figure 1.
Conclusion Positive FB in the 48 hours preceding the SBT predicted
WF in COPD individuals. We recognized that no intervention was
performed in order to accelerate the weaning process. Brain natriuretic
peptide levels were not available.
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Figure 1 (abstract P299). Association between positive fluid balance WF
in COPD patients.
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Role of the rapid shallow breathing index to predict the success of
mechanical ventilator liberation in acute respiratory failure
C Chanpharm, R Bhurayanontachai
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Critical Care 2014, 18(Suppl 1):P300 (doi: 10.1186/cc13490)
Introduction The rapid shallow breathing index (RSBI) is considered
a good parameter to predict mechanical ventilator liberation. We
hypothesized that the RSBI provides no benefit when clinical readiness
criteria are met.
Methods Adults with acute respiratory who required MV for more than
24 hours, excluding COPD, were assessed daily as a liberation protocol
(Figure 1). During the RSBI step, RSBI was recorded and blinded to the

Figure 1 (abstract P300). Standard mechanical ventilator weaning
protocol.
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Table 1 (abstract P300).
Character
Age

CR

CR + RSBI

P value

55.79 ± 19.6

56.62 ± 19.4

0.74

Male sex (%)

58.3

59.1

0.90

Success rate (%)

89.2

92.2

0.43

researcher. The liberation process was continued regardless of the
RSBI result. The primary outcome was the success rate of mechanical
ventilator liberation with or without RSBI.
Results Analysis of 120 cases with clinical characteristics as presented
in Table 1. There was no statistically significant difference between
using only clinical readiness and using clinical readiness and the RSBI
(92% vs. 89%, P = 0.43).
Conclusion The inclusion of RSBI in our standard mechanical ventilator
liberation protocol for patients who met the clinical readiness criteria
did not significantly increase the success rate of mechanical ventilator
liberation.

P301
Determinants of ventilator weaning outcome in a medical–surgical
ICU
G Georgiev1, S Milanov1, L Todorova2, M Matveev2
1
University Emergency Hospital ‘Pirogov’, Sofia, Bulgaria; 2Bulgarian Academy
of Sciences, Sofia, Bulgaria
Critical Care 2014, 18(Suppl 1):P301 (doi: 10.1186/cc13491)
Introduction The purpose of this study is to prospectively evaluate the
determinants of weaning outcome in a selected sample of ventilatordependent patients.
Methods After fulfilling a set of inclusion/exclusion criteria, 46 patients
treated in a single medical–surgical ICU were prospectively evaluated
between October 2011 and January 2013. The study protocol
followed the generic course of mechanical ventilatory support and its
discontinuation. A period of CMV was followed by stepwise reduction
in pressure support. The outcomes were recorded at the second and
24th hour after the beginning of the PSV (8 cmH2O PS) spontaneous
breathing trial (SBT). A short period of ZEEP breathing was introduced
after the CMV as an additional respiratory stressor. A large number
of parameters (including those derived via indirect calorimetry and
esophageal balloon catheter) were analyzed. The following statistical
methods were used: Student’s t test or its nonparametric alternatives
for intergroup comparisons, repeated-measurements ANOVA for
intragroup comparisons, cross-tabulation and Fisher’s exact test
to compare categorical variables. Logistic regression analysis was
conducted with regard to success/failure classification.
Results Twenty-two (63.04% of all) patients successfully passed the
2-hour SBT. Of them, five failed the subsequent 24-hour SBT. Almost
all of the latter (four out of five) were ventilated due to chronic
respiratory or cardiac diseases. The following parameters were
significantly different between the groups of patients who successfully
and unsuccessfully completed 2-hour SBT: pre-inclusion body weight;
PEEPi (end-expiratory occlusion method), peak and mean airway
pressures during CMV; PaO2, PaO2/FiO2 and oxygenation index during
the SBT; respiratory rate, tidal volume, f/Vt, patient work of breathing
(modified Campbell method), total body oxygen consumption,
respiratory quotient and energy expenditure during ZEEP and the SBT.
The logistic regression model devised to predict the outcome of the
2-hour SBT included the following parameters: type of artificial airway
(tracheotomy vs. translaryngeal), oxygen consumption, f/Vt and energy
expenditure during the SBT.
Conclusion The presence of serious respiratory and/or cardiac
comorbidities might require longer duration of the SBT. In our study,
respiratory load–muscle capacity balance and metabolic activity
appear to play a major role in determining the weaning outcome. A
short period of ZEEP breathing is safe and might have prognostic
utility regarding the outcome of mechanical ventilatory support
discontinuation.

P302
Microbiology and outcomes of severe pneumonia in critically ill
cancer patients
L Rabello1, J Salluh1, M Soares1, M Rosolem1, V Bogado1, I Souza1,
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1
DOr Institute of Research, Rio de Janeiro, Brazil; 2Postgraduate Program of
Internal Medicine – Universidade Federal do Rio de Janeiro, Brazil; 3Hospital
Sirio-Libanês, São Paulo, Brazil
Critical Care 2014, 18(Suppl 1):P302 (doi: 10.1186/cc13492)
Introduction Pneumonia is the most frequent types of infection in
cancer patients. The presence of multiresistant pathogens (MR) is
often associated with inadequate antimicrobial therapy. The aims of
this study were to describe the microbiology and outcomes of cancer
patients with severe pneumonia requiring ICU admission.
Methods A secondary analysis of a prospective cohort study was
performed from 2002 to 2011 at Instituto Nacional de Cancer and
Hospital Sirio-Libanes, Brazil. Adult patients with a diagnosis of cancer
with pneumonia (not acquired in the hospital setting) were evaluated
at ICU admission. Demographic, clinical and laboratory data were
collected during the first day in the ICU, severity scores, comorbidities,
performance status, cancer-related data, microbiologic identification,
empiric antibiotics and the adherence to treatment guidelines.
Results A total of 268 patients were enrolled: 187 (69.8%) patients with
solid tumors and 81 (30.2%) patients with hematological malignancies.
In total, 167 (62.3%) patients had septic shock, and ICU and hospital
mortality rates were 45.5% and 67.9%. Microbiological confirmation
was present in 140 (52%) patients with 56% Gram-negative. The most
frequent pathogens were methicillin-sensitive S. aureus (36 (26%)),
P. aeruginosa (35 (25%)) and S. pneumoniae (16 (12%)). Low incidence
of MR (16 (11.4%)) was observed. Adequate antibiotic therapy based on
microbiological identification was prescribed in 120 (85.72%) patients.
Adherence to ATS/IDSA guidelines was observed in 41 (15.3%) patients.
There were no differences regarding ATS/IDSA guideline adherence
(MR 3 (18.8%) vs. no MR 38 (15.1%), P = 0.719). We observed a trend
towards higher hospital mortality in the MR patients (MR 14 (87.5%)
vs. no MR 168 (66.7%), P = 0.101). In multivariate analysis, mechanical
ventilation (OR 2.52 (1.19 to 5.32)), dialysis (3.86 (1.23 to 12.10)) and
higher SAPS2 (OR per point 1.03 (1.01 to 1.05)) were associated
with increased hospital mortality whereas successful noninvasive
ventilation was associated with lower mortality (0.32 (0.13 to 0.77)). MR
were forced into MV analysis but were not associated with outcomes.
Conclusion Severe pneumonia in cancer patients presents high
hospital mortality, with particular clinical and microbiology features.
Despite low adherence to ATS/IDSA guidelines, antibiotic therapy was
adequate in most of patients following local guidelines based on local
bacterial profiles. Further investigation is needed to clarify the impact
of MRs in clinical outcomes of cancer patients with severe pneumonia.
P303
Biomarker-based exclusion of ventilator-associated pneumonia:
a multicentre validation study
T Hellyer, J Simpson
Newcastle University, Newcastle, UK
Critical Care 2014, 18(Suppl 1):P303 (doi: 10.1186/cc13493)
Introduction Ventilator-associated pneumonia (VAP) remains a leading
cause of nosocomial infection in the ICU [1]. VAP is confirmed by positive
microbiology in approximately one-third of patients with suspected VAP
[2], implying that there is scope to improve antibiotic stewardship. In a
single-centre study, bronchoalveolar lavage fluid (BALF) inflammatory
mediators (in particular interleukin-1 beta (IL-1β)) [3] and neutrophil
proteases [4] demonstrated potential as biomarkers to exclude VAP. We
aimed to validate these findings in a multicentre study.
Methods We conducted a prospective, multicentre observational
study of 167 patients with clinically suspected VAP from 12 ICUs across
the UK. VAP was confirmed by growth of a potential pathogen in BALF
at >104 colony-forming units/ml. IL-1β, IL-8, matrix metalloproteinase-8
(MMP-8), MMP-9 and human neutrophil elastase (HNE) were measured
in BALF by cytometric bead array. IL-6, IL-8, MMP-8, MMP-9 and HNE
were measured in serum. Patients were dichotomised into VAP and
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non-VAP groups and receiver operating characteristics (ROC) curves
were constructed for individual biomarkers and combinations of
markers before optimum cutoff points were determined.
Results A total of 150 patients had paired semi-quantitative culture
and biomarker results. Fifty-three (35%) patients had VAP and 97
(65%) patients formed the non-VAP group. All BALF biomarkers were
significantly higher in the VAP group (P <0.001). The area under the ROC
curve for IL-1β was 0.81, for IL-8 was 0.736, for MMP-8 was 0.758, for
MMP-9 was 0.785 and for HNE was 0.777. Using a cutoff value of 17 pg/
ml, IL-1β had a sensitivity of 96.2%, a specificity of 43.3%, a negative
predictive value (NPV) of 95.5% and a post-test probability of 4.5%
(95 CI: 1 to 16%). A combination of IL-1β and IL-8 excluded VAP with a
sensitivity of 100%, a specificity of 44.3% and a NPV of 1. There was no
significant difference in serum biomarkers between the VAP and nonVAP groups.
Conclusion This study demonstrates that IL-1β effectively excludes
VAP when validated in a multicentre study. The performance is further
improved by the addition of IL-8, and the combination could form a
rapid diagnostic assay to exclude VAP. Biomarker analysis appears to
have the potential to improve antibiotic stewardship, and this concept
should be formally tested in the setting of a randomised controlled
trial.
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Clinical pulmonary infection score calculator in the early diagnosis
and treatment of ventilator-associated pneumonia in the ICU
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Istanbul, Turkey
Critical Care 2014, 18(Suppl 1):P304 (doi: 10.1186/cc13494)
Introduction Ventilator-associated pneumonia (VAP) is a frequently
occurring nosocomial infection in ICU patients and has been associated
with increased morbidity, prolonged duration of ventilation and ICU stay
and increased costs for healthcare. It was shown that early diagnosis of
VAP and immediate initiation of appropriate antibiotics is associated
with reduced morbidity and mortality. The aim of this study is to evaluate
the potential ability of a screening test based on the clinical pulmonary
infection score (CPIS) to identify and treat patients with VAP.
Methods All files belonging to patients between 18 and 80 years old
admitted to the ICU and supported by mechanical ventilation for
longer than 48 hours were evaluated retrospectively. Demographic
data of the patients, the time of mechanical ventilation, duration of
the ICU stay and results (survival or death) were recorded. The CPIS was
calculated after 48 hours for the diagnosis of VAP. The patients with CPIS
>5 intubated were evaluated VAP(+) and the others with CPIS ≤5 were
thought VAP(–). The diagnosis of VAP was bacteriologically confirmed
with the culture of endotracheal aspirate. Statistical evaluations were
done according to the results on the day of intubation and the results
on days 2, 3, 5, 8 and 10 after intubation. Scores of APACHE II and CRP
levels were also recorded on the same days.
Results The duration of mechanical ventilation and ratio of death
were significantly higher in the patients with VAP(+). CPIS levels in the
patients with VAP(+) were significantly higher than the patients with
VAP(–) in the days after the diagnosis. CPIS levels were also higher in
the patients with VAP(+) on the day of diagnosis. At the same day the
parameters, which included the CPIS, body temperature, leukocyte
number, tracheal secretions, PaO2/FiO2 levels and the presence of
infiltrates on the chest radiograph, were significantly higher in VAP(+)
patients (P <0.05). ROC curves were formed for CPIS scores to be used
in diagnosis VAP and the cutoff point had a sensitivity of 97.44% and a
specificity of 100% for diagnosing VAP.
Conclusion At the end of the study, it was concluded that using the
CPIS for early diagnosis and treatment of VAP and thinking that the
patients with CPIS >5 were VAP(+) are guiding factors to resolve the
problems associated with VAP in ICU patients.
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Validation of the 2005 American Thoracic Society/Infectious
Diseases Society of America guidelines for ventilator-associated
pneumonia: a Japanese multicenter observational study
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Critical Care 2014, 18(Suppl 1):P305 (doi: 10.1186/cc13495)
Introduction To select the empirical antimicrobial treatment for
patients with ventilator-associated pneumonia (VAP), the 2005
American Thoracic Society/Infectious Disease of America (ATS/IDSA)
guidelines classify patients according to time of onset and risk factors
for potential multidrug-resistant pathogens (MDRPs). This study aimed
to evaluate the effectiveness of microbial prediction and validate the
adequacy of these guidelines for antibiotic strategy in VAP patients.
Methods We retrospectively analyzed 296 patients who received
empiric antimicrobial treatment for VAP between January 2006 and
December 2010 in 10 ICUs of Japanese tertiary hospitals. VAP was
diagnosed according to CDC criteria. After assigning patients to the
ATS/IDSA risk group (n = 250; late onset or risk factors for MDRPs) or
non-risk group (n = 46; early onset without risk factors for MDRPs), we
determined the accuracy of the guidelines for predicting pathogens
and the impact of guideline adherence on patient outcome.
Results Median age and SOFA scores on ICU admission were 66
(interquartile range: 50 to 77) years and 6 (4 to 8) years, respectively.
Primary diagnosis on ICU admission was coma including post-cardiac
arrest syndrome (31%), trauma (29.4%), and sepsis (9.8%). Prediction
of MDRPs was significantly higher in the risk group than in the nonrisk
group (36.8% vs. 15.2%, P = 0.004). Guideline adherence was lower in the
risk group (45.6% vs. 65.2%, P = 0.016). Treatment adequacy was greater
with guideline adherence than with nonadherence (75.7% vs. 55.9%,
P <0.01). Hospital mortality was not affected by guideline adherence
(P = 0.70). Multivariate analysis revealed that the independent factors
related to hospital mortality were adequate antimicrobial treatment
(odds ratio: 0.53, 95% CI: 0.29 to 0.95; P = 0.034), age (1.02, 1.00 to
1.04; P = 0.004), history of malignancy (8.59, 1.48 to 49.6; P = 0.016),
trauma (0.41, 0.2 to 0.87; P = 0.02), acute kidney injury (5.54, 2.69 to
11.4: P <0.001), and severe sepsis at VAP onset (2.7, 1.4 to 5.1; P = 0.002).
Conclusion The prediction of MDRPs using the 2005 ATS/IDSA
guidelines was acceptable. To ensure adequate antimicrobial treatment,
strict guideline adherence is required in the Japanese setting.
P306
Surveillance and evaluation of ventilator-associated events as per
Centers for Disease Control and Prevention guidelines
M Brown, B Rose
Lewisham and Greenwich NHS Trust, London, UK
Critical Care 2014, 18(Suppl 1):P306 (doi: 10.1186/cc13496)
Introduction While ventilator-associated pneumonia (VAP) can affect
all patients ventilated for >2 days in an ICU, an issue during the last two
decades has been identification of a universally accepted definition.
The Centers for Disease Control and Prevention (CDC) in Atlanta, GA,
USA, have designed a new surveillance paradigm aiming to increase
the objectivity of VAE diagnosis ranging from ventilator-associated
condition (VAC), infective VAC to possible and probable VAP [1]. We
assessed the feasibility and accessibility of the audit tool developed
from the CDC guidelines as a marker of quality assurance.
Methods A prospective audit of patients admitted to University
Hospital Lewisham ICU for intubation and ventilation was performed
for September and October 2013. Recording of minimum PEEP and
FiO2, minimum and maximum temperatures, WBC count, specimens
sent, antibiotics administered and date of organisms found was
performed on a daily basis. VAEs were recorded as per modified CDC
criteria (absence of quantitative microbiological testing) and compared
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against a surrogate marker of clinically diagnosed VAEs based on
information available to the clinician.
Results Forty patients were admitted with 29 fulfilling inclusion
criteria. Of n = 29, mean age was 58 (SD 21) with a median number
of 5 (2 to 29) ventilator-days. We recorded eight VAEs based on CDC
criteria, one VAC, four IVAC and three VAPs. Clinical decision-making
indicated seven VAEs, of which five were VAPs. CDC and clinical criteria
correlated in only five of eight VAPs and clinical criteria alone would
have indicated 40% more VAPs than CDC criteria. Median time to VAE
trigger was 8 days (4 to 20), median number of ventilator-days if a CDC
VAE triggered was 14 compared with 3 if no CDC VAE was triggered
(P <0.01), and 11 compared with 3 (P <0.01) for clinical VAEs.
Conclusion While similar numbers of VAEs are triggered using CDC
and clinical criteria, we noted a disparity in the VAP incidence. Four
clinical VAPs were not triggered due to the hierarchical nature of the
CDC criteria because the initial criterion of sustained minimum PEEP or
FiO2 rise was not met despite clear clinical criteria based on increased
inflammatory markers, temperature spikes and new microbiology. We
are therefore doubtful of the robustness of this tool in its current format
as an accurate measure of quality assurance and agree with recent
statements from the CDC [1] that modifications may be necessary.
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Medical University of Vienna, Austria
Critical Care 2014, 18(Suppl 1):P307 (doi: 10.1186/cc13497)
Introduction The introduction of the lung allocation score has
resulted in a growing number of patients who are considered for
lung transplantation (LTX) while being acutely decompensated. In the
sickest of these patients, mechanical ventilation (MV) alone may not be
sufficient to establish adequate gas exchange. Thus, different modes
of extracorporeal life support have come to the focus of interest in this
setting.
Methods A retrospective analysis of 17 patients (male/female ratio:
6/11; median age: 35 (range 16 to 63)) who underwent arteriovenous
or venovenous interventional lung assist (iLA; Novalung, Germany)
support as bridging to primary LTX (n = 11) or re-LTX (n = 6) between
2005 and 2013.
Results The underlying diagnosis was bronchiolitis obliterans
syndrome III in re-LTX patients (n = 6), cystic fibrosis (n = 5), idiopathic
pulmonary fibrosis (n = 2), emphysema (n = 1), adult respiratory distress
syndrome (n = 1), hemosiderosis (n = 1), and chronic obstructive lung
disease (n = 1), respectively. The type of iLA was arteriovenous in 10 and
venovenous (iLA active) in seven patients. The median bridging time
was 14 (1 to 58) days. The type of transplantation was bilateral LTX (n =
6), size-reduced bilateral LTX (n = 5), lobar bilateral LTX (n = 4), and right
single LTX with contralateral pneumonectomy (n = 1), respectively.
Hypercapnia was effectively corrected in all patients within the first
12 hours of iLA therapy: PaCO2 levels declined from 145 (70 to 198) to
60 (36 to 99) mmHg, P <0.0001. iLA was initiated during non-invasive
ventilation in three patients, of whom one was intubated prior to LTX.
All other patients (n = 14) were placed on iLA while on invasive MV. Of
those, three patients were extubated and remained on iLA until LTX,
one patient was weaned from iLA and remained on MV until LTX, and
one patient was weaned from iLA and MV prior to LTX. Five patients
were switched to extracorporeal membrane oxygenation (venovenous
n = 2, venoarterial n = 3) after 5 (1 to 30) days on iLA support. One
patient died prior to LTX due to septic multiorgan failure (SMOF). All
others (n = 16; 94%) were successfully transplanted. Of these, two
patients died in the ICU due to SMOF. The remaining 14 patients (82%)
survived to hospital discharge and were alive at a median follow-up of
20 (1 to 63) months.
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Conclusion In patients with life-threatening hypercapnia, bridging to
LTX with iLA is feasible, and results in favorable short-term and longterm outcome.
P308
Difference in physiological parameters between sitting out of bed
into a chair or sitting up on an electric bed in the adult ICU
A Fitzgerald, D Breen
Cork University Hospital, Cork, Ireland
Critical Care 2014, 18(Suppl 1):P308 (doi: 10.1186/cc13498)
Introduction The primary aim of this study was to identify in adult
intensive care patients whether there was a difference in the acute
physiological response when a patient is sat out into a chair compared
with when a patient is placed in a chair position using an electric bed.
The secondary aim of this study was to observe the functional outcome
of these patients [1].
Methods The study was conducted in an adult tertiary referral ICU over
a 3-month period. Patients that met predetermined inclusion/exclusion
criteria were allocated to either sitting in a chair or sitting up in an
electric bed. Heart rate, respiratory rate, tidal volume and mean arterial
pressure were obtained for all patients when they were supine in bed,
at 1 minute and at 1 hour in the new position. Arterial blood gases
were obtained at 1 hour in their new position. A functional outcome
measure known as the Chelsea Critical Care Physical Assessment Tool
(CPAX) was also taken on the day of admission, on the day of sitting out,
on the day of discharge from intensive care and at ward level. All data
were analysed using Student’s t test.
Results Sixteen subjects were recruited for this study. There was a
significant increase in paO2 (13.6 ± 2.35 kPa, P = 0.01) and decrease
in paCO2 (4.82 ± 1.27 kPa, P = 0.02) in the chair group at 1 hour after
sitting out in the chair when compared with baseline (10.9 ± 2.44 kPa;
5.41 ± 1.32 kPa). Also there was a significant increase in tidal volume in
the chair group after 1 minute of sitting out (403 ± 118 ml) compared
with baseline (314 ± 105 ml). There was no difference in the electric bed
group for all physiological parameters. The chair group had a better
CPAX score on discharge from intensive care (chair group 24; electric
bed group 13) and on discharge from the hospital (chair group 39;
electric bed group 16). There were no adverse cardiovascular responses
to either position.
Conclusion Sitting suitable critically ill patients out into a chair is safe
and can significantly improve the arterial blood gas measurement and
the tidal volume when compared with sitting a patient into the sitting
position in an electric bed.
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Quantifying sputum production in intensive therapy
C Pope, R Spacie, S Reynolds, H Jones
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Critical Care 2014, 18(Suppl 1):P309 (doi: 10.1186/cc13499)
Introduction Sputum is essential for the protection of the respiratory
tract but also plays a significant role in the pathophysiology of lung
disease [1]. This is evident in critical care where high sputum loads
contribute to respiratory failure [2]. The quantity of sputum produced
by a patient can impact on key decisions such as weaning, extubation
and discharge. We undertook a survey to establish whether there was
a consensus on how we quantify sputum on our intensive therapy unit
(ITU).
Methods We conducted a multidisciplinary team questionnaire of our
28-bed tertiary ITU. Staff were asked how they quantified sputum load
in intubated patients. They were also asked to rate statements on a
five-point scale pertaining to sputum characteristics. The results were
analysed in Excel 2010.
Results One hundred members of staff completed the sputum
production in intensive therapy (SPIT) questionnaire (21% doctors,
71% nurses, 8% physiotherapists). Sputum load was deemed to be
important or essential by more than 95% of respondents when making
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decisions to extubate or decanulate. The quantification of sputum was
inconsistent: 39% of respondents counted the frequency of suctioning,
24% measured the quantity of sputum in the suction tubing, whereas
25% used another method. An effective cough, consistency and colour
were felt to be more important features of sputum than blood staining.
Conclusion Our results showed a very high level of agreement on
the importance of knowing sputum load for decisions to extubate,
decanulate or discharge from the ITU. In contrast, there was little
consensus on how we should quantify sputum load in ventilated
patients. This lack of standard approach may contribute to uncertainty
in the clinical decision-making process. We have developed an objective
sputum scoring system. Components identified as important by our
survey such as suction frequency, sputum consistency and colour
are included. We have recognised the benefits of the standardised
Bristol stool chart to facilitate communication and believe this can be
achieved with sputum load in ventilated patients.
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Outcomes of patients with acute respiratory failure of mixed
aetiology treated with non-invasive ventilation in a large teaching
hospital critical care unit
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Critical Care 2014, 18(Suppl 1):P310 (doi: 10.1186/cc13500)
Introduction Bilevel non-invasive ventilation (NIV) is an established
therapy in chronic obstructive pulmonary disease (COPD) and
cardiogenic pulmonary oedema but evidence for its use in other acute
respiratory conditions is less robust. Reported ICU mortality after NIV
treatment of pneumonia ranges between 18 and 33% [1,2], compared
with 10% in exacerbations of COPD [3]. We aimed to study the
outcomes of patients with acute respiratory failure of mixed aetiology
treated with NIV in our critical care unit and compare findings with
those already published.
Methods Data were collected retrospectively on patients admitted
to our critical care unit with acute respiratory failure requiring NIV
over a 3-year period using the Metavision electronic patient record
system. Patients with a primary surgical problem and those who
received continuous positive airway pressure as a primary intervention
were excluded. We recorded: primary respiratory diagnosis causing
respiratory failure; patient demographics; serial arterial blood gas
results; success of NIV as defined by the British Thoracic Society (BTS)
[4]; and mortality statistics.
Results In total, 113 consecutive patients were identified. Mean
age was 64 and 50% (56/113) were male. The primary diagnosis was
pneumonia in 55 patients and exacerbation of COPD in 40 patients.
The overall mortality on critical care, in hospital and at 1 year was 19%
(22/113), 34% (38/113) and 41% (46/113) respectively. Success of NIV as
defined by BTS criteria (pH >7.3 or reduction in PaCO2 by 0.5 kPa) in the
first 6 hours was seen in 72% (80/111) of patients. In NIV responders,
1-year mortality was 31% (25/80) compared with 65% (20/31) in
nonresponders.
Conclusion NIV is used to treat acute respiratory failure due to a wide
range of aetiologies in our unit with comparable mortality rates to large
published series [1,2,5]. A successful response to NIV in the first 6 hours
is associated with a reduction in 1-year mortality when compared with
nonresponders.
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Effect of nasal high flow for postoperative respiratory failure:
a prospective observational study
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Critical Care 2014, 18(Suppl 1):P311 (doi: 10.1186/cc13501)
Introduction We studied the effect of nasal high flow (NHF) for
postoperative respiratory failure after extubation in our general
surgical ICU. Recently some studies have reported that NHF improves
oxygenation and reduces respiratory rate. However, the usefulness of
NHF in the general surgical ICU has not been fully determined.
Methods A prospective observational study was conducted in our
general surgical ICU to investigate the effect of NHF on respiratory
parameters in patients with postoperative respiratory failure. Patients
who were admitted to the ICU for postoperative respiratory failure
(defined as oxygen saturation as measured by pulse oximetry <96%
and/or respiratory rate>24 beats/minute while receiving more than 6 l/
minute oxygen through a facemask) were eligible in this study. Pre and
1 and 6 hours after NHF treatment, we collected PaO2, PaCO2, respiratory
rate, heart rate, and blood pressure. Data were presented with means
and standard deviations. P <0.05 was considered statistically significant.
Results Forty-two patients were treated using NHF in our ICU from
February 2013 to November 2013. The mean age of the patients was
62.8 ± 15.8 years, and the male:female ratio was 22:19. PaO2 values after
1 and 6 hours of NHF (104 ± 34 mmHg, 107 ± 26 mmHg, respectively)
were significantly higher than that before NHF (89 ± 38 mmHg;
P <0.02). The PaO2/FiO2 ratio was increased from 1 hour to 6 hours of
NHF (from 218 ± 90 mmHg to 236 ± 86 mmHg, P <0.05). Respiratory
rate after NHF (19.6 ± 4.7/minute) was significantly lower than that at
baseline (22.3 ± 4.8/minute; P = 0.0006), whereas PaCO2 after NHF was
reduced compared with baseline (from 41 ± 7 mmHg to 39 ± 5 mmHg,
P <0.02). Thirty-two (76%, success group) patients did not need other
positive ventilation. On the other hand, 10 (24%, failure group) patients
required non-invasive positive pressure ventilation or intubation. We
compared the failure group with the success group. However, there
were no significant differences in vital signs, total bleeding, operative
duration and preoperative respiratory function between the groups.
Conclusion In this study, NHF gradually improved oxygenation.
Additionally, NHF reduces the respiratory rate and the value of PaCO2.
This result might suggest that NHF decreased dead-space ventilation.
There was no difference between the success group and the failure
group. So we can use NHF as the first choice for postoperative
respiratory failure, but it is difficult to predict success or failure.

P312
Inhalation injury and clinical course in major burned patients
S Henrich, TH Rech, IC Warwzeniak, RB Moraes, E Parolo, K Prado, SR Vieira
Hospital de Clínicas de Porto Alegre, Brazil
Critical Care 2014, 18(Suppl 1):P312 (doi: 10.1186/cc13502)
Introduction Inhalation injury is the primary determinant of
mortality in major burned patients, particularly when associated with
pneumonia. This study sought to describe the association between
severity of inhalation injury on bronchoscopic examination and clinical
course among fire victims of Santa Maria, RS, Brazil. Two hundred and
forty-two people were killed in the disaster.
Methods Eighteen patients with inhalation injury secondary to smoke
and fire exposure in an enclosed space admitted to Hospital de Clínicas
de Porto Alegre were divided into groups according to the severity
of injury as determined by bronchoscopic criteria: grade 1 (moderate
edema and hyperemia), grade 2 (marked edema and hyperemia, with
or without carbonaceous debris), or grade 3 (mucosal ulceration or
necrosis). Duration of mechanical ventilation (MV), length of ICU stay,
overall length of hospital stay, and PaO2/FiO2 ratio on days 1 and 3 were
compared among these groups by means of ANOVA with Tukey’s posthoc correction.
Results Three patients had grade 1 injury, four had grade 2 injury, and
11 had grade 3 injury. Seven patients developed ventilator-associated
pneumonia. Mean duration of MV increased progressively in relation
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to injury severity (grade 1: 2.7 ± 0.6 days vs. grade 2: 5.7 ± 2.1 days vs.
grade 3: 13.0 ± 5.4 days; P = 0.004), as did length of ICU stay (grade
1: 4 days vs. grade 2: 7.2 ± 2.2 days vs. grade 3: 19.9 ± 7.7 days; P =
0.001) and overall length of hospital stay (grade 1: 5 days vs. grade
2: 14.5 ± 5.0 days vs. grade 3: 63.4 ± 43.6 days; P = 0.025). There were
no significant differences in PaO2/FiO2 ratio between groups at day 1.
However, as expected, differences in PaO2/FiO2 ratio were found on day
3 (grade 1: 501 vs. grade 2: 424 ± 115 vs. grade 3: 318 ± 120; P = 0.049).
Conclusion In this cohort of patients with major burns, the severity
of inhalation injury was associated with prolonged MV, length of ICU
stay, and overall length of hospital stay, as well as with deterioration in
oxygenation on day 3.
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Severe respiratory failure in multiple trauma patients:
extracorporeal support as a salvage therapy – a single-center
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Introduction Use of extracorporeal life support (ECLS) in trauma
casualties is limited by concerns regarding hemorrhage, particularly in
the presence of traumatic brain injury (TBI). We report usage of ECMO/
interventional lung assist (iLA) as salvage therapy in 13 trauma patients.
A high-flow technique without anticoagulation was used in cases with
coagulopathy or severe TBI.
Methods Data were collected from all adult trauma cases referred to one
center for ECMO/iLA treatment due to severe hypoxemic respiratory
failure. Thirteen consecutives cases are reported. The type of assistance
was chosen based on a flowchart. Type of study: therapeutic, level of
evidence IV. We analyzed patient data, injury data, blood gases before
connection, methods of assistance, coagulation study, complications,
survival and neurological outcome.
Results Thirteen casualties had an average Injury Severity Score of
50.3 ± 10.5 (age 27.7 ± 8.6 years, 69.2% male) and were supported
9.9 ± 4.8 days on ECMO (n = 7) and 7.16 ± 5.9 days on iLA (n = 6). All
suffered severe chest injuries, including one cardiac perforation. Most
were coagulopathic prior to initiation of ECMO/iLA support. Among
the seven patients with TBI, four had active intracranial hemorrhage.
Only 30% of the patients received continuous anticoagulation during
the first 24 hours of support without clotting of the system or diagnosis
of a thromboembolic event. Complications directly related to support
therapy were not lethal; these included hemorrhage from a cannulation
site (n = 1), accidental removal of a cannula (n = 1) and pressure sores
(n = 3). Deaths occurred due to septic (n = 3) and cardiogenic shock
(n = 1). Survival rates were 57 and 83% on ECMO and iLA, respectively.
Follow-up of survivors detected no neurological deterioration.
Conclusion ECMO/iLA therapy can be used as rescue therapy in adult
trauma cases with severe hypoxemic respiratory failure, even in the
presence of coagulopathy, bleeding and/or brain injury. The benefits
of oxygenation and circulatory support must be weighed individually
against the risk of hemorrhage. Further research should determine
whether ECMO therapy also confers survival benefit.
P314
Advanced respiratory care techniques in a severe adult respiratory
failure unit
D Rafiq, A Needham, R Porter, G Lau
Glenfield Hospital, Leicester, UK
Critical Care 2014, 18(Suppl 1):P314 (doi: 10.1186/cc13504)
Introduction Outcome is improved when patients with severe adult
respiratory distress syndrome are transferred to an extracorporeal
membrane oxygenation (ECMO)-capable unit [1]. Not all patients
transferred require ECMO, and this service evaluation examines which
techniques are utilised in patients who ultimately do not require ECMO.

Figure 1 (abstract P314). Frequency of interventions in the base hospital
(BH) and SARF centre.

Methods All patients transferred to the Severe Adult Respiratory
Failure (SARF) unit between April 2012 and April 2013 for advanced
respiratory care who did not require ECMO, identified from the ECMO
database, underwent retrospective notes’ review to identify the
advanced respiratory techniques performed at the SARF unit and the
base hospital.
Results Ten patients were admitted for advanced respiratory care
who did not require ECMO. Eight patients had community-acquired
pneumonia, one had an inhalational injury and one had a previously
undiagnosed cardiac sarcoma. The techniques utilised in the SARF unit
and base hospital are shown in Figure 1. Nine patients were discharged
from the SARF unit alive (90%).
Conclusion A negative fluid balance and targeting higher haemoglobin
are more frequently achieved in a SARF unit. Further studies are
required to fully elucidate the advanced respiratory care techniques
undertaken at specialist SARF units.
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Nebulized C1-esterase inhibitor treatment does not attenuate
pulmonary complement activation in a rat model of severe
Streptococcus pneumoniae pneumonia
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Critical Care 2014, 18(Suppl 1):P315 (doi: 10.1186/cc13505)
Introduction While complement protein deficiencies are associated
with severe and recurrent pulmonary infections, excessive complement
activation plays a role in the pathogenesis of lung injury. We hypothesized that inhibition of the complement system by repetitive
treatment with nebulized plasma-derived human C1-esterase inhibitor
(C1-INH) reduces pulmonary complement activation and subsequently
attenuates lung injury and lung inflammation in a model of severe
Streptococcus pneumoniae pneumonia.
Methods Thirty-two male rats were intratracheally challenged with S.
pneumoniae to induce pneumonia. Rats were repeatedly exposed to
nebulized C1-INH or saline, 30 minutes before induction of pneumonia
and every 6 hours thereafter. Rats were sacrificed 20 or 40 hours after
inoculation to investigate early and late effects. BALF and lung tissue
were obtained for measuring levels of complement activation (C4b/c in
BALF), lung injury (total protein levels in BALF), and inflammation (IL-6
levels in lung tissue).
Results Pneumonia was characterized by bilateral macroscopic
infiltrates, bacterial outgrowth in the lung and clinical signs of illness.
Pneumonia was associated with pulmonary complement activation.
In rats treated with nebulized C1-INH, a functional fraction of C1-INH
was detectable in BALF. However, C1-INH treatment did not affect
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Figure 1 (abstract P315).

pulmonary complement activation (Figure 1A), lung injury (Figure 1B)
or inflammation (Figure 1C).
Conclusion Severe S. pneumoniae pneumonia is associated with
pulmonary complement activation in rats. Nebulized C1-INH treatment, in an attempt to reduce pulmonary complement activation,
neither affects pulmonary complement activation or lung injury and
inflammation.
P316
Novel carbon dioxide removal device driven by a renal-replacement
system without hemofilter: an experimental approach and
validation
T Godet1, A Combes2, E Zogheib3, M Jabaudon1, E Futier1, J Constantin1
1
CHU Clermont-Ferrand, France; 2CHU Pitié-Salpêtrière, Paris, France; 3CHU
Amiens, France
Critical Care 2014, 18(Suppl 1):P316 (doi: 10.1186/cc13506)
Introduction Management of acute respiratory diseases must avoid
ventilator-induced lung injuries along with the rise of PaCO2 and
respiratory acidosis [1]. Efforts are made to find devices assisting
protective ventilation and able to remove arterial CO2 and correct
acidosis [2]. An extracorporeal CO2 removal device driven by the widely
used Prismaflex® platform called PrismaLung® was tested in vivo.
Methods Five hypercapnic ventilated pigs were equipped with the
PrismaLung® system designed to remove CO2 from the bloodstream
through a decarboxylation membrane mounted on a renal replacement
device without any hemofilter. Experiments examined the potential for
blood decarboxylation by gas-exchanger membrane with different sets

Figure 1 (abstract P316). CO2 removal rates at FiO2 1.

of parameters (blood flow rate: 200, 300 and 400 ml/minute, sweep gas
flow: 2, 5, 10 and 50 l/minute, FiO2: 21 and 100%). Statistical analysis
was performed with the Student t test.
Results The extracorporeal device allowed efficient CO2 removal
rates at FiO2 1 (Figure 1) and 0.21 (Figure 2), ranging from 40 to 60 ml/
minute. Efficiency was increased with blood and sweep gas flows.
Carbia and pH of animals were significantly modified after 10 minutes
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centre and mortality among patients with severe 2009 influenza A(H1N1).
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Davies A, et al.: Australia and New Zealand Extracorporeal Membrane
Oxygenation (ANZ ECMO) Influenza investigators. Extracorporeal
membrane oxygenation for 2009 influenza A(H1N1) acute respiratory
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Figure 2 (abstract P316). CO2 removal rates at FiO2 0.21.

of treatment. No significant modification of blood oxygenation was
obtained with pure oxygen, allowing the use of ambient air as the
sweep gas through the membrane. No side effects or filter clotting
occurred during experiments.
Conclusion The device based on the Prismaflex® platform efficiently
removed CO2 from blood and decreased PaCO2 and acidosis of
hypercapnic pigs. Benefits for patients with acute to chronic respiratory
diseases need evaluation.
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Introduction Referral for ECMO has been demonstrated to reduce
mortality in severe hypoxic respiratory failure [1-3]. The numbers of
patients that undergo ECMO is still small and the service depends on
timely referral from regional ICUs. There is evidence that intensivists’
views on the role of ECMO are mixed [4]. The purpose of this study is to
determine whether there are variations in the geographical distribution
of patients that receive ECMO.
Methods NHS England provided the home primary care trust (PCT) of
all adult patients referred for ECMO for potentially reversible respiratory
failure from 2008 to 2012. The referrals from each PCT were indexed
to the population of each area to produce a referral rate per 1,000,000
people.
Results See Figure 1. ECMO services have expanded rapidly in the
last 5 years in England following the publication of evidence for its
efficacy and concerns regarding an influenza pandemic. The referral
rates for ECMO for severe hypoxic respiratory failure vary greatly
around the country from 88 per 1,000,000 population in Leicester City
to no referrals in 32 PCTs. Possible explanations could include: the
distributions of swine flu around the country, referring doctors’ beliefs
about the efficacy of ECMO, local access to high-frequency oscillation
ventilation and possible reluctance of teaching hospitals to refer to
specialist centres. Further investigation to account for this variation
appears indicated.
Conclusion The referral rates for ECMO vary greatly around the country.
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Introduction Using micro-computed tomography (MicroCT), we
assessed the effectiveness of a cleaning closed-suctioning system (CSS)
to remove secretions from the endotracheal tube (ETT) lumen. Biofilm
growing within the ETT, soon after intubation, increases the patient’s
risk to develop ventilator-associated pneumonia, and new cleaning
devices have been designed to keep the ETT clean from secretions [1].
Methods In a bench test, we injected a water-based gel into unused
ETTs to evaluate MicroCT scan (SkyScan 1172; Bruker, Belgium)
effectiveness to measure secretions. In six critically ill patients, a
cleaning CSS (Airway Medix Closed Suction system; Biovo, Tel Aviv)
was used three times a day to keep the ETT clean. After extubation, we
measured ETT secretions volume by MicroCT scanning over a length
of 20 cm from the ETT tip. We also collected ETTs from 11 patients
treated with a standard CSS as controls, and evaluated ETT microbial
colonization.
Results The volume of gel measured by MicroCT strongly correlated
with the volume of injected gel (P <0.001, R2 = 0.99). At extubation,
a lower amount of secretions was measured in the ETTs treated
with the cleaning CSS as compared with controls (0.031 ± 0.029 vs.
0.350 ± 0.417 mm3, P = 0.028), corresponding to a smaller occupation
of the cross-sectional area (average 0.3 ± 0.4 vs. 3.8 ± 4.5% respectively,
P = 0.030). Microbial colonization tended to be reduced in the ETTs
treated with the cleaning CSS (total bacterial charge 1.3 ± 1.7 vs.
3.6 ± 2.7 log(CFU/ml), P = 0.08).
Conclusion MicroCT scan showed high precision and accuracy in
measuring the volume of secretions in bench tests and can thus
be used to evaluate the effectiveness of actions or devices studied
to reduce ETT biofilm accumulation. In a small nonrandomized
population of critically ill patients, the use of an ETT cleaning device
appeared effective to reduce the volume of secretions present in the
ETT at extubation.
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Introduction Today’s healthcare environment has forced providers
to constantly evaluate the materials used, and to find less expensive
alternatives. Recently, low-cost endotracheal tubes (ETTs) have been
introduced to the market. The aim of this study was to test these tubes
(Portex AirCare and Cardinal Health ETT) compared with endotracheal
tubes with known performance (Hi-Lo Covidient pre ISO standard and
Taper-Guard Covidient, post ISO standard).
Methods We used the required test setups according to the ISO
standard for cuff sealing performance. The tubes were tested versus
each other in size 7.0, 7.5 and 8.0 mm. Kink performance was done in
the routine manner.
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Figure 1 (abstract P317).

Results The leak test showed that the Portex AirCare ETT leaked
significantly more compared with both the Hi-Lo (P <0.05) or TaperGuard (P <0.001) ETTs. The standard deviation leak rate for AirCare
was large, suggesting varying seal performance between tubes from
various lots. The kink test showed no difference among tubes.
Conclusion Although tubes look the same there may be differences in
performance. This study demonstrated that the new cheaper ETTs had
greater cuff leak compared with the two tubes used for comparison. We
can only speculate whether differences found in this study is a result
of cost cutting. However, the great variability in sealing performance
between ETTs of the same size from different lots would indicate that
manufacturing controls may be less stringent. Although we cannot
demonstrate that the higher incidence of leak will result in adverse
patient outcomes, one can surmise that the possibility exists. Thus,
selection of endotracheal tubes should not be based on purchase

price alone but should take into account documented performance in
standardized tests.
P320
Tracheostomy in obese patients: the best tube choice issue
L Marullo, G Izzo, A Torino, A D’Elia, L Vessicchio, F Ferraro
Second University of Naples, Italy
Critical Care 2014, 18(Suppl 1):P320 (doi: 10.1186/cc13510)
Introduction Obesity is not an absolute contraindication for
percutaneous tracheostomy (PDT). Video-endoscopy (video-FBS) and
ultrasound (US) facilitate PDT techniques and reduce complications in
obese patients (OPs) [1,2]. OPs may have a higher trachea–skin distance
that makes it difficult to place or to manage a tracheostomy tube (TT).
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Methods A retrospective review was performed using data in the
last 5 years. All OPs were from the ICU of our university hospital. Only
OPs who underwent a PDT were selected with BMI >30 kg/m2. All OPs
needed prolonged mechanical ventilation. A total of 67 OPs were
identified, with 60 PDTs placed using the Ciaglia Blue Rhino (CBR)
Introducer Kit and seven PDTs with the UniPerc PDT Kit. All PDTs were
performed by dedicated staff including residents. Valuation of clinical
anatomical and physio-pathological features of the OPs and US scan
of the neck came before the procedure. At the beginning of the
procedure we placed a 5 mm ID orotracheal tube by tube exchange
with video-FBS assistance, as already described [3]. An 8 to 9 mm ID
wire-reinforced silicone tracheostomy tube (rTT) with adjustable
flange was chosen instead of a standard PVC or silastic TT (sTT) in all
OPs treated with CBR because of the anatomical particularities of OPs
and because of external traction by the weight of the tubing attached
to the TT. An extralong TT (eTT) was chosen because the pretracheal
tissue was too thick for a regular-sized TT in 16 OPs with BMI >40 kg/m2
treated with CBR. For three OPs treated with CBR we needed to change
rTT to eTT because of tube dislodgement and subocclusion X-ray and
video-FBS diagnosis. The UniPerc technique was chosen for OPs with
BMI >40 kg/m2.
Results No major complications (aborting procedure, >50 ml bleeding, TT misplacement, death) were observed. We had only minor
complications (<50 ml bleeding: 3%; ring fracture: 2%; difficult insertion:
21% only with CBR rTT because of the step between the tip of the rTT and
its introducer). UniPerc eTT placement has always been easy.
Conclusion In our experience, the data do not support what previous
studies have shown suggesting increased risk of complication in OPs
[1,2]. We know that the sTT could not be effective in OPs. The use of US,
video-FBS assistance [3], and rTT with an adjustable flange allows a safe
and effective adjustment to anatomical OP particularities, avoiding
collected risks.
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Critical Care 2014, 18(Suppl 1):P321 (doi: 10.1186/cc13511)
Introduction High-flow oxygen therapy (HFOT) delivered through
nasal cannulas can improve oxygenation as compared with low-flow
oxygen devices. It has been shown that nasal HFOT can generate a
positive airway pressure, which increases linearly with the gas flow rate.
Data on the use of HFOT delivered through a tracheostomy are scarce.
The aim of the present randomized, controlled, cross-over trial was to
assess the effects of HFOT delivered through a tracheostomy on arterial
blood gases and endotracheal pressure in critically ill patients.
Methods Tracheostomized patients underwent HFOT with three gas
flow rates (10 l/minute, 30 l/minute and 50 l/minute), randomly applied
for 20-minute periods. At the end of each period, arterial blood gases,
respiratory rate, and endotracheal pressure (Ptrach) were measured.
Ptrach was recorded over the last 3 minutes of each study period:
the maximum expiratory pressure (MEPtrach) and mean expiratory
pressure were measured and averaged for all respiratory cycles during
1-minute recording with stable breathing. FiO2 was kept constant
during the whole study.
Results Seventeen tracheostomized patients were enrolled (SAPS II
52 ± 10, PaO2 96 ± 27 mmHg, PaCO2 33 ± 10 mmHg). Increasing the
gas flow rate from 10 l/minute to 30 l/minute was associated with an
increase in PaO2/FiO2 that did not improve further when 50 l/minute
was used (259 ± 66, 317 ± 79, and 325 ± 76, respectively, P <0.001). The
same trend was observed with PaO2 (89 ± 19 mmHg, 109 ± 26 mmHg,
and 113 ± 29 mmHg, respectively, P <0.001) and SaO2 (96 ± 3%,
98 ± 2%, 98 ± 2%, respectively, P <0.001). PaCO2 (32 ± 8 mmHg on
average) and respiratory rate (27 ± 7 breaths/minute on average) did
not change with different gas flow rates. MEPtrach (0.96 ± 0.43 cmH2O,
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1.32 ± 0.4 cmH2O, and 1.89 ± 0.5 cmH2O at 10 l/minute, 30 l/minute
and 50 l/minute, respectively, P <0.01) and mean expiratory pressure
(0.54 ± 0.27 cmH2O, 0.91 ± 0.29 cmH2O, and 1.36 ± 0.35 cmH2O, at 10 l/
minute, 30 l/minute and 50 l/minute, respectively, P <0.01) increased
with flow. Changes in PaO2/FiO2 were not correlated with changes in
expiratory pressures.
Conclusion When HFOT is used through a tracheostomy at increasing
gas flow rate, oxygenation increases up to 30 l/minute while CO2
clearance and the respiratory rate do not vary. Tracheal expiratory
pressure increases with flow, but changes are small and probably of
limited clinical relevance. Changes in oxygenation are not related
to the variations of tracheal expiratory pressure. HFOT through a
tracheostomy has different effects from when a nasal interface is used.
P322
Development of the novel Tracoe Twist Plus tracheostomy tube
L Barrass, M Healy, D Kennedy, H Drewery
Royal London Hospital, London, UK
Critical Care 2014, 18(Suppl 1):P322 (doi: 10.1186/cc13512)
Introduction The 4th National Audit project, conducted by the Royal
College of Anaesthetists in 2011, reviewed major airway complications
in the UK [1]. It highlighted tracheostomy tube displacement as a
significant risk in critical care patients. Prior to 2011, at the Royal London
Hospital ICU, the Tracoe Twist (marketed by Kapitex) was primarily used
as the default choice of tracheostomy tube. However, over a 5-year
period, there were a significant number of critical incidents related
to tracheostomy tube displacement or blockage. On investigation of
these incidents, root-cause analysis identified inadequate length of
the Tracoe Twist as a major contributing factor. As a consequence of
this, there was also an increasing requirement for the use of adjustable
flange tubes. This was particularly apparent in obese patients. Our
objective was to develop a new tracheostomy tube that would reduce
the number of incidents related to inadequate length. An additional
aim was to maximise the inner diameter for a given external diameter,
thus reducing airway resistance and potentially aiding weaning.
Methods We formed a consultation committee, consisting of
consultants in critical care, a consultant surgeon and a consultant
anaesthetist with a specialist interest in head and neck anaesthesia
and tracheostomy care. We collaborated with the Kapitex design team
to develop a new tracheostomy tube which addressed some of the
perceived deficits of existing devices.
Results We developed a prototype tracheostomy tube that had an
increased length for a given internal diameter. We also increased
the mobility to flange, in order to reduce pressure areas and assist
with fixation. A third modification was to ensure a maximal internal
diameter for a given external diameter. We piloted its use in 20 patients.
No adverse events were observed and the clinical impression was that
the increased length was beneficial to the patients.
Conclusion Following the success of the pilot study, this new
tracheostomy tube was developed and then marketed by Kapitex. This
tube was named the Tracoe Twist Plus. We have now used this tube for
2 years. We have since performed an extensive retrospective audit of
tracheostomy usage and the effect of the introduction of the novel
Tracoe Twist Plus, and the complication rate was reduced in terms of
displacement and obstruction.
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Introduction Mechanical ventilation (MV) and inability to speak
increases psycho-emotional distress [1]. Although not commonly used
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Figure 1 (abstract P323). Number of patients able to speak.

in ICU patients, MV with a deflated cuff in patients with a tracheostomy
can be provided safely and comfortably, by use of a BiPAP Vision®. Air
leakage to the upper airway enables speech [2]. By adding a PassyMuir® speaking valve as second step, the quality of speech and cough
will improve. The ability to speak provides an important improvement
in communication.
Methods The aim of this study was to compare weaning from MV by
gradually decreasing the level of support in cuff-deflated ventilation
with use of a BiPAP Vision® and a Passy Muir® speaking valve, or by
trials of spontaneous breathing with use of a speaking valve, both for
progressively longer periods of time. We examined the differences in
the ability to speak, the duration of the weaning period, the occurrence
of delirium and the frequency of tracheal suctioning. We performed a
single-centre retrospective and prospective observational study in a
22-bed mixed ICU during 1 year. Data were collected using the patient
data management system. Baseline criteria were age, gender, APACHE
IV score, ICU length of stay and duration of MV before placement of the
tracheostomy.
Results Ten patients were included, five in the BiPAP group and five
in the spontaneous group. There were no significant differences in
the baseline criteria. On the second day after tracheostomy, three
out of five patients in the BiPAP group were able to speak compared
with one in the spontaneous method group. A difference in speaking
ability remained until day 9 (see Figure 1). At first time of speaking, the
BiPAP group had higher PEEP level (10 vs. 7.5 cmH2O) and higher SOFA
score (6.2 vs. 4.6) compared with the spontaneous group. There was
no significant difference in delirium, duration of weaning and tracheal
suctioning between both groups.
Conclusion Cuff-deflated MV in ICU patients enables speaking during
ventilator dependence. With this technique the ability to speak
started in an earlier phase of weaning compared with weaning with
spontaneous breathing trials and a speaking valve.
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Introduction A double-lumen endotracheal tube (DLET; bilumen
ventilation tube, PCT/IT2012/000154; Deas S.r.l., Italy) (Figure 1) has
been developed to improve the safety of patients and procedural
comfort during percutaneous tracheostomy (PT). The DLET is divided
into an upper channel, for placement of a fiberoptic bronchoscope
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Figure 1 (abstract P324). Point 1 just before vocal cord, point 2
asymmetric elliptical cuff just before the carena.

(FOB), and a lower channel exclusively dedicated to the patient’s
ventilation. The aim of this study is to achieve an in vitro and an in vivo
evaluation of PT performed with the DLET.
Methods The nonlinear constant of the Rohrer equation (K2) was
calculated as resistive properties, during a continuous flow of 10
to 90 l/minute, for a conventional endotracheal tube (ETT) with and
without FOB (ETT size 7, 7.5, 8, 7f, 7.5f, 8f ), ventilation tube of TLT (F4
and F5) and DLET. The variation of gas exchange (Δ) was measured with
arterial blood gas samples obtained before and after the PT. During
PT, all patients received sedation, analgesia, neuromuscular blocking
and volume-controlled ventilation set with FiO2 100%, TV 500 ml, RR
15 breaths/minute, PEEP 5 cmH2O.
Results In vitro evaluation showed that the DLET had the lowest K2 (7 =
11.33; 7.5 = 8.74; 8 = 7.57; 7f = 6.13; 7.5f = 10.52; 8f = 12.28; F4 = 130.0;
F5 = 11.12; DLET = 5.25 cmH2O/l/minute). During in vivo evaluation, PT
was performed with the conventional ETT with FOB and DLET for five
patients in each group (age 69 ± 13 vs. 71 ± 16; SAPS II: 56 ± 14 vs.
52 ± 20; GCS 3 vs. 4). Gas exchange before and after the procedure did
not differ between the groups, but the Δ values of pH, PaO2 and PaCO2
measured before and after the procedure were, ETT+FOB versus DLET:
ΔpH: –0.05 ± 0.05 versus 0.01 ± 0.02, P = 0.04; ΔPaO2: –112.6 ± 112.6
versus 41.6 ± 25.3, P = 0.01; ΔPaCO2: 14.5 ± 10.8 versus 0.6 ± 1.1, P =
0.02; ΔHCO3: 0.5 ± 2 versus –0.04 ± 0.3, P = 0.6.
Conclusion The DLET resulted in adequate airway patency and minimal
obstruction due to the lower channel exclusively dedicated to patient’s
ventilation. Gas exchange in PT with the DLET remained stable without
any variation in oxygenation and carbon dioxide levels, although the
same settings of mechanical ventilation.
P325
National survey of ICUs in the UK: discharging patients with
tracheostomies
A Garrett, C Strauss, S Saha
Barking, Havering and Redbridge University Hospitals NHS Trust, Romford, UK
Critical Care 2014, 18(Suppl 1):P325 (doi: 10.1186/cc13515)
Introduction Respiratory weaning in ICUs can be a lengthy
and expensive process [1], but may be facilitated by the use of
tracheostomies. Discharging patients with tracheostomies to general
wards improves ICU bed availability but raises potential patient safety
issues. This is demonstrated by the increased mortality compared
with patients decannulated before discharge from the ICU [2].
We investigated how often ICUs in the UK discharge patients with
tracheostomies to wards, which wards these are and whether systems
are in place to ensure adequate safety on discharge.
Methods We telephoned 217 ICUs in the UK. Nursing staff answered
a series of questions regarding the discharge of patients with
tracheostomies to the wards and their follow-up.
Results We obtained information from 203 ICUs. A total of 201 units
used tracheostomies for respiratory weaning. In total, 151 routinely
discharged patients to wards with tracheostomies, 11 never did and
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39 did occasionally. Five discharged to the high dependency unit
only, 60 to respiratory wards only, 70 to specialist wards and 15 to any
or most wards. Eighty-five out of 190 units discharged patients with
tracheostomy cuffs both up and down, 72 discharged with the cuff
down or cuffless and 16 with the cuff ‘usually down’. A total of 141
hospitals had routine follow-up for tracheostomy patients from critical
care outreach or other services. Critical care outreach was available
24 hours a day in 65 hospitals.
Conclusion The vast majority of ICUs in the UK perform tracheostomies
for respiratory weaning and many routinely discharge patients to the
wards prior to decannulation. Routine follow-up is usually available,
but cover may only be available during the day. Patients may go to
a specialist ward with trained nurses but this is not always the case.
Patients are often discharged to wards with their tracheostomy cuff
up, raising major safety issues if their tracheostomy tubes block and
nurses are not trained for such emergencies. Twenty-four hours a day
critical care outreach cover may improve patient safety, but further
research and the production of guidelines is needed to facilitate the
safe discharge of patients with tracheostomies from ICU to the wards.
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Introduction Percutaneous dilatational tracheostomy (PDT) is the
standard airway access in critically ill patients who require prolonged
mechanical ventilation. However, patients with severe coagulopathy
or thrombocytopenia might have an increased risk of periprocedural
bleeding.
Methods We retrospectively reviewed the records of all patients who
underwent PDT (using the Ciaglia technique with bronchoscopic
guidance) on our cardiothoracic ICU between January 2004
and February 2013. Patients were stratified into two groups: no
coagulopathy (group 1), and coagulopathy/thrombocytopenia defined
as international normalized ratio >1.5, partial thromboplastin time >50
seconds and/or platelet count <50 × 109/l (group 2).
Results From a total of 1,001 patients (46% male, mean age 68.1 years)
that underwent PDT, we identified 441 patients (44.1%) with a severe
coagulopathy (group 2). There were no procedure-related deaths.
Major procedure-related complications included a severe bleeding
(requiring transfusion and/or surgery) in two patients in each group
(one laceration of the brachiocephalic trunk, one venous bleeding, two
bleedings from a thyroid vessel), injury of the membranous wall of the
trachea in two patients in group 2 as well as a pneumothorax and a
device failure in group 1. The incidence of moderate periprocedural
bleeding was comparable between the two groups (n = 43 (9.75%) vs.
n = 41 (7.3%), P = NS).
Conclusion Periprocedural bleeding complications during and after
PDT are rare, even in patients with a severe coagulopathy, and thus PDT
can be safely performed in these patients.
P327
Repeat bedside percutaneous tracheostomy: still a contraindication?
K Pilarczyk, F Dusse, G Marggraf, B Schönfelder, H Jakob
University Hospital Essen, West German Heart Center, Essen, Germany
Critical Care 2014, 18(Suppl 1):P327 (doi: 10.1186/cc13517)
Introduction Percutaneous tracheostomy has become an established
procedure in airway management of critically ill patients. Repeat PDT is
considered a (relative) contraindication as a result of distorted anatomy.
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Methods A retrospective review of all repeat bedside percutaneous
dilatational tracheostomies (Ciaglia technique with direct bronchoscopic guidance) performed on our cardiothoracic critical care unit
from January 2004 to February 2013 was conducted.
Results From a total of 1,001 patients undergoing PDT, we identified
36 patients with repeat PDT. Patients’ previous tracheostomies dated
back between 5 days and 2.7 years (mean 122 days). Mean age was
60.3 ± 14.3 years, 42% of patients were female. The mean time from
intubation to PDT was 3.7 ± 3.9 days. There were no deaths associated
with PDT but one major procedure-related complication: one patient
suffered from a periprocedural laceration of the brachiocephalic trunk.
After emergency surgery and surgical tracheotomy (ST), the patient
recovered completely. In all other patients, no conversion to ST, no
loss of airway, no paratracheal insertion, and no accidental tracheal
extubation was observed. No pneumothorax, pneumomediastinum,
hypotension, hypoxemia, or arrhythmias were recorded. A mild
bleeding was observed in 13 patients (36%). A moderate but not
significant bleeding was observed in only one patient (2.8%). A
tracheal ring fracture occurred in six patients (16.7%). Fourteen
patients (38.9%) could be weaned successfully from the respirator
and the tracheostomy could be removed. Thirteen patients (36.1%)
were transferred to another ICU with the tracheostomy in place. The
functional and cosmetic outcomes of PDT were excellent.
Conclusion Repeat PDT is a safe procedure in experienced hands
and should not be generally considered a contraindication. However,
special attention should be paid to the anatomical situation with an
increased risk of vascular complications.
P328
National UK survey: a review of percutaneous tracheostomy and
auxiliary subglottic suction port use
J Rees, R McCartney, S Saha, T Wickrama
Queen’s Hospital, Romford, UK
Critical Care 2014, 18(Suppl 1):P238 (doi: 10.1186/cc13518)
Introduction The tracheostomy is an ancient technique that more
recently has developed a percutaneous technique. Percutaneous
tracheostomies (PCT) have been shown to be safer and reduce infection,
cost and other complications over surgical techniques [1-3]. Ventilatorassociated pneumonia (VAP) is a serious complication resulting from
the use of endotracheal tubes (ETT) and tracheostomies. Changes in
design of these tubes by the addition of a subglottic suction port have
been shown to improve VAP rates in mechanically ventilated patients
[4,5]. A large meta-analysis review showed that subglottic drainage
reduced the number of days of mechanical ventilation required and
reduced the number of days stayed on the ICU [4].
Methods We contacted all ICUs in the UK by telephone and spoke to
the nurse-in-charge to ascertain their normal practice with regards to
PCT and subglottic suction use.
Results We contacted a total of 246 general ICUs, 72% of which we
received a response. The average number of beds per ICU from all
units who responded was 11. Ninety-eight per cent of ICUs that we
questioned did use PCT. For three units, the average bed number per
unit was 11 and the other 2% of ICUs who did not use PCT had five beds
per unit on average. The proportion of ICUs that employed subglottic
suction ports on their ETTs was 43% having on average 11 beds per
unit, whilst the proportion of ICUs that did not employ subglottic
suction ports was 57%, also with 11 beds per unit on average.
Regarding PCT subglottic suction ports, 38% of ICUs did utilise these
tubes whilst 62% did not. Of the group of ICUs that did use subglottic
suction ports on their tracheostomy tubes, the average beds per unit
was 12. Of the group of ICUs that did not use subglottic suction ports
on their tracheostomy tubes, the average beds per unit was 10.
Conclusion Significant differences in practise exist with PCT and
subglottic suction ports on tubes. The size of the ICUs in these groups
is variable. The larger units are more likely to use PCT over the smaller
units. Regarding subglottic suction ports on ETT and tracheostomy
tubes, the size of the ICU does not necessarily dictate their use. We
propose that all ICUs review their policy on the use of PCT and subglottic
suction-assisted tubes to help improve surgical complications, cost,
VAP rates and ICU stays.
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Is the post-critical care environment safe for tracheostomy patients?
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Introduction Over 5,000 tracheostomies are performed in the UK per
year [1]. The 4th National Audit Project identified significant morbidity
and mortality associated with tracheostomy care [1]. The National
Tracheostomy Safety Project (NTSP) 2013 manual highlighted the
need for: local policy; an appropriate care environment; immediate
availability of emergency equipment; trained staff and local training
programmes; and bed-head sign and emergency algorithms for
tracheostomy patients [2]. Following these guidelines, we asked: how
are adult tracheostomy patients managed post discharge from the
intensive care/high dependence unit (ICU/HDU) throughout the UK?
Methods In November 2013, 200 adult ICU/HDUs throughout the UK
were contacted to take part in a telephone survey. Data were collected
on tracheostomy weaning, post-ICU/HDU care, safety guidelines,
emergency protocols and training for clinicians and nurses.
Results Out of the 200 adult ICU/HDUs contacted, 134 took part in
the survey. Out of these, 44% have a tracheostomy weaning protocol,
69% initiate weaning whilst the patient is mechanically ventilated, and
92% use a speaking valve in their weaning process. Also, 87% allow
tracheostomy patients to have oral nutritional intake and in 59% of
these the decision involves speech and language therapy. Post ICU/
HDU, 67% of units discharge to specialised wards, 22% to nonspecialised
wards, 4% to dedicated step-down units and 6% do not step down
their tracheostomy patients. A critical care outreach team reviews the
patients in 73% of the hospitals surveyed. Furthermore, only 11% of
the hospitals have a consultant lead tracheostomy ward round and
17% have a tracheostomy multidisciplinary team (MDT). Also within
these hospitals, 57% have their own tracheostomy safety guidelines
and 70% have emergency tracheostomy management protocols. On
the wards: 34% have tracheostomy bed-head information signs, 93%
have emergency bed-side tracheostomy equipment, 89% have a
tracheostomy training programme, and 50% have a MDT approach to
decannulation.
Conclusion There is a wide variation in post-ICU/HDU management
of tracheostomy patients throughout the UK. Although there are
well established UK national guidelines for the management of
tracheostomy patients, outside the ICU/HDU environment there is a
lack of full implementation of the NTSP recommendations, increasing
the risk of tracheostomy-related morbidity and mortality.
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Introduction Ventilator-associated pneumonia (VAP) is the most
common nosocomial infection among ventilated patients and
is associated with increased mortality and morbidity [1]. Oral
chlorhexidine has been used to decontaminate the airway in critically

Table 1 (abstract P330). Timing difference between toothpaste and
chlorhexidine (minutes)
Minutes

Number of ICUs (%)

>30

74 (50.3%)

<30

32 (21.8%)

Nil

38 (25.9%)

Variable

3 (2.0%)

ill patients, as studies suggest a risk reduction in VAP [2]. Chlorhexidine
reacts with soaps in toothpaste to form inactive insoluble salts [3]. A
minimum delay of 30 minutes between tooth brushing and the subsequent application of chlorhexidine is therefore recommended [4].
Methods A telephone questionnaire was conducted on all ICUs in the
UK to assess current oral decontamination procedures with regards to
chlorhexidine use and the timing of tooth brushing with toothpaste.
Results Sixty-five per cent of ICUs in the UK responded to our survey
(n = 157). Ninety-seven per cent (n = 152) used chlorhexidine and 96%
(n = 150) used it as part of a ventilator care bundle. Forty-six per cent
(n = 70) used a gel, 32% (n = 48) used a mouthwash and 23% (n = 34)
used both preparations. The frequency of chlorhexidine application
varied between ICUs; 15 (9.9%) applied 4-hourly, 91 (59.9%) 6-hourly,
20 (13.2%) 8-hourly, 19 (12.5%) 12-hourly and seven (4.6%) applied at
variable times. Ninety-seven per cent (n = 152) brushed patient’s teeth;
86% (n = 130) used toothpaste, 3% (n = 5) used chlorhexidine gel and
11% (n = 17) used both. Ninety-seven per cent (n = 147) of ICUs using
chlorhexidine also brushed patient’s teeth with toothpaste. Forty-eight
per cent (n = 70) administered chlorhexidine within 30 minutes of
toothpaste application (Table 1).
Conclusion Chlorhexidine is being used too soon after the application
of toothpaste in 48% of ICUs in the UK. This results in attenuation of its
effect and may remove its beneficial risk reduction in VAP. Awareness of
this interaction should be emphasised.
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Introduction We aimed to assess the effect of continuous drainage
of subglottic secretion in the prevention of ventilator-associated
pneumonia (VAP) in patients requiring prolonged mechanical
ventilation for more than 48 hours in the ICU as a prospective,
randomized, controlled study.
Methods Our study was performed with a document from the ethics
committee and written informed consent from the relatives of patients
between April 2011 and February 2012 in our 14-bed ICU. Fifty-four
patients whose mechanical ventilation requirements were expected
to be longer than 72 hours were included in our study. Patients were
randomly divided into two groups. These were formed as the group
using a conventional intubation tube (Group C) and the group using an
intubation tube allowing aspiration of subglottic secretions (Group S).
In Group S, continuous subglottic aspiration occurred under constant
pressure with a special device. In both groups, the cuff pressure was
maintained at a constant pressure of 20 to 30 using a digital cuff
pressure device [1].
Results In Group C, VAP was developed in 10 (35.7%) of 28 patients.
In group S, VAP was developed in five (21.7%) of 23 patients. In both
groups when compared according to the development of VAP, no
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statistically significant differences were detected (P = 0.276). However,
in the first 5 days the development of VAP was significantly higher in
Group C (respectively, 4.3% vs. 25%, P = 0.046). The growth rate of VAP
(VAP number/ventilator-day × 1,000) in Group C was 17.48, while in
Group S it was 11.62. Between the groups there were no statistically
significant difference according to ICU mortality, length of ICU stay and
length of hospital stay (P ≥0.05).
Conclusion This prospective randomized controlled study
demonstrated that the incidence of VAP (especially early development
of the VAP) with continuous aspiration of subglottic secretions
without creating any undesirable clinical damage in the airways was
significantly reduced.
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Introduction Subglottic secretion drainage (SSD) has been shown
to reduce the incidence of ventilator-associated pneumonia (VAP)
[1]. We reviewed current UK practice and practicalities surrounding
implementation of SSD using a survey.
Methods We constructed a survey of 10 questions using SurveyMonkey
and circulated it via an email link to the Linkmen of the UK Intensive
Care Society. Responses were received between August and November
2013.
Results We had 77 responses. The majority were from doctors (88%)
and the rest from nurses. Of respondents, 63% worked in district
general hospitals, 28% in teaching hospitals and the rest in specialist
units. Overall, 54% of respondents worked in units using SSD. From
these responses, the types of patients receiving SSD are summarised in
Table 1. One hundred per cent of units used intermittent SSD. Seventyone per cent of respondents reported that SSD tubes were stored only
on their ICU, with 26% reporting availability in acute areas and the
rest hospital wide. Twenty-eight per cent of respondents indicated
it was unit policy to reintubate patients to facilitate SSD. More than
90% of units had a ventilator care bundle and regularly measured cuff
pressures. Overall, 83% of those surveyed thought SSD was beneficial
in the prevention of VAP.
Table 1 (abstract P332). SSD in specific patient groups (more than one per
responder)
Patients
All

Number
23

Tube >72 hours

6

Tracheostomy

13

Selected

7

Conclusion Despite specific recommendations from the UK Department
of Health [2], only about one-half of respondents work in ICUs where
SSD has been adopted. Most studies show benefit in patients expected
to be ventilated for greater than 72 hours [1], but most units used SSD
in all intubated patients. The reintubation rate to facilitate SSD was also
reasonably high, despite a lack of evidence to support this practice. In
the vast majority of hospitals, SSD endotracheal tubes are stored only
on the ICU and so the need for reintubation may result from a lack of
available appropriate tubes at the point of first intubation.
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Introduction Emulsified perfluorocarbons (PFC) are synthetic
hydrocarbons that can carry 50 times more oxygen than human
plasma. Their properties may be advantageous in applications
requiring preservation of tissue viability in oxygen-deprived states,
which makes them a potential candidate for combat and civilian prehospital resuscitation. Our hypothesis was that an intravenous dose of
PFC increases vital organ tissue oxygenation, improves survival and
reduces or prevents the development of ventilator-associated ARDS.
Here we report data from the second part (ARDS only) of a multiphase
swine study to investigate the benefits of PFC in treating hemorrhagic
shock and preventing ARDS.
Methods Anesthetized Yorkshire swine were randomized (n = 6/
group) to receive a bolus of the PFC Oxycyte™ either 45 minutes before
(PFC-B) or after (PFC-A) induction of ARDS or nothing as a control
(NON). ARDS was induced via intravenous oleic acid infusion (time 0
(T0)) over 30 minutes. Animals were monitored for physiological and
hematological parameters. They were euthanized at T180 minutes and
a full necropsy and histopathological analysis was performed.
Results Survival was 100% in the NON group, 80% in the PFC-A group
and 20% in the PFC-B group. Mean arterial pressure (MAP) and mean
pulmonary artery pressure (MPAP) were significantly increased during
infusion of PFC and during ARDS in the PFC-B group, while cardiac
output (CO) was significantly reduced. In the PFC-A group it was
observed that MAP and MPAP increased and CO decreased during ARDS
induction, but not during PFC infusion. Those changes were significant
in comparison with the NON group. Oxygen delivery and consumption
in the PFC-A group were significantly increased. Histopathological
analysis is currently being performed. Interim analysis showed a trend
to reduced alveolar damage in PFC-A animals.
Conclusion Administration of PFC before induction of ARDS was
detrimental, while giving PFC after ARDS improved oxygen delivery and
increased oxygen consumption. Although survival in this group was
lower than in the NON control group (80% vs. 100%, not significant), a
reduction in alveolar damage was observed. This might improve longterm outcome after ARDS. Based on these data we will continue to the
final phase of this project and evaluate the capacity of PFC to prevent
ARDS in combination with HS.
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respiratory distress syndrome with emphysematous/cystic changes
in the lung
T Otani, S Ohshimo, K Ota, Y Kida, T Inagawa, J Itai, S Yamaga, K Une,
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Critical Care 2014, 18(Suppl 1):P334 (doi: 10.1186/cc13524)
Introduction Venovenous extracorporeal membrane oxygenation (VV
ECMO) is a treatment option for acute respiratory distress syndrome
(ARDS) to minimize ventilator-induced lung injury including lifethreatening pneumothorax. The purpose of our study was to investigate
the safety and efficacy of VV ECMO for preventing pneumothorax in
ARDS patients who were complicated with emphysematous/cystic
changes in the lung.
Methods We have retrospectively analyzed data of ARDS patients
complicated with emphysematous/cystic changes in the lung who
were admitted to our ICU from 2006 through 2012. We divided the
subjects into two groups, patients treated with VV ECMO (ECMO group),
and those treated only by conventional ventilator management (nonECMO group). Correlations between age, sex, underlying disease, PaO2/
FIO2 ratio on admission, duration of ICU stay, survival and incidence of
pneumothorax were evaluated.
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Results Forty-one patients were included in this study (ECMO and nonECMO group, 21 and 20 patients, respectively). There were no significant
differences between ECMO and non-ECMO groups as regards age, sex,
underlying disease, PaO2/FIO2 ratio, duration of ICU stay, and survival.
In the ECMO group, the mean duration of ECMO use was 17 ± 13 days,
and bleeding due to anticoagulation was observed in five patients. The
mean airway pressure in the ECMO group was significantly lower than
in the non-ECMO group (12 ± 6 cmH2O, 22 ± 6 cmH2O, respectively;
P <0.0001). The incidence of pneumothorax was also significantly lower
in the ECMO group than the non-ECMO group (10%, 45%, respectively;
P = 0.015). In Kaplan–Meier analysis, the proportion of pneumothoraxfree patients was significantly higher in the ECMO group (P = 0.014). In
multivariate analysis, conventional ventilator management, presence
of interstitial pneumonia and the duration of intubation were the
independent risk factors of pneumothorax (hazard ratio (HR), 18.0, P =
0.010; HR 33.3, P = 0.025; HR 1.05, P = 0.041, respectively).
Conclusion Although the survival rate was not statistically different,
the use of ECMO for ARDS patients complicated with emphysematous/
cystic changes in the lung markedly reduced the incidence of
pneumothorax.
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Injurious ventilation has an age-dependent affect on the
pulmonary renin–angiotensin system in LPS-challenged rats
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Introduction The underlying molecular mechanisms for the association
between aging and a higher susceptibility to develop ARDS are poorly
understood. The pulmonary renin–angiotensin system (RAS), with a
lung-protective (angiotensin-converting enzyme (ACE)2–angiotensin
(Ang)-1,7–Mas receptor) axis and a lung-injurious (ACE–Ang II–Ang II
receptor (AT1)) axis, has been implicated in the pathogenesis of ARDS
and changes with age. We hypothesized that injurious ventilation has
an age-dependent effect on the pulmonary RAS in LPS-challenged rats
that is associated with increased lung injury.
Methods Infant (~1/2 month), juvenile (~1 month), adult (~4 months)
and older (~19 months) Wistar rats were challenged with intratracheal
LPS and injurious ventilation using tidal volumes of 15 ml/kg for 4 hours.
Lung injury was assessed by wet-to-dry ratio and changes in P/F ratio.
Levels of inflammatory mediators were measured in bronchoalveolar
lavage fluid; mRNA expression of key genes of the pulmonary RAS was
determined in lung homogenates.
Results LPS-challenged and ventilated older rats showed higher
mortality, larger change in wet-to-dry ratio and larger decline in
P/F ratio, compared with other age groups. Increases in neutrophil
influx and inflammatory mediators were age dependent, with higher
levels with increasing age. Compared with controls, ventilated LPSchallenged rats showed a decrease in mRNA expression of ACE, ACE2,
AT-1 and Mas receptor in all age groups, except for infants. The relative
decrease in the mRNA expression of the Mas receptor was most
extensive in older rats, thereby shifting the balance towards the lung
injurious axis in this age group.
Conclusion The effects of injurious ventilation on lung injury are age
dependent in a model of LPS-challenged rats, which is associated with
a more pronounced imbalance of the pulmonary RAS at the expense of
the lung-protective axis with increasing age.
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Introduction Acute lung injury (ALI) is characterized by an excessive
inflammatory response. Several recent clinical observations have
shown that severe H1N1 influenza with ARDS is characterized by early
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secretion of Th17 (IL-6, IL-8, IL-9, IL-17) and Th1 (TNFα, IL-15, IL-12p70)
cytokines [1,2]. However, the exact role of T-helper cells (Th) in the
ALI model remains unknown. We hypothesized that there might be
Th imbalance within the lung in the early phase of LPS-induced ALI.
This study was to assess the role of lung Th polarization response in
ALI mice.
Methods C57BL/6 mice were randomly divided into two groups:
control group and ALI group. ALI animals received 2 mg/kg LPS. Lung
wet weight/body weight (LW/BW) was recorded to assess lung injury.
The pathological changes were examined under an optical microscope.
The mRNA expression levels of T-bet, GATA-3 and RORγt were
determined by quantitative real-time reverse transcriptase-polymerase
chain reaction. Meanwhile, levels of IL-6, IFNγ, IL-4 and IL-17 in lung
homogenates were assessed by enzyme-linked immunosorbent assay.
Results The increase in LW/BW was induced in ALI mice. Histologically,
widespread alveolar wall thickening caused by edema, severe
hemorrhage in the interstitium and alveolus, and marked and diffuse
interstitial infiltration with inflammatory cells were observed in the ALI
group. Meanwhile, the levels of IL-6 in lung tissue were significantly
enhanced in the LPS-induced ALI mice. The mRNA expression of T-bet
and RORγt was upregulated in ALI mice at 24 hours and 48 hours
relative to normal mice (P <0.05 vs. Con). There was no significant
difference in the expression of GATA-3 among groups at 24 hours and
48 hours. Meanwhile, the levels of IFNγ, IL-17 and IL-6 in lung tissue were
significantly enhanced at 24 hours and 48 hours in the LPS-induced
ALI mice. In addition, the levels of IL-4 in lung tissue were significantly
enhanced at 48 hours in the LPS-induced ALI mice. The expression of
T-bet mRNA and RORγt mRNA had a strong correlation with the IL-6
concentration. However, there was no significant correlation of GATA3 with the IL-6 concentration. In addition, there was a significant
correlation of IFNγ, IL-4 and IL-17 with the IL-6 level in LPS-induced ALI
at 24 hours and 48 hours.
Conclusion ALI provokes Th1 and Th17 polarization response. Th1 and
Th17 may participate in the early inflammatory response to ALI.
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Introduction Dendritic cells (DC) may play an important role in acute
lung injury (ALI) [1]. CD80 is the crucial co-stimulatory molecule that
is expressed on the surface of DCs. However, little is known about
the expression of CD80. The purpose of this study was to observe the
expression of CD80 on circulating, lung and splenic dendritic cells (DC)
in ALI mice.
Methods Twelve C57BL/6 mice were randomly divided into two groups:
control group and ALI group. Blood, lungs and spleens were harvested
at 6 hours after LPS or PBS administration. The level of CD80 on DC
was assessed by flow cytometry (FCM). The IL-6 level in the lung was
measured by enzyme-linked immunosorbent assay. Lung wet weight/
body weight (LW/BW) was recorded to assess lung injury. Meanwhile,
pathological changes were examined under an optical microscope.
Results LPS-ALI resulted in a significant increase in lung W/D ratio.
Histologically, widespread alveolar wall thickening caused by edema,
severe hemorrhage in the interstitium and alveolus, and marked and
diffuse interstitial infiltration with inflammatory cells were observed
in the ALI group. Meanwhile, the levels of IL-6 in lung tissue were
significantly enhanced in the LPS-induced ALI mice. FCM analysis
showed that the level of CD80 on circulating DC in control group
was (3.3 ± 1.5)%, CD80 expression on lung DC was (3.6 ± 1.2)%,
and expression of CD80 on splenic DC was (9.0 ± 3.6)%, which was
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significantly higher than that on circulating DC and lung DC (P <0.05).
In the ALI mouse, the level of CD80 on peripheral blood DC was
(5.1 ± 2.1)%; the CD80 level on lung DC was (9.6 ± 2.50)%, which was
significantly higher than that on peripheral blood DC (P <0.05); and the
level of CD80 on splenic DC was (25.2 ± 4.7)%, which was significantly
higher than CD80 levels on the peripheral blood and lung DC (P <0.05).
The CD80 level on lung and splenic DC in ALI mice was significantly
higher than that on lung and splenic DC in control mice (P <0.05 vs.
Con).
Conclusion There is a dynamic characteristic in the expression of CD80
on DC populations in normal and ALI mice. Elevated expression of
CD80 on DC seems to play an important role in the pathogenesis of ALI.
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Introduction Two recent RCTs (OSCAR and OSCILLATE [1,2]) showed
that high-frequency oscillatory ventilation (HFOV) had no positive
impact on mortality. We present our experience over 5 years.
Methods Adult ARDS patients who received HFOV from 2008 to 2012
were included. Demographics, illness severity and outcomes were
collected retrospectively.
Results A total of 118 patients were included; 56.8% were male, mean
age was 54.8 years. RRT use was 45% during admission. Vasoactive
agent use and neuromuscular blockade infusion rate was 81.9 and
29.7% pre HFOV respectively. The 28-day and 6-month mortality was
61.9 and 70.3%. A total of 60.1% had less than 48 hours conventional
ventilation (CV) pre HFOV. The 6-month mortality was 64.8% for this
group. Patients who had over 48 hours CV pre HFOV had a 6-month
mortality of 76.6%. See Table 1.
Conclusion Mortality rates were higher than in recent trials [1,2]. Our
patients represent a more critically unwell group with lower PF ratios
pre HFOV and high vasoactive and RRT use. HFOV may still have a role
in the treatment of these very sick patients with treatment refractory to
conventional ventilation.
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Th17-mediated responses in lipopolysaccharide-induced acute lung
injury mice
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Introduction Losartan, an antagonist of angiotensin II (Ang II) type
1 receptor, is a potential therapeutic drug for acute lung injury
(ALI). Recent reports suggest that losartan inhibits T-helper (Th)-1
immune response and ultimately attenuates inflammation in several
angiotensin II-mediated inflammatory diseases [1,2]. However, the
possible protective mechanisms of losartan in ALI remain poorly
understood. This study was to assess the effect of losartan on the lung
Th polarization response in ALI.
Methods C57BL/6 mice were randomly divided into three groups:
control group, ALI group and ALI + losartan group. ALI animals
received 2 mg/kg LPS; ALI + losartan animals received 2 mg/kg LPS and
15 mg/kg losartan 30 minute before intratracheal injection of LPS. The
pathological changes were examined under an optical microscope. The
mRNA expression levels of T-bet, GATA-3 and RORγt were determined
by quantitative real-time reverse transcriptase-polymerase chain
reaction.
Results The increase in LW/BW induced by LPS was partly prevented
by pretreated with losartan. Histologically, losartan effectively
attenuated the LPS-induced lung hemorrhage, and leukocyte cell
infiltration in the interstitium and alveolus. Meanwhile, the levels of
IL-6 in lung tissue were significantly enhanced in the LPS-induced ALI
mice. With pretreatment of ALI mice with losartan, the level of IL-6 in
lungs markedly decreased. The mRNA expression of T-bet and RORγt
was upregulated in ALI mice at 24 hours and 48 hours relative to
normal mice (P <0.05 vs. Con). There was no significant difference in
the expression of GATA-3 among groups at 24 hours and 48 hours. Of
note, pretreatment of ALI mice with losartan resulted in significantly
reduced mRNA expression of T-bet at 24 hours and 48 hours and RORγt
mRNA expression at 48 hours (P <0.05 vs. ALI). Meanwhile, the levels
of IFNγ, IL-4, IL-17 and IL-6 in lung tissue were significantly enhanced
at 24 hours and 48 hours in the LPS-induced ALI mice. In addition,
both IFNγ and IL-17 in lung tissue at 24 hours and 48 hours decreased
significantly in losartan-pretreated mice compared with the ALI mice.
With pretreatment of ALI mice with losartan, the level of IL-4 in lungs
was not changed.
Conclusion Ang II-induced Th1 and Th17 polarization response could
upregulate inflammatory response and induce lung injury, and losartan
may be a promising substance for clinical use in LPS-induced ALI.
Acknowledgements Supported by the Research Project CPSFG
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Table 1 (abstract P338).
OSCAR

OSCILLATE

Hull

HFOV

Control

HFOV

Control

Mean APACHE II

22.0

21.8

21.7

29

29

Mean Vt (ml/kg predicted)

8.6

8.7

8.3

7.2

7.1

PaO2:FiO2 (mmHg)

81.5

113

113

121

114

Vasoactive agents (%)

81.9

43.5 (day 1)

44.6 (day 1)

67

63

Hospital mortality (%)

66.1

50.1

48.4

46.9

35.2
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Echocardiographic guidance for Avalon Elite dual-lumen catheter
implantation
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Critical Care 2014, 18(Suppl 1):P340 (doi: 10.1186/cc13530)
Introduction Venovenous ECMO is a therapeutic option in patients
with severe ARDS. The dual-lumen catheter (Avalon Elite; Maquet
Medical) offers excellent oxygenation and decarboxylation through
a single insertion site and facilitates patient mobilization as it avoids
femoral access. As incorrect placement of the catheter might result in
perforation and cardiac tamponade, fluoroscopy guidance is advocated
in the literature. Transporting an unstable patient for fluoroscopy,
however, can endanger the patient.
Methods We report a retrospective analysis of out-of-center ECMO
implantation in patients with severe ARDS. Our center provides a 24/7
service for out-of-hospital ECMO implantation with a team consisting
of two intensive care physicians and a perfusionist. In all patients, ECMO
therapy was initiated in a non-ECMO center prior to transportation to
our hospital. Implantation of a dual-lumen catheter was first choice in
all patients and was guided echocardiographically.
Results Between January 2011 and November 2013, a total of 56
patients (average age 53.3 years) underwent out-of-center venovenous
ECMO implantation. In 52 cases (94.6%), a dual-lumen catheter could
be implanted successfully using echocardiographic guidance. Either
31 Fr (65.0%) or 27 Fr (35.0%) Avalon Elite catheters were employed.
No patient developed any major or even fatal complications related to
ECMO implantation. In three out of 56 patients, poor imaging quality or
technical issues hampered the implantation of a dual-lumen catheter
and a femoral approach had to be made. Concerning short-term
survival, 81.0% of all patients could be dismissed from the ICU.
Conclusion Echocardiographic guidance for out-of-center Avalon Elite
catheter implantation is a safe and efficient option when performed by
an experienced team.
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Lower airway sampling greatly increases detection of respiratory
viruses in critically ill patients: the COURSE study
F Van Someren Gréve1, KF Van der Sluijs1, NP Juffermans1, T Winters1,
SP Rebers1, KD Verheul1, R Molenkamp1, AM Spoelstra-de Man2, P Spronk3,
MD De Jong1, MJ Schultz1
1
Academic Medical Center, Amsterdam, the Netherlands; 2VU Medical Center,
Amsterdam, the Netherlands; 3Gelre Hospitals, Apeldoorn, the Netherlands
Critical Care 2014, 18(Suppl 1):P341 (doi: 10.1186/cc13531)
Introduction The prevalence of viral respiratory infections in critically
ill patients on the ICU and the diagnostic potential of tracheal aspirate
sampling are unknown. For this study, the prevalence of respiratory
viruses was investigated in intubated patients by simultaneous
sampling of nasopharynx and tracheal aspirate.
Methods During March and April 2013, consecutive acutely admitted,
intubated patients were included in three ICUs in the Netherlands,
regardless of diagnosis at admission. Daily sampling of the nasopharynx
(NP) with flocked swab and tracheal aspirate (TA) was performed until
successful weaning from mechanical ventilation or death. Admission
samples were tested via multiplex RT-PCR for influenza A and B,
parainfluenza, RSV, human metapneumovirus, bocavirus, coronavirus,
rhinovirus, enterovirus, parechovirus and adenoviruses. Of the
influenza-positive patients, subsequent daily samples were tested for
influenza. Results of viral diagnostics performed by routine care were
collected, and compared with results found in this study.
Results As part of an ongoing observational study (COURSE study), 128
patients were included, of which 35 were virus-positive (27%). Of these,
13 patients were positive in both NP and TA, eight only in NP, and 14
only in TA. Thereby, 40% of the viruses would have been missed if only
NP was performed in this study group. In eight out of 12 coronaviruspositive patients, only the TA sample was virus-positive, with negative
NP. In subsequent daily samples of influenza-positive patients, viral
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loads were higher in TA compared with NP, up to 2 log viral copies.
Duration of positivity of influenza in daily samples was up to two
times longer in TA samples than in NP samples. Of all 35 virus-positive
patients, 10 had received viral diagnostics via routine care.
Conclusion The prevalence of respiratory viruses in this unselected
patient population is high. Forty percent would have been missed if
only NP was sampled. Thereby, TA sampling adds to the detection of
respiratory viruses in critically ill patients. Accuracy and implications of
these results needs to be investigated further.
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Risk factors for multi-resistant organisms in sepsis
L Serpa-Pinto, T Cardoso
Oporto Hospital Center, Oporto, Portugal
Critical Care 2014, 18(Suppl 1):P342 (doi: 10.1186/cc13532)
Introduction The increasing prevalence of infections by multi-resistant
organisms (MDR) has increased over the last decades, with implications
not only in the overall level of therapeutic success, but also in the
selective pressure exerted by the use of broad-spectrum antibiotics to
defeat increasingly resistant agents, thereby creating a vicious cycle
[1,2]. The aim of this study is to describe risk factors associated with
infection by MDR organisms among septic patients.
Methods A retrospective cohort study including all adult patients with
microbiological documented sepsis, admitted to the emergency room
of a tertiary care, university hospital between 1 July 2011 and 30 June
2012.
Results During the study period, 162 patients were admitted to the
emergency room with severe sepsis; 79 (49%) had microbiological
documentation, and were included in this study. The mean (SD) age
was 71 (15) years; 62% were men. Forty patients (51%) had an infection
by a MDR organism. Risk factors associated with infection by a MDR
organism were the presence of any comorbidity (OR = 3.542, P = 0.022),
diabetes mellitus (OR = 4.500, P = 0.006), Karnofsky performance
status (KPS) <70% (OR = 3.882, P = 0.005), the presence of modifiers of
etiology (OR = 5,040, P = 0.010), chronic wounds (OR = 5.371, P = 0.040),
healthcare-associated infections (OR = 3.325, P = 0.026) and hospitalacquired infections (OR = 5.225, P = 0.016). The multivariate model
retained as independent variables associated with infection by a MDR
organism: the presence of diabetes mellitus (adjusted OR = 4.1,95% CI:
1.4 to 12.6) and the need for assistance in daily activities (KPS <70%,
adjusted OR = 3.6, 95% CI: 1.3 to 9.7).
Conclusion The presence of diabetes and decreased functional
capacity should be considered risk factors for infection by a MDR
organism and should be taken into consideration in the empirical
therapy prescription.
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Infections from MDR strains (K. pneumoniae, P. aeruginosa,
A. Baumannii complex) in a multivalent ICU
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Introduction The infection incidences from MDR strains in our ICU are
in accordance with the results of respective studies in other ICUs of our
country. Our aim is to identify potential risk factors for the development
of MDR infection in ICU patients.
Methods The sample consisted of 882 patients, admitted to our ICU
from 1 January 2010 until 30 June 2013. The factors studied were:
age, gender, length of stay in the ICU, origin of patient (for example,
home or transferred from another institution), APACHE II score,
adjusted mortality score, previous colonization with MDR, prior use of
antimicrobial agents, duration of ventilator use, immunosuppression,
diabetes, hypoproteinemia and presence of central venous catheter
(CVC). Bivariable analyses were conducted to determine the association
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between potential risk factors and development of MDR infection.
Categorical variables were compared using the Fisher test. Odds ratios
(ORs) and 95% confidence intervals (CIs) were calculated to evaluate the
strength of any association. Continuous variables were compared using
the Student t test or the Wilcoxon test where appropriate. Multivariable
analysis was performed using multiple logistic regression. Variables
with P <0.20 in bivariable analyses were considered for inclusion in a
multivariable model.
Results Out of 882 patients, 135 (15.3%) developed MDR infection. The
following factors showed statistical significant difference (P <<0.01):
length of stay in the ICU, origin of patient, APACHE II score, previous
colonization, previous use of carbapenems, duration of mechanical
ventilation, immunosuppression, diabetes mellitus, hypoproteinemia
and the presence of CVC. The multivariant analysis showed statistically
significant correlations for the following independent risk factors:
previous use of carbapenems (OR = 632.64, P <<0.01), origin of patient
(OR = 19.60, P = 0.014), presence of CVC (OR = 14.19, P = 0.015), previous
colonization (OR = 4.71, P = 0.037) and duration of ventilator use (OR =
1.10, P = 0.029).
Conclusion The analysis showed a very strong correlation between
prior use of carbapenems and development of MDR infection. Other
significant factors are presence of CVC, origin of patient, previous
colonization and duration of ventilator use. The identification of
the above factors and the effort for their restriction redound to the
reduction of the MDR infections and, consequently, to the reduction
of the morbidity and the mortality of the patients hospitalized in ICUs.
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Clostridium difficile infection in ICU patients
E Belesiotou, C Routsi, M Nepka, E Magira, P Kaltsas, Z Psaroudaki,
E Kraniotaki, A Argyropoulou, T Pittaras, S Zakynthinos
Evangelismos Hospital, Athens, Greece
Critical Care 2014, 18(Suppl 1):P344 (doi: 10.1186/cc13534)
Introduction Clostridium difficile infection is becoming more common
worldwide. Critically ill patients are at particularly high risk for this
disease due to multiple risk factors in this population. Accurate
diagnosis is essential for patient management, infection control and
epidemiology. There are a variety of methods to detect the presence of
toxigenic C. difficile in stools [1,2]. The aim of this study was to evaluate
the incidence of C. difficile infection in our ICU. Laboratory results of
C. difficile toxin detection performed by the methods available in our
institution are presented.
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Methods During the last year, all stool specimens received in the
microbiology department from patients hospitalized in the 30-bed,
multidisciplinary ICU of a tertiary-care hospital were evaluated.
Specimens were ordered by physicians in the presence of clinical
features compatible with C. difficile-associated infection. Each specimen
was subjected to diagnostic tests for C. difficile infection including toxin
enzyme immunoassays for C. difficile toxins A and B detection (DUO
Toxin A&B; VEDA.LAB, France), and glutamate dehydrogenase (GDH) for
cell wall antigen detection (C. DIFF Quik Chek Complete®; USA).
Results During the study period, 335 stool specimens were evaluated.
Results obtained with the two-stage immunoassay tests are shown
in Figure 1. All infected patients were treated with metronidazole or
vancomycin. Following a course of therapy, 2% of the infected patients
had recurrence or relapse. The crude mortality rate was 17%.
Conclusion GDH antigen was positive in 12% of the stool specimens
received from ICU patients with suspected C. difficile-associated
infections. The majority of these specimens (51.4%) produce both C.
difficile toxins A and B, whereas toxin B is produced in 31.4% and toxin
A in the remaining 17.2%.
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Introduction This study aims to describe the infective morbidity of
arterial line catheters in a general ICU.
Methods All ICU admissions for the year 2012 were listed on the
WardWatcher database. All cases in which arterial line tip samples
returned any growth were reviewed in conjunction with the medical,
nursing and daily chart recordings. Data were collected on the
organisms grown and antimicrobial sensitivities. A qualitative decision
of clinical relevance was established based on necessitated change
in patient management, signs of local site infection or evidence of
bacteraemia with the same organism.
Results During 2012 there were 416 ICU admissions, representing
a total of 2,440 ITU-days and 1,994 arterial line-days. A total of 48
arterial line tips suspected of being infected were sent for culture.

Figure 1 (abstract P344). Illustration of the tests performed for detection of C. difficile.
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Thirty-seven arterial lines returned no growth (77.08%). Seven cultures
grew organisms likely to be contaminants (14.58%). Four cultures
grew significant organisms (yield of 8.33%). There were two cases with
documented clinical signs of catheter-related local infection (CRLI) at
the arterial line puncture site. In one case of CRLI the primary source
of infection was felt to be remote from the arterial line. The second
represented a local infection with organisms that are typically skin
commensals. Of the four cultures likely to represent invasive pathogens,
three had clinical suspicion that the primary source was a site remote
from the arterial line. In two of these cases this was confirmed by
growing the same organism at an alternative site more likely to be the
source of infection.
Conclusion These results suggest that CRLI rates for arterial lines are
low at 1.003 per 1,000 arterial line-days. However, there is a significant
bacterial colonisation rate of the arterial lines sampled. Three arterial
lines (6.25%) grew organisms that could represent an important
potential source of ongoing bacteraemia. There is evidence to suggest
that the risk of infection and colonisation of arterial lines may be similar
to that of central lines [1]. Further prospective work is needed to assess
the impact of catheter care bundles on colonisation and infection rates
of arterial lines in the ICU.
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Introduction Central venous catheters (CVCs) are essential for the
delivery of medications and fluids in the ICU patient; however, they
carry a substantial infection risk. Evidence from a collaborative, cohort
study suggests bundled interventions can provide a sustained decrease
in infection [1].
Methods Since December 2009, data have been collected daily on
the number of patients with one or more CVC. All positive blood
cultures are reviewed monthly against predefined criteria to judge
whether these are genuine bacteraemic episodes and thus classified
as laboratory-confirmed bloodstream infections. A monthly rate for
CR-BSI per 1,000 dwell-days is calculated from these data. Since July
2010, a number of interventions aimed at reducing CR-BSI have been
introduced to the ICU.
Results Data are presented on 15,644 CVC dwell-days over 47 months.
Table 1 presents data for three full years and one part year* (January
to November 2013). Despite an increase in bed-days per year, there
has been a sustained reduction in infection rates and a reduction in
dwell-days.
Table 1 (abstract P346). Catheter infection rates, APACHE score and
bed-days 2010 to 2014
Total
CR-BSI/
CVC
CR-BSI
1,000
APACHE II
dwell-days annually dwell-days (mean)

Year

Beddays

Dwell-days/
bed-days

2010

4,037

6

1.5

15.8

5,870

0.69

2011

3,942

2

0.5

16.3

5,967

0.66

2012

3,822

3

0.8

15.9

6,117

0.62

2013*

3,863

1

0.3

16.0

6,059

0.64

Conclusion CR-BSI rates of 1.5/1,000 dwell-days in the first year were
similar to the post-intervention rate of 1.4 in the Pronovost study [1].
Subsequent rates have reduced, suggesting we are outperforming
the secular trend [2]. The proportion of dwell-days to bed-days was
reduced, which may suggest a reduction in duration and/or quantity
of CVC placements.
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Introduction The prediction for and the mortality of patients with
candidemia are highly adverse. The aim of this study was to identify
the risk factors for the development of candidemia in postoperative
patients.
Methods From 1 July 2010 to 30 June 2013 all postoperative patients
(n = 588) admitted to the multivalent ICU of our hospital were
enrolled in this study. We recorded the age, sex, length of stay in the
ICU, APACHE II score upon admission to the ICU, adjusted mortality
score, underlying conditions, recent operations, invasive therapeutic
procedures and prior usage of antimicrobial agents. Initial bivariable
statistical comparisons were conducted using the χ2 test for categorical
data and the Student t test or Wilcoxon test for continuous data.
Relative risks (RRs) and their 95% confidence intervals (CIs) were
calculated. Statistical significance was set at P <0.05. To identify patient
characteristics associated with candidemia we used multivariable
logistic regression. In the multivariant analysis we also included the
independent risk factors reported in recent medical literature. Results
of the logistic regression analysis are reported as adjusted odds ratio
(OR) with 95% CI.
Results Out of 588 patients, 30 (5.1%) developed candidemia
(frequency: 12 per 1,000 days of hospitalization). The mortality
of patients with candidemia was 66.7% (20/30). The monovariant
analysis showed statistical significant difference in the following
factors: immunosuppression (P = 0.0005), diabetes mellitus (P =
0.0005), hypoproteinemia (P = 0.0005), the presence of central venous
catheter (P = 0.0005), the coexistence of bacteremia and the prior use
of antimicrobial agents (P = 0.0005), length of stay in the ICU >5 days
(P = 0.004) and the type of intervention (P = 0.001). As independent
risk factors from the multivariant analysis were found the following:
immunosuppression (exp(B) = 218.37, 95% CI = 11.76 to 4,053.72,
P = 0.0005), hypoproteinemia (exp(B) = 25.69, 95% CI = 2.82 to 296.8,
P = 0.009), presence of central venous catheter (exp(B) = 13.79, 95%
CI = 1.86 to 102.51, P = 0.01) and the coexistence of bacteremia in
combination with prior use of antimicrobial agents (exp(B) = 404.94,
95% CI = 11.61 to 14190.41, P = 0.001).
Conclusion Early candidemia identification, prompt collaboration
of intensivists with biopathologists and immediate initiation of the
proper antifungal treatment is of great significance. The concurrent
understanding of the predisposing risk factors constitutes a significant
supportive tool for the prediction of such infections.
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Escherichia coli infection in Polish neonatology ICUs in 2009 to 2012
J Wójkowska-Mach1, A Chmielarczyk1, D Romaniszyn1, E Helwich2,
R Lauterbach2, M Pobiega1, M Borszewska-Kornacka2, E Gulczyńska2,
A Kordek2
1
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Critical Care 2014, 18(Suppl 1):P348 (doi: 10.1186/cc13538)
Introduction The aim of our study was the analysis of the epidemiology
of infections caused by ECO in Polish NICUs and their resistance to
antibiotics, with particular reference to their impact on the safety of
infants with very low birth weight, and their relationship to the care of
women who are pregnant and in labour. The routes of transmission of
ECO strains were also evaluated.
Methods Continuous prospective infection surveillance was conducted
in 2009 to 2012 in five NICUs and included 1,768 newborns whose birth
weight was lower than 1,500 g.
Results The incidence of ECO infections was 5.4% and 2.0/1,000 patientdays. The occurrence of ECO infections depended significantly on the
NICU and ranged from 3.9 to 17.9%. Multivariate analysis that took into
account the combined effect of demographic data (gender, gestational
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age and birth weight) and place of birth (NICUs, where the baby was
born) showed that only the place of hospitalisation had a significant
effect on the ECO infection risk. The highest levels of resistance
among all ECO isolates were observed against ampicillin (88.8%) and
amoxicillin/clavulanic acid (62.2%). ECO isolates showed very different
pulsotypes and dominant epidemic clones were not detected. Cluster
analysis based on PFGE of the 90 isolates showed 71 unique types,
some of which were less than 70% similar, suggesting a genotypically
variable population. Isolates that have identical pulsotypes usually
were derived from the same patient (as in the case of 11 isolates) or
were isolated from different patients of the same NICU in the same
period of time (in the case of seven isolates). The location of the NICU
and the site of the isolation did not appear to have a correlation in the
cluster analysis
Conclusion Unfortunately, the presented data indicate that antibiotic
prophylaxis in the presence of symptoms such as chorioamnionitis
and PROM did not help to reduce the risk of ECO infection in the group
of examined infants. In addition, multivariate analysis demonstrated
only one significant risk factor for ECO infection among infants with
a birth weight <1,500 g; that is, the impact of the NICU. Epidemiology
of ECO infections clearly indicated that observed cases of infections
have no connection with the horizontal transmission (thus no proof of
a link between the observed ECO infections with possible negligence
in hand hygiene or excessive congestion on NICUs). This is confirmed
by the fact that no epidemic clones were observed (DEC-2011/01/D/
N27/00104).
P349
Infection control as a nonpharmacologic strategy for the prevention
of healthcare-associated infections in a Ukrainian hospital
Y Nalapko
Lugansk State Medical University, Lugansk, Ukraine
Critical Care 2014, 18(Suppl 1):P349 (doi: 10.1186/cc13539)
Introduction Healthcare-associated infections (HAI) in ICU patients are
related to intubation, mechanical ventilation, and central venous and/
or urinary catheters. The incidence of HAI is too high, and antibiotic
strategies suffer from resistance to the common classes of antibacterial
agents [1].
Methods A complex program including staff teaching on the basic
approaches of hand hygiene, microbiological passport of the ICU
departments, and detection of the sources of the pathogens polluting
the treatment area of the ICU was implemented at the Lugansk Regional
Clinical Hospital. The incidence of the HAI was studied in polytrauma
patients in 1999 to 2003 (before the implementation of the program)
and in 2008 to 2012 (after its implementation).
Results Before the implementation of the infection control program, the
incidence of respiratory tract infections in polytrauma patients staying
in ICUs was 57.4% of patients. Urinary infections occurred in 51.9% of
patients. Surgical site infections were found in 32.8% of the patients.
Combination of the infections was detected in 33.8% of patients. The
incidence of the multiple-drug-resistant bacterial colonies was 5.8%.
In contrast, recent data obtained after the implementation of the
program of the infection control showed that the respiratory infections
occurred in 29.3% of the patients, catheter-related urinary tract
infections were detected in 32.8%, and surgical site infections were
detected in 8.6% of the polytrauma patients. On the other hand, the
incidence of the multiple-drug-resistant bacterial colonies increased
significantly up to 14.2% (P <0.001). Other types of HAI changed
nonsignificantly.
Conclusion In the era of the total antibacterial resistance, the education
strategies and organization approaches (for example, infection control,
antibiotic susceptibility, hand hygiene, and so forth) become more
potent and effective than pharmacology innovations. Polytrauma
patients, as one of the most severe categories suffering from the HAI,
demand a high level of compliance of the infection control approaches
from the side of doctors as well as staff of and visitors to ICUs.
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Surveillance for nosocomial pathogens in our ICU
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Critical Care 2014, 18(Suppl 1):P350 (doi: 10.1186/cc13540)
Introduction The use of contact precautions is recommended to reduce
the transmission of these pathogens. However, there is little research
regarding the relationship between the rate of patients with culturepositive findings for Acinetobacter baumannii and the consumption of
hand disinfectant. The objective of this study was therefore to evaluate
trends in nosocomial bacterial detection, including A. baumannii, and
the use of hand disinfectant in our ICU.
Methods A single-center, retrospective, observational study was
carried out. The results of all cultures (sputum, urine, blood, and so
forth) were used to examine trends in the detection of microbiology in
our ICU over a 4-year period from April 2009 through March 2013. The
rate of culture-positive patients, frequency of use of hand disinfectant
and the antimicrobial use density (AUD) values were investigated for
the described periods and compared between the early period group
(April 2009 to March 2011) and the late period group (April 2011 to
March 2013).
Results We encountered 3,302 patients in our ICU during this period.
No patients with culture-positive findings for multidrug-resistant
A. baumannii were identified in this study. The rates of patients
with culture-positive findings for multidrug-resistant Pseudomonas
aeruginosa (0‰ vs. 0.05‰ per 1,000 patient-days, P = 0.99) and P.
aeruginosa (6.96‰ vs. 7.21‰ per 1,000 patient-days, P = 0.7) were
not significantly different between the early period group and the
late period group. The rates of patients with culture-positive findings
for MRSA (6.96‰ vs. 8.94‰ per 1,000 patient-days, P <0.05) and A.
baumannii (4.98‰ vs. 6.51‰ per 1,000 patient-days, P <0.05) were
significantly higher in the late period group than in the early period
group. The frequency of use of hand disinfectant (99.5 ml/patientday vs. 85 ml/patient-day, P <0.05) was significantly lower in the late
period group. The AUD values for fluoroquinolones (34 vs. 31.1 defined
daily doses/1,000 bed-days, P = 0.69), third-generation cephalosporins
(23.5 vs. 38.4 defined daily doses/1,000 bed-days, P = 0.55) and
glycopeptides (34.9 vs. 35.9 defined daily doses/1,000 bed-days, P =
0.66) were not significantly different between the early period group
and the late period group. However, the AUD values for carbapenems
were significantly higher in the early period group (40.6 vs. 71.8 defined
daily doses/1,000 bed-days, P < 0.05).
Conclusion Improving compliance with hand hygiene and appropriate
use of carbapenems is important for decreasing the rate of patients
with culture-positive findings for MRSA and A. baumannii.

P351
Comparison of multidrug-resistant Acinetobacter and
non-Acinetobacter infections in terms of outcome in critically ill
patients
A Madaan1, V Singh1, P Shastri2, C Sharma3
1
Patel Cancer and Superspeciality Hospital, Jalandhar, India; 2Sir Gangaram
Hospital, New Delhi, India; 4Lovely Professional University, Jalandhar, India
Critical Care 2014, 18(Suppl 1):P351 (doi: 10.1186/cc13541)
Introduction Acinetobacter infections have increased and gained
attention because of the organism’s prolonged environmental survival
and propensity to develop antimicrobial drug resistance [1,2]. We
performed a retrospective, matched cohort investigation at a tertiary
care hospital in a tier II city hospital of India to examine morbidity
and mortality outcome of patients with multidrug-resistant (MDR)
Acinetobacter (AB) infection compared with patients with MDR nonAcinetobacter (non-AB) infections.
Methods Patient records from the last 3 years from 2011 through 2013
were studied (n = 104) to examine outcomes of hospitalized patients
in terms of number of organ dysfunctions, ICU length of stay, hospital
length of stay and mortality in patients infected with MDR AB infection
compared with the patients with MDR non-AB infection.
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Table 1 (abstract P351).
Outcome evaluated

MDR AB

MDR non-AB

P value

F value

Mean length of stay
after index day

8.488889

6.101695

0.029299

4.886684

Mean ICU stay after
index day

5.311111

0.864407

1.73×10–11

57.30083

Results MDR AB-infected patients (n = 45, 43%) had greater number of
organ dysfunctions, and higher mean lengths of hospital stay (8.4 days
vs. 6.1 days) and ICU stay (5.3 days vs. 0.8 days) after the index day than
MDR non-AB infection (n = 59, 57%) (Table 1). In-hospital mortality
rates for patients with MDR AB infections (42%) were higher than for
MDR non-AB infection (10%). F critical = 3.934253.
Conclusion We demonstrated in patients infected with MDR strains
of any organism that patients infected with Acinetobacter have
greater number of organ dysfunction, longer lengths of stay in both
the hospital and the ICU as well as increased mortality than patients
infected with non-Acinetobacter infection when we controlled for
severity of illness.
References
1.
2.

Mahgoub S, et al.: Infection Control Hosp Epidemiol 2002, 23:477-479.
Hsueh PR, et al.: Emerg Infect Dis 2002, 8:827-832.

P352
Candida in the respiratory tract secretions of critically ill patients
and the impact of antifungal treatment: a randomized placebocontrolled pilot trial (CANTREAT study)
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Critical Care 2014, 18(Suppl 1):P352 (doi: 10.1186/cc13542)
Introduction Candida spp. are frequently recovered from endotracheal
secretions in critically ill patients suspected of having ventilatorassociated pneumonia. Observational studies reported an association
with worse clinical outcomes [1] but the effect of antifungal therapy in
these patients remains unclear. We designed this pilot study to assess
the feasibility of a larger trial and to evaluate inflammatory profiles and
clinical outcomes in these patients.
Methods We conducted a double-blind, placebo-controlled, multicenter, pilot randomized trial of antifungal therapy in critically ill
patients with a clinical suspicion of ventilator-associated pneumonia
with positive airway secretion specimens for Candida spp. We also
included an observational group without Candida spp. in their airway
secretions. We measured the recruitment rate, inflammatory profiles
over time and clinical outcomes.
Results We recruited 60 patients into the randomized trial; 29 patients
into the observational study. Recruitment was halted before the end
of the study because of difficulty in recruiting patients. Markers of
inflammation and all clinical outcomes were comparable between
placebo and antifungal treatment groups at baseline and overtime. At
baseline, TNFα levels were higher in the VAP with Candida compared
with the observational group (mean ± SD) (21.8 ± 23.1 vs. 12.4 ± 9.3 pg/
ml, P = 0.02) and these patients had lower response to the LPS
stimulation test (854.8 ± 855.2 vs. 1,559.4 ± 1,290.6 pg/ml, P = 0.01).
Conclusion Given the difficulty recruiting patients and the lack of
signal in clinical or inflammatory outcomes, this study does not provide
evidence to support a larger trial examining the efficacy of empiric
antifungal treatment in patients with a clinical suspicion of ventilatorassociated pneumonia and Candida in the endotracheal secretions.
The presence of Candida in the lung may be associated with persistent
inflammation and immunosuppression.
Reference
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Retrospective analysis of respiratory isolates post out-of-hospital
cardiac arrest to establish choices in empirical antibiotic cover
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Critical Care 2014, 18(Suppl 1):P353 (doi: 10.1186/cc13543)
Introduction We analysed positive respiratory isolates for antibiotic
resistance in our out-of-hospital cardiac arrest (OOHCA) population
to establish adequacy of current empirical regimes. Pneumonia
commonly complicates OOHCA, with studies suggesting a prevalence
up to 48% [1].
Methods Patients admitted to the ICU between May 2007 and
September 2013 who underwent therapeutic hypothermia post
OOHCA were included in this study. Demographics and antibiotic
resistance were collected from an electronic database.
Results A total of 160 patients were admitted to the ICU post OOHCA.
In total, 37.5% (60/160) had no respiratory sample sent within 72 hours
of admission and were excluded. Forty per cent (40/100) grew a
clinically important isolate. Gram-negative bacteria (GNB) were most
frequently isolated (42.5%, 17/40) followed by Gram-positive bacteria
(32.5%, 13/40) and mixed bacterial growth (25%, 10/40). S. aureus (n =
14) isolates were often resistant to penicillin (92.8%, 13/14 isolates
tested) but maintained macrolide (erythromycin 92.8%, 13/14),
clindamycin (92.8%, 13/14) and vancomycin (100%, 13/13) sensitivity, if
tested. S. pneumoniae isolates (n = 8) maintained penicillin (87.5%, 7/8),
levofloxacin (100%, 6/6), erythromycin (87.5%, 7/8) and vancomycin
(100%, 6/6) sensitivity. The most commonly isolated GNB, H. influenzae,
maintained high-level sensitivity to amoxicillin (81.8%, 9/11) and coamoxiclav (90.9%, 10/11). Other isolated GNB, however, demonstrated
variable resistance to co-amoxiclav (69.2%, 9/13). Isolates were 100%
sensitive to pipericillin–tazobactam (17/17), amikacin (12/12) and
meropenem (16/16). The British Thoracic Society suggests co-amoxiclav
and clarithromycin for first-line treatment of severe communityacquired pneumonia [2]. Based on this, 77.5% (31/40) of our patients
would have received adequate cover. If pipericillin–tazobactam
replaced co-amoxiclav, 95% (38/40) of our patients would have been
treated with appropriate antibiotics.
Conclusion Respiratory samples post OOHCA frequently grow
potentially pathogenic bacteria but current antibiotic guidelines fail to
provide adequate cover in this population.
References
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Pharmacokinetics of antituberculosis drugs in critically ill patients
with tuberculosis and acute respiratory failure
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Critical Care 2014, 18(Suppl 1):P354 (doi: 10.1186/cc13544)
Introduction The purpose of this study was to describe the
pharmacokinetics of antituberculosis drugs, isoniazid (INH), rifampicin
(RIF) and pyrazinamide (PZA), in eight critically ill patients with
tuberculosis and acute respiratory failure.
Methods We analyzed plasma concentrations of RIF, INH and PZA.
Blood samples were obtained at steady state. Plasma concentrations
were determined with HPLC. A population pharmacokinetic
approach using a nonlinear mixed-effect model was implemented
[1]. Interindividual variability in PK parameters was ascribed to an
exponential model according to the equation: θj = θp × exp(nj), where
θj is the estimate for a pharmacokinetic parameter in the jth patient,
θp is the typical population PK parameter value (ka, CL/F, V/F), and n
is a random variable from a normal distribution with zero mean and
variance ω2. Residual variability was estimated using additive and
additive-proportional error models; Cij = Cj + εadd and Cij = Cj(1 + εp)
+ εadd, where Cij and Cj are observed–predicted concentrations for the
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Table 1 (abstract P354). Mean population parameters of antituberculosis
drugs
Parameter

Table 1 (abstract P355).
2005
2006
2007
2008
2009
2010
2011
2012
(n = 77) (n = 76) (n = 79) (n = 89) (n = 92) (n = 93) (n = 46) (n = 59)

RIF

INH

PZA

ka

0.459

3.58

1.41

VA

0

0

CL/F

6.69

2.74

1.56

TEC

1.3

2.6

0

0

0

1.1

0

0

V/F

105

42.3

33.4

LZ

0

0

1.4

1.2

6.8

12.6

23.1

27.1

ωka

0.645

38.7

0.98

DA

0

0

0.23

Not
tested

0

65.6

Not
tested

0

0.391

Not
tested

0

ωCL/F
ωV/F

0.469

46.8

0.38

ε

0.441

0.235

0.089

jth patient at time i, respectively, and ε is the error, a random variable
with a normal distribution with zero mean and variance σ2. Bayesian
estimates were obtained and the pharmacokinetic parameters Cmax,
Tmax and AUC0–24 hours were calculated.
Results Cmax of PZA was above the recommended concentration
(>20 mg/l). For RIF the Cmax was below the recommended level
(>8 mg/l), and the Cmax of INH was below the recommended levels
(>3 mg/l). See Table 1.
Conclusion Large interindividual pharmacokinetic variability and
concentrations below the recommended levels for RIF and ISO. We
need to monitor drugs and to re-evaluate the doses.
Reference
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Critical Care 2014, 18(Suppl 1):P355 (doi: 10.1186/cc13545)
Introduction Staphylococcus epidermidis (SE) is the most often isolated
species of coagulase-negative staphylococci, which are recognized as
one of the main causes of ICU infections [1]. In this study we aimed
to study the resistance profile of SE clinical isolates against last-line
antibiotics (vancomycin (VA), teicoplanin (TEC), linezolid (LZ) and
daptomycin (DA)) for treating CNS infections, during an 8-year period.
Methods From January 2005 until December 2012 we examined 518
nonduplicated SE isolates recovered from blood cultures of 421 patients
hospitalized in a surgical ICU of our hospital. Species identification
and susceptibility testing were performed using the automated
VITEK II system (Biomerieux). Additionally we used the E-test method
(Biomerieux, ABI-Biodisk) in order to confirm some isolation resistances
against TEC and LZ found by the VITEK II system and to estimate the
MIC levels of DA and VA. Mueller–Hinton agar adjusted to contain
physiologic levels of free calcium ions (50 μg/ml) was used when
testing DA susceptibility. Isolates with MIC >4 mg/l were considered
resistant to TEC and LZ and those with MIC <1 mg/l and MIC <4 mg/l
susceptible to DA and VA, respectively.
Results The percentage resistance rate of the examined SE isolates is
shown in Table 1. Methicillin resistance was observed with an overall
prevalence of approximately 84.6%. All of the resistant isolates to TEC
and LZ were also resistant to methicillin. The MIC values of VA were
lower than 2 mg/l (Table 1).
Conclusion The examined SE isolates present a scattered resistance
to TEC and they show a remarkable continuing increase of resistance
to LZ. These findings enforced the necessity to take the appropriate
measures in the ICU environment and during the clinical practice to
limit the dissemination and the amplification of these resistances. DA
and VA possess an excellent in vitro activity against SE isolates and they
could be very good alternative solutions for treating ICU infections
caused by this species.

0

0

0

0

0

0
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Introduction Patient-to-patient transmission enables vancomycinresistant enterococci (VRE) outbreaks. Outbreak management is expensive
and time consuming, and therefore the possibility of VRE eradication is
desirable. Since vancomycin is scarcely absorbed in the gastrointestinal
tract, treatment with vancomycin per os may result in very high
gastrointestinal concentrations (many times the minimum inhibiting
concentration (MIC)). The purpose of this study is to measure in vivo
gastrointestinal concentrations of vancomycin in patients that are treated
with a standard dose orally, and to investigate in vitro whether vancomycin
is able to kill VRE at concentrations up to 2,000 times the MIC.
Methods The faecal vancomycin concentration was measured in eight
patients who suffered a Clostridium difficile infection and were treated
with 4×500 mg vancomycin orally per day. In vitro, a (1:2) dilution
series of vancomycin (range 6,250 to 0.4 μg/ml) was created and 1 ml
vancomycin solution was then added to 1 ml standardized inoculum.
One vancomycin-susceptible enterococcus isolate (VSE, MIC = 3 μg/
ml) and two VRE isolates (MIC = 16 μg/ml) were studied. After 1, 7 and
14 days incubation at 35°C, growth was defined as macroscopic visible
turbidity. To test for surviving bacteria, all inocula were cultured to
sheep blood agar plates, which were read after 24-hour incubation at
35°C. E-tests to measure MIC were performed on relevant samples. The
in vitro experiment was performed twice.
Results The faecal vancomycin concentration in patients treated orally
with vancomycin was 8,000 μg/ml on average. VSE growth at day 14
was detected at up to 1.5 μg/ml vancomycin, whereas VRE growth was
detected at up to 98 μg/ml. The MIC of these VRE species growing at
98 μg/ml vancomycin was increased (≥256 μg/ml). For both VSE and
VRE, surviving bacteria were detected at very high concentrations of
vancomycin (>98 μg/ml): the MIC of these survivors was not increased.
Conclusion Oral treatment with vancomycin results in extremely high
faecal concentrations. At these high concentrations, VRE bacteria
are killed in vitro; however, a minority of the VRE is able to survive.
Vancomycin thus seems unsuitable for eradication. However, high
concentrations of vancomycin dramatically reduce the bacterial VRE
load. Therefore oral treatment with vancomycin may help to terminate
VRE outbreaks: a dramatic reduction in bacterial load of the colonised
patient will minimise the risk of patient-to-patient transmission.
P357
Audit of bacteraemia management in a university hospital ICU
V De Santis, MG Gresoiu, A Peter, R Wilson, M Singer
University College London Hospital, London, UK
Critical Care 2014, 18(Suppl 1):P357 (doi: 10.1186/cc13547)
Introduction The optimal duration of antibiotic treatment in critically
ill patients remains a subject of debate. In our multidisciplinary ICU, a
short course of antibiotic monotherapy (5 to 7 days) is generally used as
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Figure 1 (abstract P357). Microorganisms isolated in each bacteraemia group. Left panel, 2000; right panel, 2013. Top panel, community-acquired
bacteraemia; Middle panel, hospital-acquired bacteraemia; lower panel, ICU-acquired bacteraemia. Shaded areas represent numbers of methicillin-resistant
strains for S. aureus and coagulase-negative staphylococci; vancomycin-resistant strains for Enterococcus spp.; multidrug-resistant strains for Gram-negative
pathogens; and fluconazole-resistant strains for Candida spp.

a strategy to treat bacteraemia, unless specifically indicated otherwise
(for example, endocarditis, osteomyelitis). We aimed to determine the
impact of this strategy on antibiotic resistance patterns and patient
outcomes compared with a similar exercise we conducted in 2000 [1].
Methods We conducted a retrospective study of all patients with
bacteraemia or fungaemia (community-acquired, hospital-acquired,
and ICU-acquired) treated in our university hospital ICU over a 6-month
period (December 2012 to May 2013). We compared this against data
from blood culture-positive patients admitted between February
and July 2000. Information was collected on bacteraemia episodes,
causative pathogens, antimicrobial resistance patterns, antibiotic use
and duration, and patient outcomes. Notably, our ICU admits many
immunosuppressed patients (for example, haemoncology).
Results Table 1 presents demographics and incidence of bacteraemia.
Antimicrobial resistance remained low in the 2013 cohort with few
multi-resistant Gram-negative organisms, few fungaemia episodes
and a marked decrease in methicillin-resistant Staphylococcus
aureus (MRSA) (Figure 1). The number of relapses and breakthrough
bacteraemias remained low.
Conclusion A strategy of short-course antibiotic monotherapy is
associated with low breakthrough and relapse rates and a low rate of
antibiotic resistance.

Table 1 (abstract P357). Demographics and incidence of bacteraemia
Variable

2000 cohort

2013 cohort

Total ICU population

713

1,318

Patients with bacteraemia

91

87

Episodes of bacteraemia

102

113

Community-acquired bacteraemia

13

37

Hospital-acquired bacteraemia

28

39

ICU-acquired bacteraemia
Hospital mortality

60

37

45%

32%

Monotherapy treatment (%); duration median (IQR)
Community-acquired bacteraemia

57%; 6 (5 to 6)

65% 5 (3 to 5)

Hospital-acquired bacteraemia

78%; 6 (5 to 8)

63%; 5 (4 to 7)

ICU-acquired bacteraemia

80%; 5 (5 to 7)

62%; 4 (3 to 6)
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Sepsis: impact of timely and appropriate empirical antibiotic
therapy on mortality
L Serpa-Pinto, T Cardoso
Oporto Hospital Center, Oporto, Portugal
Critical Care 2014, 18(Suppl 1):P358 (doi: 10.1186/cc13548)
Introduction The administration of timely and appropriate antibiotic
therapy is a well-known prognostic factor among severe sepsis
patients [1-4]. The purpose of this study is to describe the magnitude
of the impact of early and appropriate empirical antibiotic therapy on
hospital mortality.
Methods A retrospective cohort study including all adult patients with
sepsis admitted to the emergency room of a tertiary care, university
hospital between 1 July 2011 and 30 June 2012.
Results A total of 1,219 patients were admitted to the emergency room
during the study period, of which 162 (13%) had severe sepsis. Forty
(25%) patients had withheld therapeutic decisions and were excluded
from the current analysis; 20 additional patients transferred from other
acute healthcare facilities were excluded due to missing or inaccurate
data, leaving 102 patients to be included with a hospital mortality rate
of 45%. The median time to antibiotics administration was 36 minutes
(IQR 0 to 174), 59 (58%) patients had antibiotic administered within the
first hour after sepsis recognition; 60 (59%) had positive microbiology,
74% with appropriate empiric antibiotic therapy. An association was
found for hospital mortality with: heart failure (OR = 4.297; P = 0.037),
decreased functional status (Karnofsky performance status <70%)
(OR = 2.368; P = 0.034) and SOFA score (OR per point = 1.415; P <0.001).
Two multivariate models with hospital mortality as the dependent
variable were built using alternative severity scores: one with SAPS II
that was retained in the final model (adjusted OR = 1.068, 95% CI =
1.020 to 1.119) along with heart failure (adjusted OR = 5.859, 95% CI =
0.996 to 34.474); and another with SOFA score that was also retained
in the final model (adjusted OR = 1.659, 95% CI = 1.227 to 2.242) along
with heart failure (adjusted OR = 12.636, 95% CI = 1.423 to 112.229).
Conclusion Contrarily to what has been described previously, early and
appropriate empirical antibiotic therapy was not associated with better
prognosis. The most probable explanation is the higher compliance
found with the current recommendations, reinforcing the need for
period audits and feedback to the team.
References
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Safety and efficacy of amphotericin B inhalation for Candida spp. in
the respiratory tract of critically ill patients
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Critical Care 2014, 18(Suppl 1):P359 (doi: 10.1186/cc13549)
Introduction Candida spp. are increasingly isolated in the critically
ill, but the clinical significance hereof is hard to establish [1].
Candida spp. colonization has been suggested as a risk factor for
ventilator-associated pneumonia (VAP) [2]. The efficacy and safety of
inhalational amphotericin B (AB) is unknown [3]. The hypothesis was
that inhalational AB deoxycholate is a safe and effective treatment for
Candida spp. colonization of the respiratory tract and thereby prevents
VAP and prolonged need for mechanical ventilation.
Methods All patients admitted to the ICU from December 2010 to
2011 with positive Candida spp. cultures of the respiratory tract
and requiring mechanical ventilation >48 hours were included. AB
treatment was decided by attending intensivists. The colonization
index was calculated to determine the effect of AB. The clinical
pulmonary infection score (CPIS) and the lung injury score (LIS) were
calculated to determine pulmonary effects of AB.
Results Fifty-five of 181 patients had been treated with AB. The AB
decreased indicators of Candida spp. load but increased the duration
of mechanical ventilation as compared with nontreated patients,

Figure 1 (abstract P359). Duration of mechanical ventilation grouped by
amphotericin B.

associated with a higher CPIS and LIS, even in those with similar degree
and duration of colonization and thus probably Candida spp. load at
baseline (P <0.001) (Figure 1). There was no difference in occurrence of
VAP or mortality.
Conclusion AB deoxycholate treatment is effective for the treatment of
Candida spp. colonization of the respiratory tract in critically ill patients.
However, patients are mechanically ventilated for longer.
References
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Introduction Nosocomial pneumonia (NP) is frequently caused by
multiresistant Gram-negative bacteria. The inhaled antibiotics provide
us with a new treatment modality for NP in sepsis. The aim of this study
was to estimate the efficacy of inhaled tobramycin (IT) as an adjunct to
systemic antibiotics in the treatment of NP in sepsis.
Methods Fifty ICU ventilated septic patients with NP were enrolled in
the study (all male, 55.3 ± 7.3 years old; primary reason for ICU stay –
intraabdominal infections (78%), mediastinitis (13%), other (9%)).
Diagnosis of NP was made according to the standard clinical and CPIS
criteria. Associations of multiresistant Gram-negative bacteria were
detected in bronchoalveolar lavage (BAL) of all patients. Seventytwo percent of bacteria were sensitive to tobramycin. Patients were
randomized into two groups: IT (group 1, n = 25), addition of IT to
systemic antibiotics (carbapenems, aminoglycosides, protected
penicillins); and no IT (group 2, n = 25), shift of systemic antibiotics
according to sensitivity. Groups were comparable in APACHE II and CPIS
scores. IT (Bramitob) was administered 300 mg twice daily via nebulizer.
The data were statistically analyzed by STATISTICA 7.0 (M, σ, Newman–
Keuls test; P <0.05).
Results Administration of IT as an adjunct to systemic antibiotics
was associated with a decrease of systemic inflammation and acute
respiratory insufficiency signs 2.3 ± 1.2 days after the treatment onset
(vs. 6.3 ± 1.5 days in group 2, P = 0.03). The decrease of microbial titer
to 103 to 104 CFU/ml was detected in both groups by days 5 to 7, but it
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was reliable in 80% of the patients of group 1 (P <0.02). It is noteworthy
that 21% of group 1 patients were in vitro resistant to tobramycin, but
it was clinically effective, probably due to a local superconcentration.
Treatment with IT was associated with an increase of sensitivity of
microbes to antibiotics they were prior resistant to (32% of patients).
This is probably due to IT effects on biolayers. De-escalation of
antibiotic therapy was possible in group 1 by day 5 in 42% of patients.
The treatment with IT made it possible to wean 40% of patients by
day 5.3 ± 1.8 after treatment cessation (vs. 35% and 11.2 ± 1.3 days
in group 2, P = 0.02). Hearing loss and tinnitus was detected only in
three patients of group 1. There were no cases of bronchospasm. The
mortality was 12% (n = 3) in group 1 and 16% (n = 4) in group 2 (P
>0.05), and was not related to a progression of NP [1].
Conclusion Administration of IT as an adjunct to systemic antibiotics
is efficient in treatment of NP caused by multiresistant Gram-negative
bacteria in sepsis.
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Introduction Appropriate antibiotic prophylaxis plays a crucial role
in preventing sternal wound infection after cardiac surgery [1]. In
institutions with high prevalence of methicillin-resistant Staphylococci
species, vancomycin prophylaxis is recommended either as a
monotherapy or as an adjuvant agent [2]. In our study, we assessed
sternal wound infection rates before and after the introduction of a
vancomycin prophylaxis protocol.
Methods Twenty-six of a total 227 consecutive cardiac surgical patients,
between July and December 2012, developed sternal wound infection
(Group A). All of the patients received a standard empirical antibiotic
prophylaxis. From January to July 2013, 308 patients underwent
cardiac surgery (Group B). In this group, we applied a more restricted
antibiotic protocol, considering the resistance patterns and the results
of microbiological tests of group A. We also evaluated the results
of MIC susceptibility testing of five antibiotics: oxacillin, linezolide,
daptomycin, teicoplanin and vancomycin. In the new protocol the first
vancomycin dose was given 1 hour before sternal incision followed by
three additional doses (48 hours duration).
Results In group A, 26 patients (11.45%) developed sternal wound
infection. Twenty out of 26 patients had staphylococcal infections
characterized by high prevalence of oxacillin resistance while six
patients had Gram-negative infections. In the vancomycin prophylaxis
group (group B) we observed a significant reduction in the incidence of
sternal wound infection rate (P <0.01). Among 308 patients, six patients
(1.94%) developed sternal wound infections, two of them caused by
coagulase-negative oxacillin-resistant staphylococci while in four
patients Gram-negative microorganisms were cultured. Mortality in
infected patients was 0% in both groups.
Conclusion Appropriate antibiotic prophylaxis in cardiac surgery
patients is of paramount importance in preventing sternal wound
infections, resulting in dramatic reduction of postoperative morbidity
and in significant economic benefits.
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Retrospective analysis of the clinical utility of blood cultures taken
surrounding intensive care admission
V Humphrey, M Clark
Victoria Hospital, Kirkcaldy, UK
Critical Care 2014, 18(Suppl 1):P362 (doi: 10.1186/cc13552)
Introduction This study aimed to establish clinical utility of blood
cultures taken surrounding ICU admission. Blood culture cost in terms
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of resources and false results is well established and unnecessary
cultures can cause patient harm.
Methods All ICU admissions in 2011 were listed retrospectively. Notes
were reviewed for those with blood cultures taken during, or within
24 hours prior to or following, ICU admission. Data collected for positive
blood cultures included organism, antimicrobial sensitivity, culture
timing with respect to ICU admission and antibiotic therapy before and
after positive blood culture. Qualitative decisions were made regarding
clinical utility of each positive blood culture. Results were deemed
useful if management changed – starting, changing or stopping
antibiotics or altering antibiotic duration. Confirmatory results or those
not altering treatment were not deemed useful. Statistical analysis was
performed using the chi-squared test.
Results During 2011 and 2012, there were 450 ICU admissions. In total,
698 blood cultures were taken during, or within 24 hours prior to or
following, ICU admission. A total of 135 blood cultures were taken
in the 24 hours prior to ICU admission. Of these, 26 grew significant
organisms (19.3%). Nine of these cultures were deemed clinically useful
(6.7%). A total of 542 blood cultures were taken during ICU admission.
Thirty-three of these yielded significant results (6.1%) but only nine
(1.7%) were deemed clinically useful. A total of 102 cultures were taken
in the first 24 hours of the ICU, of which 17 were positive (16.7%) and
six were useful (5.9%). Fifty-three were taken over the next 24 hours,
of which two were positive and two were useful (3.8%). Forty-four
cultures were taken over the following 24 hours, of which two were
positive (4.5%) and one was useful (2.3%). A total of 343 cultures were
taken subsequent to this in the ICU, of which 12 were positive (3.5%)
and three were deemed useful (0.9%). Of 22 blood cultures taken in
the 24 hours post ICU, one was positive but deemed useful (4.5% yield).
Conclusion These results demonstrate overall low clinical utility of
blood cultures but specifically that utility of ICU cultures is significantly
lower than pre ICU (1.7% vs. 6.7%; P = 0.0001). The yield of positive blood
cultures and their clinical utility also decrease during ICU stay. This may
reflect appropriate empirical antibiotics and lower bacteraemia burden
in later illness. Given the low clinical yield and a lack of established
sensitive or specific triggers [1], we suggest further work in an ICU
setting to maximise utility whilst minimising harm.
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Employing quality improvement methodology in sepsis:
an electronic sepsis order set further improves compliance with the
Surviving Sepsis Campaign 3-hour bundle
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Guys and St Thomas NHS Foundation Trust, London, UK
Critical Care 2014, 18(Suppl 1):P363 (doi: 10.1186/cc13553)
Introduction The Surviving Sepsis Campaign (SSC) has developed
guidelines to promote evidence-based management for patients with
severe sepsis [1]. Improvements in bundle compliance have been
demonstrated over time, but compliance remains below 40%. Sepsis
has been studied in acute and critical care environments, but little
research has focused on the management in level 1 wards. An initial
audit of patients with sepsis who were referred to the GSTT critical care
outreach team revealed very low overall compliance to the SSC 3-hour
bundle. A novel quality improvement campaign was instituted with the
aim of improving bundle compliance.
Methods A retrospective cohort study in a university hospital was
performed. Patients on level 1 wards with severe sepsis registered in
the adult critical care response team (CCRT) database in November
2012 were identified (Cohort A). Physiological observation, track
and trigger scores, compliance with the 3-hour bundle elements
(measured lactate, blood cultures before antibiotics, fluid challenge,
early antibiotics), antimicrobial stewardship and 28-day mortality
were recorded. Following this, a quality improvement project was
initiated: central to this was an electronic ‘SEPSIS’ order set, containing
appropriate investigations and a step-by-step management guide for
use on level 1 wards. A ‘viral’ print and social media campaign were also
undertaken. Compliance to the SSC early care bundle was re-examined
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in two cohorts of patients in July 2013; patients that were referred to
the CCRT as before (Cohort B) and also patients who had the electronic
order set activated (Cohort C).
Results The mean age of all patients studied (n = 79) was 66.5 years.
Fifty-three per cent of the patients were male. Thirty-one per cent
were in septic shock at the time of sepsis identification. Overall SSC
bundle compliance was 6.60% (Cohort A), 24% (Cohort B) and 45.5%
(Cohort C). Improvements in other bundle parameters were also seen,
including blood culture (54%, 72%, 91%), antibiotic administration
(50%, 69%,76%) and fluid administration in septic shock (50%, 42%,
75%) in Cohort A, Cohort B and Cohort C respectively.
Conclusion Baseline compliance with the SSC 3-hour bundle on level
1 wards was very low. An electronic sepsis order set was associated
with marked improvement. Novel quality improvement methodology
may be important to achieve optimal compliance with evidence-based
guidelines and an electronic sepsis order set is recommended.
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Acute kidney injury in cardiorenal syndrome type 1: a meta-analysis
W Vandenberghe, S Gevaert, H Peperstraete, I Herck, J Decruyenaere,
E Hoste
University Hospital Ghent, Belgium
Critical Care 2014, 18(Suppl 1):P364 (doi: 10.1186/cc13554)
Introduction Cardiorenal syndrome type 1 (CRS-1) reflects an abrupt
worsening in cardiac function leading to acute kidney injury (AKI).
Acute cardiac conditions contributing to CRS-1 include acute heart
failure (AHF), acute coronary syndrome (ACS) and cardiac surgery (CS).
The objective of this study was to evaluate the epidemiology of AKI in
CRS-1.
Methods This is a systematic review and meta-analysis. AKI defined by
the RIFLE definition and its modifications AKIN and KDIGO is grouped
as AKIRIFLE. Similarly, AKI defined by variations of worsening renal
failure is grouped as AKIWRF. Incidence of AKI is reported by the
different definitions of AKI. In addition, we report on mortality and
length of intensive care and hospital stay (LOSICU and LOShosp) for
AKIRIFLE. Data are reported as percentage, risk ratio (RR), and mean
difference (MD).
Results Our literature search yielded 316 potential papers, of which
57 were included (20 papers on AHF, 15 ACS and 22 CS). A risk of bias
analysis showed a low risk for selection bias in 55% of the studies and
prospective data collection in 45%. AKIRIFLE was used in 33 studies
(RIFLE in 22, AKIN in 14, KDIGO in four), AKIWRF, with six variants, in
24 studies and use of RRT (AKIRRT) in 20 studies. The incidence of
AKI in CRS-1 patients defined by AKIRIFLE and AKIWRF was similar
(22.5%, respectively 22.4%, P = 0.401), and greater than AKIRRT (2.6%,
both P <0.001). AKIRIFLE occurred more frequently in AHF patients
compared with ACS and CS patients (55.0% vs. 14.9% vs. 19.3%; P =
0.009 respectively P = 0.001, P = NS for ACS vs. CS). This was similar
when defined by AKIWRF. AKIRRT was evenly distributed among CRS1 subtypes (AHF 4.3%, ACS, 1.7%, and CS 3.1%, P = 0.611). Despite
predominant low severity of AKIRIFLE (stage 1: 16.9%, stage 2: 3.7%,
and stage 3: 3.6%), AKIRIFLE was associated with increased mortality
(RR = 5.4), LOSICU (MD 1.7 days), and LOShosp (MD 4.4 days), and
increasing AKIRIFLE severity was associated with increase in these three
outcomes in all CRS-1 patients as well as in the three subgroups. The
impact of AKIRIFLE on mortality was greatest in CS patients (AHF RR =
2.8, ACS RR = 3.5, and CS RR = 9.1). Not surprisingly, AKIWRF had similar
impact on outcomes, but AKIRRT had greater impact compared with
AKIRIFLE (mortality RR = 9.16, LOSICU MD = 10.6 days, and LOShosp,
MD = 20.2 days).
Conclusion Almost one-quarter of patients with an acute cardiac
condition had AKI, and RRT was used in approximately 3%. AKI was
associated with significant worse outcomes. AHF patients experienced
the highest incidence of AKI, but the impact on mortality was greatest
in CS patients.
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Early detection of postoperative acute kidney injury by Doppler
renal resistive index in major lung and cardiac operations
M Arslantas, I Cinel, A Kararmaz
Marmara University Pendik Education and Research Hospital, Istanbul, Turkey
Critical Care 2014, 18(Suppl 1):P365 (doi: 10.1186/cc13555)
Introduction Lung and cardiac operations cause significant changes in
the fluid balance, and thus have a high incidence of development of
postoperative acute kidney injury (AKI). The renal resistive index (RRI)
calculated by the pattern of the renal artery flow is an indicator of renal
artery flow. In this research work, we aimed to evaluate the efficiency of
the RRI on the early prediction of postoperative kidney injury in major
lung and cardiac operations.
Methods Twenty-two patients who have undergone lung or cardiac
surgery were included in the study. After the kidneys were localized by
ultrasonography, the best regions of blood flow were detected using
color Doppler and then the arterial waveforms of these regions were
obtained and optimized by Doppler. The measurements taken from
three different regions were averaged. The RRI was calculated at the
preoperative and postoperative first and 24th hours respectively.
Results A significant correlation was established between RRI and
postoperative creatinine levels (P <0.01). RRI values reached their
highest point at the postoperative first day whereas the creatinine
levels reached their highest level at the postoperative third day.
Although there was no correlation between postoperative creatinine
level and duration of staying in hospital, a significant relationship was
detected between duration of staying in ICU and the creatinine levels
(P <0.01). When the cases were divided into two groups as RRI is less
(n = 13) and larger (n = 9) than 0.7, significant differences were present
with regard to age and creatinine levels.
Conclusion The RRI, which is used to evaluate renal arterial flow, is
directly related with increasing renal vascular resistance in the case of
AKI. The usefulness of RRI for prediction of AKI was shown both clinically
following a renal allograft and experimentally in the acute tubular
necrosis modeling [1,2]. Also in septic patients this was asserted, as RRI
is a better marker than cystatin C, which is one of the popular markers
of recent times for prediction of development of AKI [3]. Our results
show that RRI could be a simple, non-invasive and useful technique for
early diagnosis of AKI in patients undergoing major operations such as
lung and cardiac surgeries.
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Renal resistive index at ICU admission and its change after 24 hours
predict acute kidney injury in sepsis
I Gornik, A Godan, V Gašparović
University Hospital Centre Zagreb, Croatia
Critical Care 2014, 18(Suppl 1):P366 (doi: 10.1186/cc13556)
Introduction The renal resistive index (RI) measured by Doppler
ultrasound reflects the changes in renal microvascular resistance. It was
recently shown that the RI measured at ICU admission was associated
with development of AKI and with persistent AKI on day 3 after
admission. The aim of this study was to investigate whether change of
RI after the first 24 ICU hours has an additional predictive value for the
development of AKI.
Methods This non-interventional study included adult patients with
sepsis admitted to a medical ICU. Patients with renal transplant and
those in terminal renal failure were excluded. The RI was measured
within 2 hours from admission and 24 ± 2 hours after ICU admission.
Occurrence of AKI within the first 5 days was classified according
to the AKI Network criteria. There was no intervention guide by RI
measurements, nor were the results known to the attending physicians.
Results There were 52 patients included in the study. At admission,
eight patients had AKI stage 2 or 3 and it was persistent in five patients
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on day 3. Within the first 5 days a total of 17 patients had AKI stage 2 or
3. The RI at admission was associated with APACHE II score, hypotension
at admission, baseline serum lactate and history of type II diabetes
treated with insulin. Patients who developed AKI stage 2 or 3 had
significantly higher RI on admission (0.79 vs. 0.67, P = 0.021). A cutoff
value of 0.72 best differentiated patients with AKI 2 or 3. Raise of RI by
≥0.05 during the first 24 hours was associated with the development of
AKI stage 2 or 3 (P = 0.034). Patients with persistent AKI on day 3 had
higher RI values on admission, and those who recovered lowered their
RIs by >0.05. In multivariate analysis, admission RI and raise of RI by
≥0.05 were independently associated with development of AKI stage 2
or 3 and ICU mortality. Best sensitivity for AKI was achieved when both
criteria were used: elevated RI at admission (>0.72) and raise of RI by
≥0.05 at 24 hours post admission.
Conclusion The renal RI measured at admission and its dynamics after
the first 24 ICU hours are predictive of the development of AKI and ICU
mortality. Further studies are needed to confirm these results.
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Acute kidney injury and cardiac surgery: impact of fluid balance on
AKI classification and prognosis
EM Moore1, A Tobin2, D Reid2, J Santamaria2, R Bellomo1
1
Monash University, Melbourne, Australia; 2St Vincent’s Hospital, Melbourne,
Australia
Critical Care 2014, 18(Suppl 1):P367 (doi: 10.1186/cc13557)
Introduction We assessed the effect of fluid balance (FB) on acute
kidney injury (AKI) classification/prognosis in cardiac surgical patients
by comparing patients classified with AKI, before and after adjusting the
creatinine (used to classify AKI) for FB. Fluid accumulation is associated
with negative outcomes including development of AKI in critically ill
patients [1]. Cardiac surgical patients commonly receive large volumes
of fluid postoperatively and could be at risk for the harmful effects of
fluid accumulation. Furthermore, fluid accumulation may influence
serum creatinine concentration and mask AKI [2].
Methods We performed a retrospective analysis of prospectively
collected data on all cardiac surgical patients admitted to St Vincent’s
Hospital ICU, Melbourne, Australia from 1 July 2004 to 30 June 2012.
AKI Network creatinine criteria were used to classify AKI in the usual
method and then using FB-adjusted creatinine (FB at 18 hours and an
assumption that total body water is 60% of weight involved). FB (total
i.v. input minus (total urine output + chest drain losses)) was calculated
for 18 hours post surgery as most patients were in the ICU for this
period.
Results Patients classified with AKI increased from 27.7% to 37.2%
(n = 2,171) after adjusting creatinine for FB. Patients were categorised
into four groups based on presence or absence of AKI before and after
adjustment for FB: group A, no AKI before or after adjustment for FB;
group B, no AKI before/AKI after; group C, AKI before/no AKI after; and
group D, AKI before and after. Group B (n = 209) had an in-hospital
mortality rate similar to patients in group D (n = 599) (3.4% vs. 4.3%,
P = 0.53) and greater than those in group A (n = 1,333) (3.4% vs. 1.6%,
P = 0.07). Group B also had an ICU mortality rate similar to patients in
group D (2.9% vs. 2.7%, P = 0.88) and significantly greater than those
in group A (2.9% vs. 0.7%, P = 0.003). The need for renal replacement
therapy (RRT) in group B was also high as for patients in group D (7.7%
vs. 12.4%, P = 0.06) and was significantly greater than those in group
A (7.7% vs. 1.6%, P <0.001). Thus, hospital and ICU mortality and use
of RRT in patients classified with AKI only after adjustment for FB were
similar to patients with AKI before and after adjustment for FB and were
notably higher than those of patients without AKI.
Conclusion Lack of adjustment for FB post cardiac surgery may mask
the presence of AKI that is associated with increased risk for death and
RRT, which could hinder optimal treatment.
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Acute kidney injury of all severity is associated with extended
hospitalization after critical illness
JR Prowle, I Kolic, J Purdell-Lewis, CJ Kirwan
Barts Health NHS Trust, London, UK
Critical Care 2014, 18(Suppl 1):P368 (doi: 10.1186/cc13558)
Introduction Acute kidney injury (AKI) complicates over 50% of ICU
admissions and is associated with significantly increased mortality,
length of stay, and costs across a broad spectrum of conditions [1].
Methods We performed a single-centre, retrospective analysis of
AKI diagnosis in patients with ICU admissions of 5 days or more who
survived to hospital discharge between 2009 and 2011. We examined
the relationship between hospital length of stay, AKI diagnosis,
demographics and clinical characteristics in a multivariable Cox-hazard
analysis.
Results We identified 700 cases, with a 66% incidence of AKI. The
AKI was associated with older age, greater initial illness severity and
longer ICU and hospital length of stay in univariate analysis (Table 1).
In Cox-hazard analysis, only AKI category and ICU length of stay were
significantly associated with lower probability of discharge over
time (Figure 1). AKI-1 was associated with a hazard ratio for hospital
discharge of 0.66 (0.55 to 0.79), AKI-2 with 0.55 (0.42 to 0.71) and AKI-3
with 0.54 (0.44 to 0.66).

Figure 1 (abstract P368). Cox-hazard prediction of AKI class on
hospitalization (ICU LOS fixed at median).

Table 1 (abstract P368). Patient characteristics by AKI
No AKI

AKI

P value

Age

46 (32 to 60)

51 (37 to 64)

<0.001

SAPS-2

35 (27 to 42)

41 (32 to 49)

<0.001

ICU LOS

8 (6 to 12)

12 (7 to 18)

<0.001

27 (17 to 42)

41 (28 to 72)

<0.001

Hospital LOS

Data presented as median (IQR).

Conclusion AKI was a significant predictor of remaining in hospital at
all levels of AKI severity even after allowing for longer ICU stay. Even
mild AKI is associated with extended recovery from critical illness and
healthcare costs even after ICU discharge.
Reference
1.

Chertow et al.: J Am Soc Nephrol 2005, 11:3365.

Critical Care 2014, Volume 18 Suppl 1
http://ccforum.com/supplements/18/S1

P369
Early acute kidney injury in nonsepsis, noncardiac surgical patients
admitted to a general surgical ICU
KS Kongsayreepong, N Rojanapithayakorn
Siriraj Hospital, Mahidol University, Bangkok, Thailand
Critical Care 2014, 18(Suppl 1):P369 (doi: 10.1186/cc13559)
Introduction Perioperative AKI is a significant factor determining
morbidity/mortality in surgical patients. We sought to determine
the prevalence and risk factors of early AKI (within 72 hours of ICU
admission) in nonsepsis, noncardiac surgical patients admitted to the
general surgical ICU.
Methods This prospective observational study was done in 600
nonsepsis, noncardiac surgical patients admitted to the 14-bed general
surgical ICU of Siriraj Hospital. The following data were collected:
patient demographic data, ASA, comorbidity, type and urgency
of surgery, type of anesthesia, preoperative and the first 72 hours
laboratory data, amount of bleeding, type/amount of fluid and blood
replacement, average intraoperative and the first 72 hours MAP, and
severity score. Outcome as ventilator-hours, ICU length of stay and ICU
mortality were also determined. Risk factors were identified by multiple
logistic regression. AKI was defined and classified according to the
AKIN criteria using adjusted serum creatinine (Cr) [1].
Results In total, 41.7% of the study patients developed AKI (AKIN-I
31.0%, AKIN-II 10%, AKIN-III 4.8%) and 4.8% received RRT. The following
factors were different between AKI and non-AKI patients: baseline
expected GFR <60 ml/minute/1.73 m2, baseline serum Cr and baseline
serum albumin, major abdominal surgery, vascular surgery, combined
regional and general anesthesia, APACHE II score, receiving 6% 130/0.4
hydroxyethyl starch (HES) >20 ml/kg/day, 4% gelatin >20 ml/kg/day,
crystalloid >30 ml/kg/day and positive fluid balance in the first 48 hours.
Multiple logistic regression showed that independent risk factors of AKI
included: baseline eGFR <60 ml/minute/1.73 m2 (OR = 1.53; 95% CI, 1.08
to 1.27, P = 0.02), baseline serum albumin <2 mg/dl (OR = 1.75; 95%
CI, 1.01 to 3.06, P = 0.049), admitting hemoglobin <8 g/dl (OR = 2.41;
95% CI, 1.14 to 5.11, P = 0.02), receiving 6% 130/0.4 HES >20 ml/kg/day
(OR = 2.02; 95% CI, 1.09 to 3.76, P = 0.03), receiving crystalloid >30 ml/
kg/day (OR = 3.15; 95% CI, 1.53 to 6.48, P = 0.01), vascular surgery (OR =
1.67; 95% CI, 1.05 to 2.64, P = 0.03), and major abdominal surgery (OR =
1.68; 95% CI, 1.11 to 2.55, P = 0.01). AKI patients had higher ventilatorhours (P = 0.02) and ICU length of stay (P = 0.04).
Conclusion The prevalence of early AKI in nonsepsis, noncardiac
patients admitted to the general surgical ICU was 41.7%. Surgical
patients with risk factors should be carefully cared for to prevent the
development of AKI. Receiving 6% 130/0.4 HES >20 ml/kg/day and
crystalloid >30 ml/kg/day increased the risk of early AKI in nonsepsis,
noncardiac surgical patients.
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Impact of kidney function calculation formulae on predicting early
adverse renal events in cardiac surgery
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Critical Care 2014, 18(Suppl 1):P370 (doi: 10.1186/cc13560)
Introduction The Cockcroft–Gault (CG) equation and the four-variable
Modification of Diet in Renal Disease (MDRD) formula are the most
commonly used methods to provide estimation of kidney function. The
newly developed Mayo Clinic quadratic equation (MCQE) is another
alternative. The scope of this study is to investigate the prognostic
value of the above algorithms as prediction models for development
of acute renal injury (AKI) and early renal dialysis (RD) in cardiac surgery
patients during the postoperative ICU stay.
Methods A retrospective single-centre study of 528 consecutive
patients admitted to the ICU, who underwent elective cardiac surgery
under extracorporeal circulation from July 2012 to November 2013.
Patients undergoing urgent or emergent surgery were excluded prior
to the study. Preoperative estimation of renal function was obtained
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using CG, MDRD and MCQE equations. The predictive capacity of these
formulae was tested and compared in relation to AKI and RD incidence
by constructing receiver operating characteristic curves for each of the
models.
Results The mean age of the cohort was 64.7 ± 0.45 years and the mean
value of estimated kidney function from MCQE, MRDR and CG formulae
was 83.7 ± 1.03 ml/minute/1.73 m2, 69.03 ± 0.82 ml/minute/1.73 m2
and 75.3 ± 1.18 ml/minute/1.73 m2 respectively. AKI was identified in 75
(14.2%) patients, whereas early RD was necessary in 16 (3%) patients.
All of the three variables showed a good predictive value for estimating
AKI and RD after cardiac surgery. The area under the curve values for
the early RD group was 0.887, 0.867 and 0.804, respectively and for the
AKI group was 0.701, 0.651 and 0.691, respectively.
Conclusion On the basis of our findings, all of the above algorithms
seem to be accurate in predicting AKI and RD incidence in the early ICU
postoperative period after elective cardiac surgery. Nevertheless, the
MCQE equation more accurately classified individuals compared with
MDRD and CG formulae. Our results extend knowledge from previous
studies [1,2]. Further investigations should be performed to determine
whether these costless formulae could be used as an additional
validated predictor in this group of patients and hence whether they
could be incorporated into clinical practice.
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Fluid accumulation increases the risk of AKI progression and death
in critically ill patients with early AKI
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Introduction Fluid therapy is a cornerstone in the management of
patients with evolving acute kidney injury (AKI). Despite the wide
availability of advanced hemodynamic monitoring to guide therapy,
there are few data on how to manage hemodynamics optimally once
early AKI has occurred. Our aim was to investigate the association
between cumulative fluid balance (FB)/fluid administration and
outcome (progression to AKI III and hospital mortality) in critically ill
patients with early AKI, and its interaction with other hemodynamic
parameters.
Methods A retrospective analysis (2-year period) of all patients
admitted to an adult ICU with AKI (defined by KDIGO criteria) who had
hemodynamic monitoring within 12 hours of AKI I. We recorded FB,
urinary output (UO), fluid administered and hemodynamic parameters
including mean arterial pressure (MAP) on the day of AKI I and in the
following 72 hours. Logistic regression was employed to determine
independent predictors of outcome.
Results A total of 210 patients (median age 70 years; 138 male) had
hemodynamic monitoring within 12 hours of AKI I. In total, 41.5%
progressed to AKI III and 43.3% died. Patients with fluid overload
after the diagnosis of AKI I (FB >1 l/day; n = 85) had a higher rate of
progression to AKI III (63.5 vs. 23.3%, respectively; P <0.001) and inhospital mortality (43.5 vs. 24.8%, respectively; P = 0.004) compared
with patients with FB <1 l/day. There was no difference in the
other parameters (demographics, comorbidities, severity scores,
hemodynamic parameters on day of AKI I, vasopressor use), with the
exception of MAP on the day of AKI I (71 vs. 74 mmHg, respectively;
P = 0.01). In multivariate analysis after adjustment for demographics,
severity scores, comorbidities and hemodynamic parameters on
the day of AKI I, a higher FB was associated with an increased risk
of progression to AKI III and death (odds ratio (OR) per each 1 l/day
increase 2.8; P <0.001) and death (OR 1.6; P = 0.001). Similarly, a higher
amount of fluid administered was associated with an increased risk of
AKI progression (OR per each 1 l/day increase 1.8; P = 0.011), even with
adjustment for UO. There were no significant interactions between
the risk of progression/death and other hemodynamic parameters.
With the exception of MAP, improvements in other hemodynamic
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parameters in the days after AKI I diagnosis did not have a significant
impact on outcome.
Conclusion In critically ill patients with early AKI, a positive fluid
balance, induced by excessive fluid administration, is associated with
an increased risk of AKI progression and death.
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Postoperative acute kidney injury in patients with gynecologic
malignancies
M Didik, P Zeyneloglu, A Pirat, A Ayhan, Z Kayhan
Baskent University Faculty of Medicine, Ankara, Turkey
Critical Care 2014, 18(Suppl 1):P372 (doi: 10.1186/cc13562)
Introduction Postoperative acute kidney injury (AKI) is an important
cause of mortality and morbidity among surgical patients. Less is
known about the occurrence of AKI after operations for gynecologic
malignancies. The aim of this study was to determine the incidence of
AKI in patients who underwent surgery for gynecologic malignancies
and to compare patients with and without postoperative AKI.
Methods A total of 1,000 patients were enrolled retrospectively from
January 2007 through March 2013. Patients under 18 years of age,
those with chronic kidney disease and patients who died within the
first week after surgery were excluded. AKI was defined according to
the KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury.
Perioperative variables of patients were collected from medical charts.
Results The mean age was 55.4 ± 12.4 years. The incidence of
postoperative AKI was 8.8%, stage 1 occurred in 5.9%, stage 2 in
2.4% and stage 3 in 0.5% of the patients. Patients who had AKI
were significantly older (57.9 ± 12.8 vs. 55.1 ± 12.3 years, P = 0.046),
had higher body mass index (30.1 ± 7.1 vs. 28.6 ± 6.4, P = 0.031),
higher preoperative C-reactive protein (CRP) levels (157.8 ± 121.5
vs. 76.6 ± 81.1 mg/dl, P = 0.037) and more frequently had history of
distant organ metastasis (13.3 vs. 7.8%, P = 0.022) when compared with
those who did not have AKI. When compared with patients who did
not develop AKI postoperatively, longer operation times (149.1 ± 62.5
vs. 123.8 ± 56.6 minutes, P = 0.001), intraoperative usage of higher
amounts of erythrocyte suspension (279.5 ± 616.7 vs. 128.3 ± 296.1 ml,
P = 0.001) and fresh frozen plasma (165.9 ± 284.8 vs. 94.1 ± 185.9 ml, P =
0.001) were seen in those who developed AKI.
Conclusion Our results demonstrate that AKI occurs in 8.8% of the
patients following surgery for gynecologic malignancies. Patients
who had AKI were older, had higher body mass index with higher
preoperative CRP levels, more frequent distant organ metastasis
and longer operation times and higher amounts of blood transfused
intraoperatively.
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Acute kidney injury after elective adult cardiac surgery
A Darbar, G Lau, R Porter
Glenfield Hospital, Leicester, UK
Critical Care 2014, 18(Suppl 1):P373 (doi: 10.1186/cc13563)
Introduction Acute kidney injury (AKI) is a significant complication
following cardiac surgery associated with an increase in morbidity,
hospital stay and mortality. Although the estimated incidence of
AKI following cardiac surgery is 30%, few studies have identified the
incidence of AKI following cardiac surgery as defined by the Kidney
Disease: Improving Global Outcomes (KDIGO) group [1]. We conducted
a prospective observational study at our institution to identify the
incidence and staging of AKI according to the KDIGO definition. We also
aim to identify the factors that predispose adult patients to developing
AKI post cardiac surgery.
Methods A prospective analysis was performed on 103 adult patients
admitted to ICU post-cardiac surgery from September to October 2013.
Data for perioperative risk factors and renal biochemical markers were
collected up to the sixth postoperative day and are expressed as mean
(SD).
Results Ordered logistic regression was used to analyse the data. Thirtythree per cent of cardiac surgery patients at our institution developed
AKI. Factors such as poor left ventricular (LV) function, low preoperative
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Table 1 (abstract P373). Results
Age (years)

66 (13.8)

Male

69

Female

34

No AKI

69

KDIGO 1

22

KDIGO 2

6

KDIGO 3

6

haematocrit and low preoperative glomerular filtration rate (GFR) were
significant risk factors (P = 0.03, P = 0.04 and P <0.01 respectively) for
developing postoperative AKI following cardiac surgery. See Table 1.
Conclusion Our results suggest that we should focus on LV function
and GFR as predictors for developing AKI following cardiac surgery.
Strategies to increase preoperative haematocrit should be investigated
to reduce in the incidence and severity of postoperative AKI.
Reference
1.

Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury
Work Group: KDIGO Clinical Practice Guideline for Acute Kidney Injury.
Kidney Int 2012, 2(Suppl):1-138.

P374
Incidence and outcomes of contrast-induced nephropathy in adult
ICU patients
S Alderson1, S Pillai2, A Manoras1, J Papanikitas1, D Lewis1, S McKechnie1
1
John Radcliffe Hospital, Oxford, UK; 2Morriston Hospital, Swansea, UK
Critical Care 2014, 18(Suppl 1):P374 (doi: 10.1186/cc13564)
Introduction Critically ill patients cared for in ICUs often require
radiological investigation using iodinated contrast agents. Contrastinduced nephropathy (CIN) – a form of acute kidney injury (AKI) – is
a complication following the use of such contrast. Although CIN has
been thoroughly studied in some populations (for example, those
undergoing coronary angiography), it has not been investigated in
large numbers of ICU patients [1].
Methods We conducted a single-centre retrospective review of the
electronic patient records of general adult ICU patients who received
iodinated contrast over a 3-year period (2009 to 2011). Our review
identified evidence of CIN or AKI post scan (assessed using CIN and
KDIGO criteria); and clinical outcomes post scan (renal replacement
therapy (RRT), ICU length of stay, mortality). Patients were excluded
if: they had received pre-scan RRT; they did not have pre/post-scan
creatinine measurements. Univariate analyses investigated the
relationship between CIN or AKI and ICU outcomes (use of RRT post
scan, ICU mortality and ICU length of stay), using chi-squared tests for
categorical outcomes and nonparametric tests for continuous outcomes.
Results A total of 479 scans involving 331 patients were included. In
total, 303 (63%) scans involved males, median age 61 (IQR 46 to 71)
years, 119 (25%) diabetic, with median pre-scan eGFR of 85 (38 to 113)
ml/minute/1.73 m2. Scans occurred a median of 2.9 (0.8 to 8.8) days
from admission. A total of 266 (56%) scans were associated with CIN
(grade 0, n = 167; grade 1, n = 39; grade 2, n = 60). Clinical outcomes
were significantly worse in patients developing higher grades of CIN
(increased use of RRT post scan, P = 0.02; increased ICU length of stay,
P = 0.04; increased ICU mortality, P = 0.01). Ninety-five (20%) scans
were associated with AKI (stage 1, n = 45; stage 2, n = 13; stage 3,
n = 37). Clinical outcomes were again significantly worse in patients
developing AKI (increased use of RRT post scan, P <0.001; increased ICU
mortality P = 0.01).
Conclusion Renal impairment/injury is common in adult ICU patients
undergoing investigations using iodinated contrast and the incidence
varies depending upon the classification used. Whichever classification
is used, patients developing CIN/AKI following contrast administration
have poorer clinical outcomes than patients who do not.
Reference
1.

Lameire et al.: Contrast-induced acute kidney injury and renal support for
acute kidney injury: a KDIGO summary (Part 2). Crit Care 2013, 17:205.
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P375
Human acute kidney injury is associated with a proinflammatory
phenotype
N Gauge, M Varrier, D Boardman, M Hernandez-Fuentes, M Ostermann
Guy’s and St Thomas’ Hospital, London, UK
Critical Care 2014, 18(Suppl 1):P375 (doi: 10.1186/cc13565)
Introduction Animal research suggests that acute kidney injury (AKI)
is an inflammatory condition [1]. Our aim was to describe the immune
phenotype in human AKI.
Methods We enrolled patients with: AKI grade II/III (defined by KDIGO
criteria) and systemic inflammatory response syndrome (SIRS) without
sepsis; SIRS without AKI; and AKI II/III without SIRS. A healthy control
population was used for baseline comparison. Serial blood samples
were taken on days 0, 2 and 7. Cells were separated using Percoll
gradients and phenotyped using flow cytometry.
Results The results from 24 day 0 samples identified statistically
significant differences between SIRS, AKI, AKI + SIRS and healthy controls
amongst: CD8+ cytotoxic T cells, CD45–CD25+++ regulatory T cells, and
CD45–CD25++ cytokine secreting non-T-regulatory cells (Table 1). The
percentage of CD69-positive neutrophils was significantly increased
across all three groups relative to controls, with little variation between
AKI, SIRS and AKI + SIRS patients.

of AKI. Significant risk factors for AKI again included male gender (P =
0.009), reduced pre-scan eGFR (P <0.001), and decreasing time from
admission to scan (P = 0.003), but also included emergency admission
to ICU (P = 0.03), pre-scan shock (P <0.001), and pre-scan oliguria
(P <0.001).
Conclusion Male gender, reduced pre-scan eGFR and decreasing time
from admission to scan are risk factors for the development of both CIN
and AKI. The association with time from admission to scan may reflect
inadequate patient optimisation prior to contrast administration; this
hypothesis is supported by the risk factors significantly associated with
AKI alone (emergency admission to ICU and pre-scan shock). Given the
adverse clinical outcomes associated with the development of CIN/AKI,
these findings necessitate a review of current practice.
Reference
1.

Lameire et al.: Contrast-induced acute kidney injury and renal support for
acute kidney injury: a KDIGO summary (Part 2). Crit Care 2013, 17:205.

P377
Test characteristics of acute kidney injury biomarkers in animal
models of sepsis
Z Peng, J Zhang, F Zhou, J Kellum
University of Pittsburgh Medical Center, Pittsburgh, PA, USA
Critical Care 2014, 18(Suppl 1):P377 (doi: 10.1186/cc13567)

Table 1 (abstract P375).
AKI + SIRS AKI no SIRS SIRS alone

Control

% CD8+ cytotoxic T cells

23.3

16.7

11.6

31.1

% Fr. II T-regulatory cells

4.1

2.7

1.6

1.2

% Fr. III cytokine T cell

11.5

21.2

13.9

8.0

% CD69+ neutrophils

83.9

69.7

65.5

7.35

Conclusion Human AKI is associated with a proinflammatory
phenotype.
Reference
1.

Akcay A, et al.: Mediators of inflammation in acute kidney injury. Mediators
Inflamm 2009, 2009:137072.

P376
Risk factors for the development of contrast-induced nephropathy
in ICU patients
S Pillai1, S Alderson2, A Manoras2, J Papanikitas2, D Lewis2, S McKechnie2
1
Morriston Hospital, Swansea, UK; 2John Radcliffe Hospital, Oxford, UK
Critical Care 2014, 18(Suppl 1):P376 (doi: 10.1186/cc13566)
Introduction Critically ill patients cared for in ICUs often require
radiological investigation using iodinated contrast agents. Contrastinduced nephropathy (CIN) – a form of acute kidney injury (AKI) – is
a complication following the use of such contrast. Although CIN has
been thoroughly studied in some populations (for example, those
undergoing coronary angiography), it has not been investigated in
large numbers of ICU patients [1].
Methods We conducted a single-centre retrospective review of the
electronic patient records of general adult ICU patients who received
iodinated contrast over a 3-year period (2009 to 2011). Our review
identified: patient demographics; ICU admission details (specialty, time
of admission, elective/emergency admission); physiological status
pre scan (evidence of shock, eGFR, urine output); volume of iodinated
contrast; and evidence of CIN or AKI post scan (assessed using CIN
and KDIGO criteria). Patients were excluded if they had pre-scan renal
replacement therapy. Analyses investigated the risk factors for CIN or
AKI using chi-squared tests for categorical variables and nonparametric
tests for continuous variables (as no continuous variable was normally
distributed, even with log transformation).
Results In total, 479 scans involving 331 patients were included. A total
of 266 (56%) scans were associated with CIN. Significant risk factors for
the development of CIN included male gender (P = 0.02), reduced prescan GFR (P <0.001), and decreasing time from admission to scan (P =
0.03). Ninety-five (20%) scans were associated with the development

Introduction Approximately 50% of acute kidney injury (AKI) is
associated with sepsis. Neutrophil gelatinase-associated lipocalin
(NGAL) and cystatin C are the two most widely used biomarkers for
AKI. However, these two markers are also affected by the systemic
inflammatory response, and their diagnostic value in sepsis-induced
AKI is disputed [1,2]. Unlike clinical AKI, animal models can be used
to explore single etiology. The purpose of this study is to examine the
relationship between inflammatory mediators and biomarkers for AKI
in a sepsis model in rats.
Methods Sepsis was induced by cecal ligation and puncture (CLP) in
60 adult SD rats and then observed for AKI and survival. Blood and
urine samples were collected at baseline, and 18, 22, and 48 hours after
CLP. AKI severity was assessed by RIFLE criteria (creatinine only). The
associations between plasma IL-6 and plasma NGAL, plasma cystatin
C, urine NGAL and urine cystatin C were analyzed. The area under the
receiver-operator characteristic curves (AUC) was used to evaluate the
diagnostic capability between severe AKI (RIFLE-I or RIFLE-F) and no AKI
(includes RIFLE-R) for different biomarkers.
Results The changes of plasma NGAL, plasma cystatin C, urine NGAL
and urine cystatin C with time were similar to the changes of plasma
IL-6. However, only plasma NGAL levels were closely correlated with
levels of plasma IL-6 (R2 = 0.36, P <0.05). The analysis for plasma cystatin
C, urine NGAL and urine cystatin C at 22 hours for severe AKI showed
AUCs of 0.78, 0.71 and 0.75 respectively (all P <0.05), and the AUC for
plasma NGAL was 0.62 (P = 0.11). There were no significant differences
in plasma NGAL at 22 hours between severe AKI and no AKI (2,143.32
vs. 2,077.02 U/ml, P = 0.21).
Conclusion In this animal model of CLP sepsis, plasma NGAL levels
were affected by the systemic inflammatory response, and did not
discriminate for AKI. Urine NGAL, plasma cystatin C and urine cystatin C
were able to differentiate severe AKI from no AKI in CLP sepsis.
References
1.
2.

Martensson J, et al.: Intensive Care Med 2010, 36:1333-1340.
Nejat et al.: Crit Care 2010, 14:R85.

P378
Perioperative measurement of urinary oxygen tension as a tool in
the prevention of acute kidney injury?
L Desteghe1, W Boer2, Q Swennen3, V Pennemans3, M Vander Laenen2,
K Engelen2, C De Deyne2, F Jans2
1
Hasselt University, Diepenbeek, Belgium; 2Ziekenhuis Oost-Limburg, Genk,
Belgium; 3Biomedical Research Institute, Diepenbeek, Belgium
Critical Care 2014, 18(Suppl 1):P378 (doi: 10.1186/cc13568)
Introduction Acute kidney injury (AKI) remains a common complication
after cardiopulmonary bypass (CPB) and can be diagnosed by
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serum creatinine [1]. However, serum creatinine is an insensitive and
nonspecific biomarker [2]. This study was designed to investigate
whether a correlation exists between urinary oxygen tension (UOT)
and early markers of AKI. The aim was to evaluate whether UOT could
provide warning signs of an insufficient renal oxygen supply, which can
lead to postoperative AKI.
Methods Fourteen subjects undergoing cardiac surgery with CPB were
included in this prospective clinical pilot study. UOT was measured
perioperatively in all patients, both in the operating room (before,
during and after CPB) and in the ICU. Biomarkers of AKI in blood
and urine were measured preoperatively and postoperatively at 3,
6, 12 and 24 hours after the initiation of CPB. These included serum
creatinine and the early urinary biomarkers kidney injury molecule-1
(KIM-1), neutrophil gelatinase-associated lipocalin (NGAL) and cystatin
C. Student’s t tests and Mann–Whitney tests were used to compare
continuous variables.
Results There was a significant decrease in UOT between the start
of CPB (138.44 ± 22.19 mmHg) and the lowest UOT during CPB
(107.70 ± 23.28 mmHg) (P = 0.001). Dividing the subjects into two groups
according to the Acute Kidney Injury Network (AKIN) classification, no
significant differences were found in mean UOTs between the group
of patients with a normal kidney function (n = 7) and the group with
AKIN stage 1 or 2 (n = 7). For KIM-1, a significant difference between the
two groups was found at 3 hours (P = 0.041) after the initiation of CPB.
Further, for NGAL a significant increase in biomarker concentrations
compared with the preoperative value was observed in the group with
an AKIN stage 1 or 2 at all different postoperative time points (3 hours
(P = 0.013), 6 hours (P = 0.003), 12 hours (P = 0.009) and 24 hours (P =
0.003)). On the contrary, there were no significant increased urinary
NGAL levels measured in the group with the normal kidney function.
Conclusion This pilot study was not able to demonstrate any
association between perioperatively measured UOT and markers of
postoperative AKI. Additional laboratory and clinical studies will be
necessary to further define the relationship between the UOT and new
biomarkers of AKI.
References
1.
2.

Mariscalco G, et al.: Ann Thorac Surg 2011, 92:1539-1547.
Vaidya VS, et al.: Annu Rev Pharmacol Toxicol 2008, 48:463-493.

P379
Postoperative acute kidney injury can be predicted by the novel
biomarkers insulin-like growth factor-binding protein 7/tissue
inhibitor of metalloproteinases-2 as early as 6 hours after surgery
I Göcze, R Herzog, M Koch, P Renner, F Zeman, BM Graf, HJ Schlitt, T Bein
University Medical Center Regensburg, Germany
Critical Care 2014, 18(Suppl 1):P379 (doi: 10.1186/cc13569)
Introduction Acute kidney injury (AKI) in surgical critically ill patients
is an independent risk factor for early mortality. Two novel urine
biomarkers, insulin-like growth factor-binding protein 7 (IGFBP7) and
tissue inhibitor of metalloproteinases-2 (TIMP-2), may help to detect
clinically silent episodes of AKI in the golden hours prior to irreversible
damage of the kidney. We evaluated the early predictive value of these
biomarkers for AKI, moderate and severe AKI, early requirement of
renal replacement therapy (RRT), and ICU mortality, with a cutoff value
of IGFBP7/TIMP-2 >0.3.
Methods Four to six hours after admission to the surgical ICU, urine
biomarkers were prospectively evaluated in all patients with present
exposures and susceptibilities for AKI according to the KDIGO
recommendation. The incidence and severity of AKI (KDIGO 2012)
and requirement of RRT were assessed over 48 hours after admission.
In addition, ICU mortality and variables such a norepinephrine dose,
mean arterial pressure, hemoglobin level, cumulative fluid balance and
urine production were noted at the time of biomarker evaluation (4 to
6 hours) and for the first 24 hours after admission.
Results A total of 120 patients were included in the study. The area under
the curve (AUC) for IGFBP7/TIMP2 >0.3 was 0.83 for early detection of
AKI, 0.86 for moderate and severe AKI, 0.86 for RRT in the first 48 hours
after admission and 0.86 for ICU mortality. Patients with IGFBP7/
TIMP-2 >0.3 had a higher risk (odds ratio 11.7) for development of AKI
compared with patients with IGFBP7/TIMP-2 ≤0.3. The norepinephrine
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dose, mean arterial pressure, fluid balance and urine output in the first
6 hours after admission were significantly different for patients with
low and high risk for AKI. The negative predictive value (NPV) of 0.41 for
urine output <1 ml/kg/hour over the first 6 hours after admission was
significantly lower if compared with NPV of 0.86 for GFBP7/TIMP-2 ≤0.3
for exclusion of AKI. Similarly NPV of urine output <1 ml/kg/hour of 0.89
for moderate and severe AKI (stage 2 and 3) was lower than the NPV of
1.00 for GFBP7/TIMP-2 ≤0.3.
Conclusion The novel urine biomarkers IGFBP7 and TIMP-2 enable early
risk stratification of surgical ICU patients at risk for development of AKI.
The predictive values of biomarkers were better for early prediction
than clinical parameters such as urine output within the first 6 hours
after admission to ICU.
P380
Urine TIMP2 × IGFBP7 increases 24 hours before severe AKI
M Ostermann1, L Chawla2, L Forni3, J Kellum, on behalf of Sapphire
Investigators4
1
Guys & St Thomas Foundation Hospital, London, UK; 2George Washington
University, Washington, DC, USA; 3Western Sussex Hospital, Worthing, UK;
4
University of Pittsburgh, PA, USA
Critical Care 2014, 18(Suppl 1):P380 (doi: 10.1186/cc13570)
Introduction We recently reported a 728-patient multicenter study
(Sapphire) where a biomarker combination of tissue inhibitor of
metalloproteinases-2 (TIMP-2) and insulin-like growth factor binding
protein 7 (IGFBP7) were validated for risk stratification for moderate or
severe acute kidney injury (AKI) KDIGO stage 2 and 3 [1].
Methods We subsequently selected two clinical cutoff values for the
TIMP2 × IGFBP7 combination from the Sapphire dataset, one (0.3)
with high sensitivity (89%) (specificity = 50%) and one (2.0) with high
specificity (95%) (sensitivity = 42%) for the development of AKI KDIGO
stage 2 and 3 within 12 hours of study enrolment. We examined the
timing of change in TIMP2 × IGFBP7 relative to change in creatinine
using the sign test.
Results TIMP2 × IGFBP7 results were available for 178 patients who
developed AKI stage 2 or 3. The median TIMP2 × IGFBP7 result was
significantly greater than the cutoff value of 0.3 from 24 hours before to
24 hours after AKI 2 or 3 (P <0.01) (Figure 1). Conversely, median serum
creatinine was not different from baseline prior to development of AKI
2 or 3.
Conclusion The TIMP2 × IGFBP7 biomarker combination identifies
patients who ultimately develop moderate or severe AKI 24 hours
earlier than serum creatinine.
Reference
1.

Kashani K, et al.: Discovery and validation of cell cycle arrest biomarkers in
human acute kidney injury. Crit Care 2013, 17:R25.

Figure 1 (abstract P380). NC, Nephrocheck (TIMP2 × IGFBP7); Cr,
creatinine.
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P381
Urinary tissue inhibitor of metalloproteinases-2 and insulin-like
growth factor-binding protein 7 as early biomarkers of acute kidney
injury and renal recovery following cardiac surgery
A Zarbock1, M Meersch1, C Schmidt1, S Martens1, J Rossaint1, K Singbartl2,
D Görlich1, J Kellum3, H Van Aken1
1
University of Münster, Germany; 2Penn State College of Medicine Hershey, PA,
USA; 3University of Pittsburgh, PA, USA
Critical Care 2014, 18(Suppl 1):P381 (doi: 10.1186/cc13571)
Introduction Difficulties in prediction and early identification of acute
kidney injury (AKI) have hindered the ability to develop preventive
and therapeutic measures for this syndrome. We tested the hypothesis
that a urine test measuring insulin-like growth factor-binding protein
7 (IGFBP7) and tissue inhibitor of metalloproteinases-2 (TIMP-2), both
inducers of G1 cell cycle arrest, a key mechanism implicated in AKI,
could predict AKI in cardiac surgery patients.
Methods We studied 50 patients at high risk for AKI undergoing cardiac
surgery with cardiopulmonary bypass. Serial urine samples were
analyzed for [TIMP-2] × [IGFBP7] concentrations. The primary outcome
measure was AKI as defined by international consensus criteria
following surgery. Furthermore, we investigated whether urine [TIMP2] × [IGFBP7] could predict renal recovery from AKI prior to hospital
discharge.
Results Twenty-six patients (52%) developed AKI. Diagnosis based on
serum creatinine and/or oliguria did not occur until 1 to 3 days after
cardiopulmonary bypass. In contrast, urine concentration of [TIMP-2] ×
[IGFBP7] rose from a mean of 0.49 (0.24) at baseline to 1.51 (0.57) 4 hours
after cardiopulmonary bypass in patients who developed AKI. The
maximum urinary [TIMP-2] × [IGFBP7] concentration achieved in the
first 24 hours following surgery (composite time point) demonstrated
an area under the receiver-operating characteristic curve of 0.84.
Sensitivity was 0.92, and specificity was 0.81 for a cutoff value of 0.50.
The decline in urinary [TIMP-2] × [IGFBP7] values was the strongest
predictor for renal recovery.
Conclusion Urinary [TIMP-2] × [IGFBP7] serves as a sensitive and
specific biomarker to predict AKI early after cardiac surgery and to
predict renal recovery.
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who developed AKI or worsening AKI (n = 58) had a mean score of
2.79 ± 1.21 versus 2.30 ± 1.14 in those who never developed AKI or
improved (n = 150), P = 0.006. UMS-ACRS score >2 on admission had a
sensitivity of 0.89 for identifying progressive AKI. UMS-ACRS score of 5
to 8 on admission had a positive predictive value for worsening AKI of
60%, a negative predictive value of 69% and a likelihood ratio 3.1 for
developing AKI or worsening AKI.
Conclusion The mean UMS-ACRS is higher in patients with AKI.
Combining UMS with ACRS improves prediction and stratification of
which patients will develop AKI, or progressive AKI, after ICU admission.
Clinical implications are that urine microscopy and ACR calculation
are safe, inexpensive, non-invasive and may improve prediction of AKI
in critically ill patients, potentially leading to earlier intervention and
improved outcomes.
P383
Resveratrol ameliorates apoptosis induced by contrast medium
ioxitalamate in HK-2 human renal proximal tubule cells in vitro
YY Chen, CC Cheng, TC Lin, Huang
Buddhist Tzu Chi General Hospital, Hualien, Taiwan
Critical Care 2014, 18(Suppl 1):P383 (doi: 10.1186/cc13573)
Introduction Computed tomography with contrast medium is a
common diagnostic tool in emergency and critical medicine. Contrastinduced nephropathy (CIN) is one of the leading causes of hospitalacquired acute kidney injury. Focus on renal tubule protection may be
a hope to improve the effectiveness of current strategies.
Methods We used HK-2 human renal proximal tubule cells to evaluate
the therapeutic potential of resveratrol, a polyphenol phytoalexin

P382
Urine microscopy score combined with albumin creatinine ratio
score improves prediction of future acute kidney injury (AKI) and
worsening AKI
JJ Dixon1, K Lane1, W Fleming-Nouri2, H Cheema2, P Walker2, I MacPhee3,
B Philips1
1
St George’s Hospital and University of London, UK; 2St George’s, University of
London, UK; 3St George’s Hospital, London, UK
Critical Care 2014, 18(Suppl 1):P382 (doi: 10.1186/cc13572)
Introduction Patients with AKI have a high morbidity and mortality.
Diagnosis of AKI may be improved by examination of the urinary
sediment with microscopy and by measurement of urine albumin.
A urine microscopy score (UMS; 0 to 4 points) of renal tubular
epithelial cells and granular casts has previously been developed to
aid diagnosis. We have devised a urine albumin:creatinine ratio score
(ACRS; 0 to 4 points) and have combined this with the UMS with the aim
of stratifying the risk of developing future AKI or worsening AKI (UMSACRS; 0 to 8 points). The aims were to compare UMS-ACRS in critically
ill patients with and without AKI at ICU admission, and to determine
whether a high UMS-ACRS can predict if critically ill patients develop
AKI or worsening AKI.
Methods Investigators were blinded to diagnosis prior to urine
collection. Microscopy was performed on centrifuged urine obtained
from 227 consecutive critically ill patients in a general ICU on day 1
of admission. Five photographs were taken and the mean UMS was
calculated. An independent reviewer scored the photographs. The urine
albumin:creatinine ratio was calculated and the ACRS determined. The
UMS was then combined with the ACRS.
Results Mean UMS-ACRS ± SD was higher (2.66 ± 1.57) in patients with
AKI on ICU admission (n = 106) compared with those without AKI (mean
UMS-ACRS = 2.40 ± 1.03; n = 120), unpaired t test P = 0.14. Patients

Figure 1 (abstract P383). Immunostaining of cytoplasmic DNA
fragmentation in HK-2 cells.

Figure 2 (abstract P383). Upregulated survivin expression by resveratrol.
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produced naturally by several plants, for contrast ioxitalamate-induced
toxicity in vitro. Cytotoxicity was determined by MTT assay. Patterns
of cell death were observed by flow cytometry. Cytoplasmic DNA
fragmentation was examined by ELISA. Western blots were used to
analyze the expression of related proteins.
Results In a 48-hour administration, ioxitalamate elicited cytotoxicity
on HK-2 cells. Annexin V+ cells were significantly increased after 30 mg/
ml ioxitalamate exposure. A decrease in bcl-2 expression explained
the ioxitalamate-induced apoptosis. Co-treatment with resveratrol
ameliorated the cytotoxicity induced by ioxitalamate. Resveratrol at
12.5 μM decreased ioxitalamate-induced DNA fragmentation through
upregulated expression of survivin. See Figures 1 and 2.
Conclusion Resveratrol ameliorated apoptosis induced by contrast
medium ioxitalamate in human renal proximal tubule cells.
Investigations using animal models will be conducted in the future.
P384
Erythropoietin and Protection of Renal function in Cardiac Surgery
(EPRICS) trial
A Dardashti
Lund University and Skane University Hospital, Lund, Sweden
Critical Care 2014, 18(Suppl 1):P384 (doi: 10.1186/cc13574)
Introduction To date, there are no known methods for preventing
acute kidney injury after cardiac surgery. Increasing evidence suggests
that erythropoietin (EPO) has renal anti-apoptotic and tissue protective
effects [1], and in animal models a single high dose of EPO has been
shown to ameliorate reperfusion injury after ischemia [2]. However,
recent human studies have shown conflicting results. We aimed to
study the effect of a single high dose of EPO preoperatively on renal
function after coronary artery bypass grafting (CABG) in patients with
preoperative impaired renal function.
Methods This single-centre, randomized, double-blind, placebocontrolled study included 75 patients scheduled for CABG with
preexisting renal impairment (estimated glomerular filtration rate
based on p-cystatin C <60 ml/minute and >15 ml/minute). The patients
either received a single high dose of EPO (400 IU/kg) or placebo
preoperatively. The primary endpoint was renal protection evaluated
by p-cystatin C at the third postoperative day compared with the
preoperative values. Incidence of acute kidney injury and other renal
biomarker changes were among secondary endpoints.
Results There was no significant difference on the third postoperative
day for p-cystatin C levels (2.1 ± 0.8 mg/l for the study group and
1.9 ± 0.5 mg/l for the control group, P = 0.51). There were no significant
differences in other renal biomarkers or measures between the groups
(p-NGAL, p-creatinine, p-urea, and estimated glomerular filtration
rate). There were no other differences in outcome variables between
the groups.
Conclusion Intravenous administration of a single high dose (400 IU/
kg) of EPO did not have a renal protective effect in patients with
reduced kidney function undergoing coronary artery bypass surgery.
References
1.
2.

Bahlmann FH, Fliser D: Erythropoietin and renoprotection. Curr Opin Nephrol
Hypertens 2009, 18:15-20.
Moore E, Bellomo R: Erythropoietin (EPO) in acute kidney injury. Ann
Intensive Care 2011, 1:3.

P385
Estimated GFR versus creatinine clearance for evaluation of
recovery from acute kidney injury
P Timmermans, J Gunst, G Van den Berghe, M Schetz
KU Leuven University Hospital, Leuven, Belgium
Critical Care 2014, 18(Suppl 1):P385 (doi: 10.1186/cc13575)
Introduction The aim of this study is to quantify the impact of using
eGFR instead of measured creatinine clearance (Clcr) on the evaluation
of recovery from acute kidney injury (AKI).
Methods From a large RCT’s database [1] we excluded patients with
end-stage renal disease and kidney transplants. In the remaining 4,560
patients, 1,296 (28%) developed AKI (KDIGO criteria). After exclusion of
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ICU nonsurvivors (n = 229), patients on dialysis at ICU discharge (n =
77) and patients for whom Clcr on the last day of ICU was not available
(n = 206), 784 patients were included in this analysis. We compared
eGFR (MDRD equation) with measured Clcr (based on 24-hour urine
collection and corrected for BSA) at ICU discharge for patient groups
with different ICU stays. We also evaluated the impact of using the two
GFR measurements on the estimation of complete recovery relative to
baseline eGFR. Parameters were compared with the paired t test and
McNemar’s test.
Results Amongst the 784 patients with AKI, 456 (58%) reached stage 1,
143 (18%) stage 2 and 185 (24%) stage 3. Mean ± SD Clcr and eGFR at ICU
discharge were respectively 54.5 ± 28 and 76 ± 55 ml/minute/1.73 m2
(P <0.0001). eGFR was not significantly different from Clcr in patients
with ICU stay <7 days. In patients with ICU stay between 8 and 14 days,
eGFR was significantly higher than Clcr (79 ± 51 vs. 48.5 ± 20, P <0.0001)
and the difference increased even further in patients with ICU stay
over 14 days (102 ± 70 vs. 42.6 ± 20, P <0.0001). The percentage of
patients with complete recovery differed significantly when evaluated
by eGFR (35.3%) or Clcr (28.7%) (P = 0.007). In patients with ICU stay
>14 days, this difference increased to 56.4% by eGFR versus 14.1% by
Clcr (P <0.0001).
Conclusion Estimated GFR at ICU discharge is significantly higher than
the measured Clcr in patients with prolonged ICU stay. This difference
can be explained by loss of muscle mass with decreased creatinine
production and results in an important overestimation of recovery.
Reference
1.

Casaer et al.: N Engl J Med 2011, 365:506-517.
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Recovery from AKI by KDIGO criteria
D Schrijvers, J Gunst, G van den Berghe, M Schetz
KU Leuven University Hospital, Leuven, Belgium
Critical Care 2014, 18(Suppl 1):P386 (doi: 10.1186/cc13576)
Introduction Data on recovery of AKI are mainly limited to persistent
dialysis dependency in patients with dialysis-requiring AKI. The aim of
this analysis is to evaluate recovery from different stages of AKI.
Methods In a large database (n = 4,640) of a previous RCT [1] we
estimated renal recovery from AKI defined by KDIGO criteria (without
urine output criteria). Patients with end-stage renal disease (n =
56), kidney transplantation (n = 15) or incomplete data (n = 9) were
excluded. Patients were classified according to their maximal AKI stage
(AKImax) during the ICU stay. Recovery was evaluated by AKI stage
at hospital discharge. Complete recovery was defined as the absence
of AKI, partial recovery as persistent AKI with a decrease in AKI stage
compared with AKImax and no recovery as persistence of AKImax or
worsening of AKI after ICU discharge. A persistent 0.3 mg/dl increase of
Screat was also considered as no or partial recovery.
Results A total of 1,296 patients (28%) developed AKI. AKImax was
stage 1 in 580 (45%) (416 with >50% increase of Screat), stage 2 in 207
(16%) and stage 3 in 509 (39%) (348 needing RRT). Mortality increased
from 12 to 42% (P <0.0001), hospital stay increased from 21 (14 to 37)
to 34 (17 to 63) days (P <0.0001) and complete recovery in survivors
decreased from 82 to 53% (P <0.0001) with increasing severity of AKI.
In patients requiring RRT, 51% of survivors left the hospital without AKI
whereas 16% remained dialysis dependent. Within the AKI 3 group, the
need for RRT significantly increased mortality (P = 0.0002), but did not
affect complete recovery in survivors (51% vs. 58%, P = 0.16). Patients
with a ‘0.3 mg/dl increase of serum creatinine only’ had a significantly
higher mortality than patients without AKI in the ICU (P = 0.0004). They
also had a worse kidney outcome at hospital discharge (P = 0.006).
Conclusion Increasing severity of AKI according to the KDIGO criteria
is associated with increased mortality and decreased recovery of
kidney function. The need for RRT significantly increases mortality but
complete recovery in survivors of AKI 3 is not different with or without
RRT. The 0.3 mg/dl criterion proves valid with regard to mortality and
kidney outcome.
Reference
1.
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Incidence and outcomes of acute kidney injury following orthotopic
lung transplant: a population-based cohort study
P Fidalgo1, M Ahmed1, SR Meyer1, D Lien1, J Weinkauf1, FS Cardoso1,
K Jackson2, SM Bagshaw1
1
University of Alberta, Edmonton, Canada; 2Alberta Health Services,
Edmonton, Canada
Critical Care 2014, 18(Suppl 1):P387 (doi: 10.1186/cc13577)
Introduction Acute kidney injury (AKI) is a serious complication
following lung transplantation (LTx) [1-3]. We aimed to describe the
incidence and outcomes associated with AKI following LTx.
Methods A retrospective population-based cohort study of all adult
recipients of LTx at the University of Alberta between 1990 and 2011
was performed. The primary outcome was AKI, defined and classified
according to the Kidney Disease: Improving Global Outcomes (KDIGO)
criteria, in the first seven postoperative days. Secondary outcomes
included risk factors, utilization of renal replacement therapy (RRT),
occurrence of postoperative complications, mortality and kidney
recovery.
Results Of 445 LTx recipients included, AKI occurred in 306 (68.8%),
with severity classified as stage I in 38.9% (n = 173), stage II in 17.5%
(n = 78) and stage III in 12.4% (n = 55). RRT was received by 36 (8.1%).
Independent risk factors associated with AKI included longer duration
of cardiopulmonary bypass (per minute, odds ratio (OR) 1.003; 95%
CI, 1.001 to 1.006; P = 0.02), and mechanical ventilation (per hour
(log-transformed), OR 5.30; 95% CI, 3.04 to 9.24; P <0.001), and use of
cyclosporine (OR 2.03; 95% CI, 1.13 to 3.64; P = 0.02). In-hospital and
1-year mortality were significantly higher in those with AKI compared
with no AKI (7.2% vs. 0%, adjusted P = 0.001; 14.4% vs. 5.0%, adjusted P =
0.02, respectively). At 3 months, those with AKI had greater sustained
loss of kidney function compared with no AKI (estimated glomerular
filtration rate (mean (SD)) 68.9 (25.7) vs. 75.3 (22.1) ml/minute/1.73 m2,
P = 0.01).
Conclusion By the KDIGO definition, AKI occurred in two-thirds of
patients following LTx. AKI portended greater risk of death and loss of
kidney function.
References
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Fluid accumulation post cardiac surgery and risk for renal
replacement therapy
EM Moore1, A Tobin2, D Reid2, J Santamaria2, R Bellomo1
1
Monash University, Melbourne, Australia; 2St Vincent’s Hospital, Melbourne,
Australia
Critical Care 2014, 18(Suppl 1):P388 (doi: 10.1186/cc13578)
Introduction We assessed the impact of fluid accumulation on the
development of acute kidney injury (AKI) and need for continuous renal
replacement therapy in cardiac surgical patients. Fluid accumulation
has been associated with negative outcomes including development of
AKI in critically ill patients [1-3]. As cardiac surgical patients commonly
receive large volumes of i.v. fluid within 24 hours of surgery, they could
be at risk of the harmful effects of fluid accumulation.
Methods We performed a retrospective analysis of prospectively
collected data on all patients admitted after cardiac surgery to St
Vincent’s Hospital ICU, Melbourne, Australia from 1 July 2004 to 30
June 2012 (n = 3,207). The fluid accumulation percentage (total urine
and chest drain losses subtracted from total i.v. intake (l) /weight (kg) ×
100) was calculated for 18 hours post surgery as most patients were in
the ICU for this period. Acute Kidney Injury Network (AKIN) creatinine
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criteria were used to classify AKI using creatinine adjusted for fluid
balance.
Results Renal replacement therapy was performed on 136 patients in
this group (4.2%). The fluid accumulation percentage was associated
with an 8% increase in odds for AKI (OR (CI), 1.08 (1.04 to 1.12)), and
a 13% increase in odds for requiring renal replacement therapy (1.13
(1.05 to 1.21)) for each percent increase in fluid accumulation (l/kg%)
after cardiac surgery, after adjusting for variables including APACHE
score, cardiac failure, type of surgery, and inotrope use in multivariate
analysis.
Conclusion In this relatively homogeneous patient group undergoing
cardiac surgery, postoperative percent fluid accumulation at 18 hours
was associated with AKI and need for renal replacement therapy.
Whether there is residual confounding due to indication for fluid use
or unmeasured risk factors requires further investigation in controlled
trials.
References
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Recovery of renal function after acute kidney injury requiring
continuous renal replacement therapy
HY Jung, KH Kim, SC Park, JY Choi, SH Park, CD Kim, YL Kim, JH Cho
Kyungpook National University Hospital, Daegu, South Korea
Critical Care 2014, 18(Suppl 1):P389 (doi: 10.1186/cc13579)
Introduction Acute kidney injury (AKI) is increasingly common in
critically ill patients and many patients with severe kidney injury require
continuous renal replacement therapy (CRRT). However, little is known
regarding the incidence rate and associated factors for developing
chronic kidney disease after CRRT in AKI patients. This study aimed to
investigate renal outcome and the factors associated with incomplete
renal recovery in AKI patients who received CRRT.
Methods Between January 2011 and August 2013, 397 patients
received CRRT in our ICU. Among them, patients who had normal renal
function before AKI and were discharged without maintenance renal
replacement therapy (RRT) were included in this study. We examined
the incidence of incomplete renal recovery with estimated glomerular
filtration rate (eGFR) <60 ml/minute/1.73 m2 during follow-up. Factors
that increased risk of incomplete renal recovery after AKI were
investigated with multiple logistic regression.
Results Forty-one AKI patients were discharged without further
RRT and followed up for a mean of 7 months. Sixteen (39.0%) of 41
patients incompletely recovered their renal function. Patients with
incomplete renal recovery showed older age and longer duration of
anuria compared with complete renal recovery patients (69.7 ± 7.0 vs.
54.8 ± 16.9 years, P = 0.002; 128.6 ± 192.1 vs. 26.9 ± 66.6 hours, P =
0.019). Multivariate analysis adjusting for sex, initial eGFR, hemoglobin
level, diabetes mellitus and hypertension showed that old age and
long duration of anuria were independent risk factors for incomplete
renal recovery (OR = 1.143, 95% CI = 1.020 to 1.281, P = 0.021 and OR =
1.011, 95% CI = 1.001 to 1.032, P = 0.038, respectively).
Conclusion The renal outcome of severe AKI requiring CRRT was
poor even in patients with previous normal renal function. Long-term
monitoring of renal function is needed especially in severe AKI patients
with old age and long duration of anuria.
P390
Relation between preoperative use of diuretics and renal
replacement therapy after cardiac surgery: a propensity score
analysis
E Curiel-Balsera1, M Delange van der Kroft2, I Macias-Guarasa1,
R Hinojosa Perez1, J Ravina-Sanz1, M Garcia-Delgado1, R Rivera-Fernandez1
1
Carlos Haya University Hospital, Malaga, Spain; 2County Hospital of
Axarquia, Velez Malaga, Spain
Critical Care 2014, 18(Suppl 1):P390 (doi: 10.1186/cc13580)
Introduction The aim was to evaluate the relation between
preoperative use of diuretics and renal replacement therapy (RRT) in
postoperative patients of cardiac surgery.
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Methods A prospective cohort of adult patients who underwent cardiac
surgery in 11 institutions all over the Andalusia community from March
2008 to July 2012 was included in the ARIAM adult cardiac surgery
project. Diuretic users prior to the intervention were pair-matched to
nonusers on the basis of a propensity score based on demographics,
comorbidities, medication and surgical data. We analysed differences
in RRT in both groups.
Results The total cohort was composed of 7,276 patients with
63.91 ± 12.45 years and 61.1% male gender. Elective scheduled surgery
was done in 85.9% of patients. Surgical risk assessed by the additive
EuroSCORE was 5.86 ± 3.14 points and predicted mortality by the
Logistic EuroSCORE was 8.10%. Mortality in the ICU was 7.6% and inhospital mortality was 10.1% (8.1% missing data). Prior to surgery,
10.4% of patients had a creatinine level between 1.2 and 2 mg/dl,
1.1% between 2 and 2.3 mg/dl, 0.8% between 2.3 and 3.5 mg/dl and
0.3% above 3.5 mg/dl. In the nonmatched cohort, 180 patients (2.5%)
needed RRT. RRT was needed in 3.5% of 3,771 patients with diuretics
and in 1.4% of 3,505 patients not treated with them (P <0.001); 2.61
(1.87 to 3.65). After adjusting with logistic regression by additive
EuroSCORE, SAPS 3, bypass time exceeding 120 minutes and prior renal
dysfunction, the OR was 1.67 (1.15 to 2.45). When we analysed 3,426
matched patients according to the propensity score, RRT was needed
in 3% of 1,713 patients with diuretics and in 1.6% of 1,713 not treated
with them (P <0.009), 1.85 (1.16 to 2.94).
Conclusion Preoperative use of diuretics is associated with an increased
risk of need for RRT.
P391
Continuous renal replacement therapy (CVVHD) for acute kidney
injury in critical care: incidence and outcome across South West Wales
K Brown, M Challis, A Mikhail
Morriston Hospital, Swansea, UK
Critical Care 2014, 18(Suppl 1):P391 (doi: 10.1186/cc13581)
Introduction Renal replacement therapy in critical care is associated
with increased mortality. It is not known for which patients RRT confers
the most benefit, or who will recover function and remain dialysis
independent on a long-term basis.
Methods All ICU patients receiving CVVHD (diffusive haemodialysis) for
AKI were analysed in a retrospective cohort study of mixed non/surgical
patients at a tertiary renal centre over a 2-year period (December
2011 to November 2013). Children <18 years, patients on intermittent
haemodialysis or patients requiring plasma exchange were excluded
from analysis.
Results A total of 2,297 patients were admitted to the ICU, of which 14%
(319) required CRRT. Thirteen patients were excluded from analysis; n =
306, of which 58% were male. Causes of AKI included sepsis (37%),
surgery (13%, of which 82% were emergency procedures) and vascular
events (9%). Mean values for patients requiring RRT versus all ICU
patients: age (65 vs. 62.5 years), APACHE II score (21.2 vs. 14.8), length of
stay (13 vs. 8.2 days). Forty-seven per cent of patients received incident
dialysis <24 hours of admission, with mean flow rates of 31 ml/kg/hour
(2 l) in 39%. Mortality at hospital discharge was 56% for RRT versus 20%
in all ICU patients admitted over the same time period.
Conclusion The reported incidence of AKI in critical care ranges from 20
to 50%, with the highest rates seen in sepsis [1]. Utilisation of CRRT for
AKI is higher at our centre than the described 5% [2], potentially due to
close collaboration between critical care and nephrology [3] or relatively
lenient ICU admission criteria. Increasing mortality was seen with age,
APACHE II score and delay in initiation of RRT. Prospective analysis is
required to look at determining biomarkers for AKI and risk factors for
mortality; dynamic monitoring of haemodynamic responders (MAP,
vasopressor requirement <24 hours), percentage creatinine decrease
[4], severity-of-illness scores and urine output. Results of current
RCTs are awaited, which may provide more information on mode of
clearance, flow rates and early versus standard initiation of RRT to more
accurately prognose patients’ outcomes.
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P392
Renal replacement therapy in very elderly critical care patients
K Brown, HG Jones
Morriston Hospital, Swansea, UK
Critical Care 2014, 18(Suppl 1):P392 (doi: 10.1186/cc13582)
Introduction The very elderly (>80 years) UK population is increasing
and along with it there is an increased utilisation of critical care resources
[1]. The use of chronological age as a bar to treatment is unethical, yet
a discrepancy of opinion remains between the disinclined and the
elderly advocate intensivist [2]. Acute kidney injury requiring dialysis
is a frequent complication of critical illness and is associated with high
morbidity and mortality. An increased risk is seen with age due to the
high prevalence of risk factors and chronic kidney disease in the elderly
[3].
Methods Very elderly patients admitted to our tertiary referral ITU were
included in a 2-year (December 2011 to November 2013) retrospective
cohort analysis. The outcome of those receiving RRT was reviewed.
Results There were 2,297 admissions to the ITU, of which 323 (14%)
were classified as very elderly with a mean APACHE II score of 17.3. RRT
was utilised in 12.4% (n = 40) of the very elderly patients with a mean
APACHE II score of 25. Forty-five per cent of AKI was due to sepsis and
25% due to emergency surgery. ITU very elderly patient mortality was
30.1%, and in those who received RRT was 42% and 67% at ITU and
hospital discharge respectively. Recovery of renal function was seen in
19 patients at ITU discharge, of these 11 survived to hospital discharge.
Two patients required ongoing IHD in the community.
Conclusion Current predictions estimate that the very elderly UK
population will almost double by 2030 [4]. The biggest uptake in
acceptance of chronic RRT has been in the elderly [5], where no
difference has been shown in health-related quality of life from the
general dialysis population [6]. Our experience suggests that RRT has
a role in the critically ill elderly patient, with 33% surviving to hospital
discharge. The challenge is identifying those most likely to benefit from
a cohort with multiple comorbidities, against the available resources,
rising demand for critical care in an aging population and increasing
expectations [7].
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Preventing continuous renal replacement therapies (CRRT)-induced
hypophosphatemia using a phosphate-containing CRRT solution in
the setting of regional citrate anticoagulation
V Pistolesi1, S Morabito1, L Tritapepe1, E Vitaliano2, L Zeppilli1, F Polistena1,
MI Sacco1, E Fiaccadori3, A Pierucci1
1
Umberto I, Policlinico di Roma, Rome, Italy; 2Pertini Hospital, Rome, Italy;
3
University of Parma Medical School, Parma, Italy
Critical Care 2014, 18(Suppl 1):P393 (doi: 10.1186/cc13583)
Introduction Phosphate depletion is a known issue during
continuous renal replacement therapies (CRRT) with an incidence
of hypophosphatemia up to 80% when standard CRRT solutions
are used. The aim was to evaluate the effects on serum phosphate
and phosphorus supplementation needs of a regional citrate
anticoagulation (RCA) protocol for CRRT combining the use of citrate
with a phosphate-containing CRRT solution.
Methods In critically ill heart surgery patients undergoing CRRT for
acute kidney injury, we adopted RCA in a CVVH or CVVHDF modality
combining a commercially available citrate solution (18 mmol/l) with a
phosphate-containing CRRT solution as dialysate and/or replacement
fluid (HCO3– 30 mmol/l, phosphate 1.2). The prescribed CRRT dose,
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corrected for predilution, was at least 25 ml/kg/hour with about
50 to 60% of dialysis dose given as phosphate-containing solution.
By convention, hypophosphatemia was defined as follows: mild
(<0.81 mmol/l), moderate (<0.61 mmol/l) and severe (<0.32 mmol/l).
Results Forty-eight patients were treated with RCA-CRRT for at least
72 hours (total running time 12,502 hours). Two-hundred and nineteen
RCA-CVVH circuits were used with a mean filter life of 57.1 ± 41.7 hours
(median 47, IQR 24 to 83). Acid–base status was adequately maintained
without the need for additional interventions on RCA-CRRT parameters
(pH 7.43 (7.40 to 7.47), bicarbonate 25.3 mmol/l (23.8 to 26.6), BE 0.9
(–0.7 to 2.4); median (IQR)). Serum phosphate was steadily maintained
in a narrow range throughout RCA-CRRT days (1.2 mmol/l (0.97 to
1.45); median (IQR)). At some times during CRRT, only 10 out of 48
patients (20.8%) received a low amount of phosphate supplementation
(D-fructose-1,6-diphosphate 1.05 ± 2.04 g/day) for mild (n = 7) to
moderate (n = 3) hypophosphatemia. In particular, considering all
patients, only 33 out of 513 serum phosphorus determinations met the
criteria for mild (n = 24) to moderate (n = 9) hypophosphatemia. Severe
hypophosphatemia was never observed.
Conclusion The use of a phosphate-containing CRRT solution,
accounting for about 50 to 60% of the CRRT dose in the setting of
RCA-CVVH or RCA-CVVHDF, allowed one to prevent CRRT-induced
phosphate depletion in most of the patients, minimizing the need for
phosphate supplementation and maintaining phosphorus levels in a
near-normal range throughout CRRT days.

P394
Elimination rates of electrolytes, vitamins and trace elements
during continuous renal replacement therapy with citrate CVVHD:
influence of treatment dose
P Von Freyberg1, W Stahl2, H Reinelt2, K Träger2
1
Klinikum Heidenheim, Germany; 2University Hospital Ulm, Germany
Critical Care 2014, 18(Suppl 1):P394 (doi: 10.1186/cc13584)
Introduction During continuous renal replacement therapy (CRRT),
relevant losses of nutritional substrates, vitamins and trace elements
due to diffusive transport and elimination via the filter may occur. We
investigated the amount of these losses with regard to treatment dose
during a 72-hour treatment period.
Methods Forty-one patients with CRRT were investigated. Patients
were treated with a citrate CVVHD with different standard doses
resulting in a treatment dose range from 14 to 53 (median 27) ml/
kg/hour. Losses were calculated from substrate concentrations in the
dialysate × (dialysate + ultrafiltration) flow. During a 72-hour treatment
period, each 24 hours were determined separately. Regression analysis
was performed for the respective per-day losses related to treatment
doses.
Results Regression analyses of ER for Ca2+, Mg2+, PO42–, zinc, folic acid
and vitamin B12 are shown in Table 1 as the median and interquartile
range.
Table 1 (abstract P394). ER elimination rates
Parameter
2+

Average daily ER Day 1 R2

Day 2 R2

Day 3 R2

Ca (mmol/day)

97 (83 to 107)

0.2125

0.2448

0.2315

Mg2+ (mmol/day)

6 (3 to 9)

0.0247

0.0708

0.0733

PO42– (mmol/day)

53 (40 to 69)

0.003

0.0556

0.0012

Zinc (μmol/day)

46 (27 to 73)

0.005

0.0527

0.0502

268 (180 to 388)

0.0935

0.0031

0.0353

2,060 (1,690 to 2,558) 0.0009

0.0092

0.0152

Folic acid (nmol/day)
Vitamin B12 (pmol/day)

Conclusion Only Ca2+ showed a correlation of ER and treatment dose.
Mg2+, PO42– zinc, folic acid and vitamin B12 were eliminated without a
correlation to treatment dose.

P395
Evaluation of functional differences between two anticoagulation
methods used in continuous renal replacement therapy in critical
patients
V Goulão, E Lafuente, J Silva, M Fernandes, F Santos, A Ferreira
CHTS, Penafiel, Portugal
Critical Care 2014, 18(Suppl 1):P395 (doi: 10.1186/cc13585)
Introduction The aim of this study is to analyze the functional
alterations that may influence the final result when using citrate versus
heparin anticoagulation in critically ill patients [1].
Methods We performed a retrospective and analytical study including
patients exclusively submitted to citrate or heparin through years 2011
and 2012. Included were demographic data with SAPS II, SOFA, RIFLE
scores and mortality rate. For functional analysis we consider the timing
of the beginning, duration, loss of dose and loss of creatinine clearance.
We analyzed dialitrauma, considering the variation of: potassium, total
and ionized calcium, magnesium, sodium, phosphorus, pH, lactates,
bicarbonate, platelets, albumin, creatinine and urea. Data are presented
as the average and standard deviations. To access the influence of dose
and clearance losses on mortality, we used logistic regression test.
Results The study included 44 patients in the citrate group versus 61
in the heparin group. We found no statistical significant differences for:
age (P = 0.06); SAPS II (P = 0.28); SOFA (P = 0.19); the timing of beginning
of the technique (P = 0.61), with 34.8% versus 47.5% of patients in R
(RIFLE), 27.8% versus 18% in I (RIFLE) and 16% versus 21% in F (RIFLE);
duration of the technique (P = 0.74) and length of stay. Although we
noticed a greater loss of dose and absolute creatinine clearance in
the citrate group, this had no statistical significance (P = 0.18 and P =
0.13). The mortality found for citrate and heparin groups was 60.4%
and 39.4% respectively. The differences with statistical significance
related to dialitrauma emerged in K+ (P = 0.03), Ca2+ (P = 0.02), Na+ (P =
0.004), platelets (P = 0.002), pH (P = 0.02) and bicarbonate (P = 0.0001).
Logistic regression for mortality in the citrate versus heparin groups
showed the following values: effective dose (ROC 0.435 vs. ROC 0.663),
clearance (ROC 0.606 vs. ROC 0.663), SAPS II (ROC 0.482 vs. ROC 0.696),
SOFA (ROC 0.713 vs. ROC 0.696) and RIFLE (ROC 0.695 vs. ROC 0.636).
Conclusion We may say that there are functional differences that must
be taken into account. Despite not having statistical significance on
this sample, losses of dose and creatinine clearance showed a direct
relation with mortality.
Reference
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Development of key performance indicators for renal replacement
therapy in adult intensive care to guide safe and cost-effective
therapy
A Fischer, S Finney
Royal Brompton Hospital, London, UK
Critical Care 2014, 18(Suppl 1):P396 (doi: 10.1186/cc13586)
Introduction Renal replacement therapy (RRT) is common. We
undertook to develop and report some key performance indicators
(KPIs) to monitor our provision of this costly therapy. We utilised data
already collected in an electronic clinical information system that
records the care received by our patients. We reduced our prescribed
RRT dose to 25 ml/kg/hour in December 2011 following an appraisal
of the literature [1]. We assessed whether the KPIs informed us if our
practice changed and such changes were sustained.
Methods We calculate the hourly effluent rate corrected for a patient’s
predicted body weight, and the lifespan of haemofilters. This takes less
than 30 minutes each month. Statistical process control charts (SPCs)
are used to assimilate the indicators over time.
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Table 1 (abstract P396). KPI for renal replacement therapy 2013

AICU-RBH no. of patients on CVVHD

Jan
2013

Feb
2013

Mar
2013

Apr
2013

May
2013

Jun
2013

Jul
2013

Aug
2013

Sep
2013

Oct
2013

Nov
2013

8

8

17

15

6

7

13

12

9

15

21

AICU-RBH no. of patient-days on CVVHD

61

73

98

86

65

85

44

77

112

119

137

AICU-RBH filter started

32

30

52

47

34

50

26

60

71

62

74

1,154

1,463

1,769

1,532

1,317

1,565

693

1,422

2,215

2,157

2,393

544

602

763

689

636

695

294

629

995

952

1,054

AICU-RBH fluid cost (£)

4,994

5,526

7,004

6,325

5,838

6,380

2,699

5,774

9,134

8,739

9,676

AICU-RBH ml/kg/hour actual

39.90

28.17

29.10

30.53

33.93

31.52

31.25

29.90

30.40

32.55

32.36

AICU-RBH ml/kg/hour 24 hours

32.46

23.44

22.23

23.60

29.32

24.43

21.34

23.93

25.25

25.38

24.01

AICU-RBH percent on CVVHDF

0.79

0.84

0.75

0.67

0.84

0.77

0.66

0.77

0.82

0.76

0.73

AICU-RBH hours of CVVHD
AICU-RBH estimated no bags

AICU-RBH average filter life (hours)

36.06

48.77

34.02

32.60

38.74

31.30

26.65

23.70

31.20

34.79

32.34

AICU-RBH filter cost (£)

2,477

2,322

4,025

3,638

2,632

3,870

2,012

4,644

5,495

4,799

5,728

AICU-RBH effluent bags cost (£)

680

753

954

861

795

869

368

786

1,244

1,190

1,318

AICU-RBH total consumable (£)

3,157

3,075

4,979

4,499

3,427

4,739

2,380

5,430

6,739

5,989

7,045

AICU-RBH total cost CVVHD (£)

8,151

8,601

11,983

10,824

9,265

11,119

5,079

11,204

15,873

14,728

16,721

AICU-RBH average cost per patient (£)

1,019

1,075

705

722

1,544

1,588

391

934

1,764

982

796

134

118

122

126

143

131

115

146

142

124

122

AICU-RBH average cost per patient day (£)

Results A total of 736 patients received RRT during the study. Prior to
the dose change, the mean set and delivered doses were 39 and 31 ml/
kg/hour respectively. Thereafter the mean set and delivered doses were
33 and 26 ml/kg/hour respectively. Whilst higher than our guideline
dose, they are significantly less than the doses prior to the change in
practice (both P <0.001). The SPC indicates that the change in practice
has been sustained. See Figure 1 and Table 1.
Conclusion The KPIs could be produced quickly and allowed monitoring
of the reduction in RRT dosing, assuring us that it is in excess of 20 ml/
kg/hour. The KPIs did not require additional data collection processes.
We are developing similar indicators for other organ systems, therapies
and processes.
Reference
1.

RENAL Investigators: Intensity of continuous renal-replacement therapy in
critically ill patients. N Engl J Med 2009, 361:1627.

Figure 1 (abstract P396). Delivered dose of RRT each month.
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P397
Effectiveness of sub-albumin protein leakage membrane EMIC2 in
post-cardiac surgery rhabdomyolysis
G Paternoster, A Covino, R Mercorella, C Di Leo, M Calabrese, G Pittella
San Carlo Hospital, Potenza, Italy
Critical Care 2014, 18(Suppl 1):P397 (doi: 10.1186/cc13587)
Introduction A high postoperative serum myoglobin (MyG)
concentration predicts the incidence of acute kidney injury (AKI)
and need for renal replacement therapy (RRT), as reported in several
surgical settings. The incidence of such events in the ICU is reported to
be 2 to 5% of all causes of AKI [1], but can even worsen in the case of
cardiac surgery (40.3%) [1]. MyG is a small protein (17.8 kDa) that can
be removed with RRT, typically in convection cases. New-generation
membranes, removing sub-albumin protein molecular weight solutes,
can be used in diffusive treatments (CVVHD) with the advantage of
limiting albumin loss and easily combining with citrate anticoagulation,
pivotal for cardio-surgical settings. We assessed the effectiveness of
EMIC2 with citrate anticoagulation in AKI prevention of post-cardiac
surgical patients.
Methods This is a case series of eight patients (mean age 62.7 years, five
male, EuroSCORE log 15.61) in cardiac surgery on CPBP for 150 minutes

Figure 1 (abstract P397).
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and mean aortic cross-clamping of 98 minutes (range 25 to 190).
We measured MyG, procalcitonin (PCT), and creatinin (sCr) at ICU
admission and, if serum MyG was higher than 600 mg/dl, the patient
was treated with CVVHD-EMIC2–citrate anticoagulant within 12 hours
of ICU admission for 72 hours and a dose of 2,000 ml/hour. Biochemical
assays were obtained at 12, 24, and 72 hours and at ICU discharge.
Results The pretreatment MyG median value was 10,789 ng/ml; it
significantly reduced on average 92.8% during CVVHD (see Figure 1)
and it remained low at ICU discharge (median value 114 ng/ml). sCr
remained stable (average time value equal to 0.94 mg/dl) during
CVVHD; PCT also decreased over time with a reduction rate equal to
78% (from 5.35 ± 4.39 mg/dl to 1.23 ± 1.09 mg/dl at the end of CVVHD).
Finally, six patients survived at 90 days.
Conclusion This small experience confirms that serum MyG is likely
to increase in post-cardiac surgical high-risk patients and suggests a
beneficial effect of CRRT treatments with EMIC2 membranes and citrate
on serum MyG, potentially preventing AKI. Further larger assessment
can be advised for confirmation.
Reference
1.

Benedetto U, et al.: J Thorac Cardiovasc Surg 2010, 140:646-670.
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Myoglobin removal of small-protein leakage membrane (EMIC2) in
patients in the ICU: a case series
P Fabbrini1, R Rona1, M Migliari1, M Viganò1, A Pesenti2, A Stella2
1
AO San Gerardo, Monza, Italy; 2Università degli Studi Milano-Bicocca, Milan,
Italy
Critical Care 2014, 18(Suppl 1):P398 (doi: 10.1186/cc13588)
Introduction Rhabdomyolysis is characterized by breakdown of striated
muscle due to a great number of causes. Acute kidney injury (AKI) is a
common complication as a consequence of high concentrations of
circulating myoglobin (Mb). The AKI degree can vary but often requires
dialysis, a condition which drastically worsens the ICU stay and prognosis.
Since Mb overconcentration represents the cause of AKI, one of the
therapy’s aims should be its removal to prevent further kidney damage
and to allow faster renal recovery. Both intermittent hemodialysis and
high-volume CVVHF are poorly effective in removing Mb, while smallprotein leakage membranes seem to be promising in this setting. The
aim of our study was therefore to measure efficacy of Mb removal of a
new high cutoff membrane (EMIC2; Fresenius, cutoff value 40 kDa) for
continuous renal replacement therapies (CRRT) in the ICU setting.
Methods We report results of EMIC2-based treatments in seven
patients (four male/three female) with different causes of
rhabdomyolysis (trauma, sepsis, limb ischemia). Five patients had
classic dialysis indications (persistent anuria) while in two patients
treatment was prophylactically started. CRRT were delivered in CVVHD
mode with the EMIC2 dialyzer and with loco-regional trisodium–citrate
anticoagulation. Mb plasma levels were assessed each 12 hours while
the removal rate, total body and dialyzer clearances were estimated by
kinetic modeling as previously described [1]. Clinical data were also
collected and both global and renal patient survival was reported.
Results The median Mb value at CRRT start was 6,971 ng/ml (range
4,679 to 48,011 ng/ml). CRRT were delivered with an average
blood flow rate of 143 ± 45 ml/minute and a dialysate flow rate of
2,134 ± 1,334 ml/hour. These operating conditions allowed one to stop
treatment on average after 75 ± 47 hours (median 54 hours) with a Mb
reduction of 82.2% (range 99.4 to 44.4%). Overall median Mb removal
per treatment was 59 mg (range 33 to 279 mg) mainly due to the first
24 hours of treatment (54 mg, range 20 to 187 mg). Only two patients
had residual renal function that was in one case measured to account
for only 7.45 mg Mb removal during the entire treatment. Six patients
survived and recovered renal function with no dialysis need at present
follow-up. One patient died during the ICU stay.
Conclusion Our data measured high performance of the EMIC2
membrane in Mb removal and confirm theoretical models indicating
that CRRT with a high cutoff membrane can achieve major Mb removal
within 24 hours with great superiority in comparison with all other
available techniques.
Reference
1.

Keil R, et al.: Comp Met Progr Biomed 2013, S0169:2607.
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Plasma filtration with dialysis (plasma diafiltration) in critically ill
patients with acute liver failure
Y Eguchi1, H Nakae2, T Furuya3, M Isono4, Y Kishi5, T Yoshioka6
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Critical Care 2014, 18(Suppl 1):P399 (doi: 10.1186/cc13589)
Introduction Removing the middle molecular weight substances
including cytokines and albumin-bound toxin could be effective
for patients with acute liver failure (ALF). We have developed a new
system, plasma filtration with dialysis (plasma diafiltration (PDF)) [1,2],
and assessed its efficacy in multicenter analysis.
Methods A subgroup analysis of an observational study conducted
in the ICUs of six hospitals. In PDF, simple plasma exchange is
performed using a selective membrane plasma separator (Evaxclio
EC-2A; Kawasumi Chemical Inc., Tokyo Japan), which has a sieving
coefficient of 0.3 for albumin, while the dialysate flows outside the
hollow fibers. The flow rate of the blood, dialysate, substitute and
additional substitute was 80 to 100 ml/minute, 600 ml/hour, and 0 to
450 ml/hour according to the rate of water elimination and 150 ml/
hour, respectively. As the substitute from the additional fluid line,
we added 1,200 ml (150 ml/hour) of fresh frozen plasma followed by
50 ml of 25% albumin considering the loss of albumin by diffusion. As
an anticoagulant, nafamostat mesilate (Torii Pharmaceutical Co. Ltd,
Tokyo, Japan) was used at a rate of 15 to 25 mg/hour.
Results A multicenter study was underway from October 2005 to
August 2011. We performed PDF on 65 patients with ALF (severe sepsis,
22; post operation, 15; fulminant hepatitis, 11; alcohol hepatitis, 3; graft
versus host disease, 4; and others, 10). The serum total bilirubin, plasma
PT-INR and the model for end-stage liver disease (MELD) score before
the PDF procedure were 15.0 ± 8.15 mg/dl (average ± SD), 2.3 ± 1.5 and
35.8 ± 9.3, respectively. PDF was performed as 9.2 ± 13.2 sessions per
patient and the overall 28-day survival rate was 68.5%. According to the
severity of the MELD score, we stratified patients into three categories
defined by the MELD score. The numbers of patients were 15 (23%) in
score 20 to 29, 30 (46%) in score 30 to 39 and 19 (29%) in score over 40.
The 28-day survival rates were 73.3%, 40% and 16%, respectively.
Conclusion PDF may be a useful blood purification therapy for ALF, but
PDF should be performed below a MELD score of 30.
References
1.
2.

Mori T, et al.: Ther Apher 2002, 6:463-466.
Nakae H, et al, Ther Apher Dial 2010, 14:444-450.
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Efficacy of continuous plasma diafiltration therapy
T Komura, T Taniguchi, T Noda, M Okajima, S Kaneko
Kanazawa University, Kanazawa, Japan
Critical Care 2014, 18(Suppl 1):P400 (doi: 10.1186/cc13590)
Introduction Acute liver failure (ALF) is a critical illness with high
mortality. Plasma diafiltration (PDF) is a blood purification therapy
in which simple plasma exchange is performed using a selective
membrane plasma separator while the dialysate flows outside the
hollow fibers. While several studies demonstrated that PDF therapy is
a useful blood purification therapy for patients with ALF, PDF therapy
is often difficult to employ in ALF patients complicated with multiple
organ failure, especially in those with unstable hemodynamics.
Furthermore, it is likely to re-occur immediately after PDF therapy. We
developed continuous PDF (CPDF) as a new concept in PDF therapy,
and assessed its efficacy and safety in ALF patients compared with
conventional plasma exchange (PE) plus continuous hemodiafiltration
(CHDF) therapy in this study.
Methods Ten ALF patients (gender: male/female = 6/4, age: 47 ± 14)
employed CPDF therapy. The primary outcomes were altered liver
function, measured by the model for end-stage liver disease (MELD)
score, and total bilirubin and prothrombin time International
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Normalized Ratio (PT-INR), 5 days after CPDF therapy. Secondary
outcomes included Sequential Organ Failure Assessment (SOFA)
scores, 5 days after CPDF therapy, and the survival rate 14 days after
this therapy.
Results The MELD score (34.5 to 28.0; P = 0.005), total bilirubin (10.9 to
7.25 mg/dl; P = 0.048), PT-INR (1.89 to 1.31; P = 0.084), and SOFA score
(10.0 to 7.5; P <0.039) were improved 5 days after CPDF therapy. Nine
patients were alive and one patient died due to acute pancreatitis,
complicated by ALF. The efficacy of CPDF therapy for maintaining liver
function and renal function was not inferior to PE plus CHDF therapy.
Parameters of renal function such as the creatinine value were also
improved 5 days after CPDF therapy. Circulation parameters such
as mean arterial pressure and heart rate were maintained without
inotropic and vasopressor support during the CPDF treatment
period. The oxygenation index (PaO2/FiO2) as a measure of pulmonary
function tended to increase after this treatment. We could employ this
treatment without any adverse events, such as infections and unstable
hemodynamics.
Conclusion In the present study, CPDF therapy safely supported liver
function and generally improved the condition of critically ill patients
with ALF.

P401
Hemodialysis with high cutoff membranes improves tissue
perfusion in severe sepsis: preliminary data of the Sepsis in Florence
sTudy (SIFT)
G Villa, C Chelazzi, S Valente, AR De Gaudio, S Romagnoli
University of Florence, Italy
Critical Care 2014, 18(Suppl 1):P401 (doi: 10.1186/cc13591)
Introduction It has been demonstrated that blood purification therapy
performed by means of venovenous hemodialysis with high cutoff
membranes (HCO-CVVHD) may modulate the host inflammatory
response in septic patients with acute kidney injury (AKI), potentially
limiting organ dysfunction. Improvement in hemodynamics and
respiratory function has been described during HCO-CVVHD treatment
[1]. The Sepsis in Florence sTudy (SIFT) has been designed to evaluate
changes in inflammatory biomarkers and tissue oxygenation/perfusion
indexes in septic ICU patients with AKI during HCO-CVVHD.
Methods Patients with microbiologically confirmed severe sepsis/
septic shock and AKI (RIFLE criteria F or more) treated with HCOCVVHD, started within 12 hours from the diagnosis, were prospectively
included in the study. The cumulative vasopressor index (CVI),
C-reactive protein levels (CRP), serum lactate concentration (Lac)
and central venous oxygen saturation (ScvO2) were measured before
(T0h) and at 24 hours and 48 hours after HCO-CVVHD initiation. Data
are expressed as the median (range). The Mann–Whitney U test was
applied to detect differences in CVI, CRP, Lac and ScvO2 at the three
time points (statistical significance for P <0.05).
Results In 16 ICUs, a total of 16 patients (six cardiac surgery, four
abdominal surgery and six medical) met the inclusion criteria and
were enrolled in the study. A significant reduction in CRP levels was
observed over time: 263 (216 to 358) mg/dl at T0h to 153 (56 to 186)
mg/dl at T48h (P <0.05). ScvO2 significantly increased from 45 (40 to
55)% at T0h to 75 (68 to 77)% at T48h (P <0.05). Finally, serum lactate
decreased from 5.1 (3.0 to 9.5) mmol/l at T0h to 1.6 (1.0 to 4.6) mmol/l
at T48h (P <0.05). Conversely, CVI did not significantly reduce over time
(8.2 (4 to 9) at T0h vs. 4.5 (4 to 8) at T48h, P >0.05).
Conclusion Our preliminary data show that patients with sepsisrelated AKI may benefit from early treatment with HCO-CVVHD. The
modulation of proinflammatory and anti-inflammatory mediators,
as previously demonstrated [1], may improve microcirculation, tissue
perfusion and cellular oxygenation. Although promising, our results
must be confirmed at the end of the study with larger observations.
Finally, a subgroup analysis is absolutely mandatory in order to explore
different behaviors of tissue perfusion indexes in different populations
of patients.
Reference
1.

Morgera S: Crit Care Med 2006, 34:2099-2104.
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Pharmacodynamics and pharmacokinetics of ciprofloxacin during
sustained low-efficiency dialysis
K Olsen, T Plumb, N Reardon, K Bogard, A Branch-Woods, G Peitz
University of Nebraska Medical Center, Omaha, NE, USA
Critical Care 2014, 18(Suppl 1):P402 (doi: 10.1186/cc13592)
Introduction Little information is available regarding ciprofloxacin
pharmacokinetics and pharmacodynamics in sepsis patients receiving
sustained low-efficiency dialysis (SLED). This study determined the
pharmacokinetics and simulated pharmacodynamics of ciprofloxacin
in ICU patients during SLED.
Methods This study was a prospective evaluation of ciprofloxacin
pharmacokinetics in patients with sepsis and >18 years of age, urine
output <200 ml/day and receiving SLED for at least 8 hours. Following
informed consent, plasma samples were collected at baseline and 1,
2, 4, and 8 hours after a ciprofloxacin 400 mg dose i.v. during SLED
and post-SLED therapy at the same times. Dialysate samples were
collected at 4-hour intervals during SLED. Pharmacokinetic parameters
were determined using WinNonlin and compared between the two
periods. Simulated pharmacodynamic parameters were determined
for Pseudomonas aeruginosa using MIC = 2.
Results A total of seven patients (four male, three female, age 56.9 ± 7.6,
APACHE II 26.8 ± 2.4) were enrolled. Ciprofloxacin was cleared relatively
rapidly with a half-life of 6.9 hours and a Ke of 0.108/hour during
SLED compared with 11.9 hours and 0.057/hour post-SLED (P <0.05).
Simulated pharmacodynamics demonstrated inadequate coverage for
P. aeruginosa during SLED with Cmax/MIC ratio 5.7 ± 1.2 and AUC/MIC
77.5 ± 22.3.
Conclusion Ciprofloxacin is rapidly cleared during SLED similar to
clearance during normal renal function, which may result in adequate
pharmacodynamic coverage for some pathogens.
P403
Pharmacokinetics of meropenem during continuous renal
replacement therapy in critically ill patients
J Solé Violán1, J Ferrer Agüero1, B Sádaba2, S Sancho3, R Zaragoza3,
P Luque4, M Nieto4, M López5, F García6, C Hernández6, J Azanza2
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Critical Care 2014, 18(Suppl 1):P403 (doi: 10.1186/cc13593)
Introduction Antibiotic dosing for patients with acute renal failure
receiving continuous renal replacement therapy (CRRT) is a clinical
challenge. The aim of this study was to investigate the pharmacokinetics
of meropenem (M) during CRRT.
Methods A prospective and multicenter study was conducted at seven
hospitals. Fifteen critically ill patients undergoing either continuous
venovenous hemofiltration (CVVHF) or hemodiafiltration (CVVHDF)
were included. Serum and ultrafiltrate (UF) levels of M were determined
by liquid chromatography. Blood samples were drawn 24 hours after
starting CRRT at 08:00 a.m., 09:00 a.m., 10:00 a.m., 01:00 p.m., 06:00 p.m.,
20:00 p.m. and 08:00 a.m. of the following day. CRRT clearance (Cl), total
amount of M in the UF (MUF), percentage of the dose extracted by
CRRT (EF) and the AUC (ng/hour/ml) were calculated.
Results Nine patients were treated with CVVHDF and six with CVVHF.
M (0.5 to 2 g) was administered every 6 to 12 h by i.v. infusion over
15 minutes. Data (mean and SD) concerning the dialysate flow rate (DF;
ml/hour), blood flow rate (ml/minute) and the average UF rate (ml/
kg/hour) for CRRT techniques are shown in Table 1. Pharmacokinetic
Table 1 (abstract P403). Parameters of CRRT techniques
CVVHF (n = 6)
DF rate

CVVHDF (n = 9)
964/94

Blood flow rate

190/33

187/29

UF rate

37.7/5.7

29.8/15.6
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Table 2 (abstract P403). Pharmacokinetic parameters for meropenem
CVVHF

CVVHDF

AUC

357/188

433/369

M dose (g/day)

1.7/0.4

2.2/1.4

MUF (mg)

338/104

625/499

EF (%)

28/13

30/26

M Cl (l/hour)

1.2/0.7

1.7/1.5

parameters for M are depicted in Table 2. No differences in either EF or
M Cl between the two CRRT techniques were observed.
Conclusion A significant removal of M by CVVHF/CVVHDF was
observed. Dose adjustment is necessary in critically ill patients
receiving CRRT.
Acknowledgement Supported by EC 81/00469.
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Impact of ideal versus estimated body weight on haemofiltration
dosing in critically ill patients with AKI
F Fischer, A Putignano, C Willars, J Wendon, S Harris, G Auzinger
Kings College Hospital, London, UK
Critical Care 2014, 18(Suppl 1):P404 (doi: 10.1186/cc13594)
Introduction Acute kidney injury (AKI) in the critically ill is an
independent risk factor for adverse outcome [1]. Previously, it was
suggested that high-volume haemofiltration (HVHF) may confer a
mortality benefit and lead to a reduction in organ failure compared
with standard ultrafiltration rates (UF) [2]. This was not confirmed by a
recent investigation [3]. It has also not been determined whether ideal
(IBW) or estimated/actual body weight (E/ABW) was used to calculate
UF rates. We sought to determine what impact different weight
calculations have on delivered UF rates.
Methods A retrospective single-centre study in a tertiary referral
institution. Continuous venovenous haemodiafiltration (CVVHDF)
was administered according to the patient’s IBW. The delivered UF
rate was then calculated both for IBW and E/ABW. The latter was
based on measurements obtained at the time of ICU admission. We
compared the highest predilution, postdilution and dialysate volume
administered each day according to the different weight estimate
measurements respectively. Student’s t tests and chi-square tests were
used for statistical analysis (P <0.05).
Results Data from 33 patients receiving renal replacement therapy
were analysed. Mean time (± SD) of treatment interruption was
1.4 ± 2.7 hours/day due to filter changes, transfers for CT scans and
surgical procedures. Therefore, 94% of the prescribed dose was
delivered. There was a mean of 2.3 filtration dose prescriptions
per patient over the observation period (due to changing clinical
conditions), with a total of 77 dose adaptations. Mean E/ABW was
significantly higher than calculated IBW (76.3 kg vs. 61.4 kg), and
thus a difference of 14.9 kg (95% CI = 9.2 to 20.6 kg). This resulted in a
significant difference in mean filtration dose delivered of 33.1 ml/kg/
hour for E/ABW versus 39.7 ml/kg/hour for IBW respectively (P <0.001).
As a consequence, in 29.6% (8/27) of cases where HVHDF (>35 ml/kg/
hour) was prescribed, standard volume haemodiafiltration (SVHDF)
(≤35 ml/kg/hour) was delivered. In 10% (5/50) of cases where SVHDF
was prescribed, HVHDF was delivered (P <0.001).
Conclusion We conclude that the delivered UF rate in our cohort of
patients differed significantly depending on measured or calculated
body weight. In almost one-third of cases where HVHDF was
prescribed, SVHDF was delivered. As many interventions in the ICU are
based on IBW and daily weighing of patients is not uniformly practiced,
this makes comparison of data difficult.
References
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ICU patients treated with RRT for AKI who have chronic kidney
disease have better 1-year outcome compared with patients with
better kidney function
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Critical Care 2014, 18(Suppl 1):P405 (doi: 10.1186/cc13595)
Introduction Chronic kidney disease (CKD) is a risk factor for developing
acute kidney injury (AKI) with need for renal replacement therapy
(RRT). AKI-RRT is associated with important short-term mortality, and
recent data showed there is also important increased risk for 1-year
mortality. The aim of this study is to evaluate variables associated with
1-year survival, and in particular the impact of baseline CKD in a cohort
of AKI-RRT patients.
Methods A single-center observational study in a 50-bed ICU tertiary
care hospital. During the study period August 2004 to December
2012, all consecutive adult AKI-RRT patients were included. Data were
retrieved from the electronic ICU patient file, the electronic hospital
patient file and the electronic ICU-RRT database. Long-term outcome
data were collected by a telephone survey.
Results During the 9-year study period, a total of 1,291 AKI-RRT patients
were included. Short-term mortality at day 30 was 47.2%; mortality at
1 year was 64.3%. Compared with nonsurvivors, 1-year survivors had
similar age (65 vs. 67 years, P = 0.077), worse kidney function at baseline
(eGFR 46 vs. 52 ml/minute/1.73 m2, P = 0.001; CKD stage ≥3 65% vs. 58%,
P = 0.019), a greater proportion was male (69.0% vs. 63.2%, P = 0.048),
and more were admitted to the cardiac surgery ICU (39% vs. 46%, P =
0.012). They were less severely ill as illustrated by lower SAPS 2 score at
ICU admission (52 vs. 69, P <0.001), and at the time of initiation of RRT,
and a lower SOFA score (9 vs. 11; P <0.001). A smaller proportion was on
mechanical ventilation (85.1% vs. 89.7%, P = 0.042) and on vasoactive
drugs (45.7% vs. 63.9%, P <0.001). Survivors had earlier initiation of RRT
(2 vs. 3 days, P = 0.034), and more frequently intermittent RRT was used
(84.8% vs. 63.2%; P <0.001). When corrected for gender, age, severity of
illness, and modality and timing of RRT, worse baseline kidney function,
defined as CKD stage ≥3, remained associated with better 1-year
survival (odds ratio 1.6, 95% CI: 1.1 to 2.2, P = 0.011).
Conclusion In ICU patients who had AKI-RRT, 1-year survival was
associated with lower severity of illness. Surprisingly, worse kidney
function or CKD stage ≥3 was also associated with long-term survival.
This effect remained present after adjudication for relevant covariates.
P406
Long-term outcomes in acute kidney injury patients treated with
renal replacement therapy who were alive at hospital discharge
V Sergoyne, W De Corte, J Vanhalst, A Dhondt, S Claus, S Oeyen,
J Decruyenaere, E Hoste
University of Ghent, Belgium
Critical Care 2014, 18(Suppl 1):P406 (doi: 10.1186/cc13596)
Introduction Acute kidney injury (AKI) treated with renal replacement
therapy (RRT) in ICU patients is associated with high mortality, chronic
kidney disease (CKD) (eGFR <60 ml/minute/1.73 m2, or CKD stage ≥3)
and end-stage kidney disease (ESKD). Data on long-term outcomes
vary among studies due to differences in age, CKD, severity of illness,
RRT modality and timing of initiation of RRT. Long-term patient and
kidney outcomes in AKI-RRT patients were evaluated in this study.
Methods A retrospective study of all consecutive treated AKI-RRT
patients in a 50-bed ICU academic hospital from August 2004 to
December 2012. Data were retrieved from the electronic ICU, RRT and
hospital patient files. Long-term outcomes data were obtained by a
telephone survey.
Results During the study period 1,291 ICU patients were treated
with RRT for AKI. Mortality was 47.2% at day 30 and 57.2% at hospital
discharge. Mortality in hospital survivors showed an important increase
until 3-year follow-up, and a moderate increase later (1 year: 14.4%,
2 years: 20%, 3 years: 35.7%, and 7 years: 39%). In-hospital survivors’
Scr and eGFR at baseline were comparable to 1-year follow-up (1.4 vs.
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1.4 mg/dl, P = 0.162, respectively 46 vs. 51 ml/minute/1.73 m2) and we
observed an increase of CKD stage in 36.0% of patients, a decrease in
36.3%, and stable CKD stage in 27.7%. A total 43.1% of patients with
CKD stage <3 at baseline had an increase to CKD stage ≥3 at 1 year.
A total 26.6% of patients with CKD stage ≥3 at baseline decreased to
CKD stage <3. A total of 8.3% of hospital survivors developed ESKD.
Patients with increase of CKD stage had similar age (67 vs. 64 years,
P = 0.145), SAPS 2 (57 vs. 51, P = 0.858), and SOFA score (9 vs. 9, P =
0.275) compared with patients with stable or decreased CKD stage.
There were no differences in type of ICU, modality of RRT, or number of
patients treated with vasopressors (44% vs. 47%, P = 0.617) or invasive
ventilation (84% vs. 81%, P = 0.496). However, these patients were more
probably male (76.9% vs. 65.6%, P = 0.042), had lower Scr at baseline
(1.1 vs. 1.7 mg/dl, P <0.001) and at ICU admission (1.7 vs. 2.4 mg/dl,
P <0.001), and were started on RRT later (3 vs. 2 days, P = 0.008).
Conclusion The annual mortality in AKI-RRT hospital survivors is
approximately 10% per year during the first 3 years of follow-up. Onethird of patients had an increase of CKD stage at 1 year of follow-up
and almost one-half of patients who had eGFR >60 ml/minute/1.73 m2
developed CKD. Patients who had an increase of CKD had similar
severity of illness, but lower Scr at baseline and at ICU admission, and
had later initiation of RRT compared with patients who had stable or
decreased CKD stage.
P407
Polymyxin B-immobilized fiber hemoperfusion therapy improves
sepsis-related immunosuppression
A Kimura, S Ono, S Hiraki, R Takahata, H Tsujimoto, M Kinoshita, S Aosasa,
K Hatsuse, D Saitoh, K Hase, J Yamamoto
National Defense Medical College, Tokorozawa, Japan
Critical Care 2014, 18(Suppl 1):P407 (doi: 10.1186/cc13597)
Introduction Sepsis-induced immunosuppression has long been
considered a factor in the late mortality of sepsis patients, but little
is known about the immunity of immunocompetent cells and the
effect of polymyxin B-immobilized fiber hemoperfusion therapy (PMXDHP) on sepsis-induced immunosuppression. The present study was
designed to evaluate the effect of PMX-DHP on recovery from sepsisrelated immunodeficiency.
Methods Patients with septic shock who were treated with PMXDHP were enrolled in this study. Study 1: (1) numbers of peripheral
lymphocytes and CD4+ T cells, especially regulatory T cells (Tregs), and
serum cytokine levels were examined to evaluate the effects of PMXDHP in septic shock patients. (2) Peripheral blood mononuclear cells
(PBMCs) in these patients were examined to evaluate inflammatory
cytokine production before and after PMX-DHP. The obtained PBMCs
were stimulated with interleukin (IL)-2 and IL-12, anti-CD3 antibody,
or lipopolysaccharide for 24 hours, and tumor necrosis factor alpha
and interferon-gamma (IFNγ) production in the culture supernatants
was measured using enzyme-linked immunosorbent assay. Study 2:
whole blood from patients with sepsis was incubated with a polymyxin
B-immobilized filter (cut into small sizes) for small animals for 2 hours
(PMX group), or were treated with 200 μg polymyxin B for 2 hours (PLB
group), or were not treated (sepsis group). IFNγ production by PBMCs
was compared among the three groups.
Results Study 1: (1) the number of CD4+ T cells was lower and the
percentage of Tregs in CD4+ T cells was higher in septic shock patients
compared with those without shock. A significant increase in the
number of CD4+ T cells, a significant decrease in the percentage of Tregs
in the CD4+ T-cell population, and a significant decrease in serum IL-10
levels were observed 24 hours after PMX-DHP in septic shock patients
who survived compared with those who did not. (2) IFNγ production
by PBMCs was significantly lower in patients with sepsis than in healthy
volunteers. IFNγ production by IL-2-stimulated and IL-12-stimulated
PBMCs significantly increased after PMX-DHP therapy. Study 2: IFNγ
production by PBMCs in patients with sepsis increased significantly in
the PMX and PLB groups compared with that in the sepsis group.
Conclusion PMX-DHP directly decreased the number and percentage
of Tregs in peripheral blood circulating CD4+ T cells in patients with
septic shock. PMX-DHP improved IFNγ production by natural killer
(NK)/NKT cells in patients with septic shock. Therefore, PMX-DHP could
improve sepsis-related immunosuppression.

S147

P408
Endotoxin activity assay and polymyxin B hemoperfusion use in a
cohort of critically ill patients
SL Cutuli, G De Pascale, V Alicino, S Cicconi, V Di Gravio, D Silvestri,
D Giacobelli, E Gasperin, S Marsili, MS Vallecoccia, M Antonelli
Sacro Cuore Catholic University, Rome, Italy
Critical Care 2014, 18(Suppl 1):P408 (doi: 10.1186/cc13598)
Introduction Endotoxin plays a crucial role in the pathogenesis of
severe sepsis and septic shock (SS&SSh) [1]. The aim of this study
is to analyze the impact of extracorporeal endotoxin removal with
polymyxin B hemoperfusion (PMX-DHP) (Toraymyxin®).
Methods All patients admitted to our ICU between 1 April 2011 and 30
June 2013 who developed SS&SSh and underwent endotoxin activity
assay (EAA) measurement were retrospectively evaluated.
Results During the study period, EAA was dosed in 100 patients. Eightyone patients were affected by septic shock. The source of infection was
identified in 70.4% of cases (45% abdominal) and the percentage of
microbiologically confirmed episodes was 77% (81% Gram-negatives).
The mortality rate was 49%. The mean EAA level was 0.66 ± 0.2, and in
66% of patients the value was higher than 0.6. No significant differences
were found in terms of SAPS II (P = 0.32) and SOFA score (P = 0.67),
according to EAA level (>/≤0.6). Patients with levels >0.6 presented a
higher percentage of microbiologically confirmed infections (84% vs.
66%; P = 0.09). Thirty-two of 66 patients with EAA >0.6 were treated
with Toraymyxin®. No complications leading to treatment interruption
were recorded and a relevant decrease of cardiovascular SOFA score
and lactate levels were observed 72 hours after treatment (P = 0.05
and P = 0.06, respectively). Source control and Toraymyxin® treatment
resulted as the only modifiable factors improving the ICU survival rate
(Table 1).
Table 1 (abstract P408). Multivariate analysis for ICU mortality risk factors
P value

OR (95% CI)

SAPS II score

0.04

1.1 (1.01 to 1.1)

Septic shock

0.02

10.4 (1.5 to 71)

PMX-DHP

0.04

0.2 (0.1 to 0.9)

Source control

0.01

0.1 (0.03 to 0.5)

Conclusion EAA is a rapid and reliable method to identify patients
who may be treated with polymyxin B hemoperfusion. Source control
and extracorporeal endotoxin removal have appeared as two effective
interventions that should be implemented in the early management of
patients with SS&SSh.
Reference
1.

Cruz DN, Antonelli M, et al.: Early use of polymyxin B hemoperfusion in
abdominal septic shock. The EUPHAS randomized controlled trial. JAMA
2009, 301:2445-2452.

P409
Awakening and Breathing Coordination, Delirium Monitoring and
Early Mobility bundle in adult ICU patients: a preliminary cost
analysis
G Peitz1, K Dvoracek2, J Sankaranarayanan3, M Balas4, K Olsen1
1
University of Nebraska Medical Center, Omaha, NE, USA; 2Avera McKennan
Hospital and University Health Center, Sioux Falls, SD, USA; 3University of
Conneticut/Hartford School of Pharmacy, Storrs, CT, USA; 4The Ohio State
University, Columbus, OH, USA
Critical Care 2014, 18(Suppl 1):P409 (doi: 10.1186/cc13599)
Introduction We previously demonstrated a significant increase in
the number of ventilator-free days and reduced the rate of delirium in
ICU patients treated with the Awakening and Breathing Coordination,
Delirium Monitoring and Early Mobility (ABCDE) bundle. This study
investigated whether implementation of the ABCDE bundle was costeffective at an academic medical center.
Methods A post-hoc cost-effectiveness study was done following
the before–after ABCDE bundle implementation study. The bundle
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consisted of the following components: daily spontaneous awakening
trials (SATs); daily spontaneous breathing trials coordinated with the
SATs; delirium monitoring; and early mobility. The study’s primary
endpoint was the cost-effectiveness of the ABCDE bundle in terms of
the bundle’s cost to prevent 1 day of mechanical ventilation (MV) or
1 day of delirium for all patients, as well as for a subgroup of non-MV
patients. All cost-effectiveness ratios (CERs) were constructed from
the hospital’s cost perspective. The economic analyses were carried
out in two steps. First, the mean cost per patient per hospital stay
and total costs in the pre-ABCDE and post-ABCDE bundle periods
were compared. Next, CERs of each respective primary endpoint were
computed as incremental costs of implementing the bundle to prevent
1 day of MV and to prevent 1 day of delirium. P <0.05 was considered
statistically significant.
Results Data were analyzed from 146 and 150 patients in the preABCDE and post-ABCDE groups respectively. There were mean
decreases of 0.59 MV days and 0.83 delirium days between the pre
and post bundle implementation. The mean costs (per patient per
ICU stay) of implementing the bundle components were significantly
higher in the post-ABCDE cohort versus the pre-ABCDE cohort ($191
vs. $92, P <0.0001), with an additional increase in total costs ($8,930 vs.
$8,624, P = 0.0233). Costs to prevent 1 day of MV and to prevent 1 day of
delirium were $552 and $368 respectively. In the non-MV patients, the
post-ABCDE bundle demonstrated fewer days of delirium than the preABCDE cohort (0.8 vs. 1.13 days, P <0.05) but had higher overall costs
($5,417 vs. $4,546, P <0.05), resulting in a cost of $2,639 to prevent 1 day
of delirium in a non-MV patient.
Conclusion Implementing the ABCDE bundle in adult ICU patients
appears to be a feasible cost-effective strategy when considering costs
of mechanical ventilation and ICU delirium.
P410
An assessment of long-term sleep quality using actigraphy in
survivors of critical illness
K Solverson, C Doig
University of Calgary, Canada
Critical Care 2014, 18(Suppl 1):P410 (doi: 10.1186/cc13600)
Introduction Recent studies have suggested that critical illness
survivors experience long-term sleep disruption [1,2]. The Actigraph
device is a sleep watch that has been shown to have equivalent
accuracy to polysomnography and previously used during critical
illness to show sleep disruption [3]. Our objective was to assess patients
long-term sleep quality using the Actigraph device.
Methods Study patients were selected from a 24-bed multidisciplinary
ICU. Thirteen patients who were ≥18 years old, stayed longer than
4 days in the ICU and did not have and acute brain injury were followed
up at 2 months post hospital discharge. The Actigraph device was
given to patients to take home and worn for 72 hours. Previously
validated algorithms were used to analyze sleep and wake cycles [4].
Additionally, patient completed the Pittsburgh Sleep Quality Index
(PQSI), as a measure of subjective sleep quality.
Results Sixty-two percent of patients at 2 months post hospital discharge
reported poor sleep quality as per the PSQI. The Actigraph results
showed patients’ average total sleep time was 6.15 hours, with a sleep
efficiency of 78%. The mean time to fall asleep was 12 minutes. Patients
had an average of 11 awakenings per night and were awake for an
average of 7 minutes during the awakenings. There were no associations
found between patients’ perceived sleep quality and total sleep, sleep
efficiency or sleep disruptions. Patients’ severity of illness, as measured
by the APACHE II score, was statistically associated with lower total sleep
time (β = –12.6, P = 0.019), reduced sleep efficiency (β = –1.18, P = 0.042)
and higher number of sleep disruptions (β = 0.64, P = 0.023). The number
of days ventilated or ICU and hospital length of stay were not statistically
associated with the Actigraph sleep parameters.
Conclusion Survivors of critical illness have high levels of sleep
dysfunction as measured by actigraphy. Patients’ severity of illness
while critically ill appears to increase the level of long-term sleep
dysfunction experienced. There is discordance between objective and
subjective measures of sleep quality, which has been shown previously
[5]. Objective measures of sleep quality are needed on a larger number
of patients to confirm these findings.
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P411
Study to assess whether staff are able to accurately assess sleep
quality and quantity in intensive care patients
J Patel, J Baldwin, P Bunting, S Laha
Royal Preston Hospital, Manchester, UK
Critical Care 2014, 18(Suppl 1):P411 (doi: 10.1186/cc13601)
Introduction Sleep deprivation is recognised as an important cause
of morbidity after ICU admission, but most centres do not routinely
assess their patients’ sleep. Considering the invasive nature and costs
associated with objective sleep measurements, they are unsuitable
for routine use. Subjective measurements offer an easy-to-use and
economical alternative, the most well validated of which is the
Richards–Campbell Sleep Questionnaire (RCSQ). This can be used
to derive an accurate estimation of the sleep efficiency index (SEI), a
well-validated measure of sleep. However, there are several concerns
regarding patients reporting their sleep quality and quantity using
these questionnaires [1]. Additionally, they cannot be used to assess
sleep in sedated or delirious patients. It has been suggested that one
way to bypass the drawbacks of patients assessing their own sleep
would be to utilise nursing staff [1]. Previous smaller scare studies
have since agreed with this suggestion [2]. This study aimed to assess
whether staff were able to use the RCSQ to accurately assess their
patients’ sleep.
Methods Fifty-nine patients consented to complete the RCSQ for each
night of their ICU admission. Alongside this, the nurses who had cared
for these patients were asked to assess their patients’ sleep using the
RCSQ. These were then matched with their patients’ responses. The
Bland–Altman method was applied to assess for agreement between
patient and nurse SEIs in order to reveal whether nurses could
accurately estimate their patients’ night sleep. Additionally, Cronbach’s
alpha was derived to assess for internal consistency. Ethical approval
was gained prior to the start of the study.
Results A total of 126 pairs or RCSQs were gathered. The mean difference
between nurse and patient SEIs was –0.9, suggesting there is no
significant trend regarding nurses overestimating or underestimating
patients’ SEIs. In total, 94.2% of nurses’ estimations fell within the limits
of agreement. The variability of the differences was consistent across
the range of averages. Cronbach’s alpha was 0.63 between nurse and
patient scores, suggesting questionable reliability between the RCSQ
pairs. See Figure 1.
Conclusion The data gathered here demonstrate that nurses are not
able to accurately estimate their patients sleep using the RCSQ, and
hence alternative methods of sleep monitoring should be developed
for routine use.
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Figure 1 (abstract P411).
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P412
Simplified versus standard EEG to measure the depth of sedation in
mechanically ventilated ICU patients
T Suys, P Bouzat, A Rossetti, M Oddo
Lausanne University Hospital, Lausanne, Switzerland
Critical Care 2014, 18(Suppl 1):P412 (doi: 10.1186/cc13602)
Introduction The accurate measure of sedation depth among
mechanically ventilated ICU patients remains challenging. The Patient
State Index (PSI) is a quantitative measure calculated using an algorithm
derived from a simplified four-channel EEG. The aim of this study was
to examine the value of the PSI to assess the level of sedation, and to
verify its accuracy in comparison with the quantitative spectral analysis
derived from a standard 19-channel EEG.
Methods Using the SEDLine four-channel simplified EEG system
(Masimo Corporation, Irvine, CA, USA), which assessed depth of
sedation through two frontal leads, we prospectively studied
mechanically ventilated sedated ICU patients and examined whether
the PSI was accurate to quantify the individual level of sedation. Pain
stimuli were applied and changes in PSI were examined and compared
with changes in electrical activity (% of delta power), measured by the
frontal Fp2–Fp1 electrodes using a standard 19-channel EEG system
(Viasys Neurocare, Madison, WI, USA). EEG recordings were performed
simultaneously during 20 minutes, and the relationship between PSI
and % of delta power was analyzed with the Pearson’s correlation
coefficient.
Results Ten consecutive patients (mean age 59 ± 12 years) were
included. EEG recordings were performed on average 6 ± 6 days
from ICU admission. Sedation consisted of propofol (seven patients),
midazolam (two patients) or both (one patient). The median PSI was
54 (range 10 to 97), indicating large individual variations in PSI values.
In contrast, the median delta power was 86.3% (range 55.2 to 99.4),
indicating a deep sedation level. Pain stimuli were associated with a
significant increase of PSI value from baseline 51 (range 16 to 96) to
68 (42 to 95) (P = 0.009). However, we found no correlation between
the PSI and the % delta power, both at baseline (R = 0.32, P = 0.37)
and after pain stimulation (R = 0.17, P = 0.63). The % delta power from
frontal electrodes (Fp2–Fp1) was well correlated with that obtained
from posterior electrodes (P4–Pz; R = 0.42, P < 0.0001), and remained
unchanged after pain stimulation, indeed confirming a deep sedation
level in our patient cohort.
Conclusion Using standard EEG in this small cohort of mechanically
ventilated ICU patients, a deep sedation level was frequently observed.
Our preliminary data suggest that simplified EEG with the SedLine
system is less accurate than the standard 19-channel EEG to assess the
depth of sedation in the ICU setting.
P413
Implementation of the Behavioural Pain Scale in sedated
mechanically ventilated patients in a UK ICU
J Jennings, R Bourne
Sheffield Teaching Hospital, Sheffield, UK
Critical Care 2014, 18(Suppl 1):P413 (doi: 10.1186/cc13603)
Introduction Pain is a common problem in mechanically ventilated
patients and assessing pain in the sedated patient is difficult, as patients
are often unable to verbalise [1]. Behavioural pain assessment tools
have been developed and validated for the assessment of pain in this
patient group. A behavioural pain assessment tool was implemented
as part of a wider ventilator-associated pneumonia (VAP) prevention
programme within a large UK ICU.
Methods The Behavioural Pain Scale (BPS) [2] was selected and
implemented into daily clinical practice supported by a tailored
education programme and incorporation into the clinical information
system (MetaVision). Questionnaires pre and post BPS implementation
were used to assess nursing staff opinions on pain assessment and
opioid infusion titration. Four months of data were compared pre
and post implementation, examining aspects of patient sedation and
analgesia exposure and ventilated patient outcome parameters.
Results In the pre-implementation and post-implementation questionnaire (response rate of 38% and 37% respectively of nurses surveyed),
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nursing staff reported they were significantly more confident in titrating
opioids after implementation (3 (2; 3) and 3 (3; 4) respectively; P <0.01),
despite a lack of significant difference in their reported confidence to
assess pain. Compliance was good, with a median daily documentation
rate of 66% with the standard being once per 8-hour shift. Median
BPS score rank was significantly higher on patient movement (2 (1;
2)) compared with at rest (1 (1; 2); P <0.001) (1 = no pain, 2 = mild
pain). No statistically significant difference was seen in the length of
stay, duration of mechanical ventilation, VAP rate or median sedation
exposure. Pre-implementation median opioid administration when
looking at morphine (mg) equivalence was 455.8 (203.1; 1,174.8), and
post implementation the median increased to 620.3 (218.1; 1,502);
however, this did not reach statistical significance (P = 0.235). There
was no statistically significant change in the prescribing of analgesic
adjuncts. The sample size was underpowered to detect significant
differences.
Conclusion The BPS was successfully implemented into routine
nursing practice and significantly improved nurse confidence in opioid
infusion titration. Analgesic use was not significantly different between
evaluation periods, but the results indicate that further education
on anticipating pain and treating pain pre-emptively with timely
administration of opioids is needed.
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Haemodynamic effects of clonidine in an ovine model of severe
sepsis with septic acute kidney injury
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Critical Care 2014, 18(Suppl 1):P414 (doi: 10.1186/cc13604)
Introduction In sepsis, sympathetic nerve activity is increased, which
helps maintain arterial pressure in the face of nitric oxide-induced
vasodilatation. Accordingly, we investigated the haemodynamic
effects of the centrally acting α-adrenoceptor agonist clonidine in an
ovine model of severe sepsis.
Methods A prospective interventional blinded crossover study in
12 Merino ewes with cardiac and renal flow probes implanted to
continuously measure cardiac output and renal blood flow. Arterial
pressure was continuously monitored and blood and urine samples
were taken. After 24 hours of control, sepsis was induced by an
intravenous bolus and continuous infusion of live Escherichia coli
for 32 hours. After 24 hours of sepsis, animals were randomly and
blindly allocated to vehicle infusion or clonidine (1 μg/ml/kg/minute)
for 8 hours. The E. coli infusion was then discontinued, gentamycin
150 mg given i.m. and the animals were followed for 16 hours during
recovery. The animals that survived were crossed over to the alternative
treatment 2 weeks later.
Results Complete data were collected on eight animals/group, three
animals died/group. Hyperdynamic sepsis with hypotension and
acute kidney injury of similar degree developed in the two groups.
Haemodynamic and renal effects of clonidine are shown in Figure 1.
Conclusion In ovine hyperdynamic sepsis, clonidine transiently
increased urine output without affecting creatinine clearance.
P415
Off-label use of clonidine for sedation in Dutch ICUs
J Van der Valk, M Zeeman, M Arbouw, H Van den Oever
Deventer Hospital, Deventer, the Netherlands
Critical Care 2014, 18(Suppl 1):P415 (doi: 10.1186/cc13605)
Introduction Clonidine is an α2-agonist, licensed in most countries
for treatment of hypertension. Other pharmacologic characteristics
of α2-agonists are sedation, hypnosis, anxiolysis, sympatholysis, and
analgesia [1]. Because of these central nervous effects, clonidine can
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Figure 1 (abstract P414). Haemodynamic and renal effects of clonidine in established sepsis.

be used off-label to augment sedation and delirium treatment. To our
knowledge there have been no publications evaluating the efficacy
and safety of clonidine in ventilated critically ill adults. A survey in
German ICUs showed that clonidine was used for sedation in 62% of
units [2]. We undertook an enquiry to investigate the off-label use of
clonidine in Dutch ICUs.
Methods An inventory was sent by email to 25 ICUs in the Netherlands,
determined by the difficulty to identify a contact person.
Results The response rate was 56%. The results are summarized in
Table 1. Clonidine was used in all 14 responding ICUs; in 36% this
use was reported as often. Licensed use (for hypertension) was 50%.
Indications for off-label use were: substance withdrawal (50%), delirium
(71%), and sedation (29%). The route of administration was intravenous
in all cases. Nine ICUs reported the use of a loading dose, irrespective
of indication, varying from 10 to 150 μg, median 150 μg. Ten ICUs
reported the use of continuous infusion, varying from 10 to 100 μg/
hour, median 50 μg/hour.
Conclusion Off-label use of clonidine for sedation and treatment of
withdrawal symptoms and delirium was common practice in Dutch
ICUs. There was a wide range of dosing regimens: infusion schedules

varied 10-fold and loading doses 15-fold. Clinical studies are required
to establish the safety and efficacy of clonidine in the ICU setting.
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Comparison of dexmedetomidine and propofol for sedation in
patients with traumatic brain injury
O Tarabrin, S Shcherbakov, D Gavrychenko, G Mazurenko
Odessa National Medical University, Odessa, Ukraine
Critical Care 2014, 18(Suppl 1):P416 (doi: 10.1186/cc13606)
Introduction Both propofol and dexmedetomidine decrease systemic
blood pressure, heart rate, and cardiac output in a dose-dependent
manner. The aim of this study was to compare their safety and efficacy
for intravenous sedation during mechanical ventilation.
Methods Eighty-four patients with traumatic brain injury (Glasgow
scale 7 to 8) entered the study, mean age 44 ± 13.37 years. All patients
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Table 1 (abstract P415). Indication and doses of clonidine used in Dutch ICUs
IC levela

Clonidine use

Indication

3

Often

Hypertension sedation

3

Often

Hypertension withdrawal; hypertension delirium; sedation

3

Often

Substance withdrawal; sedation

3

Often

Substance withdrawal

3

Often

Substance withdrawal; hypertension; delirium

10

40 to 100

3

Sometimes

Delirium

ns

30 to 100

3

Sometimes

Hypertension; delirium

150

ns

3

Sometimes

Substance withdrawal; delirium

ns

40

2

Sometimes

Substance withdrawal; delirium

ns

20 to 50

2

Sometimes

Hypertension; sedation

150

40

2

Sometimes

Substance withdrawal; hypertension; delirium

150

12 to 25

1

Sometimes

Hypertension; delirium

150

ns

1

Sometimes

Delirium

50

50 to 100

1

Sometimes

Delirium

ns

ns

Loading dose (μg)

Continuous infusion dose (μg/hour)

ns

ns

40 to 120

10 to 80

150

50

75 to 150

50

a

ns, not specified. Level of ICU care, with level 3 being the most advanced.

underwent mechanical lung ventilation. Patients were divided into two
groups depending on the type of intravenous sedation. In the first group
(n = 42), sedation was performed by intravenous propofol infusion at a
dose of 4 to 12 mg/kg/hour. In patients of the second group (n = 42),
sedation was carried out by intravenous infusion of dexmedetomidine
at a dose of 0.2 to 1.4 mg/kg/hour. The level of sedation was assessed
with bispectral index monitoring, targeting index 70. For comparison
of methods we evaluated heart rate, blood pressure, SpO2 30, 90 and
180 minutes after the start of sedation. Both groups were matched for
sex, age and comorbidity.
Results Thirty minutes after the start of sedation in patients of the
first group, HR was 83 ± 11.31 beats/minute, blood pressure was
127 ± 12.87/64 ± 8.54 mmHg, SpO2 was 97 ± 3.01%. In patients of the
second group 30 minutes after the beginning of sedation, HR was 87 ±
10.01 beats/minute, blood pressure was 131 ± 11.67/68 ± 8.19 mmHg,
SpO2 was 97 ± 2.98%. After 90 minutes in the first group of patients, we
observed HR was 81 ± 6.27 beats/minute, blood pressure was 119 ±
11.46/59 ± 4.29 mmHg, SpO2 was 98 ± 2.35%. In the second group,
HR was 82 ± 7.31 beats/minute, blood pressure was 94 ± 13.62/55 ±
7.81 mmHg, SpO2 was 97 ± 2.76%. In the first group 180 minutes after
the start of sedation, HR was 86 ± 6.19 beats/minute, blood pressure
was 105 ± 10.34/54 ± 4.28 mmHg, SpO2 was 98 ± 1.32%. In the second
group, HR was 75 ± 6.27 beats/minute, blood pressure was 92 ±
12.54/51 ± 6.91 mmHg, SpO2 was 96 ± 2.91%.
Conclusion Using dexmedetomidine at a dose of 0.2 to 1.4 mg/kg/hour
for intravenous sedation is safe in terms of hemodynamic stability and
blood oxygenation for sedation during mechanical lung ventilation in
traumatic brain injury patients.

P417
Different effects of propofol and dexmedetomidine on preload
dependency in endotoxemic shock with norepinephrine infusion:
a randomized case–control study
T Yu1, C Pan1, S Liu1, F Guo1, F Longhini2, Y Yang1, H Qiu1
1
Zhong-Da Hospital, Southeast University, Nanjing, China; 2Eastern Piedmont
University ‘A. Avogadro’, Novara, Italy
Critical Care 2014, 18(Suppl 1):P417 (doi: 10.1186/cc13607)
Introduction Septic shock is a status characterized by the simultaneous
use of vasopressors and sedative drugs in critical care patients. Little
is known about the possible interference of these drugs during shock
status. We aimed to clarify how propofol could differently affect the
preload dependency in an endotoxemic model in comparison with

dexmedetomidine, by evaluation of the systemic vascular system and
cardiac function.
Methods After animal preparation and under PiCCO monitoring
(BL), endotoxemic shock was induced by an intravenous bolus of
lipopolysaccharide (LPS, 055:B5) in ketamine-anesthetized rabbits.
After fluid resuscitation and norepinephrine infusion (SD0), animals
were randomized to propofol (PROP, n = 8) or dexmedetomidine (DEX,
n = 8) sedation, with two incremental doses (SD1 and SD2). The mean
arterial pressure (MAP) and central vein pressure (CVP) were monitored.
Pulse pressure variation (PPV) and stroke volume variation (SVV) were
assessed to evaluate the preload dependency. Global end-diastolic
volume, vascular resistances, mean systemic filling pressure, cardiac
functional index and vascular resistances were assessed at each time
point. Normality was assessed by the Kolmogorov–Smirnov test. Twoway analysis of variance for repeated measures was applied, and the
Student–Newmann–Keuls post-hoc test when indicated. P <0.05 was
considered significant.
Results At the increasing dose of propofol, both PPV and SVV significantly increased in SD1 versus SD0 (P <0.01) and SD2 versus SD0
(P <0.001), but only PPV in SD2 versus SD1 (P = 0.024). Dexmedetomidine
infusion did not affect PPV and SVV. At SD1 and SD2, PPV and SVV were
higher in PROP with respect to DEX (P <0.001). Moreover, propofol
infusion increased the heart rate and had no effects on cardiac
contractility and vascular resistances. On the contrary, in the DEX group
we recorded a significant decrease in heart contractility and increment
of vascular resistances at SD2. Nonetheless, both drugs affected the
MAP, CVP, mean systemic filling pressure, global end-diastolic volume
and venous return.
Conclusion In an endotoxemic shock model, after fluid resuscitation
and during norepinephrine infusion, propofol increased more PPV
and SVV in comparison with dexmedetomidine. At high dosage
the vascular resistances and heart contractility were influenced by
dexmedetomidine, but not by propofol.
P418
Propofol: monitoring for complications
F Yau, M Healy
Royal London Hospital, London, UK
Critical Care 2014, 18(Suppl 1):P418 (doi: 10.1186/cc13608)
Introduction This re-audit aims to test our strategy for monitoring
patients on propofol sedation for prolonged periods. Propofol infusion
syndrome (PRIS), once established, is difficult to treat and currently
there is limited guidance on how best to monitor for this potentially
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life-threatening complication [1]. An audit done in 2011 highlighted
that lipid profile and electrocardiograms (ECGs) were rarely monitored.
We recommended regular monitoring of these parameters when
propofol sedation is used for over 3 days and that propofol-sparing
agents are considered in these patients at risk of developing PRIS.
Methods In patients who required propofol sedation for 4 days or more,
we prospectively monitored: frequency of performing lipid profile and
12-lead ECG; and frequency of co-administration of a propofol-sparing
agent.
Results We collected data from 25 patients. The duration of propofol
infusion was 4 to 15 days (mean 8.5 days). Mean propofol dose in
the first 4 days was 2.2 mg/kg/hour. Maximum daily propofol dose
ranged from 2.1 to 3.8 mg/kg/hour. Lipid profile was checked in 16/25
(64%) patients (20% in 2011) whilst on propofol sedation. However,
these were checked following 3 days continuous infusion in only
three patients. The triglyceride level was ≥2.2 mmol/l (very high) on
first testing in 75% of patients. All patients had a 12-lead ECG done
on admission. Seventeen of 25 (68%) had a further ECG performed
whilst on continuous propofol infusion (45% in 2011). Additional ECGs
were done in 13/17 patients (zero in 2011). ECG changes that we feel
were attributable to propofol occurred in two patients, one of whom
developed severe PRIS. Fourteen of 25 (56%) patients (55% in 2011)
were on concomitant sedative agents. This included the patient who
developed PRIS.
Conclusion Awareness of complications from prolonged propofol
sedation is increasing amongst our clinicians. This is reflected in the
increased frequency of lipid profile and ECG monitoring compared
with 2011. However, we feel that more regular and routine monitoring
is essential to aid early detection of this potentially fatal complication.
We recommend that all patients at risk of developing PRIS should have
these parameters monitored on a daily basis as standard.
Reference
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Jacobi J, et al.: Clinical practice guidelines for the sustained use of sedative
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P419
Influence of increased intracranial pressure on sevoflurane-fentanyl
anesthesia in major abdominal surgery
N Trembach, I Zabolotskikh
Kuban State Medical University, Krasnodar, Russia
Critical Care 2014, 18(Suppl 1):P419 (doi: 10.1186/cc13609)
Introduction Increased intracranial pressure (ICP) may adversely affect
sevoflurane anesthesia and the recovery period due to a disturbed
cerebral blood flow. Effect of sevoflurane on cerebral hemodynamics
remains controversial and depends on the extent of the initial value of
ICP [1]. This study was designed to evaluate the safety of sevofluranefentanyl anesthesia during major abdominal surgery in patients with
increased ICP.
Methods A total of 124 ASA 3 patients, undergoing major abdominal
surgery (duration 5.6 (4.1 to 6.4) hours), were divided into two
groups: with normal ICP (≤12 mmHg) (N group, 70 patients) and
with ICP >12 mmHg (H group, 54 patients). Initial ICP was evaluated
by venous ophthalmodynamometry [2]. ICP, mean arterial pressure
(MAP) and cerebral perfusion pressure (CPP) were assessed every hour
of anesthesia. Time of recovery of consciousness after anesthesia,
complications and length of stay in the ICU and in the hospital were
also evaluated.
Results Initial ICP was 8 ± 3 mmHg in the N group and 15 ± 2 mmHg in
the H group. During the anesthesia ICP increased in the H group with
a total increase of 33% (from 15 ± 2 to 20 ± 3 mmHg (P <0.05)). In the
N group ICP was stable without any significant change. Decrease of
MAP after induction of anesthesia was similar in the two groups and
was stable during anesthesia. CPP was stable in the N group (above
70 mmHg during the anesthesia), but in the H group CPP decreased
significantly (from 82 mmHg to 63 mmHg (P <0.05)). Time of recovery
of consciousness in the H group was higher (32 ± 6 minutes vs.
20 ± 4 minutes (P <0.05)). The incidence of postoperative delirium
was higher in the H group (22.2% vs. 12.8% in the N group (P <0.05)).
There were no significant differences between two groups in other
complications. Total length of stay in the ICU and in the hospital was
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higher in the H group (6 ± 2 days vs. 4 ± 2 days (P <0.05) and 15 ± 3 days
vs. 11 ± 2 days in N group (P <0.05)).
Conclusion Sevoflurane-fentanyl anesthesia in patients with increased
ICP was characterized by a delayed recovery with a higher incidence of
postoperative delirium and higher length of stay in the ICU and in the
hospital. The main cause of this is a decrease of CPP in patients with
high ICP due to low craniocerebral compliance.
References
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P420
Quantifying sedation satisfaction during bronchoscopy using the
Bispectral Index
J Palminteri, J Dziodzio, D Seder, J Zuckerman, R Riker
Maine Medical Center, Portland, ME, USA
Critical Care 2014, 18(Suppl 1):P420 (doi: 10.1186/cc13610)
Introduction Sedation monitoring with the Bispectral Index (BIS) is
uncommon during bronchoscopy but allows for a more objective
measure of sedation; we hypothesized that higher BIS scores would
correlate with lower patient satisfaction and that lower BIS scores (deep
sedation) would result in better patient and physician satisfaction.
Methods Between October 2012 and August 2013, bronchoscopy
using conscious (CS) or monitored anesthetic deep sedation (DS) was
monitored with BIS. Medication administration and procedures were
time-stamped. Sedation was administered blinded to BIS score. DS
cases used propofol infusions, CS cases used bolus midazolam and
fentanyl. Providers rated sedation satisfaction, cough, and the ability
to perform the intended procedure using a 100 mm visual analog
scale at the end of the procedure blind to BIS (0 unsatisfied to 100
satisfied). Patients were surveyed at 1 hour and 24 hours regarding
overall sedation, symptoms, and procedure recall (unpleasant recall 1,
no recall 4). Group differences were considered statistically significant
at P <0.05.
Results Twenty-six procedures were monitored, 20 with CS and six
endobronchial ultrasound procedures with DS. There was no difference
with respect to age or gender. The mean doses of midazolam and
fentanyl were 5 mg and 85 μg, respectively. BIS values were lower at all
predefined points of the procedure for DS cases versus CS. Physicians
were more satisfied with sedation and the lack of cough with DS, but
there was no significant difference in patient satisfaction between
the two groups with regards to overall sedation, procedure-related
symptoms or willingness to have repeat bronchoscopy. Patients with
no recall had lower nadir BIS scores (46 vs. 71, P = 0.03) and scores
at procedure end (76 vs. 94, P = 0.04) compared with those with any
recall. There was no difference in the doses of midazolam or fentanyl
in CS cases despite statistically significant differences in patient recall
and BIS scores. Junior fellows scored greater satisfaction with sedation,
were less bothered by cough and more often felt able to perform the
intended procedure compared with senior fellows.
Conclusion Deep sedation resulted in greater physician satisfaction
with procedural conditions as well as lower BIS scores but no significant
difference in patient satisfaction compared with conscious sedation.
Patients with no recall of the procedure had lower BIS scores at the
nadir and end of the procedure. BIS may be a novel tool to monitor
procedural depth, allowing proceduralists to better monitor the narrow
window between adequate sedation and dangerous oversedation.
P421
Risk factor of withdrawal syndrome in the paediatric ICU
C Tanaka1, N Shimizu2, O Staito2, M Motomura2, I Watanabe2
1
Japanese Musashino Red Cross Hospital, Tokyo, Japan; 2Tokyo Metropolitan
Children’s Centre, Tokyo, Japan
Critical Care 2014, 18(Suppl 1):P421 (doi: 10.1186/cc13611)
Introduction Critically ill paediatric patients supported on mechanical
ventilation frequently receive analgesia and sedation. Iatrogenic
withdrawal syndrome occurs with the abrupt discontinuation or
too rapid weaning of opioids and benzodiazepines. We induce the
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Withdrawal Assessment Tool-1 (WAT-1) [1] to evaluate children during
weaning from analgesics and sedatives. The patient is diagnosed
with withdrawal syndrome when the score is 3 or >3. We compared
the subjects who ever had a score over 3 and those with lower scores
and assessed the risk factors and outcome of withdrawal syndrome
between two groups.
Methods A total of 932 patients were admitted to our PICU from 1
October 2011 to 31 March 2013. Of these, 127 paediatric patients
were supported on mechanical ventilation on the first day in the PICU
and received intravenous analgesics and sedatives. A retrospective
review of a prospectively collected database. The statistical method
was the Mann–Whitney U test, and P <0.05 was considered statistically
significant.
Results Twenty-eight patients were scored with the WAT-1 during
weaning from the drugs. Median age was 14 months (1 to 73 months)
and the most common reasons for ventilation were airway trouble
and pneumonia. Eight of 28 were diagnosed withdrawal syndrome,
20 were not. There were no significant differences in age, body weight,
cumulative morphine and benzodiazepine dose before weaning. In the
withdrawal group, the lactate level, catecholamine index, Paediatric
Index of Mortality 2 and heart rates were greater when they were
admitted to hospital. Further, there are longer length of PICU stay and
shorter ventilator-free days for patients with WAT-1 score >3. But all of
them are alive at 28 days, so there is no difference in 28-day mortality.
Conclusion Our study suggest that severely ill paediatric patients
tended to suffer from withdrawal syndrome and then resulted in short
ventilator-free days and longer PICU stay. But there is no difference in
mortality.
Reference
1.

Franck LS, et al.: Pain 2012, 153:142-148.

P422
Epidural analgesia reduces perioperative myocardial infarction and
all-cause mortality after cardiac surgery: but at least 25 epidural
hematomas have already happened
G Landoni, M Greco, I Francesca, D Taddeo, O Saleh, A Belletti, A Putzu,
R Lembo, A Zangrillo
Vita-Salute San Raffaele University, Milan, Italy
Critical Care 2014, 18(Suppl 1):P422 (doi: 10.1186/cc13612)
Introduction Epidural analgesia on top of general anesthesia in cardiac
surgery might improve relevant clinical outcomes but the incidence of
epidural hematoma is under-reported.
Methods An international web-based, online, viral, anonymous survey,
a systematic review of the literature, and a meta-analysis of randomized
and matched studies were performed.
Results Nine epidural hematomas were identified in 198 published
manuscripts. The risk of epidural hematoma (9:13,429) calculated on all
published evidence might be therefore estimated to be 1:1,492 (95%
confidence interval (CI) = 1:2,857 to 1:833). Through an anonymous,
web-based, viral, international survey, we identified at least 16 further
nonpublished epidural hematomas together with at least 72,400
epidural analgesia catheters positioned in cardiac surgery in the last
20 years. The risk of epidural hematoma (25:85,829) is therefore 1:3,436
(95% CI = 1:2,325 to 1:5,076) including both published and unpublished
data. Out of the 66 randomized and case-matched studies, 57 trials
reported the incidence of all-cause mortality at the longest available
follow-up with a significant reduction in the epidural group (59/3,137
(1.9%) in the epidural group vs. 108/3,246 (3.3%) in the control arm, RR
0.64 (95% CI 0.48 to 0.85), P = 0.002, NNT = 69).
Conclusion Epidural analgesia on top of general anesthesia in cardiac
surgery might reduce the incidence of all-cause mortality (NNT 69).
The incidence of epidural hematoma in this setting is 1:3,436 (95% CI =
1:2,325 to 1:5,076) including both published and unpublished data. In
fact, we identified at least 25 epidural hematomas that occurred so far
from the following countries: Belgium (n = 1), Brazil (n = 1), France (n =
1), Germany (n = 2), India (n = 2), Italy (n = 1), Japan (n = 2), Korea (n =
1), Malaysia (n = 1), Norway (n = 2), Russia (n = 3), Sweden (n = 1), the UK
(n = 3), and the USA (n = 4). Even if from the public health point of view
the benefits seem to encourage the use of epidural analgesia in cardiac
surgery with a possible reduction in perioperative mortality, this topic
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merits further investigation and the decision to insert the epidural
catheter should be discussed with the patient considering both local
experience and legal dispute in case of medical complications.
P423
Delirium screening, prevention and treatment in the ICU:
a systematic review of implementation strategies
Z Trogrlic1, M Van der Jagt1, J Bakker1, MC Balas2, EW Ely3,
PH Van den Voort4, E Ista5
1
Erasmus MC University Medical Center Rotterdam, the Netherlands 2The
Ohio State University, Columbus, OH, USA; 3Vanderbilt University Medical
Center, Nashville, TN, USA; 4Onze Lieve Vrouwe Gasthuis, Amsterdam, the
Netherlands; 5Erasmus MC University Medical Center Rotterdam – Sophia
Children’s Hospital, Rotterdam, the Netherlands
Critical Care 2014, 18(Suppl 1):P423 (doi: 10.1186/cc13613)
Introduction The occurrence of delirium heralds a circumstance of
higher risk of death, longer stay, higher cost, and greater likelihood
of long-term brain dysfunction, and yet the majority of ICU patients
worldwide do not get routinely monitored for delirium, thus obstructing
timely prevention and management strategies. Determination of
effective implementation strategies regarding screening, treatment
and prevention of delirium is critical to address needed modifications
in the culture of patient care in the ICU. The aim of this study was to
summarize the efficacy of and the barriers to implementation of
delirium management.
Methods We searched PubMed, Embase, PsychINFO, Cochrane and
CINAHL for studies published between January 2000 and October
2012, and included them when implementation strategies and their
efficacy and/or potential barriers of implementation were described.
Results In all studies (n = 34) multifaceted education strategies
were used and combined (median: 5; IQR: 4 to 6). Positive results
were reported for both process and clinical outcomes: adherence to
delirium screening – improvement after implementation compared
with the before measurement, by 15 to 57%; only measured after
implementation, between 84 and 92%; delirium knowledge (on
a 10-point scale; improved from 6.1 and 6.2 before to 8.2 and 7.4
respectively (P <0.001) after implementation); length of stay in the ICU
(4.1 vs. 5.9 days; P = 0.21 and 6.3 to 5.35 days; P < 0.009) and hospital
stay (12 days vs. 18 days; P = 0.036 and from 55 to 27 days; P <0.0001);
and decreased mortality (29.4% vs. 22.9%; P = 0.009; and OR = 0.45;
95% CI = 0.22 to 0.92; P = 0.03). The major barriers found impairing
implementation concerned clinicians’ attitude and healthcare
professionals’ knowledge.
Conclusion Implementation strategies used suggest a strong potential
for multifaceted strategies to be able to affect both process and clinical
outcomes. The majority of studies focused only on implementation
of delirium screening. There is a knowledge deficit regarding efficacy
of well-prepared implementation of integral delirium management
considering screening, prevention, and treatment preceded by
analysis of barriers. Further research on the extent and contents of
implementation interventions aimed at integral delirium management
such as those described in the recent ABCDE bundle and PAD guideline
are necessary.
P424
Effect of enteral and/or parenteral glutamine supplementation on
mortality and morbidity in the critically ill
H Sungurtekin, I Ozturk, B Beder, S Serin
Pamukkale University Medical Faculty, Denizli, Turkey
Critical Care 2014, 18(Suppl 1):P424 (doi: 10.1186/cc13614)
Introduction In this study we aimed to compare the effectiveness
of enteral, parenteral and combined enteral–parenteral glutamine
supplementations in the nutrition of critical care patients.
Methods This is a single-center, randomized controlled clinical trial.
During the 5-day study period, all patients received standard enteral
nutrition product and were divided into three groups, including
parenteral glutamine (Group I), enteral glutamine (Group II) and
enteral + parenteral glutamine (Group III) supplementations. Blood
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biochemistry, rates of infections, length of stay in the ICU and duration
of mechanical ventilation were evaluated.
Results Sixty patients were included in this study. There was no
statistically significant difference for biochemical values between the
different feeding groups. Frequency of infections ranged as Group
II >Group III >Group I and mortality as Group II = Group III >Group I.
Length of stay in the ICU and duration of mechanical ventilation were
significantly longer in Group II than the others.
Conclusion Although mortality was not significantly different between
groups, parenteral glutamine administration causes less stay of ICU
and mechanical ventilation. This needs a more powerful randomized
controlled study [1].
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P425
Increased threshold for gastric residual volumes and impact on
nutrition in the ICU
J Brohan, M Richardson, S O Riain
Limerick Regional Hospital, Limerick, Ireland
Critical Care 2014, 18(Suppl 1):P425 (doi: 10.1186/cc13615)
Introduction Gastric residual volumes (GRVs) as measured at regular
intervals are considered a marker of tolerance of enteral nutrition (EN).
There is controversy surrounding this practice, however. The absolute
value for the designated cutoff value for GRVs varies widely in the
literature. No prospective randomized control trials have suggested
that their use improves patient outcomes in the ICU. It has also not been
shown, therefore, that GRVs are an accurate predictor of aspiration or
pneumonia. However, the use of GRVs as a guide to the continuation
of EN can result in a reduction in the percentage of goal calories
received by patients. Prior to February 2013, in our ICU the threshold
of GRVs prior to withholding of EN was 200 ml. This tolerated volume
was increased to 500 ml in February 2013, in compliance with recent
guidelines. By increasing the acceptable GRVs to this level, the aim was
to increase the percentage of goal calories received by patients via the
enteral route.
Methods Following ethical approval, the practice of measuring
GRVs and the subsequent management of EN was retrospectively
reviewed over a 3-month period, September to December 2012, and
prospectively reviewed over a 3-month period, September to December
2013, following the change in practice. Recorded parameters included:
length of ICU admission; admitting diagnosis; duration of EN; GRVs;
prescribed calories; delivered calories via an enteral route; requirement
for PN; duration of PN; and cost of total parenteral nutrition (TPN).
Results The change of practice in terms of GRVs and management
of EN led to an increased percentage of prescribed calories that was
delivered. There was a reduced requirement for PN and reduced cost of
TPN also associated with this change in practice.
Conclusion Increasing the threshold of GRV prior to reducing or
stopping EN can result in increased calories delivered to ICU patients
and a reduced requirement for and cost of TPN.
P426
Early enteral feeding in the septic critically ill patient: evaluation of
our feeding protocol
M Theodorakopoulou, I Dimopoulou, S Karambi, A Strilakou,
A Diamantakis, S Orfanos, A Armaganidis
University Hospital of Athens Greece ‘Attikon’, Attiki, Greece
Critical Care 2014, 18(Suppl 1):P426 (doi: 10.1186/cc13616)
Introduction It has been established that early enteral nutrition
in critically ill patients improves overall outcome and mortality. In
our unit, feeding protocols were established based on the ESPEN
recommendations and have been implemented for the last 2 years.
The purpose of this study was to evaluate the compliance of our septic
patients’ nutritional approach with our feeding protocols.
Methods A prospective study was done on a 24-bed mixed ICU over a
period of 18 months. Eighty-three patients ≥18 years were included in
the study. All patients were dependent on mechanical ventilation and
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met the CCM criteria for sepsis upon admission to the ICU. APACHE II
score, SOFA score, weight, BMI and nutritional status were calculated.
Patients were initiated for enteral feeding based on the established
feeding protocol within 48 hours of admission. The feeding status of
the patient was recorded on the start day (D0), day 3 (D3) and day 7
(D7). Factors affecting the feeding process and its progression were
also recorded
Results The patient mean age was 71.4 ± 12.2. LOS in the ICU was 9 to
21 days. Based on BMI, 18% of the patients were malnourished upon
admission. APACHE II was 26 ± 7.8 and SOFA was 9.2 ± 4.6. The mortality
rate was 42.5%. Enteral nutrition started early in 64 (77.1%) of the
patients (D0), on day 3 (D3) 29 (45.31%) patients met their caloric goals
and on day 7 (D7) only 18 (28.1%) patients achieved their caloric goals.
Discontinuation of enteral feeding was mainly due to procedures,
whereas late start and/or decreased hourly intake were due to GI
complications, GI intolerance, excessive diarrhoea and hemodynamic
instability. There was no association between compliance with the
feeding protocol and the LOS, nutritional status, severity or disease
progression.
Conclusion Although the initiation of early enteral feeding seems
adequate for a good number of septic patients on D0, is still far off for a
significant percentage of those patients on D3 and is even worse on D7.
The caloric goal achievements were better on D3 but very suboptimal
on D7. There was no association, however, between nutritional status
and compliance with the feeding protocols. It is therefore mandatory
to follow daily the nutritional therapy of the septic patient and not rely
only on the feeding protocols.
P427
A nutritional protocol and personalized support reduce the
cumulative caloric deficit of cardiac surgery patients
E De Waele, K De Bondt, J Czapla, J Nijs, D Nguyen, PM Honoré, H Spapen
Universitair Ziekenhuis Brussel, Jette, Belgium
Critical Care 2014, 18(Suppl 1):P427 (doi: 10.1186/cc13617)
Introduction Providing adequate feeding in cardiac surgery patients
is gaining importance [1]. The aims were to assess the preoperative
nutritional status, to compare postoperative energy needs with
effectively delivered amounts, and to evaluate the impact of a dietitian
on optimizing postoperative energy balances.
Methods A prospective interventional study in adult patients after
elective CABG and/or heart valve surgery. The patients’ nutritional
risk was determined by the NRS 2002 and the Malnutrition Universal
Screening Tool (MUST) [2]. A dedicated dietitian managed and assisted
the nutritional approach. For each patient, global energy intake
(intentional and non-intentional) and balance (difference between
energy target and global caloric intake) were calculated daily during
and after ICU stay until hospital discharge. The Harris–Benedict
equation was used to calculate daily energy requirements. When
energy delivery did not reach 60% of calculated needs, a protocoldriven nutritional intervention was initiated.
Results Two hundred patients were enrolled during a 10-month period,
representing 2,690 study-days. Mean age was 67 ± 11 years. In total,
42.5% of the patients had a NRS 2002 score >3 and were considered
to be nutritionally at risk. MUST identified a high, medium, or low risk
in respectively 1%, 4% and 95% of subjects. Mean energy requirement
was 2,046 ± 347 kcal and mean daily intake 1,452 ± 335 kcal. Sixty-two
percent of the caloric need was met during the entire hospital stay.
Nutritional intervention was necessary in 52% of cases: oral feeding
supplementation for 546 study-days, enteral feeding: 401 days,
parenteral feeding: 367 days. This reduced the mean cumulative caloric
deficit to 9,085 kcal.
Conclusion Close monitoring of caloric intake shouldered by interventions
based on a predefined algorithm under supervision of a dedicated
nutrition team restricts the caloric deficit in cardiac surgery patients.
References
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P428
Vitamin B and C levels of homeless patients who visit the
emergency department with alcohol ingestion
HJ Lee, JH Shin, E Kang, J Jung, DK Kim
SMG-SNU Boramae Medical Center, Seoul, South Korea
Critical Care 2014, 18(Suppl 1):P428 (doi: 10.1186/cc13618)
Introduction Vitamins are essential micronutrients and depletions are
reported for chronically ill patients. It is well known that the general
nutrition status of the homeless is poor, especially for heavy alcoholics.
But there were few data about the actual vitamin status of homeless
patients. We want to evaluate the vitamin levels of homeless patients.
Methods This study was conducted at a single urban teaching hospital
emergency department. We performed a retrospective chart review
of blood vitamin B1, B12, B6 and C levels of homeless patients. These
vitamins are a common supplement in our center and sometimes
blood levels are drawn if the patient is drunk, needs i.v. hydration and
has cachexic features.
Results During study periods, vitamin levels were checked for 156
patients. The number of male patients was 146 (94%) and the mean
age was 50 ± 10.2. Vitamin C levels were 15.8 ± 1.3 mg/l. For 84 patients,
levels of vitamin C were decreased. For vitamin B1 (152 ± 7.2 nmol/l),
vitamin B12 (725.5 ± 35.4 pg/ml), and vitamin B6 (50.3 ± 5.5 ng/ml),
there were three, two and 23 patients below the reference ranges
respectively. See Table 1.
Table 1 (abstract P428).
Mean (SD)

Reference
range

Lower than
reference (%)

Higher than
reference

(%)
Vitamin B1

158.1 (80.2)

59 to 213

3.1

13.8

Vitamin B12

741.5 (432.2)

200 to 950

2.7

22.6

Vitamin B6

51.9 (53.8)

20 to 202

23.1

1.9

Vitamin C

15.57 (13.4)

26.1 to 84.6

82.7

0

Conclusion The level of vitamin C was markedly decreased.
Replacement of vitamin C should be considered for the homeless who
visit the emergency department after alcohol ingestion.

P429
Acid–base disorders according to the Stewart approach in septic
patients
J Szrama, P Smuszkiewicz, I Trojanowska
University Hospital, Poznan, Poland
Critical Care 2014, 18(Suppl 1):P429 (doi: 10.1186/cc13619)
Introduction ICU patients often develop acid–base disorders. In
clinical practice, there are several methods (for example, Henderson–
Hasselbalch) used to interpret acid–base data, but most of them
provide little information and fail to identify the cause of the problem.
Stewart’s approach which is based on physicochemical principles
has growing popularity among clinicians in critical care. This method
includes three independent variables that determine plasma pH
(strong ion difference (SID), PCO2, and total weak acid concentration –
mainly albumins and phosphate).
Methods The prospective analysis of arterial blood gases (ABG) was
performed according to the Henderson–Hasselbalch approach and
the Stewart method. The results were categorized into three groups
according to the Henderson–Hasselbalch concept and the BE values:
BE <–2, metabolic acidosis; BE between –2 and 2, normal values; BE >2,
metabolic alkalosis. The aim of the study was to compare the efficacy
of the traditional Henderson–Hasselbalch approach with acid–base
disturbances with the Stewart concept in the population of critically
ill septic patients.
Results The analysis included 990 arterial blood gases taken from 43
consecutive septic patients admitted to the ICU. One hundred and

ninety-three ABG results met the criteria of metabolic acidosis, 473 were
categorized into the metabolic alkalosis group and 324 results were
within the range value of BE according to the Henderson–Hasselbalch
concept. In the metabolic acidosis group (BE <–2), 34.7% of the results
had elevated lactate concentration, 100% revealed hypoalbuminemia,
96.9% had Cl/Na ratio >0.75 revealing SID acidosis, while 42.5% met the
criteria of SIG acidosis. In the normal range BE group, 21.3% revealed
lactate concentration >2 mmol/l, 100% had hypoalbuminemia, 98.4%
had Cl/Na ratio >0.75 revealing SID acidosis and hyperchloremia, while
14.5% showed SIG acidosis. The analysis of the ABG with BE >2 group
showed that 18.4% had elevated lactate concentration, 99.1% revealed
hypoalbuminemia, 88.8% had Cl/Na ratio >0.75 (SID acidosis) and 4.6%
showed SIG acidosis.
Conclusion In critically ill patients with the BE values <–2, with
BE in the range of normal value and BE >2 we observed complex
acid–base disturbances with coexistence of hyperchloremic
acidosis, hyperlactatemia, SIG acidosis and alkalosis caused by
hypoalbuminemia. The Stewart approach is more effective in detecting
acid–base disturbances and quantifying individual components of
acid–base abnormalities and provides a detailed insight into their
pathogenesis.

P430
Changes in urinary electrolytes during acute respiratory acid–base
modifications
M Ferrari
Fondazione IRCCS Cà Granda – Ospedale Maggiore Policlinico, Milan, Italy
Critical Care 2014, 18(Suppl 1):P430 (doi: 10.1186/cc13620)
Introduction The renal system compensates respiratory disorders
of acid–base equilibrium by modifying the urinary electrolyte
composition [1]. Such a condition mainly involves changes in urinary
ammonium excretion as a reaction to prolonged periods of acid–base
disequilibrium, leaving the renal response to acute derangements
unexplored. We aimed to determine the acute variations of urinary
ammonium [NH4+]u, sodium [Na+]u, potassium [K+]u and chloride
[Cl–]u concentrations following controlled minimal respiratory acid–
base imbalances, and to further investigate whether urinary anion
gap ([AG]u = [Na+]u + [K+]u – [Cl–]u) and sodium and chloride difference
([Na+]u – [Cl–]u) might unveil an early activation of the renal response.
Methods Patients admitted to the ICU after major surgery were
enrolled, during intubation and sedation. Patients with chronic renal
failure were excluded. A urinary catheter was connected to the quasicontinuous urinary analyzer KING®, measuring [NH4+]u, [Na+]u, [K+]u and
[Cl–]u over time. Based upon the arterial pH (pHa) at entrance, patients
were randomly assigned to controlled hypoventilation (30% reduction
of minute ventilation if pHa ≥7.40) or hyperventilation (30% increase
of minute ventilation if pHa <7.40) for 2 hours. Samples for blood gas
analysis were collected every 30 minutes.
Results Thirty patients were enrolled; 20 were hypoventilated,
10 hyperventilated. At 2 hours from ventilation change, pHa was
respectively decreased from 7.44 ± 0.02 to 7.34 ± 0.02 and increased
from 7.37 ± 0.03 to 7.44 ± 0.02 (P <0.001) in the two groups. Mean
[NH4+]u rose by 2.6 ± 3.3 mEq/l in hypoventilated patients and fell by
2.5 ± 2.4 mEq/l in the hyperventilated (P <0.001). No difference in mean
[K+]u was observed at any time, while [Na+]u and [Cl–]u progressively
decreased in both groups (P <0.05). [Na+]u was reduced by 48 ± 43 mEq/l
during hypoventilation and by 32 ± 41 mEq/l during hyperventilation
(P = 0.14), while [Cl–]u decreased by 29 ± 69 and by 46 ± 66 mEq/l
respectively (P = 0.93). Whereas [AG]u did not differ between groups,
[Na+]u – [Cl–]u variation of hyperventilated patients was greater than
that of hypoventilated (17 ± 34 vs. –18 ± 54 mEq/l, P <0.05).
Conclusion During acute respiratory modifications, changes in urinary
ammonium can be observed within the first 2 hours even while
maintaining arterial pH within a physiologic range. This response
seems to be better associated with changes in the difference between
urinary sodium and chloride rather than anion gap.
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P431
Admission hypomagnesemia as a mortality predictor in medical
critically ill patients
A Permata Sari, C Pitoyo, D Aditianingsih, C Rumende
Medical Faculty Indonesia University, Jakarta Pusat, Indonesia
Critical Care 2014, 18(Suppl 1):P431 (doi: 10.1186/cc13621)
Introduction Magnesium is the second most abundant intracellular
cation and serves as a cofactor in more than 300 enzymatic reactions.
Hypomagnesemia is a common electrolyte imbalance in critically ill
patients; yet it is frequently overlooked. Previous studies highlighted
the relationship between hypomagnesemia and mortality in these
patients [1,2]. This study was carried out on patients admitted to the
critical care unit and seeks to find admission hypomagnesemia’s role as
a 28-day mortality predictor in medical critically ill patients.
Methods This is a cohort prospective study with prognostic research
recruiting 150 critically ill patients in a major tertiary hospital. Blood
samples were collected for estimation of serum total magnesium on
admission, and then the patients were followed over 28 days.
Results This study was conducted consecutively from April to July 2013.
Most subjects were male (62%) with mean age 52.6 ± 15.93 years. The
occurrence of sepsis (33.3%) and cardiac disturbances (24.7%) were the
most common problems among patients. The mean MSOFA score for
the hypomagnesemics was higher than the normal group (4.91 ± 4.19
vs. 3.77 ± 3.52). Subgroup analysis in the MSOFA 0 to 7 group had
significant P = 0.015 (chi-square) and crude RR = 2.2 (95% CI = 1.19 to
4.06). From survival analysis, the survival mean of hypomagnesemia
patients was lower than the normal group (19.4 vs. 22.8 days), and so
was the survival percentage (52.7% vs. 74.7%).
Conclusion There was a high prevalence of hypomagnesemia in
medical critically ill patients and it was associated with a high mortality
rate.
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Impact of reduced frequency of phosphate testing on detected
phosphate levels and phosphate prescription in critical care
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Critical Care 2014, 18(Suppl 1):P432 (doi: 10.1186/cc13622)
Introduction Phosphate is essential for cell and bone function [1]. In
critical illness, hypophosphatemia is common and practice is often
to correct even mild derangement [2]. Its supplementation has
significant cost and risk including hypotension and hypocalcaemia. We
investigated whether changing frequency of routine serum phosphate
testing had effects on the detected incidence of abnormal plasma
levels and prescription of phosphate.
Methods This was a service improvement project using observational,
anonymous data. We collected data on serum phosphate levels in a
33-bed ITU over two 6-month periods before and after introduction of
a new testing regime (phases 1 and 2). In phase 1, phosphate levels
were tested daily. In phase 2, phosphate levels were tested three times
per week. Replacement was at clinical discretion. Pharmacy data on
phosphate prescription were compared for both phases.
Results A total of 4,253 tests were performed in phase 1, and 3,641
in phase 2 – a reduction of 612 (14.4%). The ICU workload was
similar in both phases. There was no significant difference in mean
phosphate levels or detected incidence of abnormal phosphate levels
in phase 1 versus phase 2. Mean level was 1.13 ± 0.40 mmol/l versus
1.14 ± 0.43 mmol/l (P = 0.42). Severe hypophosphatemia (<0.4 mmol/l)
was relatively uncommon: n = 18 in phase 1 (0.42% of tests) versus 19
(0.52%), P = 0.42, in phase 2. Mild hypophosphatemia (0.4 to 0.7 mmol/l)
was frequent, with 1,203 episodes (28.2% of tests) versus 1,088 (29.8%),
P = 0.42. Hyperphosphatemia (>1.5 mmol/l) was also common in both
phases with 608 detected episodes (14.3% of tests) versus 572 (15.7%),
P = 0.49. Pharmacy data show phosphate replacement fell significantly,
from 687 prescriptions in phase 1 to 395 in phase 2, with drug costsavings estimated at £1,430.
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Conclusion Reducing testing from daily to three times weekly was not
associated with a significant change in mean phosphate levels nor
with detection of abnormally high/low phosphate levels. Daily testing,
however, is associated with higher rates of phosphate prescription. It is
known that there is significant diurnal variation in serum phosphate [2]
and we speculate that mild hypophosphataemia self-corrects without
intervention. Treating mild hypophosphatemia may therefore not be
indicated.
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Effect of albumin and total protein concentration on plasma sodium
measurements in the ICU
F Gennart, T Vanwynsberghe, M Nauwynck, M Bourgeois
AZ Sint Jan Brugge, Bruges, Belgium
Critical Care 2014, 18(Suppl 1):P433 (doi: 10.1186/cc13623)
Introduction Direct ion-selective electrode without dilution is the most
effective method for determination of the concentration of the ionized
fraction of sodium [1]. We tested the hypothesis that the difference
between indirect and direct sodium assays would be related to the
plasma albumin concentration or the total protein concentration.
Methods A retrospective observational study was conducted in which
plasma sodium concentrations, from 101 paired venous and arterial
samples from patients admitted to the ICU, were respectively analyzed on
the arterial blood gas (ABG) analyzers (direct ion-selective electrode) and
the central laboratory auto-analyzers (indirect ion-selective electrode). A
paired t test was performed comparing the central laboratory and ABG
measurements. Correlation and regression analysis were performed
between total protein concentration, albumin and the differences
between the central laboratory and ABG assays for sodium.
Results The central laboratory sodium measurement was, on average,
1.46 mmol/l more than the ICU assay, limits of agreement 1.18 to
1.74 mmol/l greater, P <0.001. Bland–Altman analysis of the central
laboratory result minus the ICU sodium measurement had limits
of agreement of 1.3 to –4.2 mmol/l. The correlation between the
assay differences and total protein concentration and albumin were
respectively r = 0.24 (P = 0.01) and r = 0.20 (P = 0.04). The difference
in plasma sodium concentration between the assays increased as
the plasma concentration albumin or total protein concentration
decreased (respectively: r2 = 0.04 and r2 = 0.06).
Conclusion The difference between indirect and direct sodium
assays was found to be statistically related to the plasma albumin
concentration and the total protein concentration. Although the
relationship was found to be weak, the total protein concentration
should be monitored when measuring sodium by indirect ion-selective
electrode.
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Main causes of water–electrolyte disturbances in patients with
acute brain injury: central diabetes insipidus and cerebral salt
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Critical Care 2014, 18(Suppl 1):P434 (doi: 10.1186/cc13624)
Introduction Water–electrolyte disturbances are one of the most
common complications of acute brain injury of various origins,
threatening the life of the patient and requiring timely correction. In
this work we studied the structure of water–electrolyte complications
in patients in the neurological intensive care with acute brain injury.
Methods We analyzed 259 cases of water–electrolyte disturbances that
developed in patients treated in the Department of Intensive Care of
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Russian Polenov’s Neurosurgical Institute from 2001 to 2012. Patients
were between 16 and 55 years old. A total of 142 patients were operated
for brain tumor, 72 of them of basal–supratentorial localization; eight
severe brain trauma; 62 of the hemorrhagic type of stroke, one herpes
encephalitis. We excluded from this study the patients with heart and
renal failure receiving diuretics. We measured BP, HR, CVP, hourly and
daily urine output, level of K and Na in plasma, brain natriuretic peptide
(BNP) one to four times a day, and levels of K and Na in urine in single
and daily servings. All patients were receiving dexamethasone at a
dose between 8 and 32 mg/day as an anti-edema therapy, and thus
levels of ACTH and cortisol were not investigated.
Results Central diabetes insipidus (CDI) developed in 106 patients.
Against the background of substitution therapy, we did not observe
the development of complications, hypovolemia, hypernatremia, or
hyperosmolality. Out of 48 cases of CSWS, in 12 cases the symptoms
interleaved with the symptoms of CDI. For 24 patients, CSWS was
complicated by depressed consciousness, for three patients by
convulsions against the background of hypovolemia, hyponatremia,
or hypo-osmolality. No correlation between BPN level and absence of
CSWS symptoms was found.
Conclusion In patients with acute brain trauma we observed two
syndromes causing water–electrolyte disturbance – CDI and CSWS.
CSWS generally is more severe than CDI. We could not determine
a correlation between BPN level and the absence of presence of the
CSWS symptoms.
P435
Cardiac surgery alters the sensitivity of the dynamic interaction
between the pituitary and adrenal glands
B Gibbison1, J Walker1, G Russell1, K Stevenson2, Y Kershaw1,
G Asimakopoulos2, GD Angelini1, SL Lightman1
1
University of Bristol, UK; 2University Hospitals Bristol NHS FT, Bristol, UK
Critical Care 2014, 18(Suppl 1):P435 (doi: 10.1186/cc13625)
Introduction Both ACTH and cortisol are secreted in a diurnal rhythm.
Underlying this is an ultradian rhythm of discrete pulses [1] as a result
of the feedforward:feedback interactions between cortisol and ACTH
[2]. These pulses are critical for normal function; pulsatile and constant
infusions yield different transcriptional responses [3] and patients on
optimal (nonpulsatile) glucocorticoid replacement have twice the
age-related mortality of the general population [4]. We have now
characterised the ultradian rhythm and pituitary–adrenal interaction
of patients undergoing coronary artery bypass grafting (CABG).
Methods Twenty male patients presenting for elective CABG (on-pump
and off-pump) were recruited. Blood samples were taken for 24 hours
from placement of the first venous access. Cortisol was sampled
every 10 minutes, ACTH was sampled every hour and cortisol binding
globulin (CBG) was sampled at baseline, at the end of operation and at
the end of the 24-hour period.
Results Cortisol and ACTH were pulsatile throughout the perioperative
period and the cortisol–ACTH interaction persists (Figure 1). The
sensitivity of this interaction (calculated by the ratio of cortisol to ACTH
pulse amplitude) changed at about 8 hours post surgery such that the
adrenal sensitivity to ACTH increased.
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Conclusion Both cortisol and ACTH remain pulsatile during and
after cardiac surgery and the pituitary–adrenal interaction persists,
although the sensitivity of the adrenal glands changes throughout the
perioperative period. Our study shows that endogenous glucocorticoid
levels reach very high oscillating levels following cardiac surgery, which
not only invalidate the interpretation of point measures of adrenal
function to diagnose adrenal insufficiency but also demonstrate that
constant infusions of hydrocortisone are unphysiological.
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Melatonin blood values and total antioxidant capacity in critically
ill patients
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Critical Care 2014, 18(Suppl 1):P436 (doi: 10.1186/cc13626)
Introduction Endogenous melatonin is decreased in critically ill
patients; oral supplementation could help them to cope with sleep
disruption and sepsis. Among patients who took part in a trial on
melatonin and need for sedation [1], some were studied with blood
sampling to describe their melatonin blood values and the relationship
with total antioxidant capacity (TAC) in plasma.
Methods Inclusion criteria: mechanical ventilation previewed at ICU
admission >8 days and mortality predicted at ICU admission over
13% (SAPS II >32 points). After the clinical run-in period of 48 hours,
samplings were taken to measure baseline blood melatonin and TAC,
beginning from the third ICU night and day (midnight and 02:00 p.m.).
At 8:00 p.m. of the third ICU day, treatment with 3 mg + 3 mg melatonin
(Group M) or placebo (Group P) began: each patient received two
tablets per day, at 8:00 p.m. and midnight, until ICU discharge. Further
samplings were taken during the early (fourth night and day) and the
late (eighth night and day) treatment phases. Melatonin was measured
through an ELISA essay; TAC was measured with a specific kit.
Results Sixty-four critically ill patients were enrolled. Endogenous
melatonin was shown decreased in the run-in period and in the
placebo group compared with healthy subjects. All patients reached
satisfying pharmacological values with enteral administration: peak of
blood melatonin value (pg/ml) was 2,514 (982 to 7,148) for the M group
versus 20 (15 to 62) for the P group (P <0.001) during the first treatment
night, while maintaining significant differences also during the
daytime: 51 (23 to 180) M group versus 14 (11 to 24) P group (P = 0.001).
The same trend was observed in the late treatment samples (eighth
ICU day). Regarding TAC values (nmol Trolox equivalent/μl plasma), a
significant difference was highlighted during the night (107 (97 to 123)
M group vs. 61 (42 to 89) P group, P <0.001), but not during the daytime
(37 (30 to 69) M group vs. 28 (25 to 50) P group, P = 0.092). Correlation
between melatonin and TAC: Spearman’s rho = 0.33 (P <0.001).
Conclusion Enteral administration of melatonin was adequate in
the early phase of critically illness, with pharmacokinetics similar to
published data [2]. The administration of melatonin seems to increase
the TAC, with a possible meaningful role in critically ill patients.
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Continuous prediction of glucose-level changes using an electronic
nose in critically ill patients
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Figure 1 (abstract P435).

Introduction Many if not most critically ill patients are treated with
insulin during their stay in the ICU [1]. Intensive monitoring of the blood
glucose level is a prerequisite for efficient and safe insulin titrations

Critical Care 2014, Volume 18 Suppl 1
http://ccforum.com/supplements/18/S1

in these patients [2]. Current continuous glucose measurement
techniques rely on subcutaneous glucose measurements [3] or
measurements in blood [4]. We hypothesized that changes in volatile
organic compound (VOC) concentrations in exhaled breath reflect
changes in the blood glucose level. Changes in VOC concentrations can
be analyzed continuously using a so-called electronic nose (eNose) [5].
Our aim was to investigate exhaled breath analysis to predict changes
in glucose levels in intubated ICU patients.
Methods Exhaled breath was analyzed in 15 intubated ICU patients
who were monitored with a subcutaneous CGM device. eNose results
were compared with subcutaneous glucose measurements and linear
regression models were built, including subject-specific models, and
whole-sample models. The models were validated using temporal
validation by training the model on the first 75% of measurements and
prospectively testing on the last 25% of measurements. Performance
of the models was measured using an R2 value, Clarke error grids (CEG)
and rate-error grid analysis (R–EGA).
Results Changes in VOC concentrations were associated with changes
in subcutaneous glucose levels. R2 performance had a mean value of
0.67 (0.34 to 0.98) for subject-specific models, and a mean value of
0.70 (0.52 to 0.96) for the model for the whole sample. However, when
externally validating the model, the predictive performance dropped
to a mean R2 of 0.19 (0.00 to 0.70) for subject-specific models, and 0.04
for the model for the whole sample. Point accuracy in CEG was mostly
good with >99% in zones A and B; trend accuracy, as visualized with
R–EGA, was low.
Conclusion Exhaled breath prediction of glucose levels seems
promising. However, performance of the current models is too low to
be used in daily practice.
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Evaluation of blood glucose control in ICU patients with Space
GlucoseControl: a European study
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Introduction Regardless of the ongoing debate on optimum target
ranges, glycaemia control (GC) remains an important therapeutic goal
in critically ill patients. Dozens of different insulin protocols for ICUs
have been developed with different complexity, effectiveness, blood
glucose (BG) variability and safety. Although comparison of existing
protocols is difficult due to significant differences in processes and
outcome measures, computerized clinical decision support systems
generally achieved better GC with consistently lower hypoglycaemia
rates than that achieved with paper-based protocols [1]. The enhanced
Model Predictive Control (eMPC) algorithm, developed by the CLINICIP
group, is the effective clinically proven protocol, which has been
successfully tested at multiple institutions on medical and surgical
patients with different nutritional protocols [2,3]. The eMPC models
the behaviour of glucose and insulin in ICU patients with a variable
sample interval based on the accuracy of the BG prediction. It has
been integrated in the B.Braun Space GlucoseControl (SGC) system,
which allows direct data communication between pumps and Space
Control with the incorporated eMPC algorithm. Although SGC is
already clinically used in dozens of ICUs worldwide, there are few only
published experiences with its use [4].
Methods The primary objective of this multicentre European noninterventional study was to evaluate the performance (efficiency)
of SGC under routine conditions in adult ICU patients requiring BG
control. The primary endpoint was the percentage of time within the
target range, and secondary outcome measures were the frequency
of hypoglycaemic episodes and BG measurement intervals. Patients in
this trial were assigned to the target range 4.4 to 8.3 mmol/l. Nutritional
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management (enteral, parenteral or both) was carried out at the
discretion of the each centre.
Results Seventeen centres from nine European countries included a
total of 508 patients. During the study a total of 29,575 BG values were
entered into the SGCs and the same number of recommendations
were rendered. The mean time-in-target was 77.5 ± 20.9%. The
mean proposed next measurement time was 2.0 ± 0.5 hours. Only
four episodes of hypoglycaemia <2.2 mmol/l occurred (0.01% of
measurements).
Conclusion SGC is a safe and very efficient system to control BG in ICU
patients.
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patients
J Joseph1, M Torjman2, J Reich3, A Furnary4, S Nasraway3,
M McNamara-Cullinane5, D Olson5, D Walton5
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Introduction Glycemic control in the ICU has been shown to reduce
morbidity, mortality and length of stay. However, current methods of
blood glucose (BG) monitoring are invasive, intermittent and laborintensive. Continuous glucose monitoring (CGM) has potential to
improve safety/efficacy of BG control. The performance of a noninvasive, transdermal CGM system (Symphony CGM; Echo Therapeutics,
Philadelphia, PA, USA) was evaluated in post-surgical ICU patients.
Methods Adult surgical patients with planned ICU admission of
≥24 hours at four medical centers were consented. Following admission
to the ICU, the skin of an upper arm was cleaned and a 6 mm diameter
site was prepared with controlled micro-abrasion using the Symphony
CGM system. A transdermal CGM sensor containing glucose oxidase
was applied. Following a 1-hour warm-up period, a calibration was
performed. Blood samples were obtained from a radial artery catheter
approximately every hour, centrifuged to plasma, and glucose was
measured using a YSI 2300 STAT Plus Glucose Analyzer (reference BG). A
maximum of 30 reference BG samples were collected for each patient.
Samples were collected as frequently as every 15 minutes for trend
analysis. CGM was prospectively calibrated every 4 hours. All treatment
decisions were based on BG alone. Safety was assessed by visual
inspection of the site using a dermatological scale following sensor
removal. A study was defined as evaluable for CGM sessions >16 hours.
Results Thirty-two subjects completed the study. Additional subjects
were not considered evaluable due to early discharge from the ICU,
failure or early removal of the radial artery catheter, or administration
of intravenous acetaminophen. The study cohort was 19% female, 28%
diabetes, 56% cardiac surgery, with a mean age of 65 ± 13 years. Overall
mean absolute relative difference between CGM and reference BG was
12.5%. Continuous glucose error-grid analysis, which assesses point
and trend accuracy, showed 98.2% of readings in the A zone (clinically
accurate) and 1.2% in the B zone (benign errors). Glucose values ranged
from 49 to 324 mg/dl. No device or study-related adverse events were
reported.
Conclusion The Symphony CGM system demonstrated clinically
relevant accuracy and excellent safety in a variety of patients and
ICU environments. Future studies are needed to determine whether
Symphony CGM can be used to direct therapy and improve BG control
in this patient population.
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Time-course evaluation of blood glucose changes in response to
insulin delivery in critically ill patients
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1
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Critical Care 2014, 18(Suppl 1):P440 (doi: 10.1186/cc13630)
Introduction Intravenous insulin by infusion is commonly used
for blood glucose control in the ICU and blood glucose is almost
exclusively monitored by intermittent sampling. The rate of change
in blood glucose concentration [BG] when the insulin infusion rate is
changed is not known, and as a result the optimum time to measure
[BG] after changing the infusion rate is unclear.
Methods Following institutional ethics approval and patient consent,
using a GluCath Continuous Glucose Monitoring system sensor
deployed via a radial artery catheter we studied the change in [BG] in
response to a 1 unit/hour increase in the insulin infusion rate during
the first 48 hours after cardiac surgery. [BG] was recorded every
10 seconds. Insulin was infused at a concentration of 1 unit/5 ml/hour
via a volumetric pump. We recorded [BG] for 2 hours after changing
the insulin infusion rate. Data affected by artifacts produced by blood
draws and subsequent flushing of the arterial catheter were excluded
and linear interpolation was used to estimate missing [BG] data.
Results There were five episodes where the insulin infusion increased
by 1 unit/hour. [BG] decreased modestly for 50 minutes, after which
there was marked interpatient variability in subsequent [BG] trend
(Figure 1). The median (range) change in BG (mmol/l) at 30 minutes: –0.5
(–0.7/+0.1), 60 minutes: –0.1 (–0.7/+1.0), 90 minutes: –0.3 (–0.7/+0.6)
and 120 minutes: –0.5(–1.2/+2.9).
Conclusion Within the first hour the change in [BG] was consistent but
beyond this time it was highly variable. Further studies are needed
to understand the dynamics of [BG] in response to changes in insulin
infusion rates, but these data suggest [BG] should be checked hourly
until stable.
P441
Glycaemia and critical care outcomes
M Cecconi1, C Ryan2, D Dawson2, N Di Tomasso2, G McAnulty2, B Philips2,
A Rhodes2
1
St George’s Hospital, London, UK; 2St George’s Healthcare NHS Trust, London,
UK
Critical Care 2014, 18(Suppl 1):P441 (doi: 10.1186/cc13631)
Introduction The aim of this study was to determine the impact of
preadmission or first 24-hour blood glucose (BG) measurements in UK
ICUs on mortality.
Methods The Intensive Care National Audit & Research Centre case-mix
programme database on adult admissions to general, neuroscience
and cardiothoracic critical care units was used for analysis. Within the
database, the highest and lowest blood glucose (BG) values measured
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Table 1 (abstract P441). Critical care outcomes
Very
low

Low

Control

High

Very
high

11,471

70,106

521,839

77,423

187,553

ICU mortality* (%)

55

31

13

18

26

ICU LOS*

7

6

4

5

6

Variable
Number of patients

*P <0.001.

during the first 24 hours from admission were recorded. BG control
value was defined as BG (≥4.0 ≤9.9 mmol/l). Other BG levels were
defined as: very low, ≤2.2 mmol/l (≤40 mg/dl); low, >2.2 ≤3.9 mmol/l
(40 to 70 mg/dl); high, ≥10.0 <11.1 mmol/l (180 to 200 mg/dl); and very
high, ≥11.1 mmol/l (200 mg/dl).
Results There was an increased incidence of mortality in those patients
with at least one BG measure below 3.9 mmol/l (70 mg/dl) compared
with those without (Table 1). There was a link between BG levels and
LoS for surviving patients with the longest hospital stays (critical
care and total hospital) experienced by those with BG levels below
2.2 mmol/l (40 mg/dl).
Conclusion There is a strong association between BG levels during
admission and mortality and LoS outcomes. Although it is not possible
to make the link with causation from our dataset, we present results
from the largest single dataset of critical care unit patients [1,2].
Acknowledgement Funding from Edwards Lifesciences.
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Continuous monitoring of blood glucose using a fiberoptic-based
intravascular sensor during postoperative care in the ICU
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1
Care Hospital Nampally, Hyderabad, India; 2STAR Hospitals, Hyderabad, India
Critical Care 2014, 18(Suppl 1):P442 (doi: 10.1186/cc13632)
Introduction While there is ongoing discussion of the optimal range
for glycemic control in hospital intensive care, recent publications from
Mackenzie and colleagues [1] and Krinsley [2-4] suggest not only that
mean BG should be considered, but also that glucose variability and
complexity may be equally important. This has increased the need for
continuous systems which can provide early warnings of hypoglycemia
and effectively measure variability. GlySure Ltd has developed an
intravascular glucose monitoring system to simplify the application of
hospital protocols for tight glycemic control (TGC) at the point of care.
Experience with the original research-based instrumentation [5] has
now been incorporated into a combined pre-production monitor and

Figure 1 (abstract P440). Blood glucose change after infusion change and after calibration.
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autocalibration unit. We have now completed a 34-patient trial using
this device and present the data collected from this study.
Methods The study used GlySure sterile, single-use sensors and a
5-lumen 9.5-Fr CVC device, allowing the fluorescence optical-based
sensor to be placed into the patient’s right internal jugular vein. The
screen data were blinded to the bedside staff. Data from the monitor
were later compared with sample measurement from the Yellow
Springs (YSI) glucose analyzer. The data accuracy was measured using
the mean absolute relative difference (MARD), an error calculation tool.
Results The device met the primary safety and effectiveness endpoints
of the trial. The 456 sample values recorded by the monitor based
on 8-hour calibrations were correlated with samples taken from the
YSI and the MARD for the study was 9.40%. The analysis showed that
89.23% of the data fell within the A zone of the Clark error grid, with the
rest falling within the B zone.
Conclusion The results demonstrate a good correlation with the
accepted standard of blood glucose determination in ICU practice.
Early detection of glycemic excursions can provide carers with the
opportunity for an early intervention and thus achieve the elusive
target of TGC around the chosen target range.
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refined to maximise the benefit of GGM. Overall, the evidence from
the first applied clinical use of this novel CGM showed that proper
safe, tight glycaemic control can be achieved. Further investigations
are required to demonstrate the reduction in morbidity and mortality
using CGM, and we plan to embark on further studies to address this.
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glucose monitoring system in the ICU
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Introduction The aim of this study was to determine the safety and
efficacy of treating patients using a novel intravenous continuous
glucose monitoring (CGM) system (GlucoClear™; Edwards Lifesciences).
The practical benefit of controlling blood glucose in the critically ill
remains contentious, largely because of the lack of tools to adequately
measure and therefore manage levels in real time. A system that is able
to provide instant, constantly calibrated, accurate values is a major
bonus to ICU care and we report here the first clinical use of a novel
CGM system directly used to manage postoperative glycaemia.
Methods All consecutive consenting adult patients undergoing
cardiac surgery involving cardiopulmonary bypass and requiring
postoperative insulin (>98% of patients) were enrolled in the study with
a target enrolment of 100. Blood glucose was measured via a dedicated
peripheral intravenous catheter with values reported every 5 minutes.
The primary outcome was the number of data points in the target
glycaemic control range (4.4 to 8.0 mmol/l), using a dynamic insulin
protocol. Secondary endpoints include mean glucose levels, time in
range and number of hypoglycaemic and hyperglycaemic episodes.
Results For the first 45 patients, mean age was 67.7 years (male
52.8%), 54% had undergone valve surgery with or without CABG and
the majority (67%) had no history of diabetes. The CGM sensor was
typically sighted in the forearm or hand (90.5%) and was resited on
7.5% occasions. Median monitoring time in the ICU was 28.4 hours.
Mean glycaemic value was 6.8 mmol/l. From the possible 18,609
glucose values (one per 5 minutes), 16,808 values were recorded
(90.3%). Overall, 13,389/16,808 values (79.6%) were within the target
range. No hypoglycaemic episodes (≤2.2 mmol/l) were recorded at
any point. There were 219/16,808 values (1.3%) in the hyperglycaemic
range (≥10.0 mmol/l).
Conclusion This new CGM system enabled significantly improved
glycaemic control despite the challenges of working with an entirely
new system of glucose control in a unit with over 200 nurses.
Performance notably improved with experience and also highlighted
that even previously validated dynamic algorithms will need to be
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Impact of corticosteroid administration in septic shock on glycemic
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Critical Care 2014, 18(Suppl 1):P445 (doi: 10.1186/cc13635)
Introduction The purpose of this study was to assess the relation
between glycemic control and the severity of sepsis in a cohort of
patients with vasopressor-dependent septic shock treated with
corticosteroids [1,2].
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Methods In a prospective, controlled study, 134 patients with septic
shock were randomized into three study groups: group A (n = 43),
200 mg/day hydrocortisone hemisuccinate in four daily doses; group
B (n = 47), same dose of hydrocortisone hemisuccinate in continuous
administration; group C (n = 44), no hydrocortisone hemisuccinate.
Patients with diabetes mellitus were excluded. The duration of
hydrocortisone treatment was a maximum 7 days. The target blood
glucose (BG) level was below 180 mg/dl. BG values were analyzed by
calculating mean daily values, standard deviation (SD) of BG values
as an index of glycemic variability, and insulin doses. The local ethics
committee approved the study.
Results There were no differences between the three groups at the
beginning of the study regarding demographic data and the clinical
characteristics, including BG value. BG levels were strongly correlated
with severity of septic shock estimated by APACHE II score (r = +0.241;
P = 0.005) or Simplified Acute Physiology Score II (r = 0.280; P = 0.001) –
Pearson correlation. The risk of death is significantly increased if SD of
BG is more than 20 mg/dl (67.7% vs. 20.8%, P = 0.000). A total 94.4% of
deceased patients in group A registered a SD of BG more than 20 mg/dl
versus 89.5% in group B or 40% in group C (P = 0.006). In total, 53.5% of
patients in group A needed insulin therapy versus 25.5% in group B or
27.3% in group C. The dose was between 30.28 ± 6.65 UI/day in group
A, 37.85 ± 11.95 UI/day in group B, and 14.28 ± 5.76 UI/day in group C
(P >0.05).
Conclusion BG variability is highly associated with mortality compared
with BG mean daily value or insulin dose. SD levels above 20 mg/dl
were associated with a significantly higher mortality rate relative to
those with SD levels below 20 mg/dl.
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Introduction Blood glucose (BG) control in acute illness improves
outcome. However, how to manage BG levels, or BG target, is not clearly
elucidated. In this study, the BG target was suggested by the analysis of
the relationship between BG profile and the severity of the diseases.
Methods Ninety-six patients were studied. The following parameters
were calculated during the first week after ICU admission. (1) Maximum
value of SOFA score (SOFAmax). (2) Mean, standard deviation,
maximum, minimum, and difference of BG levels (BGm, BGsd, BGmax,
BGmin, BGd (BGmax – BGmin), respectively). BG levels were measured
basically every 6 hours. (3) Correlation between SOFAmax and BG
parameters using two-dimensional (correlation coefficient rt) and linear
regression analysis (rl).
Results (1) Mortality of the patients with SOFAmax 0 to 3, 4 to 5, 6 to 7, 8
to 9, and 10 or more were 0%, 14%, 23%, 40%, and 89%, respectively. (2)
rt and rl (rt/rl) between SOFAmax and BG parameters: BGsd (0.49/0.36),
BGmax (0.47/0.32), BGm (0.45/0.23), BGd (0.44/0.32), and BGmin
(0.25/0.06). (3) BG ranges that indicate SOFAmax less than 5 calculated
from the two-dimensional correlation curves between SOFAmax and
BGsd, BGmax, BGm, and BGd were 35 ± 25, 250 ± 112, 150 ± 33, and
156 ± 115 mg/dl, respectively.
Conclusion BG parameters except BGmin were two-dimensionally
related to the severity. Therefore, a part of the severe patients seemed
to have lower BG levels and lower BG variability. Targeting those BG
parameters in early phase within the abovementioned levels was
considered to link to better outcome.
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Anti-inflammatory and antioxidant effects of ranolazine on primary
cultured astrocytes
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Introduction Because of its ability to block late INa [1], ranolazine is
used as an antianginal agent for the treatment of chronic angina
pectoris when angina is not adequately controlled by other agents
[2]. Besides its cardiovascular effects, ranolazine improves different
neuronal functions, and thus its use has been proposed for the
treatment of pain and epileptic disorders [3,4]. Since astrocytes are
involved in neuronal inflammatory processes, and autoimmune
and neurodegenerative diseases [5], we have investigated the antiinflammatory and antioxidant effects of ranolazine in primary cultured
astrocytes.
Methods We incubated differentiated rat astrocytes in primary culture
(10 days of culture) [5] for 24 hours with ranolazine (10–5, 10–6, 10–7 M).
We measured the protein expression levels of PPARγ and Cu/Zn-SOD by
western blot technique. Protective effect of ranolazine on cell viability
was assayed using MTT conversion assay. Finally, to evaluate the effect
of ranolazine on the IL-1β cytokine and TNFα mediators, we used the
enzyme-linked immunosorbent assay technique.
Results Compared with control cells, treatment with ranolazine
induced an increment of anti-inflammatory PPARγ and reduced
the proinflammatory mediators IL-1β and TNFα in primary cultured
astrocytes. Ranolazine (10–6 M) also increased the expression of
antioxidant protein Cu/Zn-SOD and caused a significant increase in cell
viability.
Conclusion Ranolazine decreases inflammatory mediators IL-1β and
TNFα, and increases anti-inflammatory PPARγ as well as the antioxidant
Cu/Zn-SOD in astrocytes in culture. These results suggest that
ranolazine could be useful as a neuroprotective drug in pathologies
inducing inflammatory damage and oxidant processes.
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Introduction Tuberculous meningitis (TBM) is the least common
extrapulmonary manifestation of tuberculosis. Although the UK
incidence of TBM is relatively low, it carries a high mortality and
morbidity [1]. Neurological deterioration continues to be an important
reason for ICU admission [2]. Little is known about the outcomes for
TBM patients requiring ICU admission. Our aim is to evaluate patient
demographics, TBM clinical data, and the necessity for organ support,
and whether this can be associated with outcome.
Methods A retrospective study at a tertiary centre of patients with TBM
admitted to our ICU between 2000 and 2012. Data were retrieved on
demographics, microbiology, radiology and pharmacological findings
and type and level of organ support. APACHE II and SOFA scores were
calculated. Patients were stratified into two groups: CSF PCR+ve and
CSF PCR–ve.
Results Eight patients (six males:two females) were evaluated. Total
mean age was 43.9 ± 8.09 years. A reduction in GCS was the main
reason for ICU admission. All patients received ≥3 anti-TBM drugs
and steroids. Two CSF PCR+ve patients had primary drug resistance
to isoniazid. There was also a longer mean delay in the time of onset
of anti-TBM treatment in CSF PCR+ve patients (4 ± 2.88 days). Higher
APACHE II and SOFA scores on admission (mean = 23, 8.5) were
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associated with a positive CSF PCR result. Increased requirements for
mechanical ventilation (100%), tracheostomy (50%), inotropes (75%),
neurosurgical intervention (predominantly CSF drainage) (100%) and
enteral feeding (50%) were all significant for this group. Mortality and
long-term neurological morbidity were substantially higher for PCR+ve
patients (75% and 25%). In contrast, the majority of culture-negative
patients survived (75%), and experienced good recoveries at follow-up.
Overall mortality was 50%.
Conclusion This is the second documented case analysis of TBM and
ICU admission in adult patients [1,2]. Findings show that poor outcomes
are associated with positive CSF PCR results. Factors linked to poor
outcomes include delays in initiating anti-TBM treatment, neurosurgical
interventions, and an increased requirement for multiorgan support.
Earlier drug susceptibility testing would be preferable particularly for
patients with positive CSF PCR cultures. Given the potential severity
of TBM, a high index of clinical suspicion remains critical towards
optimizing outcomes.
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abdominal surgery
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Introduction The aim was to evaluate the role of intrathecal lactate as
an early predictor of spinal cord injury during thoracoabdominal aortic
aneurysmectomy. Forty-four consecutive patients were scheduled to
undergo thoracoabdominal aortic aneurysmectomy. Two patients
had a type B dissecting aneurysm; all other 42 patients suffered from
degenerative aneurysm.
Methods During surgery, samples of cerebrospinal fluid and
arterial blood were simultaneously withdrawn to evaluate lactate
concentration. Samples were collected at five fixed times during and
after surgery: T1 (beginning of the intervention), T2 (15 minutes after
aortic cross-clamping), T3 (just before unclamping), T4 (end of surgery),
and T5 (4 hours after the end of surgery).
Results Mean lactate levels in cerebrospinal fluid rose consistently
from the beginning of the intervention steadily until after surgery (T1 =
1.83 mmol/l, T2 = 2.10 mmol/l, T3 = 2.72 mmol/l, T4 = 3.70 mmol/l,
T5 = 4.31 mmol/l). Seven patients developed spinal cord injury; two of
them had delayed injury occurring 24 hours after the end of surgery;
the remaining five had early onset. In this group of five patients,
preoperative cerebrospinal fluid lactate levels were significantly
(P = 0.04) higher than those of the other 40 patients preoperatively
(2.12 ± 0.35 vs. 1.79 ± 0.29 mmol/l).
Conclusion The preoperative cerebrospinal lactate concentration is
elevated in patients who will develop early-onset spinal cord injury
after thoracoabdominal aortic aneurysmectomy. This may allow a
better stratification of these patients, suggesting a more aggressive
strategy of spinal cord function preservation and possibly guaranteeing
them a better outcome.
P450
Predictors of ventilatory outcome in cervical spinal injuries
HT Wang, DW Williamson, MA Albert
Hopital Sacre-Coeur de Montreal, Canada
Critical Care 2014, 18(Suppl 1):P450 (doi: 10.1186/cc13640)
Introduction Spinal cord injuries affect 50 persons per million every
year in North America [1], with over 50% occurring at the cervical
level [2]. Cervical spinal cord injuries (CSI) are at particular risk for
mechanical ventilation (MV), pulmonary complications and increased
length of hospital stay. A few small cohort studies looked at predictors
of MV [3-6], and to our knowledge there are no studies addressing
factors associated with prolonged MV. The purpose of this study was
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to compare known clinical predictors of MV and determine predictors
of prolonged MV.
Methods We conducted a retrospective chart review of consecutive
CSI admitted between 1 January 2005 and 1 March 2009. We recorded
data related to the injury, the duration of MV, respiratory complications,
ICU and hospital length of stay and patients’ outcomes. A review of the
literature identified known predictors (ASIA level, ISS, level of injury,
and so forth). Univariate and multivariate logistic regression were used
to identify predictors of MV and prolonged MV.
Results Of the 208 patients, 82% were male and the mean age was
51 years. Hospital mortality was 8.7%. Main causes of injury were
motor vehicle accidents (39.7%) and falls (43.2%). Injuries below C4
level represented 51.5% of the population. A complete loss of motor
function (ASIA level A and B) was found in 34.9% of patients. The mean
and median ISS score was 20.7. In total, 78 patients required MV (37.5%)
and 30 patients required prolonged MV (14.4%). After multivariate
analysis, four predictors of MV were identified: pneumonia (OR = 52.83);
ISS score >22 (OR = 4.09); age (OR = 1.02); level C1 to C4 (2.34); and
two predictors of prolonged MV: ASIA score A and B (OR = 5.57) and
pneumonia (OR = 8.76).
Conclusion In our study ISS, cervical level and age were associated with
MV but not with the need for prolonged MV, whereas pneumonia was
an independent risk factor for both. This is a potentially preventable
risk factor where specific strategies can be applied to improve patients’
outcome.
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Introduction Multimodal neuromonitoring is a part of goaldirected therapy in severe neurosurgical pathology that leads to
better understanding and therefore accurate and timely correction
of disturbances of cerebral perfusion. The aim of our study was to
evaluate and compare microcirculation in the conjunctiva of the eye
and sublingual mucosa in brain-dead patients and healthy volunteers.
No studies to our knowledge with this purpose were performed
previously. We hypothesized that direct videomicroscopic evaluation
of conjunctival microcirculation is linked to cerebral blood flow.
Methods We evaluated microcirculation of the eye conjunctiva and
sublingual mucosa of 10 brain-dead diagnosed patients and 10
healthy volunteers. Brain-death diagnoses were certified by cerebral
angiography. Direct in vivo observation of the microcirculation
was obtained with sidestream dark-field imaging. Assessment
of microcirculatory parameters of convective oxygen transport
(microvascular flow index (MFI), proportion of perfused vessels (PPV)),
and diffusion distance (perfused vessel density (PVD) and total vessel
density (TVD)) was performed according to international criteria.
Results All brain-dead patients required vasopressor support to sustain
perfusion of donor organs. The MFI of small vessels was significantly
lower in brain-dead patients in comparison with healthy controls in
ocular conjunctiva (2.6 (2.4 to 2.8) vs. 3.0 (3.0 to 3.0), P = 0.03) and in
sublingual mucosa (2.8 (2.6 to 2.9) vs. 3.0 (3.0 to 3.0), P = 0.04). TVD
and PVD of small vessels were significantly lower in brain-dead patients
in comparison with healthy controls in ocular conjunctiva (10.2 (5.2
to 14.8) vs. 17.0 (15.4 to 27.2) mm/mm2, P = 0.023 and 5.2 (2.9 to 7.2)
vs. 10.1 (8.5 to 16.7) l/mm, P = 0.023), but there was no difference in
sublingual mucosa.
Conclusion We were able to identify a significant reduction of capillary
density in the eye conjunctiva but not in sublingual mucosa when
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comparing microcirculation of brain-dead diagnosed patients and
healthy volunteers. However, the presence of conjunctival flow in case
of general cerebral flow is completely absent, making it difficult to use
conjunctival flow as a substitute for brain flow.
P453
External validation of an early warning alert for elevated
intracranial pressure in the Avert-IT database
M Beckers1, F Güiza1, B Depreitere1, I Piper2, R Donald3, G Van den Berghe1,
G Meyfroidt1
1
University Hospitals Leuven, Belgium; 2Southern General Hospital, Glasgow,
UK; 3University of Glasgow, UK
Critical Care 2014, 18(Suppl 1):P453 (doi: 10.1186/cc13643)
Introduction After severe traumatic brain injury (TBI), episodes of
elevated intracranial pressure (ICP) are associated with poor outcome.
Previously we developed a model to predict increased ICP, 30 minutes
in advance, using the dynamic characteristics of routinely monitored
minute-by-minute ICP and mean arterial blood pressure (MAP) signals
[1]. The model was developed using data from the Brain-IT database
[2]. Here we present external validation results of this model, on a more
recent cohort of adult TBI patients from the AVERT-IT project [3].
Methods A retrospective analysis of physiological data collected at the
minute resolution, from 43 adult patients from the AVERT-IT project. A
total of 67 episodes of ICP above 30 mmHg lasting at least 10 minutes
were identified in this cohort. Four-hour time series of ICP and MAP
anteceding each episode by 30 minutes were analyzed. Additional time
series not preceding elevated ICP episodes were used for validation.
Results Table 1 summarizes the main findings. Performance of the
model in the original study [1] is reproduced in the first column. The
model retains identical performance for all criteria in the cohort of
more recent TBI patients of the AVERT-IT database.
Table 1 (abstract P453).
Database
AUROC
aBrier SS (%)

Brain-IT

Avert-IT

0.85

0.83

34

30

Cal large

0.00

0.01

Cal slope

0.99

1.03

77

77

Accuracy (%)

Conclusion The obtained external validation results, on a previously
unseen cohort of adult TBI patients, confirm the robustness of the
model to accurately predict future increased ICP events 30 minutes
in advance. The general applicability of the model is probably due to
its sparseness, as it only uses two routinely monitored signals as input,
namely ICP and MAP. These results are a large step forward in our work
toward an early warning system for elevated ICP that can be used
worldwide.
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Introduction Stroke is the main cause of deterioration of activity of
daily living in Japan. The social problem in Japan is the difference in

medical quality between the urban and depopulated areas. To improve
the problem, telemedicine using a mobile device between general
physicians and stroke specialists became important with the increasing
demand for rapid and correct diagnosis for treatment of acute stroke.
We developed a system for rapidly exchanging diagnostic images and
clinical information in depopulated areas to develop the standard
thrombolytic therapy using alteplase for acute ischemic stroke [1,2].
Methods A system was consisted of communicating patient data and
imaging between the hospital system and participating staff members
in and out of the hospital using mobile devices. The system can transfer
clinical data and large volumes of CT and MRI, and expert opinion in
real time. We developed the system (k-support) in the Kaifu area, which
is a typical depopulated area in Tokushima Prefecture, Japan, between
the general physicians in Tokushima Prefectural Kaifu Hospital and
specialists in stroke and cardiovascular disease at Tokushima University
Hospital from February 2013.
Results The k-support system was managed in 102 emergency
patients, 65 patients (64%) were classified as neurological disease, 41
(40%) as stroke, 11 (11%) as head injury, two (2%) as epilepsy. The detail
of stroke was ischemia in 35 (34%), hemorrhage in four (4%) and SAH in
two (2%). Two ischemic stroke patients were treated with intravenous
thrombolysis of alteplase using the k-support system and a ‘dripand-ship’ paradigm. One patient using alteplase showed complete
recanalization of the middle cerebral artery. The consultations resulted
in hospitalization in 42%, transfer in 37% and return home in 20%.
Conclusion Before introduction of the k-support system, the standard
thrombolytic therapy using alteplase for acute ischemic stroke could
not operate in the Kaifu area due to the absence of stroke specialists
and the long distance to a neighboring stroke center. The telemedicine
system using a mobile device as the k-support system can be used
anytime, anywhere and by anyone. This system can communicate
with the doctors, between general physicians in depopulated areas
and specialists in urban areas, and may become a useful tool for acute
patient management in not only stroke but also other emergency
diseases.
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fluid administration after aneurysmal subarachnoid hemorrhage
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Introduction In patients with aneurysmal subarachnoid hemorrhage
(SAH), hypervolemic therapy may result in fluid overload that may be
associated with adverse clinical outcomes [1,2]. We hypothesized that
a goal-directed transpulmonary thermodilution (TPT) monitoring
protocol aiming for normovolemia may result in decreased fluid intake
while sustaining adequate volume status in poor-grade SAH patients.
Methods Following the introduction of the hemodynamic protocol
in 2011, 26 consecutive patients with SAH were included until
2013. Using TPT (PiCCO; Pulsion), cardiac output (CO), global enddiastolic volume index (GEDVI) and extravascular lung water index
(EVLWI) were determined. Fluid administration was targeted at
fluid unresponsiveness. Indications for start of the protocol were:
hypotension (in spite of fluids), pulmonary edema or cardiac stunning,
daily fluid balance ≤–1 l, cerebral ischemia (DCI) with progressive
symptoms. Data were collected on fluid intake and output up to 3 days
before and 3 days after the start of TPT. We assessed the course of fluid
input and output and hemodynamic parameters before and after the
start of the protocol with the generalized estimating equation.
Results Mean age was 55 ± 16, and median Glasgow Coma Scale on
admission was 8 (IQR 6 to 13). TPT was started at a median of 1 day after
ICU admission (IQR 0 to 4). DCI developed in 70% and the in-hospital
death rate was 45%. Compared with days preceding the protocol (day
–3 to –1), TPT (day 0 to 3) was associated with decreased fluid intake
(compared with day 3 as reference; day –1: +1.14 ± 0.31 l, P <0.001; day
0: +0.68 ± 0.29 l, P = 0.019; day 1: +0.73 ± 0.31 l, P = 0.02), increased
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fluid output (day –2: –0.91 ± 0.46 l, P <0.05 compared with day 3), and
consequently a strong decrease in fluid balance (day –3: +2.10 ± 0.56
l, P <0.001; day –2: +2.66 ± 1.14 l, P = 0.02; day –1: +1.41 ± 0.37 l,
P <0.001). The decreased fluid intake and fluid balances did not result
in decreased CO, GEDVI or EVLWI on days 1 to 3 compared with day
0 (mean PCCI 3.5 l/minute/m2, mean GEDVI 761 ml/m2, mean EVLWI
10.8 ml/kg).
Conclusion Our data suggest that in poor-grade SAH patients goaldirected fluid management with TPT is feasible to decrease intake and
increase diuresis without adverse effects on cardiac output or preload
parameters. Future research should assess the effect of such a protocol
on clinical outcomes.
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Introduction The receptor for advanced glycation end products
(RAGE) is a multiligand receptor of the immunoglobulin superfamily
that has been implicated in multiple neuronal and inflammatory stress
processes. In the present study, we investigated changes in RAGE
immunoreactivity and its protein levels in the gerbil hippocampus (CA1
to 3 regions) after 5 minutes of transient global cerebral ischemia.
Methods The ischemic hippocampus was stained with cresyl violet
(CV), NeuN (a neuron-specific soluble nuclear antigen) antibody and
Fluro-Jade B (a marker for neuronal degeneration).
Results Five days after ischemia–reperfusion, delayed neuronal death
occurred in the stratum pyramidale (SP) of the CA1 region. RAGE
immunoreactivity was not detected in any regions of the CA1 to 3
regions of the sham group. RAGE immunoreactivity was detected
only in the CA1 region from 3 days post ischemia, and the RAGE
immunoreactivity was newly expressed in astrocytes, not in neurons. In
addition, the level of RAGE protein was highest at 5 days post ischemia.
In brief, both the RAGE immunoreactivity and protein level were
distinctively increased in astrocytes in the ischemic CA1 region from
3 days after transient cerebral ischemia.
Conclusion These results indicate that the increase of RAGE expression
in astrocytes at post ischemia may be related to the ischemia-induced
activation of astrocytes in the ischemic CA1 region.
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PbrO2 (Licox, GMS) ICP, CPP, MABP, CVP, local brain temperature, body
core temperature, PCO2, and blood glucose among others. The cerebral
monitoring probes were inserted via a Bolt (ICP, PbrO2, microdialysis)
and an additional burr hole (CBF). All probes were positioned in the
penumbra and location was verified by brain CT. The PbrO2 arm of this
study and its significance is still underway and will be announced later.
Thirteen of the patients were successfully discharged from the ICU
while eight did not survive.
Results The final data are currently under statistical evaluation, which
will be completed at the time of presentation. However, there is
indication of a link between brain glucose levels and CBF values, but
it is not clear as to the CBF–PbrO2 correlation that is the second part
of this study under evaluation. This may be due to the fluctuation of
brain glucose because of brain ischemia, hyperemia, hypermetabolism
or hypometabolism. So far we are able to establish a correlation of CBF
and lactate/pyruvate ratio only in persistently low CBF values.
Conclusion This will be a final report of a study in human patients
with severe subarachnoid hemorrhage and traumatic brain injury. The
results indicate correlations of varying significance between the pooled
data still under statistical analysis. We hope that the outcome of our
study will be able to answer questions regarding the pathophysiology
of severe brain injury and guide us in the titration of therapy, as it is
needed by each individual patient [1-4].
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New look at the 20 mmHg ICP threshold
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Introduction We present a method based on minute-by-minute ICP
monitoring and outcome (GOS) to visualize in a clinically useful way
the dynamic aspects of secondary injury.
Methods A retrospective analysis of data from 165 adult patients from
the Brain-IT database [1]. A color-coded contour plot was made for the
association between good outcome and the number of secondary
insults of ICP during the ICU stay, as defined by continuous values of
insult duration and thresholds.
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Correlation of thermal Doppler flowmetry and microdialysis values
in patients with severe subarachnoid hemorrhage and traumatic
brain injury
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TH Bekiari4, KN Fountas5, G Vretzakis5, KN Paterakis5, A Komnos1
1
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Critical Care 2014, 18(Suppl 1):P457 (doi: 10.1186/cc13647)
Introduction The purpose of this study is to investigate the relationship
between continuously monitored regional cerebral blood flow (CBF)
and microdialysis values in severe subarachnoid hemorrhage and
traumatic brain injury patients.
Methods Advanced multimodal neuromonitoring including measurements of CBF (QFlow, Hemedex) and brain lactate, pyruvate, lactate/
pyruvate ratio, glycerol and glucose values using microdialysis
(CMA600, microdialysis) were performed in 21 patients with severe
subarachnoid hemorrhage (n = 17) and traumatic brain injury (n = 4).
Thirteen of the patients were successfully discharged from the ICU
while eight did not survive. Additional recorded parameters include

Figure 1 (abstract P458).
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Results Figure 1 visualizes in blue the region associated with good
outcome for continuous values of thresholds and durations of
secondary insults. The thick black line indicates the transition towards
the negative association region in red. A best-fit exponential curve is
superimposed. This clearly shows that insults below 20 mmHg of ICP
can be detrimental if sustained for long periods. Alternatively, they can
be tolerated for higher thresholds but only for shorter periods.
Conclusion Secondary injury is dynamic such that not only thresholds
but also insult duration are relevant. The proposed visualization goes
beyond the static 20 mmHg ICP threshold introduced in [2] and
provides a more accurate representation that could help the clinician
in identifying when the patient’s outcome could be making a turn for
the worse.
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Model of intracranial hypertension of tumor etiology in laboratory
rats
AN Kolesnikov, VI Cherniy, KA Kardash, TA Mustafin, VN Stasyuk,
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Introduction The objective of this research is the creation of an
experimental model of intracranial hypertension (ICH) of the tumor
etiology in white nonlinear rats.
Methods Work was executed in the neurophysiology laboratory on
12 white nonlinear rats, weight 280 to 320 g, preselected according
to criteria of bioethical rules. For modeling ICH in animals, standard
anesthesia was carried out. A longitudinal section was spent in the
projections of saggital suture from the frontal to occipital bone. The
offensive surgical stage anesthesia showed loss of palpebral and
lingual reflexes. Further, according to the stereotactic atlas coordinates,
a burr hole was performed, through which sterile two-component antiallergen and depyrogenized gel in the amount of 0.025 ml was applied
into the fourth ventricle with an intracerebroventricular microinjector.
The injector was at an angle of 12° in order to avoid injuring vessels,
its distal end entering a depth 4.5 mm in the fourth ventricle, and was
installed and documented in the burr hole for measuring intracranial
pressure. Monitoring during operations included: respiration, heart
rate, ECG, thermometry, and control of diuresis.
Results In all animals the heart rate decreased to an average of
180 beats/minute during 90 minutes after the introduction of the
intracerebroventricular two-component gel. Also there was a decrease
in respiration rate by an average of <70 breaths/minute. Behavioral
responses of animals were evaluated. The average intensity and the
duration of such actions as shaking, friction, licking and carding
decreased. Decline in grooming was possibly associated with breached
central regulation in the brain of studied rats. Macroscopically in
the preparation we observed a pronounced hyperemia of obtained
materials, which may indirectly indicate the syndrome of ICH. Survival
of the animals was: 3 days – 100%, 7 days – 100%, 14 days – 92%,
21 days – 83%.
Conclusion The main result of this work can be considered creation of
a successful and workable model of ICH. The developed model is the
testing ground to assess especially anesthesia protection in patients
with the syndrome of ICH including tumor etiology and has no analogs.
P460
Arterial–jugular bulb differences in pCO2, lactate, serum sodium
and C-reactive protein in neurocritical patients
M Canitrot, S Ugarte
INDISA Clinic, Santiago, Chile
Critical Care 2014, 18(Suppl 1):P460 (doi: 10.1186/cc13650)
Introduction Several reports indicate the potential usefulness of
monitoring brain metabolic parameters and their correlation with the
system [1-4]. We want to establish differences and correlation in pCO2,

Figure 1 (abstract P460).

lactate, serum sodium and C-reactive protein (CRP) between arterial
and jugular venous bulb blood.
Methods An observational study. Between 1 January and 31 October
2013 we included neurocritical patients (NCP) with multimodal
neuromonitoring (MMN). Daily samples of arterial blood and venous
jugular bulb blood were obtained for measuring pCO2, lactate, serum
sodium and CRP.
Results There were 45 NCP, six (13%) with MMN (five men). Mean age
was 37 ± 11 years (35 to 61). Diagnostics: two TBI, two SAH, one stroke,
one lupus encephalitis. APACHE II was 27 ± 6.5 (25 to 39). Glasgow
Coma Scale at admission was 14 ± 4 (4 to 14). pCO2 (mmHg): arterial
41 ± 6.3 versus jugular 45 ± 7.4 (r = 0.7, P = 0.007). Lactate (mg/dl):
arterial 11 ± 5.6 versus jugular 13.5 ± 3.9 (r = 0.7, P = 0.9). Sodium (mEq/dl):
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arterial 141 ± 4.5 versus 141 ± 4.4 (r = 0.8, P = 0.15). CRP (mg/dl): arterial
8 ± 7.4 versus 17 ± 11.6 (r = 0.9, P <0.001). The correlation and trend
curves are shown in Figure 1.
Conclusion A suitable correlation is observed for the arterial–jugular
bulb in different variables. There is a significant difference in CRP and
pCO2 values being persistently higher in the jugular, particularly for
CRP. Studies are required to define its interpretation and potential
usefulness.
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Introduction After a subarachnoid hemorrhage (SAH), delayed
cerebral ischemia (DCI) remains the principal cause of morbid
mortality. F2-isoprotanes are recognized as biomarkers of DCI. These
lipid metabolites, by fixing the thromboxane and prostaglandin
(TP) receptor, induce vasoconstriction and platelet aggregation. Our
objective was to evaluate the efficacy of terutroban (TER), a TP receptorspecific antagonist, in preventing DCI after SAH.
Methods Twenty rats were assigned to one of three groups: a double
250 μl intracisternal injection (ICI) was realized with saline in the
CONTROLS group (n = 6) or with autologous arterial blood in the SAH
(n = 8) and SAH+TER (n = 6) groups. Treated animals received an oral
administration of 30 mg/kg/day TER during 5 days following blood
injection. Rats were evaluated using a functional isotope imaging
technique (high-resolution microSPECT). Brain capture of three 99m
technetium radiolabeled tracers was evaluated: HMPAO at day (D) 0, 2
and 5 for cerebral perfusion quantification, DTPA at D3 for blood–brain
barrier (BBB) integrity study and annexin V-128 at D4 for apoptotic
activity study. Radioactivity was measured in a predefined region of
interest: cerebrum, cerebellum and brainstem. Statistical analysis: oneway ANOVA followed by Student’s t test.
Results Brain HMPAO perfusion microSPECT (Figure 1) reveals a
transient hypoperfusion after ICI (D2) and a lasting hypoperfusion in
the SAH group. TER curtailed the SAH-induced decrease of the HMPAO
uptake. TER also significantly counteracted the SAH-induced increase
of DTPA in the brainstem (SAH 2.6 ± 0.7 vs. SAH+TER 1.3 ± 0.1 ppm/
mm3; P <0.05) and increase of annexin V-128 in the cerebrum (SAH
1.2 ± 0.1 vs. SAH+TER 1 ± 0.06 ppm/mm3; P <0.05).
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Conclusion We made the first microSPECT scan description of a DCI
rat model. After induction of SAH, TER improves cerebral perfusion,
prevents BBB disruption in the brainstem and decreases apoptotic
phenomenon in the cerebrum.
P462
Accuracy of transcranial color-coded duplex sonography in
predicting clinical vasospasm and delayed cerebral ischemia in
patients with subarachnoid hemorrhage
F Di Corte, S Pifferi, L Capuano, S Magnoni, V Conte, F Ortolano, N Stocchetti
Fondazione IRCCS Cà Granda – Ospedale Maggiore Policlinico, Milan, Italy
Critical Care 2014, 18(Suppl 1):P462 (doi: 10.1186/cc13652)
Introduction Cerebral vasospasm (VSP) and delayed cerebral ischemia
(DCI) play a central role in worsening the neurological outcome
in patients with aneurismal subarachnoid hemorrhage (aSAH) [1].
Transcranial color-coded duplex sonography (TCCS) is a non-invasive
tool to detect VSP and predict DCI, but its clinical utility is limited by
low accuracy. Our aim was to perform a sensitivity/specificity analysis
of TCCS in predicting clinical VSP and DCI.
Methods Consecutive patients admitted to our ICU for aSAH were
enrolled in the study. CBF-Vm and the pulsatility index (PI) were
obtained by TCCS in both mean cerebral arteries (MCAs) at two
scheduled time points, <3 days (T1) and 7 to 10 days (T10), and at
least once every other day after bleeding. The highest Vm between
left and right and the corresponding PI were chosen for analysis. All
patients underwent brain MRI plus TOF-MRI angiography at T1 and
T10 to assess radiologic VSP. Symptomatic VSP was defined as a new
neurologic deficit associated with radiological VSP. The occurrence of
DCI was evaluated on DWI sequences. The C statistic (ROC curves) and
nonparametric t test were used for analysis.
Results Forty-three consecutive patients were recruited. Thirty-seven
patients had simultaneous TCCS measures and MRI (mean age 58 years,
28% WFNS 4 to 5). Eleven patients (30%) developed symptomatic VSP
and 26 (70%) did not (NVSP). Vm increased significantly from T1 to T10
in both groups (VS: P = 0.03, NVSP P = 0.01). The accuracy of TCCS at T10
(Vm) for predicting vasospasm was described by an AUC of 0.86 (CI =
0.74 to 0.98) and a cutoff value >115 cm/seconds (90% sensitivity, 73%
specificity). Interestingly, a cutoff value >168 cm/second corresponded
to the best specificity (92% specificity), but low sensitivity (45%). The
accuracy of PI for predicting VSP was lower (AUC 0.75). The accuracy of
TCCS for predicting DCI was also poor (AUC 0.57). Considering larger
DCI only (volume >2 ml), the accuracy was slightly increased (AUC 0.75).
Conclusion TCCS is useful to predict clinical VSP with good accuracy.
The Vm cutoff value >115 cm/second might be considered as a warning
threshold, while higher values (>168 cm/second) identify high-risk
patients. The accuracy of TCCS in predicting DCI is low, which indicates
that mechanisms other than VSP are likely to play a role.
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Figure 1 (abstract P461). HMPAO uptake at day 2 and day 5. *P <0.01
versus day 0; #P <0.01 versus day 2; ‡P <0.01.

Introduction The aim was to evaluate the prognostic importance of
the MRI examination using Block Design fMRI in patients in a vegetative
state (VS).
Methods Twenty-two patients corresponding to the international
standards of VS underwent high-resolution MRI (T2 and T1, isomatrix
with slice thickness 1.00 mm, T2 FLAIR FS, DWI, SWI) examination and
Block Design fMRI (paradigm of passive speech). The patients were
aged from 4 to 42 years. Causes of VS: TBI in 19 patients, hypoxia in
three patients. By the time of the examination the patients were in VS
from 1 to 4 months.
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Results Wernicke’s area activation was observed in nine patients
(eight patients with TBI, one with hypoxia). During the subsequent
examination, which lasted from 3 to 12 months, seven patients with
activated Wernicke’s area showed further consciousness expansion up
to the minimal consciousness state (further consciousness expansion
was seen in two patients). Two other patients with activated Wernicke’s
area did not show any signs of consciousness. Two patients revealed
significant activity in the Broca’s area.
Conclusion According to the first results of the study one can conclude
that behind the outwardly similar clinical symptoms in patients in VS
lies a diverse (due to the organization of brain functions) group of
patients. fMRI enables one to reveal the first signs of cognitive activity;
that is, reveals the linguistic value of speech addressed to the patient
which cannot be detected during routine neurological examination.
P464
Brain death determination in Europe: one condition with too many
nuances
IA Crippa, A Bronco, A Vargiolu, G Citerio
San Gerardo Hospital, Monza, Italy
Critical Care 2014, 18(Suppl 1):P464 (doi: 10.1186/cc13654)
Introduction A patient is declared brain dead (BD) when physicians
determine permanent loss of brain functions. Unfortunately, criteria for
defining BD vary across different countries [1]. We therefore decide to
survey BD diagnostic modalities in Europe in order to describe differences.
Methods A multiple-choice questionnaire was developed on an online
platform [2]. Direct link was sent to national representatives of the
European Society of Intensive Care Medicine and NeuroIntensive Care
section’s members. Thirty-three countries were contacted. Answers were
reviewed. In cases of discrepancies or missing data, participants were
contacted for further clarification. Descriptive statistics have been applied.
Results Twenty-eight participants returned the questionnaire (85%).
Every country has either specific law (93%) or guidelines issued by the
scientific society (89%). Clinical examination, essential to the diagnosis,
is the only requirement in 50% of countries. Coma, apnea, absence
of corneal and cough reflexes are always necessary. Blood pressure
and electrolytes are checked in 64% as mandatory prerequisites. The
apnea test is legally defined in 86% of countries. Eighty-two percent
of countries require achievement of a target paCO2 level while the
Netherlands’ law states target apnea duration. Number of physicians
(median 2, range 1 to 4), number of clinical examinations (median 2,
1 to 3), and minimum observation time (median 3 hours, 0 to 12) are
variable requisites in different countries. In 50% of nations, additional
tests are required. Hypothermia (4%), anoxic injury (7%), inability
to complete clinical examination (61%), toxic drug levels (57%),
and inconclusive apnea test (54%) are legal indications to perform
additional tests. Cerebral blood flow investigation is mandatory in 18%
of countries, while it is either optional or used only in selected cases
in 82%. Conventional angiography is still the preferred method (50%),
followed by transcranial Doppler (43%), angioCT (39%), CT perfusion
and angioMR (11%). EEG is always (21%) or optionally (14%) recorded.
Russia and Croatia evaluate both EEG and cerebral blood flow (7%).
Conclusion There are still areas of uncertainty and disparities in
brain death diagnosis in European countries. This predisposes to
misdiagnosis and confusion both for clinicians and families. Measures
to promote uniformity of brain death procedures and clinical practice
are therefore desirable.
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What do brain-dead patients ultimately die of?
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Introduction After a patient is declared brain dead, the cessation or
withdrawal of therapy in Japan is quite a difficult operation because
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of the legal issues involved. Therapy is continued except in the case of
donation of organs for transplantation from brain-dead patients until
their cardiac arrest. Consequently, we may determine what the final
cause of death is in brain-dead patients. Our hypothesis is that braindead patients ultimately die of cardiac failure.
Methods From January 2011 to December 2012, brain-dead
adult patients in our ICU were investigated. The declaration of
brain death is determined by clinical neurological examinations,
electroencephalography, and the auditory brain-stem response test.
Age, sex, primary diagnosis, Glasgow Coma Scale (GCS) on admission,
the number of days from the diagnosis of brain death until cardiac
arrest (days), the final cause of cardiac arrest, urine volume for the
last 24 hours (ml), serum potassium levels (mEq/l), PaO2 (mmHg) and
PaCO2 (mmHg) on the last day were evaluated. Values are expressed
as mean ± SD. Data were analyzed by Kruskal–Wallis test and Mann–
Whitney U test. P <0.05 was considered statistically significant.
Results Of a total 1,221 patients admitted to our ICU, 37 patients (18
men, 19 women, age 65 ± 20) were clinically diagnosed with brain
death. Primary diagnoses were 18 post-cardiac arrest syndromes,
14 cerebrovascular diseases, and four traumatic subarachnoid
hemorrhages. GCS on admission was 4.5 ± 2.7 and days to cardiac
arrest after diagnosed brain death was 8.6 ± 13.2. Urine volume for the
last 24 hours was 997 ± 1,712 and serum potassium level was 4.8 ± 1.7.
PaO2 and PaCO2 were 131.9 ± 80.6 and 48.9 ± 13.8, respectively. The
final causes of cardiac arrest were 20 cardiac failures, 11 renal failures
and six respiratory failures, although with mechanical ventilator
support. The final cause of cardiac arrest due to respiratory failure had
significantly longer stay in the ICU and days after diagnosis of brain
death than cardiac failure or renal failure (27.2 ± 22.6 days vs. 9.2 ± 10.0
and 8.1 ± 4.6, P <0.05; 23.2 ± 24.0 vs. 6.0 ± 9.0 and 5.4 ± 5.2, P <0.05,
respectively).
Conclusion There were significantly longer days until final cardiac arrest
that was caused by respiratory failure than by cardiac failure or renal
failure. Many different observations in each case were shown, such as
urine volume or potassium level on the last day. Not only cardiac failure
but also other failures might lead to final cardiac arrest.
P466
Acute and long-term outcomes of ICU-acquired weakness: a cohort
study and propensity matched analysis
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D Mesotten2, A Wilmer1, MP Casaer2, P Meersseman1, Y Debaveye2,
PJ Wouters2, R Gosselink2, G Van den Berghe2
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Critical Care 2014, 18(Suppl 1):P466 (doi: 10.1186/cc13656)
Introduction ICU-acquired weakness is a frequent complication of
critical illness. It is unclear whether it is a marker or mediator of poor
outcomes. We aimed to determine acute and long-term outcomes and
costs of ICU-acquired weakness among long-stay (≥8 days) ICU patients
and to assess the impact of recovery of weakness at ICU discharge.
Methods Data were prospectively collected during an RCT (Clinical
trials.gov: NCT00512122) [1,2]. Impact of weakness (MRC sum <48) on
outcomes and costs was analyzed with 1:1 propensity score-matching
for baseline characteristics, illness severity and risk factor exposure
prior to assessment. Among weak patients, impact of persisting
weakness at ICU discharge on risk of death after 1 year was examined
with multivariable Cox proportional-hazard analysis.
Results A total 227 of the 405 (56%) long-stay assessable ICU patients
were weak; 122 weak patients were matched to 122 not-weak patients.
As compared with matched not-weak patients, weak patients had
a lower likelihood at any time for live weaning from mechanical
ventilation (HR: 0.709 (0.548 to 0.918), P = 0.009), live ICU (HR: 0.738
(0.570 to 0.955), P = 0.021) and hospital discharge (HR: 0.682 (0.521 to
0.893), P = 0.005). In-hospital costs/patient (+30.5%, €+5,443/patient,
P = 0.04) and 1-year mortality (30.6% vs. 17.2%, P = 0.015) were also
higher. The 105/227 (46%) weak patients not matchable to not-weak
patients had even worse prognosis and higher costs. At any time
within the first year following ICU admission, compared with patients
who recovered from weakness and adjusted for potential confounders,
those with persistent weakness and MRC sum between 36 and 47 at
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ICU discharge had a higher likelihood of death (HR: 1.937, 95% CI: 1.048
to 3.581, P = 0.035). This likelihood of late death was even higher for
those patients with a more severe degree of persistent weakness (MRC
sum <36) (HR: 1.815, 95% CI: 3.693 to 7.514, P <0.001).
Conclusion Patients with ICU-acquired weakness had worse acute
morbidity outcomes, consumed more resources and revealed higher
mortality after 1 year than patients without weakness. Persistence of
weakness at ICU discharge further increased late mortality.
Acknowledgement GH and HVM contributed equally to this study.
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Introduction An early diagnosis of ICU-acquired weakness (ICU-AW)
is difficult because disorders of consciousness preclude strength
assessment [1]. Electrophysiological (EMG) studies may be an
alternative approach [2]. In this study we investigated feasibility and
diagnostic accuracy of EMG studies to diagnose ICU-AW in unconscious
patients.
Methods Newly admitted unconscious ICU patients (RASS <–3),
ventilated for ≥2 days, were included in this single-center prospective
cohort study. EMG testing included ulnar (motor/sensory), peroneal
(motor) and sural (sensory) studies. Myography was performed
when coagulation was normal (dorsal interossei I/II, deltoid and
tibial muscles). Reliability of results was checked by an experienced
neurophysiologist, blinded for strength. Motor/sensory studies were
abnormal if amplitudes were below the 2.5th percentile reference
values [3]. Myography was abnormal if spontaneous abnormal activity
was found in ≥1 muscles. Upon awakening, strength was assessed (ICUAW: average MRC <4 [1]), blinded for EMG. Feasibility was determined
as the percentage of measurements that could be performed and
were reliable. Diagnostic accuracy was analyzed using sensitivity and
specificity.
Results We included 35 patients (ICU-AW: 17). EMG testing was done
on day 4 (IQR: 3 to 6). Feasibility was 94%, 89%, 77%, 34% and 31%
for ulnar motor, peroneal motor, ulnar sensory, sural sensory and
myography studies, respectively. Figure 1 displays amplitude values.
Sensitivity/specificity was 100%/0%, 100%/31%, 31%/100%, 50%/25%
and 67%/38%, respectively.
Conclusion Feasibility of ulnar and peroneal studies was acceptable;
feasibility of sural and myography studies was low. Diagnostic accuracy
was low for all studies. This may be improved with new reference values.

Figure 1 (abstract P467). Dotted lines represent 2.5th percentile
reference values [3].
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Introduction Cerebral near-infrared spectroscopy (NIRS) represents
an exciting prospect for the non-invasive monitoring of cerebral
tissue oxygenation in traumatic brain injury (TBI). Earlier attempts at
clinical application of cerebral NIRS demonstrated that further work
was needed [1]. The basic layout of the probe portion of these devices
consists of a light source and a light detector, arranged at calculated
distances and configurations in order to observe target tissue. We aim
to determine which commercially available NIRS probe represents the
most sensitive layout of sources/detectors for the greatest sensitivity in
observing tissue oxygenation at the optimal depth for TBI.
Methods The optimal depth for grey matter target tissue (grey–white
matter junction) was ascertained by reviewing a series of brain CT
scans of patients who had sustained a TBI. Set (average) measurements
were derived from these identifying the target depth of the grey
matter strip from the point of probe placement. Currently there are
five commercially available cerebral NIRS systems. Table 1 presents the
variety of configurations offered by each device. Source detector layouts
were modelled and simulated using the NIRFAST® computational light
modelling software (developed at the University of Birmingham) [2].
The novel approach of this modelling system makes no extrapolated
assumptions based on subtraction.

Figure 1 (abstract P468). Light scatter predictions of available systems/
probes illustrated.
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Table 1 (abstract P468). Available source detector layouts
Probe

Wavelengths (nm)

Sources

Detectors

Spacing (mm)

Peak depth sensitivity

Optiplex TX (ISS, IL, USA)

690, 830

4

1

30, 35, 40, 45

8

INVOS (Covidien, MA, USA)

730, 810

1

2

30, 40

8

EQUANOX (Nonin, MN, USA)

730, 810, 880

2

2

20, 40

7

FORE-SIGHT (CAS Medical, CT, USA)

690, 780, 805, 850

1

2

20, 50

10

NIRO-200NX (Hamamatasu, Japan)

735, 810, 850

1

2

19.2, 20

9
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Single-subject assessment of the distribution of white matter
abnormalities measured by diffusion tensor imaging in patients
with severe traumatic brain injury
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Figure 2 (abstract P468). CT measurements and sensitivities at depth.

Results We reviewed 32 trauma series CT brain images and the
average depth to grey matter was derived as 21.37 mm (range 16.59
to 31.03 mm, SD 2.33) from the surface (Figure 1). The spectrum of
sensitivity of the five probes was modelled (Figure 2). As is apparent
here, the FORE-SIGHT (CAS Medical, CT, USA) probe currently offers the
greatest sensitivity at our derived target depth.
Conclusion Based on the computational modelling of our work,
the FORE-SIGHT NIRS device by CAS Medical source detector layout
provides the greatest sensitivity at depth for the purposes of cortical
monitoring in trauma. Variations in the layout have a significant impact
on the quality of signal detected.
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Introduction Traumatic axonal injury (TAI) is a major contributor to
adverse outcomes following traumatic brain injury (TBI). Diffusion
tensor imaging (DTI) is a magnetic resonance imaging technique,
which provides a robust measure of white matter integrity in patients
with TBI. Certain brain regions have been identified as particularly
susceptible to TAI by means of DTI. Few studies, however, have focused
on describing the distribution of DTI abnormalities in individual TBI
patients. The aim of this project was to conduct an exploratory analysis
of the extent and distribution of axonal injury in TBI patients at a singlesubject level.
Methods Patients admitted to the ICU for severe TBI underwent brain
MRI and DTI (32 directions, b = 1,000, voxel size 2 × 2 × 2 mm3) between
2 weeks and 3 years after injury. For each individual patient, we
enrolled five age-and-sex-matched healthy volunteers who underwent
the same DTI protocol and were used as controls (31 total). We used a
region of interest (ROI) automated analysis [1] to quantify white matter
integrity. The fractional anisotropy (FA) maps were segmented using a
white matter parcellation map covering the entire brain. Our primary
outcome was the normalized difference in FA between each patient
and the controls. Abnormalities were defined as values that were more
than 2 SD below the mean of the values for the matched controls for
each ROI.
Results Twelve TBI patients with a median age of 30 years (range 20 to
38) and a median GCS of 5 (range 5 to 7) were included. The majority of
them had diffuse axonal injury according to CT and conventional MRI.
Analysis of individual ROIs revealed that all subjects had numerous
abnormal ROIs, varying from 14 to 64 (median 21) out of 78 regions
assessed. The most frequently altered regions were the frontal lobe,
orbital–frontal regions, corpus callosum, internal capsules, superior
and inferior longitudinal fasciculi, cingulum, cerebellar structures and
corona radiata. Thalamus, hippocampus and occipital lobes were less
frequently affected.
Conclusion The extent and distribution of TAI varies on a patient
basis. These findings highlight the need for standardized methods to
precisely assess TAI in single subjects. Such single-subject methods will
probably improve prognostic accuracy and may be useful in clinical
trials.
Reference
1.

[www.mristudio.org]

P470
Long-term outcome after severe traumatic brain injury
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Introduction Traumatic brain injury is a major public health issue,
which results in significant mortality and long-term disability [1,2]. The
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profound impact of TBI is not only felt by the individuals who suffer
the injury but also their caregivers and society as a whole. In this study
we observed the long-term outcome of patients with severe traumatic
brain injury admitted to our intensive care.
Methods This study includes all patients (n = 160) with severe head
trauma (GCS <9) admitted to the ICU of the emergency department
of a tertiary referral center (Careggi Teaching Hospital, Florence, Italy)
from 2009 to 2012. All patients will undergo a clinical assessment
after 1 year, which is routine post-intensive follow-up. As an objective
index of ability to function after injury, the Glasgow Outcome Scale
(GOS) will be used. The neurological evaluation to determine the
outcome of patients by GOS is performed in two different modes. All
eligible patients 1 year after discharge from the ICU are contacted by
telephone by a nurse of the intensive care staff and invited to make a
visit to the surgery follow-up, where a intensivist evaluates the patient
and determines the GOS. For the patients who were still hospitalized at
6 months in rehabilitation departments, GOS assessment is performed
by a doctor of the structure and notified by telephone.
Results The ICU and hospital mortality was respectively 33.7% (n =
54) and 36.9% (n = 59). The mortality at 1 year was 44.4% (n = 71). The
results of the neurological follow-up at 1 year were: GOS 2: 5.6% (n = 9),
GOS 3: 10% (n = 16), GOS 4: 13.1% (n = 21), GOS 5: 26.9% (n = 43).
Conclusion According to the other studies, our data confirm that the
severe traumatic brain injury is associated with a high mortality at 1
year. One-half of the survivors have a different level of disability.
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Introduction Recent studies have shown that 1,25-dihydroxyvitamin
D3 (vitamin D) deficiency may affect negatively the clinical course of
traumatic brain injury (TBI) [1]. This problem becomes important with
respect to the older patient considering a 50% prevalence of vitamin
D deficiency [2]. Data from the Third National Health and Nutrition
Examination Survey [3] document more than 60% of Caucasians
affected by D deficiency [4] so that all patients with TBI of any age are
theoretically at risk of unfavorable outcome [2]. The objective of this
preliminary study was to determine whether low levels of vitamin D at
admission to the ICU (<24 hours) could negatively affect neurological
recovery of patients with TBI.
Methods We retrospectively analyzed the data of 46 patients affected
by TBI (65% severe, 9.5% moderate, 28.5% moderate) both isolated or
associated with other extracranial lesions. The sampling of vitamin D
was carried out within 24 hours from ICU admission. We had registered
GCS at the moment of presentation (GCS in) and at discharge (GCS
out) and their difference (GCS diff ) compared with levels of vitamin D.
Patients that died in the ICU were assigned a GCS out = 0. See Table 1.
Results Our data, according to other studies [5], confirm the presence of
a deficiency of vitamin D (Table 1); however, they do not demonstrate a
statistical significance correlation at the univariate regression (R = 0.04;
P = 0.786) between vitamin D level and outcome from the ICU. There
was no correlation stratifying patients for age, for TBI class, for Injury
Severity Score and for BMI.
Conclusion Vitamin D deficiency is really prevalent in our TBI cases
but does not seem to affect neurological recovery at ICU discharge;
however, these preliminary results should be exposed to several
criticisms and need to be confirmed with prospective studies.
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Table 1 (P471)
TBI
Descriptive statistics
Dead

8.70%

Isolated Associated P value
Percentage

22

78

Male

87%

GCS in

4±3

8±5

0.043

Age

50 ± 21

GCS out

10 ± 4

10 ± 5

0.933

BMI

26.36 ± 4.14

GCS diff

6±4

3±6

0.151

ISS

29 ± 15

Vitamin D (ng/ml)

17 ± 8.5

17 ± 9.8

0.597

Vitamin D
deficiency
(<30 ng/ml)

73.90%

Length of
stay ICU (days)

12 ± 7

8±9

0.261

2.

3.

4.
5.

Milos C, et al.: Combination treatment with progesterone and vitamin D
hormone may be more effective than monotherapy for nervous system
injury and disease. Neuroendocrinology 2009, 30:158-172.
Plan and Operation of the Third National Health and Nutrition Examination
Survey, 1988–94. DHHS publication No. (PHS)94-1308 – Vital and Health
Statistics, series 1, no. 32. Hyattsville, MD: US Department of Health and
Human Services, Public Health Service, CDC; 1994.
Khazai N, et al.: Calcium and vitamin D: skeletal and extraskeletal health.
Curr Rheumatol Rep 2008, 10:110-117.
Cecchi A, et al.: Vitamin D deficiency in septic patients at ICU admission is
not a mortality predictor. Minerva Anest 2011, 77:1184-1189.
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Introduction Severe traumatic brain injury (TBI) is a major cause
of death in people between 19 and 45 years old. Gastrointestinal
dysfunction is the most common complication due to mucosal
ischemia, motility disorders, and disruption of the gut barrier, with
severe consequences: malnutrition, weight loss, and high risk of
infections [1]. Therefore, maintaining the intestinal barrier function is
a systematic engineering project. Selected new probiotics due to the
capacity to bind and neutralize toxins, and to interfere with pathogen
adherence, by immunomodulatory properties, mopping up the
infection, could improve recovery of critically ill patients [2]. Our aim
was to assess the effects of a new probiotic in an early enteral regimen
on clinical outcome of severe TBI patients, in terms of VAP incidence,
tolerance to enteral nutrition, duration of mechanical ventilation, and
mortality rate.
Methods A prospective randomized 1-year study of 64 patients 19
to 78 years old allocated to receive for 10 days either an early enteral
diet plus a new probiotic (Bioent; Lactobacillus bulgaricus 10 trillion
CFU/cp + activated charcoal) every 6 hours (Group A) or the same
formula without probiotics (Group B). The diets were isocaloric and
isonitrogenous, and there were no differences between groups in
gender, age, and nutritional status. We assessed the VAP incidence,
duration of mechanical ventilation, tolerance to enteral nutrition,
length of ICU stay, duration of diarrhea episodes, and mortality rate.
The ANOVA test and t test were carried out; P <0.05 was considered
significant.
Results The infection rate was higher in group B, the duration of
mechanical ventilation was shorter in group A, and the patients in
group A received 91.7% of total caloric needs by an enteral route versus
74.68% in group B. There is a significant difference in the number of
diarrhea episodes, and the ICU length of stay was significantly lower
in group A; there was no significant difference in the mortality rate
between groups. See Figure 1.
Conclusion Early administration of new probiotics to severe TBI patients
could have beneficial effects in terms of reduction of GI dysfunction,
VAP incidence and length of ICU stay.
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Figure 1 (abstract P472).
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Effect of blood alcohol level on outcome of patients with traumatic
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Introduction We investigated whether blood alcohol levels (BAL) had
any impact on presentation and outcome in patients with traumatic
brain injury (TBI).
Methods Forty-six patients with TBI requiring intubation between
January 2000 and December 2012 were included. Patients were
grouped into BAL-positive (>0.5‰; n = 24) and BAL-negative (<0.5‰;
n = 22). Physiological parameters and outcome (survival to hospital
discharge (STHD)) and neurological outcomes (Glasgow Outcome
Scale (GOS), Cerebral Performance Category (CPC) and Glasgow Coma
Scale (GCS)) were analyzed. Differences between groups were analyzed
using Student’s t test and results presented as mean ± SD.
Results There were no significant differences in gender and age
distributions between the BAL-negative and BAL-positive groups (73%
vs. 88% male; P = 0.218; 53 ± 21 vs. 43 ± 17 years; P = 0.098). There were
also no differences in initial systolic blood pressure (BP; 144 ± 30 vs.
132 ± 37 mmHg; P = 0.241) and respiratory rate (RR; 13 ± 6 vs. 12 ± 7/
minute; P = 0.891) but BAL did affect the initial GCS score (7 ± 3 vs. 5 ± 2;
P = 0.022). There was no effect on CPC (3.5 ± 1.9 vs. 2.8 ± 1.8; P = 0.185),
GOS (2.4 ± 1.8 vs. 3.0 ± 1.7; P = 0.270), and GCS at discharge from the
hospital (14 ± 2 vs. 14 ± 2; P = 0.801). There were also no differences in
length of hospital stay (LOHS; 15 ± 23 vs. 23 ± 34; P = 0.372) and STHD
(1.6 ± 0.5 vs. 1.3 ± 0.5; P = 0.083).

Conclusion BAL did not have a significant effect on presenting
physiological parameters such as systolic BP and RR. It did, however,
affect the presenting GCS score, which was significantly lower in the
BAL-positive group. BAL did not seem to have an effect on functional
outcome or mortality measured by STHD. No favorable neuroprotective
or deleterious effect was observed, demonstrated by no significant
differences in CPC, GOS or GCS scores at discharge.
P474
Long-term outcome prediction using IMPACT and APACHE II in
patients with traumatic brain injury treated in the ICU
R Raj, R Kivisaari, J Siironen, M Skrifvars
Helsinki University Central Hospital, Helsinki, Finland
Critical Care 2014, 18(Suppl 1):P474 (doi: 10.1186/cc13664)
Introduction The International Mission for Prognosis and Analysis of
Clinical Trials (IMPACT) is currently the most robust prognostic model
in patients with traumatic brain injury (TBI). No studies have compared
this TBI-specific prediction model with general ICU models, such as the
Acute Physiology and Chronic Health Evaluation II (APACHE II) [1,2]. This
study investigates the performance and the correlation of the IMPACT
and APACHE II models for long-term outcome prediction in patients
with TBI.
Methods The study population consisted of TBI patients admitted to
a designated ICU in southern Finland during a 4-year period (2009
to 2012). The IMPACT and APACHE II performances were assessed by
calculating discrimination (by area under the curve), calibration (by
GiViTI calibration test and Hosmer–Lemeshow C statistic) and precision
(by Brier score). Correlation between the IMPACT and APACHE II was
tested by Spearman’s rho. Primary outcome was 6-month mortality.
Results Of the total 897 included patients, overall 6-month mortality
was 22%. The IMPACT and APACHE II showed similar AUCs (0.81, 95%
CI = 0.77 to 0.84; 0.80, 95% = CI 0.76 to 0.83) and Brier scores (0.134,
0.135). Calibration tests revealed significant (P <0.05) deviations
between observed and predicted risk for both models. A moderately
strong, positive correlation between the IMPACT and the APACHE II
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Results During an 8-month period, 61 patients (mean age
56.4 ± 18.5 years, mean APACHE II score 11.4 ± 6.5, mean GCS 13 ± 2)
were enrolled. The overall sensitivity and specificity for CAM-ICU (62%
and 74%, respectively) and ICDSC (64% and 79%, respectively) were
similar. The overall kappa for inter-rater reliability for the CAM-ICU and
ICDSC was 0.64 and 0.68, respectively. In subgroup analyses, the CAMICU and ICDSC showed increased sensitivity and decreased specificity
in moderate TBI as well as deeper levels of sedation (RASS –2 to –3).
Conclusion Criterion validity and inter-rater reliability of the CAM-ICU
and ICDSC were good. Severity of TBI and depth of sedation influence
delirium assessments. Clinicians should be aware of those limitations
before using these clinical tools in this population.
P476
Functional status after 3 years in ICU patients with traumatic brain
injury
M Delange van der Kroft1, M Arias-Verdú2, E Banderas-Bravo2,
E Curiel-Balsera2, A Muñoz-Lopez2, J Fernandez-Ortega2,
R Rivera-Fernandez2, M Prieto-Palomino2
1
County Hospital of Axarquia, Velez Malaga, Spain; 2Carlos Haya University
Hospital, Malaga, Spain
Critical Care 2014, 18(Suppl 1):P476 (doi: 10.1186/cc13666)
Figure 1 (abstract P474). Area under the curve for the new models.

was noted (Spearman’s rho = 0.566, P <0.001). The IMPACT and the
APACHE II were found to identify slightly different groups of patients
that eventually do not survive (Figure 1).
Conclusion The IMPACT and the APACHE II models showed equal
performance for 6-month mortality prediction. A moderately strong,
positive correlation, with some major discrepancies between the
models, was found. Thus, features of both the IMPACT and APACHE II
models are valuable for optimal outcome prediction in patients with
TBI treated in the ICU.
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Introduction The Confusion Assessment Method for the ICU (CAMICU) and the Intensive Care Delirium Screening Checklist (ICDSC) are
recommended for routine delirium screening. However, literature
about delirium assessment in traumatic brain injury (TBI) remains
scarce. The aim of our study was to evaluate the validity and reliability
of the CAM-ICU and the ICDSC for delirium assessment in patients with
mild to moderate TBI.
Methods A prospective observational study of mild to moderate TBI
adult patients in two critical care trauma centers. Patients underwent
delirium assessment on days 3, 5 and 7 with the CAM-ICU and the
ICDSC. Psychiatrists or neurointensivists evaluated delirium using the
DSM-IV criteria for delirium. Assessments results were blinded and
performed independently. Criterion validity of the CAM-ICU and the
ICDSC were calculated from 2 × 2 frequency tables using standard
definitions of sensitivity, specificity, positive and negative predictive
value, and overall accuracy. Because delirium was assessed repeatedly,
estimates of 95% CIs for binary repeated data using generalized
estimating equation in conjunction with the Huber–White estimator
were performed. Inter-rater reliability for the CAM-ICU and ICDSC was
assessed with the kappa coefficient.

Introduction The aim was to study the functional status at 1 year and
after 3 years in ICU patients with traumatic brain injury (TBI).
Methods A prospective cohort study of patients with TBI admitted to
Carlos Haya Hospital, Malaga, between 2004 and 2008.
Results We studied 531 patients, age 40.35 ± 19.75 years, APACHE II
17.94 ± 6.97, GCS admission 7.53 ± 3.83 points. Cranial tomography
at admission was: diffuse injury type I (10.4%), diffuse injury type
II (28.1%), diffuse injury type III (24.5%), diffuse injury type IV (8.3%),
evacuated mass lesion (22.6%), non-evacuated mass lesion (6.2%).
Hospital mortality was 28.6%. One-year mortality was 171 (32.2%)
(missing: 6.6%). After 3 years, mortality was 181(34.1%) (16.2% missing).
We followed 496 patients for 1 year after admission (35 were missing)
and assessed their functional status using the GOS. Thus, 22.7% were
normal and 20% presented some limitations but were self-sufficient,
representing 55.6% of those who survived hospital admission. A
total of 57.3% presented bad evolution (died: 34.5%, vegetative: 3%,
disabled not self-sufficient: 19.8%). After 3 years we followed 445
patients and 86 (16.2%) were missing. Thus, 132 patients (29.7% of 445
patients) were normal and 15.3% presented some limitations but were
self-sufficient, representing 75.76% of those who survived hospital
admission. Fifty-six percent of 445 patients presented bad evolution
(died: 40.7%, vegetative: 2.2%, disabled not self-sufficient: 12.1%). Of
445 patients studied after 3 years of admission 171 died, and of the 274
who survived 198 (72.2%) were in a similar functional situation after
1 year, 11 (4.01%) had worsened functional situation, of which 10 had
died, and 65 (27.72%) had improved situation (P <0.001).
Conclusion This study shows that approximately 75% of the patients
who survived after 3 years from admission to the ICU with traumatic
brain injury presented good recovery with functional situation normal
or with some limitations but self-sufficient. Between 1 and 3 years after
admission, approximately 25% of patients improved their functional
situation.
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Demographic profiles and extent of critical care resources
utilisation in patients with severe traumatic brain injury: a Tan Tock
Seng Hospital National Neuroscience Institute study
J Yang1, JZ Wee2, CT Chong1
1
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Introduction Trauma is the fifth principal cause of death in Singapore,
with traumatic brain injury (TBI) being the leading specific subordinate
cause [1].
Methods This 8-year retrospective review of patients with severe
TBI admitted to the neuroICU (NICU) of the National Neuroscience
Institute, Tan Tock Seng Hospital between 2004 and 2011 reports the
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demographic profiles of severe TBI in the local context, with implications
in the management of severe TBI, particularly the utilisation of critical
care resources.
Results A total of 780 patients were admitted with TBI during the
study period, of which 365 patients (46.8%) sustained severe TBI. The
majority (75.3%) of the severe TBI patients were male. There was a
bimodal preponderance of severe TBI cases in young adults (age 21
to 40) and older people (age >61). Motor vehicle accidents (48.8%)
and falls from <2 m (35.1%) were the main mechanisms of injury.
Invasive monitoring was frequently employed in these patients with
severe TBI: arterial blood pressure monitoring in 298 patients (81.6%),
central venous pressure monitoring in 219 patients (60.0%), and
intracranial pressure monitoring in 173 patients (47.4%). The incidence
of use of tiered therapy such as sedation, mild hyperventilation,
osmotherapy with mannitol, cerebrospinal fluid drainage, barbiturate
coma and decompressive craniectomy to control ICP converged with
international practices.
Conclusion Young adults and older people involved mainly in motor
vehicle accidents and falls respectively were among the high-risk
groups for severe TBI. Management of these patients goes beyond
the ICU and involves, but is not limited to, social support, emotional
motivation and community reintegration of these patients [2]. TBI
among the high-risk groups is largely preventable. Public awareness
and prevention programmes will go some way in reducing the
incidence of TBI amongst the high-risk groups.
References
1.

2.

Ministry of Health 2012 Health Facts Singapore [http://www.moh.gov.sg/
content/moh_web/home/statistics/Health_Facts_Singapore/Principal_
Causes_of_Death.html]
Chua KS, et al.: A brief review of traumatic brain injury rehabilitation. Ann
Acad Med Singapore 2007, 36:31-42.

P478
Outcome measures in randomized controlled trials of patients with
severe traumatic brain injury: a systematic review
G Lalonde1, M Shemilt1, F Lauzier1, P Desjardins1, A Boutin1, L Moore1,
D Fergusson2, R Zarychanski3, A Turgeon1
1
Laval University, Quebec, Canada; 2OHRI, Ottawa, Canada; 3University of
Manitoba, Winnipeg, Canada
Critical Care 2014, 18(Suppl 1):P478 (doi: 10.1186/cc13668)
Introduction Traumatic brain injury (TBI) is a major cause of death
and long-term disability worldwide, and understanding its effect on
health is critical. Although mortality has been a gold standard for years,
functional scales and quality of life have been used as main outcome
measures over the last decades due to their usefulness and aid in
decision-making for medical teams, patients, and families. Despite
this preference, no consensus exists for the most optimal outcome
measure. We systematically reviewed outcome measures used in
randomized controlled trials (RCTs) in patients with severe TBI admitted
to an acute care hospital.
Methods We searched MEDLINE, EMBASE, Cochrane Central, BIOSIS and
references of eligible trials. RCTs published over the last 7 years (2006
to October 2013) in 18 selected journals (based on impact factor) were
considered for inclusion. RCTs performed in adults with severe TBI (GCS
≤8) were eligible. The primary endpoint was the outcome measures
used in RCTs. The secondary outcomes were the timing of assessment
and the methodological quality of trials using the Cochrane risk of
bias assessment tool. Two independent reviewers selected trials and
collected data using a standardized form.
Results From 5,602 citations retrieved after removal of duplicates, 36
RCTs met eligibility criteria. The outcome measures most frequently
used were neurophysiologic indices (n = 18, 50%), the Glasgow Outcome
Scale (n = 17, 47%), mainly at 6 months, nonspecific complications
(n = 15, 42%), mortality (n = 12, 33%), and biomarkers (n = 10, 28%).
Nine trials reported only physiologic indices and did not present any
clinical or functional outcome measures. The methodological quality
of included RCTs was heterogeneous. We observed a low risk of bias
for sequence generation (n = 29, 80%), allocation concealment (n =
20, 55%), complete data reporting (n = 30, 83%), selective reporting
(n = 36, 100%), and sample size (n = 21, 58%) but a high risk of bias for
blinding (n = 20, 55%).
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Conclusion Outcome measures used to evaluate the effect of
intervention in RCTs performed in patients with severe TBI in acute
care are heterogeneous. A significant proportion of trials did not
consider evaluating the functional status or other clinically meaningful
outcomes, and very few trials assessed outcomes beyond 6 months.
Thus, a significant proportion of RCTs in patients with severe TBI are
based on outcome measures not clinically useful to guide or change
practice in this population.
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Predicting 6-month mortality of patients with traumatic brain
injury: usefulness of common severity scores
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Introduction Severity of illness scoring systems is paramount for the
evaluation of quality of care of critically ill and trauma patients [1-3].
The purpose of the present study was to evaluate the usefulness of
the Acute Physiology and Chronic Health Evaluation II (APACHE II),
Simplified Acute Physiology Score II (SAPS II) and Sequential Organ
Failure Assessment (SOFA) scores in predicting long-term outcome of
patients with moderate-to-severe traumatic brain injury (TBI).
Methods A Finnish multicenter ICU database was screened for TBI
patients admitted in 2003 to 2012. Logistic regression was used
for customization of the APACHE II, SAPS II and SOFA for 6-month
mortality prediction. An adjusted SOFA model, including age, and a
reference model, including only age and Glasgow Coma Scale, were
built for comparison. A randomized split-sample technique was used
for internal validation and prognostic performance was determined by
assessing discrimination, calibration and precision.
Results A total of 1,625 patients were included. Overall 6-month
mortality was 33%. The APACHE II and SAPS II-based models showed
good discrimination (area under the curve (AUC) 0.79, 95% confidence
interval (CI) = 0.75 to 0.82; and 0.80, 95% CI = 0.77 to 0.83), calibration
(P >0.05) and precision. The SOFA-based model showed poor
discrimination (AUC 0.68, 95% CI = 0.64 to 0.72) and precision but
good calibration (P >0.05). The adjusted SOFA model displayed better
discrimination (AUC 0.79, 95% CI = 0.76 to 0.82). The reference model
showed comparable performance with all scoring system-based
models regarding discrimination (AUC 0.77, 95% CI = 0.74 to 0.80),
precision and calibration. See Figures 1 and 2.
Conclusion A simple prognostic model, based only on age and GCS,
displayed a fairly good prognostic performance in predicting 6-month
mortality of ICU-treated patients with moderate-to-severe TBI. The
use of more complex scoring systems added little to the prognostic
performance.
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Work activities after 3-year follow-up in ICU patients with traumatic
brain injury
M Arias-Verdu1, M Delange van der Kroft2, E Curiel-Balsera1, A Muñoz-Lopez1,
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Introduction The aim was to study work activities after 3 years in
patients admitted to the ICU with traumatic brain injury (TBI).
Methods A prospective cohort study in an ICU of a reference hospital.
We studied ICU-admitted patients consecutively with TBI between 2004
and 2008. We used validated scales including the Glasgow Outcome
Scale (GOS) and the Project for the Epidemiological Analysis of Critical
Care Patients Quality of Life questionnaire.
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Figure 2 (abstract P479). Discrimination.

(16.2% missing). Regarding work activities, after 1 year, 28.5% of 326
patients evaluated have no difficulties with work, 4.6% have difficulties
but work as before, 10.1% work only part-time or have changed to a
job requiring minimum effort and 56.7% of patients do not work. After
3 years, 41.2% of 238 patients evaluated have no difficulties with work,
4.6% have difficulties but work as before, 12.6% work only part-time or
have changed to a job requiring minimum effort and 41.6% of patients
do not work. Evolution between 1 and 3 years by the McNemar test was
statistically significant (P <0.001). A total of 173 patients were in similar
situation, only one had deteriorated and in 62 (26.05%) patients the
evaluation of work activity had improved.
Conclusion After 1 year of admission from the ICU with TBI, more than
50% of patients have difficulties with work. After 3 years the number of
patients who work has increased although approximately 40% of the
surviving patients do not work.
P481
Enteral administration of antiepileptic agents could have efficacy
for prevention of post-traumatic seizures in severe traumatic brain
injury
K Mocjiduki, H Suzuki, A Kawasaki, M Hotta, M Namiki, T Harada, M Takeda,
A Yaguchi
Tokyo Women’s Medical University, Tokyo, Japan
Critical Care 2014, 18(Suppl 1):P481 (doi: 10.1186/cc13671)

Figure 1 (abstract P479). Calibration.

Results We studied 531 patients, age 40.35 ± 19.75 years, APACHE II
17.94 ± 6.97 points, Glasgow Coma Scale at admission 7.53 ± 3.83 points.
Cranial tomography at admission was: diffuse injury type I (10.4%),
diffuse injury type II (28.1%), diffuse injury type III (24.5%), diffuse
injury type IV (8.3%), evacuated mass lesion (22.6%), non-evacuated
mass lesion (6.2%). Hospital mortality was 28.6%, 171 (32.2%) patients
died after 1 year (6.6% missing) and 181 (34.1%) died after 3 years

Introduction Antiseizure prophylaxis is recommended for preventing
only early post-traumatic seizures (PTS) in the guidelines for the
management of severe traumatic brain injury (TBI) by the Brain Trauma
Foundation. Phenytoin is recommended to reduce the incidence
of early PTS prophylaxis. Early enteral nutrition has recently shown
theoretical advantages for prevention of bacterial translocation to
maintain normal turnover of gut mucosa and is commonly used for
TBI patients. Our hypothesis is that the enteral administration of
antiepileptic agents is also useful for early PTS.
Methods This retrospective observational study included all adult
patients admitted to our tertiary academic medico-surgical ICU due to
TBI from September 2011 to August 2012. Patients who have epilepsy
as a past history were excluded. Clinical data were collected from
electrical medical archives. The baseline characteristics collected were
age, gender, diagnosis, antiepileptic agents, timing of start and adverse
effects of those agents, and methods of administration.

Critical Care 2014, Volume 18 Suppl 1
http://ccforum.com/supplements/18/S1

Results Of 65 patients with TBI, 25 patients (18 men, seven women;
mean age 56.7 ± 20.1) who were administered antiepileptic agents for
PTS prophylaxis were studied. Fifteen cerebral contusions, 10 acute
subdural hematomas, nine traumatic subarachnoid hemorrhages,
two cerebral infarctions, two pneumocephalus and one traumatic
intracerebral hemorrhage were shown in 25 patients. All patients
were alive 28 days after the injury. Fourteen patients (56%) were
intravenously administered (13 phenytoin and one phenobarbital),
while 11 patients (44%) were administered with enteral feeding
(four valproates, four carbamazepine and three zonisamides) as PTS
prophylaxis. The average start day of PTS prophylaxis was 2.6 days
after the injury by intravenous administration, and 2.2 days by enteral
administration, respectively. Two patients with phenytoin showed
hepatic dysfunction as an adverse effect and no patient showed early
PTS both by intravenous and by enteral administrations.
Conclusion The present study has some limitations because it is a
single-center retrospective analysis. However, enteral administration of
antiepileptic agents could be useful for PTS prophylaxis. Considering
cost, adverse effects and serum monitoring, there is a possibility of
enteral administration of antiepileptic agents as an alternative to
intravenous phenytoin.
P482
Simulation-based education for cardiopulmonary resuscitation and
airway management protocols: a brief report of a systematic review
and meta-analysis
A Cortegiani, V Russotto, A Naro, G Sanzo, G Grutta, SM Raineri,
A Giarratano
University of Palermo, Italy
Critical Care 2014, 18(Suppl 1):P482 (doi: 10.1186/cc13672)
Introduction We aimed to summarize the efficacy of simulation-based
education in cardiopulmonary resuscitation and airway management
[1].
Methods We searched the MEDLINE, Scopus and EMBASE databases
for all peer-reviewed articles enrolling physicians/medical students
in a simulation of either cardiopulmonary resuscitation or airway
management protocols compared with no intervention or traditional
teaching methods. We categorized the outcomes of the studies into
four groups: task success, process skill, time skill, knowledge. Task
success was defined as evaluation of successful completion of the
task, process skill as evaluation of the procedure, time skill as the
time required to complete the task, and knowledge as the objective
assessment of conceptual understanding. When studies investigated
more than one outcome, we considered the primary outcome, the
overall measure or the most clinically relevant outcome.
Results From 8,528 articles, we selected 24 studies (13 randomized
controlled studies, eight pre–post studies, three case–control
studies) involving 1,149 participants. Compared with no intervention
or traditional teaching methods, simulation was associated with
a significant improvement from mild to moderate of all outcomes
(Figure 1). Log of odds ratio for task success was 2.03 (0.46 to 3.59) in

Figure 1 (abstract P482).
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favor of simulation. Pooled effect size for process skill was 0.48 (0.11 to
0.84), for time skill was 0.29 (0.13 to 0.73) and for knowledge was 0.41
(0 to 0.84).
Conclusion Simulation is an effective educational method to improve
performance of physicians/medical students in the application of
protocols for cardiopulmonary resuscitation and airway management.
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Video analysis of cardiopulmonary resuscitation performance of
ambulance crews during transportation
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Critical Care 2014, 18(Suppl 1):P483 (doi: 10.1186/cc13673)
Introduction High quality of chest compressions during cardiopulmonary resuscitation (CPR) is a critical determinant of outcome from
out-of-hospital cardiac arrest (OHCA). Unfortunately, however, victims
often do not receive adequate chest compression for various reasons,
particularly during transportation. Recent studies have demonstrated
the interruption time of chest compression using transthoracic
impedance analysis, but more information is needed to evaluate the
performance of CPR provided by ambulance crews and reveal reasons
for hands off chest during CPR.
Methods All ambulances of the Hiroshima City Fire Department are
equipped with a specially designed transmission device (RVT-SD200;
Sony) that transmits high-resolution visual images and patient vital
data using video cameras and a bio-monitor. We analyzed video data
of OHCA patients transported by ambulance from November 2012
through December 2012, and evaluated the performance of CPR
during transportation in accordance with the 2010 guidelines. The
hands-off time was calculated as the time without chest compressions
divided by the total CPR time.
Results Thirty-two resuscitation episodes during transportation by
ambulance were analyzed. Median CPR time per episode was 846
seconds (range 126 to 1,833 seconds). In total, the fraction of time
without chest compression was 19.5 ± 7.6% (mean ± SD). Reasons
for interruption and its fraction of time in total hands-off time were
as follows: 36% accounted for rhythm analysis/pulse check, 31% for
ventilation, 11% for setting up automated chest compression devices,
8% for tracheal intubation/placement of supraglottic airway devices,
4% for intravenous line placement/administration of adrenaline, 3% for
rescuer change, and 7% for adjustment of patient position/correction
of rescuer posture and others.
Conclusion The fraction of time without chest compression observed
in this study was comparative with those found in other studies in spite
of the difficult situations, such as during transportation. Most frequent
reasons for hands-off time were rhythm analysis and ventilation even
though the ambulance crews strictly adhered to the guidelines.
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crowd-sourcing bystander resuscitation
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Critical Care 2014, 18(Suppl 1):P484 (doi: 10.1186/cc13674)
Introduction Only a minority of patients suffering out-of-hospital
cardiac arrest receive any bystander cardiopulmonary resuscitation
(CPR). Bystander CPR is associated with improved odds for survival.
The PulsePoint smartphone application alerts users in the vicinity of
a cardiac arrest to facilitate immediate citizen bystander resuscitation.
Addressing implementation barriers may provide an opportunity
to increase effectiveness of the application. PulsePoint is currently
active in over 400 communities in the United States. Our objective
was to identify modifiable barriers to optimal implementation of the
PulsePoint smartphone application.
Methods We conducted a structured survey delivered via Survey
Monkey optimized for mobile devices. All alerted PulsePoint users
between 28 June 2012 and 1 November 2013 were sent an invitation
to participate in the survey. Survey responses associated with test
activations and emergency medical services (EMS) professionals on
active duty were excluded from the analysis.
Results Of 4,827 survey requests sent, 995 responded and completed
our survey (response rate 21%). Respondents identified themselves
as firefighters (30%), paramedics (19%), EMTs (16%), nurses (4.4%),
MDs (0.83%) and other professions (50%). Of those who received
a PulsePoint alert, 23% (157/690) responded by making their way
towards the location of the emergency. Of those who responded, 70%
(110/157) arrived on scene. Most of those who did not arrive said they
saw professional rescuers already on scene and turned back (52%,
24/47). Of those who arrived on scene, only 34% (37/110) found a
person unconscious and not breathing normally. The majority found
a person on scene who was not suffering cardiac arrest. Of those who
arrived on scene prior to EMS and also found a cardiac arrest victim
on scene who required resuscitation, 80% (8/10) performed bystander
CPR.
Conclusion We observed a very high proportion of bystander CPR
(80%) for victims of out-of-hospital cardiac arrest when PulsePoint
users arrived before EMS. This suggests that optimized PulsePoint
implementation may increase community bystander CPR rates. Alert
specificity for cardiac arrest may be too low (the cry wolf scenario) with
current default activation criteria. Also, the current activation radius
(0.5 mile) may be too large because EMS frequently arrive before the
PulsePoint responder.
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with 100% survival and in-hospital ICU transfer. The cardiac arrest (CA)
group depended on cause of CA: cardiac arrhythmia (n = 12), survival
50%; surgical etiology (nontraumatic), survival 50%, mean age 70;
myocardial infarction (n = 12), survival 83%, mean age 61; sepsis (n =
6), survival 67%, mean age 48; drugs overdose (n = 2), survival 100%;
traumatic cardiac arrest (n = 15), 89% mortality, mean age 41; and CA
with unknown etiology, survival 38%, mean age 68.
Conclusion Emergency room cardiac arrest arrivals are not correlated
with ER-CPA total activity. Good survival rates are probably related to a
special quick response protocol and trained teams. Outcomes research
to detect potential improvement in nurse care is needed, and should
be evidence guided. Worst results in survival rates must be detected as
the main topics for nursing care development.
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What is the role of head computed tomography in
post-resuscitation care?
Y Valzani1, A Marudi2, S Baroni2, G De Grandis2, R Stacca2, E Bertellini2
1
University of Modena and Reggio Emilia, Modena, Italy; 2Nuovo Ospedale
Civile Sant’Agostino Estense, Modena, Italy
Critical Care 2014, 18(Suppl 1):P486 (doi: 10.1186/cc13676)
Introduction Guidelines recommend to perform head computed
tomography (CT) in nontraumatic cardiac arrest only if the patient
remains unconscious after return of spontaneous circulation [1].
Nevertheless, in cardiac arrest due to neurological causes, head CT
would dramatically change the therapeutic strategy in these patients
[2]. The aim of this study is to present the experience of our ICU in
nontraumatic out-of-hospital cardiac arrest (OHCA) patients and to
demonstrate that neurological abnormalities can be the primary cause
of cardiac arrest.
Methods We collected data for all patients with nontraumatic OHCA
admitted to the ICU from 1 January 2012 to 31 December 2012. We
recorded mean age, male-to-female ratio, cause of cardiac arrest and
mortality in the ICU.
Results Thirty-four survive cardiac arrest patients were admitted to the
ICU. Mean age was 66 years. The male-to-female ratio was 2:1. Sixteen
patients died in the ICU. Head CT scans obtained in the immediate postarrest period found significant abnormalities in four patients (three
subarachnoid hemorrhage and one ischemic ictus) with immediate
modification of treatment.
Conclusion Head CT abnormalities can be found in cardiac arrest
patients. Further investigations are necessary to evaluate the impact
of cardiac arrest from neurological causes and to establish the role of
neuroimaging in these patients.
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Emergency room advanced life support after cardiac arrest:
outcomes and survival, nursing care and team response
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Critical Care 2014, 18(Suppl 1):P485 (doi: 10.1186/cc13675)
Introduction An organized team response and trained nursing staff in
the emergency room critical patient area (ER-CPA) are the main factors
to determine cardiopulmonary resuscitation (CPR) success rates. The
objective was to evaluate outcomes in the emergency room after
advanced life support (ALS) by reanimation teams, to improve nursing
care, quality of resuscitation and survival.
Methods We included all adult patients receiving ALS in the ER-CPA
during 1 year. Cases not allowed CPR are excluded. A retrospective
design, multivariate with ALS performed, gender, age, cause of arrest,
precedence, outcome and hospital derivation, and 100% of cases
studied.
Results A total of 149 patients were attended in the ER-CPA with
ALS maneuvers during the studied period (9.23% of a total 1,613).
Thirty-four of them were nonheart-beating donors. The protocol was
performed with 23 effective donors and 31 organs were obtained for
transplant. Respiratory arrest (n = 31) was the best outcome group,
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To see or not to see: does video CPR perform better than telephone
CPR?
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1
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Critical Care 2014, 18(Suppl 1):P487 (doi: 10.1186/cc13677)
Introduction The ALERT algorithm, a simple and effective compression-only telephone CPR (t-CPR) protocol, has been previously
demonstrated to help bystanders initiate CPR. According to their
worldwide availability, mobile phone communications may play
an increasing role in emergency calls. Preliminary studies suggest
that they might improve dispatcher’s understanding of the rescuer’s
situation. However, there is currently no validated protocol for
videoconference-assisted CPR (v-CPR). We initiated the present study
to validate an original protocol of v-CPR based on the ALERT algorithm
and to evaluate the potential benefit of this assistance in comparison
with classical t-CPR.
Methods We developed a strictly worded algorithm for v-CPR, adapted
from the ALERT t-CPR protocol, with additional re-evaluation loops,
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every 2 minutes. A total of 120 students without prior CPR training were
recruited from upper secondary school, during regular class hours,
and randomly assigned to the t-CPR group (n = 60) versus the v-CPR
group (n = 60). The Resusci®Anne SkillReporter™ manikin was used to
evaluate CPR performance. Data were transferred from the manikin
into a computerized database using the Laerdal SkillReporting System
V.2.2.1 software. Further analysis was based on audio-recordings and
video-recordings. Primary outcome measures were the results of the
Cardiff evaluation test; the secondary measures were global scoring of
a complete 7-minute period of CPR.
Results The mean chest compression rate increased significantly in the
v-CPR group as compared with t-CPR (110 ± 16 vs. 86 ± 28; P <0.0001),
while depth remained constant (48 ± 13 mm vs. 47 ± 16 mm, P =
NS). Hand positioning was correct in 91.7% of cases with v-CPR, but
only in 68% with t-CPR (P = 0.001). The hands-off period was almost
nonexistent in the v-CPR group (0 vs. 7 seconds; P = 0.0016), but the
median no-flow time was significantly greater in the v-CPR group (146
vs. 122 seconds, P < 0.0001). As a consequence, global evaluation of
CPR performance revealed a significant improvement in v-CPR group
score as compared with the t-CPR group (6 vs. 5, P < 0.001).
Conclusion Video-assisted CPR using this original algorithm allows
bystanders to reach compression rates and depths close to international
guidelines and to reduce hands-off events during CPR.
P488
Initial anticoagulation strategy for extracorporeal cardiopulmonary
resuscitation patients
Y Iwashita, M Matsuduki, M Yukimitsu, K Yokoyama, T Nakata,
A Yamamoto, K Ishikura, H Imai
Mie University Hospital, Tsu, Mie, Japan
Critical Care 2014, 18(Suppl 1):P488 (doi: 10.1186/cc13678)
Introduction Extracorporeal cardiopulmonary resuscitation (ECPR)
is increasingly being used in emergency and critical care medicine in
Japan. Although a major complication of this procedure is bleeding,
the optimal heparin dose and activated coagulation time (ACT) remain
unknown.
Methods We retrospectively evaluated the initial heparin doses, ACT
values, and complications of patients who received ECPR between
February 2011 and November 2013 at the Emergency and Critical Care
Center, Mie University Hospital, Japan.
Results ECPR was performed in 45 patients, and the ACT was evaluated
in 32 patients. All patients were administered 3,000 U unfractionated
heparin at the time of priming the circuit. Patients for whom
cannulation took a longer time received an additional 2,000 to 3,000 U
unfractionated heparin. The average heparin dose administered

was 53.6 U/kg body weight. The average ACT was 231.3 seconds. In
17 of the 32 patients, the ACT exceeded 200 seconds. Three patients
experienced fatal bleeding in the chest wall, which could not be
stabilized by conservative treatment. One patient developed a cerebral
infarction. There were no significant differences between the patients
with fatal bleeding and those without fatal bleeding with regard to the
heparin dose, ACT, and duration of CPR.
Conclusion According to the Extracorporeal Life Support Organization
guidelines, the target ACT should be around 1.5 times the normal
ACT. However, it is difficult to obtain the normal ACT in emergency
situations. Many of our patients’ ACTs exceeded 200 seconds, and
three patients experienced fatal bleeding that was possibly due to
chest compression. Post-cardiac arrest patients often experience
coagulopathy due to either cardiac arrest or hypothermia therapy.
Therefore, an anticoagulation protocol other than the pulmonary
extracorporeal membrane oxygenation protocol is required for ECPR
patients. We evaluated our anticoagulation protocol for ECPR and
observed that our patients’ ACTs frequently exceeded the target value
and some experienced fatal bleeding. The anticoagulation protocol for
post-CPR patients may need to be reconsidered.
P489
Predictors of poor outcome in out-of-hospital cardiac arrest
JE Petrie, S Brett, R Stümpfle
Hammersmith Hospital, London, UK
Critical Care 2014, 18(Suppl 1):P489 (doi: 10.1186/cc13679)
Introduction Out-of-hospital cardiac arrest (OOHCA) causes 60,000 UK
and 300,000 US deaths each year. Survival to hospital discharge in the
developed world has historically been 7 to 10% with obvious cognitive
impairment in 10% of survivors. Primary percutaneous coronary
intervention (PPCI) and targeted temperature management (TTM) (or
at least hyperthermia avoidance) have been shown to improve survival
in comatose patients post OOHCA. There is no reliable method to
predict poor outcome on presentation. We aimed to identify factors
associated with poor outcome in our single-centre regional referral
OOHCA population.
Methods We performed a pragmatic single-centre retrospective
review over 18 months commencing 1 January 2011 of all patients
admitted to our regional OOHCA centre ICU following successful
resuscitation from OOHCA. In keeping with guidelines, all patients
were assessed for suitability for PPCI and TTM. A good outcome was
defined by a Pittsburgh Cognitive Performance Category (CPC) score
of 1 to 2 (independence, mild impairment) on hospital discharge. A
poor outcome was defined as death or CPC 3 to 4 (moderate to severe
impairment, coma) on hospital discharge. CPC scoring was determined

Table 1 (abstract P489). Presenting features and outcome at hospital discharge of ICU OOHCA patients
Good outcome (CPC 1 to 2)

Poor outcome (dead or CPC 3 to 4)

Total

P value

Age

63.3 ± 16.8

63.6 ± 14.4

63.5 ± 14.7

NS

Male sex

21/26 (81%)

29/43 (67%)

50/69 (72%)

NS

Arrest occurring 08:00 to 20:00

14/19 (74%)

16/36 (44%)

30/55 (55%)

<0.05

VF/VT as initial rhythm

25/26 (96%)

25/43 (58%)

50/69 (72%)

<0.001

Bystander CPR

12/26 (46%)

24/43 (56%)

36/69 (52%)

NS

Time from collapse to ROSC (minutes)
Advanced airway management

18.3 ± 11

32.3 ± 26

27.1 ± 23

<0.05

14/24 (58%)

38/42 (90%)

52/66 (79%)

<0.005

Cardiac cause

24/26 (92%)

30/43 (70%)

54/69 (78%)

<0.05

Angiography

19/26 (73%)

23/43 (53%)

42/69 (61%)

NS

Therapeutic hypothermia

24/26 (92%)

41/43 (95%)

64/69 (93%)

NS

Presenting pH

7.21 ± 0.11

7.08 ± 0.18

7.13 ± 0.17

<0.01

Presenting base deficit (mmol/l)

–7.9 ± 6.2

–13.8 ± 5.9

–11.5 ± 6.7

<0.001

Presenting lactate (mmol/l)

4.3 ± 3.0

8.3 ± 4.5

6.8 ± 4.4

<0.0005
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from physiotherapy and occupational therapy assessments in the
clinical notes. Continuous data were analysed using a two-tailed t test
or Mann–Whitney U test, categorical data with a chi-squared test.
Results Sixty-nine patients were admitted to our ICU following
successful resuscitation from OOHCA in the 18-month period.
Presenting features and outcomes are shown in Table 1.
Conclusion Good outcome was associated with a shockable rhythm on
presentation, cardiac cause, arrest occurring in daylight hours (08:00
to 20:00) and shorter time between collapse and ROSC. Poor outcome
was associated with placement of an advanced airway device, lower
pH, higher base deficit and higher lactate.
P490
Mean initial cerebral saturation and time to start advanced life
support in out-of-hospital cardiac arrest: are they correlated?
C Genbrugge, C De Deyne, I Meex, F Jans, W Boer, J Dens
ZOL, Genk, Belgium
Critical Care 2014, 18(Suppl 1):P490 (doi: 10.1186/cc13680)
Introduction During advanced life support (ALS) it is still impossible to
predict return of spontaneous circulation (ROSC) or outcome. Cerebral
saturation (rSO2) measurements with near-infrared spectroscopy
can be used in cardiac arrest circumstances and could play a role in
predicting ROSC or neurologic outcome [1]. It is known that an initial
rhythm of asystole and a long no/low-flow time has a worse outcome.
We measured rSO2 during ALS in out-of hospital cardiac arrest (OHCA)
patients and compared the mean rSO2 during the first minute with the
time between the emergency call (EC) and start of ALS.
Methods With IRB approval, rSO2 was prospectively measured between
December 2011 and November 2013 in 51 OHCA cases with presumed
cardiac cause during ALS. One sensor of the EQUANOX Advance was
applied to the right side of the patient’s forehead when the medical
emergency team arrived. The measurement was continued until death
of the patient or arrival at the ICU. Survivors (S) are defined as sustained
ROSC longer than 20 minutes. CPR data were collected using the
Utstein CPR data registration. The Mann–Whitney test and Pearson chisquare were utilized for comparison of S and nonsurvivors (NS) data.
The Pearson test was used to examine correlation.
Results Of the 51 patients, 21 were S. Mean age was 70 years (± 15) in
the S, of which 10 (48%) were male, and in the nonsurvivors (NS) mean
age was 70 years (± 17) (P = 0.916) with 23 (77%) male patients (P =
0.042). The initial rhythm was asystole in 11 S and in 20 NS (P =0.386),
pulseless electrical activity in two S and NS (P = 1), and ventricular
fibrillation in eight S and six NS (P = 0.207). The arrest was witnessed
in 15 NS and 16 S (P = 0.083). Lay rescuer BLS was performed in 17 NS
and nine S (P = 0.4). A significant difference in time of EC and start of
ALS was observed between S (12 minutes; 8 to 15) and NS (14 minutes;
12 to 17) (P = 0.03). Mean initial rSO2 was 34% (± 23) and 24% (± 12.5)
in S and NS (P = 0.077). We observed a negative correlation between
mean initial rSO2 and time between EC and ALS (correlation coefficient
–0.243; P = 0.041).
Conclusion A tendency towards higher mean initial rSO2 in S compared
with NS was observed together with a negative correlation between
mean initial rSO2 and time between the EC and start of ALS. Also a
significant difference in time between the EC and start of ALS between
S and NS is observed. Larger studies are needed to confirm the possible
function of rSO2 as a surrogate for time between the EC and start of ALS.
Reference
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Predicting survival in patients admitted to intensive care
following out-of-hospital cardiac arrest using the Prognosis After
Resuscitation score
H Davies, A Loosely, S Dolling, R Eve
University Hospitals Bristol NHS Foundation Trust, Bristol, UK
Critical Care 2014, 18(Suppl 1):P491 (doi: 10.1186/cc13681)
Introduction Out-of-hospital cardiac arrest (OHCA) has a poor
prognosis even after successful resuscitation [1]. No scoring system
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has been fully validated for predicting survival following OHCA. The
Prognosis After Resuscitation (PAR) score was developed from metaanalysis in 1992. A score >5 (from seven variables) predicts nonsurvival
following in-hospital cardiac arrest (IHCA) [2,3]. Porter and colleagues
demonstrated that PAR >5 is a useful predictor of nonsurvival for
combined IHCA/OHCA ICU admissions [4]. We aim to evaluate PAR
application to adult ICU admissions at University Hospitals Bristol
(UHB), UK following OHCA.
Methods The Innovian (Dräger) electronic clinical information database
was searched retrospectively for all OHCA ICU admissions from 2010 to
2012. Data were extracted using an electronic pro forma in Microsoft
Excel. Missing/incomplete data were excluded. Survival was defined as
survival to discharge from the acute hospital (UHB).
Results There were 247 admissions to the ICU following OHCA from
2010 to 2012. Seven patients were excluded for missing/incomplete
data. In total, 102 patients (42.5%) survived to discharge. PAR ranged
from –2 to 18. Zero was the most frequent score. Only one of 15
admissions with PAR >5 (PAR 13) survived. A total of 101 patients with
PAR ≤5 survived (45%). Acute myocardial infarction was identified as
the precipitating event in 111 patients (46%).
Conclusion Only one of 240 OHCA patients admitted to the ICU over
a 3-year period with PAR >5 survived until discharge. PAR scoring has
been shown to be useful in helping decide the appropriateness of ICU
admission for combined IHCA/OHCA. Our data support its use in isolated
OHCA. PAR ≤5 appears to be poorly predictive of survival. However,
PAR >5, combined with clinical evaluation, could help identify OHCA
nonsurvivors and avoid ICU admissions that do not benefit the patient.
References
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1
Queen’s University, Kingston, Canada; 2University of Toronto, Canada;
3
Sunnybrook Health Sciences Centre, Toronto, Canada; 4St Michael’s, Toronto,
Canada
Critical Care 2014, 18(Suppl 1):P492 (doi: 10.1186/cc13682)
Introduction Lack of standardized care contributes to low survival in
admitted out-of-hospital cardiac arrest (OHCA) patients. The objective
of our study was to implement a Post Arrest Consult Team (PACT) and
improve the quality of care for admitted OHCA patients.
Methods We conducted a prospective cohort study with concurrent
controls from February 2011 to February 2013 in a network of 29
Toronto-area hospitals. The PACT was implemented in two hospitals
and functioned as a consult service with a nurse and physician oncall 24/7. Patients from other network hospitals acted as concurrent
controls. The PACT focused on four key processes of care: targeted
temperature management (TTM); coronary angiography; avoidance of
premature withdrawal of life-sustaining therapy (WLST <72 hours) on
the basis of neuroprognostication; and electrophysiology assessment.
We included nontraumatic OHCA patients who were >18 years old,
survived at least 6 hours, and were comatose. We excluded patients
with do-not-resuscitate orders, intracranial or other severe bleeding.
We used generalized linear mixed models to assess whether PACT
implementation was associated with higher odds of achieving each of
the four targeted processes of care while adjusting for secular trends
unrelated to the intervention.
Results The primary analysis included 162 patients from two
intervention hospitals and 892 from 27 control hospitals. Thirtytwo percent of the patients were female and the mean age was
65.3 ± 16.5 years. Almost one-half (46%) of patients had a shockable
initial cardiac arrest rhythm, 41% had bystander CPR, and 5% had an
AED applied. PACT did not improve use of TTM (ratio of ORs = 1.03,
95% CI = 0.89 to 1.20), angiography for patients without ST-elevation
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myocardial infarction (ratio of ORs = 1.10, 95% CI = 0.87 to 1.40), or
electrophysiology assessment (ratio of ORs = 1.06, 95% CI = 0.81 to
1.38) as compared with concurrent control hospitals. Patients in the
intervention group were less likely to have life support withdrawn
within 72 hours on the basis of neuroprognosis compared with patients
in the concurrent control group (ratio of ORs = 0.62, 95% CI = 0.39 to 0.98).
Conclusion PACT was associated with reduced WLST <72 on the
basis of neuroprognostication but did not improve other important
post-cardiac arrest processes of care. Further work is underway to
identify factors that influenced implementation. This will guide future
consideration of the PACT model in other settings.
Figure 1 (abstract P494).

P493
One-year assessment of in-hospital cardiac arrest
M Ahmed, A Kochhar, O Rose
Univeristy Hospital Lewisham, London, UK
Critical Care 2014, 18(Suppl 1):P493 (doi: 10.1186/cc13683)
Introduction This retrospective audit evaluated adult patients who
suffered in-hospital cardiac arrest (IHCA) against the recent National
Confidential Enquiry into Patient Outcome and Death (NCEPOD)
report [1]. It looked specifically at the recognition of the acutely
unwell, the interventions made, the decisions taken from admission
through to the post-arrest period and the outcomes following
cardiopulmonary resuscitation (CPR). The audit aims to guide future
improvements in preventing cardiac arrest and enhancing end-of-life
care decision-making.
Methods Medical notes of adult patients suffering IHCA, over a 1-year
period, were identified and data were collected using a validated
NCEPOD audit tool. These data included patient demographics, initial
clerking and consultant review, patient care during the 48 hours prior to
cardiac arrest, the resuscitation status of the patient, the resuscitation
attempt, the post-cardiac arrest care and survival to discharge rates.
Results Medical notes were available for assessment for 69 out of the 82
patients that were identified as having IHCA between 1 October 2011
and 30 September 2012. The frequency of IHCA showed no correlation
to day of the week or month. Initial clerking was incomplete in historytaking (16% vs. 14% in NCEPOD) and in examination (46% vs. 24% in
NCEPOD). The majority of patients were appropriately escalated in a
timely fashion (94% vs. 82% in NCEPOD), but first consultant review
was delayed beyond 12 hours in 49% of cases (48% in NCEPOD). A
total 81% of patients suffered cardiac arrest 24 hours after admission
(68% in NCEPOD). Warning signs for cardiac arrest were considered
present in 59% of cases (75% in NCEPOD), with a significant proportion
going unrecognised (27%) despite multiple medical reviews. Out-ofhours CPR attempts (68% vs. 59% in NCEPOD) seemed be associated
with poorer survival. The survival to discharge rate after in-hospital
cardiac arrest was 10.1%. This compares with 14.6% in the NCEPOD
data and 20% in larger studies [2]. Ninety per cent of patients had no
documentation of resuscitation status (78% in NCEPOD).
Conclusion The results from this audit highlight persistent deficiencies
in the care pathway for the acutely unwell patient. Improvement will be
focused on earlier consultant review and better recognition of warning
signs with appropriate action taken. Furthermore, earlier routine and
senior clinician-led discussions on appropriate end-of-life care are vital.
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Endovascular hypothermia after cardiac arrest in a Chilean ICU
M Canitrot, S Ugarte
INDISA Clinic, Santiago, Chile
Critical Care 2014, 18(Suppl 1):P494 (doi: 10.1186/cc13684)
Introduction For more than a decade, mild hypothermia has been
a standard for enhancing the neurological prognosis in comatose

survivors of cardiac arrest (CA). Despite this, in our country there are
still few centers that apply hypothermia post CA regularly. We describe
a Chilean experience with endovascular hypothermia post CA, in three
ICUs of the same university clinical center [1-3].
Methods A descriptive cohort study. All surviving comatose patients
after CA were included, and underwent endovascular hypothermia
management according to protocol. CoolGard™ internal cooling
equipment was used. Variables: delay between CA and hypothermia
(34°C), time in hypothermia, complications, ventilatory and hemodynamic management. Main outcome measures: mortality and neurological follow-up to 6 months with Glasgow Outcome Score Extended
(GOSE).
Results Twenty-seven patients were managed in the ICU post CA (18
outpatients). Twenty-four were men (89%), mean age 33.5 ± 19 years
(16 to 76). Delay was considered (time between CA and achieving
target temperature of 34°C): median 10.5 ± 3.3 hours (3 to 18 hours).
Hypothermic maintenance (from when it reaches 34°C until it returns
to 36°C): 24 ± 18 hours (24 to 48 hours). Complications of hypothermia:
five hypokalemia (18.5%), three ventricular arrhythmias (11%), one
vein thrombosis (3.7%). There were no deaths during hypothermia.
Hospital mortality was two cases (7.4%). At 6 months it was three
(11%). Neurological outcome at discharge and 6 months are shown in
Figure 1. Good outcome (GOSE 5 to 8) occurred in 11 patients (40%) at
discharge. Good outcome at 6 months occurred in 20 patients (74%).
Conclusion Our series shows a low mortality and a very good
neurological outcome. There was no mortality or severe complications
associated with endovascular hypothermia. It is a safe and feasible
technique implemented in Latin American critical care units. Even the
delay in achieving the objective of hypothermia is very long.
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Knowledge and use of therapeutic hypothermia in cardiac arrest
victims among healthcare staff in Greece
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Critical Care 2014, 18(Suppl 1):P495 (doi: 10.1186/cc13685)
Introduction Therapeutic hypothermia (TH) improves the neurologic
outcome of patients who survive after cardiac arrest but suffer from
severe secondary neurological damage [1]. In 2010, the use of TH after
cardiac arrest was included in the ERC guidelines. The purpose of this
study was to investigate the knowledge of the medical and nursing
staff on the implementation of TH in patients after cardiac arrest [2].
Methods Data were collected by an anonymous questionnaire
designed for the purpose of research, addressed to medical and nursing
staff of Greek hospitals. The questionnaire consisted of questions about
knowledge and behavior related to TH induction, target temperature
and duration of cooling. Information about the potential barriers to
implementation of TH was also collected.
Results We obtained 344 questionnaires from 16 hospitals. The
population of the study was registered nurses (RN) (63.8%) and doctors
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(36.2%). The majority of health staff (81.5%) had never implemented
TH. A total 45.8% of respondents stated that the main reasons for not
using TH were the lack of information and training about the method,
the lack of nursing staff, the lack of available cooling methods and the
required time. The most common methods of application were cold
packs and intravenous fluids. Only 30.2% of the doctors and 5.5% of
the nurses (P <0.001) actually had the knowledge to implement TH,
and this was demonstrated by correct answers. Of the respondents
who answered that they did know the method, only 23.9% answered
correctly; about the target temperature, the maintenance and
rewarming phase. A total 59.1% of doctors, despite having attended
the Advanced Cardiac Life Support seminar, were not able to answer
correctly the knowledge questions. Continuous education of health
professionals and the existence of a protocol were proposed by 65%
of participants as the best way of increasing knowledge and adherence
with ERC guidelines about TH.
Conclusion Therapeutic hypothermia is rarely used in Greek hospitals.
The level of knowledge is mainly related to the lack of education and
the lack of information about new techniques. Programs for continuing
education are necessary for the use of new therapeutic techniques in
the field of health.
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Induced hypothermia of 33°C does not affect host response
compared with maintaining 36°C
C Beurskens, J Horn, E Van Leeuwen, N Juffermans
AMC, Amsterdam, the Netherlands
Critical Care 2014, 18(Suppl 1):P496 (doi: 10.1186/cc13686)
Introduction Induced hypothermia is applied in the ICU and in the
operating theater to reduce ischemia–reperfusion injury. It is thought
that induced hypothermia may hamper the immune response and
therefore carry the risk of acquiring or aggravating an infection. We
investigated the effect of hypothermia on host response by comparing
survivors of cardiac arrest in which body temperature was kept at
either 33°C or 36°C.
Methods As a substudy to the Target Temperature Management trial [1]
in which cardiac arrest patients admitted to the ICU were randomized
to maintaining either 33°C (n = 11) or 36°C (n = 9) for 24 hours, blood
was drawn at the start and end of the target temperature phase as well
as after reaching normotemperature. Host response was measured via
monocyte human leukocyte antigen-DR (HLA-DR) expression and via
whole blood stimulation with TLR ligands lipopolysaccharide (LPS) and
lipoteicoic acid (LTA) for 24 hours. Plasma levels of interleukin (IL)-1β,
IL-1RA, IL-6, IL-8, IL-10, tumor necrosis factor alpha (TNFα), macrophage
inflammatory proteins (MIP)-1, monocyte chemotactic protein (MCP)1 and soluble CD40 ligand levels were determined with ELISA or
Luminex. Statistics were by unpaired Mann–Whitney U tests.
Results HLA-DR expression was decreased compared with healthy
controls, without differences between 33°C and 36°C. Following whole
blood stimulation with LPS, TNFα and IL-6 production was lower
after cardiac arrest compared with healthy controls. The 33°C and
36°C groups differed at baseline in TNFα levels after LPS whole blood
stimulation. After 24 hours of temperature management, there was
no difference in both TNFα and IL-6 production between the groups
following TLR ligand stimulation. After cessation of temperature
management only TNFα levels increased after LTA stimulation. Plasma
levels of IL-1RA, IL-8 and IL-10 were decreased after cardiac arrest
compared with healthy controls. In plasma levels of IL-1β, MIP-1 and
soluble CD40 ligand there were no differences between the 33°C and
36°C groups at all time points. Apart from baseline differences, there
were no differences between 33°C and 36°C in plasma levels of IL-1RA,
IL-8, IL-10 and MCP-1.
Conclusion Cardiac arrest induces a decrease in proinflammatory
response. There were no differences in immune host response after
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24 hours of targeting body temperature at 33°C or 36°C. These results
suggest that hypothermia does not alter host immune response.
Reference
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Derived electromyography is an accurate measure of shivering
burden during targeted temperature management
T May, DS Seder, GF Fraser, BM McCrum, CF Hoover, RR Riker
Maine Medical Center, Portland, ME, USA
Critical Care 2014, 18(Suppl 1):P497 (doi: 10.1186/cc13687)
Introduction Shivering complicates targeted temperature management (TTM) by increasing metabolism, oxygen consumption,
resting energy expenditure, and carbon dioxide production and
is associated with lower brain tissue oxygen levels; all of these
may limit the effectiveness of TTM. However, the recognition and
measurement of shivering are subjective and ill-defined. The Bedside
Shivering Assessment Scale (BSAS) is the only validated tool to
describe the intensity of shivering. We hypothesized that the derived
electromyography (dEMG) value measured by the bispectral index
monitor (BIS) would agree with energy expenditure due to shivering,
compared with the BSAS.
Methods We measured continuous indirect calorimetry during a 2
to 5 hour time span during targeted temperature management in
12 patients being treated for hypoxic ischemic encephalopathy after
cardiac arrest. Patients were excluded if seizing, requiring >FiO2 0.5,
exhibiting early spasticity, or not shivering. The BSAS was measured
every 15 minutes by a blinded observer and shivering was treated for
a BSAS ≥1, as per institutional protocol. The association of dEMG and
BSAS as a predictor of resting energy exposure (REE) was measured
using linear regression and Pearson’s correlation.
Results The study population included 12 patients. Average age was
54 years, nine patients were male, eight patients had a CPC of 1 to 3 on
hospital discharge. There were a total of 182 measurements of BSAS,
dEMG, and REE. There is improved correlation between REE and dEMG
compared with REE and BSAS (0.24 (CI = 0.10 to 0.37) vs. 0.10 (CI =
–0.04 to 0.24); P <0.001 vs. 0.14). Each increase in dEMG resulted in an
increase of 14 kcal of energy expenditure (P = 0.003).
Conclusion Continuous dEMG power measured by Covidien BIS monitors
is a more accurate and less subjective measure of shivering burden
compared with the intermittent BSAS. Introducing dEMG into clinical
practice may improve recognition of shivering, allow quantification of
the metabolic cost of shivering, and serve as a more reliable research tool
for diagnostic and treatment strategies of shivering.
P498
Shivering during targeted temperature management after cardiac
arrest: a physiologic description
T May, DS Seder, GF Fraser, CF Hoover, RR Riker, BM McCrum
Maine Medical Center, Portland, ME, USA
Critical Care 2014, 18(Suppl 1):P498 (doi: 10.1186/cc13688)
Introduction Targeted temperature management (TTM) is used to treat
hypoxic ischemic encephalopathy (HIE), elevated intracranial pressure,
status epilepticus, and other brain injuries. Shivering complicates TTM,
and the associated energy burden and its response to treatment are
poorly understood. We describe the pattern of shivering and response
to neuromuscular blockade in a series of patients undergoing TTM
after cardiac arrest using continuous indirect calorimetry.
Methods With IRB approval, we studied 16 patients undergoing
TTM for HIE with continuous calorimetry during their treatment.
The calorimeter measures inspired and expired oxygen and carbon
dioxide, which are used in the Weir equation to calculate resting
energy expenditure (REE). We excluded patients known to be actively
seizing, requiring FiO2 >0.5, with early spasticity, or who did not shiver.
All patients received counterwarming, moderate analgosedation, and
bolused vecuronium in response to visible shivering, measured hourly
by nurses using the Bedside Shivering Assessment Scale.

Critical Care 2014, Volume 18 Suppl 1
http://ccforum.com/supplements/18/S1

Results Sixteen patients of average age 57 included 12 men. Twelve
patients had CPC of 1 to 3 on hospital discharge. Sixteen shivering
events were monitored with calorimetry among the 12 patients. The
average rate of energy expenditure (without shivering) leading up to
and following paralytic treatment was 1,425 kcal/hour (± 489 kcal/
hour) and 1,386 kcal/hour (± 235 kcal/hour). This was significantly
greater than the predicted basal energy expenditure (1,089 ± 222
kcal; P = 0.007 and P <0.001). Time from a change in baseline energy
expenditure to recognition and treatment of clinical shivering was 57
(± 64) minutes, and from treatment with neuromuscular blockade to
baseline energy expenditure was 30 (± 20) minutes. This accounts for
a total difference of 15,223 kcal (± 10,997 kcal) before treatment and
7,113 kcal (± 3,706 kcal) after treatment for each shivering episode
compared with baseline (P = 0.01 and P = 0.003).
Conclusion The energy burden of shivering is underestimated by
standard nutritional formulas in patients undergoing TTM after cardiac
arrest. Subclinical shivering is associated with increased energy
expenditure. Clinical recognition occurs long after the increase in
metabolic activity, and persists for a significant period of time after
treatment. These findings should influence how shivering is monitored
and treated during TTM.
P499
Temperature management following cardiac arrest: introducing a
protocol improves compliance with targets
P Creber, G Talling, M Oram
Cheltenham General Hospital, Cheltenham, UK
Critical Care 2014, 18(Suppl 1):P499 (doi: 10.1186/cc13689)
Introduction We audited the achievement of therapeutic hypothermia
(TH) before and after the introduction of a cooling protocol. Instituting
TH is recommended following the return of spontaneous circulation
(ROSC) for many patients who survive a cardiac arrest [1,2]. The key
intervention may be the avoidance of hyperthermia rather than
cooling [3].
Methods We conducted a chart review of all patients admitted to the
Department of Critical Care (DCC) at our hospital following cardiac arrest
over 2 years in 2010 to 2012 (Group 1). We recorded compliance with key
recommendations produced by the Royal College of Anaesthetists [4]
although we defined post-ROSC hyperthermia as >37.2°C rather than
>38°C. A TH protocol was designed and personnel in the emergency
department and DCC educated as to its use. Recommended practice
was the infusion of cold i.v. normal saline (1 to 2 l) followed by the use
of an intravascular cooling device (Alsius CoolGard™). Data collection
was then undertaken after introduction of the protocol for all patients
admitted to the DCC following cardiac arrest in November 2012 to 2013
(Group 2).
Results Forty-three patients were admitted in Group 1, 28 in Group
2. Of these, 42% in both groups were following out-of-hospital
(OOH) VF arrests. Cooling was attempted in 88% and 82% of OOH VF
patients respectively. For patients with either in-hospital or non-VF/
VT cardiac arrests, the numbers cooled were 16% and 12.5%. Cooling
initiation within 1 hour increased from 27 to 50%. Achievement of a
target temperature of 32 to 34°C within 4 hours of ROSC was 55% and
50% respectively. Target maintenance for 12 to 24 hours after ROSC
increased 79% to 100%. Avoidance of hypothermia <31°C for 48 hours
after ROSC improved 95% to 100%. Slow rewarming at 0.25 to 0.5°C/
hour to 37°C was achieved in 76% and 90%. Avoidance of temperature
>37.2°C for 48 hours after ROSC increased 84 to 100%. Of the patients
cooled, survival with good neurological outcome was achieved in 52%
in Group 1 and 88% in Group 2.
Conclusion The institution of a temperature management protocol
improved compliance with recommended goals, both in achieving
hypothermia and in the avoidance of hyperthermia.
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Factors involved in prolonged effect of neuromuscular blockade in
therapeutic hypothermia
H Tanaka, T Mochizuki, S Ode, S Ishimatsu
St Lukes International Hospital, Akashi-Chou Chuo-Ku, Japan
Critical Care 2014, 18(Suppl 1):P500 (doi: 10.1186/cc13690)
Introduction Therapeutic hypothermia (TH) following out-of-hospital
cardiac arrest (OHCA) improves neurological outcomes in such patients.
During TH, neuromuscular blockade is used to control shivering in
the patient. In our hospital, we use vecuronium as a neuromuscular
blocker. However, occasionally, prolonged effects of vecuronium delay
accurate evaluation of patients’ neurological function or extubation.
Unfortunately, the factors involved in the prolonged effect of
vecuronium in TH remain unclear.
Methods We conducted a retrospective cohort study of patients
managed with TH following OHCA at our institution from April 2010
to September 2013. We defined full-muscle reaction to train-of-four
stimulation (TOF) as the end of effects of vecuronium. In this study, the
time from the end of vecuronium administration to full-muscle reaction
to TOF was evaluated as the outcome. We calculated the adjusted
hazard ratio (HR) for the outcome using Cox regression analysis after
adjustment for age, gender, albumin levels, estimated glomerular
filtration rate, temperature at the end of vecuronium administration,
and total amount of vecuronium per kilogram of body weight.
Results In total, 52 patients were evaluated in this study (86.5% male;
average age, 55.2 years). The median time from the end of vecuronium
administration to full-muscle reaction to TOF was 660 minutes
(maximum: 10,363 minutes; minimum: 72 minutes). Blood albumin
levels on admission decreased the time (adjusted HR: 2.31, 95% CI:
1.073 to 5.004; P <0.05). However, other factors had no significant
difference on the time. The amount of vecuronium per kilogram of
weight had no significant differences (adjusted HR: 1.073, 95% CI: 0.869
to 1.325; P = 0.511).
Conclusion The time from the end of vecuronium administration to
full-muscle reaction to TOF decreased in relation to blood albumin
levels on admission. Other factors had no significant difference on the
outcome time. Taken together, the outcome time may be determined
by albumin levels and not by the administered amount of vecuronium
per kilogram of body weight. Based on this result, we suggest that
blood albumin levels on admission should be taken into consideration
for appropriate use of vecuronium in TH.
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Serum phosphate concentration during the rewarming period after
deep hypothermic circulatory arrest
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Introduction Short-term neuropsychologic dysfunction (SND) is often
observed during the postoperative period of open total arch repair
(TAR) under deep hypothermic circulatory arrest (DHCA). We supposed
that there might be a large consumption of high-energy phosphates
during the rewarming period, and this might be associated with
awakening and SND. Due to difficulty in measuring such high-energy
phosphates at the bedside, we measured the serum phosphate
concentration (P) as a substitute, and assessed its influence on
awakening and postoperative SND.
Methods Twenty patients with a mean age of 68 ± 11 years who
underwent open TAR under DHCA applied at a temperature of 20°C,
with antegrade cerebral perfusion (ACP) or retrograde cerebral
perfusion (RCP), were enrolled. Arterial blood gas lactate concentration
(ALac), ScvO2, and P were measured at 2, 4, 6, and 10 hours after
weaning from cardiopulmonary bypass (CPB). We also measured time
to confirm M6 on the Glasgow Coma Scale (GCS), and incidence of SND.
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Occurrence of SND was defined as neurological disarrangement such
as irritability, confusion, or delirium within 48 hours after operation.
Results Durations of CPB, aortic clamp, and circulatory arrest were
194 ± 51, 136 ± 53, and 70 ± 17 minutes respectively. Nine patients
underwent ACP (89 ± 26 minutes) and 11 patients underwent RCP
(56 ± 25 minutes). Concentration of ALac, ScvO2, and P changed at 2, 4, 6,
10 hours after CPB as follows: ALac 4.0 ± 1.9, 5.1 ± 2.6, 5.3 ± 3.3, 4.0 ± 2.8
mmol/l, ScvO2 71 ± 6.7, 67 ± 10, 67 ± 9.7, 65 ± 11%, and P 2.9 ± 0.9,
2.4 ± 0.7, 2.2 ± 1.0, 1.8 ± 0.8 mg/dl, respectively. Serum P recovered to
2.6 ± 1.4 at 18 hours after CPB. The incidence of hypophosphatemia
(<2.6 mg/dl) and SND in our series were 18/20 (90%) and 14/20(70%)
respectively. There was a correlation between minimum P and time to
confirm M6 on the GCS (P = 0.508, Fisher r-to-z transformation), but no
significant correlation between SND. The mortality rate during the first
28 days was 5% (1/20).
Conclusion Serum phosphate decreased dramatically during
the rewarming period after deep hypothermic circulatory arrest.
There was a moderate correlation between minimum phosphate
concentration and time to confirm M6 on the GCS. Monitoring
phosphate concentration might predict neurological recovery after
deep hypothermic circulatory arrest.
P502
Influence of baseline magnesium concentrations on shivering in
therapeutic temperature modulation
KL Johnson
HCMC, Minneapolis, MN, USA
Critical Care 2014, 18(Suppl 1):P502 (doi: 10.1186/cc13692)
Introduction Therapeutic temperature modulation (TTM) is widely
used in the care setting to improve outcomes of patients with traumatic
brain injury (TBI). Through fever prevention, both oxygen utilization
and caloric expenditure are reduced, so metabolic efficiency can be
maximized [1]. However, patient cooling is not without consequences
and shivering is experienced by more than 70% of patients achieving
TTM. Because shivering triggers an increase in metabolic demand,
causing additional oxygen consumption and the promotion of
catabolism, its prevention is ideal [2]. We set out to review the data
surrounding the anti-shivering component of a normothermia protocol
in the surgical ICU (SICU) of one Minnesota hospital.
Methods A retrospective review was conducted looking at SICU
patients managed with a normothermia protocol, with particular
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Figure 1 (abstract P502).

attention paid to the anti-shivering portion of the protocol. Serum
magnesium (Mg) levels were assessed prior to initiation of TTM and
Bedside Shivering Assessment Scale (BSAS) scores were collected.
Results Twenty patients receiving TTM for TBI were evaluated (March
to October 2013). One-half of the patients maintained targeted BSAS
scores <1 for the full duration of TTM (n = 10 of 20). Serum Mg levels
at the initiation of TTM were observed to negatively correlate with the
level of shivering, as indicated by the BSAS scoring system (P = 0.02).
See Figure 1.
Conclusion The literature suggests the positive impact of TTM on
patient outcomes can be maximized with shivering prevention [2].
Current SICU practices provide a similar Mg loading dose for all patients,
regardless of baseline Mg levels. In our observed patients, achieving a
baseline serum Mg level >2 was associated with lower shivering scores
throughout the TTM course. This supports the hypothesis that serum
Mg concentrations prior to TTM are important predictors of shivering
reduction, and suggests that loading doses of Mg should be tailored to
the individual patient to achieve such levels.
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